<SEC-DOCUMENT>0000927653-22-000017.txt : 20220203
<SEC-HEADER>0000927653-22-000017.hdr.sgml : 20220203
<ACCEPTANCE-DATETIME>20220202174112
ACCESSION NUMBER:		0000927653-22-000017
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		79
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220203
DATE AS OF CHANGE:		20220202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		22585072

	BUSINESS ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
		BUSINESS PHONE:		972-446-4800

	MAIL ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mck-20211231.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:b0c4267c-1381-4f10-888f-434d9ccb5c99,g:6c581a7b-6b71-4a88-8456-a4823e8897d4,d:4a2b465c28834dc9a8864e8f5f9a3d9a--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:mck="http://mckesson123.com/20211231" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:country="http://xbrl.sec.gov/country/2021" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mck-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80L2ZyYWc6NDljMmY4NGViNjI4NGU0M2FmZjFlZWE5ODZmMmE4MWUvdGFibGU6M2U3NjVjMTgxYTllNDhhYzhjNzQxMGNiZGM3YzIxY2EvdGFibGVyYW5nZTozZTc2NWMxODFhOWU0OGFjOGM3NDEwY2JkYzdjMjFjYV8zLTItMS0xLTQ3Mjg0_2035bfc4-e0f5-4856-873d-2387499c755d">0000927653</ix:nonNumeric><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80L2ZyYWc6NDljMmY4NGViNjI4NGU0M2FmZjFlZWE5ODZmMmE4MWUvdGFibGU6M2U3NjVjMTgxYTllNDhhYzhjNzQxMGNiZGM3YzIxY2EvdGFibGVyYW5nZTozZTc2NWMxODFhOWU0OGFjOGM3NDEwY2JkYzdjMjFjYV80LTQtMS0xLTQ3Mjg0_9561dd20-a794-4451-80f8-5ceb1a99c431">03/31</ix:nonNumeric><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80L2ZyYWc6NDljMmY4NGViNjI4NGU0M2FmZjFlZWE5ODZmMmE4MWUvdGFibGU6M2U3NjVjMTgxYTllNDhhYzhjNzQxMGNiZGM3YzIxY2EvdGFibGVyYW5nZTozZTc2NWMxODFhOWU0OGFjOGM3NDEwY2JkYzdjMjFjYV8xMS0yLTEtMS00NzI4NA_c90ac5eb-1914-4d87-91b5-5201fc6d110f">2022</ix:nonNumeric><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80L2ZyYWc6NDljMmY4NGViNjI4NGU0M2FmZjFlZWE5ODZmMmE4MWUvdGFibGU6M2U3NjVjMTgxYTllNDhhYzhjNzQxMGNiZGM3YzIxY2EvdGFibGVyYW5nZTozZTc2NWMxODFhOWU0OGFjOGM3NDEwY2JkYzdjMjFjYV8xMi0yLTEtMS00NzI4NA_52b4c80a-100d-4f77-96e4-8f73f8456f78">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80L2ZyYWc6NDljMmY4NGViNjI4NGU0M2FmZjFlZWE5ODZmMmE4MWUvdGFibGU6M2U3NjVjMTgxYTllNDhhYzhjNzQxMGNiZGM3YzIxY2EvdGFibGVyYW5nZTozZTc2NWMxODFhOWU0OGFjOGM3NDEwY2JkYzdjMjFjYV8xMy0yLTEtMS00NzI4NA_8f979932-bcf3-4b3f-9f56-6555e9eb8d5e">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mck-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42c76eb99b0a4559a5de3adcd86f6edd_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b63e34ea5fd40c091185d9028f7ce9e_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88eff9c3909e492a8890b0de1ca7a9a6_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i653ff56b96724c2aad5d2fedce9f8538_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iafc802238be540dba818f29ae266827f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i439966e71d2144ef842f55e3776ff357_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8436ab31a1f04277a0978cc5082487d6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i700f01544539495e9ffcc43f6df2519a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1be4875f550d4562b96d61a975ce1384_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida99689579c54617a262daa0e8430ed6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68c571fe607348cdab2a44a5f011467b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1ad330dab834c37a1beaf31343ccddc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic47507086542449a87995a47b6731b7a_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b2766918b80463a9b60d65600e7b809_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b8216d3c52941658551f660f72d6248_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd7e5ba6748444768519a57ab6d455e1_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51890ebfb4e6484b85eee1fcde455801_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccaf4a3f07d140fa8a374c7d818db2c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dc60e1226cd4fcfbed4ac8715e43490_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib041b764acbd496ba6cd257448c9a6ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i954d5ded78d141c1aab9b2f0e240b4e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic820959a12ab4a0bae3278102cbe3604_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0187d0ab0c2b497ba13eb86f09ee7b1d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icea0e96cfe3d44cabedc838f2e613c8f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia38d606928fc4b3db6f2c28bb6975efc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bf3b3d119214ddc994b0fa424595480_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5708808d3fca428a8db75e932c0ab1ed_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6da59171484d4afba5f49534b2709456_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b44821ac2c64fd7ab23957aaf69ef0e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29dac400581c4ad0a015f1f22afc419d_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i395b68d034cb497d9e909bd37a723bb3_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie535baeb0dd347cd978917e66bf4f610_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8bdea9022ea4c33963371f1d4922ff7_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c35edcf7a034a8083f41df320050fd4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic093d490b58f4f6da8f7e05176f1fcb5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44427056526c458db776d32cda88d623_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19c25b891e2446a6bab4b8ee69b28057_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d421e0224fb47f8b7a8dc9b60947bdb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64318d5dd9f1472c90248ebb8e0becbf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92b029a90e9640e6a41de2c763149aec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacce3d46e1114af0a96f49bb08fb9657_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d4a47e592514d34b5bd2a736f25f14e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i140e091483a24a50921565a4f50f0bc6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd1f982f3f4042c9badc91a36fff0cc1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id250b6c030544199b7220d3a2aca9cc0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0d467e35eb14c31bcba781b26964717_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if543dc69884c4140a12003d1148abf8b_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b0c099b1c004a6c8a540a2430721bbb_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9f93739e19b4aafadc89d067d383156_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i178f7de2928e404a940f4fec020ed2b2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f5ef3a9f2864706b17af4a3663282d5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i196e981a1d044679b7aa89e65f24dc73_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebc1818efd944fffbeda92744ddd19d5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9df402b98dd84868a1686daf16596424_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i805c937398e343ddbade7f441c4786b9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cd3b8f0b9fb4e3b80f26f6a286a8c4c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i608ff3c7e46a422da1a3bca44aba8bb7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i746a7ab451924975842c08464b7c24d1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i705e588d2f514ff7bd717969c76affb2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3486e22c3b4e49d2a3c85ce54a4b1ef6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bcf0ae780a4416aab58b011355b0f70_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i646e69bc99874247b6c06d6a96b329e7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec61b139f8d42da8e958f556f58020e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7cfe7694bf045d993d3e0e6ac8a85dd_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8d647cddebc42c3a78ef89fe06d1cfa_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49683251f292481d9201d661f7720626_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c6fe05296e94ff8845fee715825c659_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8d1cfbcdd084d568e496e899582fa21_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2db64a62c8943349987209b0adb60c1_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>mck:segment</xbrli:measure></xbrli:unit><xbrli:context id="i309bd0e5ce434017a3985a239297e197_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if55a1f085e0849c78909dea0bbe21536_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e504a0e274543e69fed9f79303ad80e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe12fecbb15d4762ad018564eb3bf31a_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bc2bdbef58a40d19661323d7b54990c_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddc5a92071754307af41a34bc9c1f1ea_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64c3f8f2f25f4734b8e1b0d9bbbae72c_I20210705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b4ca1a6e16e4bbeb9da4a62c3265a52_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if374ea59631143b09b6e3e2a5671193c_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f779261e3804b478a035d030ffeb926_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternallyDevelopedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aadd60f8b644a8ba5a20fae10cb7b86_I20211101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a2ecac161104759a17bcb76d94a2b91_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b6587768d5e4ba2b267df62494974ef_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf6948803676498cbf4f702d46fd11ac_I20211220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0914720c662a4ad59b56ab30f003e13e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90d1e84fd58d41a08c7559556cfa6e5e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e0e546ae1e249039d79b3c361e64a24_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i082db05a184a45abb24328a6c95b59c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i890b4a0eb5514ad49a5ab0eda1744e3e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i278171a6be044601b82b45db97c44012_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67f5dae20f6d49a8b3c72b65242baec8_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ef12d06d22b408b9631eede48f318c6_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if17bd5af058345ef8f80c5f477b1769a_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6255fa153b8b446d9bdaa92a69dc6082_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie95102b563614313b48519acd3293019_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3742a9e3c767428ca709e210fa6bad34_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0a87db44d0d4d4182e198de1c5b21c4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8294a77ec53f4808af02d30170fb109a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf0b19c69df049fa808f63371bd26ec9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05d03e41b9ee4dcd81af0575a30e3f45_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bd134a4f3094ace932c748910dea417_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa2ddeb82199484c81ead365111b0450_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80e1a134cedf416a93e2147fb33ab4a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8490ed3cfc74500b6dec809af6c38fb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0f61357f5234a798f4dce41029f5202_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5673a7452c840fab96c68406dedc263_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a02716128214d2eb9f7820b420c8182_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia211c26831c34274a5c1964a280c0daf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74ddcf1aa661488db155891acc773561_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i009f49e0941d419aa250d05631fa2fba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c351ccf073b47a9b3c10a8e07901940_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i53948167a7da4f68be6121c6d4840331_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i262128f4e5f940ada5343a7bf5fe0a97_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupAndAustrianBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f49b1ee7cfe4b72a4014ddd42947be3_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupAndAustrianBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b6bcdc79602464fb68d237e91f2c420_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96393cf84f184dd1a34604191f7e8463_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45576a15c2784ff6aa60281bbbd7fc94_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36b8a9d0b6414497bb8f44ec79a79e4f_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i36e918c6183c4f78895df724b9cd04c0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ba029fe46a542dfbd04dc832ae15366_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd6ba103380e4fe88bf3646afc1959fd_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29833bf67ca6476e970b86ed97f2e301_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74388bba79ec4594ae5515983a877ddf_I20180919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92bc310247354b8c924fe8c7f5b5b506_I20210412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3993b3a21a449f38c8b6792da95b13e_I20210412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic547f16da1eb490b8049506b5f0658f0_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a074287e0774fecbde0c96584206770_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eb5d4844c44421d8fe111518bf52e1d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9fe220da3a84c2a9f05f0cdd2906fd0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id82faee2169b4c03851f9e48fd63456a_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa26af6e2fc04c6da537c566605c6805_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd14b94896e64108be04ae3457f1a609_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13af6ba5a424438aa3988581a89555a8_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c40279fd2ae42f882d256f241b6eeb9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfbf1847be9645d4a2fcb3f516d062d2_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00c5c61ba79d490583932b1ea0ae6fee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i966a1c60d7794ac19c4b0482afbd9d63_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie38d6747b6b2440cb19da83a637e8e0c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie23170f25899482c8fb14218e9b36811_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad4dcc2e71484863b95577492db41418_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f407b53967e488c8979843a9f2e0587_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31bf4f7d1a23482c831cafb66e4eeb11_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia20f2ae234824563aaf020230203bc95_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85920522622d4e87a1778b8915896cd9_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i429c33e0c248436d9d40564788aef7cc_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17e68fc5432d42999abbd9cfb84788b2_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd7d6c6918264060a11449cce87c8a74_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c44d406842b4dfd9be43d9417c45d16_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aad64ed07e840d48b824f939696d040_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4a94e99c27749f9bb0cdf58b9fb0d21_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic904723c4ba64a05ae420a0be5054017_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1152c87f165d4441a106e92fb010eee7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5b0a5563e78433e81c99f7828894e50_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd869a8aa917470b91d673083a1c9728_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcceb81b10094fe38a52a708698e8e26_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4fff6966c2f4bf68a5a99a525be017b_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8581c40a6994c56adbfa16cef30adce_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe27bfd9e2c41d58630861c22b41289_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32326b7bf53a4dd384901e9903f9bba5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd6a711404a649daa658dfed92674336_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d3dae03307347b1aaa7f9adb1a1146e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c38b50f2e6d4df48e12878cd04a1f29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5940c64b0f72408a95d2a120f5c0cb9d_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib25c56b1dc1542b8b6cba0c5909ee061_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f9282a1be1949719baad2d71826d505_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74ed405c42b74c4389c3f91f5005ff7a_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5ddfbf05bb24ccba4c97a3aa8391604_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec8b0c080d464091895e0a8629dc3b8f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4867f847dac14e859a18453f84be838e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie340410ba12c44e9911705e385d3b53b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb766b9c9d944af29da2f7e212da9b0f_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6350e24aa5bc4ecdb728677b7257e206_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e6e140e0372458c969bb39e40eb721e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa5fb8b105594c8e8a3005b94b561d93_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabb0392b7148487bb4a2f65bf6026803_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93c95e7a4b934ef38d46deb03522e7e9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7552b3f9fefa4753841e20f4ee183f59_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib39a321c4bcc4b6cb3698d1b56855f45_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i373201c35c334793a8e487531dd13808_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5f3b27c39db4b379168925a74818f88_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanAssetsHeldForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8746bc225334425396ca59f548e37a0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e16308e8f8a44b0b56714da70bdba87_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3131096ca12e4ff79f710ef33e1fad9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4460ad7ee7034da6ab6577545bb4e0db_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia93f81c5e6b04232b2292683ca038221_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if114852dcd424e71925af80e34de7a6c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3719b3f8d244ac494c2824c0832d07e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9174bf78e06c4f3d84ca5ac5c9b2aba5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f726c763f9a479b8e540f1c1a4b7bfe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfaf4e782dc9445ab195eab4ffe8ab10_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f67c3e22d524b2bb83fd6759a331308_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia28dcbf6b06649eb9dff2cfa25450e96_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e57c87f990a465aa51e7b583931c71c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88366d3c093b4dc49a21a6e0db895a8d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02cb6f0f6a454110948073b47a98653b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i586efb75ab5d463cb59b296f08231f94_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc040bd3b61f4ac2897cb464802aff8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d47528c190644909c718b0fb28a8991_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18921a55bfdb4914912bf2fcd15ae90c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i109f3a112c2942a89945755f920801f5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9237fc120ce474f8df6c1ab559748c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idce1a776f3f4491eaecf73c69740b2c1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib02bd64fd220450cb919b052658bd225_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i980877648a26404c9f3f88facfab3a12_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i594a4fdaee3b4bb29cfb65eb877bdf18_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd138e409b7b4f81be9450bcf3b931dd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40926358e8e740acb1b20bcaef8dbb44_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ca68483b5e748d296466ae242322a5b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i792e3f3cd2194564994f887fa0311091_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i069e5020023e41c2aedab80fbb7726b6_I20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dde3db75bc9423db7d08caf0b284aa7_D20210812-20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6122fb9648ed4fbf9da45b3e8dd631d2_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31809c12d9a9402ea8b76662fed12284_I20210717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd10c718453c405e97d6ad84b80e8fc1_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64f43622e576465e9b38ab4c248303f2_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia80e8f219b104e7b8095a386e548a730_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfb5001dc67f4f8a896d6c6104d869ab_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i610e62fc020849aaa1514bb64ecea83d_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a21be0ee8945e1bc0d1cb119b3e6dd_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fbbaa7c754d4333bc9a4584cc99c906_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbb3c18dcf864424ae20c2a6f59a05a6_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-23</xbrli:startDate><xbrli:endDate>2021-07-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41cdbb2354254500bac2539b51ef63ea_I20190925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fde2411c1644621b3365876316b4cbf_D20190925-20190925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-25</xbrli:startDate><xbrli:endDate>2019-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8665153941be4bb7b02bd203a47d4f00_I20190925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0f0596aa0084e20afa89597288e93c4_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b04286cc90b410990ef32577b13b1cf_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5854b4d082a04d84aa8c864577be8b31_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07aa03a3cf46464cbc26feec1d3d32c1_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6953458f6f674d6ab890f86f4cd4f38e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dafe850daa44ba092c57047f0ce2877_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89b9210a5ce84d4c8f57ef708a9e06d0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb82d8e0e0254d2e8fef071a792829d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if95be6cfe924456c8da8cea9e5d5e974_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief157ea0a56249a692efe8e3d4607fa5_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1fc9c20fe7d4693bf05d2692768da1f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f3051bdb38143259288f549f974a0e9_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i090754fc8e614e6bbad26c7f79ea2655_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fd478d8076c43f6abb4a6dd08e769d8_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4730e8d997974abd8395c6ed22b656fe_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2d4d8bd24764afda92f5b33e18eec02_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:UKPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b06140a4e4b45c08325af13b9477bc5_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:UKPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96f5c70408574f04b15b2f7ec7679bb4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a47389171bb414193fe6314b964f7fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e8c8f89b9ff413690a3a67eb1468bb1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ed6b36701e4a04bfe99fe455ef93a9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3f95e7d8ccb40f9b9eb2820e1c96850_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib56a0acb015f42a9b6db7d566e4d694a_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0fb12228284472bb3616ebca5add51a_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c56745c1ad842ad90cf4a2cd11ebec9_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i306448d022c44df8b4a9d9a3a303bd36_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="i4fd28eaef6c94a969cb3718719b09b86_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id80470ece115487a90c8e9f0d8fa5909_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0562d50847594e68a2ad757563e23331_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if413ab2045f7407d94fd20c0c60e1710_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i096c4c0268604806b329bdf3f18855cc_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0efacf445fc46d1b3325b78010882fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab7a4eb1e70b4fa1b361a9b44cd85bf4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29742682b8ef4a26affbcf74cb0801e1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65f089e2f1a9456e92ea3681ece4ea46_I20200427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0079095dff44d82a99df4fa0de3968c_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i759ece90e4a84418bd88eef741535d3a_I20211104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32ba2d1a45c445c583e6de9a264e133b_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17d15431fbc54c0ca88b62ba4fa8a2af_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieddd952970aa4ffdac4cb0616cd91e55_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0f2aab0d3e545aeb80528ab93b0610b_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cccab8b5e8e4f7eb85e366050dd0c6e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31ea48b5b7c94d91be10ded715dc2ed7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91a4aa2234e64d5492f8ae8c66bf803a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i952999021b6746f7bb3d33905898d07e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9e7d0745bdf49c39fe6e13e746c332d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61fc3b32631340948c814ea6d7f2e4bd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24f081c15f3b4160a10acf6eb389de1b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i319b6b970e834bb696c416ea5807f857_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1586fe22fd6646a0a008cea296ca2866_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90925257b3bd4257846aefcd6879fc30_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44441409ce5e4ca6988aff06c61dae4f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3caf14c9bd64234ba322f53161f25e5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e6556feb6b14585bc7a63dbc68b457d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fcadcad601441e0af45b696a5ae82cb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i547bb2984de34a9496536b9a8f7fb1d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieac471f0e5ea44638e9f45f235e28103_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63bb1d026acc4fe6bdcd0573dcf77353_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57cdcb90e9d24ccb8237b2d0adc78da8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie81c569998f846eabdd329f198f8fb80_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if71186c9249547a6bb4645f7ef5e00bc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i058558a97c0745aaadbecc089580e6ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5fd50078c2b473ba6fa21c1d3fc3a83_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia57f313fd26c4d74b79a639aec5953e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic780468f2c1a40329586136abdfe217f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b6ebdeadc4946d3be80756e21be72d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mck:case</xbrli:measure></xbrli:unit><xbrli:context id="ic4f1a5ddaf4d4944b94efda2a00dba4b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>mck:state</xbrli:measure></xbrli:unit><xbrli:context id="if18621054cc940498e59d84996888935_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="stateattorney"><xbrli:measure>mck:stateAttorney</xbrli:measure></xbrli:unit><xbrli:context id="i2c8b3f7cefb949109e7eb1c36b7d7bc5_I20210721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="distributor"><xbrli:measure>mck:distributor</xbrli:measure></xbrli:unit><xbrli:context id="i29032cc93762461290c629af975e89f1_D20210721-20210721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-21</xbrli:startDate><xbrli:endDate>2021-07-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccc8e044a04f4f06a7102fd769862177_D20210721-20210721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-21</xbrli:startDate><xbrli:endDate>2021-07-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63ddda3383cb497a8aa380352d746509_I20210904"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1bd51abcbd045cd983975696083a0d4_I20220126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="territory"><xbrli:measure>mck:territory</xbrli:measure></xbrli:unit><xbrli:context id="i4c5fee0b311f4c85ad63d103f1e8aa63_D20210920-20210920"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-20</xbrli:startDate><xbrli:endDate>2021-09-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i649beb76d86943469243e3ece439fa07_D20220125-20220125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-25</xbrli:startDate><xbrli:endDate>2022-01-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6421afdc7756406892c7733f92c74bf9_I20210720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9571ebfcfb4243d4b7416b6bf1f52242_D20210720-20210720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-20</xbrli:startDate><xbrli:endDate>2021-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2de5ab2204a4239a0132d31018e9977_D20210720-20210720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-20</xbrli:startDate><xbrli:endDate>2021-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad569f2cde004174b037e2447153313c_I20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOhioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cac7c85628448f5aeb6a8aa1a8dd896_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOhioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dccdea006cd4f81805e1bde772196ee_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOhioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82197fca02554991b73acbc4d68ccac2_I20220124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfRhodeIslandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic684bd89db914674b6775e7c4d69f963_D20220124-20220124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfRhodeIslandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-24</xbrli:startDate><xbrli:endDate>2022-01-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i643abe1e48c24a8aa9d02dfbe10b9c8c_D20220124-20220124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfRhodeIslandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-24</xbrli:startDate><xbrli:endDate>2022-01-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c604a712f64457faf00ef87a115fbda_I20220128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfFloridaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2df648f57fa54b56a5008f3783b93493_D20220128-20220128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfFloridaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-28</xbrli:startDate><xbrli:endDate>2022-01-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if78131496b944f1cae74e5708bfd519c_D20220128-20220128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfFloridaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-28</xbrli:startDate><xbrli:endDate>2022-01-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdab83fc6b78425a832a4ba53f78811c_I20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if72c9e5652044d418c8a4b5883f5f283_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd87c8cd4564444caf1bfeedc9bedcad_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6b31bd1cab64e2aa516e6a01c17aabb_I20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a960216fc5047ae9856d959b0a6c287_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eaaa89dea4740b0bc8eb0ada92ff0b3_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85eff5aee4c3446698c4907a3978d21b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a2ded36405146879cf86872b0b24b1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16fa32e7eb8c4c528a92f587159347b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:GovernmentalEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ca435af43514f1eac1c81fefbc999f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b789596251942f2bfcd923a95ccdf00_I20171229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="investmentfund"><xbrli:measure>mck:investmentFund</xbrli:measure></xbrli:unit><xbrli:context id="ie3c0a2798de8485c9bfc70f3983c4ff0_I20171230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e0bc32bb6704e56a7596ad34859790f_D20130416-20130416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelPiacentileVAmgenIncEtAlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-04-16</xbrli:startDate><xbrli:endDate>2013-04-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="relator"><xbrli:measure>mck:relator</xbrli:measure></xbrli:unit><xbrli:unit id="defendant"><xbrli:measure>mck:defendant</xbrli:measure></xbrli:unit><xbrli:unit id="vote"><xbrli:measure>mck:vote</xbrli:measure></xbrli:unit><xbrli:context id="i4e3b4356f92241a79cba33c2ed751c94_D20210722-20210722"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-22</xbrli:startDate><xbrli:endDate>2021-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dfc838eb1ac450fa9327128ad95b9f4_D20210723-20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-23</xbrli:startDate><xbrli:endDate>2021-07-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4651daec0fcd4008b8fbcb1cba4827c1_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i843f7e95b9d346549a854382391ff392_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib17c7ffbc55e498aa48c293d6f774907_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if205d6ef74be40cfa4f1e33f2e553e47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ed2ad6a9a9245ffb0210d01707cf604_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0933f1ae15e649a1b3f3599aeed9843f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f96be18861e4831bbe49116594b08c3_I20211208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i540273ce247f4e77bcb256bd6ff2edea_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i054b314a3e2a4b9d9bc83711755c16c6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b65ae2097be4ee9b04fbfebc350aa5c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea19c1464fd3431fbfd6ec399c1e71c7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f08193bb90c44f6ae9ec36df03a265a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia35d1f63c33540bea2b1ae396c7e4d9d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a19c7ce388247dd9c4fff8563e46afd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5033f6f00844a00b920db06167d72c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb80f013f5b04877be046df73b8ea013_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica87d626efb840368fbbe575e025eb74_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f90b71776b5462a8d1be5c313a0e1c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7225d41e4b98447f94299cb918d544af_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ed06ba2cb5a4c79824d9a614fb48e1f_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ec1ab358f1c44c4b1d28bfe361d9694_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a7350f891f34c389f5314b093c80f47_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4cae94d5a4343dea4571122ba91a7dd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc95fc7008f24256bb487870b5b105be_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i884c5bc5307442deb92721feb1328c24_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddd5269e4982442faf5d718821e185be_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idac086104fd949cabcf4563c6be329c2_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i213dfc02855e4772998e42a0ea099c76_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70cfadc2fd5f4b4a9277df704a122f06_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13b43080a3b24a16ae2b97ea91852b4c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5cec83dac43442fb28746e2671aa4ef_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f84efb755fb430185527dfc44d3694e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73ca4490ab994f9aab3a6fe25a21c69c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f489db5b4e04093bf6487d97631d28a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb666f100afe4890aa66b7e618e14266_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8ce0eeffaae46c29688d5a5b4ce0c65_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e495f371886450bba3a39c61d7905dd_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia33af281a8774481b036a38c796706ec_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76a341aced7248cd9123b95a14c8a92e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c22952abf9142609c8c89682fe068ff_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e78796fe5fa418093c4d5c12a166c69_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if03813c6358648a394e5872d25a93782_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cfcd79590b140b1936d216597d97299_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8f475edd8834ac5b7034c3816c08c6b_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e50b6a1f79d4e56ac4b54c8d2eae50e_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice5d0a8bd1a546f9bd990cd472b21d74_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>mck:product</xbrli:measure></xbrli:unit><xbrli:context id="i196f51a7ced74f518fa05fcb8b2e53bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>mck:country</xbrli:measure></xbrli:unit><xbrli:unit id="business_operation"><xbrli:measure>mck:business_operation</xbrli:measure></xbrli:unit><xbrli:context id="i9da13a8ac8824096b8684170e319eb8c_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a3c9d231a79420980fb15fd08fb296f_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6926dac9087a4729876428bc63b1680e_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id99d6b8c9b1d4b43b119e8ff00e3fdf7_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i538bea40557c484aac444eeb523f853a_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d5729dcafe64c6b8bf4d8ca0546c7a2_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4d53e061fc145b591fc79c6361e5475_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9752827ca2c41efadc1fd4270e49ff3_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27ff3ca362ce4d138f3855742853ed06_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieefe2d7dc09b481daf49a5152e7f4971_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e45b6151afc4cf1bed1110c1034f5c6_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia429fdc9639444a39fdf735d731eed0d_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70cbdd4364d74ecbb61747d6ff39ba0f_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i924634ae29da4f73998a60b0bbcf1083_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c361f72849a4e38a3998abb4c3cd3d1_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10248887c7a5482389fdac7a1610cf69_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i535080de97454a9fac988b095055839e_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:AntitrustLegalSettlementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7b7e620d7a14950b39e853f79b975ee_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eda82f8d025454abf73c560d50c29b3_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i826a607678f54e2a86f5a30f297b657c_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id15b966c53f8432785b54e03b4585bb3_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83044c196239439998e7c6a17739816c_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia091e797b3e14a3f9b725a69bf843a92_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9c32c72ede24d538c9aaaa3b64848d1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e5e6c1fd605455eab552c5ec9e5d777_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i987a6d37125a48a0a90ff128963d4df6_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cf49f518ed74829b2b4b51a44b670a5_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e881354ecc94f77a5d413d65a33f8b8_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24f8b8a283c34dc597297cbaa2899171_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd5e0dbe10d64b948193be43501d890e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74f39cabd47c4d089eb231a7347761c6_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be96b105bae4665a5c985276d810148_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eb76a4477ee48c8a318ceb3d69a0f20_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7173dc2a4c04d2f81bcc70922723445_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ShareholderDerivativeActionInsuranceProceedsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec63485adeb64ac4b82621f5ef551144_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesAndDebenturesExtinguishedFebruary72018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;           &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ5_2bd2ea44-e7de-4dcb-9cc1-1262ee9bbc91">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NGNhYjJkYzVjODAzNDgwYmIzYzQxZWI1NGU5ZjQ2M2UvdGFibGVyYW5nZTo0Y2FiMmRjNWM4MDM0ODBiYjNjNDFlYjU0ZTlmNDYzZV8wLTAtMS0xLTQ3Mjg0_a80761b7-6690-4cf5-b0da-11f6de63bd65">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18xMDk5NTExNjI5OTc4_db930471-8205-41e7-96f1-60888df446cd">December 31, 2021</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NjZkZDQ5ZWIwMWM0NGVmOThiYmRlZTBiYjE4M2RiZDkvdGFibGVyYW5nZTo2NmRkNDllYjAxYzQ0ZWY5OGJiZGVlMGJiMTgzZGJkOV8wLTAtMS0xLTQ3Mjg0_90e4204c-2e23-4121-817c-474139de0662">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQy_55f37f18-4754-4d17-97da-484b055b0011">1-13252</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><img src="mck-20211231_g1.jpg" alt="mck-20211231_g1.jpg" style="height:29px;margin-bottom:5pt;vertical-align:text-bottom;width:196px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ2_d8cb374b-f2e5-445b-9150-0bef4976b61d">McKESSON CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NGMwNjY5Nzk2MTZlNDM1YWExMDhlMTFmMjZkZDkxNzcvdGFibGVyYW5nZTo0YzA2Njk3OTYxNmU0MzVhYTEwOGUxMWYyNmRkOTE3N18wLTAtMS0xLTQ3Mjg0_8c31e30b-ecf5-4f34-ae01-5c148cfcb04f">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NGMwNjY5Nzk2MTZlNDM1YWExMDhlMTFmMjZkZDkxNzcvdGFibGVyYW5nZTo0YzA2Njk3OTYxNmU0MzVhYTEwOGUxMWYyNmRkOTE3N18wLTItMS0xLTQ3Mjg0_22333edc-c8e3-46e5-867a-4f7c3135d350">94-3207296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQz_7098b0bd-9832-490c-b387-ca29bb332f60">6555 State Hwy 161</ix:nonNumeric>, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ0_7865809e-b00f-42de-ac12-d1cb815802c4">Irving</ix:nonNumeric>, <ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTUw_0ce21753-1073-49e5-8e9e-46c0b583b71a">TX</ix:nonNumeric> <ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ1_653c09ed-c9e5-4f89-94b7-762f00a0e220">75039</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ3_84fbdbb9-29b6-4d5c-a658-c6f7a5b4140e">972</ix:nonNumeric>) <ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTM4_f5a0440c-7fce-4913-a8f7-e9fbe7187f30">446-4800</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Title of each class)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Trading Symbol)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Name of each exchange on which registered)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i42c76eb99b0a4559a5de3adcd86f6edd_D20210401-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8xLTAtMS0xLTQ3Mjg0_eb887261-af24-4dce-b4db-c755227b83a7">Common stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i42c76eb99b0a4559a5de3adcd86f6edd_D20210401-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8xLTEtMS0xLTQ3Mjg0_dbf117ef-c8fc-490a-afdf-f3ab4634b3d2">MCK</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i42c76eb99b0a4559a5de3adcd86f6edd_D20210401-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8xLTItMS0xLTQ3Mjg0_c1c59316-fb67-4c5c-9deb-aa39a369b842">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6b63e34ea5fd40c091185d9028f7ce9e_D20210401-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8yLTAtMS0xLTQ3Mjg0_f5feb609-c9cb-484a-95aa-90ee464faec7">1.500% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6b63e34ea5fd40c091185d9028f7ce9e_D20210401-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8yLTEtMS0xLTQ3Mjg0_ff8746e7-f895-447d-b8e5-7aa40f212da4">MCK25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6b63e34ea5fd40c091185d9028f7ce9e_D20210401-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8yLTItMS0xLTQ3Mjg0_8181f070-e442-4307-865d-2fcb2ba6cfa6">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i88eff9c3909e492a8890b0de1ca7a9a6_D20210401-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8zLTAtMS0xLTQ3Mjg0_949af8b0-595a-424f-94ec-b62043bda40a">1.625% Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i88eff9c3909e492a8890b0de1ca7a9a6_D20210401-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8zLTEtMS0xLTQ3Mjg0_4b9901e8-e350-4989-b3ad-10ee3a5860e0">MCK26</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i88eff9c3909e492a8890b0de1ca7a9a6_D20210401-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8zLTItMS0xLTQ3Mjg0_e830d31e-c83b-4601-98a0-9e63660facf0">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i653ff56b96724c2aad5d2fedce9f8538_D20210401-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF80LTAtMS0xLTQ3Mjg0_fec4b129-6f5a-406f-b890-9b5f3a9ed397">3.125% Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i653ff56b96724c2aad5d2fedce9f8538_D20210401-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF80LTEtMS0xLTQ3Mjg0_2527e468-fdbd-4821-98aa-388fc3d36d39">MCK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i653ff56b96724c2aad5d2fedce9f8538_D20210401-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF80LTItMS0xLTQ3Mjg0_029ab1b9-533c-410b-8276-7f89453254e6">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTM5_93293f30-b401-491b-817a-e5454a783d21">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQw_a74f677e-656b-4120-93d9-67480e136f91">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:29.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.278%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.920%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6MTc3NWU4OWRiZmE2NDQ5YWFhZWUwNmUxZmY3NWM5NWUvdGFibGVyYW5nZToxNzc1ZTg5ZGJmYTY0NDlhYWFlZTA2ZTFmZjc1Yzk1ZV8wLTAtMS0xLTQ3Mjg0_b2f958ea-3d19-4379-a354-8ad0d9a10ff3">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6MTc3NWU4OWRiZmE2NDQ5YWFhZWUwNmUxZmY3NWM5NWUvdGFibGVyYW5nZToxNzc1ZTg5ZGJmYTY0NDlhYWFlZTA2ZTFmZjc1Yzk1ZV8xLTYtMS0xLTQ3Mjg0_b886cf4f-d833-4663-bef4-0437f1b3544f">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6MTc3NWU4OWRiZmE2NDQ5YWFhZWUwNmUxZmY3NWM5NWUvdGFibGVyYW5nZToxNzc1ZTg5ZGJmYTY0NDlhYWFlZTA2ZTFmZjc1Yzk1ZV8yLTYtMS0xLTQ3Mjg0_c075d42d-ea81-4cc8-b803-a13e5d1f1acd">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ4_87fa46e6-ce76-424d-8682-cc2629b4c96e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date. <ix:nonFraction unitRef="shares" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMDcy_535abef5-b18b-46ae-8761-387814aa461c">149,798,378</ix:nonFraction> shares of the issuer&#8217;s common stock were outstanding as of December 31, 2021.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_10">PART I&#8212;FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_10">Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_13">Condensed Consolidated Statements of Operations for</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_13"> the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_13">three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_13">nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_13"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_13">months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_13"> a</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_13">nd </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_13">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_16">Condensed Consolidated Statements of Comprehensive Income</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_16"> (Loss)</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_16"> for the three and</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_16"> nin</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_16">e</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_16"> months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_16"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_19">Condensed Consolidated Balance Sheets as of </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_19"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_22">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) for the three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_22">nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_22"> months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_22"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_28">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_28">nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_28"> months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_28"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_28">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_31">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_31">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_34">Note 1 - Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_34">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_37">Note 2 - Held for Sale</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_37">10</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_40">Note 3 - Restructuring, Impairment, and Related Charges</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_40">12</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_43">Note 4 - Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_43">15</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_46">Note 5 - Redeemable Noncontrolling Interests and Noncontrolling Interests</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_46">16</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_49">Note 6 - Earnings (Loss) per Common Share</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_49">18</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_52">Note 7 - Goodwill and Intangible Assets, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_52">19</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_55">Note 8 - Debt and Financing Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_55">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_58">Note 9 - Pension Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_58">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_61">Note 10 - Hedging Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_61">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_64">Note 11 - Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_64">26</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_67">Note 12 - Commitments and Contingent Liabilities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_67">28</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_70">Note 13 - Stockholders&#8217; Equity (Deficit)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_70">33</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_73">Note 14 - Segments of Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_73">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_79">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_79">40</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_118">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_118">62</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_121">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_121">62</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_124">PART II&#8212;OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_127">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_127">63</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_130">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_130">63</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_133">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_133">63</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_136">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_136">64</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_139">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_139">64</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_142">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_142">64</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_145">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_145">65</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_148">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_148">66</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Financial Statements.</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_13"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMi0xLTEtMS00NzI4NA_238d73c6-b777-4c52-b761-42444eb686f6">68,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMi0zLTEtMS00NzI4NA_01321167-a8a9-4afa-a05f-82693761eede">62,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMi01LTEtMS00NzI4NA_3b19c3f1-10d3-4a39-b4e7-5c1f63326a88">197,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMi03LTEtMS00NzI4NA_7b8da9ea-5908-4402-920a-d479e8f1002e">179,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMy0xLTEtMS00NzI4NA_f6f5a46e-4c58-439d-9e49-0d693671a7b0">65,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMy0zLTEtMS00NzI4NA_ff3ce8f5-3d75-4441-97cd-efcdef9967b0">59,448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMy01LTEtMS00NzI4NA_0679cd5b-672d-4a96-96d3-61a9894f8421">188,052</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMy03LTEtMS00NzI4NA_95288156-5ec4-49c9-91f8-2c601d476b7b">170,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNC0xLTEtMS00NzI4NA_0fd261c9-db27-48bb-9c45-65c98ffca4ce">3,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNC0zLTEtMS00NzI4NA_132c7a79-784d-4720-946f-de6beeb5aefe">3,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNC01LTEtMS00NzI4NA_061f8576-577e-4b86-bd5e-ae41e2ce79b4">9,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNC03LTEtMS00NzI4NA_4a8013db-e0ee-4736-97a3-4862be429c36">8,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNS0xLTEtMS00NzI4NA_72312112-d847-4e23-be1c-1699347d36ce">3,105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNS0zLTEtMS00NzI4NA_454d36db-bad1-4dc4-a677-e1d508d26a76">2,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNS01LTEtMS00NzI4NA_b025069e-f674-4ef5-bbcc-f6c460d382ed">8,006</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNS03LTEtMS00NzI4NA_c3d13ac6-0dfc-45bf-8892-a136bd4c4e2b">6,625</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNi0xLTEtMS00NzI4NA_6449b9ef-9039-426a-9dff-7d92ade681d6">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNi0zLTEtMS00NzI4NA_288aa1d9-e585-4fdd-a11d-732b1787ffba">8,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNi01LTEtMS00NzI4NA_e2de7b6e-e5a5-4f13-ae10-55eb89e1a7cc">193</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNi03LTEtMS00NzI4NA_7bf3103d-16ae-4752-ad87-bdef120824b1">7,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNy0xLTEtMS00NzI4NA_643630e9-0741-40d6-baa9-7696f75a8de2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNy0zLTEtMS00NzI4NA_3e47fbd6-2341-4763-90cf-e215c0c6ddcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNy01LTEtMS00NzI4NA_841f213c-0deb-4479-8b91-d8085f40dbf0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNy03LTEtMS00NzI4NA_15860233-13d1-447d-a102-ac268a29c588">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOC0xLTEtMS00NzI4NA_54b1ae3c-6197-44b9-8d0f-e0d0a33c25dc">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOC0zLTEtMS00NzI4NA_75175188-35d1-4200-87c2-75af8574c249">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOC01LTEtMS00NzI4NA_298973f1-8ace-41c0-b8f2-a1403028e2bf">208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOC03LTEtMS00NzI4NA_d7c59dd8-24a0-440b-9a47-5060f51bb9b9">271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOS0xLTEtMS00NzI4NA_6574eb38-33d3-4a90-bd58-269044d97504">3,130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOS0zLTEtMS00NzI4NA_0156c6af-7f18-429b-bd41-7129226d9f76">10,513</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOS01LTEtMS00NzI4NA_a57f56ed-3325-4a4e-b1dd-8234ce113b37">8,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOS03LTEtMS00NzI4NA_64852b83-e5ec-46c7-80ca-8d6672b52701">14,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTAtMS0xLTEtNDcyODQ_88f15218-30b9-4e02-91a7-ec7116e2d480">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTAtMy0xLTEtNDcyODQ_ddb4594a-3d92-465f-ac97-76e2cff20a66">7,362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTAtNS0xLTEtNDcyODQ_0eafde85-b612-4fb0-9629-b7b48f9ec0db">1,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTAtNy0xLTEtNDcyODQ_bbff9c59-7d05-4b3e-9174-efb09429de65">6,050</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTEtMS0xLTEtNDcyODQ_883e4d23-a89b-4aa2-bc5f-6b34191cf20c">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTEtMy0xLTEtNDcyODQ_0580916d-2211-44ef-863c-eabc9c7273bc">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTEtNS0xLTEtNDcyODQ_ac3ea19f-b317-49eb-9d76-30cc2d67bc8d">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTEtNy0xLTEtNDcyODQ_4daf8d4c-bb67-4e5c-884f-785f42d1941c">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTItMS0xLTEtNDcyODQ_39007049-d274-4656-ba43-f8dcca155ce7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTItMy0xLTEtNDcyODQ_67e7c3b2-c6e3-46e5-9ca1-781ed417040f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTItNS0xLTEtNDcyODQ_00d4e35f-7566-46b5-bb6a-c9091ce0c932">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTItNy0xLTEtNDcyODQ_73efcb8c-64d5-460f-8302-d907023d65ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTQtMS0xLTEtNDcyODQ_e7fb7fa6-1b4a-4810-a26f-77e39b242953">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTQtMy0xLTEtNDcyODQ_1c69eb09-5b5c-4229-8bc9-c47ec60fefcb">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTQtNS0xLTEtNDcyODQ_f427b8ad-f908-49c0-a0c2-7c3911f2629b">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTQtNy0xLTEtNDcyODQ_50318fb8-d284-4002-a208-40c35766b8b5">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTUtMS0xLTEtNDcyODQ_7d75793c-9da0-41f0-90ab-0304627587d2">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTUtMy0xLTEtNDcyODQ_6e2da3a5-5120-4d9f-82da-4ade6e64839c">7,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTUtNS0xLTEtNDcyODQ_4e174ec1-37e9-4219-81bf-7ccac94e4df9">1,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTUtNy0xLTEtNDcyODQ_0940ae3c-d420-473d-9ed1-06825be89e6a">6,063</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTYtMS0xLTEtNDcyODQ_3ae96190-d3a8-4226-b76b-0e550617d5c7">238</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTYtMy0xLTEtNDcyODQ_63eb641b-c260-43bc-ba5b-5615dde49e3b">1,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTYtNS0xLTEtNDcyODQ_24d71596-5585-459c-991c-7544f6183b0b">396</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTYtNy0xLTEtNDcyODQ_2aa049b6-4b38-4ebd-833f-e6c58a88da5d">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTctMS0xLTEtNDcyODQ_87c07a14-bc99-4f9f-9e0a-8efc2656b5f0">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTctMy0xLTEtNDcyODQ_a5f78eea-47bd-438e-b85a-0c78985789e1">6,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTctNS0xLTEtNDcyODQ_4eceb1df-a94d-4f95-8154-e4ac2a486d6e">885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTctNy0xLTEtNDcyODQ_201c74b5-b2f9-4062-99e3-28c6394f53d2">5,052</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTgtMS0xLTEtNDcyODQ_cfbbdacd-f97a-4874-8f30-c397f64893dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTgtMy0xLTEtNDcyODQ_83fa9e89-ae59-4e45-b4e8-59645807bdcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTgtNS0xLTEtNDcyODQ_025d8e19-5b36-41ae-8845-6daba1a55392">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTgtNy0xLTEtNDcyODQ_b5667315-ff36-4447-b6c7-ef7e29dc726d">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTktMS0xLTEtNDcyODQ_5a9b2c0c-ac77-4cb4-a41c-803e3b73033c">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTktMy0xLTEtNDcyODQ_59beedac-5510-4466-be2e-8129b0e01b9b">6,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTktNS0xLTEtNDcyODQ_10c4ff1a-08f9-4410-a5c4-a711e2e4877d">882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTktNy0xLTEtNDcyODQ_b6832923-8a7b-46e2-b336-778bcd523833">5,053</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjAtMS0xLTEtNDcyODQ_e7d17c6b-b4d3-43d4-bb2a-28e31d1a2e83">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjAtMy0xLTEtNDcyODQ_45748771-5d23-4c91-8e75-4ccb910350f5">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjAtNS0xLTEtNDcyODQ_8e5f665c-2456-417f-8253-c37271ec16e4">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjAtNy0xLTEtNDcyODQ_14773e81-7c10-4f13-a1ea-8742673836e4">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjEtMS0xLTEtNDcyODQ_125708f5-24cd-4436-8779-1cea9fc93f2c">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjEtMy0xLTEtNDcyODQ_01b6a654-13e9-47b0-b7a9-aeddcdc23620">6,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjEtNS0xLTEtNDcyODQ_8fb23b2a-5a4f-49e8-8d12-ce90aeaba4b2">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjEtNy0xLTEtNDcyODQ_8781f394-2961-48d6-b253-8342e0c8a183">5,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjUtMS0xLTEtNDcyODQ_ea51b969-8e9f-4403-8684-bca3961cd020">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjUtMy0xLTEtNDcyODQ_bd249b49-ca8b-4b7d-835d-128e60c05d8d">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjUtNS0xLTEtNDcyODQ_aaeabba9-2609-4c5e-9da9-9b0a04f66095">4.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjUtNy0xLTEtNDcyODQ_6c232c61-35e6-4b73-b9ae-487b1c9b6afd">32.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjYtMS0xLTEtNDcyODQ_d67f52e1-5094-42aa-9328-126ebc620ec1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjYtMy0xLTEtNDcyODQ_6dfdc0c7-1c27-4635-9023-0d00a72a3c38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjYtNS0xLTEtNDcyODQ_05f9fbd2-a2c3-42b4-a199-6777980b2067">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjYtNy0xLTEtNDcyODQ_99a9eebb-b44f-4667-a7dd-f8b422169f65">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjctMS0xLTEtNDcyODQ_dba34460-bf2e-4f00-814f-5abad97ff800">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjctMy0xLTEtNDcyODQ_69faf159-8115-42ac-b240-306f05453cb2">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjctNS0xLTEtNDcyODQ_34e07c30-7f8f-4e89-a323-fd339aabfb46">4.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjctNy0xLTEtNDcyODQ_1a57a25c-1b89-4372-bc36-d3a23dc1c987">32.29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjktMS0xLTEtNDcyODQ_6582c668-2354-4a0d-bfbc-476d9ea48b8b">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjktMy0xLTEtNDcyODQ_7eb4a1f5-99a8-4b1f-ad6b-81d758ffb036">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjktNS0xLTEtNDcyODQ_1c7913b4-648e-45ec-b184-c046dad71c71">4.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjktNy0xLTEtNDcyODQ_4538274e-e912-4977-8785-f79127bdd8d2">32.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzAtMS0xLTEtNDcyODQ_8a3fe01c-43cd-49f2-a548-6d9d3a1cc0ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzAtMy0xLTEtNDcyODQ_d45205a1-5c50-43de-b897-9ac27fc55359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzAtNS0xLTEtNDcyODQ_15f67d18-7ea5-40a6-8f5f-bc1eb11006cc">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzAtNy0xLTEtNDcyODQ_325673c8-8ea5-46b0-8f86-87c896b83393">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzEtMS0xLTEtNDcyODQ_6f087b9f-897d-4ffd-8af4-32338a3ce72d">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzEtMy0xLTEtNDcyODQ_3a128334-16f8-4042-b607-91ab31bc6147">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzEtNS0xLTEtNDcyODQ_c28a3448-d588-4bd8-b38c-a86dbc725789">4.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzEtNy0xLTEtNDcyODQ_372c50fc-ada4-4f5f-bf6a-ffe6f129a6e1">32.29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzQtMS0xLTEtNDcyODQ_56a88764-0e1e-4ea2-a4fa-ae832992ef19">151.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzQtMy0xLTEtNDcyODQ_a8a85c6f-d0ef-4d97-876e-34ee89e7e5ad">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzQtNS0xLTEtNDcyODQ_6a918d8c-d1e6-423f-a8b9-18c55e37b009">155.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzQtNy0xLTEtNDcyODQ_e5715295-fc93-415f-91b5-f070a26d26f1">161.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzUtMS0xLTEtNDcyODQ_6be5b585-d984-49c1-8a6b-e4045f3814d4">151.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzUtMy0xLTEtNDcyODQ_43ccc1f0-5c4c-46b8-be1b-a830436b339f">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzUtNS0xLTEtNDcyODQ_24ec0839-5ceb-4cbd-aea9-68aee0b80147">154.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzUtNy0xLTEtNDcyODQ_f6ff93c8-496f-4007-bfd6-bfe54e998356">161.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:58.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMi0xLTEtMS00NzI4NA_8eb02ef4-7c0a-4b82-bef5-40c63e4c8cf5">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMi0zLTEtMS00NzI4NA_b910637b-1fd8-4320-bc8d-90c675442742">6,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMi01LTEtMS00NzI4NA_b8d7998b-d57e-4ba7-bc96-f7c464820a42">882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMi03LTEtMS00NzI4NA_a14a4116-9dbc-46ee-9465-62bc4ba14ade">5,053</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNS0xLTEtMS00NzI4NA_9c0f83d4-d3f5-4440-b457-eac72c67b5b5">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNS0zLTEtMS00NzI4NA_ef78aad2-d04c-4ed9-a0a5-f270f028adbe">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNS01LTEtMS00NzI4NA_4207ab8a-1ebc-407a-9789-67471b08db9d">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNS03LTEtMS00NzI4NA_70a45dea-295b-4254-a434-17e5fbe58658">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNi0xLTEtMS00NzI4NA_6299f2d0-eb4d-4eda-b3fc-8b1cb221ebbb">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNi0zLTEtMS00NzI4NA_fbd2a539-cbcd-4724-8a6f-0c7fcfa1c047">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNi01LTEtMS00NzI4NA_41c580c6-dd26-44bb-ac0c-0094ed9cf399">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNi03LTEtMS00NzI4NA_2dd9bb16-51be-48d3-a876-31393a976dbd">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNy0xLTEtMS00NzI4NA_206cdec0-9e1a-4dfe-a2c1-94484195ff0b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNy0zLTEtMS00NzI4NA_7d000715-bce0-4d8c-ae8d-51ededa476a9">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNy01LTEtMS00NzI4NA_5a24b56f-709f-4779-8a3f-9b2bb9a9bedb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNy03LTEtMS00NzI4NA_2ac8e774-df2a-4cab-983e-6c3c884ae5e9">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfOC0xLTEtMS00NzI4NA_e9c8967e-b0cc-4240-a12b-58762619c011">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfOC0zLTEtMS00NzI4NA_43f165b5-0400-4782-8932-10b7cbbffae1">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfOC01LTEtMS00NzI4NA_7901dafb-04de-4735-b97d-53670ae71c0c">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfOC03LTEtMS00NzI4NA_099ff21e-0ecb-42c8-8aae-33e767fe95e6">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTAtMS0xLTEtNDcyODQ_36bca4ad-5f9e-47da-910b-1b676c2f4886">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTAtMy0xLTEtNDcyODQ_1c372d78-0854-4fed-b0c6-717b76ea39b2">6,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTAtNS0xLTEtNDcyODQ_06615cc7-f761-4dc8-afcc-18b075fddf2b">878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTAtNy0xLTEtNDcyODQ_d4467abf-c1a2-4660-a0bd-a709923fc521">4,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTEtMS0xLTEtNDcyODQ_5ba8f033-19a0-418c-94df-8f830bf6494b">44</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTEtMy0xLTEtNDcyODQ_4932b50e-a248-4317-9c1e-b18c7fcaaa23">77</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTEtNS0xLTEtNDcyODQ_3892b415-6396-4fe4-964f-273bfdf4f584">137</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTEtNy0xLTEtNDcyODQ_791db15f-7d00-465a-bcf2-40f5d4eedff3">113</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTItMS0xLTEtNDcyODQ_25eadbc6-caba-4ba0-ba8c-29e6c6212a5c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTItMy0xLTEtNDcyODQ_ed04e2bc-eba8-4744-9cc4-f03638f7f96a">6,132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTItNS0xLTEtNDcyODQ_3375a56b-7673-4b23-a590-808087f58390">741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTItNy0xLTEtNDcyODQ_416e2e02-5322-4d5e-aa73-d4fcbf5fc8fc">5,005</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMy0xLTEtMS00NzI4NA_d63dde59-49b7-4719-8842-df78f237c0b0">2,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMy0zLTEtMS00NzI4NA_2a905c89-7bf5-4bde-b188-1f2ffe6e0cec">6,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNC0xLTEtMS00NzI4NA_727fa6fa-43c3-423c-9497-3765b8e48ba9">18,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNC0zLTEtMS00NzI4NA_9721a996-a778-47eb-9d84-08a58dc24950">19,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNS0xLTEtMS00NzI4NA_e9ad5319-6027-436e-9ff5-41691b201076">19,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNS0zLTEtMS00NzI4NA_993a1f95-fdf9-4b74-8368-7887581f5b63">19,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNi0xLTEtMS00NzI4NA_8a4eaa4d-8e84-42ff-af93-69e64ccba324">5,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNi0zLTEtMS00NzI4NA_14f3932e-02d1-44b1-885e-853924a9ee97">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNy0xLTEtMS00NzI4NA_adb93899-cad8-4b38-8d4a-d59edca44d4f">831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNy0zLTEtMS00NzI4NA_859ac446-23af-443c-bd54-603ff43a2eb8">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfOC0xLTEtMS00NzI4NA_c058efb5-0997-414a-bc56-929251bd27f4">46,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfOC0zLTEtMS00NzI4NA_e78f6958-7d55-4734-b976-d050bf5507b1">45,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfOS0xLTEtMS00NzI4NA_8a063fc3-0ab1-4893-a855-bcec66d71e4c">2,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfOS0zLTEtMS00NzI4NA_cd51430d-17d7-4630-803c-0d8569236093">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTAtMS0xLTEtNDcyODQ_cdfebef4-2272-40b0-9d1b-e2ec7873b1c1">1,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTAtMy0xLTEtNDcyODQ_5f0114d4-e7f2-4190-bebf-d3008fb2cc8f">2,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTEtMS0xLTEtNDcyODQ_a78d60df-fec8-44e1-9e8a-7a65ebcd9429">9,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTEtMy0xLTEtNDcyODQ_e6990466-bbeb-4d7d-9832-01238cdd6502">9,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTItMS0xLTEtNDcyODQ_4c89fc4b-0d13-4331-9154-b2154c6a250d">2,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTItMy0xLTEtNDcyODQ_79dea4f3-ba7e-49bd-b4f7-54f176160fc1">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTQtMS0xLTEtNDcyODQ_b95bd24a-fc23-463e-8a79-105101a3c383">1,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTQtMy0xLTEtNDcyODQ_ad264afd-879d-49f7-8393-f7aa968d316a">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTUtMS0xLTEtNDcyODQ_1e3ee774-0b7a-429e-b0b9-0c0e758609dc">63,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTUtMy0xLTEtNDcyODQ_6c6d7154-dbc9-4fe3-9fb6-4e93e140030b">65,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTktMS0xLTEtNDcyODQ_3ab4f25e-9a95-4163-af45-1482037a9419">37,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTktMy0xLTEtNDcyODQ_fb9a627c-9af6-4a45-9b57-b4df8dc491fd">38,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjAtMS0xLTEtNDcyODQ_33dd44d4-3cfc-4fff-b503-fc23d5f8a7cc">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjAtMy0xLTEtNDcyODQ_8e881951-1a82-48a0-a7cc-77d2835e667b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjEtMS0xLTEtNDcyODQ_3bc1a21b-6756-43df-9e80-4bd5c6b1722a">438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjEtMy0xLTEtNDcyODQ_8581eff0-b4ea-4c42-803a-32d9b3759839">742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjItMS0xLTEtNDcyODQ_a5627218-7063-49bc-bca0-b58924a50d72">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjItMy0xLTEtNDcyODQ_f0a87d0b-bd09-4b1e-ae94-43a0d215cf49">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjMtMS0xLTEtNDcyODQ_db4bc84c-45cc-4e48-a255-325dc6e58de2">4,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjMtMy0xLTEtNDcyODQ_c2e4ee4f-1d1f-402f-a3a2-e44a4ff75cef">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjQtMS0xLTEtNDcyODQ_b2fcfd69-c200-4ff7-9588-74d8a74d9f84">4,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjQtMy0xLTEtNDcyODQ_161ef465-bfac-4350-996b-7be7fc6f2a5a">3,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjUtMS0xLTEtNDcyODQ_7e9f6be6-fcfc-49ad-9a52-e27c7f9a70bb">47,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjUtMy0xLTEtNDcyODQ_057066b2-574c-4e69-ab57-20e4ed8b4100">44,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjYtMS0xLTEtNDcyODQ_85a10295-a242-4ef8-8089-42f8f392f734">5,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjYtMy0xLTEtNDcyODQ_565b8d0f-7f30-43a1-bc8a-25ffdc6adb37">6,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjctMS0xLTEtNDcyODQ_538f4b86-8e2f-45e6-a9e2-9bb90b34e5a2">1,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjctMy0xLTEtNDcyODQ_35f8359b-60f5-4ddd-8e76-0d9d394e3cd0">1,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjgtMS0xLTEtNDcyODQ_3204f4d1-d48e-4a36-ac43-5950b3753476">1,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjgtMy0xLTEtNDcyODQ_56c4e535-7780-4f98-a040-38b2b9560306">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjktMS0xLTEtNDcyODQ_ebc63202-588f-4752-a5a6-33d1fd108c45">7,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjktMy0xLTEtNDcyODQ_7d4ee3f8-ff1a-4050-97a2-ec3a497df97b">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzAtMS0xLTEtNDcyODQ_157a7aec-f645-4bdb-821c-a27af847f54f">1,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzAtMy0xLTEtNDcyODQ_a00bb303-466c-4efe-b7f1-f5890bffbff0">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzEtMS0xLTEtNDcyODQ_8319ab7d-0159-46c1-bf47-03b996c2bc05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzEtMy0xLTEtNDcyODQ_39af3cdb-ac82-436b-ae75-bde409a00d4f">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N18yMQ_801ae82b-7356-4cbd-ad4f-ed93c2cc8479"><ix:nonFraction unitRef="usdPerShare" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N18yMQ_b2670a3f-a4bb-4357-a71d-0de7ff771549">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N18zNQ_6f834177-ed7d-426c-9e33-327e8d2ed102"><ix:nonFraction unitRef="shares" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N18zNQ_77b41a9f-a47a-47a8-992f-9ee311851392">100</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N181Nw_6cc17ca3-513c-4cdb-836c-34804fb1b1cb"><ix:nonFraction unitRef="shares" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N181Nw_a379f0d1-6103-4388-85a3-ed30a8989fe2"><ix:nonFraction unitRef="shares" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N181Nw_b6782544-f515-41b9-a06e-0561b6395f19"><ix:nonFraction unitRef="shares" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N181Nw_cd1af9a2-43fa-4212-aeff-2cd089b05dbd">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMS0xLTEtNDcyODQ_10d2c87c-cc53-4820-a9b2-ae600931b403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMy0xLTEtNDcyODQ_333399f4-c261-4ebf-bc66-66e41a46b5c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF8xOA_8f757c35-3d2a-4826-9ca8-9235129d1853"><ix:nonFraction unitRef="usdPerShare" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF8xOA_978e7e6d-202a-44c5-89db-5174e2f818bf">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF8zMg_044b3516-4b2a-4970-8215-a5c4d4c16fa4"><ix:nonFraction unitRef="shares" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF8zMg_bbce8676-9c6c-4757-80b5-0336cf6902fe">800</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF81Nw_50e212d7-006a-400b-ab7f-ce3f75aa2872">275</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF82NA_bbe9669f-72a0-4540-97d7-93a36965d217">273</ix:nonFraction> shares issued at December 31, 2021 and March 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMS0xLTEtNDcyODQ_979f911f-9d80-4f8e-b5ce-11da2cace20f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMy0xLTEtNDcyODQ_002f4aef-fd38-4086-acd3-38b0e278fdc9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzUtMS0xLTEtNDcyODQ_4eaca4d1-7b3c-433c-82b0-6771129e31b6">7,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzUtMy0xLTEtNDcyODQ_eca83892-51f0-4947-bd7f-e400cf2ec7dc">6,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzYtMS0xLTEtNDcyODQ_297071a1-da8c-4ff0-ba02-8da74dc976df">8,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzYtMy0xLTEtNDcyODQ_cd893dda-f778-4ab2-8203-9e0e18f74892">8,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzctMS0xLTEtNDcyODQ_0fe0c6ed-fc2f-41ac-8ea3-32a01ad96b6c">1,655</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzctMy0xLTEtNDcyODQ_2560f0c4-adae-4142-a280-67c4d4fb6ab0">1,480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury shares, at cost, <ix:nonFraction unitRef="shares" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzktMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo0NTUzNjI2Yjg2ODM0MTE5Yjg1MmUwYzMxYmMxMzEyZV8zMA_6d4750b3-b7f4-4516-b177-352892fcd1b8">125</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzktMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo0NTUzNjI2Yjg2ODM0MTE5Yjg1MmUwYzMxYmMxMzEyZV8zNw_795c710a-b2fa-4ac0-9f9f-6d7e019e5362">115</ix:nonFraction> shares at December 31, 2021 and March 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzktMS0xLTEtNDcyODQ_af4d987c-004c-4f0d-9102-b0f462f1a16a">15,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzktMy0xLTEtNDcyODQ_7b6cce7c-989f-4809-b1ef-46e8c661ec96">13,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDAtMS0xLTEtNDcyODQ_88213b09-691d-4bbf-ac91-a6f8ca6ff343">1,274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDAtMy0xLTEtNDcyODQ_71046014-e91e-4907-9bf4-2f18648a94c7">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDEtMS0xLTEtNDcyODQ_e5286501-908f-4802-a100-f4ee7a0f997c">487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDEtMy0xLTEtNDcyODQ_cc851e3f-dbb0-4eb9-83c1-59a16b1f3e4a">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity (deficit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDItMS0xLTEtNDcyODQ_ed1f368b-49a9-4128-85f1-5356d780faab">787</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDItMy0xLTEtNDcyODQ_2ad02e92-e444-4303-8dcd-5c99182e6a6c">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDMtMS0xLTEtNDcyODQ_fe8174bf-3551-4dd9-a77d-700e4f2d395b">63,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDMtMy0xLTEtNDcyODQ_b259376d-0453-477e-aeeb-759763c872c1">65,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Deficit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:19pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, September 30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i439966e71d2144ef842f55e3776ff357_I20210930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xLTEtMS00NzI4NA_5939d470-0dbd-468a-bc88-ef949d6ae638">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i439966e71d2144ef842f55e3776ff357_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0zLTEtMS00NzI4NA_e97cb1f5-840c-4e82-83cb-f546e5b16c3b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8436ab31a1f04277a0978cc5082487d6_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy01LTEtMS00NzI4NA_3bb92cd0-f46d-4ea6-85bf-a6653934b390">7,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i700f01544539495e9ffcc43f6df2519a_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy05LTEtMS00NzI4NA_33ee7bc4-6677-4097-bc51-6ef016be00fb">8,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1be4875f550d4562b96d61a975ce1384_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xMS0xLTEtNDcyODQ_16094244-2efb-42e6-a1a0-92c224d95428">1,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ida99689579c54617a262daa0e8430ed6_I20210930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xMy0xLTEtNDcyODQ_69f2b826-d354-42cd-abf2-4f9b8ff570e7">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida99689579c54617a262daa0e8430ed6_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xNS0xLTEtNDcyODQ_8aaa5388-1c91-46e0-a3e2-0cc491587b4f">15,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c571fe607348cdab2a44a5f011467b_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xNy0xLTEtNDcyODQ_e0c0bb9b-be9b-425d-be51-66bf81c70dbc">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1ad330dab834c37a1beaf31343ccddc_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xOS0xLTEtNDcyODQ_1e4f0cb7-7c5b-467c-a495-057fecb7bfec">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47507086542449a87995a47b6731b7a_D20211001-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNC01LTEtMS00NzI4NA_93986b89-1a14-4d11-95ed-68332515c4cf">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b2766918b80463a9b60d65600e7b809_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNC0xNS0xLTEtNDcyODQ_4e5a3623-0be9-4705-9c4d-7905cba9aa94">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNC0xOS0xLTEtNDcyODQ_911f91da-0bbd-4f26-81ff-c791e6bd270d">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47507086542449a87995a47b6731b7a_D20211001-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNS01LTEtMS00NzI4NA_73900f4e-0001-4997-a448-9e085d55f5c8">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNS0xOS0xLTEtNDcyODQ_2fe46997-665e-4de4-b979-a98eb00a6ca9">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNi0xNy0xLTEtNDcyODQ_c2e3a413-531f-4b4d-bfc2-85e3f805a9b9">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNi0xOS0xLTEtNDcyODQ_d3ebc6c2-7014-4745-a2e2-cbfc439f81dd">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNy0xMS0xLTEtNDcyODQ_fe2c3697-963c-4a05-a698-75de93bf98d3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNy0xNy0xLTEtNDcyODQ_610e7290-1190-4258-92ce-69aa0dfaa8d3">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNy0xOS0xLTEtNDcyODQ_fac578dd-4dfa-4263-ac6e-431685ff1a4d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd7e5ba6748444768519a57ab6d455e1_D20211001-20211231" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOC05LTEtMS00NzI4NA_28d3c462-7f09-4da9-8ffc-7acaf942dba5">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOC0xNy0xLTEtNDcyODQ_4379b474-ab72-41e5-b3ed-1584cdb9c867">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOC0xOS0xLTEtNDcyODQ_33eb8aa6-b300-49c1-ac75-68f8b75264a7">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7b2766918b80463a9b60d65600e7b809_D20211001-20211231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOS0xMy0xLTEtNDcyODQ_136d2fde-de09-4af7-be0a-d00deb59438d">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b2766918b80463a9b60d65600e7b809_D20211001-20211231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOS0xNS0xLTEtNDcyODQ_bc2795e1-4ed6-47cf-9e99-eae2df8abb8a">728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOS0xOS0xLTEtNDcyODQ_b67c1715-4816-4524-a8d6-48c0d558bdbb">728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTItMTctMS0xLTQ3Mjg0_1fbdca44-60cf-4b58-a3f6-4ce8ca849cf8">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTItMTktMS0xLTQ3Mjg0_bf843a17-1fdb-4c8a-8b8e-4d58bc306010">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo3YjcxOTA2MzQ0OTI0YTUwYjVlNDJkMDVmOWNmNjY1Yl8yOQ_a80b2318-c023-44ee-ab76-3b910985bd14">0.47</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd7e5ba6748444768519a57ab6d455e1_D20211001-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTMtOS0xLTEtNDcyODQ_0321e5f9-d853-40ca-b33d-b179c8bc75a5">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTMtMTktMS0xLTQ3Mjg0_fa32cf86-a271-4ee9-838f-30bee7457166">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47507086542449a87995a47b6731b7a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTQtNS0xLTEtNDcyODQ_5ea06d95-3bcd-4825-8917-43fc5d2d2ac4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd7e5ba6748444768519a57ab6d455e1_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTQtOS0xLTEtNDcyODQ_ae06062c-36f5-4642-b12f-70d844544a80">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTQtMTktMS0xLTQ3Mjg0_13247c2c-5388-4d50-ab3a-aac36f85510e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i51890ebfb4e6484b85eee1fcde455801_I20211231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMS0xLTEtNDcyODQ_181aae56-951d-43cc-8fec-4f8349c4748a">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51890ebfb4e6484b85eee1fcde455801_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMy0xLTEtNDcyODQ_ea7c0261-7d1d-43a9-9a8a-1448cdc7b7cd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccaf4a3f07d140fa8a374c7d818db2c4_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtNS0xLTEtNDcyODQ_3dac77dc-249b-455e-9e1c-72e4e62123a0">7,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc60e1226cd4fcfbed4ac8715e43490_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtOS0xLTEtNDcyODQ_b2439be7-3b42-4f74-92c4-cf69087e3d7b">8,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib041b764acbd496ba6cd257448c9a6ba_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMTEtMS0xLTQ3Mjg0_274a4c28-8dd9-4255-997d-c45d95b4838a">1,655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i954d5ded78d141c1aab9b2f0e240b4e9_I20211231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMTMtMS0xLTQ3Mjg0_59269c3e-2a4c-4c4b-9528-278397e6e188">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i954d5ded78d141c1aab9b2f0e240b4e9_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMTUtMS0xLTQ3Mjg0_e9459fc2-0dfd-457a-9b71-ba1f26d5f53c">15,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic820959a12ab4a0bae3278102cbe3604_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMTctMS0xLTQ3Mjg0_84a9daa0-ba39-4a13-8004-5ff208683840">487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMTktMS0xLTQ3Mjg0_e5531ba4-014a-4192-8b54-8b054e31f861">787</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity (Deficit)</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, September 30, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0187d0ab0c2b497ba13eb86f09ee7b1d_I20200930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xLTEtMS00NzI4NA_43a21e18-04b5-4c6e-a2fe-dcb8832f542d">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0187d0ab0c2b497ba13eb86f09ee7b1d_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0zLTEtMS00NzI4NA_1187d9eb-260a-41a3-9a08-e31a95d2272a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0e96cfe3d44cabedc838f2e613c8f_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy01LTEtMS00NzI4NA_dc73080b-a482-4e02-88ea-15b480ee0a6c">6,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38d606928fc4b3db6f2c28bb6975efc_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy05LTEtMS00NzI4NA_be250db6-0405-4504-8345-a23388e38ed6">13,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf3b3d119214ddc994b0fa424595480_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xMS0xLTEtNDcyODQ_498f0d68-834a-4972-a350-caeb29a0314c">1,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5708808d3fca428a8db75e932c0ab1ed_I20200930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xMy0xLTEtNDcyODQ_621ebdd2-3332-457c-8ad3-e70fbe722149">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5708808d3fca428a8db75e932c0ab1ed_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xNS0xLTEtNDcyODQ_5115b963-69c8-4d6d-b2e0-5a98558f71df">13,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6da59171484d4afba5f49534b2709456_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xNy0xLTEtNDcyODQ_759ee0cd-03fc-4dcf-a56d-da60a5c630d1">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b44821ac2c64fd7ab23957aaf69ef0e_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xOS0xLTEtNDcyODQ_8696de6c-860a-4e47-bdc2-86e7a6b074b8">6,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29dac400581c4ad0a015f1f22afc419d_D20201001-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNC01LTEtMS00NzI4NA_4da64041-51ae-42d4-9f6a-69a023021cdc">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i395b68d034cb497d9e909bd37a723bb3_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNC0xNS0xLTEtNDcyODQ_218fa09d-caa9-4826-89d4-4c4952414cac">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNC0xOS0xLTEtNDcyODQ_8e3ddeed-01f7-4d6b-a164-1573f8d7ee44">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29dac400581c4ad0a015f1f22afc419d_D20201001-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNS01LTEtMS00NzI4NA_f1bcd6c5-f79d-4ea9-9450-86af4520fbdb">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNS0xOS0xLTEtNDcyODQ_c8108e06-6f7c-40ee-bc0b-33c8dd1cc583">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNi0xNy0xLTEtNDcyODQ_9d7ea056-58f0-471e-8cae-fa11b8a5ad5d">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNi0xOS0xLTEtNDcyODQ_78c14e76-913c-4d99-a057-b1cf5d3e04f8">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie535baeb0dd347cd978917e66bf4f610_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNy0xMS0xLTEtNDcyODQ_a958f43e-abe6-4b09-b7e6-015e53d3337c">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNy0xOS0xLTEtNDcyODQ_d443d63a-a362-4008-a026-752b9445903f">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8bdea9022ea4c33963371f1d4922ff7_D20201001-20201231" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOC05LTEtMS00NzI4NA_1b6b7173-05b6-4a44-8bcf-f4c08954938d">6,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOC0xNy0xLTEtNDcyODQ_1f677182-5f19-46be-a4d8-fbbf20be1577">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOC0xOS0xLTEtNDcyODQ_b3e9fcc7-d1ca-4bcc-aca0-28f336bcd40e">6,185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i395b68d034cb497d9e909bd37a723bb3_D20201001-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOS0xMy0xLTEtNDcyODQ_09113d85-b01d-4ec6-81f5-fcd984e5ca02">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i395b68d034cb497d9e909bd37a723bb3_D20201001-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOS0xNS0xLTEtNDcyODQ_dd7755a7-b4e8-4c55-b661-5766c10c5c05">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOS0xOS0xLTEtNDcyODQ_f631a180-14c5-4cb7-ba69-812f551d901c">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTEtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo2YzM1OWIzNmMxODA0MjE3YWRkNzM2Nzc5MWY2NzM4ZV8yOQ_0bbdf373-e2dd-44cc-bacb-a62702baa023">0.42</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8bdea9022ea4c33963371f1d4922ff7_D20201001-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTEtOS0xLTEtNDcyODQ_fa917568-8ca8-49d2-8da1-b6551f5f3789">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTEtMTktMS0xLTQ3Mjg0_a61755a6-d02f-4372-ac27-47ccfdf33bd0">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8bdea9022ea4c33963371f1d4922ff7_D20201001-20201231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTItOS0xLTEtNDcyODQ_b7490ffa-bde0-42bb-a968-45334d8b0f49">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTItMTktMS0xLTQ3Mjg0_b6ea6bc9-d58c-4a32-8e5c-850aac7d8680">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, December 31, 2020</span></div></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c35edcf7a034a8083f41df320050fd4_I20201231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMS0xLTEtNDcyODQ_bacc33a3-0a88-4601-98e0-b6e2eb4af64a">273</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c35edcf7a034a8083f41df320050fd4_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMy0xLTEtNDcyODQ_a5b0c431-1dcb-4be2-a78d-d052d9d8b4f1">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic093d490b58f4f6da8f7e05176f1fcb5_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtNS0xLTEtNDcyODQ_2be61387-9067-4282-b504-4b43ad613f2b">6,847</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44427056526c458db776d32cda88d623_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtOS0xLTEtNDcyODQ_14aa04c5-d123-41bc-948c-382228cfed15">7,595</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19c25b891e2446a6bab4b8ee69b28057_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMTEtMS0xLTQ3Mjg0_4db6b15f-4f32-477b-82c2-0d46f604ee43">1,503</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0d421e0224fb47f8b7a8dc9b60947bdb_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMTMtMS0xLTQ3Mjg0_0fa9af86-5ff8-4835-b5fe-fd2d954b5946">114</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d421e0224fb47f8b7a8dc9b60947bdb_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMTUtMS0xLTQ3Mjg0_a1eb9ca4-679e-4654-bcb0-b22922d38078">13,418</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64318d5dd9f1472c90248ebb8e0becbf_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMTctMS0xLTQ3Mjg0_693059ea-09f5-4f42-bf3d-9112f391f2f8">200</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92b029a90e9640e6a41de2c763149aec_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMTktMS0xLTQ3Mjg0_695dc70d-e3e1-4a85-81ad-bb0ed6d40b56">277</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity (Deficit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iacce3d46e1114af0a96f49bb08fb9657_I20210331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xLTEtMS00NzI4NA_ac3834ba-30d5-4e09-b07f-8f6aabdca22d">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacce3d46e1114af0a96f49bb08fb9657_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0zLTEtMS00NzI4NA_6a90756d-ee9e-4947-a2bb-018ee9707e5d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4a47e592514d34b5bd2a736f25f14e_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy01LTEtMS00NzI4NA_de2198b1-cdd2-4e7f-847a-628f4347aa8f">6,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i140e091483a24a50921565a4f50f0bc6_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy05LTEtMS00NzI4NA_527f93da-0959-4022-bfed-a47a2a7c8a74">8,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd1f982f3f4042c9badc91a36fff0cc1_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xMS0xLTEtNDcyODQ_69fb11a4-ce42-4f56-849e-0a9d2a10b26f">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id250b6c030544199b7220d3a2aca9cc0_I20210331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xMy0xLTEtNDcyODQ_44f2ade6-b4ff-4851-b17d-f738ba5e2cc7">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id250b6c030544199b7220d3a2aca9cc0_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xNS0xLTEtNDcyODQ_547ffd8b-00d2-4b11-8f9f-19b3ec1ac973">13,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d467e35eb14c31bcba781b26964717_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xNy0xLTEtNDcyODQ_bb84a684-b31a-4c5e-ba59-9259fd481413">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xOS0xLTEtNDcyODQ_8654d4ad-75de-4e1f-9342-3930da984276">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if543dc69884c4140a12003d1148abf8b_D20210401-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNC0xLTEtMS00NzI4NA_8540fe4e-d168-4ce4-b293-15fc9b64ef86">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNC01LTEtMS00NzI4NA_997e1a37-0b3d-4ab7-8105-0e0f8e780565">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0c099b1c004a6c8a540a2430721bbb_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNC0xNS0xLTEtNDcyODQ_8351fbae-e004-4652-bbbf-b8dbc198e6dd">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNC0xOS0xLTEtNDcyODQ_431366d7-0ea8-47ae-b3d6-2746f2f635f0">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNS01LTEtMS00NzI4NA_1c01d2e1-2f69-4313-a48c-cd0e0a202c1b">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNS0xOS0xLTEtNDcyODQ_3127f1a4-b1db-4595-ad36-e4512b63be22">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNi0xNy0xLTEtNDcyODQ_853ab27c-5579-44b3-85fb-f499558c2448">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNi0xOS0xLTEtNDcyODQ_f97d9d00-ab1d-4f72-bad5-b42a15617612">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNy0xMS0xLTEtNDcyODQ_6bc5a1fc-0c66-4259-a8d4-48c41b6d4fc1">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNy0xNy0xLTEtNDcyODQ_050fb580-daef-417a-b5a4-df474acb5b7b">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNy0xOS0xLTEtNDcyODQ_42af46fa-7d35-49f1-9b1a-2fad2f58078e">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9f93739e19b4aafadc89d067d383156_D20210401-20211231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOC05LTEtMS00NzI4NA_64b9ba9c-a60e-454a-820c-ef38a5fa15dc">746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOC0xNy0xLTEtNDcyODQ_5817b4d9-3a40-4f88-b47f-a08c512462e5">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOC0xOS0xLTEtNDcyODQ_106ba0a0-b249-49c0-886b-bc18212d75ea">874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOS01LTEtMS00NzI4NA_8e389df6-1d2a-42a4-9dd5-c7c614709562">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOS0xMS0xLTEtNDcyODQ_41c68e51-d4db-46df-ae17-737cb05b61b1">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOS0xOS0xLTEtNDcyODQ_9b99eab3-4eb6-44d5-a63e-5230d1ea4133">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTAtNS0xLTEtNDcyODQ_19306347-060f-4eb0-a924-d104695acee7">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8b0c099b1c004a6c8a540a2430721bbb_D20210401-20211231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTAtMTMtMS0xLTQ3Mjg0_68c41fff-d650-4ebf-b74b-2eece65c6c6f">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0c099b1c004a6c8a540a2430721bbb_D20210401-20211231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTAtMTUtMS0xLTQ3Mjg0_2dcbda25-aecb-45e3-a7ff-5b0d445e948c">2,029</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTAtMTktMS0xLTQ3Mjg0_f10d455e-17e8-4871-b606-a01a57b3b144">2,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe AG redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTEtMTctMS0xLTQ3Mjg0_58834409-d24e-4718-920d-c51e2757806c">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTEtMTktMS0xLTQ3Mjg0_f54484b1-1941-412c-abbb-23aa9f835a64">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTItMTctMS0xLTQ3Mjg0_64a78c7f-206d-404d-a7e5-ec27e3c3be66">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTItMTktMS0xLTQ3Mjg0_0c428b1e-bd82-42d7-b6a3-b4118bd3a26c">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjozMjVkNWY0YzBhMzM0OWRkODczOGM4OGJjOTkzMDdkNV8yOQ_834c9146-3634-48e3-97fc-fe14c9724795">1.36</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9f93739e19b4aafadc89d067d383156_D20210401-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTMtOS0xLTEtNDcyODQ_a5e441e2-5caa-4900-b7ce-e0c9e487cb7b">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTMtMTktMS0xLTQ3Mjg0_3ba1f223-91f8-4e3d-a17a-fb19f1a25386">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTQtNS0xLTEtNDcyODQ_6881a7b2-49d1-4c4e-b124-d8defea01827">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9f93739e19b4aafadc89d067d383156_D20210401-20211231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTQtOS0xLTEtNDcyODQ_ba80c52a-0ac2-4446-a346-c66a1a217d5b">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTQtMTktMS0xLTQ3Mjg0_4fe7c225-70d4-453d-a88c-8818334056d8">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i51890ebfb4e6484b85eee1fcde455801_I20211231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMS0xLTEtNDcyODQ_3089954a-7c38-4c34-8c89-637634e044b9">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51890ebfb4e6484b85eee1fcde455801_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMy0xLTEtNDcyODQ_e2c26624-bbe1-4d27-9a91-fc37ab64e719">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccaf4a3f07d140fa8a374c7d818db2c4_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtNS0xLTEtNDcyODQ_c344afd6-6429-41ed-922a-f31aafd304ea">7,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc60e1226cd4fcfbed4ac8715e43490_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtOS0xLTEtNDcyODQ_fc666c57-a9d7-4001-bc24-a99b3abb3d26">8,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib041b764acbd496ba6cd257448c9a6ba_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMTEtMS0xLTQ3Mjg0_0eeaa282-0cb2-4c23-94b7-b1eb1ad542d0">1,655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i954d5ded78d141c1aab9b2f0e240b4e9_I20211231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMTMtMS0xLTQ3Mjg0_8d264038-ebf8-4617-8479-264633fa8daf">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i954d5ded78d141c1aab9b2f0e240b4e9_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMTUtMS0xLTQ3Mjg0_379d99b6-b983-4541-a728-f3dc010dce4c">15,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic820959a12ab4a0bae3278102cbe3604_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMTctMS0xLTQ3Mjg0_8237ecfb-a70f-4cad-a4bb-da0a6cf98f94">487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMTktMS0xLTQ3Mjg0_9a7cc511-16c2-403d-b315-477f5db32b85">787</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity (Deficit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, March 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i178f7de2928e404a940f4fec020ed2b2_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xLTEtMS00NzI4NA_1552dbe0-0a15-44df-a2bc-cddc2939c8a9">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i178f7de2928e404a940f4fec020ed2b2_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0zLTEtMS00NzI4NA_a6e4e53a-0e82-4042-a2cd-c7e233fd40f6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5ef3a9f2864706b17af4a3663282d5_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy01LTEtMS00NzI4NA_41a88f6a-8dea-4b8c-ab3c-f2d790f147b2">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i196e981a1d044679b7aa89e65f24dc73_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy05LTEtMS00NzI4NA_e8e0aca7-3d5b-4cad-91b2-20e330a12885">13,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebc1818efd944fffbeda92744ddd19d5_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xMS0xLTEtNDcyODQ_7dce64b3-f78d-4bbe-a22f-0a169b7ee992">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9df402b98dd84868a1686daf16596424_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xMy0xLTEtNDcyODQ_6b01c3c6-1587-4037-9b19-303428dd45fb">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9df402b98dd84868a1686daf16596424_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xNS0xLTEtNDcyODQ_bae9db72-e1c1-447d-98be-5934be134d26">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805c937398e343ddbade7f441c4786b9_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xNy0xLTEtNDcyODQ_5340d916-b555-4968-8391-834fa290a063">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd3b8f0b9fb4e3b80f26f6a286a8c4c_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xOS0xLTEtNDcyODQ_1207b56c-3782-4747-bba3-5389424614a9">5,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opening retained earnings adjustments: adoption of new accounting standard</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i608ff3c7e46a422da1a3bca44aba8bb7_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNC05LTEtMS00NzI4NA_d86f4726-7da2-4e75-97ba-550be3a3eddd">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i746a7ab451924975842c08464b7c24d1_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNC0xOS0xLTEtNDcyODQ_5b94cd40-1531-494c-b169-49bdc5a0cbb2">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, April 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i705e588d2f514ff7bd717969c76affb2_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xLTEtMS00NzI4NA_85a7fd07-b6e0-4c8e-9539-3d5c855a5097">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i705e588d2f514ff7bd717969c76affb2_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0zLTEtMS00NzI4NA_4d872b35-26ff-4b48-ab23-1a1e6296f479">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3486e22c3b4e49d2a3c85ce54a4b1ef6_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS01LTEtMS00NzI4NA_f82df57f-c69f-444b-a19a-e86dba5977a5">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bcf0ae780a4416aab58b011355b0f70_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS05LTEtMS00NzI4NA_847d7f89-c6ca-4dec-b93f-4b9d2f330cb4">13,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i646e69bc99874247b6c06d6a96b329e7_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xMS0xLTEtNDcyODQ_0d028b0b-3278-48d7-b4c3-330e09e51612">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0ec61b139f8d42da8e958f556f58020e_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xMy0xLTEtNDcyODQ_7e40b765-2733-4126-bb19-0c5f5e000260">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ec61b139f8d42da8e958f556f58020e_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xNS0xLTEtNDcyODQ_d0314b2b-d2f2-4799-86c3-4b28b8a8a980">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7cfe7694bf045d993d3e0e6ac8a85dd_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xNy0xLTEtNDcyODQ_5f366707-cd36-48e8-a4ea-9419ee99ff44">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d647cddebc42c3a78ef89fe06d1cfa_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xOS0xLTEtNDcyODQ_e9c119d9-e5dd-4fe0-a1e4-24229af58e3f">5,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49683251f292481d9201d661f7720626_D20200401-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNi0xLTEtMS00NzI4NA_74a7fa29-4efc-4b37-a5dd-8e3edf63c5db">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNi01LTEtMS00NzI4NA_e6c87637-aeb7-4a33-a9dd-3b466cef3306">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c6fe05296e94ff8845fee715825c659_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNi0xNS0xLTEtNDcyODQ_aab45830-a824-4731-be34-3d9826aaa270">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNi0xOS0xLTEtNDcyODQ_f790c9b9-cb6e-4ea7-894b-1f0fb8dd0ec5">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNy01LTEtMS00NzI4NA_82c01f47-0226-4903-b8c3-64ca0f454533">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNy0xOS0xLTEtNDcyODQ_ed286a21-2520-4535-93c1-d42c33b424b6">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfOC0xNy0xLTEtNDcyODQ_efa52b0a-65e3-4eee-ab4b-a9c180f8c652">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfOC0xOS0xLTEtNDcyODQ_cbb3f731-b609-432a-8ad8-77cd325ebc81">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d1cfbcdd084d568e496e899582fa21_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfOS0xMS0xLTEtNDcyODQ_a61f0d0d-5b16-443c-97be-265020ef5205">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfOS0xOS0xLTEtNDcyODQ_e3c02268-d8bc-44f1-b663-8f70277aa863">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2db64a62c8943349987209b0adb60c1_D20200401-20201231" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTAtOS0xLTEtNDcyODQ_128a4f2e-2eac-485c-bb94-da31d4686ee9">5,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTAtMTctMS0xLTQ3Mjg0_e542a8d4-a8ec-464c-a3ca-97a2e6c4204c">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTAtMTktMS0xLTQ3Mjg0_d91eaa6b-07f0-4dc6-aeda-9018825787f2">5,085</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTEtNS0xLTEtNDcyODQ_8a2d3128-d66f-452a-b380-f24c1be01cb1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTEtMTktMS0xLTQ3Mjg0_934cc600-a7a2-492e-9c03-cf3fb7044e6e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4c6fe05296e94ff8845fee715825c659_D20200401-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTItMTMtMS0xLTQ3Mjg0_a11adb8a-bbce-4013-bfdf-9d21fd51c240">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c6fe05296e94ff8845fee715825c659_D20200401-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTItMTUtMS0xLTQ3Mjg0_b04696ea-430d-4be1-846b-8b35215bfe31">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTItMTktMS0xLTQ3Mjg0_d11714b9-4902-4b0b-8c48-6a510ff95514">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo3ZGZjMjc0MWJkOGQ0NDI1OGVmMjJkNzI3OTQ1OTRlNF8yOQ_5fb6bb19-4770-483f-9698-77bf6d5a85ae">1.25</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2db64a62c8943349987209b0adb60c1_D20200401-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTQtOS0xLTEtNDcyODQ_ab3f91e4-daad-4980-a775-1b53be2c1ed7">203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTQtMTktMS0xLTQ3Mjg0_1b6cfc7c-9fa3-4225-973f-c468acd56dac">203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTUtNS0xLTEtNDcyODQ_69c91c80-e266-4754-8815-f8d05f604e18">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2db64a62c8943349987209b0adb60c1_D20200401-20201231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTUtOS0xLTEtNDcyODQ_f32c8f4d-ba3c-4a03-976f-e7d4babf4043">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTUtMTctMS0xLTQ3Mjg0_5b4ccad7-7688-497b-9a65-c66a4b9f3f0c">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTUtMTktMS0xLTQ3Mjg0_6247abb4-d146-4d7b-a394-8e97d3c477c8">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c35edcf7a034a8083f41df320050fd4_I20201231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMS0xLTEtNDcyODQ_20ceffe8-da69-4fbc-989b-b4f04ecb7ea7">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c35edcf7a034a8083f41df320050fd4_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMy0xLTEtNDcyODQ_300cdeec-d37a-48d7-b722-93aad5ae28d0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic093d490b58f4f6da8f7e05176f1fcb5_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtNS0xLTEtNDcyODQ_016566c5-eb61-4174-a826-69e8a5c48aba">6,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44427056526c458db776d32cda88d623_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtOS0xLTEtNDcyODQ_2c7f625c-5197-4cfa-b24b-f0baa7e22a21">7,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19c25b891e2446a6bab4b8ee69b28057_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMTEtMS0xLTQ3Mjg0_aa67b8ad-c2f0-40df-b4c8-72ac1c160b4c">1,503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0d421e0224fb47f8b7a8dc9b60947bdb_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMTMtMS0xLTQ3Mjg0_49519865-644c-4004-a71e-7031449a8645">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d421e0224fb47f8b7a8dc9b60947bdb_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMTUtMS0xLTQ3Mjg0_2a69bc67-60bb-44df-8f31-685ea6231011">13,418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64318d5dd9f1472c90248ebb8e0becbf_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMTctMS0xLTQ3Mjg0_516b3bf1-b4ee-4733-b8ca-e33d73cd21dd">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92b029a90e9640e6a41de2c763149aec_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMTktMS0xLTQ3Mjg0_90c7e2e9-04f4-4155-9941-0e24ea9fc0ca">277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMy0xLTEtMS00NzI4NA_afdd1156-43a9-4281-91d7-f424d1a63c47">882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMy0zLTEtMS00NzI4NA_2548815d-dd04-407b-8414-d03934d153ea">5,053</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNS0xLTEtMS00NzI4NA_0981479e-e215-42a0-9573-6051351ce169">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNS0zLTEtMS00NzI4NA_7493be1f-e9fc-418b-9b5d-15606bbf2726">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNi0xLTEtMS00NzI4NA_a56c6e3d-a6f4-43b4-8df1-c7c9940226e7">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNi0zLTEtMS00NzI4NA_33899b91-feb2-463d-99bc-6c52c71553ba">429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and long-lived asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNy0xLTEtMS00NzI4NA_0d74c42d-f93a-474b-8e14-217593037c15">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNy0zLTEtMS00NzI4NA_6d4af2db-e878-4e7a-bb58-d95ba28bbb3e">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfOS0xLTEtMS00NzI4NA_a0b6a359-40db-43bd-b909-cb7b1582da8d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfOS0zLTEtMS00NzI4NA_9d2221d7-97ac-4cfc-bdba-2e3b66d7bd83">1,520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credits associated with last-in, first-out inventory method</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTAtMS0xLTEtNDcyODQ_56e7a92b-261c-493e-9d0f-54c5ee910ee6">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTAtMy0xLTEtNDcyODQ_a9490120-5693-4007-b993-627eb121142d">115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTEtMS0xLTEtNDcyODQ_efde1a4c-c3a1-44aa-81ea-2f6389336e79">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTEtMy0xLTEtNDcyODQ_9225d23b-b864-41ba-8604-bd4de6e680b3">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) from sales of businesses and investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTItMS0xLTEtNDcyODQ_1de29969-ba2e-4056-a5e1-07fceb0f26dd">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTItMy0xLTEtNDcyODQ_f31c85b9-b5da-4329-b0b2-3028de31c0ff">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">European businesses held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTMtMS0xLTEtNDcyODQ_ba45fef5-f0cc-424a-9e32-6451c12d5140">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTMtMy0xLTEtNDcyODQ_ba37a9be-cd1c-4f34-82bf-9921589c82ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTQtMS0xLTEtNDcyODQ_35cbcb53-605b-45c0-afa1-8cf78299d747">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTQtMy0xLTEtNDcyODQ_8d4bce20-fe29-4d7b-99ad-6fc3eeb4ba44">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTYtMS0xLTEtNDcyODQ_24715bcb-35eb-4ed3-98b9-edffcdc48322">1,925</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTYtMy0xLTEtNDcyODQ_f50b3dea-39d1-45aa-b17e-18b44b035d7d">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTctMS0xLTEtNDcyODQ_1a54efa9-e8d5-4dba-aad7-8ba7be0cc285">1,659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTctMy0xLTEtNDcyODQ_754ba64d-0625-45ef-b9f4-abce809d9975">2,046</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTgtMS0xLTEtNDcyODQ_ff9250af-9bc0-41c9-9f68-f23913864f69">1,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTgtMy0xLTEtNDcyODQ_2e2fa3df-f64e-43a5-87a9-ca80f1abc6ac">1,240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTktMS0xLTEtNDcyODQ_ab6fee7c-0943-4220-9f84-d47cd432f3fb">276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTktMy0xLTEtNDcyODQ_c85e325d-34ea-4728-9046-2c2404ff87a1">291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjAtMS0xLTEtNDcyODQ_e3804951-bdb0-4f56-8cdb-ebbb8313160e">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjAtMy0xLTEtNDcyODQ_1767a507-f46d-4349-9e98-9beb24c4bf8f">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjEtMS0xLTEtNDcyODQ_aa0b164f-3f5c-4c16-939f-8cd938f9f9cd">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="mck:IncreaseDecreaseInLitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjEtMy0xLTEtNDcyODQ_3411f144-2067-4ab9-b27a-219929a03d98">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjItMS0xLTEtNDcyODQ_0fd514d7-3fd1-428d-889d-742d2e0f0eb8">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjItMy0xLTEtNDcyODQ_8fbfce65-543f-4ee7-8dce-9e6b6b195ee3">403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjMtMS0xLTEtNDcyODQ_31b67bc0-ee2e-447c-87de-c8b5d0322244">1,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjMtMy0xLTEtNDcyODQ_e5f13703-ecd9-482c-b397-d0859060d217">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjYtMS0xLTEtNDcyODQ_25589a87-a56e-4f81-9ce2-746e94884403">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjYtMy0xLTEtNDcyODQ_67dd82ea-4fc8-4f5b-a61f-517b769d3320">293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized software expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjctMS0xLTEtNDcyODQ_3be7449f-d627-48e0-be78-fb3776d392e3">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjctMy0xLTEtNDcyODQ_ef1dc6c8-d0c8-4959-a596-f84db6593d60">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjgtMS0xLTEtNDcyODQ_7b377ce8-d330-4847-9223-4c8d970d5d49">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjgtMy0xLTEtNDcyODQ_61988dd5-f20a-4cb3-8315-727d91f62968">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of businesses and investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjktMS0xLTEtNDcyODQ_23a11162-abe1-4442-b48c-2a51e4f959c4">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjktMy0xLTEtNDcyODQ_0551ae0e-dbbf-43fc-9a22-0d9f32847a37">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzAtMS0xLTEtNDcyODQ_51447257-e60c-4828-8729-408575fdd723">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzAtMy0xLTEtNDcyODQ_0c819f8b-20c1-48ca-b100-ab5842047fc8">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzEtMS0xLTEtNDcyODQ_295d387a-efac-49fc-90ea-95b1193b6f5c">272</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzEtMy0xLTEtNDcyODQ_9b5d429e-4aff-420e-ab01-30118c21357a">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzQtMS0xLTEtNDcyODQ_5763eac9-b59e-4926-8831-6cf86dc8dc73">3,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzQtMy0xLTEtNDcyODQ_9a220388-0258-4a6d-8828-6bf21883c067">5,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzgtMS0xLTEtNDcyODQ_cc4fd4a8-5055-4525-adda-7e63c02b3b0c">3,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzgtMy0xLTEtNDcyODQ_859c7a70-4b40-4311-9bd5-525ee7627c7c">5,303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuances of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzktMS0xLTEtNDcyODQ_988c5bde-32b7-4b05-8e08-38ec7d86d5f3">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzktMy0xLTEtNDcyODQ_9db8b2c3-3e58-4f1b-9b02-21e4dd7c3725">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDAtMS0xLTEtNDcyODQ_834ab430-5c7f-4229-93f3-e3cc730610cf">1,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDAtMy0xLTEtNDcyODQ_f4ada092-3176-4811-aef7-7f83c7afa0dd">1,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for debt extinguishments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDEtMS0xLTEtNDcyODQ_4a1c5fcd-d8e0-478c-9797-8cadb5fe0b56">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDEtMy0xLTEtNDcyODQ_2cdecdbf-5a5d-4882-a4e5-edbffb686c9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDMtMS0xLTEtNDcyODQ_b8e5b1b9-76d4-467a-bf8e-54281ed45057">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDMtMy0xLTEtNDcyODQ_3227703f-cef1-4daa-b036-46d0e9f731d9">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDQtMS0xLTEtNDcyODQ_5e935a7a-e2fa-4717-b173-c6c609a5139b">1,986</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDQtMy0xLTEtNDcyODQ_08ed7e6e-a6d3-47d0-93ee-dcb52c032f6b">500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDUtMS0xLTEtNDcyODQ_c2f2f41b-79ae-4de8-8630-f0da79cb9c92">206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDUtMy0xLTEtNDcyODQ_f464891b-a622-4494-b9a4-244e4e3b8b3e">209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDYtMS0xLTEtNDcyODQ_8c4722d3-d872-4013-b194-9eecd6f77db1">1,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDYtMy0xLTEtNDcyODQ_452670d2-6fdf-471d-b220-007aab08763f">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDctMS0xLTEtNDcyODQ_b64bf8b2-8861-43e1-90ba-50df6854875d">323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDctMy0xLTEtNDcyODQ_b4d63b82-835a-4038-9663-30a4e8ae4263">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDgtMS0xLTEtNDcyODQ_b49dd416-84c0-4922-b455-66ca53c143ec">4,332</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDgtMy0xLTEtNDcyODQ_0cfc2b7f-b725-4cd6-bf77-b852f31ac873">1,176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDktMS0xLTEtNDcyODQ_c41a0174-858f-4a19-8b0e-9f52786d5244">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDktMy0xLTEtNDcyODQ_d086eece-0c6e-40f9-b89b-b02d9a84b31a">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash classified within Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTAtMS0xLTEtNTM3MjA_7b3aa86c-11ed-48a9-9dd8-77cec0ecab30">215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTAtMy0xLTEtNTM3MjA_63b6d921-ff4f-4e80-8aee-cdbf80a45086">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTAtMS0xLTEtNDcyODQ_c65e5b7c-e8b3-49b5-b7f9-33e41537e43d">3,237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTAtMy0xLTEtNDcyODQ_6f545269-da92-4983-8f76-2f0b8dcdcd48">291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTEtMS0xLTEtNDcyODQ_9a39bcde-7857-42ae-bddc-d1d46328fc19">6,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd3b8f0b9fb4e3b80f26f6a286a8c4c_I20200331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTEtMy0xLTEtNDcyODQ_8af227a5-de5e-4ad3-ae20-ad26a01d5810">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTItMS0xLTEtNDcyODQ_ca9586af-6d18-4191-a16d-929238d00354">3,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b029a90e9640e6a41de2c763149aec_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTItMy0xLTEtNDcyODQ_fdc7fdbe-1742-4947-b02d-ee4bbcc9751c">3,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Restricted cash at end of period included in Prepaid expenses and other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTMtMS0xLTEtNDcyODQ_5bf7e09c-52ad-4e6c-ba0b-c0b4698ae35d">405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92b029a90e9640e6a41de2c763149aec_I20201231" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTMtMy0xLTEtNDcyODQ_218c5f9d-d8e6-4e15-affc-6337ea2fbf16">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTUtMS0xLTEtNDcyODQ_a918fd6c-c8b8-4396-99d5-5ec7b383b232">2,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b029a90e9640e6a41de2c763149aec_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTUtMy0xLTEtNDcyODQ_1e50e691-a8d7-4b75-b8f6-bb80512afcec">3,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_31"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_34"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY2OA_538a51ba-966c-4521-afb8-a376feb7deec" continuedAt="i0661e10d54454372afd74fc64f055236" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i0661e10d54454372afd74fc64f055236" continuedAt="id7dc48d3327c42d0810c92fb1aa9d8db"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations in healthcare to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. The Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNTcx_463d7fc6-8d21-4d8d-b29d-45115b5bdf9c">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; for more information.</span></div><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY4NA_448b9c6a-8d5c-4383-9d72-9ac39aa3fd5e" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY5OA_f54b7431-7898-4b06-a448-bef0ce51cb11" escape="true">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic. As COVID-19 further evolves, the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ComparabilityOfPriorYearFinancialData" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY3OQ_60374c9e-bed0-442f-ba09-1f6194d0c6c0" escape="true">The results of operations for the three and nine months ended December 31, 2021 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, previously filed with the SEC on May&#160;12, 2021 (&#8220;2021 Annual Report&#8221;).</ix:nonNumeric> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY4Ng_dd8793e8-1a53-40e8-907b-2f0bc6893fb9" escape="true">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY5MA_bee877ca-4194-4a5c-810d-b507f5e505e6" escape="true">Certain prior year amounts have been reclassified to conform to the current year presentation.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id7dc48d3327c42d0810c92fb1aa9d8db"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY4Mw_f3da760e-04cb-4835-a80c-389eb4e931c3" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div></ix:nonNumeric></ix:continuation><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_37"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfNTA0NQ_98dfb516-2c64-48f0-8844-30e3d8f0d21c" continuedAt="ie5f4ba9a31de44e8affa3b6cbaaf7b08" escape="true">Held for Sale</ix:nonNumeric></span></div><ix:continuation id="ie5f4ba9a31de44e8affa3b6cbaaf7b08" continuedAt="id054498fb7144fe2819642e400538177"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe. <ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="mck:HeldForSalePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfNTA0Ng_b73344ec-7e2f-4e17-8802-cce9ea7dd3a3" escape="true">Assets and liabilities of certain European businesses to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group.</ix:nonNumeric> Assets and liabilities that have met the classification of held for sale were $<ix:nonFraction unitRef="usd" contextRef="i309bd0e5ce434017a3985a239297e197_I20211231" decimals="-8" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA1NQ_f1ba2af1-b4fd-4806-ab6e-f3a2fdfac114">5.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i309bd0e5ce434017a3985a239297e197_I20211231" decimals="-8" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA2Mg_37728971-d4b6-4b66-94b1-c7a967df5ae9">4.8</ix:nonFraction> billion, respectively, at December 31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="if55a1f085e0849c78909dea0bbe21536_I20210331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5MA_5a8f2052-383b-42b5-8cc5-ccf3d620762a">12</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if55a1f085e0849c78909dea0bbe21536_I20210331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5Nw_f9d1dbd5-002a-4ab0-a220-1a1a0b1094b1">9</ix:nonFraction> million, respectively, at March 31, 2021. The amounts at December 31, 2021 primarily consisted of disposal groups related to the Company&#8217;s European divestiture activities, as discussed below. During the three and nine months ended December 31, 2021, the Company recorded charges totaling $<ix:nonFraction unitRef="usd" contextRef="i9e504a0e274543e69fed9f79303ad80e_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1MTA3Ng_7112d60c-6770-449e-8e22-21d74d3b717f">879</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ibe12fecbb15d4762ad018564eb3bf31a_D20210401-20211231" decimals="-8" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1MTA5MA_d91f9334-8414-449d-a910-f52542f20b28">1.4</ix:nonFraction>&#160;billion, respectively, primarily to remeasure the assets and liabilities of the disposal groups related to European divestiture activities discussed below to the lower of their carrying value or fair value less costs to sell. These charges were largely driven by declines in the British pound sterling and the Euro. During the three and nine months ended December 31, 2020, the Company recorded losses of $<ix:nonFraction unitRef="usd" contextRef="i4bc2bdbef58a40d19661323d7b54990c_D20201001-20201231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1MTAyMg_0450b368-8326-417f-9462-e51f8b0874c8">47</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iddc5a92071754307af41a34bc9c1f1ea_D20200401-20201231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1MTA1NQ_0906cba0-a800-42f2-9192-c87e6b1028d5">57</ix:nonFraction>&#160;million, respectively, related to the contribution of its German pharmaceutical wholesale business to the joint venture with Walgreens Boots Alliance which was completed on November 1, 2020. The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#8220;E.U.&#8221;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;<ix:nonFraction unitRef="eur" contextRef="i64c3f8f2f25f4734b8e1b0d9bbbae72c_I20210705" decimals="-8" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDIzNQ_8877ebe5-f9bb-4cc4-8285-9b8506b4f08b">1.2</ix:nonFraction> billion (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i64c3f8f2f25f4734b8e1b0d9bbbae72c_I20210705" decimals="-8" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDIyNQ_df5a5f1d-603d-41c6-8f89-4ab30aa2fa7b">1.4</ix:nonFraction> billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. The transaction is anticipated to close within the first half of fiscal year 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable. As of December 31, 2021, the E.U. disposal group, consisting of $<ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-8" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMjM0NQ_9ce348c0-322a-415f-9c16-d0cfe1a11434">3.1</ix:nonFraction> billion of assets and $<ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-8" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMjM2Mg_610bc4b2-6376-4f86-b21d-ccf631976d52">2.3</ix:nonFraction> billion of liabilities primarily within the Company&#8217;s International segment, was classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2021, the Company recorded charges totaling $<ix:nonFraction unitRef="usd" contextRef="i5b4ca1a6e16e4bbeb9da4a62c3265a52_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1MjI5MQ_33a8da34-e338-4d25-b9d7-2fbead7c34ce">26</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if374ea59631143b09b6e3e2a5671193c_D20210401-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMjYzMQ_9a26cc4a-6705-48c9-9b69-f004e0a49505">517</ix:nonFraction>&#160;million, respectively, to remeasure the E.U. disposal group to the lower of its carrying value or fair value less costs to sell. These charges also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole. The remeasurement adjustment includes net losses of $<ix:nonFraction unitRef="usd" contextRef="if374ea59631143b09b6e3e2a5671193c_D20210401-20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMjk3Ng_e8b8c63c-9ea3-4a02-b7cf-7baa0e43c116"><ix:nonFraction unitRef="usd" contextRef="i5b4ca1a6e16e4bbeb9da4a62c3265a52_D20211001-20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMjk3Ng_efbec70b-50ce-4aa6-b7d2-1dcd7e616c23">230</ix:nonFraction></ix:nonFraction> million related to the accumulated other comprehensive income balances associated with the E.U. disposal group, driven by declines in the Euro. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id054498fb7144fe2819642e400538177" continuedAt="ia0c842b866a94a81878e5fa294e2834f"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfNTA0Mw_771fc291-c15c-4d67-aa11-6828d13e63c5" continuedAt="ib772d72e9ab04d6ab4a20e54c8363992" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMy0xLTEtMS00NzI4NA_20866763-29ef-4662-9a21-3ebed43cd120">1,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfNC0xLTEtMS00NzI4NA_012d83f3-318a-4d5c-861a-0d52761bdd94">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfNS0xLTEtMS00NzI4NA_840fbed0-3cc8-4489-b7fb-aae48b4ac694">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfNi0xLTEtMS00NzI4NA_afa20dee-6fc1-4043-a9d4-68cddac36204">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfNy0xLTEtMS00NzI4NA_c141a84b-2803-4f5f-bc52-6400d4999f80">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfOC0xLTEtMS00NzI4NA_4162f4aa-9811-4379-bf3d-0b2c179cb77f">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfOS0xLTEtMS00NzI4NA_4020a185-8529-45e2-a1e9-7961622a5553">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTAtMS0xLTEtNDcyODQ_b2eee9cf-7b68-4489-a534-544375d02cd3">387</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTEtMS0xLTEtNDcyODQ_050e3a29-d59f-4e69-8021-0fab9d237068">3,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTUtMS0xLTEtNDcyODQ_ba118ab4-a5cb-428e-abee-e28a3bc21d17">1,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTYtMS0xLTEtNDcyODQ_b521e732-ded5-4c90-9a40-8ffbe64e8436">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTctMS0xLTEtNDcyODQ_eacb7dc7-bd9a-4928-b461-650a8ce5ec8f">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTgtMS0xLTEtNDcyODQ_37d5b994-4ed3-4053-a89d-7c731c0ac034">440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTktMS0xLTEtNDcyODQ_dd1fc9db-f882-4390-a1d3-6fbc91ab46e7">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMjAtMS0xLTEtNDcyODQ_5a2516a6-dfe3-4071-8265-f60f404dc339">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMjEtMS0xLTEtNDcyODQ_158615ed-5e82-4d26-aaf9-557ab9743ef4">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMjItMS0xLTEtNDcyODQ_ae83d35e-f336-4b07-9009-0a2413486704">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMjMtMS0xLTEtNDcyODQ_e3ced062-d193-4cab-9cd1-62c7d3f0a23c">2,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges related to the impairment of individual assets, which are primarily comprised of a $<ix:nonFraction unitRef="usd" contextRef="i6f779261e3804b478a035d030ffeb926_D20210401-20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMzc4OQ_0bd62298-56ff-40e5-b5ba-74c343a9d289">113</ix:nonFraction> million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2021, the Company announced an agreement to sell its retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;<ix:nonFraction unitRef="gbp" contextRef="i8aadd60f8b644a8ba5a20fae10cb7b86_I20211101" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDI3MA_358458aa-c64a-45c4-b361-b942b8af1339">325</ix:nonFraction>&#160;million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i8aadd60f8b644a8ba5a20fae10cb7b86_I20211101" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDI3Nw_933dc2e7-d18b-4ca8-954f-38da71e5724d">440</ix:nonFraction>&#160;million), subject to certain adjustments. As of December 31, 2021, the U.K. disposal group, consisting of $<ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-8" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDI1MQ_ca4d1b3a-8d91-4fc2-a527-e544c5c3c7fd">1.9</ix:nonFraction>&#160;billion of assets and $<ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-8" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDI1Nw_3ef5e8e2-ba06-4ebd-a241-3276398d270b">2.3</ix:nonFraction>&#160;billion of liabilities primarily within the Company&#8217;s International segment, was classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheet. The transaction is expected to close in the fourth quarter of 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2021, the Company recorded charges totaling $<ix:nonFraction unitRef="usd" contextRef="i7a2ecac161104759a17bcb76d94a2b91_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTYzNjI5MQ_cbea14f1-9edb-4012-9985-819bbce44d99"><ix:nonFraction unitRef="usd" contextRef="i7b6587768d5e4ba2b267df62494974ef_D20210401-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTYzNjI5MQ_d4b85730-318c-44e0-b2ee-f949b73d3942">823</ix:nonFraction></ix:nonFraction>&#160;million to remeasure the U.K. disposal group to the lower of its carrying value or fair value less costs to sell. The remeasurement adjustment includes a $<ix:nonFraction unitRef="usd" contextRef="i7a2ecac161104759a17bcb76d94a2b91_D20211001-20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTYzNjMwNQ_f62d3c0d-7004-4182-9d61-7712275ef58f"><ix:nonFraction unitRef="usd" contextRef="i7b6587768d5e4ba2b267df62494974ef_D20210401-20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTYzNjMwNQ_f77a8146-1787-429b-b740-41412d5e2350">731</ix:nonFraction></ix:nonFraction>&#160;million loss related to the accumulated other comprehensive income balances associated with the U.K. disposal group, driven by declines in the British pound sterling. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the U.K. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy. </span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ia0c842b866a94a81878e5fa294e2834f"><ix:continuation id="ib772d72e9ab04d6ab4a20e54c8363992"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the U.K. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMy0xLTEtMS01NDU3OQ_d939ea0b-65dc-468b-a0b6-ff4e57ec6529">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMy0xLTEtMS00ODc4OQ_4cb28b95-b59c-48b8-87cf-494f8b9c293a">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfNC0xLTEtMS00ODc4OQ_b49bab5f-47ab-43f7-87fc-143e374dce6a">698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfNS0xLTEtMS00ODc4OQ_f8be62d5-e499-4758-8399-6fafdd15468a">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfNi0xLTEtMS00ODc4OQ_aa16dd61-2ec6-45fd-a19d-82aef318d294">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfNy0xLTEtMS00ODc4OQ_d5c526a4-f5e3-4f75-b165-dd0661b2794c">259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfOC0xLTEtMS00ODc4OQ_52e574e7-79ff-454b-b1d2-985bb430133c">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfOS0xLTEtMS00ODc4OQ_0ac2e91b-0b30-4d83-8439-a56de0f87eaf">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMTAtMS0xLTEtNDg3ODk_b3c9f737-7ce6-43ac-927f-386ef70c4285">822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMTEtMS0xLTEtNDg3ODk_6397d54e-7e59-45a4-956d-4a416222d365">1,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMTUtMS0xLTEtNDg3ODk_c75e281a-6e5e-4e8f-842e-5966da693883">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMTctMS0xLTEtNDg3ODk_0ee02ab3-5c62-4032-98b0-19be529786db">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMTgtMS0xLTEtNDg3ODk_1dfdc43e-59b5-4aa0-9e18-bfd387a42299">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMjEtMS0xLTEtNDg3ODk_5d79c552-4153-4313-a488-3faab0aba924">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMjItMS0xLTEtNDg3ODk_d57dc624-c967-4a85-8ae5-3119691619cf">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMjMtMS0xLTEtNDg3ODk_faf71233-ff32-4c77-ba61-455112ae2c61">2,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2021, the Company announced an agreement with Quadrifolia Management GmbH for a management-led buyout of its Austrian business for a purchase price of &#8364;<ix:nonFraction unitRef="eur" contextRef="icf6948803676498cbf4f702d46fd11ac_I20211220" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ2Njc4Mw_38d4e832-de58-48b1-ba0a-4f58ec6da849">226</ix:nonFraction>&#160;million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="icf6948803676498cbf4f702d46fd11ac_I20211220" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ2Njc5Nw_7bfd3ed5-007c-4013-8dd9-b8116189de35">257</ix:nonFraction>&#160;million), subject to certain adjustments. At December 31, 2021, the net assets of the Austrian business of $<ix:nonFraction unitRef="usd" contextRef="i0914720c662a4ad59b56ab30f003e13e_I20211231" decimals="-6" name="us-gaap:AssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDM0Nw_502ce08a-a007-4ce3-8658-f4419f6eaaaa">290</ix:nonFraction>&#160;million, primarily within the Company&#8217;s International segment, were classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale&#8221; in the Condensed Consolidated Balance Sheet. The transaction closed on January 31, 2022. In the three and nine months ended December 31, 2021, the Company recognized a loss of $<ix:nonFraction unitRef="usd" contextRef="i90d1e84fd58d41a08c7559556cfa6e5e_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1NjkwNw_233ff5b0-37dd-4a07-abac-abf7ac309949"><ix:nonFraction unitRef="usd" contextRef="i0e0e546ae1e249039d79b3c361e64a24_D20210401-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1NjkwNw_aff591a2-996d-4097-b7c5-2bddbfa22fef">30</ix:nonFraction></ix:nonFraction>&#160;million to remeasure the assets and liabilities of the business to the lower of its carrying value or fair value less costs to sell. The charge was recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations.</span></div></ix:continuation><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_40"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDkxMQ_d5ea832a-3b2f-4aeb-8ff6-cf68f5e84f60" continuedAt="i61cd642747a64acd9cfdc8e793011f11" escape="true">Restructuring, Impairment, and Related Charges</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i61cd642747a64acd9cfdc8e793011f11" continuedAt="iaa3610adde8240ed8e0ecdd74763983b">The Company recorded restructuring, impairment, and related charges of $<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfODM_fa767fbf-a001-45f8-b0e6-0ffbb36172a0">18</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfOTA_1b284a85-d714-4cc0-842e-a19eed5708cc">208</ix:nonFraction> million during the three and nine months ended December 31, 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMTI2_db30fd78-acb2-450a-b46c-d719a8e0a93c">155</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMTMz_09638ab5-603f-4216-92d8-5be12b8eb1fe">271</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively. These charges are included in &#8220;Restructuring, impairment, and related charges&#8221; in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives were included in &#8220;Cost of sales&#8221; in the Condensed Consolidated Statement of Operations and were not material for the nine months ended December 31, 2020.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="iaa3610adde8240ed8e0ecdd74763983b" continuedAt="ic914d37bca4d414989f8e1bd5c4d0e80"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily includes the rationalization of the Company&#8217;s office space in North America. Where it determines to cease using office space, the Company plans to exit the portion of the facility no longer used. It also may retain and repurpose certain other office locations. The Company expects to incur total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i082db05a184a45abb24328a6c95b59c7_I20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfOTkw_2c2fa927-a723-456f-8390-c72ae9a5a68f">140</ix:nonFraction> million&#160;to $<ix:nonFraction unitRef="usd" contextRef="i890b4a0eb5514ad49a5ab0eda1744e3e_I20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfOTk2_cc1e9522-f855-4398-bac2-5899aed97670">180</ix:nonFraction> million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i278171a6be044601b82b45db97c44012_D20211001-20211231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMTE4Mw_dcb67157-6c54-48e5-9a81-2453ddd75208">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i67f5dae20f6d49a8b3c72b65242baec8_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMTE5MA_9cb01722-377d-4a75-aa2e-947ecf2a2466">115</ix:nonFraction> million, respectively, in the three and nine months ended December 31, 2021. Charges primarily relate to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative is anticipated to be substantially complete in 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative included reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Charges incurred for this initiative were not material for the three and nine months ended December 31, 2021 and were $<ix:nonFraction unitRef="usd" contextRef="i7ef12d06d22b408b9631eede48f318c6_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMjA5MA_d9e429df-d1d3-4871-8661-3a16b977ff2d">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if17bd5af058345ef8f80c5f477b1769a_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMjA5Nw_263e0a7c-64b3-4ab0-a32f-f6f1916a53f0">50</ix:nonFraction> million for the three and nine months ended December 31, 2020, respectively, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. This initiative was substantially complete in the third quarter of 2022, and remaining costs the Company expects to record under this initiative are not material.</span></div><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNzE0NjgyNTU4ODY1MA_cc028c5b-3b73-407c-b5f6-2fc51ce2ec7b" continuedAt="i1c7c633c692c4d0284398fb370e7dad9" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2021 consisted of the following: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi0xLTEtMS00NzI4NA_cce215d4-20fa-4d1d-afe2-40f2b7941bc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi0zLTEtMS00NzI4NA_dea8bcc5-af31-4016-8660-a8333c3737c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi01LTEtMS00NzI4NA_1122dd07-7d7d-4c00-9196-e098484326d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi03LTEtMS00NzI4NA_e7cf5c0b-5e73-4b68-b3c5-0f573bef1414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6255fa153b8b446d9bdaa92a69dc6082_D20211001-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi05LTEtMS00NzI4NA_09266f39-ee70-46b7-9a0c-8e7c0b2ff28f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi0xMS0xLTEtNDcyODQ_3ff00c10-a15b-4b8c-888f-882042358397">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy0xLTEtMS00NzI4NA_bd9b0c28-d949-48d2-ae3c-a95ca02bf7a8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy0zLTEtMS00NzI4NA_f2347c21-489e-435d-8763-2389ef92b5b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy01LTEtMS00NzI4NA_ddd465fe-912d-4714-a60c-d0c3a8b71699">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy03LTEtMS00NzI4NA_7ac8840b-6747-4788-813f-577e62d94e31">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6255fa153b8b446d9bdaa92a69dc6082_D20211001-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy05LTEtMS00NzI4NA_9ce7db68-c928-4603-8ff9-bba7db4c3fac">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy0xMS0xLTEtNDcyODQ_67434f82-d709-4204-accd-e47a5353222c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC0xLTEtMS00NzI4NA_fe4de353-1ff7-40dc-a6c9-07707da22013">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC0zLTEtMS00NzI4NA_7e54757e-91bb-4add-81cc-06413aa888f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC01LTEtMS00NzI4NA_28e0a0c4-0c89-4283-bb22-822d01cec97a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231" decimals="-6" sign="-" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC03LTEtMS00NzI4NA_5af9c37d-790d-4de9-88a5-1b8a887e8cef">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6255fa153b8b446d9bdaa92a69dc6082_D20211001-20211231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC05LTEtMS00NzI4NA_6588f4cf-027a-4adc-bd61-60418392e63b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC0xMS0xLTEtNDcyODQ_8759d22c-aa4a-4a29-875f-6677b2f14e9a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS0xLTEtMS00NzI4NA_21bc12ed-8044-4720-b120-d0033dcf648c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS0zLTEtMS00NzI4NA_1b20391b-efe4-4aef-a27f-74e8dad28836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS01LTEtMS00NzI4NA_514a043c-54c5-4eb2-8923-5a60344275d0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS03LTEtMS00NzI4NA_9aa74558-677b-4b09-93e6-806b86b96ee0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6255fa153b8b446d9bdaa92a69dc6082_D20211001-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS05LTEtMS00NzI4NA_e10ca9c6-0098-4d76-84f5-edf53f4b0aa6">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS0xMS0xLTEtNDcyODQ_68351941-8638-49aa-b1e3-d7d36523e241">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ic914d37bca4d414989f8e1bd5c4d0e80" continuedAt="iebca0a307ae34da9babea05981bbe9a2"><ix:continuation id="i1c7c633c692c4d0284398fb370e7dad9"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi0xLTEtMS00NzI4NA_d03470e9-8dff-4479-8982-5ba742386435">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi0zLTEtMS00NzI4NA_080c064f-13fc-4307-a1ad-2ff435e97bc6">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi01LTEtMS00NzI4NA_e51c1688-9e67-477b-9656-6de99acd8c6d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi03LTEtMS00NzI4NA_d5f179dc-8c41-4701-9e53-f92cf441c299">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi05LTEtMS00NzI4NA_385598f0-7376-412e-9b5a-50dba839f67e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi0xMS0xLTEtNDcyODQ_dc293104-02a2-43a8-bc43-00af0166e3f2">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy0xLTEtMS00NzI4NA_d9627435-d889-41c4-8260-c04cad241f1a">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy0zLTEtMS00NzI4NA_45921e7d-df7e-4855-9d10-082a5d9cedf3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy01LTEtMS00NzI4NA_df3117c9-70fb-4382-9cbe-e709018ca072">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy03LTEtMS00NzI4NA_7e257cea-50d1-43e3-87a7-addc0def2ec7">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy05LTEtMS00NzI4NA_1614ea6f-373a-47b8-ac8c-878ceb9beaad">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy0xMS0xLTEtNDcyODQ_74c23d41-572a-4387-b9e3-3b5bd1cac286">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC0xLTEtMS00NzI4NA_2f83c874-6c11-45fe-9ca0-0302a6cc390a">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC0zLTEtMS00NzI4NA_7d617949-eeda-4501-9951-c394d6aeb9e2">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC01LTEtMS00NzI4NA_ad8e4b71-647c-4434-aabd-9e929963c0d4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC03LTEtMS00NzI4NA_d733ed40-41e8-4ae6-b907-e0cff00f1347">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC05LTEtMS00NzI4NA_4c428d73-0f35-4b92-b3b2-d3b3029d33b4">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC0xMS0xLTEtNDcyODQ_85993b49-63e3-464f-aa6a-0a41841616d7">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS0xLTEtMS00NzI4NA_faed0162-5467-4e70-9eaf-a66b7075b1f7">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS0zLTEtMS00NzI4NA_885f696a-6c49-47d7-9a80-359e41c675c0">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS01LTEtMS00NzI4NA_2ebf9a25-8993-4cb6-b039-d9280146fa93">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS03LTEtMS00NzI4NA_a9ef0e8c-d450-4fc2-b24b-57621ca36602">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS05LTEtMS00NzI4NA_f0127312-a647-49ea-ad72-2cccf31d8637">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS0xMS0xLTEtNDcyODQ_d378e51d-e7b2-465b-be27-1a8c38d65078">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs related to optimization programs in Canada as well as the transition to a partial remote work model and the U.K. operating model and cost optimization efforts both described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2020 consisted of the following: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi0xLTEtMS00NzI4NA_4de7af2a-088d-4d4b-8784-09bd3a2862d5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi0zLTEtMS00NzI4NA_431a9ba9-88f0-407a-b3a8-7f628788c86d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi01LTEtMS00NzI4NA_94dcb014-4af5-4adf-8fad-4482e248060a">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi03LTEtMS00NzI4NA_a7d9a340-cd2d-4028-8a5c-78d528ab1c6e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi05LTEtMS00NzI4NA_8eeedfe4-06a4-4937-a0e6-8fc151e188fd">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi0xMS0xLTEtNDcyODQ_bd274653-d09a-40c1-9dff-c8616ec4b898">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy0xLTEtMS00NzI4NA_4ce54fbb-baa8-4186-8315-ea8ee2f00c96">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy0zLTEtMS00NzI4NA_8f0bbe84-b704-429e-8bf5-81aa8e992e7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy01LTEtMS00NzI4NA_6a3e797d-e7d8-43fc-b94c-b5ab3c54dc88">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy03LTEtMS00NzI4NA_89c07d08-3074-41a9-9e3e-6f8da230654d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy05LTEtMS00NzI4NA_ea7cebfc-325e-4585-b9f5-d5aa8471073a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy0xMS0xLTEtNDcyODQ_2d58397f-d20a-4072-a04a-6bc07ae95198">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC0xLTEtMS00NzI4NA_3a91caae-92ef-4356-8ca3-7ca1a4c67b60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC0zLTEtMS00NzI4NA_161019cb-a9b3-4c0e-842d-40d3228e071a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC01LTEtMS00NzI4NA_e02a9201-b138-43dd-bebb-aef60c5cf6e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC03LTEtMS00NzI4NA_467d030a-2569-4ea6-9adf-6ab209e98478">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC05LTEtMS00NzI4NA_fbc3d3d2-13c1-4083-a9fc-5017488238da">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC0xMS0xLTEtNDcyODQ_9f20a42b-0c66-4ae6-b2f9-468c62669278">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS0xLTEtMS00NzI4NA_f21b19e3-96f0-4dc6-b6c8-a473fb6d5814">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS0zLTEtMS00NzI4NA_1a196fec-d853-4f06-b36a-17b8a7995d76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS01LTEtMS00NzI4NA_049b132a-d647-49b4-840d-b8444b7485fc">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS03LTEtMS00NzI4NA_0f191a83-abd9-4e32-8cca-b3599d6507af">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS05LTEtMS00NzI4NA_f426ae8f-51ba-465d-b286-1ffcc9506020">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS0xMS0xLTEtNDcyODQ_c8e72e42-003d-445c-92b9-a1ae76d00e7b">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with an operating model and cost optimization initiative and with the relocation of the Company&#8217;s corporate headquarters. Both of these initiatives were substantially completed in the year ended March 31, 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi0xLTEtMS00NzI4NA_50c4dc24-16eb-45ae-8060-1306319c5b47">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi0zLTEtMS00NzI4NA_04ab3008-43ce-4411-9c1f-b9e25d556e12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi01LTEtMS00NzI4NA_ea1fe7b7-f654-4320-ae9a-95a659b6f1bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi03LTEtMS00NzI4NA_20ef510c-b835-4267-8b34-e6c666da56e9">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi05LTEtMS00NzI4NA_1d0c5ce8-9150-4142-9433-03c225663c3c">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi0xMS0xLTEtNDcyODQ_d0fae2cc-e5db-4e81-9aa7-180a36a38cd1">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy0xLTEtMS00NzI4NA_67037302-162d-4fd4-b044-46641d7b8870">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy0zLTEtMS00NzI4NA_4c230f02-b5f3-4801-9d88-2e63de2179b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy01LTEtMS00NzI4NA_e0c38116-6249-4505-a925-1bb2b2aec7f1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy03LTEtMS00NzI4NA_77b82759-ad8f-46e8-832a-b0737bcafdf3">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy05LTEtMS00NzI4NA_8c11a95c-8b19-4171-a444-a56c9d4d1383">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy0xMS0xLTEtNDcyODQ_40bb3922-ce2b-4bb3-9543-1a501a4d06d6">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC0xLTEtMS00NzI4NA_38bc2d64-3c9f-47fe-8778-6b8cdb900ec5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC0zLTEtMS00NzI4NA_45c422a5-871f-437e-b4ee-f7f11329a2a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC01LTEtMS00NzI4NA_293f4484-8902-4041-abae-a89dda4e56c7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC03LTEtMS00NzI4NA_3deef6db-9d19-4cf3-a569-6596536eaaeb">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC05LTEtMS00NzI4NA_c15c835c-312c-4087-b538-f3c00f4e9ff0">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC0xMS0xLTEtNDcyODQ_6e160929-707c-4fbc-b2fc-c05d533f3e0b">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS0xLTEtMS00NzI4NA_0ee8390d-0992-43df-9327-25012d3668ba">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS0zLTEtMS00NzI4NA_76e2cd15-1725-4f11-91a2-51cf4b5d7a8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS01LTEtMS00NzI4NA_86cf1247-813e-47a2-a001-4d7c9cda8e3e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS03LTEtMS00NzI4NA_63c91732-6693-4465-8b5f-d35716974ebd">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS05LTEtMS00NzI4NA_fa4cd0bd-35fd-414e-823d-6d530c3673bb">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS0xMS0xLTEtNDcyODQ_9b369804-5f03-4c2f-b6b9-06a20264a144">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above, and an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with an operating model and cost optimization initiative and with the relocation of the Company&#8217;s corporate headquarters. Both of these initiatives were substantially completed in the year ended March 31, 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="iebca0a307ae34da9babea05981bbe9a2"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNzE0NjgyNTU4ODY1MQ_2f3a19f4-455c-4e4e-9d90-1fb2f5fd97c7" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the nine months ended December 31, 2021:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3742a9e3c767428ca709e210fa6bad34_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS0xLTEtMS00NzI4NA_72ad49df-d52d-412f-96cd-605e6b9c55c8">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0a87db44d0d4d4182e198de1c5b21c4_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS0zLTEtMS00NzI4NA_e7b12359-bb6f-4960-bdd6-418d9ecb7ef0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8294a77ec53f4808af02d30170fb109a_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS01LTEtMS00NzI4NA_fc80393a-ffe8-4d0b-bd0e-1d96f6f1d5d2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0b19c69df049fa808f63371bd26ec9_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS03LTEtMS00NzI4NA_3e9dbc05-a660-4b23-9b6d-b90ea3c25ed2">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05d03e41b9ee4dcd81af0575a30e3f45_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS05LTEtMS00NzI4NA_fa82031d-6a57-47f3-accf-ee24f3d3fcc9">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS0xMS0xLTEtNDcyODQ_a02e874b-4b4c-4194-84e7-0e9f136dab97">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi0xLTEtMS00NzI4NA_af831fe3-eba5-4c9a-af07-9d75c1b725bc">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi0zLTEtMS00NzI4NA_2103a950-9a14-4730-abbb-7f195dee7179">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi01LTEtMS00NzI4NA_dfc496eb-fef7-4b54-9c4a-64e9134da69f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi03LTEtMS00NzI4NA_dc7440a0-4a68-4b0e-a391-2d87e5adcbcd">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi05LTEtMS00NzI4NA_1b6e4c17-5a97-4a88-b7fb-aac58f6e9e0a">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi0xMS0xLTEtNDcyODQ_bab09bc3-d47a-4372-bfaa-dec66489f503">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy0xLTEtMS00NzI4NA_cf07fa52-e344-42d8-9bfd-a06ccd71141a">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy0zLTEtMS00NzI4NA_10783241-b62b-42b5-a1e7-e0cb0b4e13ed">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy01LTEtMS00NzI4NA_acf0b7a9-a76a-49ae-a0e3-497198797ad1">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy03LTEtMS00NzI4NA_71781db9-1835-454b-9336-1223ce9c7d7e">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy05LTEtMS00NzI4NA_18dde85b-a3f4-497f-9476-4d18b52314c0">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy0xMS0xLTEtNDcyODQ_9dd39077-a37d-4c52-b7ff-8bcfb6ae43cf">128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC0xLTEtMS00NzI4NA_816a1720-3a79-478b-afff-4a5f56fede59">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC0zLTEtMS00NzI4NA_824889df-c540-4291-8823-18d1beb8e9d3">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC01LTEtMS00NzI4NA_ea946a97-01b3-4c53-ba7e-1a8c47fbda21">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC03LTEtMS00NzI4NA_c8973b74-bf37-4020-8383-54bc3a7f1922">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC05LTEtMS00NzI4NA_bf6832d6-80f1-4785-989e-91890a0afd07">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC0xMS0xLTEtNDcyODQ_e8ab5221-e363-4242-9482-51708316029c">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS0xLTEtMS00NzI4NA_5eda7f3f-181c-4e0e-adb0-af2d01f4ccd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS0zLTEtMS00NzI4NA_32effd0b-d1ac-4ff7-98d1-f2c1fca2dff6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS01LTEtMS00NzI4NA_1d2154e3-4ace-46a5-9238-fa7862d3c722">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS03LTEtMS00NzI4NA_a21e1c23-5d3a-42b4-94b3-a3323aeaa028">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS05LTEtMS00NzI4NA_603cdcb7-4e63-4a9f-9039-88f6257dca37">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS0xMS0xLTEtNDcyODQ_e7fa2419-34ec-40b2-bc32-34bbba79dd7b">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd134a4f3094ace932c748910dea417_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi0xLTEtMS00NzI4NA_412e9f46-c4e7-4bc7-afc3-f8bfaa5eed71">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa2ddeb82199484c81ead365111b0450_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi0zLTEtMS00NzI4NA_9b359af6-0a30-446a-8de5-b81319b67d0c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e1a134cedf416a93e2147fb33ab4a7_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi01LTEtMS00NzI4NA_713441ce-3293-4317-a827-635a21406653">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8490ed3cfc74500b6dec809af6c38fb_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi03LTEtMS00NzI4NA_c2ec6623-fad7-434c-ac38-fb312c695b5b">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f61357f5234a798f4dce41029f5202_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi05LTEtMS00NzI4NA_0d6fcff1-e337-4d81-81e5-61e2dfb299ee">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi0xMS0xLTEtNDcyODQ_bdf4db8d-8346-456b-8fe5-c8c6427d7a40">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2021, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDYxNg_435f627f-bbde-4069-a84e-5757857b02b5">151</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ib5673a7452c840fab96c68406dedc263_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDYyOQ_568e4014-7cc9-424a-8ee0-99f01dc4c029">99</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities&#8221; and $<ix:nonFraction unitRef="usd" contextRef="i3a02716128214d2eb9f7820b420c8182_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDY1Nw_0518c148-e2fa-45a9-884c-2a3cca79ab19">52</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of December 31, 2021, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDc2Nw_7395ee10-d55b-47ee-9c69-5b32d2d01aed">144</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ia211c26831c34274a5c1964a280c0daf_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDc4MA_9b9346d7-814b-471e-b2cc-eb34c54c8e42">52</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities,&#8221; $<ix:nonFraction unitRef="usd" contextRef="i74ddcf1aa661488db155891acc773561_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDgwNQ_dbc72818-a60a-4e14-a404-d61b7993f60b">44</ix:nonFraction> million was recorded in &#8220;Liabilities held for sale,&#8221; and $<ix:nonFraction unitRef="usd" contextRef="i009f49e0941d419aa250d05631fa2fba_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDgzNA_311d756f-f866-460d-87c4-17c9efdf9b9d">48</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Asset Impairments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="i4c351ccf073b47a9b3c10a8e07901940_D20201001-20201231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMjk2ODY4MTM5NjE5ODA_eacee2f5-87b1-451d-8db7-9439d01fdb06">115</ix:nonFraction>&#160;million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach (a discounted cash flow (&#8220;DCF&#8221;) method) and a market approach to estimate the fair value of the long-lived assets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the long-lived assets is considered a Level 3 fair value measurement due to the significance of unobservable inputs developed using company specific information. Refer to Financial Note 11, &#8220;Fair Value Measurements,&#8221; for more information on nonrecurring fair value measurements.</span></div></ix:continuation><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_43"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMzM1NA_ad11fd0e-2327-4095-b049-f87fc2afa960" continuedAt="i5a71659adbfe4c8182106b21ff4bf730" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="i5a71659adbfe4c8182106b21ff4bf730" continuedAt="ia1dc392a88c2489b8b5c433ff0c129ae"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021 and 2020, the Company recorded income tax expense of $<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjIxOA_1a731332-1f9c-49d2-be26-f9e5532d4483">238</ix:nonFraction> million and an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-8" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjIyNQ_056721ba-2706-4f59-87e8-003f4cdcef60">1.2</ix:nonFraction> billion, respectively. During the nine months ended December 31, 2021 and 2020, the Company recorded income tax expense of $<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjIzMg_8f85f4ed-c01b-4d15-8e0d-532eb1749073">396</ix:nonFraction> million and an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-8" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjI0Mg_0467ab58-ae9e-4672-81c3-2a9d8c2f44d2">1.0</ix:nonFraction> billion, respectively. The Company&#8217;s reported income tax expense rate was <ix:nonFraction unitRef="number" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjI1Mw_3e9a3610-d4f9-45a8-a6e7-67c4b2d24a6b">85.9</ix:nonFraction>% and an income tax benefit rate of <ix:nonFraction unitRef="number" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjI1Nw_1f40d39b-c73a-4084-854b-502d6e23a125">16.1</ix:nonFraction>% for the three months ended December 31, 2021 and 2020, respectively, and an income tax expense rate of <ix:nonFraction unitRef="number" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjI2MQ_3e70a230-f41c-4cf1-b0d3-cbab4fd5443d">30.9</ix:nonFraction>% and an income tax benefit rate of <ix:nonFraction unitRef="number" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjI2NQ_b2c6d511-74e8-4fa8-a994-701804f9f943">16.7</ix:nonFraction>% for the nine months ended December 31, 2021 and 2020, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to non-cash charges related to remeasuring the value of its E.U. and U.K disposal groups held for sale to the lower of its carrying value or fair value less costs to sell, changes in the mix of earnings between various taxing jurisdictions, and discrete items recognized in the quarters.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended December 31, 2021, the Company recorded non-cash pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i53948167a7da4f68be6121c6d4840331_D20210401-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfNzcy_f5533b8a-55a2-4e8a-b1af-4d8bd916306c">517</ix:nonFraction> million primarily to remeasure the E.U. disposal group to the lower of its carrying value or fair value less costs to sell, and, during the three and nine months ended December 31, 2021, the Company recorded non-cash pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i262128f4e5f940ada5343a7bf5fe0a97_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjM3OQ_43affdd0-a03f-4509-b439-4927794d351e"><ix:nonFraction unitRef="usd" contextRef="i6f49b1ee7cfe4b72a4014ddd42947be3_D20210401-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjM3OQ_9a3f28be-8801-4a1c-866e-91fa8f144131">853</ix:nonFraction></ix:nonFraction> million to remeasure the U.K. disposal group and the Austrian business to the lower of carrying value or fair value less costs to sell, as described in Financial Note 2, &#8220;Held for Sale.&#8221; The Company&#8217;s reported income tax rates for the three and nine months ended December 31, 2021 were unfavorably impacted by the non-deductible nature of the majority of these charges for income tax purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rates for the nine months ended December 31, 2021 and 2020 were impacted by the charges for opioid-related claims of $<ix:nonFraction unitRef="usd" contextRef="i6b6bcdc79602464fb68d237e91f2c420_D20210401-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMzQwNw_206f7b06-99e6-440c-9932-bd0af31d5150">193</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="i6b6bcdc79602464fb68d237e91f2c420_D20210401-20211231" decimals="-6" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMzM4OQ_f9d2fc0f-0cd4-48fb-970e-db5248481b8d">160</ix:nonFraction> million after-tax) and $<ix:nonFraction unitRef="usd" contextRef="i96393cf84f184dd1a34604191f7e8463_D20200401-20210331" decimals="-8" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMzM1Mw_247f30ed-c3e9-4151-bb50-4aa4949e0d71">8.1</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="i45576a15c2784ff6aa60281bbbd7fc94_D20200401-20201231" decimals="-8" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMzM3MQ_4338fa19-49ce-4a27-96e5-a189653762ad">6.7</ix:nonFraction> billion after-tax), respectively, as described further in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ia1dc392a88c2489b8b5c433ff0c129ae"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company recognized a net discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" sign="-" name="mck:EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTE5MQ_8daee0c2-1571-4779-8f79-d6b55673f256">42</ix:nonFraction> million primarily related to a decrease in the income recognized pursuant to the global intangible low-tax income (&#8220;GILTI&#8221;) regime in its 2021 U.S. Federal income tax return and the statute of limitation expirations in various taxing jurisdictions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended December 31, 2020, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gain was eliminated upon consolidation. The acquiring entity of the intellectual property is entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; a discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="mck:IncomeTaxExpenseBenefitDiscreteItems" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTkwNA_2513c169-2e0b-4de0-b1ca-a086841b7c44">105</ix:nonFraction> million was recognized with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#8217;s excess tax basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-8" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMjIwNQ_5ad5b66e-68af-48ca-b105-893672f8987c">1.6</ix:nonFraction> billion of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-8" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMjI0Nw_d1565a04-acf2-4176-9937-f451a8e1846c">1.3</ix:nonFraction> billion would reduce income tax expense and the effective tax rate if recognized. During the nine months ended December 31, 2021, the Company recognized a net discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMjQwOA_1ec5ccf9-0027-4f28-8f3f-ff124f2b4a22">115</ix:nonFraction> million related to statute of limitation expirations in various taxing jurisdictions. During the next twelve months, the Company does not anticipate any material reduction in its unrecognized tax benefits. However, this may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.</span></div></ix:continuation><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_46"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDYwOQ_70e236ef-97d8-4be1-b57d-5e099275493b" continuedAt="ice20f3912be94890a52deac1c7c76abf" escape="true">Redeemable Noncontrolling Interests and Noncontrolling Interests</ix:nonNumeric></span></div><ix:continuation id="ice20f3912be94890a52deac1c7c76abf" continuedAt="ib5c3c43c739f43fdaa7e08f7ea51e568"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i36b8a9d0b6414497bb8f44ec79a79e4f_I20141231" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMzg4_70ec4ce1-c945-4d8d-b3ed-16e19b4bf5b4">0.83</ix:nonFraction> per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $<ix:nonFraction unitRef="usd" contextRef="i36e918c6183c4f78895df724b9cd04c0_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNTI3_4ecdcb66-a23e-4369-b6d2-69e5ec08a13e">8</ix:nonFraction> million during the three months ended June 30, 2021, and $<ix:nonFraction unitRef="usd" contextRef="i6ba029fe46a542dfbd04dc832ae15366_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNTc5_973129d6-af21-49cb-8a48-356be618d82a">11</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifd6ba103380e4fe88bf3646afc1959fd_D20200401-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNTg2_d3ae683d-db6c-4d04-ae81-5b04a1b63398">32</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively. All amounts were recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i29833bf67ca6476e970b86ed97f2e301_I20141231" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfOTgx_047658f3-b76a-44d4-9acc-46586c809e52">22.99</ix:nonFraction> per share, increased annually for interest in the amount of <ix:nonFraction unitRef="number" contextRef="i29833bf67ca6476e970b86ed97f2e301_I20141231" decimals="INF" name="mck:PutRightValueInterestRateSpread" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMTA0NA_7cf51ce0-74e9-45dc-ba0b-e757b8d9aa8d">five</ix:nonFraction> percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). Subsequent to the Domination Agreement&#8217;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#8220;Appraisal Proceedings&#8221;) with the Stuttgart Regional Court (the &#8220;Court&#8221;) to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified in the Domination Agreement. On September 19, 2018, the Court ruled that the Put Amount shall be increased by &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i74388bba79ec4594ae5515983a877ddf_I20180919" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePriceIncrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMTc5Mg_a2b85d6c-d34e-4219-9666-8969f468066b">0.51</ix:nonFraction> resulting in an adjusted Put Amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i74388bba79ec4594ae5515983a877ddf_I20180919" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMTgzNA_2e4ce109-a250-4e96-8b7e-f412ccc8fc2a">23.50</ix:nonFraction>. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount shall remain &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i92bc310247354b8c924fe8c7f5b5b506_I20210412" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjE5Mw_042612c8-d4e3-49f5-b376-86078ac728bb">22.99</ix:nonFraction>, thereby rejecting the lower court&#8217;s increase, and the recurring compensation remained at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="ic3993b3a21a449f38c8b6792da95b13e_I20210412" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjI4Ng_16a4f102-5a9e-45c5-9f84-990b850e2a6a">0.83</ix:nonFraction> per share.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ib5c3c43c739f43fdaa7e08f7ea51e568" continuedAt="ic5dc231dabe44ce9becddca6d5a49c43"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended December 31, 2021 and 2020, the Company paid $<ix:nonFraction unitRef="usd" contextRef="ic547f16da1eb490b8049506b5f0658f0_D20210401-20211231" decimals="-8" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjM1NQ_285a9eee-88a4-41ec-b300-5bf881752146">1.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ifd6ba103380e4fe88bf3646afc1959fd_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjM2Mg_bdbc3d37-e3c9-4ef4-b77a-b43090373312">49</ix:nonFraction>&#160;million, respectively, to purchase <ix:nonFraction unitRef="shares" contextRef="ic547f16da1eb490b8049506b5f0658f0_D20210401-20211231" decimals="-5" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjM5Mg_c286c9c0-cc19-4656-8045-66c37cb07d30">34.5</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="ifd6ba103380e4fe88bf3646afc1959fd_D20200401-20201231" decimals="-5" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjM5OQ_0d899292-1300-44c6-a65e-0a972cfbbf31">1.8</ix:nonFraction>&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $<ix:nonFraction unitRef="usd" contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjU4Mw_2299da69-6a42-457d-86ef-2a1a7dc78aea">983</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjU5MA_b52ee408-c59a-4cf0-ac44-48982fde7b20">49</ix:nonFraction> million, respectively, for the nine months ended December 31, 2021 and 2020, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $<ix:nonFraction unitRef="usd" contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjc0NQ_8e389df6-1d2a-42a4-9dd5-c7c614709562">178</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjc1Mg_8a2d3128-d66f-452a-b380-f24c1be01cb1">3</ix:nonFraction>&#160;million, respectively, as an increase to McKesson stockholders&#8217; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjk3Nw_0e7e3021-7092-437d-a021-4025bab551b9">287</ix:nonFraction> million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. Prior to expiration of the Put Right, the balance of the redeemable noncontrolling interests was reported as the greater of its carrying value or its maximum redemption value at each reporting date. At March 31, 2021, the carrying value of $<ix:nonFraction unitRef="usd" contextRef="i4eb5d4844c44421d8fe111518bf52e1d_I20210331" decimals="-8" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMzUxMw_bc859323-2dff-45bf-a5a7-3a43be7aad18">1.3</ix:nonFraction>&#160;billion exceeded the maximum redemption value of $<ix:nonFraction unitRef="usd" contextRef="i4eb5d4844c44421d8fe111518bf52e1d_I20210331" decimals="INF" name="mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMzU1Nw_86fd8b1f-34cc-4c74-931a-af8a317b60fa">1.2</ix:nonFraction> billion and the Company owned approximately <ix:nonFraction unitRef="number" contextRef="i4eb5d4844c44421d8fe111518bf52e1d_I20210331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMzU5Ng_1e5ad389-0283-4d71-a9db-be9985f81e9b">78</ix:nonFraction>% of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021 noncontrolling interests also represent minority shareholder equity interests in McKesson Europe. At December 31, 2021, the Company owned approximately <ix:nonFraction unitRef="number" contextRef="ib9fe220da3a84c2a9f05f0cdd2906fd0_I20211231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDA0Mg_e3811332-53a9-425e-8f38-9c4af19e32a6">95</ix:nonFraction>%, of McKesson Europe&#8217;s outstanding common shares. The Company&#8217;s noncontrolling interest in McKesson Europe will be included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#8220;Held for Sale.&#8221; The Company allocated $<ix:nonFraction unitRef="usd" contextRef="id82faee2169b4c03851f9e48fd63456a_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDI2Ng_af08426e-f12d-47ab-99e1-3bb28be272c9">46</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaa26af6e2fc04c6da537c566605c6805_D20210401-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDI3Mw_a8f570d6-bff2-41b0-8514-527384f6ab5e">128</ix:nonFraction> million of net income to noncontrolling interests during the three and nine months ended December 31, 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="idd14b94896e64108be04ae3457f1a609_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDM1MQ_cc0c5c8a-2a61-499d-9e6b-1036a814578d">41</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i13af6ba5a424438aa3988581a89555a8_D20200401-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDM1OA_121d05ca-a4c2-4771-ac75-125371f00ff2">120</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively.</span></div><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDYxNw_837f85c1-93c9-4cbf-8c2a-dbf8112b6c93" continuedAt="ia47622a3b3744e0582e2331d5e79d7a9" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c571fe607348cdab2a44a5f011467b_I20210930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMS0yLTEtMS00NzI4NA_cd6dea3d-b263-49b0-bcf1-2e4bc38a9789">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c40279fd2ae42f882d256f241b6eeb9_I20210930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMS00LTEtMS00NzI4NA_94501300-74a4-413a-a53b-565431c1ce43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMi0yLTEtMS00NzI4NA_1fd11318-93ca-49c8-a951-370b43c3dee3">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbf1847be9645d4a2fcb3f516d062d2_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMi00LTEtMS00NzI4NA_8019d0f9-991e-4995-ac44-4315ab329b13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMy0yLTEtMS00NzI4NA_f501ba6d-6072-46a3-8b26-5efe12784e37">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbf1847be9645d4a2fcb3f516d062d2_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMy00LTEtMS00NzI4NA_4e133a97-0259-44fe-9d98-f46c6e154888">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfNC0yLTEtMS00NzI4NA_e2eeefcb-088e-4f2c-b5c4-68553b0b92d1">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbf1847be9645d4a2fcb3f516d062d2_D20211001-20211231" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfNC00LTEtMS00NzI4NA_d9a51bad-88b8-4311-842e-5420002b4e77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfNS0yLTEtMS00NzI4NA_4fbc4795-26a1-49ae-9577-d33b65b072b4">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbf1847be9645d4a2fcb3f516d062d2_D20211001-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfNS00LTEtMS00NzI4NA_c990d61d-3c2a-4b02-82f5-ea8f6d8b6c18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic820959a12ab4a0bae3278102cbe3604_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfOS0yLTEtMS00NzI4NA_d23e2959-ec0c-4016-8f01-4edb6866897f">487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c5c61ba79d490583932b1ea0ae6fee_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfOS00LTEtMS00NzI4NA_f52ef355-6aa2-41da-bd5a-18840e280ff9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d467e35eb14c31bcba781b26964717_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMS0xLTEtMS00NzI4NA_de0e6f54-53c4-4cbd-8b75-e0598b0bd28a">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966a1c60d7794ac19c4b0482afbd9d63_I20210331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMS0zLTEtMS00NzI4NA_d5662c73-8b1a-4884-9692-5cb7732b6790">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMi0xLTEtMS00NzI4NA_17889623-58e9-4f34-a9a1-26065cec1ef9">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMi0zLTEtMS00NzI4NA_7a01d3f8-14cc-44cc-b02c-52120c1fbdef">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMy0xLTEtMS00NzI4NA_6571d242-c03c-4df0-baa2-5cfbc1564760">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMy0zLTEtMS00NzI4NA_09bfaa65-f400-45ca-860e-70760fc72570">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNC0xLTEtMS00NzI4NA_97871cd5-c585-42d1-ab48-398e27a48c93">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNC0zLTEtMS00NzI4NA_04ee16ba-5a12-44a2-a928-45d16571370a">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNS0xLTEtMS00NzI4NA_b0a0231e-d008-47de-8817-8649bac7c70d">117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNS0zLTEtMS00NzI4NA_e082bbe6-98bb-4bac-8554-5b43bf632227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNi0zLTEtMS00NzI4NA_2299da69-6a42-457d-86ef-2a1a7dc78aea">983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNy0xLTEtMS00NzI4NA_0e7e3021-7092-437d-a021-4025bab551b9">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231" decimals="-6" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNy0zLTEtMS00NzI4NA_71c3f04e-ebf6-4937-97b5-127944fedada">287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfOC0xLTEtMS00NzI4NA_d1ca0295-689e-4731-b53b-4f4291f653d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfOC0zLTEtMS00NzI4NA_12e044e8-1e70-4382-8720-0d39599fe9b5">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic820959a12ab4a0bae3278102cbe3604_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfOS0xLTEtMS00NzI4NA_9396ff4e-4d1f-4290-bd78-9df1ded55d80">487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c5c61ba79d490583932b1ea0ae6fee_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfOS0zLTEtMS00NzI4NA_0f4978aa-7a66-4a7f-9ea6-b24ce6678688">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ic5dc231dabe44ce9becddca6d5a49c43"><ix:continuation id="ia47622a3b3744e0582e2331d5e79d7a9"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2020 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6da59171484d4afba5f49534b2709456_I20200930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMS0yLTEtMS00NzI4NA_b20f20d5-5114-47fd-89a6-354a8a763257">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38d6747b6b2440cb19da83a637e8e0c_I20200930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMS00LTEtMS00NzI4NA_253eba48-6e81-4e7d-b7dc-1f734f2f77a4">1,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMi0yLTEtMS00NzI4NA_ff03cebd-f6dc-48db-b4b1-185366ae8bdb">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie23170f25899482c8fb14218e9b36811_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMi00LTEtMS00NzI4NA_25d46ec6-0095-422d-ae9d-a6eebffa53bd">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMy0yLTEtMS00NzI4NA_96d297f1-009c-46be-9577-2cc44c920489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie23170f25899482c8fb14218e9b36811_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMy00LTEtMS00NzI4NA_c076f699-c72e-46aa-8921-06c93623c3b5">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie23170f25899482c8fb14218e9b36811_D20201001-20201231" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfNC00LTEtMS00NzI4NA_745b3baa-e41f-4952-ade3-6d84a3bba12f">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfNS0yLTEtMS00NzI4NA_681e31ff-b16f-4f97-90a8-2aebd2bf26bb">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie23170f25899482c8fb14218e9b36811_D20201001-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfNS00LTEtMS00NzI4NA_98f086e4-9893-43e4-90da-33476d96dc30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfNy0yLTEtMS00NzI4NA_a825ecf0-3569-42b1-bab3-9ae742b23107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie23170f25899482c8fb14218e9b36811_D20201001-20201231" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfNy00LTEtMS00NzI4NA_9105bd5f-12dd-47fd-9f54-5633f09a743e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64318d5dd9f1472c90248ebb8e0becbf_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfOC0yLTEtMS00NzI4NA_ee57769a-04b2-40a5-a2b8-29a4600c3e49">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad4dcc2e71484863b95577492db41418_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfOC00LTEtMS00NzI4NA_d388e9b7-6c50-4f6f-b84a-6a6145db4f19">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805c937398e343ddbade7f441c4786b9_I20200331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMS0yLTEtMS00NzI4NA_d9c13b0e-03be-484a-aa17-0b51d8199f88">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f407b53967e488c8979843a9f2e0587_I20200331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMS00LTEtMS00NzI4NA_adab4494-4133-4a5d-91b9-a5b6659cec84">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMi0yLTEtMS00NzI4NA_784899b8-5a32-43cd-8b3d-1a44465bd44d">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMi00LTEtMS00NzI4NA_fcda1a81-cd72-42dc-8ebe-7456cea92593">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMy0yLTEtMS00NzI4NA_4322086b-b811-49ae-bcce-e179f53792d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMy00LTEtMS00NzI4NA_2ad2452e-e86b-419f-b27e-81874c93e972">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNC00LTEtMS00NzI4NA_a08980e7-0b4b-4df2-a0e6-85b16e0b1748">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNS0yLTEtMS00NzI4NA_69902c45-4f2c-4292-9f06-3e670b56c72d">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNS00LTEtMS00NzI4NA_079d0a79-3b0d-4dae-a7f6-25423b1652f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNi00LTEtMS00NzI4NA_b52ee408-c59a-4cf0-ac44-48982fde7b20">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNy0yLTEtMS00NzI4NA_46bfa2a5-305f-4c96-a327-8e249d0ce8ed">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNy00LTEtMS00NzI4NA_264a567e-9d27-40de-bdfd-30fa3819c103">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64318d5dd9f1472c90248ebb8e0becbf_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfOC0yLTEtMS00NzI4NA_4dc7fa9f-d619-482f-9267-3a195ff32420">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad4dcc2e71484863b95577492db41418_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfOC00LTEtMS00NzI4NA_5cad19f0-27fd-43e6-b35c-18d30cda9992">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_49"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RleHRyZWdpb246ZmUyNTE4ZmE4OGMxNDAyNmJmOTUzZjFmNTJiOGZiMWRfMTEzNA_b581455f-7157-4bd2-89c2-245ab19b4d0e" continuedAt="i61dc43a0e9034d5195f01507aec80747" escape="true">Earnings (Loss) Per Common Share</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i61dc43a0e9034d5195f01507aec80747" continuedAt="i8b5ea985020a432ea1f0eabf38f5dfff">Basic earnings (loss) per common share are computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Diluted loss per common share for the three months ended December 31, 2021 and the three and nine months ended December 31, 2020 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Less than <ix:nonFraction unitRef="shares" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RleHRyZWdpb246ZmUyNTE4ZmE4OGMxNDAyNmJmOTUzZjFmNTJiOGZiMWRfNjQw_da143cdf-1088-4582-bff7-14be546ee59a">1</ix:nonFraction>&#160;million of potentially dilutive securities for the nine months ended December 31, 2021 were excluded from the computation of diluted earnings per common share as they were anti-dilutive.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i8b5ea985020a432ea1f0eabf38f5dfff"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RleHRyZWdpb246ZmUyNTE4ZmE4OGMxNDAyNmJmOTUzZjFmNTJiOGZiMWRfMTE1Mw_508baaea-96f8-4a7c-89de-d32489e50e23" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMi0xLTEtMS00NzI4NA_c6b961fb-85ae-4dbe-87e2-6917372ebf1d">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMi0zLTEtMS00NzI4NA_1a7e9779-51a5-4365-aebc-626a80436e39">6,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMi01LTEtMS00NzI4NA_bff6ba88-8a63-4f33-98a9-4ed46842410c">885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMi03LTEtMS00NzI4NA_61035d7a-6c87-4f6e-8dc6-e61b2394028a">5,052</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMy0xLTEtMS00NzI4NA_e7d17c6b-b4d3-43d4-bb2a-28e31d1a2e83">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMy0zLTEtMS00NzI4NA_45748771-5d23-4c91-8e75-4ccb910350f5">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMy01LTEtMS00NzI4NA_8e5f665c-2456-417f-8253-c37271ec16e4">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMy03LTEtMS00NzI4NA_14773e81-7c10-4f13-a1ea-8742673836e4">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNC0xLTEtMS00NzI4NA_82accfaa-22c0-4029-b3e3-08dc8b669c0b">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNC0zLTEtMS00NzI4NA_6955c30a-44f9-482a-896f-12e18459200d">6,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNC01LTEtMS00NzI4NA_9cd7998b-11a6-458a-bd74-2481d9c6e789">749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNC03LTEtMS00NzI4NA_248e4463-48ff-4de9-a695-ee1721309e50">5,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNS0xLTEtMS00NzI4NA_10923f6e-313a-4ade-8ff2-9a110cd058c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNS0zLTEtMS00NzI4NA_afe2c330-9455-4998-ac5a-09013a315ece">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNS01LTEtMS00NzI4NA_3d5ca656-534b-4c83-82e2-cb0f4fda0943">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNS03LTEtMS00NzI4NA_33531c41-2cc3-4bef-835e-54e5040eb31d">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNi0xLTEtMS00NzI4NA_e680c7e8-ace9-4506-b475-0be2218da121">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNi0zLTEtMS00NzI4NA_fd86f906-5353-4913-abf8-ab2853eb7349">6,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNi01LTEtMS00NzI4NA_25a3f642-96cf-4a9a-98f9-26d0b46b879a">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNi03LTEtMS00NzI4NA_165d8d4f-f707-4804-9f07-7a673ef4048e">5,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfOS0xLTEtMS00NzI4NA_6be5b585-d984-49c1-8a6b-e4045f3814d4">151.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfOS0zLTEtMS00NzI4NA_43ccc1f0-5c4c-46b8-be1b-a830436b339f">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfOS01LTEtMS00NzI4NA_24ec0839-5ceb-4cbd-aea9-68aee0b80147">154.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfOS03LTEtMS00NzI4NA_f6ff93c8-496f-4007-bfd6-bfe54e998356">161.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31bf4f7d1a23482c831cafb66e4eeb11_D20211001-20211231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTEtMS0xLTEtNDcyODQ_c4dddb0d-e9f5-4d0b-8121-f2a6a742348a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia20f2ae234824563aaf020230203bc95_D20201001-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTEtMy0xLTEtNDcyODQ_2abc39a7-5499-4cd7-80f8-7ca0041f9aa3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85920522622d4e87a1778b8915896cd9_D20210401-20211231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTEtNS0xLTEtNDcyODQ_fbd821d3-162a-4496-9ef5-39f06f0ea36c">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i429c33e0c248436d9d40564788aef7cc_D20200401-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTEtNy0xLTEtNDcyODQ_07fd1527-8ad6-4d5f-a44e-adb8afa515cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17e68fc5432d42999abbd9cfb84788b2_D20211001-20211231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTItMS0xLTEtNDcyODQ_147c8532-77c7-4d88-9c32-a32524c74e7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd7d6c6918264060a11449cce87c8a74_D20201001-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTItMy0xLTEtNDcyODQ_bd20dd1f-5e8f-463a-b992-cf5845364ccf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c44d406842b4dfd9be43d9417c45d16_D20210401-20211231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTItNS0xLTEtNDcyODQ_c93a2196-c4df-41ba-80f1-1d81bd1ea726">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5aad64ed07e840d48b824f939696d040_D20200401-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTItNy0xLTEtNDcyODQ_8afc19f9-cfc7-4a17-b40b-ae15299d6709">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTMtMS0xLTEtNDcyODQ_74bcf668-11d6-46c9-a235-cfc82192540d">151.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTMtMy0xLTEtNDcyODQ_7232c952-06ce-43b6-b860-a27a980f38f2">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTMtNS0xLTEtNDcyODQ_49e8cfb3-5793-467c-b8c6-c0e334ab8f98">155.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTMtNy0xLTEtNDcyODQ_4c7010cd-9574-4082-be47-d499574d24de">161.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTctMS0xLTEtNDcyODQ_ea51b969-8e9f-4403-8684-bca3961cd020">0.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTctMy0xLTEtNDcyODQ_bd249b49-ca8b-4b7d-835d-128e60c05d8d">39.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTctNS0xLTEtNDcyODQ_aaeabba9-2609-4c5e-9da9-9b0a04f66095">4.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTctNy0xLTEtNDcyODQ_6c232c61-35e6-4b73-b9ae-487b1c9b6afd">32.28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTgtMS0xLTEtNDcyODQ_d67f52e1-5094-42aa-9328-126ebc620ec1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTgtMy0xLTEtNDcyODQ_6dfdc0c7-1c27-4635-9023-0d00a72a3c38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTgtNS0xLTEtNDcyODQ_05f9fbd2-a2c3-42b4-a199-6777980b2067">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTgtNy0xLTEtNDcyODQ_99a9eebb-b44f-4667-a7dd-f8b422169f65">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTktMS0xLTEtNDcyODQ_3bf635b0-ea5f-4c09-bd53-a512d656835a">0.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTktMy0xLTEtNDcyODQ_3e1b2ef7-887c-4447-a1c6-7beb32a0eae6">39.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTktNS0xLTEtNDcyODQ_ee2bbc3d-8dc8-4e9e-be4a-82f61d519028">4.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTktNy0xLTEtNDcyODQ_67b4614c-8ff1-44df-92ed-613f2bb79461">32.29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjEtMS0xLTEtNDcyODQ_6582c668-2354-4a0d-bfbc-476d9ea48b8b">0.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjEtMy0xLTEtNDcyODQ_7eb4a1f5-99a8-4b1f-ad6b-81d758ffb036">39.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjEtNS0xLTEtNDcyODQ_1c7913b4-648e-45ec-b184-c046dad71c71">4.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjEtNy0xLTEtNDcyODQ_4538274e-e912-4977-8785-f79127bdd8d2">32.28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjItMS0xLTEtNDcyODQ_8a3fe01c-43cd-49f2-a548-6d9d3a1cc0ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjItMy0xLTEtNDcyODQ_d45205a1-5c50-43de-b897-9ac27fc55359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjItNS0xLTEtNDcyODQ_15f67d18-7ea5-40a6-8f5f-bc1eb11006cc">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjItNy0xLTEtNDcyODQ_325673c8-8ea5-46b0-8f86-87c896b83393">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjMtMS0xLTEtNDcyODQ_4fc3fbcd-7449-45be-9a7e-f198c7dd8222">0.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjMtMy0xLTEtNDcyODQ_0a2e35f0-d6eb-40a8-8787-c6dd64628fdd">39.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjMtNS0xLTEtNDcyODQ_7f3e4c1d-7b6d-485d-98d9-b5116b5aeb4d">4.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjMtNy0xLTEtNDcyODQ_7d0bf09d-76ee-4eb0-98dd-87b92b78cd37">32.29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units, performance-based restricted stock units, and performance-based stock units.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div></ix:nonNumeric></ix:continuation><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_52"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTU4NA_9cc4a2d8-e9e4-49ba-b4b5-6fda8f5df112" continuedAt="i1d40cdc08f4f4399b1926264c406311a" escape="true">Goodwill and Intangible Assets, Net </ix:nonNumeric></span></div><ix:continuation id="i1d40cdc08f4f4399b1926264c406311a" continuedAt="i1f08d62df75e4e62aeff341249872902"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the Company implemented a new segment reporting structure which prompted changes in multiple reporting units across the Company. As a result, goodwill included in the impacted reporting units was reallocated using a relative fair value approach and assessed for impairment before and after the reallocation. The Company recorded a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ic4a94e99c27749f9bb0cdf58b9fb0d21_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfNDA1_380cd640-b8a5-4f8c-8ed5-53f944d1985a"><ix:nonFraction unitRef="usd" contextRef="ic4a94e99c27749f9bb0cdf58b9fb0d21_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfNDA1_457e753b-bf5a-4155-878f-0abe97d1d50a">69</ix:nonFraction></ix:nonFraction> million in the nine months ended December 31, 2020 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of this reporting unit within the International segment. This impairment charge is included in &#8220;Goodwill impairment charges&#8221; in the Condensed Consolidated Statement of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist. The annual impairment testing performed for 2022 and 2021 did not indicate any impairment of goodwill.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i1f08d62df75e4e62aeff341249872902"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTU2NA_9d719544-4b92-456f-9abd-5143d8b05ee0" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:26.212%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic904723c4ba64a05ae420a0be5054017_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMS0xLTEtMS00NzI4NA_ea92a9df-08e1-4008-a76b-683e3f9ab77c">3,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1152c87f165d4441a106e92fb010eee7_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMS0zLTEtMS00NzI4NA_1abe4bf3-745c-4203-b451-d2c6d5dc1c4e">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b0a5563e78433e81c99f7828894e50_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMS01LTEtMS00NzI4NA_87ab18ff-6174-4f50-a16a-e111ad70c143">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd869a8aa917470b91d673083a1c9728_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMS03LTEtMS00NzI4NA_9d98c365-6351-4b64-a863-0daed13ad086">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMS05LTEtMS00NzI4NA_050f81cc-8c18-45c7-a2ee-9a9567288f7c">9,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcceb81b10094fe38a52a708698e8e26_D20210401-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMi0xLTEtMS00NzI4NA_ff66f593-30e2-4db9-8452-90301c0e88ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4fff6966c2f4bf68a5a99a525be017b_D20210401-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMi0zLTEtMS00NzI4NA_4ed341a6-8e9a-4493-b8da-909aef0a7b5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8581c40a6994c56adbfa16cef30adce_D20210401-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMi01LTEtMS00NzI4NA_285fb652-d8bc-4e20-a416-0d6392bd42ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe27bfd9e2c41d58630861c22b41289_D20210401-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMi03LTEtMS00NzI4NA_1f88a844-bf12-4609-ab70-d71ffe0ca109">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMi05LTEtMS00NzI4NA_b57aed07-efdd-44df-a8d1-19c6d95818ef">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifcceb81b10094fe38a52a708698e8e26_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNi0xLTEtMS00NzI4NA_a36f2217-c5cf-4166-8880-bc655079bea0">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4fff6966c2f4bf68a5a99a525be017b_D20210401-20211231" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNi0zLTEtMS00NzI4NA_65f729fb-6d22-40d4-b721-b9f8ca781a35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8581c40a6994c56adbfa16cef30adce_D20210401-20211231" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNi01LTEtMS00NzI4NA_d6f181f2-b981-4e25-9a16-32999e555202">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe27bfd9e2c41d58630861c22b41289_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNi03LTEtMS00NzI4NA_4c38f4cf-348f-4e76-a05c-b2ee3ce28368">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNi05LTEtMS00NzI4NA_8c105b29-4f47-4918-b978-1843a26a46d2">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32326b7bf53a4dd384901e9903f9bba5_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNy0xLTEtMS00NzI4NA_26e14b4b-471d-4c2f-8053-df9b0c2b8b50">3,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd6a711404a649daa658dfed92674336_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNy0zLTEtMS00NzI4NA_a8b032b4-1d2c-419f-8c09-86e80d6b76a2">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d3dae03307347b1aaa7f9adb1a1146e_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNy01LTEtMS00NzI4NA_59c9fd86-646a-439c-866f-71906ec4aed4">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c38b50f2e6d4df48e12878cd04a1f29_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNy03LTEtMS00NzI4NA_8c8b7280-c78d-449b-9435-9a7be93b7285">1,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNy05LTEtMS00NzI4NA_b67a9712-a194-4095-9c41-62c1176aa79d">9,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Remaining goodwill for this segment primarily relates to the McKesson Canada reporting unit.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTU3NQ_460e39e0-329b-4902-9421-ba2e5b90eb66" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5940c64b0f72408a95d2a120f5c0cb9d_D20210401-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi0xLTEtMS00NzI4NA_b161de19-f7a8-446f-b463-167022cac786">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25c56b1dc1542b8b6cba0c5909ee061_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi0zLTEtMS00NzI4NA_9c058b04-b1e8-4f77-939c-d12e0a751216">2,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib25c56b1dc1542b8b6cba0c5909ee061_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi01LTEtMS00NzI4NA_1c478be9-8032-49e3-b13d-b5a3d5261489">1,718</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25c56b1dc1542b8b6cba0c5909ee061_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi03LTEtMS00NzI4NA_cd9ef3f8-4a41-4204-9944-9292c736aa1e">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f9282a1be1949719baad2d71826d505_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi05LTEtMS00NzI4NA_28334aa5-cc0e-4fd8-a9ba-ef041fe931ee">3,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f9282a1be1949719baad2d71826d505_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi0xMS0xLTEtNDcyODQ_1e436aee-e938-439b-a385-730fd3251b6d">2,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f9282a1be1949719baad2d71826d505_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi0xMy0xLTEtNDcyODQ_0d3a5258-9450-4e8e-bbe6-5d6af4830b5d">1,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i74ed405c42b74c4389c3f91f5005ff7a_D20210401-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy0xLTEtMS00NzI4NA_0a25cdd0-da40-469a-9a2d-002dd9c7761d">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5ddfbf05bb24ccba4c97a3aa8391604_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy0zLTEtMS00NzI4NA_202e1da7-63e5-48ab-870a-4e6beb485a16">1,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5ddfbf05bb24ccba4c97a3aa8391604_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy01LTEtMS00NzI4NA_b5e4f06e-3095-46a6-81a1-a6f28b10b0ae">558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5ddfbf05bb24ccba4c97a3aa8391604_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy03LTEtMS00NzI4NA_c5eedb36-15fb-48fd-af4d-7779d73884b3">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8b0c080d464091895e0a8629dc3b8f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy05LTEtMS00NzI4NA_7a96f3f4-b4c8-40f2-b04c-1fa7b12ae340">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec8b0c080d464091895e0a8629dc3b8f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy0xMS0xLTEtNDcyODQ_21b90f13-530f-47a3-9050-fa2bb2a45398">513</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8b0c080d464091895e0a8629dc3b8f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy0xMy0xLTEtNDcyODQ_0a3f79a0-a3af-4068-b32b-85800b0f8154">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4867f847dac14e859a18453f84be838e_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC0zLTEtMS00NzI4NA_2bb8d815-4067-409e-983d-fd8c5c44f4f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4867f847dac14e859a18453f84be838e_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC01LTEtMS00NzI4NA_cf4308b0-cfb1-4c55-b829-964a91ab7a39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4867f847dac14e859a18453f84be838e_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC03LTEtMS00NzI4NA_db3a1c4d-6857-4230-aee4-3fa56ab51ba3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie340410ba12c44e9911705e385d3b53b_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC05LTEtMS00NzI4NA_a623971b-9eab-43ff-aa73-62184483b51e">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie340410ba12c44e9911705e385d3b53b_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC0xMS0xLTEtNDcyODQ_86158638-79e8-4abc-8689-34e5248984b9">244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie340410ba12c44e9911705e385d3b53b_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC0xMy0xLTEtNDcyODQ_e2e1d468-ef39-4a5b-b57b-a5660f323029">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icb766b9c9d944af29da2f7e212da9b0f_D20210401-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS0xLTEtMS00NzI4NA_e1e3648d-3cf4-4ec9-8e46-1a7d7fede416">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6350e24aa5bc4ecdb728677b7257e206_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS0zLTEtMS00NzI4NA_96869f9a-5e34-45dd-94ee-a79d9c768139">816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6350e24aa5bc4ecdb728677b7257e206_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS01LTEtMS00NzI4NA_7eb3bd3c-99a7-41c1-b49f-d8036b7a6560">371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6350e24aa5bc4ecdb728677b7257e206_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS03LTEtMS00NzI4NA_46ec2405-d1f6-4673-9e54-2f55be000909">445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6e140e0372458c969bb39e40eb721e_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS05LTEtMS00NzI4NA_31fd6fa0-e9e6-47be-bfed-50aba37a976e">925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e6e140e0372458c969bb39e40eb721e_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS0xMS0xLTEtNDcyODQ_4fcf0088-e5a4-41fe-8891-6f96b02c102a">394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6e140e0372458c969bb39e40eb721e_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS0xMy0xLTEtNDcyODQ_5ced770b-3a79-4c74-98a4-da7cd30feced">531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaa5fb8b105594c8e8a3005b94b561d93_D20210401-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi0xLTEtMS00NzI4NA_18f4c572-0308-427d-8acc-49822a8ccb9e">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabb0392b7148487bb4a2f65bf6026803_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi0zLTEtMS00NzI4NA_c55f4068-07d0-41f7-ae1d-3d8381f7b04f">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabb0392b7148487bb4a2f65bf6026803_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi01LTEtMS00NzI4NA_ab346ca6-84e8-4070-a0a9-ee46a352749d">113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabb0392b7148487bb4a2f65bf6026803_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi03LTEtMS00NzI4NA_bf8f9261-459e-42b1-a4ae-c720aeb8b5c0">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93c95e7a4b934ef38d46deb03522e7e9_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi05LTEtMS00NzI4NA_7806b278-1d91-4648-8c9c-3288a7ef1f47">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93c95e7a4b934ef38d46deb03522e7e9_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi0xMS0xLTEtNDcyODQ_0ae09fcd-69bf-47f8-a3aa-a500ee407f95">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93c95e7a4b934ef38d46deb03522e7e9_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi0xMy0xLTEtNDcyODQ_3e8cab6f-1a59-4d02-970f-71d49ad75d35">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7552b3f9fefa4753841e20f4ee183f59_D20210401-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy0xLTEtMS00NzI4NA_0cac0fab-3ca3-4e90-a21b-1de1ddc94041">8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib39a321c4bcc4b6cb3698d1b56855f45_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy0zLTEtMS00NzI4NA_592ebf84-bbcc-40c7-beed-77dbcd630f58">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib39a321c4bcc4b6cb3698d1b56855f45_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy01LTEtMS00NzI4NA_023a507f-92a7-4a07-8826-61c10ee4c9b6">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib39a321c4bcc4b6cb3698d1b56855f45_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy03LTEtMS00NzI4NA_ed36868b-e970-480f-b60f-7a426f12a9a7">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i373201c35c334793a8e487531dd13808_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy05LTEtMS00NzI4NA_f57372a8-46f2-4d7e-b511-eb2f777f64ac">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i373201c35c334793a8e487531dd13808_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy0xMS0xLTEtNDcyODQ_0260b706-a4c0-4af5-97d1-cf51de1508f2">226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i373201c35c334793a8e487531dd13808_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy0xMy0xLTEtNDcyODQ_339207a3-7a44-4ca3-ad6e-7b44469a8334">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC0zLTEtMS00NzI4NA_69095b18-95b1-4430-b8df-40a54195c468">5,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC01LTEtMS00NzI4NA_6b982a5c-a962-4cf1-8f52-22768c47031a">2,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC03LTEtMS00NzI4NA_dbf62572-5da7-4c27-8d09-bdcba7146026">2,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC05LTEtMS00NzI4NA_16476058-085e-4291-a1aa-8e3a62c8980f">6,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC0xMS0xLTEtNDcyODQ_1a71fb67-2ab8-4dea-b904-136ff5ea0381">3,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC0xMy0xLTEtNDcyODQ_d88ff0f9-2f07-4a63-bfa6-ff99e077fb65">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes net intangible assets of approximately $<ix:nonFraction unitRef="usd" contextRef="ia5f3b27c39db4b379168925a74818f88_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTA5OTUxMTYyOTczMg_df61d600-2722-4081-ac30-4d6ed484a783">452</ix:nonFraction> million related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; This amount was included under the caption &#8220;Assets held for sale&#8221; in the Condensed Consolidated Balance Sheet as of December 31, 2021. Amortization of these assets ceased upon classification as Assets held for sale in the second and third quarters of 2022.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTIzOQ_f889eb3f-d12b-48fc-8d9f-06e58cb77e46">80</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTI0Ng_9f0e7d23-9baa-4754-8711-15a3ef3dc8a2">262</ix:nonFraction> million during the three and nine months ended December 31, 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTI4Mg_1e8e1fc6-ac33-4cf9-82d5-33ab20c71823">108</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTI4OQ_ef888db4-1f30-4c84-b4cd-91b02e1364ff">320</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively. Estimated amortization expense of these assets is as follows: $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTM4Mw_62b54915-cdc7-43b7-a9f1-5bc39c641429">70</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTM4Nw_09d68f69-e985-466a-ad5d-469e38759a14">226</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTM5MQ_efc5427a-f2d0-496c-97c9-430b1dd12d67">215</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTM5NQ_2001a0f7-47a7-497b-b697-9f0545df6a12">209</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTQwMw_03cb42f5-ae4d-4b1d-ad7b-bacc8f1407cb">177</ix:nonFraction> million for the remainder of 2022 and each of the succeeding years through 2026, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-8" name="mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTQ3OA_3ae358eb-3811-4c79-b3d2-1d4ede2ee4f0">1.2</ix:nonFraction> billion thereafter. All intangible assets were subject to amortization as of December 31, 2021 and March 31, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_55"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjA5Mw_5202ce7f-4b1a-4128-9cc8-3c9f5abbee54" continuedAt="i461fd4923b5542ceba796e7e3fa09b7a" escape="true">Debt and Financing Activities</ix:nonNumeric></span></div><ix:continuation id="i461fd4923b5542ceba796e7e3fa09b7a" continuedAt="i0f74103d35334d479fab035e7eccafca"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjA5OA_6fed3a99-d273-47b1-b548-62e1ead4498a" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8746bc225334425396ca59f548e37a0b_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMi0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjU4ZjIwYjU0YTA0ZTQxNWU5YWM0ZjQ4NTdlMDczZjg3XzQ_cf3e34d3-6155-49a3-adad-0841b4d18254">2.70</ix:nonFraction>% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8746bc225334425396ca59f548e37a0b_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMi0xLTEtMS00NzI4NA_ced8ec26-c09f-497c-87b8-8e09366f1154">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e16308e8f8a44b0b56714da70bdba87_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMi0zLTEtMS00NzI4NA_d0ee4923-d90f-4bcc-a5a6-b1b2b3d0af9d">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3131096ca12e4ff79f710ef33e1fad9f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMy0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjVjMTFhY2ZiNWEzMzQ1YzVhZDc5ZTM1YjBlNDc4NmU3XzQ_22ea5843-9c4d-4f98-b141-cb75012c2378">2.85</ix:nonFraction>% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3131096ca12e4ff79f710ef33e1fad9f_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMy0xLTEtMS00NzI4NA_63bee7c6-7836-44c1-9995-ceb1178fcef3">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4460ad7ee7034da6ab6577545bb4e0db_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMy0zLTEtMS00NzI4NA_e203d72b-8142-43dd-9559-25a7a99041d5">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia93f81c5e6b04232b2292683ca038221_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNC0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjM5YTkyNzk1YTUxYjRmZWI4OTgyNGZiZmQwMTM0ZTM4XzQ_c9d9b0f9-6a41-486d-b5fd-fb3603337a2c">3.80</ix:nonFraction>% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia93f81c5e6b04232b2292683ca038221_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNC0xLTEtMS00NzI4NA_e2dcde5d-d85b-4935-ab3d-238753cac598">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if114852dcd424e71925af80e34de7a6c_I20210331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNC0zLTEtMS00NzI4NA_64c72276-93c4-4067-853c-4f95fe0414a3">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if3719b3f8d244ac494c2824c0832d07e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNS0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOmUwMWE3MTg3NmMxMzQwYmZhMzdiZTg4NWZlNDdhYmE1XzQ_74091bce-eafe-43b4-a407-d26d9b2a347c">0.90</ix:nonFraction>% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3719b3f8d244ac494c2824c0832d07e_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNS0xLTEtMS00NzI4NA_e3cc1b96-2f82-4366-a416-1192c53a5f5d">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9174bf78e06c4f3d84ca5ac5c9b2aba5_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNS0zLTEtMS00NzI4NA_828ca38a-8376-42d3-9a69-a7c4c1d22e15">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f726c763f9a479b8e540f1c1a4b7bfe_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNi0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjA5MTg0MzcwNzMzYjQyNTE5NDAzZTc2MTY4MWEzNjgxXzQ_e82864b6-a602-42a6-bf66-436cced0ace1">1.30</ix:nonFraction>% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f726c763f9a479b8e540f1c1a4b7bfe_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNi0xLTEtMS00NzI4NA_21855c83-a071-4720-bafe-958342266bdb">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfaf4e782dc9445ab195eab4ffe8ab10_I20210331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNi0zLTEtMS00NzI4NA_8d6f6c69-90b4-4d69-82d4-43541ecd3a6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f67c3e22d524b2bb83fd6759a331308_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNy0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjA3N2MyYTljNTIxZDQ5Y2NiNTA4Mzc3OTYxMTA2ZTg5XzQ_5bcd4a6c-5eea-4f1d-b8f3-0d8aee7ddafc">7.65</ix:nonFraction>% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f67c3e22d524b2bb83fd6759a331308_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNy0xLTEtMS00NzI4NA_bbd41dcf-f73d-40ba-ad54-e341298b1236">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia28dcbf6b06649eb9dff2cfa25450e96_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNy0zLTEtMS00NzI4NA_7bc90ad3-3332-46bb-b006-a88641a4d0d8">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e57c87f990a465aa51e7b583931c71c_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOC0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjQzMDYyZTNmMjg4MzRiMzVhYmUwMTE0MDA0ZjkyMzkxXzQ_a6d02020-34a0-4ad4-93a3-26837ca1e78b">3.95</ix:nonFraction>% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e57c87f990a465aa51e7b583931c71c_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOC0xLTEtMS00NzI4NA_397f245b-0de0-4f0f-9481-fd4c75ecb923">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88366d3c093b4dc49a21a6e0db895a8d_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOC0zLTEtMS00NzI4NA_b84ec5d4-191c-4894-a82b-f7894f1a5cc1">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02cb6f0f6a454110948073b47a98653b_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOS0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjdmM2NkMjlmMWViNzRlNjliYmM2MDcyZmEwYTNhNjc5XzQ_a2d2189b-eeef-4f5f-8b1d-163633f79dd9">4.75</ix:nonFraction>% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02cb6f0f6a454110948073b47a98653b_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOS0xLTEtMS00NzI4NA_7d1cbab5-4b72-43c6-8b35-09cf2a8c5703">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i586efb75ab5d463cb59b296f08231f94_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOS0zLTEtMS00NzI4NA_09a5bc30-79f8-445b-a742-88b188343248">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc040bd3b61f4ac2897cb464802aff8a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTAtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1ZTYzYmMwYTRjN2M0NzVkYmViMmIxZWI5NjkxZWUzZF80_ab4e130d-ac7e-4a05-b739-dfbefa105b96">6.00</ix:nonFraction>% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc040bd3b61f4ac2897cb464802aff8a_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTAtMS0xLTEtNDcyODQ_7382d3d7-3492-4935-8ea1-b5ddedb9ccf0">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d47528c190644909c718b0fb28a8991_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTAtMy0xLTEtNDcyODQ_c2659220-825a-4d6b-9e80-92d6780ecafd">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i18921a55bfdb4914912bf2fcd15ae90c_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTEtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo5ZDc5NDYyZGY0N2I0YzJlYjYwZmVlMjUxZjgzZmQ0OF80_efc1221d-5a57-490d-8b02-a23c308ecba3">4.88</ix:nonFraction>% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18921a55bfdb4914912bf2fcd15ae90c_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTEtMS0xLTEtNDcyODQ_ac90a03f-3f1a-4acc-8740-c5331f6856f0">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109f3a112c2942a89945755f920801f5_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTEtMy0xLTEtNDcyODQ_3f27ec5b-b6b3-47d5-8af8-7af5176baf2b">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic9237fc120ce474f8df6c1ab559748c0_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo3NGZjNzAxNWE2MGU0NWQwYmNjNmM5MTExOWEwMTIyNV80_ac0aabd4-6729-459d-bdce-4d6053179186">0.63</ix:nonFraction>% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9237fc120ce474f8df6c1ab559748c0_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTMtMS0xLTEtNDcyODQ_25fb02cc-653c-4445-828c-75e782dce3b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idce1a776f3f4491eaecf73c69740b2c1_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTMtMy0xLTEtNDcyODQ_dc0c9872-57a4-42b3-8e31-92cf93a5ab8b">704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib02bd64fd220450cb919b052658bd225_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpiMDc0ZDcxNjJhNGI0OTc1Yjc1OWMxMTMxYmY1MTRkYl80_2ac499e1-485c-4fac-91d8-8245b8fa1de1">1.50</ix:nonFraction>% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02bd64fd220450cb919b052658bd225_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTQtMS0xLTEtNDcyODQ_be1fbe88-46dd-4e17-a78d-0e642a700ca8">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i980877648a26404c9f3f88facfab3a12_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTQtMy0xLTEtNDcyODQ_8dcf5ba8-c9f9-4289-ad9a-fc1844f4a1f4">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i594a4fdaee3b4bb29cfb65eb877bdf18_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTUtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo4OGNlYzg5ZDUzN2Y0NmM0ODA2MTc4ZTU5ZGU4OTZhN180_92111cd9-fe6c-4eea-b04b-dbaeb1e70358">1.63</ix:nonFraction>% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i594a4fdaee3b4bb29cfb65eb877bdf18_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTUtMS0xLTEtNDcyODQ_d18e44e1-9bb7-4909-806a-412f76931690">568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd138e409b7b4f81be9450bcf3b931dd_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTUtMy0xLTEtNDcyODQ_40add0e6-4a3a-4253-9ab6-355a78d3ec65">587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40926358e8e740acb1b20bcaef8dbb44_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTYtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo5ZTliYzE1MjViMzc0Nzk3OWQ3ODY4YzZlMWYwMTFiNV80_a01bddef-d8db-4844-aaf3-beca29f71e34">3.13</ix:nonFraction>% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40926358e8e740acb1b20bcaef8dbb44_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTYtMS0xLTEtNDcyODQ_b4468e1d-3917-48c6-8c78-908e05bc049b">618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ca68483b5e748d296466ae242322a5b_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTYtMy0xLTEtNDcyODQ_3a2bc7c9-06cf-4111-89aa-8d38636da934">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTgtMS0xLTEtNDcyODQ_0cc23a42-2008-4eba-8a96-16026e3ba1d5">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTgtMy0xLTEtNDcyODQ_c4029351-5a46-4c56-b167-d13f7cd97032">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTktMS0xLTEtNDcyODQ_37ac301b-c799-4aba-b124-5b87d4189f23">5,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTktMy0xLTEtNDcyODQ_20d5edf0-f6dd-4bc6-ba51-cc856b5f83ca">7,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMjAtMS0xLTEtNDcyODQ_d7396880-4e29-414a-b367-838af593d2df">438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMjAtMy0xLTEtNDcyODQ_70a84ee5-2fc3-41d6-9ed4-589c793ef861">742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMjEtMS0xLTEtNDcyODQ_a39ac37e-6b67-480a-91b4-8d11800e999b">5,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMjEtMy0xLTEtNDcyODQ_afcd2374-ff17-4ae8-aa49-805626661401">6,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term debt of approximately $<ix:nonFraction unitRef="usd" contextRef="i792e3f3cd2194564994f887fa0311091_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMTA5OTUxMTYzNDA4Mg_eaf8ef9b-6f7b-4396-a20a-e0e5b2afd716">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i792e3f3cd2194564994f887fa0311091_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMTA5OTUxMTYzNDA4Ng_87421931-9635-4e23-b7a0-6fa4e65abb36">12</ix:nonFraction> million, respectively, as of December 31, 2021 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Condensed Consolidated Balance Sheet as of December 31, 2021.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-8" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjYy_84566d44-22ea-4099-a6c8-1fd6338a8fbb">6.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-8" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjY5_26a3b011-00f8-4df8-96a3-1e245b4ff0e8">7.1</ix:nonFraction> billion at December 31, 2021 and March 31, 2021, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNzA5_640b5d1f-8618-49d6-a60a-a9f66b37114f">438</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNzE2_0010c3e9-b92e-4cf8-bbef-eed7e3df6ba4">742</ix:nonFraction> million, respectively, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021, the Company completed a public offering of <ix:nonFraction unitRef="number" contextRef="i069e5020023e41c2aedab80fbb7726b6_I20210812" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfODkz_bd741356-bf9d-4a77-824a-399feddea31d">1.30</ix:nonFraction>% Notes due August 15, 2026 (the &#8220;2026 Notes&#8221;) in a principal amount of $<ix:nonFraction unitRef="usd" contextRef="i069e5020023e41c2aedab80fbb7726b6_I20210812" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfOTY2_09de43bc-e858-4fc4-bd98-24828953911c">500</ix:nonFraction>&#160;million. Interest on the 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on February 15, 2022. Proceeds received from this note issuance, net of discounts and offering expenses, were $<ix:nonFraction unitRef="usd" contextRef="i8dde3db75bc9423db7d08caf0b284aa7_D20210812-20210812" decimals="-6" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMTE5MA_9cf0e44f-3921-493c-90a7-40f2904183d9">495</ix:nonFraction>&#160;million. The Company utilized the net proceeds from this note for general corporate purposes.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i0f74103d35334d479fab035e7eccafca" continuedAt="ieea33f291f004adc846fbc1b079722a3"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2026 Notes, which constitutes a &#8220;Series,&#8221; are an unsecured and unsubordinated obligation of the Company and rank equally with all of the Company&#8217;s existing, and from time-to-time, future unsecured and unsubordinated indebtedness outstanding. The 2026 Notes are governed by materially similar indentures and officers&#8217; certificates as those of other Series issued by the Company. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#8217;s Investors Service, Inc. and Standard &amp; Poor&#8217;s Ratings Services within a specified period, an offer must be made to purchase the 2026 Notes from the holders at a price equal to <ix:nonFraction unitRef="number" contextRef="i6122fb9648ed4fbf9da45b3e8dd631d2_D20210401-20211231" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMjE5OQ_2854098f-9167-413c-afea-9bc2604c2bb9">101</ix:nonFraction>% of the then outstanding principal amount of the 2026 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#8217; certificate for the 2026 Note, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without lenders&#8217; consent. The indentures also contain customary events of default provisions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 17, 2021, the Company redeemed its <ix:nonFraction unitRef="number" contextRef="i31809c12d9a9402ea8b76662fed12284_I20210717" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMjgxMA_87fc077c-3634-44ca-9d01-1be3e3240cc7">0.63</ix:nonFraction>% &#8364;<ix:nonFraction unitRef="eur" contextRef="i31809c12d9a9402ea8b76662fed12284_I20210717" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMjgxMw_31075461-8b3a-4f21-bd70-bf03fa278039">600</ix:nonFraction> million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i31809c12d9a9402ea8b76662fed12284_I20210717" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMjgzNQ_d6869644-e9e9-4d49-b534-93476321267e">709</ix:nonFraction> million) total principal Euro-denominated notes, originally due on August 17, 2021, prior to maturity. The notes were redeemed at par value using cash on hand.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tender Offer</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) <ix:nonFraction unitRef="number" contextRef="icd10c718453c405e97d6ad84b80e8fc1_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzEwOQ_a1a396f6-aff8-46ab-b9de-41d058371aa6">2.85</ix:nonFraction>% Notes due 2023, (ii) <ix:nonFraction unitRef="number" contextRef="i64f43622e576465e9b38ab4c248303f2_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzEzMw_868b13fc-483d-4842-9d0f-cf1dfdb96f82">3.80</ix:nonFraction>% Notes due 2024, (iii) <ix:nonFraction unitRef="number" contextRef="ia80e8f219b104e7b8095a386e548a730_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzE1OA_e1231de2-df1b-4c83-9bce-754be3ed6231">7.65</ix:nonFraction>% Debentures due 2027, (iv) <ix:nonFraction unitRef="number" contextRef="ibfb5001dc67f4f8a896d6c6104d869ab_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzE4Nw_493e6371-1149-44aa-9962-82384a9c9668">3.95</ix:nonFraction>% Notes due 2028, (v) <ix:nonFraction unitRef="number" contextRef="i610e62fc020849aaa1514bb64ecea83d_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzIxMA_6aee04f9-347c-4030-b81d-3740d4a3767e">4.75</ix:nonFraction>% Notes due 2029, (vi) <ix:nonFraction unitRef="number" contextRef="i04a21be0ee8945e1bc0d1cb119b3e6dd_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzIzNA_74f6938e-d7d9-477f-a0fc-f723aed1aab8">6.00</ix:nonFraction>% Notes due 2041, and (vii) <ix:nonFraction unitRef="number" contextRef="i8fbbaa7c754d4333bc9a4584cc99c906_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzI2Mw_e3a0b244-e0d3-4774-a9ba-86fd0b84222c">4.88</ix:nonFraction>% Notes due 2044 (collectively referred to herein as the &#8220;Tender Offer Notes&#8221;). In connection with the tender offer, the Company paid an aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="icbb3c18dcf864424ae20c2a6f59a05a6_I20210723" decimals="-8" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzQyOA_f10a2fc2-5809-4b95-978d-461d92d8a3e0">1.1</ix:nonFraction>&#160;billion to redeem $<ix:nonFraction unitRef="usd" contextRef="icbb3c18dcf864424ae20c2a6f59a05a6_I20210723" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzQ0MQ_c6200274-50d0-48ba-9c8d-689ecd8ec633">922</ix:nonFraction>&#160;million principal amount of the notes at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzUwNQ_8ccb46ef-ef89-46be-b8a9-0560733ce361">100</ix:nonFraction>% of the principal amount and premiums of $<ix:nonFraction unitRef="usd" contextRef="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzU0OA_944bd5ce-416b-4f06-80be-1a58ca9ba087">182</ix:nonFraction>&#160;million, plus accrued and unpaid interest of $<ix:nonFraction unitRef="usd" contextRef="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723" decimals="-6" name="us-gaap:InterestPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzU4OA_5ab72215-290a-415a-9992-2bfea2a529a7">14</ix:nonFraction>&#160;million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $<ix:nonFraction unitRef="usd" contextRef="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzc3MA_ea6bbd8e-e3e5-49e3-aca5-5d606cc3874f">191</ix:nonFraction>&#160;million in the nine months ended December 31, 2021, which included premiums of $<ix:nonFraction unitRef="usd" contextRef="icbb3c18dcf864424ae20c2a6f59a05a6_I20210723" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzgwMQ_c7a0936e-c00a-4b67-bc99-e89c6f8a38a2">182</ix:nonFraction>&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $<ix:nonFraction unitRef="usd" contextRef="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723" decimals="-6" name="mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzkwMw_d1d1e832-8b4c-437e-8d39-b64d329eea8c">9</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Credit Agreement, dated as of September 25, 2019 (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $<ix:nonFraction unitRef="usd" contextRef="i41cdbb2354254500bac2539b51ef63ea_I20190925" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDA2MA_9704642c-2dbe-4809-aea2-f5d274a682cc">4.0</ix:nonFraction> billion <ix:nonNumeric contextRef="i4fde2411c1644621b3365876316b4cbf_D20190925-20190925" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjA4Nw_b24ee3e7-c243-42a8-b384-b924dc5c50f2">five-year</ix:nonNumeric> senior unsecured credit facility with a $<ix:nonFraction unitRef="usd" contextRef="i8665153941be4bb7b02bd203a47d4f00_I20190925" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDExMQ_fccaf705-1655-4394-b3ec-88880161794f">3.6</ix:nonFraction> billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had <ix:nonFraction unitRef="usd" contextRef="ia0f0596aa0084e20afa89597288e93c4_D20201001-20201231" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU0MA_0e9daa8b-1056-4016-bd69-abf0245c6477"><ix:nonFraction unitRef="usd" contextRef="i6b04286cc90b410990ef32577b13b1cf_D20200401-20201231" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU0MA_c4025aca-cfb2-4d7f-a8e6-4b5164d1a39d"><ix:nonFraction unitRef="usd" contextRef="i5854b4d082a04d84aa8c864577be8b31_D20211001-20211231" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU0MA_e60f231c-5ebf-4f8b-bffc-a08fcc43302a"><ix:nonFraction unitRef="usd" contextRef="i07aa03a3cf46464cbc26feec1d3d32c1_D20210401-20211231" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU0MA_fb3e0c39-4396-45d9-93b6-9edd9c1cc4ed">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> borrowings during the three and nine months ended December 31, 2021 and 2020 and <ix:nonFraction unitRef="usd" contextRef="i6953458f6f674d6ab890f86f4cd4f38e_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU4Mg_55004fd9-4e18-425e-87c1-b61864624b71"><ix:nonFraction unitRef="usd" contextRef="i0dafe850daa44ba092c57047f0ce2877_I20210331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU4Mg_774c2523-b2c6-4c1e-83a5-e2120b5ca978">no</ix:nonFraction></ix:nonFraction> amounts outstanding as of December 31, 2021 and March 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At December 31, 2021, the Company was in compliance with all covenants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $<ix:nonFraction unitRef="usd" contextRef="i89b9210a5ce84d4c8f57ef708a9e06d0_I20211231" decimals="-6" name="us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTQwOA_2936aa2b-e6ea-4b11-a91d-8cb56376d704">7</ix:nonFraction> million and an uncommitted amount of $<ix:nonFraction unitRef="usd" contextRef="i89b9210a5ce84d4c8f57ef708a9e06d0_I20211231" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTQ0MA_b5873c9b-6968-4f52-930b-c809ebca0772">114</ix:nonFraction> million as of December 31, 2021. Borrowings and repayments were not material during the three and nine months ended December 31, 2021 and 2020. Amounts outstanding under these credit lines were not material as of December 31, 2021 and March 31, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ieea33f291f004adc846fbc1b079722a3"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $<ix:nonFraction unitRef="usd" contextRef="ibb82d8e0e0254d2e8fef071a792829d2_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTgwNQ_cdb453c9-0b94-476b-a2ef-29616e58e7b8">4.0</ix:nonFraction> billion in outstanding commercial paper notes. During the nine months ended December 31, 2021, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="if95be6cfe924456c8da8cea9e5d5e974_D20210401-20211231" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTg5OQ_f27ec612-1ed5-4058-bf18-b9e073b0f39f">3.6</ix:nonFraction> billion and repaid $<ix:nonFraction unitRef="usd" contextRef="if95be6cfe924456c8da8cea9e5d5e974_D20210401-20211231" decimals="-8" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTkxMw_3e7fabd5-0d93-4e07-b86d-32a0c858f347">3.3</ix:nonFraction> billion under the program. During the nine months ended December 31, 2020, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="ief157ea0a56249a692efe8e3d4607fa5_D20200401-20201231" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTk4Nw_121bba89-5593-4c91-9d12-ff23b26477e8">5.5</ix:nonFraction> billion and repaid $<ix:nonFraction unitRef="usd" contextRef="ief157ea0a56249a692efe8e3d4607fa5_D20200401-20201231" decimals="-8" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjAwMQ_0def5b5b-93ef-43f4-b581-3da287f00347">5.3</ix:nonFraction> billion under the program. At December 31, 2021 there were $<ix:nonFraction unitRef="usd" contextRef="ibb82d8e0e0254d2e8fef071a792829d2_I20211231" decimals="-6" name="us-gaap:LongTermCommercialPaperCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMTA5OTUxMTYzMzkzMQ_f58abbe4-9879-4d61-afce-406042e92949">372</ix:nonFraction> million commercial paper notes outstanding at a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="ibb82d8e0e0254d2e8fef071a792829d2_I20211231" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMTA5OTUxMTYzNDAzOQ_cbe805c0-548b-4d7b-aff6-3156481b64f1">0.29</ix:nonFraction>%. At March 31, 2021, there were <ix:nonFraction unitRef="usd" contextRef="ie1fc9c20fe7d4693bf05d2692768da1f_I20210331" decimals="INF" name="us-gaap:LongTermCommercialPaperCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjA0OA_4c56da82-823d-4345-954b-9b05bd38f4df">no</ix:nonFraction> commercial paper notes outstanding.</span></div></ix:continuation><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_58"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfODY2_02378a10-730c-41e4-8746-43ca80f08607" continuedAt="i74f58b7482034fd3aa1297114fa41ad8" escape="true">Pension Benefits</ix:nonNumeric></span></div><ix:continuation id="i74f58b7482034fd3aa1297114fa41ad8"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was approximately $<ix:nonFraction unitRef="usd" contextRef="i3f3051bdb38143259288f549f974a0e9_D20211001-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfODk_3b81a626-1ebd-4413-a8de-b837f31d4c07">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i090754fc8e614e6bbad26c7f79ea2655_D20210401-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTA5OTUxMTYyODY2Mg_b5f776d8-6d93-49ad-a478-98d9746f7f90">4</ix:nonFraction> million for the three and nine months ended December 31, 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i3fd478d8076c43f6abb4a6dd08e769d8_D20201001-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTA3_3d198711-2dd1-4f6f-9308-b7fb7d62e6c3">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4730e8d997974abd8395c6ed22b656fe_D20200401-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTE0_9d61a636-078f-4af3-b8f8-1bd33ba36388">17</ix:nonFraction> million for the three and nine months ended December 31, 2020, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash contributions to these plans were $<ix:nonFraction unitRef="usd" contextRef="i3f3051bdb38143259288f549f974a0e9_D20211001-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTgy_4c42e230-a1e9-44c1-b03a-d416d019b189">18</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i090754fc8e614e6bbad26c7f79ea2655_D20210401-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTg5_b6444a42-a8e7-4cb4-94dc-d06714cd38bd">35</ix:nonFraction> million for the three and nine months ended December 31, 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i3fd478d8076c43f6abb4a6dd08e769d8_D20201001-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMjIy_ac8196d3-1631-4260-b82d-5d5aef5de510">8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4730e8d997974abd8395c6ed22b656fe_D20200401-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMjI5_edc5b14d-2d44-49b2-9d46-c05e675fedc5">19</ix:nonFraction> million for the three and nine months ended December 31, 2020, respectively. The cash contributions for the three and nine months ended December 31, 2021 included a $<ix:nonFraction unitRef="usd" contextRef="if2d4d8bd24764afda92f5b33e18eec02_D20210401-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTY0OTI2NzQ0MjgwOA_283e5609-bbb3-4560-b7de-271caec9c99c"><ix:nonFraction unitRef="usd" contextRef="i2b06140a4e4b45c08325af13b9477bc5_D20211001-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTY0OTI2NzQ0MjgwOA_dbb4c0e7-25ea-42ed-b5ee-dceed7ff6bc4">17</ix:nonFraction></ix:nonFraction>&#160;million payment to a U.K. pension plan. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding <ix:nonFraction unitRef="number" contextRef="i96f5c70408574f04b15b2f7ec7679bb4_I20211231" decimals="INF" name="us-gaap:DefinedBenefitPlanFundedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfNDQx_22f0539f-18d7-42ee-8843-20b42deff5a3">10</ix:nonFraction>% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale,&#8221; pension assets of $<ix:nonFraction unitRef="usd" contextRef="i1a47389171bb414193fe6314b964f7fd_I20211231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTY0OTI2NzQ0Mjg2MQ_d7570984-7c58-4937-9c5c-5e87c274dc4f">52</ix:nonFraction>&#160;million and pension liabilities of $<ix:nonFraction unitRef="usd" contextRef="i1a47389171bb414193fe6314b964f7fd_I20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfNzY4_9fd435b3-7030-4dc5-af0d-dcb2f0f7402b">148</ix:nonFraction>&#160;million were included under the captions &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheet as of December 31, 2021.</span></div></ix:continuation><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_61"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfOTg0NA_2af08ef6-50f3-4b11-9b3e-0ed9b65ec7ba" continuedAt="iab0b5f6fa07b43148a1e0dc79d7d4178" escape="true">Hedging Activities</ix:nonNumeric></span></div><ix:continuation id="iab0b5f6fa07b43148a1e0dc79d7d4178" continuedAt="ibb0f7901997a406fb13e349a1d41197a"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021 and March 31, 2021, the Company had &#8364;<ix:nonFraction unitRef="eur" contextRef="i9e8c8f89b9ff413690a3a67eb1468bb1_I20211231" decimals="-8" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMTUwMQ_764c82ef-c62f-46df-b41b-da12b2fbd6c8">1.1</ix:nonFraction> billion and &#8364;<ix:nonFraction unitRef="eur" contextRef="ib7ed6b36701e4a04bfe99fe455ef93a9_I20210331" decimals="-8" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMTUwOA_a7e99da4-27da-49a5-8aff-c7494038a1bc">1.7</ix:nonFraction> billion, respectively, of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ibb0f7901997a406fb13e349a1d41197a" continuedAt="icad79afc392a42c1abb198cd68b893cd"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from net investment hedges recorded within Other comprehensive income were gains of $<ix:nonFraction unitRef="usd" contextRef="ic3f95e7d8ccb40f9b9eb2820e1c96850_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjU3OQ_528e4541-61c7-4383-bba3-30933f1204e2">23</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib56a0acb015f42a9b6db7d566e4d694a_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjU4Ng_a3b5d2b1-30de-4f73-b5c3-c2ca88f9ec0c">34</ix:nonFraction> million during the three and nine months ended December 31, 2021, respectively, and losses of $<ix:nonFraction unitRef="usd" contextRef="id0fb12228284472bb3616ebca5add51a_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjYzMg_82caeed4-99f4-4fee-a645-f5930b283e8c">84</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9c56745c1ad842ad90cf4a2cd11ebec9_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjYzOQ_e3e731c8-ab48-4de2-a129-6377209341f4">201</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three and nine months ended December 31, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021 and March 31, 2021, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $<ix:nonFraction unitRef="cad" contextRef="i306448d022c44df8b4a9d9a3a303bd36_I20210331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjkxMw_3a048555-7278-445a-8bf1-83260d218909"><ix:nonFraction unitRef="cad" contextRef="i4fd28eaef6c94a969cb3718719b09b86_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjkxMw_6caafb3a-fc40-4a91-ad05-0b7f4a88fa76">500</ix:nonFraction></ix:nonFraction> million Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the three and nine months ended December 31, 2021 and 2020. The remaining cross-currency swaps will mature in November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="id80470ece115487a90c8e9f0d8fa5909_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNDM5Nw_83b29576-d200-4cec-aff5-f8da236d5429">2</ix:nonFraction> million and gains of $<ix:nonFraction unitRef="usd" contextRef="i0562d50847594e68a2ad757563e23331_D20210401-20211231" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNDQwNA_6f30fe90-cbcb-4163-883e-a12513b75d16">3</ix:nonFraction> million during the three and nine months ended December 31, 2021, respectively, and losses of $<ix:nonFraction unitRef="usd" contextRef="if413ab2045f7407d94fd20c0c60e1710_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNDQ1MA_ef3df82a-9628-48e0-b2c4-7f312afc8738">45</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i096c4c0268604806b329bdf3f18855cc_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNDQ1Nw_094b31c9-b03b-4f71-a371-8cac6fc03f36">108</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively. There was no ineffectiveness in the Company&#8217;s cross-currency swap hedges for the three and nine months ended December 31, 2021 and 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;<ix:nonFraction unitRef="gbp" contextRef="if0efacf445fc46d1b3325b78010882fa_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNDY5Nw_cc13afb1-12a1-4330-97a5-bf5564ceff80">450</ix:nonFraction> million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;<ix:nonFraction unitRef="gbp" contextRef="if0efacf445fc46d1b3325b78010882fa_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNTA0OQ_cc13afb1-12a1-4330-97a5-bf5564ceff80">450</ix:nonFraction> million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At December 31, 2021 and March 31, 2021, the Company had cross-currency swaps with total gross notional amounts of approximately $<ix:nonFraction unitRef="usd" contextRef="iab7a4eb1e70b4fa1b361a9b44cd85bf4_I20211231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNjI3Mg_4ef04221-0921-4e18-a033-3986258e570d">1.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i29742682b8ef4a26affbcf74cb0801e1_I20210331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNjI3OQ_6c2f4dff-2608-42e6-95a6-e0c477c2cebc">2.6</ix:nonFraction> billion, respectively, which are designated as cash flow hedges. These swaps will mature between December 2022 and January 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="icad79afc392a42c1abb198cd68b893cd" continuedAt="i4244a892eca34fc89442afa9745c7240"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNjkxNA_28f2ce5c-21e9-43e4-b2ae-630a59668bff">500</ix:nonFraction> million and &#8364;<ix:nonFraction unitRef="eur" contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNjkyMQ_2a733d77-c86a-40eb-bd83-502c4a98a897">600</ix:nonFraction> million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $<ix:nonFraction unitRef="usd" contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNzE1MA_28f2ce5c-21e9-43e4-b2ae-630a59668bff">500</ix:nonFraction> million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;<ix:nonFraction unitRef="eur" contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNzM3NQ_2a733d77-c86a-40eb-bd83-502c4a98a897">600</ix:nonFraction> million swaps. The $<ix:nonFraction unitRef="usd" contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNzM4OQ_28f2ce5c-21e9-43e4-b2ae-630a59668bff">500</ix:nonFraction> million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and is being amortized on a straight-line basis as interest expense over the <ix:nonNumeric contextRef="ic0079095dff44d82a99df4fa0de3968c_D20210401-20211231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfOTg0Ng_d9ccd05e-0c76-452d-a07b-7dc5c9ffb16c">five-year</ix:nonNumeric> life of the 2025 Notes. The &#8364;<ix:nonFraction unitRef="eur" contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNzYzMQ_2a733d77-c86a-40eb-bd83-502c4a98a897">600</ix:nonFraction> million swaps were terminated in the second quarter of 2022 and the loss on termination of the swaps recorded in interest expense was not material for the nine months ended December 31, 2021. Refer to Financial Note 8, &#8220;Debt and Financing Activities,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From September 20, 2021 to November 4, 2021, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with a combined notional amount of $<ix:nonFraction unitRef="usd" contextRef="i759ece90e4a84418bd88eef741535d3a_I20211104" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNzk5Mw_c84cb153-0a93-48c2-805a-7976744228fc">500</ix:nonFraction> million, to hedge the variability of future benchmark interest rates on a planned bond issuance. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $<ix:nonFraction unitRef="usd" contextRef="i759ece90e4a84418bd88eef741535d3a_I20211104" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfODIyMw_c84cb153-0a93-48c2-805a-7976744228fc">500</ix:nonFraction> million swaps for floating interest payments in U.S. dollars based on three-month LIBOR.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="i32ba2d1a45c445c583e6de9a264e133b_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMTA5OTUxMTYzODAxMA_0b7f64e7-6348-4296-9339-706c62f2928a">8</ix:nonFraction> million and gains of $<ix:nonFraction unitRef="usd" contextRef="i17d15431fbc54c0ca88b62ba4fa8a2af_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfODM5OA_815d8e0f-e4a2-4bbc-b712-aece5ce7b424">3</ix:nonFraction> million during the three and nine months ended December 31, 2021 and losses of $<ix:nonFraction unitRef="usd" contextRef="ieddd952970aa4ffdac4cb0616cd91e55_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfODQyOQ_4324cf42-6563-495e-827e-4b79b3e07b4a">14</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib0f2aab0d3e545aeb80528ab93b0610b_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfODQzNg_246890c5-c5ce-4d85-8bf2-9e362b5468bf">42</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations were not material in the three and nine months ended December 31, 2021 and 2020. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the three and nine months ended December 31, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At December 31, 2021 and March 31, 2021, the total gross notional amounts of these contracts were $<ix:nonFraction unitRef="usd" contextRef="i3cccab8b5e8e4f7eb85e366050dd0c6e_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfOTEzOQ_e30ad1b0-a255-44b3-b42a-165f61fff9cd">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i31ea48b5b7c94d91be10ded715dc2ed7_I20210331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfOTE0Ng_37714e86-8976-435a-8465-103b6a07bee9">39</ix:nonFraction> million, respectively. These contracts matured between October 2021 and January 2022 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material in the three and nine months ended December 31, 2021 and 2020. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i4244a892eca34fc89442afa9745c7240" continuedAt="ie1582f0a774845caaddeef807ccb4f63"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfOTg0MQ_33699f3d-0902-4acf-8c4d-2972d31f4e70" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.206%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91a4aa2234e64d5492f8ae8c66bf803a_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS0yLTEtMS00NzI4NA_aa479ffa-71cf-4ee8-9259-e7fddec0129d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91a4aa2234e64d5492f8ae8c66bf803a_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS00LTEtMS00NzI4NA_50521412-d10a-4432-8dea-37392c2f0a2a">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91a4aa2234e64d5492f8ae8c66bf803a_I20211231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS01LTEtMS00NzI4NA_73666f34-7566-4245-856d-b3efe9f963e4">570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i952999021b6746f7bb3d33905898d07e_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS03LTEtMS00NzI4NA_1f95226d-0079-4745-bca0-8d9d33cee92b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i952999021b6746f7bb3d33905898d07e_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS05LTEtMS00NzI4NA_618af7f4-eb1a-41d8-abae-3954bee79950">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i952999021b6746f7bb3d33905898d07e_I20210331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS0xMC0xLTEtNDcyODQ_6c29a7a1-0bca-4684-a7d5-300cf9cb6e0e">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e7d0745bdf49c39fe6e13e746c332d_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi0yLTEtMS00NzI4NA_d863e1ac-abe6-4781-9271-3c7bfc3e884d">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e7d0745bdf49c39fe6e13e746c332d_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi00LTEtMS00NzI4NA_3de98d31-f408-44de-837b-2d2ba1043f1d">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e7d0745bdf49c39fe6e13e746c332d_I20211231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi01LTEtMS00NzI4NA_5a4796cc-09f4-4736-990d-6e0b03d49ab2">2,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61fc3b32631340948c814ea6d7f2e4bd_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi03LTEtMS00NzI4NA_5baa9e43-16ab-4acc-9bca-0eef4240343e">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61fc3b32631340948c814ea6d7f2e4bd_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi05LTEtMS00NzI4NA_93cfb6c4-bfdf-4819-a508-e474852245d1">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61fc3b32631340948c814ea6d7f2e4bd_I20210331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi0xMC0xLTEtNDcyODQ_91767ebb-96fe-4e9e-9681-f4faf5f8dc72">2,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f081c15f3b4160a10acf6eb389de1b_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy0yLTEtMS00NzI4NA_af1fe2de-5f49-470e-b660-895092283388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f081c15f3b4160a10acf6eb389de1b_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy00LTEtMS00NzI4NA_dc144924-4403-4144-8119-cb9ec5c1eab1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f081c15f3b4160a10acf6eb389de1b_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy01LTEtMS00NzI4NA_2e2b3bb6-1b01-4051-afcf-a90e7d3e1c6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i319b6b970e834bb696c416ea5807f857_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy03LTEtMS00NzI4NA_b89c0f3f-2a89-4dcf-8712-ffa281b21502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i319b6b970e834bb696c416ea5807f857_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy05LTEtMS00NzI4NA_07e13bca-abb9-4a74-a6cc-47d3318fa901">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i319b6b970e834bb696c416ea5807f857_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy0xMC0xLTEtNDcyODQ_a29f1ec8-a707-4f32-a3cb-f6605adef77a">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1586fe22fd6646a0a008cea296ca2866_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC0yLTEtMS00NzI4NA_a5cce0bf-ab7f-47d8-90e4-7658f9acd63d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1586fe22fd6646a0a008cea296ca2866_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC00LTEtMS00NzI4NA_60bed5a0-c77d-4756-bce6-a4b81e0a146c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1586fe22fd6646a0a008cea296ca2866_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC01LTEtMS00NzI4NA_3072615a-1de8-4d55-9704-c7b4bfd6ee1b">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90925257b3bd4257846aefcd6879fc30_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC03LTEtMS00NzI4NA_bd964cd5-1916-4450-aa39-663f5b086d73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90925257b3bd4257846aefcd6879fc30_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC05LTEtMS00NzI4NA_8a3c5557-0316-41ce-8f9b-4e786bfea9e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90925257b3bd4257846aefcd6879fc30_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC0xMC0xLTEtNDcyODQ_75ab1ddf-2442-46c9-a27a-30c55b457960">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44441409ce5e4ca6988aff06c61dae4f_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOS0yLTEtMS00NzI4NA_7ba71d8e-13ac-4789-a7b3-796e91bd4a6e">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44441409ce5e4ca6988aff06c61dae4f_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOS00LTEtMS00NzI4NA_9ce3000b-f84c-4762-8190-54d3203acf18">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3caf14c9bd64234ba322f53161f25e5_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOS03LTEtMS00NzI4NA_0bfe67e3-7f4f-4309-abb1-4d18909a7597">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3caf14c9bd64234ba322f53161f25e5_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOS05LTEtMS00NzI4NA_adcd35f1-2709-43e6-9185-f914e3eeae6f">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e6556feb6b14585bc7a63dbc68b457d_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtMi0xLTEtNDcyODQ_bcc32cb5-6dcc-45eb-8bcf-de1acee255ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e6556feb6b14585bc7a63dbc68b457d_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtNC0xLTEtNDcyODQ_875c3549-4d33-4d0b-93fa-3af9007bb3cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e6556feb6b14585bc7a63dbc68b457d_I20211231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtNS0xLTEtNDcyODQ_389dc7b9-7ee7-437e-9f18-35d4137da75b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fcadcad601441e0af45b696a5ae82cb_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtNy0xLTEtNDcyODQ_e6c37cf8-394c-4de2-b25c-aea2ec46bbfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fcadcad601441e0af45b696a5ae82cb_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtOS0xLTEtNDcyODQ_8d65cea3-74e3-42db-8736-f2357821c834">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fcadcad601441e0af45b696a5ae82cb_I20210331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtMTAtMS0xLTQ3Mjg0_7add724b-d105-4d32-a65a-aecf76c76274">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547bb2984de34a9496536b9a8f7fb1d6_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItMi0xLTEtNDcyODQ_a79d6396-0d56-4d30-af8f-533c043b9b32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547bb2984de34a9496536b9a8f7fb1d6_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItNC0xLTEtNDcyODQ_bfae85d0-2ad7-4a96-ab39-0b36f90cb18f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547bb2984de34a9496536b9a8f7fb1d6_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItNS0xLTEtNDcyODQ_e9ee57ae-bad0-4bf7-ae3c-608e7d36a51c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieac471f0e5ea44638e9f45f235e28103_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItNy0xLTEtNDcyODQ_b1fa06d3-a6b1-463a-9270-b2fe674034c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieac471f0e5ea44638e9f45f235e28103_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItOS0xLTEtNDcyODQ_d535449f-0deb-424c-aa85-74124e375c35">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieac471f0e5ea44638e9f45f235e28103_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItMTAtMS0xLTQ3Mjg0_f5f0b0c4-0942-4515-82c5-edb3818399cc">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bb1d026acc4fe6bdcd0573dcf77353_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTMtMi0xLTEtNDcyODQ_e0806c24-9196-45b1-acd2-ff7d00bbdfc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bb1d026acc4fe6bdcd0573dcf77353_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTMtNC0xLTEtNDcyODQ_0578d9af-c5ea-4ad3-b83f-16aba1903fb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57cdcb90e9d24ccb8237b2d0adc78da8_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTMtNy0xLTEtNDcyODQ_e41e3f93-fc22-4f7a-8f14-e82c8dab19c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57cdcb90e9d24ccb8237b2d0adc78da8_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTMtOS0xLTEtNDcyODQ_a4735f46-5292-4673-8ecc-2fe177d3ce5e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie1582f0a774845caaddeef807ccb4f63">Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.</ix:continuation> </span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_64"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfODM1MQ_0bd478cd-e6b3-4484-8699-182b7bc13609" continuedAt="i2c51a5284a2d477da745f0a8ae22317d" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i2c51a5284a2d477da745f0a8ae22317d" continuedAt="i9a13fe1d30fc47dfb92b190237875be3"><div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at December 31, 2021 and March 31, 2021 included investments in money market funds of $<ix:nonFraction unitRef="usd" contextRef="ie81c569998f846eabdd329f198f8fb80_I20211231" decimals="-8" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfNzY4_8e517191-0e7b-4ccd-9709-fe73643b1bb7">1.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if71186c9249547a6bb4645f7ef5e00bc_I20210331" decimals="-8" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfNzc1_e578c7dc-c98d-4be9-b9cd-7ee97d11b390">1.6</ix:nonFraction> billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#8217;s marketable securities were not material at December 31, 2021 and March 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps, foreign currency forward contracts, and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i9a13fe1d30fc47dfb92b190237875be3" continuedAt="i851efc514dfd4bda970a053e63bdc723"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfMjE2Nw_7b85f1a4-483b-47d5-8192-ef4d92a09904">358</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iafc802238be540dba818f29ae266827f_I20210331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfMjE3NA_cbf44504-aedf-40cb-bb24-c7706162a880">269</ix:nonFraction> million, respectively, at December 31, 2021 and March 31, 2021. These investments primarily consist of equity securities without readily determinable fair values and are included in &#8220;Other non-current assets&#8221; in the Condensed Consolidated Balance Sheets. During the nine months ended December 31, 2021 and 2020, certain of the Company&#8217;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities. Additionally, during the nine months ended December 31, 2020, certain of the Company&#8217;s investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. Net gains related to the Company&#8217;s investments in these equity securities, primarily representing unrealized gains on the securities discussed above, were $<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfMjk1OA_d96aca2e-1625-44b2-920d-6e9dd98eadae">104</ix:nonFraction> million for the nine months ended December 31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfMzg0ODI5MDcwNTU3OQ_61ed76fd-7397-4374-95ec-3a91f6698f2a">28</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfMzg0ODI5MDcwNTU4NA_0f339941-4408-4aa1-8d99-5b0a6768a951">87</ix:nonFraction> million for the three and nine months ended December 31, 2020, respectively. These net gains were recorded in &#8220;Other income, net,&#8221; in the Condensed Consolidated Statements of Operations. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the assets and liabilities associated with the disposal groups in Europe held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale." At December 31, 2021 and 2020, assets measured at fair value on a nonrecurring basis included long-lived assets associated with the Company&#8217;s restructuring initiatives as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges.&#8221; Assets measured at fair value on a nonrecurring basis as of December 31, 2020 included long-lived assets in the Company&#8217;s International segment and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment. Refer to Financial Note 7, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information. At March 31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s International segment and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i058558a97c0745aaadbecc089580e6ca_I20211231" decimals="INF" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfNTEwOA_6eee0583-1815-4377-85f1-ed213efbf3ef"><ix:nonFraction unitRef="usd" contextRef="ib5fd50078c2b473ba6fa21c1d3fc3a83_I20210331" decimals="INF" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfNTEwOA_7daa3be0-ab10-4df5-91f7-cf5919eb4518">no</ix:nonFraction></ix:nonFraction> other liabilities measured at fair value on a nonrecurring basis at December 31, 2021 and March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021 and March 31, 2021, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfODM1MA_8a8c1d88-b354-4016-8061-fcef8bcfa5f4" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:55.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.903%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57f313fd26c4d74b79a639aec5953e7_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RhYmxlOmE3ZGE1YjVlZDMwZTQyZGE4ZDVmMzY2OTUwOTEwMmYxL3RhYmxlcmFuZ2U6YTdkYTViNWVkMzBlNDJkYThkNWYzNjY5NTA5MTAyZjFfMi0xLTEtMS00NzI4NA_1f3831c2-4306-4f04-86dc-67a070fbec91">5,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57f313fd26c4d74b79a639aec5953e7_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RhYmxlOmE3ZGE1YjVlZDMwZTQyZGE4ZDVmMzY2OTUwOTEwMmYxL3RhYmxlcmFuZ2U6YTdkYTViNWVkMzBlNDJkYThkNWYzNjY5NTA5MTAyZjFfMi0zLTEtMS00NzI4NA_2668003c-3177-42b9-aeb1-e6bf06f84e36">6,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic780468f2c1a40329586136abdfe217f_I20210331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RhYmxlOmE3ZGE1YjVlZDMwZTQyZGE4ZDVmMzY2OTUwOTEwMmYxL3RhYmxlcmFuZ2U6YTdkYTViNWVkMzBlNDJkYThkNWYzNjY5NTA5MTAyZjFfMi01LTEtMS00NzI4NA_497bb5f0-ba9f-4ae3-80db-eb7fd6411d27">7,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic780468f2c1a40329586136abdfe217f_I20210331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RhYmxlOmE3ZGE1YjVlZDMwZTQyZGE4ZDVmMzY2OTUwOTEwMmYxL3RhYmxlcmFuZ2U6YTdkYTViNWVkMzBlNDJkYThkNWYzNjY5NTA5MTAyZjFfMi03LTEtMS00NzI4NA_4ebdbc8c-5d79-481b-85cb-b162e9d5e048">7,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i851efc514dfd4bda970a053e63bdc723"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within &#8220;Prepaid expenses and other&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets as of December 31, 2021, primarily consists of $<ix:nonFraction unitRef="usd" contextRef="i3b6ebdeadc4946d3be80756e21be72d2_I20211231" decimals="-6" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfNjM3MQ_7cf57b0d-8b0e-4382-b714-213c9087f4e7">354</ix:nonFraction>&#160;million held in escrow related to the initial payment under the proposed settlement agreement for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221; Additionally, restricted cash as of December 31, 2021 and March 31, 2021 includes funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. These amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities and corresponding deposit liabilities associated with these funds have been recorded by the Company within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets as of December 31, 2021 and March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of reporting units.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div></ix:continuation><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_67"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTk5Mzc_429d5b16-7d9f-42b4-93ee-2441fa302ad6" continuedAt="i734798ca490041de9c18d457465d6efe" escape="true">Commitments and Contingent Liabilities</ix:nonNumeric></span></div><ix:continuation id="i734798ca490041de9c18d457465d6efe" continuedAt="ia85f983974524c649e228ac62f92bfaf"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTk5MzI_b5cb6176-4dc2-423a-8fe5-c4f2a8dbb059" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765321000039/mck-20210331.htm#i08f9baf810c0412e93ea6effc6d22995_214">Financial Note 19 to the Company&#8217;s 2021 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statement of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ia85f983974524c649e228ac62f92bfaf" continuedAt="i1c6e1c60eda54099830fa19c769b4c9d"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#8220;MDL&#8221;) in the United States District Court for the Northern District of Ohio captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 17-md-2804. At present, there are approximately <ix:nonFraction unitRef="case" contextRef="i3b6ebdeadc4946d3be80756e21be72d2_I20211231" decimals="-2" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMzc0Mg_ab41bbbe-ffa7-482f-8825-f0f467fdfd3f">2,800</ix:nonFraction> cases under the jurisdiction of the MDL court.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also named in approximately <ix:nonFraction unitRef="case" contextRef="ic4f1a5ddaf4d4944b94efda2a00dba4b_I20211231" decimals="-1" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMzgzNQ_9eb15852-8c8d-4378-bb34-f5023c1d041c">350</ix:nonFraction> similar state court cases pending in <ix:nonFraction unitRef="state" contextRef="ic4f1a5ddaf4d4944b94efda2a00dba4b_I20211231" decimals="INF" name="mck:LossContingencyNumberofStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMzg3NQ_fe88de99-8714-4998-90a7-014ba1a6e78c">40</ix:nonFraction> states plus Puerto Rico, along with <ix:nonFraction unitRef="case" contextRef="if18621054cc940498e59d84996888935_I20211231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMzkxNA_3a533d92-22b7-4b62-8546-49dab88cf4ae">4</ix:nonFraction> cases in Canada. These include actions filed by <ix:nonFraction unitRef="stateattorney" contextRef="ic4f1a5ddaf4d4944b94efda2a00dba4b_I20211231" decimals="INF" name="mck:LossContingencyNumberofStateAttorneyGenerals" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMzk2NQ_e4890cd0-e083-4148-b473-5c55914633e2">23</ix:nonFraction> state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trial in the case brought by the Washington attorney general began on November 15, 2021. Trial in the case brought by the Alabama attorney general was postponed until April 18, 2022, and the parties continue to engage in settlement negotiations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2021, the Company and the <ix:nonFraction unitRef="distributor" contextRef="i2c8b3f7cefb949109e7eb1c36b7d7bc5_I20210721" decimals="INF" name="mck:LossContingencyNumberOfOtherDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNDc3OQ_4e8dccf4-3aa7-4590-a0a1-e1ea04886075">two</ix:nonFraction> other national pharmaceutical distributors announced that they had negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. If the proposed settlement agreement and settlement process leads to final settlement, the <ix:nonFraction unitRef="distributor" contextRef="i29032cc93762461290c629af975e89f1_D20210721-20210721" decimals="INF" name="us-gaap:LossContingencyNumberOfDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTE2MQ_7803f0ed-a362-4fe3-a1d4-9a941ac9c703">three</ix:nonFraction> distributors would pay up to approximately $<ix:nonFraction unitRef="usd" contextRef="iccc8e044a04f4f06a7102fd769862177_D20210721-20210721" decimals="-9" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTIwNw_685513d2-3f02-4874-a8a7-464a3e08d43c">21</ix:nonFraction> billion over <ix:nonNumeric contextRef="iccc8e044a04f4f06a7102fd769862177_D20210721-20210721" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTIxNQ_5d448093-cff6-4b74-8ee3-ae78a0516a95">18</ix:nonNumeric> years, with up to $<ix:nonFraction unitRef="usd" contextRef="i29032cc93762461290c629af975e89f1_D20210721-20210721" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTIzMA_0ad19d75-8a8b-41ee-be6c-9ef28b0fd491">7.9</ix:nonFraction> billion to be paid by the Company for its <ix:nonFraction unitRef="number" contextRef="i2c8b3f7cefb949109e7eb1c36b7d7bc5_I20210721" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTI2Nw_734ae8b4-a08c-4bc2-8c73-e5a0e91e2163">38.1</ix:nonFraction>% portion; a minimum of <ix:nonFraction unitRef="number" contextRef="i2c8b3f7cefb949109e7eb1c36b7d7bc5_I20210721" decimals="2" name="mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTI5Mg_c78ff411-3320-4572-90b2-95705e01e502">85</ix:nonFraction>% of such payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed agreement would also establish a clearinghouse that would consolidate controlled-substance distribution data from the <ix:nonFraction unitRef="distributor" contextRef="i29032cc93762461290c629af975e89f1_D20210721-20210721" decimals="INF" name="us-gaap:LossContingencyNumberOfDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTY2Mw_7c97bd21-5c5e-4f96-8dce-85478d9b9848">three</ix:nonFraction> largest U.S. distributors, which will be available to the settling states to use as part of their anti-diversion efforts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed agreement only addresses the claims of U.S. state attorneys general and political subdivisions in participating states. The West Virginia subdivisions and Native American tribes are not part of this settlement process. The proposed agreement is subject to contingencies and will not become effective unless the Company determines that a sufficient number of states and political subdivisions, including those that have not sued, have agreed to be bound by the agreement (or otherwise had their claims foreclosed).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 4, 2021, the Company announced that <ix:nonFraction unitRef="state" contextRef="i63ddda3383cb497a8aa380352d746509_I20210904" decimals="INF" name="mck:LossContingencyNumberofStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MjU1Mg_208e1f70-e512-4c9e-a978-ad18511a5a85">42</ix:nonFraction> of <ix:nonFraction unitRef="state" contextRef="i63ddda3383cb497a8aa380352d746509_I20210904" decimals="INF" name="mck:LossContingencyNumberOfEligibleStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MjU1Ng_4405d8da-9fc9-4ffc-a9b1-cd89f30610f5">49</ix:nonFraction> eligible states had affirmatively signed on to the proposed agreement. Since that time, the attorneys general of Georgia, Nevada, New Mexico, and Rhode Island have announced that they will join, bringing the state total to <ix:nonFraction unitRef="state" contextRef="ie1bd51abcbd045cd983975696083a0d4_I20220126" decimals="INF" name="mck:LossContingencyNumberofStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ2MjA3Mg_4b67f866-e7a0-4a71-93a8-749767dad01b">46</ix:nonFraction> out of <ix:nonFraction unitRef="state" contextRef="ie1bd51abcbd045cd983975696083a0d4_I20220126" decimals="INF" name="mck:LossContingencyNumberOfEligibleStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ2MjA4NQ_ea581503-8449-4cac-a852-94b178d4f6bc">49</ix:nonFraction> eligible states, all <ix:nonFraction unitRef="territory" contextRef="ie1bd51abcbd045cd983975696083a0d4_I20220126" decimals="INF" name="mck:LossContingencyNumberOfTerritories" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNjQzNw_ae6521ff-71b4-428d-9e66-901798524ac0">5</ix:nonFraction> U.S. territories, and Washington, DC. The attorneys general of Alabama, Oklahoma, and Washington have not joined the proposed settlement. Beginning on September 4, 2021, each participating state offered its political subdivisions, including those that have not sued, the opportunity to participate in the settlement. That period concluded on January 26, 2022. Under the agreement, the participating states have until February 7, 2022 to determine whether there is sufficient participation in the settlement by political subdivisions to proceed to implementation. After the conclusion of this period, the Company will have until February 25, 2022 to determine whether a sufficient number of states and political subdivisions have joined for the settlement to proceed to implementation.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i1c6e1c60eda54099830fa19c769b4c9d" continuedAt="i40c9266d83fa4fb69d50a5c36c993c84"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exact amount that would be due under the proposed agreement depends on several factors, including the participation rate of states and political subdivisions, the extent to which states take action to foreclose opioid lawsuits by political subdivisions, and the extent to which political subdivisions in settling states file additional opioid lawsuits against the Company after the proposed agreement becomes effective. The proposed agreement contemplates that if certain governmental entities do not agree to a settlement under the framework, but the distributors nonetheless conclude that there is sufficient participation to warrant the settlement, there would be a corresponding reduction in the amount due from the Company to account for the unresolved claims of the governmental entities that do not participate. Those non-participating governmental entities could continue to pursue their claims against the Company and other defendants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the terms of the proposed agreement, the Company placed its first annual payment of approximately $<ix:nonFraction unitRef="usd" contextRef="i4c5fee0b311f4c85ad63d103f1e8aa63_D20210920-20210920" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfODMzMQ_3fef9c95-f60d-4a38-9eb4-26008092d709">354</ix:nonFraction>&#160;million, into escrow on September 30, 2021. Those escrow amounts were presented as restricted cash within &#8220;Prepaid expenses and other&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheet as of December 31, 2021. On January 25, 2022, the Company placed approximately $<ix:nonFraction unitRef="usd" contextRef="i649beb76d86943469243e3ece439fa07_D20220125-20220125" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MTk0MQ_0636dd2b-d2b0-4574-9d15-1b787444091f">19</ix:nonFraction>&#160;million into escrow to reflect the participation of Georgia, New Mexico, and Nevada. The amounts placed into escrow exclude the proportionate allocation under the proposed settlement for each non-participating state and would be disbursed when and if the proposed agreement becomes effective. Subsequent annual payments would be due on July 15 of each year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2021, the Company announced that it and the <ix:nonFraction unitRef="distributor" contextRef="i6421afdc7756406892c7733f92c74bf9_I20210720" decimals="INF" name="mck:LossContingencyNumberOfOtherDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfODgwOQ_cee7e8a0-45d7-4441-a6a3-f980787a79f6">two</ix:nonFraction> other national pharmaceutical distributors had agreed to pay up to $<ix:nonFraction unitRef="usd" contextRef="i9571ebfcfb4243d4b7416b6bf1f52242_D20210720-20210720" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfODg3OQ_3c57e6cf-d059-4509-a12b-a684a3ab801e">1.2</ix:nonFraction>&#160;billion, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="i6421afdc7756406892c7733f92c74bf9_I20210720" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfODkyMw_77085d22-fd19-4703-b4a9-d1053880d871">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="if2de5ab2204a4239a0132d31018e9977_D20210720-20210720" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MjY5NA_464d8ef5-99df-4565-84f3-c1301ffcf434">450</ix:nonFraction>&#160;million), in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that New York and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#8217; fees and costs. If the broad settlement is finalized, New York and its participating subdivisions will become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2021, the Company and the <ix:nonFraction unitRef="distributor" contextRef="iad569f2cde004174b037e2447153313c_I20210928" decimals="INF" name="mck:LossContingencyNumberOfOtherDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfOTc4Mw_2f9845f7-c06e-4330-86b8-2eb3ad366c22">two</ix:nonFraction> other national pharmaceutical distributors reached an agreement with the state of Ohio and its participating subdivisions and agreed to pay $<ix:nonFraction unitRef="usd" contextRef="i4cac7c85628448f5aeb6a8aa1a8dd896_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfOTkyNg_b1bd57b3-2b02-48b5-9970-a280b2ab1663">881</ix:nonFraction>&#160;million, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="iad569f2cde004174b037e2447153313c_I20210928" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2NTY0Mg_b34e3cd1-e8db-419a-bc29-d92c15c82de1">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i5dccdea006cd4f81805e1bde772196ee_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3Mjc0Ng_211bf09c-201c-4943-891f-101b38eb8cc0">336</ix:nonFraction>&#160;million), to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that Ohio and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#8217; fees and costs. If the broad settlement is finalized, Ohio and its participating subdivisions will become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 24, 2022, the Company and <ix:nonFraction unitRef="distributor" contextRef="i82197fca02554991b73acbc4d68ccac2_I20220124" decimals="0" name="mck:LossContingencyNumberOfOtherDefendants" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ2ODM2Mg_1309b531-820d-4526-bb1a-575364706d63">two</ix:nonFraction> other national pharmaceutical distributors reached an agreement with the state of Rhode Island and its participating subdivisions and agreed to pay approximately $<ix:nonFraction unitRef="usd" contextRef="ic684bd89db914674b6775e7c4d69f963_D20220124-20220124" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2NTE3MQ_88e38bb0-c336-4189-b9a4-ef7ac6706e8d">91</ix:nonFraction>&#160;million, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="i82197fca02554991b73acbc4d68ccac2_I20220124" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2NTcwNg_60ea9226-5f3e-4917-9a72-7f8dabdc0c1b">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i643abe1e48c24a8aa9d02dfbe10b9c8c_D20220124-20220124" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MjgwNA_622d7cab-f5c4-4180-948d-cf4c82deafbe">35</ix:nonFraction>&#160;million), plus certain attorneys&#8217; fees and costs, to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that Rhode Island and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#8217; fees and costs. If the broad settlement is finalized, Rhode Island and its participating subdivisions will become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 28, 2022, the Company and <ix:nonFraction unitRef="distributor" contextRef="i7c604a712f64457faf00ef87a115fbda_I20220128" decimals="0" name="mck:LossContingencyNumberOfOtherDefendants" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ2ODM2MQ_b5344753-8355-4196-9b2b-9fc77eea5ae8">two</ix:nonFraction> other national pharmaceutical distributors reached an agreement with the state of Florida and its participating subdivisions and agreed to pay approximately $<ix:nonFraction unitRef="usd" contextRef="i2df648f57fa54b56a5008f3783b93493_D20220128-20220128" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2NTc0Mw_4244592c-8929-45ec-afce-0a9d87940ac0">1.4</ix:nonFraction>&#160;billion, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="i7c604a712f64457faf00ef87a115fbda_I20220128" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTE2MjU_330e1f86-dd8d-4ba0-9023-491d775f072b">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="if78131496b944f1cae74e5708bfd519c_D20220128-20220128" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3Mjg4MQ_c9499fb9-14c0-4d47-9e7e-44b016b6239d">530</ix:nonFraction>&#160;million), to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that Florida and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework. If the broad settlement is finalized, Florida and its participating subdivisions will become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2021, the Company announced that it and the <ix:nonFraction unitRef="distributor" contextRef="icdab83fc6b78425a832a4ba53f78811c_I20210928" decimals="INF" name="mck:LossContingencyNumberOfOtherDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA0NjI_4a97de9d-c02c-470d-a01b-91ff118554ba">two</ix:nonFraction> other national distributors had reached an agreement with the Cherokee Nation to pay approximately $<ix:nonFraction unitRef="usd" contextRef="if72c9e5652044d418c8a4b5883f5f283_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA1NjQ_4d0d0fc4-b3ce-46d3-a072-828b529ff788">75</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="ibd87c8cd4564444caf1bfeedc9bedcad_D20210928-20210928" name="mck:LossContingencySettlementPaymentTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ4MzE3Mw_67985888-dc64-4b52-9f93-4ec1e53e740b">6.5</ix:nonNumeric> years to resolve opioid-related claims, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="icdab83fc6b78425a832a4ba53f78811c_I20210928" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA2NTU_42c3480d-f34b-4706-a393-8957c30f570e">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="ibd87c8cd4564444caf1bfeedc9bedcad_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MzAwMw_dc638dda-1cbf-4de5-9a56-e839c1bb4e83">29</ix:nonFraction>&#160;million).</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i40c9266d83fa4fb69d50a5c36c993c84" continuedAt="i09d6304bb8cd4b62bc7023dadc5bfaaa"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also negotiated a broad resolution of opioid-related claims brought by Native American tribes. Under the proposed agreement, which has been endorsed by the leadership committee of counsel representing the tribes, the Company and the <ix:nonFraction unitRef="distributor" contextRef="id6b31bd1cab64e2aa516e6a01c17aabb_I20210928" decimals="INF" name="mck:LossContingencyNumberOfOtherDefendants" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTE2MzE_605d7667-b5f4-4bb2-a28f-f6c546d9f431">two</ix:nonFraction> other national distributors would pay the Native American tribes other than the Cherokee Nation approximately $<ix:nonFraction unitRef="usd" contextRef="i6a960216fc5047ae9856d959b0a6c287_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2OTI0Mw_ed412d70-81a2-4b76-83c1-55d2e8130dd4">440</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="i7eaaa89dea4740b0bc8eb0ada92ff0b3_D20210928-20210928" name="mck:LossContingencySettlementPaymentTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2OTI5Mg_91176e1f-def2-4b95-9a04-71b55627ca1d">6</ix:nonNumeric> years, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="id6b31bd1cab64e2aa516e6a01c17aabb_I20210928" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2OTIzNg_c83f57ab-778b-41fe-82f7-fa2da652cb08">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i7eaaa89dea4740b0bc8eb0ada92ff0b3_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MzA4Ng_173329a9-e893-479d-9986-1f9eeeeffc9e">167</ix:nonFraction>&#160;million). This broad resolution is contingent on the participation of a substantial majority of the Native American tribes that have brought opioid-related claims against the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the West Virginia subdivisions, trial in the case of Cabell County and City of Huntington, occurred in the U.S. District Court for the Southern District of West Virginia, and concluded on July 28, 2021. The outcome of that trial is pending. The claims of certain other West Virginia subdivisions are pending in the federal MDL and before the state Mass Litigation Panel. On September 30, 2021, the Mass Litigation Panel issued an order scheduling a liability-only trial on the public nuisance claims of certain political subdivisions against the Company and the two other national pharmaceutical distributors for July 5, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that a broad settlement of opioid claims by governmental entities is probable, and that the loss related thereto can be reasonably estimated. The Company recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="i96393cf84f184dd1a34604191f7e8463_D20200401-20210331" decimals="-8" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTE2Mjg_247f30ed-c3e9-4151-bb50-4aa4949e0d71">8.1</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="i96393cf84f184dd1a34604191f7e8463_D20200401-20210331" decimals="-8" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2Mzk3OA_95cf6aa5-25d1-4ab8-8bbd-f8182272ab00">6.8</ix:nonFraction> billion after-tax) in the fiscal year ended March 31, 2021 related to its share of the global settlement as well as claims of West Virginia municipalities and the Native American tribes. In connection with the matters described above, the Company recorded additional charges of $<ix:nonFraction unitRef="usd" contextRef="i6b6bcdc79602464fb68d237e91f2c420_D20210401-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ3NzMwNw_206f7b06-99e6-440c-9932-bd0af31d5150">193</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i6b6bcdc79602464fb68d237e91f2c420_D20210401-20211231" decimals="-6" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ3NzMxNQ_f9d2fc0f-0cd4-48fb-970e-db5248481b8d">160</ix:nonFraction>&#160;million after-tax) in the nine months ended December 31, 2021 within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statements of Operations, in connection with the proposed settlement agreement and other opioid related settlement accruals.</span></div><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTk5MzY_2060225b-5423-4c66-8439-4a625ff33549" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for opioid-related claims of governmental entities is as follows as of December 31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85eff5aee4c3446698c4907a3978d21b_I20211231" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RhYmxlOmNjZTk4OTk3NGMwMTQwN2ViMGVhNzgzOTRjYjExOWQ4L3RhYmxlcmFuZ2U6Y2NlOTg5OTc0YzAxNDA3ZWIwZWE3ODM5NGNiMTE5ZDhfMS0xLTEtMS00NzI4NA_2684fc68-2dde-4554-a95d-008d48d4657b">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85eff5aee4c3446698c4907a3978d21b_I20211231" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RhYmxlOmNjZTk4OTk3NGMwMTQwN2ViMGVhNzgzOTRjYjExOWQ4L3RhYmxlcmFuZ2U6Y2NlOTg5OTc0YzAxNDA3ZWIwZWE3ODM5NGNiMTE5ZDhfMi0xLTEtMS00NzI4NA_78900e3b-5ab8-4041-8854-415da8779611">7,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85eff5aee4c3446698c4907a3978d21b_I20211231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RhYmxlOmNjZTk4OTk3NGMwMTQwN2ViMGVhNzgzOTRjYjExOWQ4L3RhYmxlcmFuZ2U6Y2NlOTg5OTc0YzAxNDA3ZWIwZWE3ODM5NGNiMTE5ZDhfNC0xLTEtMS00NzI4NA_592a9a39-914d-436a-978a-404cd960e4d1">8,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This amount, recorded in &#8220;Other accrued liabilities&#8221; in the Condensed Consolidated Balance Sheet, is the amount estimated to be paid prior to December 31, 2022.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a broad settlement is not reached under the proposed agreement, litigation will continue. The Company continues to prepare for trial in these pending matters, and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as <ix:nonFraction unitRef="case" contextRef="i9a2ded36405146879cf86872b0b24b1c_I20211231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTMwMTg_4b4cb030-55d2-4436-99f6-1c66f3425e9e">four</ix:nonFraction> cases brought in Canada (<ix:nonFraction unitRef="case" contextRef="i16fa32e7eb8c4c528a92f587159347b8_I20211231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTMwNDY_e4bb76c3-2bba-4f66-be2d-98ee71b9c038">three</ix:nonFraction> by governmental or tribal entities and <ix:nonFraction unitRef="case" contextRef="i5ca435af43514f1eac1c81fefbc999f1_I20211231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTMwODg_57a96d24-5619-4f2d-b5ea-341e2ca3ee8a">one</ix:nonFraction> by an individual). These claims, and those of private entities generally, are not included in the settlement framework for governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court seeks to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CE19-00472. Trial in that case is scheduled to begin on March 21, 2022. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any potential settlement arrangement or other resolution of all of these opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">a</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">b</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">e</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">f</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">e</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">s</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i09d6304bb8cd4b62bc7023dadc5bfaaa"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2017, <ix:nonFraction unitRef="investmentfund" contextRef="i4b789596251942f2bfcd923a95ccdf00_I20171229" decimals="INF" name="mck:NumberOfInvestmentFundsThatFiledClaims" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTI0MDQ_c806e149-de32-4846-ad75-da2dc21dec69">two</ix:nonFraction> investment funds holding shares in Celesio AG filed a complaint against McKesson Europe Holdings (formerly known as &#8220;Dragonfly GmbH &amp; Co KGaA&#8221;), a subsidiary of the Company, in a German court in Stuttgart, Germany, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 18 O 455/17. On December 30, 2017, <ix:nonFraction unitRef="investmentfund" contextRef="ie3c0a2798de8485c9bfc70f3983c4ff0_I20171230" decimals="INF" name="mck:NumberOfInvestmentFundsThatFiledClaims" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTI0MDc_e6b59282-8bad-48e3-bd4c-4009b454d37a">four</ix:nonFraction> investment funds, which had allegedly entered into swap transactions regarding shares in Celesio AG that would have enabled them to decide whether to accept McKesson Europe Holdings&#8217;s takeover offer in its acquisition of Celesio AG, filed a complaint, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson Kempner International (BVI) Ltd. et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No.16 O 475/17. The complaints allege that the public tender offer document published by McKesson Europe in its acquisition of Celesio AG incorrectly stated that McKesson Europe&#8217;s acquisition of convertible bonds would not be treated as a relevant acquisition of shares for the purposes of triggering minimum pricing considerations under Section 4 of the German Takeover Offer Ordinance. On May 11, 2018, the court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dismissed the claims against McKesson Europe. Plaintiffs appealed this ruling and, on December 19, 2018, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. On November 23, 2021, the Federal Court of Justice (Bundesgerichtshof) rejected the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plaintiffs&#8217; further appeal. On March 15, 2019, the lower court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> similarly dismissed the case. Plaintiffs appealed this ruling and, on October 9, 2019, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. On November 23, 2021, the Federal Court of Justice (Bundesgerichtshof) rejected the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plaintiffs&#8217; further appeal. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2013, the Company&#8217;s subsidiary, U.S. Oncology, Inc. (&#8220;USON&#8221;), was served with a third amended qui tam complaint filed in the United States District Court for the Eastern District of New York by <ix:nonFraction unitRef="relator" contextRef="i2e0bc32bb6704e56a7596ad34859790f_D20130416-20130416" decimals="INF" name="mck:LossContingencyNumberOfRelators" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTMzNjc_75cb8990-7f98-44b3-a4bc-718ab8c39c78">two</ix:nonFraction> relators, purportedly on behalf of the United States, <ix:nonFraction unitRef="state" contextRef="i2e0bc32bb6704e56a7596ad34859790f_D20130416-20130416" decimals="INF" name="mck:LossContingencyNumberOfStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ3NzMwMg_51fe37b7-962a-4213-a6ca-5afc59e0c85e">21</ix:nonFraction> states and the District of Columbia, against USON and <ix:nonFraction unitRef="defendant" contextRef="i2e0bc32bb6704e56a7596ad34859790f_D20130416-20130416" decimals="INF" name="mck:LossContingencyNumberOfAdditionalDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTMzNjg_e55abb24-a8ae-44e2-9a6e-80297a9fc846">five</ix:nonFraction> other defendants, alleging that USON solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Piacentile v. Amgen Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 30, 2013, the court granted the United States&#8217; motion to dismiss the claims pled against Amgen. On September 17, 2018, the court granted USON&#8217;s motion to dismiss the claims pled against it, with leave to amend. On November 16, 2018, the relators filed a fourth amended complaint; that complaint was dismissed with prejudice on December 1, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2016, the Belgian Competition Authority carried out inspections at the premises of several Belgian wholesalers, including Belmedis SA, which was subsequently acquired by the Company. Pharma Belgium NV was also part of the investigation. On April 23, 2021, the Company received correspondence from the Belgian Competition Authority seeking civil penalties. The Company was fully reserved related to this matter for the third quarter of 2022, and the outcome will have no significant impact to the financial statements.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDY0OA_dedca418-c8de-41c6-84c0-dc8c749cc83f" continuedAt="i9533652839634ef6b33051bd895a4e78" escape="true">Stockholders' Equity (Deficit) </ix:nonNumeric></span></div><ix:continuation id="i9533652839634ef6b33051bd895a4e78" continuedAt="i064efd8840784724813b81ccdd56da53"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted <ix:nonFraction unitRef="vote" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="INF" name="mck:CommonStockVotingRightsNumberofVotesPerCommonShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNzk_18c35eec-0e9f-4845-ba60-03c966345ada">one</ix:nonFraction> vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company raised its quarterly dividend from $<ix:nonFraction unitRef="usdPerShare" contextRef="i4e3b4356f92241a79cba33c2ed751c94_D20210722-20210722" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzAy_3c6dc11e-8424-4395-8830-338dec5b8dc4">0.42</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="i5dfc838eb1ac450fa9327128ad95b9f4_D20210723-20210723" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzA4_630de847-2894-425c-b7ef-0b6f342296a1">0.47</ix:nonFraction> per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $<ix:nonFraction unitRef="usd" contextRef="i4651daec0fcd4008b8fbcb1cba4827c1_D20210501-20210531" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTQ1MQ_13bdc400-0997-49ff-ae20-99fe37ee14d1">1.0</ix:nonFraction>&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was <ix:nonFraction unitRef="shares" contextRef="i4651daec0fcd4008b8fbcb1cba4827c1_D20210501-20210531" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTU1MQ_fd0d0c80-ccc0-477a-aa02-477a78734fa7">5.2</ix:nonFraction> million shares at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4651daec0fcd4008b8fbcb1cba4827c1_D20210501-20210531" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTU5NA_d3f90d53-0107-4860-a2af-71ede6cc95c0">193.22</ix:nonFraction>. The Company received <ix:nonFraction unitRef="shares" contextRef="i4651daec0fcd4008b8fbcb1cba4827c1_D20210501-20210531" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTYxOQ_34fb57a6-9575-4558-8255-0df3a2aa5504">4.3</ix:nonFraction> million shares as the initial share settlement, and in August 2021 the Company received an additional <ix:nonFraction unitRef="shares" contextRef="i843f7e95b9d346549a854382391ff392_D20210801-20210831" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTcxNg_4ba624db-68cf-43f3-8055-c3491ed15a26">0.9</ix:nonFraction> million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="ib17c7ffbc55e498aa48c293d6f774907_D20211001-20211231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMyOTY5OA_fb6ed07b-0bd9-4544-9f0e-6683a1936d1b">3.3</ix:nonFraction> million of the Company&#8217;s shares for $<ix:nonFraction unitRef="usd" contextRef="ib17c7ffbc55e498aa48c293d6f774907_D20211001-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMyOTczMA_cfc9bc74-90cf-4b30-bcfa-8596b9e64e5f">728</ix:nonFraction> million through open market transactions at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib17c7ffbc55e498aa48c293d6f774907_D20211001-20211231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMyOTgwMA_4545afbf-f786-4d0d-b28d-cab2d0d2d5b4">223.89</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="if205d6ef74be40cfa4f1e33f2e553e47_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTA5OTUxMTYzNDEyNg_0f6afdb2-f2c8-4971-b03d-02bb5bdb4d3e">30</ix:nonFraction> million was accrued at December 31, 2021 within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheet for share repurchases executed in late December and settled in early January. Additionally, during the three months ended September 30, 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i1ed2ad6a9a9245ffb0210d01707cf604_D20210701-20210930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTA5OTUxMTYzMzU3Mg_36b34845-98aa-4bb0-8bdc-b5415ced09db">1.4</ix:nonFraction> million of the Company&#8217;s shares for $<ix:nonFraction unitRef="usd" contextRef="i1ed2ad6a9a9245ffb0210d01707cf604_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTA5OTUxMTYzMzU5Mg_285889b6-5343-4cb5-b242-edb48faeb7d8">280</ix:nonFraction> million through open market transactions at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1ed2ad6a9a9245ffb0210d01707cf604_D20210701-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTA5OTUxMTYzMzYwNw_ac748988-2efa-4a46-b04f-edf4bebd1350">203.20</ix:nonFraction>. There were <ix:nonFraction unitRef="shares" contextRef="i0933f1ae15e649a1b3f3599aeed9843f_D20210401-20210630" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjk2ODY4MTM5NTc0Mjk_b8fa95a3-e831-448a-9615-42da4a49b1df">no</ix:nonFraction> open market share repurchases during the three months ended June 30, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 8, 2021, the Company announced that the Board approved an increase of $<ix:nonFraction unitRef="usd" contextRef="i1f96be18861e4831bbe49116594b08c3_I20211208" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTA5OTUxMTYzMzcyMg_a3690955-a7aa-4f9b-84e8-c8133568d99e">4.0</ix:nonFraction>&#160;billion in the authorization for repurchase of McKesson&#8217;s common stock. The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at December 31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjIzMA_19bfa6ad-a8a5-438d-b111-59fc621c85da">4.8</ix:nonFraction> billion.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i540273ce247f4e77bcb256bd6ff2edea_D20201001-20201231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMzMDMzNA_ab354645-abe3-4af5-b894-e00914e0e6ec">1.5</ix:nonFraction>&#160;million of the Company&#8217;s shares for $<ix:nonFraction unitRef="usd" contextRef="i540273ce247f4e77bcb256bd6ff2edea_D20201001-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMzMDM0Nw_74110c49-b15b-4e03-a922-b2a705a20b2c">231</ix:nonFraction>&#160;million through open market transactions at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i540273ce247f4e77bcb256bd6ff2edea_D20201001-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMzMDM2MQ_04d6773c-83fe-4fa0-be90-9dd13ee1d8cc">151.12</ix:nonFraction>. During the three months ended September 30, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i054b314a3e2a4b9d9bc83711755c16c6_D20200701-20200930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjMwOA_317ac6c2-3b85-482b-ab4d-ff61ca58edc7">1.8</ix:nonFraction>&#160;million of the Company&#8217;s shares for $<ix:nonFraction unitRef="usd" contextRef="i054b314a3e2a4b9d9bc83711755c16c6_D20200701-20200930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjMzOQ_94950e0f-736f-4967-b782-590acff140ca">269</ix:nonFraction>&#160;million through open market transactions at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i054b314a3e2a4b9d9bc83711755c16c6_D20200701-20200930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjQwOA_3437a336-86c3-4421-89ea-6693286abf13">151.23</ix:nonFraction>. There were <ix:nonFraction unitRef="shares" contextRef="i6b65ae2097be4ee9b04fbfebc350aa5c_D20200401-20200630" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjYyNg_cdbcf3c8-8a39-4b56-8fb6-c2e67a7eb01c">no</ix:nonFraction> share repurchases during the three months ended June 30, 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i064efd8840784724813b81ccdd56da53" continuedAt="i9d950abc251c4b19912dd10ae80dbed4"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss) </span></div><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDYzMQ_1938ad34-233b-4b9c-bee9-07903988eb54" continuedAt="id75eb8372a4148b8b83a57e5b6c695bf" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss), including noncontrolling interests and redeemable noncontrolling interests, by components for the three and nine months ended December 31, 2021 and 2020 are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea19c1464fd3431fbfd6ec399c1e71c7_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMi0xLTEtMS00NzI4NA_617ac710-cf71-4d95-9a45-89f353494f47">1,557</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f08193bb90c44f6ae9ec36df03a265a_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMi0zLTEtMS00NzI4NA_61bd69d9-923d-4a83-8b72-2c8351a9c54f">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia35d1f63c33540bea2b1ae396c7e4d9d_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMi01LTEtMS00NzI4NA_ba02f7df-82c8-4101-8bf0-742b73ee301e">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a19c7ce388247dd9c4fff8563e46afd_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMi03LTEtMS00NzI4NA_bdc9cb3b-be8a-4d39-ba69-97ddf186f947">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1be4875f550d4562b96d61a975ce1384_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMi05LTEtMS00NzI4NA_b7adc45b-c60b-4aa3-86a0-ed3d019fc745">1,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMy0xLTEtMS00NzI4NA_e5de4f37-5b7f-4d4a-afa4-edea78c97671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMy0zLTEtMS00NzI4NA_5d8ec7c9-5f32-4e3d-8a22-39e271913cb5">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMy01LTEtMS00NzI4NA_1f08ea2d-c299-4af8-a420-96e3b9eac5d1">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMy03LTEtMS00NzI4NA_72792876-0d7e-423c-b0ec-e737a27febab">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMy05LTEtMS00NzI4NA_f5e1c31d-848d-44a5-8265-87afb66bdb73">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNC0xLTEtMS00NzI4NA_323fee97-3ba0-40d6-8399-a1688611497f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNC0zLTEtMS00NzI4NA_ee0c6632-d401-45c5-906e-d5aefaa79550">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNC01LTEtMS00NzI4NA_436ee599-24e5-489b-b7d7-0b37a5ebe059">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNC03LTEtMS00NzI4NA_ce5acfe5-4bc3-4205-8115-5e8ac6dccfdf">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNC05LTEtMS00NzI4NA_c300acd4-34b7-43ae-b359-46b554187b12">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNS0xLTEtMS00NzI4NA_73594e8a-8bd2-43ae-a125-4f69d14a9495">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNS0zLTEtMS00NzI4NA_30bd7b4d-21af-4ee6-b8dc-18b72deff048">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNS01LTEtMS00NzI4NA_7dfd7437-7337-44c7-b658-105df3b4f8a1">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNS03LTEtMS00NzI4NA_bbca8cf3-f56d-46ba-8f67-e1d8b7062b21">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNS05LTEtMS00NzI4NA_90cc280a-bc4d-46e6-8e2f-57f37eb5af81">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNi0xLTEtMS00NzI4NA_f955f11e-9420-4b8d-9a99-45a7ebe70bce">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNi0zLTEtMS00NzI4NA_b4b2993f-3a32-4b33-ae25-5d48d1581ab7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNi01LTEtMS00NzI4NA_48543f18-2f7f-424e-b0a6-9b19667fec7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNi03LTEtMS00NzI4NA_5140157b-90e1-4e0c-a778-a789cbd460f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNi05LTEtMS00NzI4NA_7a3b871e-7fde-4ee9-8107-1db3f454195b">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNy0xLTEtMS00NzI4NA_2e7414bf-7e95-4472-8f7f-b7bf2d591de6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNy0zLTEtMS00NzI4NA_a7285ae7-80bc-48a4-9369-028ecf32b306">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNy01LTEtMS00NzI4NA_490e9456-2bbd-42b7-b6b6-343fbe5a3595">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNy03LTEtMS00NzI4NA_e221417c-bcf0-4b31-b8bd-6fc388723028">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNy05LTEtMS00NzI4NA_cf80c94d-e67c-4644-9a6e-d171b419bfc1">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5033f6f00844a00b920db06167d72c6_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfOS0xLTEtMS00NzI4NA_6e569161-35f6-4a46-a0cc-42175e4c9940">1,555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb80f013f5b04877be046df73b8ea013_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfOS0zLTEtMS00NzI4NA_095f29bb-880a-4530-ba5f-b72c3266e954">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica87d626efb840368fbbe575e025eb74_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfOS01LTEtMS00NzI4NA_41939645-effd-44fc-8835-2788cf3335bd">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f90b71776b5462a8d1be5c313a0e1c6_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfOS03LTEtMS00NzI4NA_d504fa8c-706a-4c03-ab16-dbd0097467a4">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib041b764acbd496ba6cd257448c9a6ba_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfOS05LTEtMS00NzI4NA_eb85aece-c1c2-456b-8c02-92a089dce213">1,655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the three months ended December 31, 2021 include gains of $<ix:nonFraction unitRef="usd" contextRef="i7225d41e4b98447f94299cb918d544af_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzE3Ng_ee8a95b5-83ce-4f01-905b-7735d4df6a80">23</ix:nonFraction>&#160;million related to net investment hedges from Euro-denominated notes and losses of $<ix:nonFraction unitRef="usd" contextRef="i3ed06ba2cb5a4c79824d9a614fb48e1f_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzI1Nw_fc60f6f0-a7c2-4520-99c9-f25390f78028">2</ix:nonFraction>&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzM2NA_4079c993-6da7-47b3-acd5-66ab823813f4">5</ix:nonFraction> million.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i9d950abc251c4b19912dd10ae80dbed4" continuedAt="i984cb6d9a191472fa501a3d9b26e8cb5"><ix:continuation id="id75eb8372a4148b8b83a57e5b6c695bf" continuedAt="i9d63eacae5764a74b26df4255f3aa4a1"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec1ab358f1c44c4b1d28bfe361d9694_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMi0xLTEtMS00NzI4NA_d08d57e6-10bf-477c-b2a4-27593535a423">1,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a7350f891f34c389f5314b093c80f47_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMi0zLTEtMS00NzI4NA_98b59810-2059-456e-aec6-cf4ed5f5662f">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4cae94d5a4343dea4571122ba91a7dd_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMi01LTEtMS00NzI4NA_b54d4ef0-15d7-4fd1-92c5-5646b61c7f0c">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc95fc7008f24256bb487870b5b105be_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMi03LTEtMS00NzI4NA_86b2cd35-0b97-4564-bb4c-25170a032ae4">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd1f982f3f4042c9badc91a36fff0cc1_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMi05LTEtMS00NzI4NA_a33ff243-fc15-47dc-ade3-e3d153981589">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMy0xLTEtMS00NzI4NA_62f775e8-8ad6-439c-bc1c-41673b60348e">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMy0zLTEtMS00NzI4NA_e9903887-13ea-4d7d-ae03-71faecc8a70d">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMy01LTEtMS00NzI4NA_5184f66e-8b94-4544-bd38-698c47b3aa4e">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMy03LTEtMS00NzI4NA_f2de1bc5-d3f9-4a31-8099-7d4f557208b2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMy05LTEtMS00NzI4NA_9f6516f3-99ca-4d4d-842c-292b514677b0">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNC0xLTEtMS00NzI4NA_c5360fb8-a34a-4389-925b-87d54536bcfb">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNC0zLTEtMS00NzI4NA_f0a229d6-1e27-4ae2-a521-bc113e4d0c7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNC01LTEtMS00NzI4NA_a6c525a2-c4ba-4f29-a95e-595fcb7de212">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNC03LTEtMS00NzI4NA_969683a1-03ed-49bf-b9c7-62cb3d738b01">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNC05LTEtMS00NzI4NA_6b56c1b9-56ee-4cb1-8898-873e79ed166a">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNS0xLTEtMS00NzI4NA_d8c38f6a-ce5e-4bd6-87ae-ea73f4b0b5c2">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNS0zLTEtMS00NzI4NA_d8247145-6faf-4ce6-8d6e-114c52fc2bd0">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNS01LTEtMS00NzI4NA_e0a83486-08f0-4e30-bc51-a525658f7608">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNS03LTEtMS00NzI4NA_23d3410c-a006-4e4c-ae39-a1151eb2cba2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNS05LTEtMS00NzI4NA_ddec8b7b-c0b8-4a90-836b-15fc154f2447">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNi0xLTEtMS00NzI4NA_88640c41-61f8-4788-89d3-d4a8be078360">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNi0zLTEtMS00NzI4NA_60e6b7c3-4b40-4e81-b4d0-24bf946c43cd">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNi01LTEtMS00NzI4NA_09d85c94-8468-47bd-a208-07e25a273c00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNi03LTEtMS00NzI4NA_a3c7e687-538f-4a87-9b5d-df391225c19a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNi05LTEtMS00NzI4NA_28d9351c-ed5c-4280-8b0c-b67817fd1d5c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNy0xLTEtMS00NzI4NA_2ab12db7-de12-4ebd-93a3-b03e69394136">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNy0zLTEtMS00NzI4NA_c946c2fd-9329-432f-98bf-d6fb1ac3b1e5">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNy01LTEtMS00NzI4NA_2c55e6c3-7a3c-485c-878f-90de87d68e39">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNy03LTEtMS00NzI4NA_f9038d54-0c36-4577-9e9f-8e58dcc61f84">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNy05LTEtMS00NzI4NA_e7deb3a9-3ca7-414f-940f-f7ffd3cac06f">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOC0xLTEtMS00NzI4NA_62a5b56a-4d84-4200-967d-2acb42a09fdb">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOC0zLTEtMS00NzI4NA_52c0e49a-726d-46c6-b4e6-1f1e4aef75ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOC01LTEtMS00NzI4NA_6890a807-9bf3-4cf5-b7d2-dd43aa1169c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOC03LTEtMS00NzI4NA_840d5731-bc53-442f-88ca-b633178e43a4">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOC05LTEtMS00NzI4NA_10a166e1-1e59-4f73-aa76-9de031c33620">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5033f6f00844a00b920db06167d72c6_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOS0xLTEtMS00NzI4NA_b5c16b2d-546c-4c02-ac65-1f1cf6b79420">1,555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb80f013f5b04877be046df73b8ea013_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOS0zLTEtMS00NzI4NA_4be4809d-0dc1-4115-b08d-459350422d88">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica87d626efb840368fbbe575e025eb74_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOS01LTEtMS00NzI4NA_87a3fc8a-2a2d-42f1-a5fc-e6c801eb98db">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f90b71776b5462a8d1be5c313a0e1c6_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOS03LTEtMS00NzI4NA_61191603-2a4d-4435-8cbc-109feec96fa0">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib041b764acbd496ba6cd257448c9a6ba_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOS05LTEtMS00NzI4NA_bee72483-e751-4510-ac3b-58a534e4ebc8">1,655</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the nine months ended December 31, 2021 include gains of $<ix:nonFraction unitRef="usd" contextRef="idac086104fd949cabcf4563c6be329c2_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzU5NQ_68196ea4-9e6f-439c-a823-c2e6bba3456a">34</ix:nonFraction>&#160;million related to net investment hedges from Euro-denominated notes and gains of $<ix:nonFraction unitRef="usd" contextRef="i213dfc02855e4772998e42a0ea099c76_D20210401-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzY3Ng_95f609e0-40e7-4540-b6b5-c3137ff79ba3">3</ix:nonFraction>&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $<ix:nonFraction unitRef="usd" contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzc4Mw_dddeaa56-5014-465e-bdd5-c136a92d66cf">10</ix:nonFraction> million.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i984cb6d9a191472fa501a3d9b26e8cb5"><ix:continuation id="i9d63eacae5764a74b26df4255f3aa4a1"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70cfadc2fd5f4b4a9277df704a122f06_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMi0xLTEtMS00NzI4NA_1c77bc03-21a3-41ce-be35-91a60e6fd024">1,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b43080a3b24a16ae2b97ea91852b4c_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMi0zLTEtMS00NzI4NA_cf52db28-3271-4300-850f-92bae0f51c7a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5cec83dac43442fb28746e2671aa4ef_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMi01LTEtMS00NzI4NA_52155c38-3978-484f-8876-e337f3f1a748">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f84efb755fb430185527dfc44d3694e_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMi03LTEtMS00NzI4NA_d9dfcb18-c9f7-4264-86d1-0a4e3c15bf52">116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf3b3d119214ddc994b0fa424595480_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMi05LTEtMS00NzI4NA_a59122ed-b016-457c-a49a-a919a2dabb0a">1,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMy0xLTEtMS00NzI4NA_8005fd6a-0ff7-404d-96be-07a7c742b796">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMy0zLTEtMS00NzI4NA_6d7ed921-b995-495a-a431-f754d82bcdf1">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMy01LTEtMS00NzI4NA_e7f29417-0fcd-468b-99d2-84d7a8c329d3">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMy03LTEtMS00NzI4NA_5b6efda0-b788-4422-a251-dde3ba6bb0fc">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMy05LTEtMS00NzI4NA_3403bf09-25ef-4397-bf66-c92205df68e5">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNC0xLTEtMS00NzI4NA_80f37431-2bd9-4637-959d-a5d7f499552d">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNC0zLTEtMS00NzI4NA_5f048072-63ce-4f08-8cb8-f45337277b2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNC01LTEtMS00NzI4NA_2d9e6f54-628a-4661-87ad-d3d69c4211fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNC03LTEtMS00NzI4NA_08eee8a4-2148-4b01-a0c8-a6a76682cecc">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNC05LTEtMS00NzI4NA_a63c31d7-a7b7-4c11-98f1-5b32bbdce858">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNS0xLTEtMS00NzI4NA_a700f89d-d710-41e3-a49d-2d5e7a1b650f">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNS0zLTEtMS00NzI4NA_8b945a18-5543-4689-bc11-dfb24e0de788">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNS01LTEtMS00NzI4NA_fc2d579c-61b4-4f99-b838-9408a4b5afd5">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNS03LTEtMS00NzI4NA_21c4a485-c57e-4e3c-bd2a-53ae0261c44a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNS05LTEtMS00NzI4NA_f51644de-c2e0-4eb0-85a7-53e7e20853c4">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNi0xLTEtMS00NzI4NA_44ae2da6-c174-494d-bce4-3daa73c16b04">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNi0zLTEtMS00NzI4NA_5bfa626d-1d7f-4158-a858-d4ab6f8fd111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNi01LTEtMS00NzI4NA_4f07e573-0f0d-4131-9315-857608e9ba2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNi03LTEtMS00NzI4NA_6144cd1e-81c3-40cd-b79b-1d1e279aae39">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNi05LTEtMS00NzI4NA_6e1fe2d6-ec4f-48fa-964a-867e001fc146">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNy0xLTEtMS00NzI4NA_bf6919dd-3dee-417f-998d-8975d180b8d2">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNy0zLTEtMS00NzI4NA_2efb2cf1-bb74-4016-9b8e-dd4e54b8013f">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNy01LTEtMS00NzI4NA_922eaf0c-b33f-4cdf-b195-08f25dd42ed4">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNy03LTEtMS00NzI4NA_15d008ce-24bb-4ac4-b21f-2dc81c432c18">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNy05LTEtMS00NzI4NA_effc0fab-7f08-4a8a-bc7d-125e5d8d1abb">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73ca4490ab994f9aab3a6fe25a21c69c_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfOC0xLTEtMS00NzI4NA_c81eddfc-a37d-46d5-8996-e4303ed2a859">1,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f489db5b4e04093bf6487d97631d28a_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfOC0zLTEtMS00NzI4NA_f8c7fda2-aafd-46cf-82d0-c62d64c312fa">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb666f100afe4890aa66b7e618e14266_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfOC01LTEtMS00NzI4NA_02a6f792-c688-48ac-b814-5dd4f0974aab">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8ce0eeffaae46c29688d5a5b4ce0c65_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfOC03LTEtMS00NzI4NA_888796ba-67fe-4a55-a129-fa44050b1ac4">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19c25b891e2446a6bab4b8ee69b28057_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfOC05LTEtMS00NzI4NA_e265e872-75d8-44cd-9b85-3651818182e8">1,503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the three months ended December 31, 2020 include losses of $<ix:nonFraction unitRef="usd" contextRef="i1e495f371886450bba3a39c61d7905dd_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDAxNA_0eab93f4-c86a-4a7e-aad1-a70b7fd743e2">84</ix:nonFraction>&#160;million related to net investment hedges from Euro-denominated notes and losses of $<ix:nonFraction unitRef="usd" contextRef="ia33af281a8774481b036a38c796706ec_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDA5Ng_4546787b-654d-4283-9c45-d9228fd82c23">45</ix:nonFraction>&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDIwNg_c0938b59-b251-4fc7-8d63-6f1b4cb64588">33</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76a341aced7248cd9123b95a14c8a92e_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMi0xLTEtMS00NzI4NA_5f6f3424-cc0c-4b29-9172-e7d2aeaec263">1,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c22952abf9142609c8c89682fe068ff_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMi0zLTEtMS00NzI4NA_02a33485-487a-4b12-8969-b7b406f9a9fb">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e78796fe5fa418093c4d5c12a166c69_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMi01LTEtMS00NzI4NA_d8686c0d-7e1e-498b-b848-5f2d66b0662e">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if03813c6358648a394e5872d25a93782_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMi03LTEtMS00NzI4NA_d4da7fd6-4395-4027-9c97-fbd8e9bc7bb3">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebc1818efd944fffbeda92744ddd19d5_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMi05LTEtMS00NzI4NA_1c8d5f93-7d13-4c86-aeb3-58199d11fead">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cfcd79590b140b1936d216597d97299_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMy0xLTEtMS00NzI4NA_2fe78567-6271-43a7-9f67-1f654cc3af65">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMy0zLTEtMS00NzI4NA_1b9998b4-7274-4e2f-9bd5-a40e6c4e14a7">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMy01LTEtMS00NzI4NA_108e0bf7-f262-4cff-9520-27e7b0265f62">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMy03LTEtMS00NzI4NA_105ea7b4-57e6-4f80-b521-e6c45cc58faa">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMy05LTEtMS00NzI4NA_4bbaf48d-8ce0-4a2e-bca7-31c70e620d74">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cfcd79590b140b1936d216597d97299_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNC0xLTEtMS00NzI4NA_05772d13-bc55-403d-ae97-8894b5b9796b">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNC0zLTEtMS00NzI4NA_eec996e0-3338-4229-83e8-eb6bb66978d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNC01LTEtMS00NzI4NA_44152aed-fb69-4d12-bffc-63dcd2a81757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNC03LTEtMS00NzI4NA_91e3e8a5-382b-4916-befe-f29a484d8bab">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNC05LTEtMS00NzI4NA_7827e564-3731-4548-a138-3d4ed1266515">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cfcd79590b140b1936d216597d97299_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNS0xLTEtMS00NzI4NA_50cc5574-6f31-4a45-bb05-a093c057cfae">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNS0zLTEtMS00NzI4NA_9835f19d-de5e-4482-bc4b-5daf268dccca">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNS01LTEtMS00NzI4NA_6c59aeff-1722-46cc-b978-80f0badb630b">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNS03LTEtMS00NzI4NA_9e389ea3-3570-4ba9-b517-ac9df9872836">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNS05LTEtMS00NzI4NA_b3fa046a-3aec-45be-946b-80a2c05421ac">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cfcd79590b140b1936d216597d97299_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNi0xLTEtMS00NzI4NA_175ee7f5-7cd1-4564-90df-0385bcd9671c">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNi0zLTEtMS00NzI4NA_84169ac7-273b-4142-8fa5-1a8fdbc7b9ab">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNi01LTEtMS00NzI4NA_d40c1839-2cde-4d28-86fe-09326c1245e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNi03LTEtMS00NzI4NA_f7713acd-5166-47f6-b336-13c243b9feaa">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNi05LTEtMS00NzI4NA_3f40c558-5da3-4ea8-b2ad-117a969386a6">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cfcd79590b140b1936d216597d97299_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNy0xLTEtMS00NzI4NA_11c26096-a720-4a2f-8311-93d3420b33b2">451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNy0zLTEtMS00NzI4NA_fe1cceb1-ec5c-48f6-be37-49cd28eaf4b0">228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNy01LTEtMS00NzI4NA_168ae13e-d810-4249-86ed-4f080864b8b6">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNy03LTEtMS00NzI4NA_ff0ae0ee-86ed-4995-addc-65cf526fa79c">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNy05LTEtMS00NzI4NA_93281423-2dda-4951-bb16-cb0e972bad40">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73ca4490ab994f9aab3a6fe25a21c69c_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfOC0xLTEtMS00NzI4NA_4f6ea674-d6c6-420d-94ce-de97f00a2719">1,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f489db5b4e04093bf6487d97631d28a_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfOC0zLTEtMS00NzI4NA_cc5b2f8f-8365-46f7-a3c1-42ffaa8a3a60">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb666f100afe4890aa66b7e618e14266_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfOC01LTEtMS00NzI4NA_e6d6443b-3a55-4c99-a356-e03fae829842">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8ce0eeffaae46c29688d5a5b4ce0c65_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfOC03LTEtMS00NzI4NA_d8152e5f-4538-48d2-8d54-9e310f2b3714">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19c25b891e2446a6bab4b8ee69b28057_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfOC05LTEtMS00NzI4NA_2e1db228-b2af-49ef-9cf2-961c475bb8a3">1,503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the nine months ended December 31, 2020 include losses of $<ix:nonFraction unitRef="usd" contextRef="ic8f475edd8834ac5b7034c3816c08c6b_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDQzNw_a41786aa-e5ce-4547-8742-200039fe90de">201</ix:nonFraction>&#160;million related to net investment hedges from Euro-denominated notes and losses of $<ix:nonFraction unitRef="usd" contextRef="i5e50b6a1f79d4e56ac4b54c8d2eae50e_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDUxOQ_4a36257c-be6e-4a90-8c4b-6671b56bd906">108</ix:nonFraction>&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDYyOQ_bdef1f8e-92c1-4e44-b838-b7aa9f538953">80</ix:nonFraction>&#160;million.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_73"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjg2OQ_a85eb811-c8bd-432b-baea-aa792832f853" continuedAt="i680fba272eb547d398c1c2dce233df21" escape="true">Segments of Business</ix:nonNumeric></span></div><ix:continuation id="i680fba272eb547d398c1c2dce233df21" continuedAt="if29badee8ac841bf9ad7c4b855654fc7"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNTc_ae83d28c-f37e-45a1-afb6-66cea11258bd">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment unifies the solutions and services of CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation to serve biopharma and life sciences partners and patients. By combining automation and expert navigation of the healthcare ecosystem, RxTS connects pharmacies, providers, payers, and biopharma to address patients&#8217; medication access, adherence, and affordability challenges to help people get the medicine they need to live healthier lives. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than <ix:nonFraction unitRef="product" contextRef="ice5d0a8bd1a546f9bd990cd472b21d74_I20211231" decimals="-3" name="mck:NumberOfNationalBrandMedicalSurgicalProducts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMjEyMw_68c8fc64-cfec-4ae4-a3ea-9beb791ed462">275,000</ix:nonFraction> national brand medical-surgical products as well as McKesson&#8217;s own line of products through a network of distribution centers within the United States.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in <ix:nonFraction unitRef="country" contextRef="i196f51a7ced74f518fa05fcb8b2e53bb_I20211231" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMjU5OQ_93bc7db8-e68e-45ab-894a-47119b1d4d95">12</ix:nonFraction> European countries where it owns, partners, or franchises with retail pharmacies and operates through <ix:nonFraction unitRef="business_operation" contextRef="i196f51a7ced74f518fa05fcb8b2e53bb_I20211231" decimals="INF" name="mck:NumberOfBusinessOperations" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMjcwNA_afa2d7bd-c06f-49db-bfb4-1bac3ec37b00">two</ix:nonFraction> businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. In the second quarter of 2022, the Company entered into an agreement to sell the E.U. disposal group and in the third quarter of 2022, the Company announced agreements to sell the U.K. disposal group and its Austrian business. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="if29badee8ac841bf9ad7c4b855654fc7" continuedAt="i237fba814ed04151b59d0d25e3308edc"><ix:nonNumeric contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjg2OA_2fc7fd9a-e2db-4ddc-b3d1-c2dffbe52e33" continuedAt="i0fb11fe779814eacb3ec1806ebca5b19" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.260%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da13a8ac8824096b8684170e319eb8c_D20211001-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMy0xLTEtMS00NzI4NA_148e887d-1c8d-4870-ad98-9406e676f610">55,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3c9d231a79420980fb15fd08fb296f_D20201001-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMy0zLTEtMS00NzI4NA_9c6a2ef0-1bd0-4be7-b400-28addeb1ba7e">49,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcceb81b10094fe38a52a708698e8e26_D20210401-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMy01LTEtMS00NzI4NA_615eef6b-ec17-415f-8dce-0ae6145f2a56">158,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6926dac9087a4729876428bc63b1680e_D20200401-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMy03LTEtMS00NzI4NA_a3a2c135-85b8-43ce-a00e-6eb22aa911cd">142,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id99d6b8c9b1d4b43b119e8ff00e3fdf7_D20211001-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNC0xLTEtMS00NzI4NA_49685d89-bb41-4eac-8254-089aafb61fcd">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i538bea40557c484aac444eeb523f853a_D20201001-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNC0zLTEtMS00NzI4NA_740e780e-125c-4c6c-b478-8b7654624afa">777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4fff6966c2f4bf68a5a99a525be017b_D20210401-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNC01LTEtMS00NzI4NA_58f720c5-e2df-4c6b-847d-463a23e708ed">2,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d5729dcafe64c6b8bf4d8ca0546c7a2_D20200401-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNC03LTEtMS00NzI4NA_705340df-8be1-4b28-b572-ad42f19273e8">2,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4d53e061fc145b591fc79c6361e5475_D20211001-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNS0xLTEtMS00NzI4NA_1aa5ac71-d290-4ee6-bfdc-f378baa3c2e7">3,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9752827ca2c41efadc1fd4270e49ff3_D20201001-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNS0zLTEtMS00NzI4NA_33217f8a-5d69-4e1e-adc9-8b61f4fb00fe">3,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8581c40a6994c56adbfa16cef30adce_D20210401-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNS01LTEtMS00NzI4NA_6201661a-7e63-49c8-9f0b-6a1d41040bef">8,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ff3ca362ce4d138f3855742853ed06_D20200401-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNS03LTEtMS00NzI4NA_fcaa0241-cd6d-4fed-918a-eb78a5d6c8ee">7,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieefe2d7dc09b481daf49a5152e7f4971_D20211001-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNi0xLTEtMS00NzI4NA_7449fbad-26d0-433c-a5aa-749d850e1758">9,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c351ccf073b47a9b3c10a8e07901940_D20201001-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNi0zLTEtMS00NzI4NA_9c5d5333-2827-4e15-9957-c1aa237262a5">9,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe27bfd9e2c41d58630861c22b41289_D20210401-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNi01LTEtMS00NzI4NA_42b82c4f-2485-4ba1-ad52-3f9e3bcd6cc3">27,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e45b6151afc4cf1bed1110c1034f5c6_D20200401-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNi03LTEtMS00NzI4NA_918d5028-bb4f-43d5-8d23-8d83a698a94d">27,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfOC0xLTEtMS00NzI4NA_6084696a-83d3-4b44-b62c-7fc2a0542751">68,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfOC0zLTEtMS00NzI4NA_134f308d-b7c9-4249-8f56-bd82d4e1b829">62,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfOC01LTEtMS00NzI4NA_ddbd2916-2ae6-4912-9e33-1dad6ebd307d">197,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfOC03LTEtMS00NzI4NA_b071ceb9-4c02-4f37-9a70-0fb0657882d3">179,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTEtMS0xLTEtNDcyODQ_239d34af-2db2-4023-ac0a-f6b00a70b6c2">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTEtMy0xLTEtNDcyODQ_e43aa4e5-9037-4a50-be2a-dbfc9ce1cd8f">635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTEtNS0xLTEtNDcyODQ_aa3b2efb-0afd-417f-b2a4-67425a74a044">2,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTEtNy0xLTEtNDcyODQ_02e8b4a9-92db-413f-a4a1-bf9054074740">1,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTItMS0xLTEtNDcyODQ_02c38bcf-c035-4239-9f3e-54ae1cd10816">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTItMy0xLTEtNDcyODQ_d70ae688-9399-462d-867b-eb0fe6dd1732">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTItNS0xLTEtNDcyODQ_464d1a3a-4ebb-4cf1-9360-c58d3f2871d1">361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTItNy0xLTEtNDcyODQ_b83dc6aa-9d67-46d4-89da-2236b4c80ed0">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTMtMS0xLTEtNDcyODQ_2f136f1f-1584-4adb-a13e-c8180717016a">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTMtMy0xLTEtNDcyODQ_4adb888d-3786-4650-8e14-1af6184cf05e">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTMtNS0xLTEtNDcyODQ_20fb9dad-3367-457e-a6f8-b670c8782d3c">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTMtNy0xLTEtNDcyODQ_c31f184c-57ea-463e-b2e0-ac23d893da94">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTQtMS0xLTEtNDcyODQ_720c857d-d6b6-4205-9e73-575ba01f6110">668</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTQtMy0xLTEtNDcyODQ_48d1bba9-7a6c-4184-8a46-cf06aabb6ca7">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTQtNS0xLTEtNDcyODQ_99b1ce7c-2549-441a-bc9a-aefecd933515">761</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTQtNy0xLTEtNDcyODQ_164ce65b-c155-48de-9632-6fcc919d8dd6">113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia429fdc9639444a39fdf735d731eed0d_D20211001-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTYtMS0xLTEtNDcyODQ_38f1a97b-2d23-41a3-a457-e284a1f66e4e">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70cbdd4364d74ecbb61747d6ff39ba0f_D20201001-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTYtMy0xLTEtNDcyODQ_894c858d-eb32-4139-9bd9-152d6b134b5e">938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i924634ae29da4f73998a60b0bbcf1083_D20210401-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTYtNS0xLTEtNDcyODQ_5ec355f1-d8ba-49d1-b073-d8edfb659e9c">2,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c361f72849a4e38a3998abb4c3cd3d1_D20200401-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTYtNy0xLTEtNDcyODQ_7d6c91ff-79ee-444e-94c2-093aafb432d0">2,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTctMS0xLTEtNDcyODQ_ac817936-9736-4a88-98e3-0145ba9abbf1">195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTctMy0xLTEtNDcyODQ_5530536e-30c3-406c-91ee-6a8a9adeeb88">8,246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTctNS0xLTEtNDcyODQ_90cdfd76-6b35-4c3a-be3f-ad832524d5c8">858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTctNy0xLTEtNDcyODQ_dcf2e527-e87e-46b9-966d-4a0033c39696">8,462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTgtMS0xLTEtNDcyODQ_e6914fd6-087f-4cf5-8ab0-c20b4f512049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTgtMy0xLTEtNDcyODQ_8406ab95-677c-4ec8-881a-4b8776d2c68e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTgtNS0xLTEtNDcyODQ_778f39fb-c1cd-404a-835a-852775d6913f">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTgtNy0xLTEtNDcyODQ_8c2c1bf1-c595-41b0-b265-be74c188b0dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTktMS0xLTEtNDcyODQ_9d40a1c8-52ff-438b-9af0-64e398220214">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTktMy0xLTEtNDcyODQ_69468796-1fb2-4715-bbe4-710e5c713d40">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTktNS0xLTEtNDcyODQ_a1c81638-b0b2-43d0-8f4f-586925ffa228">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTktNy0xLTEtNDcyODQ_8908fad0-5ced-483c-ac31-d2e328ae9b51">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMjAtMS0xLTEtNDcyODQ_7df6f3fc-7d68-4b6c-89fc-7b37d503b579">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMjAtMy0xLTEtNDcyODQ_c4d8601d-0859-45be-9c65-0c32aabe2b51">7,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMjAtNS0xLTEtNDcyODQ_a74d3e24-ebef-4865-a8a2-8447b51adb24">1,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMjAtNy0xLTEtNDcyODQ_6cd95f1f-11b8-4341-bced-0bd0b4cbd790">6,063</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than <ix:nonFraction unitRef="number" contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMzQ0MA_5536a51a-8a46-40f5-8daa-dcb848b0190b">1</ix:nonFraction>% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMzUwNg_fd5d84c0-1a99-4a0f-9135-d9c38b901711">40</ix:nonFraction>% of the RxTS segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMzU1Nw_4219060c-60b7-4085-9d99-aacf9e026502">4</ix:nonFraction>% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than <ix:nonFraction unitRef="number" contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMzYzNA_dcf75a17-47f2-45ee-ae97-046476a94f1f">8</ix:nonFraction>% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining <ix:nonFraction unitRef="segment" contextRef="i10248887c7a5482389fdac7a1610cf69_D20210401-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMjk2ODY4MTM5NjI5NDg_0f3712c3-c80b-45ce-9a80-bb7e573c4ae3">three</ix:nonFraction> reportable segments are domestic.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three and nine months ended December 31, 2021 includes $<ix:nonFraction unitRef="usd" contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231" decimals="-6" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDA0Mg_85a40ce1-0bad-4f67-8e05-342f65eefa79">33</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231" decimals="-6" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDA0OQ_6846bb80-0b5f-471b-8c4e-c4cb16b755c7">79</ix:nonFraction> million, respectively, and for the three and nine months ended December 31, 2020 includes $<ix:nonFraction unitRef="usd" contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231" decimals="-6" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDA5MQ_cd88c2ab-ba05-4183-83c7-309316150669">11</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231" decimals="-6" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDA5OA_653e4d54-97df-4d0b-8404-edee9827bc22">115</ix:nonFraction> million, respectively, of credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. The nine months ended December 31, 2021 includes $<ix:nonFraction unitRef="usd" contextRef="i535080de97454a9fac988b095055839e_D20210401-20211231" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDIzMQ_447c520e-ad5f-4c98-bad2-ded99775f8e5">46</ix:nonFraction> million of cash receipts for the Company&#8217;s share of antitrust legal settlements. The nine months ended December 31, 2020 includes a charge of $<ix:nonFraction unitRef="usd" contextRef="ic7b7e620d7a14950b39e853f79b975ee_D20200401-20201231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDM1NQ_2d082492-3ef3-4b75-ba30-6edc44d91d02">50</ix:nonFraction> million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s Opioid Stewardship Act.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the nine months ended December 31, 2021 includes $<ix:nonFraction unitRef="usd" contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMTk3Mg_e7d5e306-5068-4f17-90bf-29f1240e1c9a">164</ix:nonFraction> million, and for the three and nine months ended December 31, 2020 includes $<ix:nonFraction unitRef="usd" contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMTk4Nw_8f87ba0b-a3e5-4569-b157-76069affbe38">35</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMTk5MQ_050d630e-19d6-48e0-bbc1-6429c8fbd0a9">49</ix:nonFraction> million, respectively, of inventory charges on certain personal protective equipment and other related products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three and nine months ended December 31, 2021 includes charges of $<ix:nonFraction unitRef="usd" contextRef="i3eda82f8d025454abf73c560d50c29b3_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzM1OA_09dd6605-c8c1-481c-a6e5-0e381f67bdaa"><ix:nonFraction unitRef="usd" contextRef="i826a607678f54e2a86f5a30f297b657c_D20210401-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzM1OA_862a8d50-8d54-449d-b486-919d1e7cded1">787</ix:nonFraction></ix:nonFraction> million to remeasure assets and liabilities of the U.K. disposal group to the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; The three and nine months ended December 31, 2021 includes charges of $<ix:nonFraction unitRef="usd" contextRef="id15b966c53f8432785b54e03b4585bb3_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzNzM0NQ_8813d59f-67e2-400f-98cd-b60468e04a5d">58</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i83044c196239439998e7c6a17739816c_D20210401-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDc5Ng_d8c3129e-5a57-49a6-a5ea-7c310565dcb1">400</ix:nonFraction> million to remeasure assets and liabilities of the E.U. disposal group to the lower of carrying value or fair value less costs to sell and to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; The nine months ended December 31, 2021 also includes a gain of $<ix:nonFraction unitRef="usd" contextRef="ia091e797b3e14a3f9b725a69bf843a92_D20210401-20211231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNTEwNg_144b1894-5539-4246-af1a-ff55dd696d0f">59</ix:nonFraction> million related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business. Operating loss for the three and nine months ended December 31, 2020 includes restructuring, impairment, and related charges of $<ix:nonFraction unitRef="usd" contextRef="i4c351ccf073b47a9b3c10a8e07901940_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMTA5OTUxMTYzOTUwNw_4736a6bd-7e7e-48ba-aa60-f7cc8a5f04c1">131</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8e45b6151afc4cf1bed1110c1034f5c6_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMTA5OTUxMTYzOTUxNQ_3bd4f6a4-18af-4937-968a-55831919decd">189</ix:nonFraction> million, respectively, driven largely by long-lived asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i8e45b6151afc4cf1bed1110c1034f5c6_D20200401-20201231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzc3MQ_14fdd42c-721f-43b0-bea7-cf892ea862de"><ix:nonFraction unitRef="usd" contextRef="i4c351ccf073b47a9b3c10a8e07901940_D20201001-20201231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzc3MQ_81f4c11d-7f7f-4bff-89ec-2db168c911d9">115</ix:nonFraction></ix:nonFraction> million primarily related to retail pharmacy businesses in Canada and Europe as well as costs associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and a second quarter goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ic9c32c72ede24d538c9aaaa3b64848d1_D20200701-20200930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNTUxOA_95a8623d-b050-4860-92d1-ed6df6f6203a">69</ix:nonFraction> million related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 7, &#8220;Goodwill and Intangible Assets, Net.&#8221; The three and nine months ended December 31, 2020 also includes charges of $<ix:nonFraction unitRef="usd" contextRef="i3e5e6c1fd605455eab552c5ec9e5d777_D20201001-20201231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMjg1NQ_20ded5d6-c6d0-47b4-94a6-a29376495fb6">47</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i987a6d37125a48a0a90ff128963d4df6_D20200401-20201231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMjg2OQ_83f82b78-ffc0-4f5e-af51-5a052b5c62a1">57</ix:nonFraction> million, respectively, to remeasure to the lower of carrying value or fair value less costs to sell the assets and liabilities of the Company&#8217;s German pharmaceutical wholesale business which was contributed to a joint venture.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i237fba814ed04151b59d0d25e3308edc"><ix:continuation id="i0fb11fe779814eacb3ec1806ebca5b19"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the three and nine months ended December 31, 2021 includes credits of $<ix:nonFraction unitRef="usd" contextRef="i0cf49f518ed74829b2b4b51a44b670a5_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzNzM3Mw_e502bdf4-3b28-4c29-bd6f-155430b7cc9e">32</ix:nonFraction> million and charges of $<ix:nonFraction unitRef="usd" contextRef="i4e881354ecc94f77a5d413d65a33f8b8_D20210401-20211231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNTY4Ng_75e3c1d3-378e-4a18-8b22-eb498ff150b8">117</ix:nonFraction> million primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; Corporate expenses, net for the nine months ended December 31, 2021 also includes charges of $<ix:nonFraction unitRef="usd" contextRef="i24f8b8a283c34dc597297cbaa2899171_D20210401-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNTkxNQ_e5650e67-2a89-48fd-a5c2-709a2057e422">193</ix:nonFraction> million related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221; The three and nine months ended December 31, 2021 includes $<ix:nonFraction unitRef="usd" contextRef="ifd5e0dbe10d64b948193be43501d890e_D20211001-20211231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjA3Mg_63e7fd37-f350-4cde-a4c6-21dae48e021d">33</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74f39cabd47c4d089eb231a7347761c6_D20210401-20211231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjA3OQ_9166e237-4544-489f-aeef-c857292ad9f1">104</ix:nonFraction> million, respectively, and the three and nine months ended December 31, 2020 includes $<ix:nonFraction unitRef="usd" contextRef="i2be96b105bae4665a5c985276d810148_D20201001-20201231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjExNw_bdaf15ea-bba6-4898-86c0-706e777a8390">34</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5eb76a4477ee48c8a318ceb3d69a0f20_D20200401-20201231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjEyNA_bc9fb17b-9d0b-4359-8577-1ede5bebd64d">118</ix:nonFraction> million, respectively, of opioid-related costs, primarily litigation expenses. Corporate expenses, net for the three and nine months ended December 31, 2020 includes a charge of $<ix:nonFraction unitRef="usd" contextRef="i5eb76a4477ee48c8a318ceb3d69a0f20_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzY3Nw_939ebbdf-3236-43ce-af0c-44c56a9d9673"><ix:nonFraction unitRef="usd" contextRef="i2be96b105bae4665a5c985276d810148_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzY3Nw_fd4768d2-fb41-4b9c-969a-78c7bfed3b1c">8.1</ix:nonFraction></ix:nonFraction> billion related to the estimated liability for opioid-related claims, as discussed in more detail in Financial </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, &#8220;Commitments and Contingent Liabilities.&#8221; The nine months ended December 31, 2020 also includes a net gain of $<ix:nonFraction unitRef="usd" contextRef="ic7173dc2a4c04d2f81bcc70922723445_D20200401-20201231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjI1Ng_56d5c6bd-0ed3-4319-b2cd-93e4bddad55d">131</ix:nonFraction> million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for the nine months ended December 31, 2021 includes $<ix:nonFraction unitRef="usd" contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjUyNA_abd2064e-5767-4891-8538-d9fe00278de3">104</ix:nonFraction> million and for the three and nine months ended December 31, 2020 includes $<ix:nonFraction unitRef="usd" contextRef="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjU2Ng_793583b7-3b57-48bf-9d06-356c51c1bb2b">30</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjU3Mw_64919de5-aee9-4c81-a59c-7c6155396428">89</ix:nonFraction> million, respectively, of net gains associated with certain of the Company&#8217;s equity investments.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for the nine months ended December 31, 2021 consists of a charge of $<ix:nonFraction unitRef="usd" contextRef="iec63485adeb64ac4b82621f5ef551144_D20210401-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMTA5OTUxMTYzNjc4Ng_36be89f0-d306-414c-9320-f987719a8ecb">191</ix:nonFraction> million on debt extinguishment related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 8, &#8220;Debt and Financing Activities.&#8221;</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_79"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:12pt;padding-left:27pt;padding-right:27pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Section</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_82">General</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_82">40</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_85">Overview of Our Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_85">40</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_88">Executive Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_88">42</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_91">Trends and Uncertainties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_91">43</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_94">Overview of Consolidated Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_94">48</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_97">Overview of Segment Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_97">53</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_106">New Accounting Pronouncements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_106">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_109">Financial Condition, Liquidity, and Capital Resources</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_109">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_115">Cautionary Notice About Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_115">61</a></span></div></td></tr></table></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_82"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of financial condition and results of operations, referred to as the &#8220;Financial Review,&#8221; is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of McKesson Corporation together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;McKesson,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221; and other similar pronouns). This discussion and analysis should be read in conjunction with the condensed consolidated financial statements and accompanying financial notes in Item 1 of Part I of this Quarterly Report on Form 10-Q and in Item 8 of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2021 previously filed with the United States (&#8220;U.S.&#8221;) Securities and Exchange Commission on May&#160;12, 2021 (&#8220;2021 Annual Report&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean our fiscal year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this report constitute forward-looking statements. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Cautionary Notice About Forward-Looking Statements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Quarterly Report on Form 10-Q.</span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_85"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Our Business:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. We partner with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations in healthcare to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report our results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of individual business activities. We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes our four reportable segments. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further information regarding our reportable segments. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">U.S. Pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">RxTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that unifies the solutions and services of CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation to serve our biopharma and life sciences partners and patients. By combining automation and expert navigation of the healthcare ecosystem, RxTS connects pharmacies, providers, payers, and biopharma to address patients&#8217; medication access, adherence, and affordability challenges to help people get the medicine they need to live healthier lives. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provides medical-surgical supply distribution, logistics, and other services to healthcare providers in the U.S.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that includes our operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. During the nine months ended December 31, 2021, we entered into agreements to sell certain of our businesses in the European Union (&#8220;E.U.&#8221;), and to sell our retail and distribution businesses in the United Kingdom (&#8220;U.K.&#8221;). These divestitures are further described in the below </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;European Divestiture Activities&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, we entered into an agreement to sell certain of our businesses in the E.U. located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with our German headquarters and wound-care business, part of a shared services center in Lithuania, and our ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;1.2 billion (or, approximately $1.4 billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. We recorded charges of $26 million and $517 million for the three and nine months ended December 31, 2021, respectively, in total operating expenses to remeasure the E.U. disposal group to the lower of its carrying value or fair value less costs to sell and to impair certain internal-use software that will not be utilized in the future. The remeasurement adjustment includes a $230 million loss related to the accumulated other comprehensive income balances associated with the E.U. disposal group, driven by declines in the Euro. The transaction is anticipated to close within the first half of fiscal year 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2021, we announced an agreement to sell our retail and distribution businesses in the U.K. (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;325&#160;million (or, approximately $440&#160;million), subject to certain adjustments. We recorded charges of $823&#160;million for the three and nine months ended December 31, 2021 in total operating expenses to remeasure the U.K. disposal group to the lower of its carrying value or fair value less costs to sell. The remeasurement adjustment includes a $731&#160;million loss related to the accumulated other comprehensive income balances associated with the U.K. disposal group, driven by declines in the British pound sterling. The transaction is expected to close in the fourth quarter of 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2021, we announced an agreement with Quadrifolia Management GmbH for a management-led buyout of our Austrian business for a purchase price of &#8364;226&#160;million (or, approximately $257&#160;million), subject to certain adjustments. The transaction closed on January 31, 2022. We recorded a charge of $30&#160;million for the three and nine months ended December 31, 2021 in total operating expenses to remeasure the Austrian business to the lower of its carrying value or fair value less costs to sell.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we had $5.5 billion of assets and $4.8 billion of liabilities classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheet primarily related to the European divestiture activities described above. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Summary: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary provides highlights and key factors that impacted our business, operating results, financial condition, and liquidity for the three and nine months ended December 31, 2021. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Coronavirus disease 2019 (&#8220;COVID-19&#8221;) continues to impact our year over year results. As previously disclosed in our 2021 Annual Report, pharmaceutical distribution volumes decreased across the enterprise during the first quarter of 2021 as a result of the weakened and uncertain global economic environment and COVID-19 restrictions following the onset of the pandemic. The recovery from the pandemic is favorably reflected in our results when comparing 2022 versus 2021. We also had favorable contributions from our COVID-19 vaccine and related ancillary supply kit distribution programs during 2022; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In response to the global pandemic, McKesson plans to donate certain personal protective equipment (&#8220;PPE&#8221;) to charitable organizations to assist with COVID-19 recovery efforts. During the nine months ended December 31, 2021, we recorded inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment. The majority of these charges are driven by the intent of management not to sell certain excess PPE inventory and instead direct it to charitable organizations. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section included below for further information on COVID-19 and related impacts; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues of $68.6 billion and $197.9 billion for the three and nine months ended December 31, 2021, respectively, increased 10% primarily driven by market growth in our U.S. Pharmaceutical segment;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross profit increased 9% and 11% for the three and nine months ended December 31, 2021, respectively, compared to the prior year primarily driven by improvements in primary care patient visits, and the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment as well as the contribution from our COVID-19 vaccination distribution program and growth of specialty pharmaceuticals in our U.S. Pharmaceutical segment. Gross profit for the nine months ended December 31, 2021 also included higher sales of COVID-19 tests in our Medical-Surgical Solutions segment and favorable effects of foreign currency exchange fluctuations in our International segment; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses for the three and nine months ended December 31, 2021 includes fair value remeasurement charges related to our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;European Divestiture Activitie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s&#8221; discussed above;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other income, net for the nine months ended December 31, 2021 includes net gains of $104 million related to our equity investments;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 23, 2021, we completed a cash tender offer and paid an aggregate consideration of $1.1&#160;billion to redeem certain notes with a principal amount of $922&#160;million. As a result of the redemption, we incurred a loss on debt extinguishment in the second quarter of 2022 of $191 million, consisting of the premiums paid and a portion of the write-off of unamortized debt issuance costs in an amount proportional to the principal amount of debt retired. Refer to Financial Note 8, &#8220;Debt and Financing Activities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diluted earnings (loss) per common share from continuing operations attributable to McKesson Corporation for the three and nine months ended December 31, 2021 of $(0.04) and $4.81, respectively, reflects the aforementioned items, net of any respective tax impacts, discrete tax items recognized, and a lower share count compared to the prior year due to the cumulative effect of share repurchases; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We paid $1.0 billion to purchase 34.5&#160;million shares of McKesson Europe during the nine months ended December 31, 2021 through exercises of a put right by the noncontrolling shareholders pursuant to the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;); </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 17, 2021, we redeemed our 0.63% Euro-denominated notes with a principal amount of &#8364;600 million (or, approximately $709&#160;million) prior to the maturity date of August 17, 2021. The notes were redeemed using cash on hand. On August 12, 2021, we also completed a public offering of 1.30% notes due August 15, 2026 with a principal amount of $500&#160;million for proceeds received, net of discounts and offering expenses, of $495&#160;million. We utilized the net proceeds from this note for general corporate purposes;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We returned $2.2 billion of cash to shareholders during the nine months ended December 31, 2021 through $2.0 billion of common stock repurchases and $206 million of dividend payments. On July 23, 2021, we raised our quarterly dividend from $0.42 to $0.47 per common share; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In December 2021, we announced that our Board of Directors (the &#8220;Board&#8221;) approved an increase of $4.0&#160;billion for the authorized share repurchase of McKesson&#8217;s common stock.</span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_91"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trends and Uncertainties:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The novel strain of coronavirus, which causes the infectious disease known as COVID-19, continues to evolve since it was declared a global pandemic on March 11, 2020 by the World Health Organization. We continue to evaluate the nature and extent of the ongoing impacts COVID-19 has on our business, operations, and financial results. Refer to Item 7 - Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Part II of our 2021 Annual Report for a full disclosure of trends and uncertainties due to COVID-19 since the onset of the pandemic. The disclosures below include significant updates that occurred during the first nine months of 2022. The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described in our &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks and Forward-Looking Information&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Response to COVID-19 in the Workplace</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed in continuing to supply our customers and protect the safety of our employees. The various responses we put in place initially at the onset of the pandemic to mitigate the impact of COVID-19 on our business operations include telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures. During the first quarter of 2022, we approved changes to our real estate strategy to increase efficiencies and support flexibility for our employees, including a transition to a partial remote work model for certain employees on a go-forward basis as further discussed in this Financial Review and in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. During the third quarter of 2022, we continued to refine our policies and apply safety measures in the workplace as recommended by the Centers for Disease Control and Prevention (&#8220;CDC&#8221;) as COVID-19 cases increased across North America and Europe driven by the highly contagious Omicron variant.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, we continued COVID-19 vaccination protocols, which are designed to be consistent with federal, state, and local laws and with customer requirements for our U.S. and Canada employees and to protect the safety of our employees, customers, patients, and communities while also safeguarding the healthcare supply chain. In Europe, we are following applicable government guidelines. We continue to monitor all of these changing requirements and guidelines. We have not observed a material increase in employee turnover as a result of COVID-19 vaccination protocols; however, we are unable to predict whether such protocols will have a material impact on our workforce in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Role in the Distribution of COVID-19 Vaccines and Ancillary Supply Kits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions, we remain well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe. We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including PPE, and medicine reach our customers and patients. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines through a contract with the CDC. We have been distributing COVID-19 vaccines that are refrigerated or frozen since December 2020, when the Emergency Use Authorization was issued by the U.S. Food and Drug Administration for the Moderna COVID-19 vaccine manufactured by ModernaTX, Inc. In the first quarter of 2022, McKesson began supporting the U.S. government&#8217;s commitment to donate COVID-19 vaccines worldwide. For this initiative, we are responsible for picking and packing the COVID-19 vaccines into temperature-controlled coolers and preparing them for pickup by an international partner. We do not manage the actual shipments of the vaccines to other countries. The results of operations related to our vaccine distribution are reflected in our U.S. Pharmaceutical segment. We also continue to manage the assembly, storage, and distribution of ancillary supply kits needed to administer COVID-19 vaccines, including sourcing some of those supplies, through agreements with both the Department of Health and Human Services (&#8220;HHS&#8221;) and Pfizer, Inc. The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment. The future financial impact of the arrangements with the CDC and HHS depend on numerous uncertainties, which are described in our &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks and Forward-Looking Information&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Canada and McKesson Europe are playing a role by supporting governments and public health entities through distributing COVID-19 vaccines and administering them in pharmacies. Additionally, McKesson Canada and McKesson Europe are also distributing COVID-19 tests and certain PPE.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends in our Business </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the onset of the COVID-19 pandemic late in our fourth quarter of 2020, we had higher pharmaceutical distribution volumes and increased retail pharmacy foot traffic as our customers increased supplies on hand in March. Subsequently, during the first nine months of 2021, pharmaceutical distribution volumes decreased as a result of the weakened and uncertain global economic environment and COVID-19 restrictions, including government shutdowns and shelter-in-place orders. We also had a decrease in demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors&#8217; offices, which was partially offset by demand for PPE and COVID-19 tests. Additionally, the decreased traffic in doctors&#8217; offices and general shelter-in-place guidance by governmental authorities negatively impacted retail pharmacy foot traffic in both Europe and Canada. This drove favorability in our results when comparing the first nine months of 2022 versus 2021, particularly during the first quarter.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have observed improvements in prescription volumes and primary care patient visits during our first nine months of 2022 compared to the same prior year period; however, the recovery of COVID-19 continues to be non-linear and impacted by variants such as Omicron and ongoing fluctuations in case levels. We observed an increase in demand for tests able to detect SARS-CoV-2 and influenza A/B simultaneously during the three months ended December 31, 2021. While we had an increase in unit sales of our COVID-19 tests, we observed a decline in the average sales price during the three months ended December 31, 2021 due to an increase in competing product offerings and a shift in product mix which negatively impacted our revenue as compared to the prior year period. During the third quarter and first nine months of 2022, the COVID-19 vaccine, and related ancillary kit distribution in the U.S. favorably impacted our results. During the first nine months of 2022, we recognized higher sales for COVID-19 tests primarily due to limited product availability in the first quarter of 2021 and increased demand during the second and third quarters of 2022 corresponding with the spike in positive COVID-19 cases as a result of the Delta and Omicron variants. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Supply Chain</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also continue to monitor and address the COVID-19 pandemic impacts on our supply chain. Although the availability of various products is dependent on our suppliers, their locations, and the extent to which they are impacted by the COVID-19 pandemic, we are proactively working with manufacturers, industry partners, and government agencies to meet the needs of our customers during the pandemic. Overall, during 2022 we had an increase in supply chain costs primarily related to transportation and labor; however, this did not materially impact our results of operations for the three and nine months ended December 31, 2021. In our Medical-Surgical Solutions segment, we have observed certain supply chain disruptions for COVID-19 tests, which poses a potential risk for supply availability to meet the future demand. As potential shortages or disruptions of any products are identified we are acting to address supply continuity, which includes securing additional products when available, sourcing back-up products when needed, and following allocation procedures to maintain and protect supply as much as possible. We are also initiating business continuity action planning to maintain and protect operations across all locations and facilities.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Results of Operations, Financial Condition, and Liquidity</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended December 31, 2021, COVID-19 tests and the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately $544 million, or 18%, to segment revenues, and contributed approximately $118 million, or 38% to segment operating profit. For the nine months ended December 31, 2021, these contributions were approximately $1.4 billion, or 16%, to segment revenues, and including total inventory charges as further described below, increased our segment operating profit by approximately $121 million, or 18%.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of COVID-19 vaccines in our U.S. Pharmaceutical segment contributed less than 10% to segment operating profit for both the three and nine months ended December 31, 2021. The financial impact from our COVID-19 response efforts in the International segment during the three and nine months ended December 31, 2021 was not material to our consolidated results, but contributed to year over year favorability in segment operating results. During the nine months ended December 31, 2020, particularly during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income from continuing operations before income taxes. The recovery of prescription volume trends and patient care visits, which are also described in more detail above in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends in our Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section, had a favorable impact year over year across our businesses when comparing 2022 versus 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels. That inventory valuation, if not supported by market resale prices, may be written down to net realizable value. We may also write-off inventory due to decreased customer demand and excess inventory. During the nine months ended December 31, 2021, we recorded inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment. Of this amount, we recorded $147 million in cost of sales driven by the intent of management not to sell certain excess PPE inventory, which required an inventory write-down to zero, and instead direct it to charitable organizations. We recorded $8 million in total operating expenses for excess inventory which has already been committed for donation during our first nine months of 2022. In addition, $9 million of inventory charges were recorded in cost of sales for PPE and other related products that management intends to sell. Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods of other PPE and related product categories, we are taking measures to mitigate such risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, these COVID-19 related items had a net favorable impact on consolidated income from continuing operations before income taxes for the three and nine months ended December 31, 2021 compared to the same prior year periods. Impacts to future periods due to COVID-19 may differ based on future developments, which is described at the end of this COVID-19 section.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended December 31, 2021, we maintained appropriate labor and overall vendor supply levels and experienced no material impacts to our liquidity or net working capital due to the COVID-19 pandemic. We continue to monitor the COVID-19 situation closely and engage with manufacturers, industry partners, and government agencies to anticipate shortages and respond to demand for certain medications and therapies. We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses. We remain well-capitalized with access to liquidity from our revolving credit facility. Long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic. At December 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioid-Related Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a defendant in a number of legal proceedings asserting claims related to the distribution of controlled substances (opioids) in federal and state courts throughout the U.S., and in Puerto Rico and Canada. Those proceedings include approximately 2,800 federal cases and approximately 350 state court cases throughout the U.S., and cases in Puerto Rico and Canada. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2021, we and the two other national pharmaceutical distributors announced that we had negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. Under the proposed agreement, the three distributors would pay up to approximately $21 billion over a period of 18 years, with up to approximately $7.9 billion to be paid by us for our 38.1% portion if all eligible entities participate. In addition, the proposed agreement would require the three distributors, including the Company, to establish a clearinghouse for controlled substances distribution data and adopt changes to anti-diversion programs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 4, 2021, we and the two other national distributors announced that 42 of 49 eligible states, all 5 U.S. territories, and Washington, DC, had affirmatively signed on to the proposed agreement. At that time, the attorneys general of Alabama, Georgia, Nevada, New Mexico, Oklahoma, Rhode Island, and Washington had not joined the proposed settlement. We further announced that we and the other two distributors had determined that enough states had signed on to the settlement for the proposed agreement to proceed to the next phase. Since that time, the attorneys general of Georgia, Nevada, New Mexico, and Rhode Island have announced that they will join the proposed agreement. In the period between September 4, 2021, and January 26, 2022, each participating state offered its political subdivisions, including those that have not sued, the opportunity to participate in the settlement. By February 25, 2022, we must determine whether a sufficient number of states and political subdivisions have joined for the settlement to proceed to implementation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed agreement only addresses the claims of U.S. state attorneys general and political subdivisions in participating states. The West Virginia subdivisions and Native American tribes are not part of this settlement process. The exact amount that would be due under the proposed agreement depends on several factors, including the participation rate of states and political subdivisions, the extent to which states take action to foreclose opioid lawsuits by political subdivisions, and the extent to which political subdivisions in settling states file additional opioid lawsuits against us after the proposed agreement becomes effective. The proposed agreement contemplates that if certain governmental entities do not agree to a settlement under the framework, but the distributors nonetheless conclude that there is sufficient participation to warrant the settlement, there would be a corresponding reduction in the amount due to account for the unresolved claims of the governmental entities that do not participate. Those non-participating governmental entities could continue to pursue their claims.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that a broad settlement of opioid claims by governmental entities is probable, and that the loss related thereto can be reasonably estimated. We recorded a charge of $8.1 billion during the year ended March 31, 2021 related to our share of the global settlement as well as claims of West Virginia municipalities and the Native American tribes. In connection with the proposed settlement agreement and other opioid-related settlement accruals described above, we recorded additional charges of $193&#160;million during the nine months ended December 31, 2021 within &#8220;Claims and litigation charges, net&#8221; in our Condensed Consolidated Statements of Operations. Our total estimated liability for opioid-related claims was $8.2 billion as of December 31, 2021, of which $1.1 billion was included in &#8220;Other accrued liabilities&#8221; for the amount estimated to be paid prior to December 31, 2022, and the remaining liability was included in &#8220;Long-term litigation liabilities&#8221; in our Condensed Consolidated Balance Sheet. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the terms of the proposed agreement, we placed approximately $354&#160;million into escrow on September 30, 2021. Those escrow amounts were presented as restricted cash within &#8220;Prepaid expenses and other&#8221; in our Condensed Consolidated Balance Sheet as of December 31, 2021. On January 25, 2022, we placed an additional approximately $19&#160;million into escrow to reflect the participation of additional states. These amounts exclude the proportionate allocation under the proposed settlement for each non-participating state and would be disbursed when and if the proposed agreement becomes effective. Subsequent annual payments would be due on July 15 of each year. Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. In light of the uncertainty, the amount of any ultimate loss may differ materially from the amount accrued. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the progress toward a broad settlement, we also continue to prepare for trial in these pending matters. We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on our financial position, cash flows or liquidity, or results of operations. Refer to Financial Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10&#8209;Q for more information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Forward-Looking Information </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments, and assumptions used in our forecasts. We still face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity. The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the COVID-19 pandemic; potential seasonality of viral outbreaks; impacts of additional variants of the SARS-Cov-2 virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the effectiveness of COVID-19 vaccines and the results of governmental measures designed to mitigate the spread of the virus; the effectiveness of treatments of infected individuals; and changes or disruptions in product supply. We have experienced and may experience difficulties in sourcing products and changes in pricing due to the effects of the COVID-19 pandemic on supply chains. Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when COVID-19 may no longer significantly impact our ability to forecast future financial performance remain challenging. Additionally, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Key assumptions and estimates about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the COVID-19 pandemic on industry and economic trends as well as on our business strategy and internal forecasts. Material changes to key assumptions and estimates can decrease the projected cash flows or increase the discount rates and have resulted in impairment charges of certain long-lived assets and could potentially result in future impairment charges. Refer to Item 1A - Risk Factors in Part I of our 2021 Annual Report for a disclosure of risk factors related to COVID-19.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021, a cybersecurity incident affecting a payroll timekeeping vendor resulted in an unavailability of the vendor&#8217;s platform. Although this incident caused operational inconveniences, it had an immaterial impact on our operations, internal controls over financial reporting, and financial condition. The vendor informed us that the incident did not result in a breach of McKesson&#8217;s or its employees&#8217; confidential or sensitive information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Consolidated Results:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.977%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,851&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total operating expenses as a percentage of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">16.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,363)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,063)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,052)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,053)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.79&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues increased for the three and nine months ended December 31, 2021 compared to the same prior year periods primarily due to market growth in our U.S. Pharmaceutical segment, partially offset by the contribution of our German pharmaceutical wholesale business to a joint venture with Walgreens Boots Alliance (&#8220;WBA&#8221;) on November 1, 2020. For the nine months ended December 31, 2021, revenues were also favorable year over year due to the recovery of pharmaceutical distribution volumes from the prior year impact of COVID-19 across our businesses. Market growth includes growing drug utilization, price increases, and newly launched products, partially offset by price deflation associated with branded to generic drug conversion.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased for the three and nine months ended December 31, 2021 largely due to the pandemic, including the favorable contributions from our COVID-19 vaccine and related ancillary supply kit distribution programs and the recovery of the prior year impacts from COVID-19, such as disruptions of doctors&#8217; office operations, deferred or cancelled elective procedures, lower demand for pharmaceuticals, and overall reduction of foot traffic in pharmacies. Gross profit was also favorably impacted by growth in specialty pharmaceuticals within our U.S. Pharmaceutical segment as well as by foreign currency exchange fluctuations for the three and nine months ended December 31, 2021, and unfavorably impacted by the contribution of our German pharmaceutical wholesale business to a joint venture with WBA on November 1, 2020. For the nine months ended December 31, 2021, gross profit was unfavorably impacted by inventory charges on certain PPE and other related products, partially offset by higher sales of COVID-19 tests.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our U.S. Pharmaceutical segment, gross profit for the nine months ended December 31, 2021 also included net cash proceeds received of $46 million representing our share of antitrust legal settlements. There were no similar cash proceeds received for the same prior year period. Last-in, first-out (&#8220;LIFO&#8221;) inventory credits were $33 million and $11 million for the three months ended December 31, 2021 and 2020, respectively, and $79 million and $115 million for the nine months ended December 31, 2021 and 2020, respectively. LIFO credits are lower in the first nine months of 2022 compared to the same prior year period primarily due to a decrease in the volume of branded off-patent to generic drug launches and higher brand inflation. Our U.S. Pharmaceutical business uses the LIFO method of accounting for the majority of its inventories, which results in cost of sales that more closely reflects replacement cost than under other accounting methods. The business&#8217; practice is to pass on to customers published price changes from suppliers. Manufacturers generally provide us with price protection, which limits price related inventory losses. A LIFO expense is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Our quarterly LIFO credit is based on our estimates of the annual LIFO credit which is impacted by expected changes in year-end inventory quantities, product mix, and manufacturer pricing practices, which may be influenced by market and other external factors. Changes to any of the above factors could have a material impact to our annual LIFO credit. The actual valuation of inventory under the LIFO method is calculated at the end of the fiscal year. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Operating Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the components of our total operating expenses for the three and nine months ended December 31, 2021 and 2020 is as follows: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Selling, distribution, general, and administrative expenses (&#8220;SDG&amp;A&#8221;):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SDG&amp;A consists of personnel costs, transportation costs, depreciation and amortization, lease costs, professional fee expenses, administrative expenses, remeasurement charges to the lower of carrying value or fair value less costs to sell, and other general charges.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Claims and litigation charges, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates. Legal fees to defend claims, which are expensed as incurred, are included within SDG&amp;A.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Goodwill impairments charges:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist. The resulting goodwill impairment charges are reflected within this line item.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Restructuring, impairment, and related charges:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restructuring charges are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Percent of revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.56&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">16.79&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,223)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.25&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8.32&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended December 31, 2021, total operating expenses and total operating expenses as a percentage of revenues increased compared to the same prior year periods. Total operating expenses were impacted by the following significant items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the three and nine months ended December 31, 2021 includes charges totaling $823&#160;million to remeasure our U.K. disposal group to the lower of its carrying value or fair value less costs to sell. The remeasurement adjustment includes a $731&#160;million loss related to the accumulated other comprehensive income balances associated with the U.K. disposal group, driven by declines in the British pound sterling. Of the total charges recorded during the period, $787&#160;million are included within our International segment and $36&#160;million are included within Corporate expenses, net;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the three and nine months ended December 31, 2021 includes charges of $26 million and $517 million, respectively, to remeasure assets and liabilities of our E.U. disposal group held for sale to fair value less costs to sell and to impair certain internal-use software that will not be utilized in the future. The remeasurement adjustment includes a $230 million loss related to the accumulated other comprehensive income balances associated with the E.U. disposal group, driven by declines in the Euro. Of the total charges recorded during the period, $400 million are included within our International segment and $117 million are included within Corporate expenses, net;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the three and nine months ended December 31, 2021 reflects a cost reduction of $49&#160;million and $82&#160;million, respectively, related to the cessation of depreciation and amortization of long-lived assets and operating lease right-of-use assets classified as held for sale for our European divestiture disposal groups;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the three months ended December 31, 2021 and 2020 includes opioid-related costs of $33&#160;million and $34&#160;million, respectively, and $104 million and $118&#160;million for the nine months ended December 31, 2021 and 2020, respectively, primarily related to litigation expenses;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the nine months ended December 31, 2021 includes a gain of $59 million related to the sale of our Canadian health benefit claims management and plan administrative services business;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the nine months ended December 31, 2020 includes a charge of $50&#160;million related to our estimated liability under the State of New York&#8217;s Opioid Stewardship Act (&#8220;OSA&#8221;);</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the three and nine months ended December 31, 2020 reflects charges of $47 million and $57 million, respectively, to remeasure to fair value less costs to sell the assets and liabilities related to our German pharmaceutical wholesale business which was contributed to a joint venture with WBA; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A for the three and nine months ended December 31, 2021 when compared to the same prior year periods also includes increased employee-related and transportation costs across our businesses, partially offset by lower operating expenses due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims and litigation charges, net for the nine months ended December 31, 2021 includes a charge of $193 million, and $8.1 billion for the three and nine months ended December 31, 2020 related to our estimated liability for opioid-related claims as previously discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims and litigation charges, net for the nine months ended December 31, 2020 includes a net gain of $131&#160;million reflecting insurance proceeds received, net of attorneys' fees and expenses awarded to plaintiffs' counsel, in connection with the previously reported $175 million settlement of the shareholder derivative action related to our controlled substances monitoring program;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Goodwill impairment charges of $69&#160;million for the nine months ended December 31, 2020 were recorded in connection with our segment realignment that commenced in the second quarter of 2021. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Goodwill Impairment&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below for further details;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restructuring, impairment, and related charges for the three and nine months ended December 31, 2021 and 2020 primarily includes charges related to Corporate expenses, net, as well as our International segment. In addition, certain charges related to restructuring initiatives are included under the caption &#8220;Cost of sales&#8221; in our Condensed Consolidated Statements of Operations and were not material for the nine months ended December 31, 2020. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Restructuring Initiatives and Long-Lived Asset Impairments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Operating Profit and Corporate Expenses, Net&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sections below as well as Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses were unfavorably impacted by foreign currency exchange fluctuations for the nine months ended December 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist. The annual impairment testing performed in fiscal 2022 and 2021 did not indicate any impairment of goodwill. However, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment, where the risk of a material goodwill impairment is higher than other reporting units. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating structure was realigned commencing in the second quarter of 2021 which prompted changes in multiple reporting units across the Company. As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge of $69&#160;million for the nine months ended December 31, 2020 in our Europe Retail Pharmacy reporting unit, which is included within the International reportable segment. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives and Long-Lived Asset Impairments </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, we approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily includes the rationalization of our office space in North America. Where we determine to cease using office space, we plan to exit the portion of the facility no longer used. We also may retain and repurpose certain other office locations. We expect to incur total charges of approximately $140 million&#160;to $180 million for this initiative, of which $115 million of charges were recorded to date. Charges primarily relate to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative is anticipated to be substantially complete in 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we committed to an initiative within the U.K., which is included in our International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. This initiative was substantially complete in the third quarter of 2022, and remaining costs the Company expects to record under this initiative are not material. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further information on our restructuring initiatives and long-lived asset impairments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net includes net gains from our equity investments for the nine months ended December 31, 2021 of $104 million and $30 million and $89 million for the three and nine months ended December 31, 2020, respectively. Refer to Financial Note 11, &#8220;Fair Value Measurements,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further information. In future periods, fair value adjustments recognized in our operating results for these types of investments may be adversely impacted by market volatility.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss on Debt Extinguishment</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss on debt extinguishment recorded for the nine months ended December 31, 2021 of $191&#160;million includes premiums of $182&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred of $9&#160;million, and was driven by our July 2021 tender offer to redeem a portion of our existing debt. Refer to Financial Note 8, &#8220;Debt and Financing Activities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense decreased for the three and nine months ended December 31, 2021 compared to the same prior year periods primarily due to the repayment of $1.0 billion of long-term debt in the third quarter of 2021 and our tender offer activity in the second quarter of 2022. Interest expense may also fluctuate based on timing, amounts, and interest rates of term debt repaid and new term debt issued, as well as amounts incurred associated with financing fees. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax (Expense) Benefit</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021 and 2020, we recorded an income tax expense of $238 million and income tax benefit of $1.2 billion, respectively. During the nine months ended December 31, 2021 and 2020, we recorded an income tax expense of $396 million and income tax benefit of $1.0 billion, respectively. Our reported income tax rates were 85.9% and 16.1% for the three months ended December 31, 2021 and 2020, respectively, and 30.9% and 16.7% for the nine months ended December 31, 2021 and 2020, respectively. Fluctuations in our reported income tax rates are primarily due to non-cash charges related to remeasuring the value of our E.U. disposal group and U.K. disposal group held for sale to the lower of carrying value or fair value less costs to sell, changes in our mix of earnings between various taxing jurisdictions, and discrete items recognized in the quarters. Refer to Financial Note 4, &#8220;Income Taxes,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests for the three and nine months ended December 31, 2021 and 2020 primarily represents ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and the accrual of the annual recurring compensation amount of &#8364;0.83 per McKesson Europe share that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe under the Domination Agreement. Noncontrolling interests with redemption features, such as put rights, that are not solely within our control are considered redeemable noncontrolling interests.&#160;Redeemable noncontrolling interests are presented outside of McKesson Corporation stockholders&#8217; deficit in our condensed consolidated balance sheets. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Selected Measures of Liquidity and Capital Resources&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this Financial Review and Financial Note 5, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information on changes to our redeemable and noncontrolling interests that occurred during the first quarter of 2022. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Attributable to McKesson Corporation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to McKesson Corporation was $(7) million and $(6.2) billion for the three months ended December 31, 2021 and 2020, respectively, and $746 million and $(5.2) billion for the nine months ended December 31, 2021 and 2020, respectively. Diluted earnings (loss) per common share attributable to McKesson Corporation was $(0.04) and $(39.03) for the three months ended December 31, 2021 and 2020, respectively, and $4.79 and $(32.29) for the nine months ended December 31, 2021 and 2020, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted-Average Diluted Common Shares Outstanding</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings (loss) per common share was calculated based on a weighted-average number of shares outstanding of</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151.6 million and 159.5 million for the three months ended December 31, 2021 and 2020, respectively, and 155.8 million and 161.2 million for the nine months ended December 31, 2021 and 2020, respectively. Weighted-average diluted shares outstanding for the three and nine months ended December 31, 2021 decreased from the same prior year periods primarily due to the cumulative effect of shares repurchases.</span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_97"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Segment Results:</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Revenues:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,614&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,864&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,086&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in revenues for each of our segments for the three and nine months ended December 31, 2021 compared to the same prior year periods consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.691%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in billions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to pharmacies and institutional healthcare providers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to specialty practices and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in U.S. Pharmaceutical revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in Prescription Technology Solutions revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to primary care customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to extended care customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in Medical-Surgical Solutions revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales in Europe, excluding FX impact</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales in Canada, excluding FX impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact from FX</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in International revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in revenues</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FX - foreign currency exchange fluctuations. We calculate the impact from FX by converting current year period results of our operations in foreign countries, which are recorded in local currencies, into U.S. dollars by applying the average foreign currency exchange rates of the comparable prior year period.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the results for the distribution of COVID-19 vaccines.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the results for the kitting and distribution of ancillary supply kits needed to administer COVID-19 vaccines.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the three months ended December 31, 2021 increased</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11% compared to the same prior year period primarily due to market growth, including higher volumes from retail national account customers, branded pharmaceutical price increases, and growth in specialty pharmaceuticals, partially offset by branded to generic drug conversions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the nine months ended December 31, 2021 increased</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11% compared to the same prior year period primarily due to market growth, including higher volumes from retail national account customers, branded pharmaceutical price increases, and growth in specialty pharmaceuticals, partially offset by branded to generic drug conversions. Market growth was partially offset by unfavorability from one less sales day this year compared to the same prior year period. Revenues for this segment were also favorable year over year due to the recovery of prescription volumes from the prior year impact of COVID-19, including increased customer demand for pharmaceuticals in retail pharmacies and institutional healthcare providers.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the three months ended December 31, 2021 increased 33% compared to the same prior year period primarily due to increased volume with new and existing customers.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the nine months ended December 31, 2021 increased 35% compared to the same prior year period primarily due to increased volume with new and existing customers and the recovery of prescription volumes from the prior year impact of COVID-19.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the three months ended December 31, 2021 increased 1% compared to the same prior year period due to improvements in patient care visits in our primary care business and the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines, partially offset by lower revenue from COVID-19 tests. Revenues for this segment were also unfavorably impacted by decreased PPE volume primarily in our extended care business.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the nine months ended December 31, 2021 increased 18% compared to the same prior year period largely in our primary care business due to improvements in patient care visits and higher sales of COVID-19 tests in the first nine months of 2022. Revenues for this segment were also favorably impacted by the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the three months ended December 31, 2021 increased 2% compared to the same prior year period. Excluding the unfavorable effects of foreign currency exchange fluctuations, revenues for this segment increased 2% largely due to sales to new customers in our Canadian business, as well as favorability year over year due to the increase in volumes in our pharmaceutical distribution and retail pharmacy businesses across the segment. These favorable impacts were partially offset by the contribution of our German pharmaceutical wholesale business to a joint venture with WBA in our European business. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the nine months ended December 31, 2021 increased 2% compared to the same prior year period. Excluding the favorable effects of foreign currency exchange fluctuations, revenues for this segment decreased 3% largely due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA. This was partially offset by favorability year over year due to the recovery of volumes from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses across the segment as well as sales to new customers in our Canadian business.</span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_100"></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Operating Profit and Corporate Expenses, Net:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,363)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,063)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bp</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.06)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.77)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(629)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.74)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for our reportable segments. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our U.S. Pharmaceutical segment includes a charge of $50 million for the nine months ended December 31, 2020 related to our estimated liability under the OSA.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our Medical-Surgical Solutions segment for the nine months ended December 31, 2021 includes inventory charges totaling $164 million on certain PPE and other related products primarily driven by the intent of management not to sell certain excess PPE inventory and instead direct it to charitable organizations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for our International segment for the three and nine months ended December 31, 2021 includes charges of $787 million to remeasure our U.K. disposal group held for sale to the lower of its carrying value or fair value less costs to sell. Operating loss for the three and nine months ended December 31, 2021 includes charges of $58 million and $400 million, respectively, to remeasure our E.U. disposal group held for sale to fair value less costs to sell and to impair certain internal-use software that will not be utilized in the future. Operating loss for the nine months ended December 31, 2021 also includes a gain of $59 million related to the sale of our Canadian health benefit claims management and plan administrative services business. Operating loss includes restructuring, impairment, and related charges of $131 million and $189 million for the three and nine months ended December 31, 2020, respectively, driven largely by long-lived asset impairment charges of $115 million primarily related to our retail pharmacy businesses in Canada and Europe as well as costs associated with the closure of certain retail pharmacy stores within our U.K. business. Operating loss for the nine months ended December 31, 2020 includes a goodwill impairment charge of $69 million related to our European retail business as well as charges of $47&#160;million and $57&#160;million for the three and nine months ended December 31, 2020, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for three and nine months ended December 31, 2021 includes credits of $32 million and charges of $117 million primarily related to the effect of accumulated other comprehensive loss components from our E.U. disposal group. Corporate expenses, net includes net gains from our equity investments of $104 million for the nine months ended December 31, 2021 and $30 million and $89 million for the three and nine months ended December 31, 2020, respectively. Corporate expenses, net includes a charge of $193 million for the nine months ended December 31, 2021, and $8.1 billion for the three and nine months ended December 31, 2020 related to our estimated liability for opioid-related claims. Corporate expenses, net includes $33 million and $104 million for the three and nine months ended December 31, 2021, respectively, and $34 million and $118 million for the three and nine months ended December 31, 2020, respectively, of opioid-related costs, primarily litigation expenses. Corporate expenses, net also includes a net gain of $131 million for the nine months ended December 31, 2020 recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for this segment for the three months ended December 31, 2021 compared to the same prior year period primarily due to the contribution from our COVID-19 vaccine distribution program, growth in specialty pharmaceuticals, and an increase in LIFO credits of $22&#160;million, partially offset by an increase in operating expenses.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for this segment for the nine months ended December 31, 2021 compared to the same prior year period primarily due to growth in specialty pharmaceuticals, the contribution from our COVID-19 vaccine distribution program, favorability from the prior year OSA charge described above, net cash proceeds received of $46 million representing our share of antitrust legal settlements, and the recovery of prescription volumes from the prior year impact of COVID-19. This was partially offset by a decrease in LIFO credits of $36&#160;million and an increase in operating expenses.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the three months ended December 31, 2021 compared to the same prior year period primarily due to increased volumes with new and existing customers.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the nine months ended December 31, 2021 compared to the same prior year period primarily due to increased volumes with new and existing customers and the recovery of prescription volumes from the prior year impact of COVID-19.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the three months ended December 31, 2021 compared to the same prior year period primarily due to the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines as well as favorability from improvements in patient care visits in our primary care business, partially offset by lower profitability from COVID-19 tests largely in our primary care business. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the nine months ended December 31, 2021 compared to the same prior year period primarily due to favorability in our primary care business from improvements in patient care visits, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines and higher sales of COVID-19 tests across the segment in the first nine months of 2022. This was partially offset by inventory charges on certain PPE and other related products and an increase in employee-related expenses to support business growth. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss for this segment increased for the three months ended December 31, 2021 compared to the same prior year period largely due to charges to remeasure assets and liabilities of our E.U. disposal group and our U.K. disposal group held for sale to fair value less costs to sell, partially offset by lower restructuring charges in Europe and Canada and the cessation of depreciation and amortization expenses.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss for this segment increased for the nine months ended December 31, 2021 compared to the same prior year period largely due to fair value remeasurement charges related to our E.U. disposal group and our U.K. disposal group, partially offset by the cessation of depreciation and amortization expenses, a prior year goodwill impairment charge related to our European retail business and a gain recognized related to the sale of our Canadian health benefit claims management and plan administrative services business. This segment also experienced favorability year over year due to the volume recovery from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses across the segment and to a lesser extent, the distribution of COVID-19 vaccines, COVID-19 tests, and PPE.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Expenses, Net</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net decreased for the three and nine months ended December 31, 2021 compared to the same prior year period primarily due to a charge of $8.1 billion recorded in the third quarter of 2021 related to our estimated liability for opioid-related claims.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in Corporate expenses, net for the nine months ended December 31, 2021 was partially offset by $193 million related to our estimated liability for opioid-related claims, fair value remeasurement charges related to our E.U. disposal group and our U.K. disposal group, and a net gain of $131 million recognized during the first quarter of 2021 in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.</span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_106"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New accounting pronouncements that we have recently adopted as well as those that have been recently issued but not yet adopted by us are included in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.</span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_109"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our available cash generated from operations and our short-term investment portfolio, together with our existing sources of liquidity from our credit facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements. We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility. At December 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net change in cash, cash equivalents, and restricted cash for the periods shown: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash classified within Assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,237)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,946)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities provided cash of $1.5 billion and $1.2 billion during the nine months ended December 31, 2021 and 2020, respectively. Cash flows from operations can be significantly impacted by factors such as timing of receipts from customers, inventory receipts, and payments to vendors. Additionally, working capital is primarily a function of sales and purchase volumes, inventory requirements, and vendor payment terms. Operating activities for the nine months ended December 31, 2021 were affected by net income adjusted for non-cash items, including the losses on our European businesses held for sale and our classifications of receivables, drafts and accounts payables, and inventories as held for sale. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further information. Excluding the aforementioned classifications, operating activities for the nine months ended December 31, 2021 were affected by increases in inventory of $1.7 billion and drafts and accounts payable of $1.6 billion due to timing of purchases, and an increase in receivables of $1.9 billion resulting from timing of collections and higher revenues. Other non-cash items for the nine months ended December 31, 2021 includes an adjustment to net income of $191 million related to loss on debt extinguishment and non-cash inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment. Operating activities for the nine months ended December 31, 2020 were affected by net income adjusted for non-cash items, a decrease in receivables of $1.5 billion and an increase in inventory of $2.0 billion, both primarily due to sales recognized at year end, as well as a decrease in drafts and accounts payable of $1.2 billion from effective working capital management at year end.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities used cash of $272 million and $210 million during the nine months ended December 31, 2021 and 2020, respectively. Investing activities for the nine months ended December 31, 2021 and 2020 includes $380 million and $427 million, respectively, in capital expenditures for property, plant, and equipment, and capitalized software. Investing activities for the nine months ended December 31, 2020 also includes net cash proceeds of $297 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities used cash of $4.3 billion and $1.2 billion during the nine months ended December 31, 2021 and 2020, respectively. In July 2021, we completed a cash tender offer and paid an aggregate consideration of $1.1&#160;billion to redeem certain notes with a principal amount of $922&#160;million and also redeemed our 0.63% Euro-denominated notes with a principal amount of &#8364;600 million (or, approximately $709&#160;million) prior to the maturity date of August 17, 2021 using cash on hand. This resulted in total repayments of long-term debt during the nine months ended December 31, 2021 of $1.8 billion, including $184 million of cash paid for premiums and transaction fees. This was partially offset by the issuance of long-term debt in August 2021 from a public offering of 1.30% notes due August 15, 2026 for proceeds received of $498 million, which was utilized for general corporate purposes. Financing activities for the nine months ended December 31, 2021 and 2020 includes $2.0 billion and $500 million of cash paid for share repurchases, respectively, and $206 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $209 million of cash paid for dividends, respectively. Additionally, financing activities for the nine months ended December 31, 2021 and 2020 includes payments of $1.0 billion and $49&#160;million, respectively, to purchase shares of McKesson Europe through exercises of a put right option by noncontrolling shareholders. The put right option expired on June 15, 2021 as further described below. Financing activities for the nine months ended December 31, 2021 includes cash receipts of $3.6 billion and payments of $3.3 billion for short-term borrowings, primarily commercial paper. Financing activities for the nine months ended December 31, 2020 includes the issuance of the 2025 Notes in a principal amount of $500 million, the retirement of our $700 million total principal amount of notes due on November 30, 2020 at a fixed interest rate of 3.65% upon maturity, and the redemption of our 4.75% $323 million total principal of notes due on March 1, 2021 prior to maturity. The notes were redeemed using cash on hand and the proceeds from the 2025 Notes. Financing activities for the nine months ended December 31, 2020 includes cash receipts of $5.5 billion and payments of $5.3 billion for short-term borrowings, primarily commercial paper. Cash used for other financing activities generally includes shares surrendered for tax withholding and payments to noncontrolling interests. Other financing activities for the nine months ended December 31, 2020 also includes restricted cash inflow related to funds temporarily held on behalf of unaffiliated medical practice groups.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has authorized the repurchase of McKesson&#8217;s common stock from time to time in open market transactions, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. Pursuant to the ASR agreement, we paid $1.0&#160;billion to the financial institution and received an initial delivery of 4.3 million shares in May 2021. The transaction was completed in August 2021, at which point we received additional shares of 0.9 million. The total number of shares repurchased under this ASR program was 5.2 million shares at an average price per share of $193.22.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021, the Company repurchased an additional 3.3 million of the Company&#8217;s shares for $728 million through open market transactions at an average price per share of $223.89, of which $30 million was accrued at December 31, 2021 within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheet for share repurchases executed in late December and settled in early January. Additionally, during the three months ended September 30, 2021, the Company repurchased 1.4 million of the Company&#8217;s shares for $280 million through open market transactions at an average price per share of $203.20. There were no open market share repurchases during the three months ended June 30, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 8, 2021, the Company announced that the Board approved an increase of $4.0&#160;billion in the authorization for repurchase of McKesson common stock. The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock was $4.8 billion at December 31, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2020, the Company repurchased 1.5&#160;million of the Company&#8217;s shares for $231&#160;million through open market transactions at an average price per share of $151.12. During the three months ended September 30, 2020, the Company repurchased 1.8&#160;million of the Company&#8217;s shares for $269&#160;million through open market transactions at an average price per share of $151.23. There were no share repurchases during the three months ended June 30, 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future operating cash flow, financial assets, and current access to capital and credit markets, including our existing credit facilities, will give us the ability to meet our financing needs for the foreseeable future. However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing. </span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_112"></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected Measures of Liquidity and Capital Resources</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(954)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt to capital ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This ratio describes the relationship and changes within our capital resources, and is computed as the sum of short-term borrowings, current portion of long-term debt, and long-term debt divided by the sum of short-term borrowings, current portion of long-term debt, long-term debt, and McKesson stockholders&#8217; equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents balance as of December 31, 2021 and March 31, 2021 included approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$795 million and $2.3 billion of cash held by our subsidiaries outside of the U.S., respectively. Our primary intent is to utilize this cash for foreign operations for an indefinite period of time. Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.&#160;Following enactment of the 2017 Tax Cuts and Jobs Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital primarily includes cash and cash equivalents, receivables, and inventories, net of drafts and accounts payable, short-term borrowings, current portion of long-term debt, and other accrued liabilities. Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands. Inventory purchase activity is a function of sales activity and other requirements. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated working capital decreased at December 31, 2021 compared to March 31, 2021 primarily due to a decrease in cash and cash equivalents and receivables, as well as an increase in other accrued liabilities, partially offset by a decrease in drafts and accounts payable, an increase in net current assets held for sale related to our E.U. disposal group and U.K. disposal group, and a decrease in our current portion of debt from the redemption of our &#8364;600 million Euro-denominated notes in July 2021. The increase in other accrued liabilities is primarily due to the classification of $1.1 billion from long-term to short-term for the total amount we expect to pay for opioid-related claims within one year as of December 31, 2021, of which $354&#160;million is held in escrow for the initial payment under the proposed settlement agreement for opioid-related claims of governmental entities, excluding the West Virginia subdivisions and Native American Tribes. The escrow payment is presented as restricted cash within &#8220;Prepaid expenses and other&#8221; on our Condensed Consolidated Balance Sheets. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Financial Review and Financial Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10&#8209;Q for further information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt to capital ratio increased for the nine months ended December 31, 2021 primarily due to an increase in McKesson stockholders&#8217; deficit driven by share repurchases, partially offset by net income for the year to date period. Our debt to capital ratio was also impacted by a decrease in total debt from the completion of a cash tender offer to redeem certain notes with a principal amount of $922&#160;million and the redemption of our &#8364;600 million Euro-denominated notes both in July 2021, partially offset by the issuance of notes with a principal amount of $500&#160;million in August 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_76">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, we raised our quarterly dividend from $0.42 to $0.47 per common share for dividends declared on or after such date by the Board. We anticipate that we will continue to pay quarterly cash dividends in the future. However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our redeemable noncontrolling interests primarily related to our consolidated subsidiary, McKesson Europe. At March 31, 2021, the carrying value was $1.3&#160;billion and we owned approximately 78% of McKesson Europe&#8217;s outstanding common shares. Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published semi-annually by the German Bundesbank, less any compensation amount or guaranteed dividend already paid by McKesson (&#8220;Put Amount&#8221;). During the nine months ended December 31, 2021 and 2020, we paid $1.0 billion and $49&#160;million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders, which reduced the balance of our redeemable noncontrolling interests.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, valued at $287&#160;million, were transferred from redeemable noncontrolling interests to noncontrolling interests. At December 31, 2021, we owned approximately 95% of McKesson Europe&#8217;s outstanding common shares. Our noncontrolling interest in McKesson Europe will be included in the sale of our E.U. disposal group.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are obligated to pay an annual recurring compensation of &#8364;0.83 per McKesson Europe share (the &#8220;Compensation Amount&#8221;) to the noncontrolling shareholders of McKesson Europe under the Domination Agreement. The Compensation Amount is recognized ratably during the applicable annual period. The Domination Agreement does not expire, but it may be terminated at the end of any fiscal year by giving at least six months&#8217; advance notice. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 5, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information on redeemable noncontrolling interests. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Resources</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund our working capital requirements primarily with cash and cash equivalents as well as short-term borrowings from our credit facilities and commercial paper issuances. Funds necessary for future debt maturities and our other cash requirements, including any future payments that may be made related to our total estimated litigation liability of $8.2 billion as of December 31, 2021 for opioid-related claims, are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions. Long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, are open and accessible to us should we decide to access those markets. Detailed information regarding our debt and financing activities is included in Financial Note 8, &#8220;Debt and Financing Activities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. </span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_115"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTICE ABOUT FORWARD-LOOKING STATEMENTS </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, including &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 2 of Part I of this report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Some of these statements can be identified by the use of terminology such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;approximately,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; or the negative of these words and other comparable terminology. The discussion of financial trends, strategy, plans, assumptions, or intentions may also include forward-looking statements. Readers should not place undue reliance on forward-looking statements, which speak only as of the date such statements were first made. Except to the extent required by law, we undertake no obligation to update or revise our forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, or implied. Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, factors described in the Risk Factors discussion in Item 1A of Part I of our most recently filed Annual Report on Form 10-K. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_118"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe there has been no material change in our exposure to risks associated with fluctuations in interest and foreign currency exchange rates as disclosed in our 2021 Annual Report. </span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_121"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Controls and Procedures. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and our Chief Financial Officer, with the participation of other members of the Company&#8217;s management, have evaluated the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;)) as of the end of the period covered by this quarterly report, and our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our &#8220;internal control over financial reporting&#8221; (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that occurred during the three months ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_124"></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_127"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Legal Proceedings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth in Financial Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, and in Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, is incorporated herein by reference. Disclosure of an environmental proceeding with a governmental agency generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.</span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_130"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.8pt">Risk Factors.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than factual updates discussed in this Quarterly Report on Form 10-Q, there have been no material changes for the period covered by this Quarterly Report on Form 10-Q to the risk factors disclosed in Part I, Item 1A, of our 2021 Annual Report on Form 10-K.</span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_133"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.2 million shares at an average price per share of $193.22. The Company received 4.3 million shares as the initial share settlement, and in August 2021 the Company received an additional 0.9 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021, the Company repurchased an additional 3.3 million of the Company&#8217;s shares for $728 million through open market transactions at an average price per share of $223.89, of which $30 million was accrued at December 31, 2021 within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheet for share repurchases executed in late December and settled in early January. Additionally, during the three months ended September 30, 2021, the Company repurchased 1.4 million of the Company&#8217;s shares for $280 million through open market transactions at an average price per share of $203.20. There were no open market share repurchases during the three months ended June 30, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 8, 2021, the Company announced that the Board approved an increase of $4.0&#160;billion in the authorization for repurchase of McKesson common stock. The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock was $4.8 billion at December 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the Company&#8217;s share repurchases during the three months ended December 31, 2021.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased<br/>As Part of Publicly<br/>Announced<br/>Program</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate<br/>Dollar&#160;Value&#160;of<br/>Shares&#160;that&#160;May<br/>Yet Be Purchased Under the Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2021 &#8211; October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.97</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2021 &#8211; November 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,112</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2021 &#8211; December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,778</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations. </span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_136"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Defaults Upon Senior Securities.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_139"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Mine Safety Disclosures.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_142"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Other Information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_145"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Exhibits. </span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits identified in parentheses below are on file with the SEC and are incorporated by reference as exhibits hereto. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit311x12312021.htm">Certification of the Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit312x12312021.htm">Certification of the Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#8224;&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit32x12312021.htm">Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the McKesson Corporation Quarterly Report on Form 10-Q for the quarter ended December 31, 2021, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Statements of Comprehensive Income (Loss), (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit), (v) Condensed Consolidated Statements of Cash Flows, and (vi) related Financial Notes.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#8224;&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i4a2b465c28834dc9a8864e8f5f9a3d9a_148"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4a2b465c28834dc9a8864e8f5f9a3d9a_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:207.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Britt J. Vitalone</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:207.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Kevin W. Emerson</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kevin W. Emerson</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Controller</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>mck_exhibit311x12312021.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i02cbcf456f814b4eb73c15278f7b0d94_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian S. Tyler, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:7pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>mck_exhibit312x12312021.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia9bb0fe491a748c4a73239f578de16eb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Britt J. Vitalone, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:7pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>mck_exhibit32x12312021.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9b082ce346e0483a8d17eed6aca8f110_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the quarterly report of McKesson Corporation (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, in the capacities and on the dates indicated below, each hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:24pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160; Brian S. Tyler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:36pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Report pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to McKesson Corporation and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>mck-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b0c4267c-1381-4f10-888f-434d9ccb5c99,g:6c581a7b-6b71-4a88-8456-a4823e8897d4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mck="http://mckesson123.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mckesson123.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://mckesson123.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSale" roleURI="http://mckesson123.com/role/HeldforSale">
        <link:definition>2104102 - Disclosure - Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleTables" roleURI="http://mckesson123.com/role/HeldforSaleTables">
        <link:definition>2305301 - Disclosure - Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleNarrativeDetails" roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails">
        <link:definition>2406402 - Disclosure - Held for Sale - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>2407403 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedCharges" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges">
        <link:definition>2108103 - Disclosure - Restructuring, Impairment, and Related Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesTables" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables">
        <link:definition>2309302 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNarrativeDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails">
        <link:definition>2410404 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails">
        <link:definition>2411405 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails">
        <link:definition>2412406 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://mckesson123.com/role/IncomeTaxes">
        <link:definition>2113104 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://mckesson123.com/role/IncomeTaxesDetails">
        <link:definition>2414407 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterests" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests">
        <link:definition>2115105 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables">
        <link:definition>2316303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
        <link:definition>2417408 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
        <link:definition>2418409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShare" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare">
        <link:definition>2119106 - Disclosure - Earnings (Loss) Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareTables" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables">
        <link:definition>2320304 - Disclosure - Earnings (Loss) Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareDetails" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails">
        <link:definition>2421410 - Disclosure - Earnings (Loss) Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>2122107 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>2323305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails">
        <link:definition>2424411 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>2425412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
        <link:definition>2426413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivities" roleURI="http://mckesson123.com/role/DebtandFinancingActivities">
        <link:definition>2127108 - Disclosure - Debt and Financing Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesTables" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables">
        <link:definition>2328306 - Disclosure - Debt and Financing Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
        <link:definition>2429414 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1">
        <link:definition>2429414 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesLongTermDebtNarrativeDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails">
        <link:definition>2430415 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
        <link:definition>2431416 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesCommercialPaperDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails">
        <link:definition>2432417 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefits" roleURI="http://mckesson123.com/role/PensionBenefits">
        <link:definition>2133109 - Disclosure - Pension Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsNarrativeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails">
        <link:definition>2434418 - Disclosure - Pension Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivities" roleURI="http://mckesson123.com/role/HedgingActivities">
        <link:definition>2135110 - Disclosure - Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesTables" roleURI="http://mckesson123.com/role/HedgingActivitiesTables">
        <link:definition>2336307 - Disclosure - Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesNarrativeDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails">
        <link:definition>2437419 - Disclosure - Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesDerivativeInstrumentsFairValueDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails">
        <link:definition>2438420 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://mckesson123.com/role/FairValueMeasurements">
        <link:definition>2139111 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://mckesson123.com/role/FairValueMeasurementsTables">
        <link:definition>2340308 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2441421 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails">
        <link:definition>2442422 - Disclosure - Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilities" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities">
        <link:definition>2143112 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesTables" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables">
        <link:definition>2344309 - Disclosure - Commitments and Contingent Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesNarrativeDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails">
        <link:definition>2445423 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
        <link:definition>2446424 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficit" roleURI="http://mckesson123.com/role/StockholdersEquityDeficit">
        <link:definition>2147113 - Disclosure - Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitTables" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables">
        <link:definition>2348310 - Disclosure - Stockholders' Equity (Deficit) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitNarrativeDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails">
        <link:definition>2449425 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
        <link:definition>2450426 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusiness" roleURI="http://mckesson123.com/role/SegmentsofBusiness">
        <link:definition>2151114 - Disclosure - Segments of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessTables" roleURI="http://mckesson123.com/role/SegmentsofBusinessTables">
        <link:definition>2352311 - Disclosure - Segments of Business (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessNarrativeDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails">
        <link:definition>2453427 - Disclosure - Segments of Business - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessReportableoperatingsegmentDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails">
        <link:definition>2454428 - Disclosure - Segments of Business - Reportable operating segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mck_NotesAndDebenturesExtinguishedFebruary72018Member" abstract="true" name="NotesAndDebenturesExtinguishedFebruary72018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NewYorkOpioidTaxSurchargeMember" abstract="true" name="NewYorkOpioidTaxSurchargeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencySettlementPaymentTerms" abstract="false" name="LossContingencySettlementPaymentTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" abstract="true" name="ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePriceIncrease" abstract="false" name="NoncontrollingInterestsPutRightExercisePriceIncrease" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" abstract="false" name="AnnualRecurringCompensationPerSharetoNoncontrollingInterests" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ReclassificationofTemporaryEquitytoLiability" abstract="false" name="ReclassificationofTemporaryEquitytoLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_VantageandClarusOneSourcingServicesLLCMember" abstract="true" name="VantageandClarusOneSourcingServicesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfFloridaMember" abstract="true" name="StateOfFloridaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A475NotesDueMay302029Member" abstract="true" name="A475NotesDueMay302029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" abstract="false" name="NoncontrollingInterestDecreaseFromReclassificationToLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EuropeanAssetsHeldForSaleMember" abstract="true" name="EuropeanAssetsHeldForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CherokeeNationMember" abstract="true" name="CherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CorporateOperatingExpenseandOtherIncomeNet" abstract="false" name="CorporateOperatingExpenseandOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_USPharmaceuticalSegmentMember" abstract="true" name="USPharmaceuticalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A270NotesDueDecember152022Member" abstract="true" name="A270NotesDueDecember152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_RestructuringImpairmentandOtherRelatedCharges" abstract="false" name="RestructuringImpairmentandOtherRelatedCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofStateAttorneyGenerals" abstract="false" name="LossContingencyNumberofStateAttorneyGenerals" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A090NotesDueDecember32025Member" abstract="true" name="A090NotesDueDecember32025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A063EuroNotesDueAugust172021Member" abstract="true" name="A063EuroNotesDueAugust172021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A150EuroNotesDueNovember172025Member" abstract="true" name="A150EuroNotesDueNovember172025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_InternallyDevelopedSoftwareMember" abstract="true" name="InternallyDevelopedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_TenderOfferNotesMember" abstract="true" name="TenderOfferNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_IncomeTaxExpenseBenefitDiscreteItems" abstract="false" name="IncomeTaxExpenseBenefitDiscreteItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_RetailPharmacyReportingUnitMember" abstract="true" name="RetailPharmacyReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" abstract="false" name="CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OperatingModelAndCostOptimizationProgramsMember" abstract="true" name="OperatingModelAndCostOptimizationProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CommonStockVotingRightsNumberofVotesPerCommonShare" abstract="false" name="CommonStockVotingRightsNumberofVotesPerCommonShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NativeAmericanTribesOtherThanCherokeeNationMember" abstract="true" name="NativeAmericanTribesOtherThanCherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A600NotesDueMarch12041Member" abstract="true" name="A600NotesDueMarch12041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NumberOfBusinessOperations" abstract="false" name="NumberOfBusinessOperations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_BritishPoundSterlingDenominatedNotesMember" abstract="true" name="BritishPoundSterlingDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" abstract="true" name="RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A380NotesDueMarch152024Member" abstract="true" name="A380NotesDueMarch152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberOfAdditionalDefendants" abstract="false" name="LossContingencyNumberOfAdditionalDefendants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_A163EuroNotesDueOctober302026Member" abstract="true" name="A163EuroNotesDueOctober302026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A2025NotesMember" abstract="true" name="A2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" abstract="false" name="NoncontrollingInterestDecreaseForExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofStates" abstract="false" name="LossContingencyNumberofStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" abstract="false" name="NoncontrollingInterestIncreaseDecreaseDuetoOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" abstract="false" name="RedeemableNoncontrollingInterestsMaximumRedemptionValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A765DebenturesDueMarch12027Member" abstract="true" name="A765DebenturesDueMarch12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_InternationalSegmentMember" abstract="true" name="InternationalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PharmacyLicensesMember" abstract="true" name="PharmacyLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberOfStatesFiledOnBehalfOf" abstract="false" name="LossContingencyNumberOfStatesFiledOnBehalfOf" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_PutRightValueInterestRateSpread" abstract="false" name="PutRightValueInterestRateSpread" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" abstract="false" name="AssetImpairmentChargesIncludingAcceleratedDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StateOfRhodeIslandMember" abstract="true" name="StateOfRhodeIslandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" abstract="false" name="ReclassificationOfTemporaryEquityToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" abstract="true" name="PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NumberOfNationalBrandMedicalSurgicalProducts" abstract="false" name="NumberOfNationalBrandMedicalSurgicalProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A130NotesDueAugust152026Member" abstract="true" name="A130NotesDueAugust152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GermanPharmaceuticalWholesaleBusinessMember" abstract="true" name="GermanPharmaceuticalWholesaleBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OpenMarketShareRepurchaseTransactionsMember" abstract="true" name="OpenMarketShareRepurchaseTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A488NotesDueMarch152044Member" abstract="true" name="A488NotesDueMarch152044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UKPensionPlanMember" abstract="true" name="UKPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfNewYorkMember" abstract="true" name="StateOfNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MckessonEuropeSubsidiaryMember" abstract="true" name="MckessonEuropeSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberOfTerritories" abstract="false" name="LossContingencyNumberOfTerritories" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" abstract="false" name="WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A285NotesDueMarch152023Member" abstract="true" name="A285NotesDueMarch152023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NumberOfInvestmentFundsThatFiledClaims" abstract="false" name="NumberOfInvestmentFundsThatFiledClaims" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_EUBusinessesDisposalGroupMember" abstract="true" name="EUBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A313SterlingNotesDueFebruary172029Member" abstract="true" name="A313SterlingNotesDueFebruary172029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_November2018CrossCurrencySwapsMember" abstract="true" name="November2018CrossCurrencySwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AustrianBusinessOperationsMember" abstract="true" name="AustrianBusinessOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" abstract="true" name="CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" abstract="true" name="ThreeLargestU.S.PharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ThreeNationalPharmaceuticalDistributorsMember" abstract="true" name="ThreeNationalPharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OtherAccruedLiabilitiesMember" abstract="true" name="OtherAccruedLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ShareholderDerivativeActionInsuranceProceedsMember" abstract="true" name="ShareholderDerivativeActionInsuranceProceedsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A1625NotesDue2026Member" abstract="true" name="A1625NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A3125NotesDue2029Member" abstract="true" name="A3125NotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CurrentAssetLiabilityMember" abstract="true" name="CurrentAssetLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EuroDenominatedNotesMember" abstract="true" name="EuroDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A395NotesDueFebruary162028Member" abstract="true" name="A395NotesDueFebruary162028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" abstract="true" name="UnitedStatesExRelPiacentileVAmgenIncEtAlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfOhioMember" abstract="true" name="StateOfOhioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GermanPharmaceuticalWholesaleJointVentureMember" abstract="true" name="GermanPharmaceuticalWholesaleJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" abstract="false" name="LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" abstract="false" name="DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A1500NotesDue2025Member" abstract="true" name="A1500NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" abstract="false" name="RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" abstract="true" name="DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementAwardPaymentPeriod" abstract="false" name="LossContingencySettlementAgreementAwardPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_UKBusinessesDisposalGroupMember" abstract="true" name="UKBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" abstract="false" name="LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberOfOtherDefendants" abstract="false" name="LossContingencyNumberOfOtherDefendants" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GovernmentalEntitiesMember" abstract="true" name="GovernmentalEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RestructuringPlanRemoteWorkTransitioningMember" abstract="true" name="RestructuringPlanRemoteWorkTransitioningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" abstract="true" name="UKBusinessesDisposalGroupAndAustrianBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_HeldForSalePolicyTextBlock" abstract="false" name="HeldForSalePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_AntitrustLegalSettlementsMember" abstract="true" name="AntitrustLegalSettlementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_IndividualClaimantMember" abstract="true" name="IndividualClaimantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PrescriptionTechnologySolutionsMember" abstract="true" name="PrescriptionTechnologySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncurrentAssetLiabilityMember" abstract="true" name="NoncurrentAssetLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MedicalSurgicalSolutionsSegmentMember" abstract="true" name="MedicalSurgicalSolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_IncreaseDecreaseInLitigationReserve" abstract="false" name="IncreaseDecreaseInLitigationReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePrice" abstract="false" name="NoncontrollingInterestsPutRightExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_LossContingencyNumberOfRelators" abstract="false" name="LossContingencyNumberOfRelators" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberOfEligibleStates" abstract="false" name="LossContingencyNumberOfEligibleStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_RevenueDerivedFromServicesPercentage" abstract="false" name="RevenueDerivedFromServicesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseMember" abstract="true" name="AcceleratedShareRepurchaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EuropeanBusinessesDisposalGroupMember" abstract="true" name="EuropeanBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NationalPrescriptionOpiateLitigationMember" abstract="true" name="NationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>mck-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b0c4267c-1381-4f10-888f-434d9ccb5c99,g:6c581a7b-6b71-4a88-8456-a4823e8897d4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1702c6ae-a7bc-4683-bff1-794de8a609af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c9050058-c5d2-4587-8255-6643b03a9747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_1702c6ae-a7bc-4683-bff1-794de8a609af" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c9050058-c5d2-4587-8255-6643b03a9747" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a42a4b5f-d8a3-4448-83bb-98cee899755e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_1702c6ae-a7bc-4683-bff1-794de8a609af" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a42a4b5f-d8a3-4448-83bb-98cee899755e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5936e2d2-4971-4c72-bb55-e52533d5aa07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_8fe1db95-73ae-495c-9d84-801fabba7242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_5936e2d2-4971-4c72-bb55-e52533d5aa07" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_8fe1db95-73ae-495c-9d84-801fabba7242" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_c0d130c5-0408-43bf-92b9-2955067209b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_5936e2d2-4971-4c72-bb55-e52533d5aa07" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_c0d130c5-0408-43bf-92b9-2955067209b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a3012b7b-c721-4965-8f05-1e47b5a95173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_071165fe-e132-479b-9e38-5955dbf5e8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a3012b7b-c721-4965-8f05-1e47b5a95173" xlink:to="loc_us-gaap_ProfitLoss_071165fe-e132-479b-9e38-5955dbf5e8f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_986d4382-6a2c-4fa8-97d4-9a51719f144e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a3012b7b-c721-4965-8f05-1e47b5a95173" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_986d4382-6a2c-4fa8-97d4-9a51719f144e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c524da68-ea5e-4325-82af-2f5ff1ab4221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_45a94854-dbb6-4bad-9895-afc74fad8da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c524da68-ea5e-4325-82af-2f5ff1ab4221" xlink:to="loc_us-gaap_OperatingExpenses_45a94854-dbb6-4bad-9895-afc74fad8da2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3a965f04-16e3-4933-831d-35ab5acab21c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c524da68-ea5e-4325-82af-2f5ff1ab4221" xlink:to="loc_us-gaap_GrossProfit_3a965f04-16e3-4933-831d-35ab5acab21c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fdd4a7e8-1a6a-4429-ba9d-94d2a09bbfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f0e4a22c-6a9a-469c-b78a-d992e8edeed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_fdd4a7e8-1a6a-4429-ba9d-94d2a09bbfe9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f0e4a22c-6a9a-469c-b78a-d992e8edeed8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1a32d1db-7d32-48fd-8d7c-885f27712af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_fdd4a7e8-1a6a-4429-ba9d-94d2a09bbfe9" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1a32d1db-7d32-48fd-8d7c-885f27712af3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_660ffb76-8434-437c-b7fc-506f5ae4ccdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8a65cb1f-21eb-4261-8047-2aef49435970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_660ffb76-8434-437c-b7fc-506f5ae4ccdd" xlink:to="loc_us-gaap_OperatingIncomeLoss_8a65cb1f-21eb-4261-8047-2aef49435970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fe497756-c028-42ab-b1e6-92ced721b9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_660ffb76-8434-437c-b7fc-506f5ae4ccdd" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fe497756-c028-42ab-b1e6-92ced721b9a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_85dcc6a1-d482-4670-bd96-c3eba08587ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_660ffb76-8434-437c-b7fc-506f5ae4ccdd" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_85dcc6a1-d482-4670-bd96-c3eba08587ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_09d908d5-38e7-40ba-87a6-89d5037cbe4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_660ffb76-8434-437c-b7fc-506f5ae4ccdd" xlink:to="loc_us-gaap_InterestExpense_09d908d5-38e7-40ba-87a6-89d5037cbe4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2543086a-7380-4174-9951-3fea2617a092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_527bb79e-aad8-45e7-9688-76fc3366b7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_2543086a-7380-4174-9951-3fea2617a092" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_527bb79e-aad8-45e7-9688-76fc3366b7ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_da04c479-0089-4324-893e-e66beb6a812b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_2543086a-7380-4174-9951-3fea2617a092" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_da04c479-0089-4324-893e-e66beb6a812b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_6a4fde2d-13c2-491c-ba4f-59ee476f8d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_389f491d-f79e-4046-85b2-c16ef784af3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_6a4fde2d-13c2-491c-ba4f-59ee476f8d3a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_389f491d-f79e-4046-85b2-c16ef784af3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a4fcc32d-d738-415d-a3d2-5beee6c7ff66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_6a4fde2d-13c2-491c-ba4f-59ee476f8d3a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a4fcc32d-d738-415d-a3d2-5beee6c7ff66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3d3c7ce8-72ef-4c14-aadf-b511cffc8662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8dd1b702-e884-4d0d-a6da-6c5b10b390d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3d3c7ce8-72ef-4c14-aadf-b511cffc8662" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8dd1b702-e884-4d0d-a6da-6c5b10b390d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_0e176619-94ce-4e3e-ab32-5838bf02f290" xlink:href="mck-20211231.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3d3c7ce8-72ef-4c14-aadf-b511cffc8662" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_0e176619-94ce-4e3e-ab32-5838bf02f290" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_f57b1d33-d79c-400c-a649-4c20880697ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3d3c7ce8-72ef-4c14-aadf-b511cffc8662" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_f57b1d33-d79c-400c-a649-4c20880697ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8314213e-9284-4af7-b2f7-6831380676a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3d3c7ce8-72ef-4c14-aadf-b511cffc8662" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8314213e-9284-4af7-b2f7-6831380676a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_97c81f96-53bc-4eb1-b684-4422238c7b13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_227b7d57-3b47-4c97-a277-a4b5bc0e8144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_97c81f96-53bc-4eb1-b684-4422238c7b13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_227b7d57-3b47-4c97-a277-a4b5bc0e8144" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ebcd514d-1eda-46a0-b96a-21d0c5404192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_97c81f96-53bc-4eb1-b684-4422238c7b13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ebcd514d-1eda-46a0-b96a-21d0c5404192" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7c25fe20-6a7f-4e6d-890e-d39653042a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_97c81f96-53bc-4eb1-b684-4422238c7b13" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7c25fe20-6a7f-4e6d-890e-d39653042a34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_50a1aeda-2d82-4de3-8beb-e3c8911ea7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e9d82a8f-4fff-48f7-ad13-7b9a9ca92ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_50a1aeda-2d82-4de3-8beb-e3c8911ea7d3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e9d82a8f-4fff-48f7-ad13-7b9a9ca92ec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b5dfbe0b-7fc7-4731-a16b-d8cb2c4548d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_50a1aeda-2d82-4de3-8beb-e3c8911ea7d3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b5dfbe0b-7fc7-4731-a16b-d8cb2c4548d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_00bb94ab-ec1f-420c-a5c0-775a59547f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d9626489-2e78-4fac-aaf0-d9b0bc4f5cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_00bb94ab-ec1f-420c-a5c0-775a59547f6f" xlink:to="loc_us-gaap_ProfitLoss_d9626489-2e78-4fac-aaf0-d9b0bc4f5cb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6f2a995c-c3a8-43c4-9656-86deebe9f743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_00bb94ab-ec1f-420c-a5c0-775a59547f6f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6f2a995c-c3a8-43c4-9656-86deebe9f743" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5718a7e5-8fcf-429a-89ab-c52a11f910e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d29d5ccf-4f70-4080-a9f0-86dca9ddc070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5718a7e5-8fcf-429a-89ab-c52a11f910e6" xlink:to="loc_us-gaap_AssetsCurrent_d29d5ccf-4f70-4080-a9f0-86dca9ddc070" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b22292ca-d0ce-454a-b98a-d11ddf452318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5718a7e5-8fcf-429a-89ab-c52a11f910e6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b22292ca-d0ce-454a-b98a-d11ddf452318" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6926f91e-5bc4-4e5f-9950-f3e76b6d1b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5718a7e5-8fcf-429a-89ab-c52a11f910e6" xlink:to="loc_us-gaap_Goodwill_6926f91e-5bc4-4e5f-9950-f3e76b6d1b75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e992c029-deb9-4f18-a8f3-cf4b35214960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5718a7e5-8fcf-429a-89ab-c52a11f910e6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e992c029-deb9-4f18-a8f3-cf4b35214960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b385146b-05c5-42c9-9ef0-771cf39f7423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5718a7e5-8fcf-429a-89ab-c52a11f910e6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b385146b-05c5-42c9-9ef0-771cf39f7423" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fa64123b-199f-4f17-9afa-f844b9f14e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5718a7e5-8fcf-429a-89ab-c52a11f910e6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fa64123b-199f-4f17-9afa-f844b9f14e32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c1ba31d8-4e96-451f-8c50-e65b6c4cf48f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a55c7d74-1d42-4429-808f-9ea87bfb1422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c1ba31d8-4e96-451f-8c50-e65b6c4cf48f" xlink:to="loc_us-gaap_PreferredStockValue_a55c7d74-1d42-4429-808f-9ea87bfb1422" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_eb2d3f2b-ea92-4d7c-88c6-bd3319d520df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c1ba31d8-4e96-451f-8c50-e65b6c4cf48f" xlink:to="loc_us-gaap_CommonStockValue_eb2d3f2b-ea92-4d7c-88c6-bd3319d520df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2325f385-10d7-484a-aaae-3d5b1a96ca8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c1ba31d8-4e96-451f-8c50-e65b6c4cf48f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_2325f385-10d7-484a-aaae-3d5b1a96ca8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7fba78e8-5bbb-481a-9fb5-1c6cc6ac5765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c1ba31d8-4e96-451f-8c50-e65b6c4cf48f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7fba78e8-5bbb-481a-9fb5-1c6cc6ac5765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_69a6fc5f-0bcf-4743-a9c6-1e770a92d4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c1ba31d8-4e96-451f-8c50-e65b6c4cf48f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_69a6fc5f-0bcf-4743-a9c6-1e770a92d4a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_8034707d-9528-4969-b5e8-6f15e57dd566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c1ba31d8-4e96-451f-8c50-e65b6c4cf48f" xlink:to="loc_us-gaap_TreasuryStockValue_8034707d-9528-4969-b5e8-6f15e57dd566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0c41249-fde8-442a-9bd2-abe9ca032705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_15937df3-6e61-4d39-a07c-1ef8acfcbe71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0c41249-fde8-442a-9bd2-abe9ca032705" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_15937df3-6e61-4d39-a07c-1ef8acfcbe71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_900056e0-eefe-42d1-b190-3ec05af3ada3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0c41249-fde8-442a-9bd2-abe9ca032705" xlink:to="loc_us-gaap_LiabilitiesCurrent_900056e0-eefe-42d1-b190-3ec05af3ada3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_696cb390-84f6-42fc-aa8c-825f442a753e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0c41249-fde8-442a-9bd2-abe9ca032705" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_696cb390-84f6-42fc-aa8c-825f442a753e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ce75b45c-c671-4d3c-ab07-94472e3c4ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0c41249-fde8-442a-9bd2-abe9ca032705" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ce75b45c-c671-4d3c-ab07-94472e3c4ae8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_fa31f673-9fe7-4b73-a172-5a97bf8c5f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0c41249-fde8-442a-9bd2-abe9ca032705" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_fa31f673-9fe7-4b73-a172-5a97bf8c5f6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_ca8b6664-efe9-4bbe-900a-e8d4e62dbc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0c41249-fde8-442a-9bd2-abe9ca032705" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_ca8b6664-efe9-4bbe-900a-e8d4e62dbc1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_91326032-c787-4126-9e4b-b4f525c5ca4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0c41249-fde8-442a-9bd2-abe9ca032705" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_91326032-c787-4126-9e4b-b4f525c5ca4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a9aeceea-a278-4de9-beef-b74b4bde6243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0c41249-fde8-442a-9bd2-abe9ca032705" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a9aeceea-a278-4de9-beef-b74b4bde6243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d071e375-d4c2-4c3a-add9-fca119342876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c8e1897d-691a-4298-bad6-2d1915d02115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d071e375-d4c2-4c3a-add9-fca119342876" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c8e1897d-691a-4298-bad6-2d1915d02115" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_f44fa5af-0dde-45fd-a94c-8aa0398f7bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d071e375-d4c2-4c3a-add9-fca119342876" xlink:to="loc_us-gaap_ReceivablesNetCurrent_f44fa5af-0dde-45fd-a94c-8aa0398f7bb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b38980e4-7f38-4b56-bd10-3760eef3214a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d071e375-d4c2-4c3a-add9-fca119342876" xlink:to="loc_us-gaap_InventoryNet_b38980e4-7f38-4b56-bd10-3760eef3214a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f6c13611-e50b-4988-9ad4-3a50e30bef3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d071e375-d4c2-4c3a-add9-fca119342876" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f6c13611-e50b-4988-9ad4-3a50e30bef3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_851aa342-f357-44f5-8c8f-dbec4b1cd2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d071e375-d4c2-4c3a-add9-fca119342876" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_851aa342-f357-44f5-8c8f-dbec4b1cd2a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cd4bb421-a13b-49bc-8ffd-ade460fa55c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_25bc30a7-3023-45e7-b536-4dafb6f441f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd4bb421-a13b-49bc-8ffd-ade460fa55c8" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_25bc30a7-3023-45e7-b536-4dafb6f441f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_77cf95c0-c297-45b8-8946-8bf024a9988f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd4bb421-a13b-49bc-8ffd-ade460fa55c8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_77cf95c0-c297-45b8-8946-8bf024a9988f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f4555b85-ba84-4d18-a088-142352fdd9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd4bb421-a13b-49bc-8ffd-ade460fa55c8" xlink:to="loc_us-gaap_AccountsPayableCurrent_f4555b85-ba84-4d18-a088-142352fdd9a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_a808bfbc-93b3-4b4b-92ac-69e6bc79fbea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd4bb421-a13b-49bc-8ffd-ade460fa55c8" xlink:to="loc_us-gaap_ShortTermBorrowings_a808bfbc-93b3-4b4b-92ac-69e6bc79fbea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_938cd960-0688-4d8b-887c-3556a3848856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd4bb421-a13b-49bc-8ffd-ade460fa55c8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_938cd960-0688-4d8b-887c-3556a3848856" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e8ec6097-1f77-4aba-b55c-ad89d8d18ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd4bb421-a13b-49bc-8ffd-ade460fa55c8" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_e8ec6097-1f77-4aba-b55c-ad89d8d18ade" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_97011ccf-3874-4dab-a6f7-5aa0bd06f1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3132b3d2-4ee1-4357-ba69-9d1ef3fd6f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_97011ccf-3874-4dab-a6f7-5aa0bd06f1e7" xlink:to="loc_us-gaap_StockholdersEquity_3132b3d2-4ee1-4357-ba69-9d1ef3fd6f94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_4a0e4025-fb06-417c-80ff-83069d2b1fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_97011ccf-3874-4dab-a6f7-5aa0bd06f1e7" xlink:to="loc_us-gaap_MinorityInterest_4a0e4025-fb06-417c-80ff-83069d2b1fa6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_aa26b766-b3c6-4e71-a51e-0a1485019261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_aa26b766-b3c6-4e71-a51e-0a1485019261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_071a01c4-2106-4309-ad7a-3e64dd74a3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_071a01c4-2106-4309-ad7a-3e64dd74a3ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_73995a17-b426-43bd-926c-f6dc39455f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_73995a17-b426-43bd-926c-f6dc39455f17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_7081e2ac-e447-4515-8e81-5b35da55eea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_AdjustmentForAmortization_7081e2ac-e447-4515-8e81-5b35da55eea0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_aaac9ca3-7d38-41b0-95db-dc96a1c9e065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_ProfitLoss_aaac9ca3-7d38-41b0-95db-dc96a1c9e065" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_f6dac230-9130-4833-8d51-83dcca1578b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_f6dac230-9130-4833-8d51-83dcca1578b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_e150f24b-7778-48cf-ba3b-43ff6d588aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_Depreciation_e150f24b-7778-48cf-ba3b-43ff6d588aaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_1a01fc36-07e5-49eb-befc-6ed763dec860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_1a01fc36-07e5-49eb-befc-6ed763dec860" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_6f241764-fb50-424c-bd3d-c63faf72b97b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_6f241764-fb50-424c-bd3d-c63faf72b97b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_9c0f1fcb-bdde-464f-a5b8-dbab4466e05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_9c0f1fcb-bdde-464f-a5b8-dbab4466e05a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_dfcaf1ba-4fa4-4c33-9cb3-6a3455e66d64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_dfcaf1ba-4fa4-4c33-9cb3-6a3455e66d64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_e3eeabdd-1a5b-494e-b906-3323d6f5b4da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_e3eeabdd-1a5b-494e-b906-3323d6f5b4da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_8205218c-5968-4698-bb90-72f09cab120f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_OperatingLeaseExpense_8205218c-5968-4698-bb90-72f09cab120f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_912d5ec5-d312-4b21-a91f-c426bbce29ab" xlink:href="mck-20211231.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_912d5ec5-d312-4b21-a91f-c426bbce29ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_33f378e1-d8f8-481e-8478-e2f7899ca19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_33f378e1-d8f8-481e-8478-e2f7899ca19d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_37b1e9da-5c3f-4f84-862c-9af1c23f3407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_37b1e9da-5c3f-4f84-862c-9af1c23f3407" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_0547a02f-c53a-455b-8d41-7c13003eab02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8daee3c2-0617-44f1-8e67-414b9d2e9f16" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_0547a02f-c53a-455b-8d41-7c13003eab02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_30347cce-2336-4e9c-b712-540cffe9abb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bc2ef462-0a85-45f9-afe8-5c2004b28685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_30347cce-2336-4e9c-b712-540cffe9abb3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bc2ef462-0a85-45f9-afe8-5c2004b28685" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_5876dc99-400b-4571-878f-3542a8e507bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_30347cce-2336-4e9c-b712-540cffe9abb3" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_5876dc99-400b-4571-878f-3542a8e507bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_64204989-d1d5-4d69-9a01-438288c4dd30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_30347cce-2336-4e9c-b712-540cffe9abb3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_64204989-d1d5-4d69-9a01-438288c4dd30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_d6139245-ea30-4be4-97d4-c111e2d67353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_30347cce-2336-4e9c-b712-540cffe9abb3" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_d6139245-ea30-4be4-97d4-c111e2d67353" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0a124ef3-2302-486c-a7fb-780af9d0bc2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_30347cce-2336-4e9c-b712-540cffe9abb3" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0a124ef3-2302-486c-a7fb-780af9d0bc2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dfecb84-1f2c-4c67-899b-c0cd7b6d9b29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_2b21934f-da33-474a-b170-310dcbfafe9b" xlink:href="mck-20211231.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dfecb84-1f2c-4c67-899b-c0cd7b6d9b29" xlink:to="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_2b21934f-da33-474a-b170-310dcbfafe9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f9024eaa-bcb9-4875-882a-422eafa40303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dfecb84-1f2c-4c67-899b-c0cd7b6d9b29" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f9024eaa-bcb9-4875-882a-422eafa40303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8dc113c0-582c-4b19-ad38-ee1a9b5cd732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dfecb84-1f2c-4c67-899b-c0cd7b6d9b29" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8dc113c0-582c-4b19-ad38-ee1a9b5cd732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_88782ecb-c726-470e-aafa-4b39de9f2d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dfecb84-1f2c-4c67-899b-c0cd7b6d9b29" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_88782ecb-c726-470e-aafa-4b39de9f2d7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_281b6f0a-8eae-493f-a824-05c3e06651cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dfecb84-1f2c-4c67-899b-c0cd7b6d9b29" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_281b6f0a-8eae-493f-a824-05c3e06651cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9323336a-7cef-4bc5-837c-e38a8061d2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_0478d947-4579-4be8-9503-8193fc69cace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9323336a-7cef-4bc5-837c-e38a8061d2e9" xlink:to="loc_us-gaap_RestrictedCashCurrent_0478d947-4579-4be8-9503-8193fc69cace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce1f6e9f-0ef9-40fa-917a-c4ec28b33c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9323336a-7cef-4bc5-837c-e38a8061d2e9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce1f6e9f-0ef9-40fa-917a-c4ec28b33c03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_96752bf6-fe3a-4cf3-914d-29455122f2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_09b4e66d-3979-47ca-b36d-bc107378b046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_96752bf6-fe3a-4cf3-914d-29455122f2b6" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_09b4e66d-3979-47ca-b36d-bc107378b046" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_47415e1b-5d52-4b28-b19c-aa317edd3e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_96752bf6-fe3a-4cf3-914d-29455122f2b6" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_47415e1b-5d52-4b28-b19c-aa317edd3e60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_a2983e02-e9c3-4ef0-bbcf-c95ffac73962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_96752bf6-fe3a-4cf3-914d-29455122f2b6" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_a2983e02-e9c3-4ef0-bbcf-c95ffac73962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_5cc5080a-2037-44ef-b425-95d9b260533e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_96752bf6-fe3a-4cf3-914d-29455122f2b6" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_5cc5080a-2037-44ef-b425-95d9b260533e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_d5e2dabc-bebc-46c7-a2ca-f6602ff4ec58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_96752bf6-fe3a-4cf3-914d-29455122f2b6" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_d5e2dabc-bebc-46c7-a2ca-f6602ff4ec58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_0c0000f3-383f-4b75-af3a-2cd13326c503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_96752bf6-fe3a-4cf3-914d-29455122f2b6" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_0c0000f3-383f-4b75-af3a-2cd13326c503" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_09fcef3f-ea5e-4e86-8fc4-d369ab6868fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_96752bf6-fe3a-4cf3-914d-29455122f2b6" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_09fcef3f-ea5e-4e86-8fc4-d369ab6868fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_82253e51-a5b6-4323-8201-f9fb1b9383e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_96752bf6-fe3a-4cf3-914d-29455122f2b6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_82253e51-a5b6-4323-8201-f9fb1b9383e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a0f7a98d-ef2a-4429-ae95-b5c2a755bbac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_96752bf6-fe3a-4cf3-914d-29455122f2b6" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a0f7a98d-ef2a-4429-ae95-b5c2a755bbac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_937bccfd-6a13-4ad4-b045-2e0607a5cb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_96752bf6-fe3a-4cf3-914d-29455122f2b6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_937bccfd-6a13-4ad4-b045-2e0607a5cb0b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0a14dcd5-c3cc-4001-a7e4-c273e8532cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_68869d44-f48d-49fa-b8d9-86aaabb704fd" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0a14dcd5-c3cc-4001-a7e4-c273e8532cef" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_68869d44-f48d-49fa-b8d9-86aaabb704fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_4ed9865c-3719-44d1-9419-16a79c8b3b20" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0a14dcd5-c3cc-4001-a7e4-c273e8532cef" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_4ed9865c-3719-44d1-9419-16a79c8b3b20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_eceb5fa4-f339-406b-b44c-25e956c6d439" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0a14dcd5-c3cc-4001-a7e4-c273e8532cef" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_eceb5fa4-f339-406b-b44c-25e956c6d439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_91059def-0ad1-4724-912b-555db4252f74" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0a14dcd5-c3cc-4001-a7e4-c273e8532cef" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_91059def-0ad1-4724-912b-555db4252f74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_e459b722-3836-47ae-9b9e-0333f58b028e" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0a14dcd5-c3cc-4001-a7e4-c273e8532cef" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_e459b722-3836-47ae-9b9e-0333f58b028e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_e1475429-da69-4531-a3fa-e4c46c79d34a" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0a14dcd5-c3cc-4001-a7e4-c273e8532cef" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_e1475429-da69-4531-a3fa-e4c46c79d34a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_fcc8e041-0aed-4754-870f-addaf8b2a521" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0a14dcd5-c3cc-4001-a7e4-c273e8532cef" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_fcc8e041-0aed-4754-870f-addaf8b2a521" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_affa07db-a4fa-42d1-9bb2-7bfd55db9ec4" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0a14dcd5-c3cc-4001-a7e4-c273e8532cef" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_affa07db-a4fa-42d1-9bb2-7bfd55db9ec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_e831de98-0d18-4d58-93c8-e2d6a1f3cae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_f53de44e-e944-4534-a11d-832570659d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_e831de98-0d18-4d58-93c8-e2d6a1f3cae9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_f53de44e-e944-4534-a11d-832570659d28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_acc249e7-e590-4186-8616-1b3486f2c440" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_e831de98-0d18-4d58-93c8-e2d6a1f3cae9" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_acc249e7-e590-4186-8616-1b3486f2c440" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_a0271915-7a60-482a-a8ee-68878e72ea29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_e831de98-0d18-4d58-93c8-e2d6a1f3cae9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_a0271915-7a60-482a-a8ee-68878e72ea29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_b5dc2ad4-f5bf-4189-aab3-1b3cab412bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_e831de98-0d18-4d58-93c8-e2d6a1f3cae9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_b5dc2ad4-f5bf-4189-aab3-1b3cab412bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_83dafc36-ace6-4e42-ab01-5663b6d4371d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_e831de98-0d18-4d58-93c8-e2d6a1f3cae9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_83dafc36-ace6-4e42-ab01-5663b6d4371d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_9bb41353-01f4-4508-8ea3-3d8e791a21b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_e831de98-0d18-4d58-93c8-e2d6a1f3cae9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_9bb41353-01f4-4508-8ea3-3d8e791a21b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_11097461-050c-4151-8e65-df1442f95e2e" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_e831de98-0d18-4d58-93c8-e2d6a1f3cae9" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_11097461-050c-4151-8e65-df1442f95e2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_42de7b9b-5404-4bf2-8ed6-7bd4d03dc2d5" xlink:href="mck-20211231.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_e831de98-0d18-4d58-93c8-e2d6a1f3cae9" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_42de7b9b-5404-4bf2-8ed6-7bd4d03dc2d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_8511220a-dc20-4cec-b387-399089e1bfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_e831de98-0d18-4d58-93c8-e2d6a1f3cae9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_8511220a-dc20-4cec-b387-399089e1bfc7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_da940671-4d52-4438-91d6-b456623dc018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_eb275abd-47a4-41b6-9089-dc844d8313ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_da940671-4d52-4438-91d6-b456623dc018" xlink:to="loc_us-gaap_SeveranceCosts1_eb275abd-47a4-41b6-9089-dc844d8313ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_546b0957-2c10-4511-ad3d-d81e764d2330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_da940671-4d52-4438-91d6-b456623dc018" xlink:to="loc_us-gaap_BusinessExitCosts1_546b0957-2c10-4511-ad3d-d81e764d2330" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_29d8a6a4-83aa-47ea-8b12-f8c39ff8eefe" xlink:href="mck-20211231.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_da940671-4d52-4438-91d6-b456623dc018" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_29d8a6a4-83aa-47ea-8b12-f8c39ff8eefe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#EarningsLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_ddc027d5-7a45-482c-b563-4424f8c0a54c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_5c028fab-4d5f-4360-863a-f083000d31df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_ddc027d5-7a45-482c-b563-4424f8c0a54c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_5c028fab-4d5f-4360-863a-f083000d31df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eece3932-a48d-4fa5-a51a-94800729e79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_ddc027d5-7a45-482c-b563-4424f8c0a54c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eece3932-a48d-4fa5-a51a-94800729e79b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_231fc313-c1c2-4acb-9632-319e196c99aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0d233635-ee78-4095-acf0-c57d1429ef10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_231fc313-c1c2-4acb-9632-319e196c99aa" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0d233635-ee78-4095-acf0-c57d1429ef10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_61c43b02-e2c3-48bd-8ec0-5ffd729ab0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_231fc313-c1c2-4acb-9632-319e196c99aa" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_61c43b02-e2c3-48bd-8ec0-5ffd729ab0f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2d89f869-5639-4865-a760-9c65ce087283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_2a7a5119-5271-4b7e-affd-21e433e7e0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2d89f869-5639-4865-a760-9c65ce087283" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_2a7a5119-5271-4b7e-affd-21e433e7e0f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ed1affed-f7ff-4573-b0dc-886c49aa5365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2d89f869-5639-4865-a760-9c65ce087283" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ed1affed-f7ff-4573-b0dc-886c49aa5365" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2ff6e02d-ca72-4cba-9272-078824fee924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7da225c2-a834-4c92-af4e-9e661904ca13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2ff6e02d-ca72-4cba-9272-078824fee924" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7da225c2-a834-4c92-af4e-9e661904ca13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ed40f83e-77d3-48da-b563-3395d8d7db47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2ff6e02d-ca72-4cba-9272-078824fee924" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ed40f83e-77d3-48da-b563-3395d8d7db47" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_a06cdf78-23d4-4ffe-9cb7-68f141e91092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a46d1f31-ef2d-4830-b51c-455cba5bc2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_a06cdf78-23d4-4ffe-9cb7-68f141e91092" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a46d1f31-ef2d-4830-b51c-455cba5bc2cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8d7247b2-ff78-4b36-bcc4-00ff3d88cedb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_a06cdf78-23d4-4ffe-9cb7-68f141e91092" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8d7247b2-ff78-4b36-bcc4-00ff3d88cedb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_62d2cc70-90c3-46ec-a4c4-4a6f581e9621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d070acc7-df36-46ba-b8bf-4fda7c95b893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_62d2cc70-90c3-46ec-a4c4-4a6f581e9621" xlink:to="loc_us-gaap_FinanceLeaseLiability_d070acc7-df36-46ba-b8bf-4fda7c95b893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3d5cb120-9d43-4955-a32d-2fa05bfc388d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_62d2cc70-90c3-46ec-a4c4-4a6f581e9621" xlink:to="loc_us-gaap_LongTermDebt_3d5cb120-9d43-4955-a32d-2fa05bfc388d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_aecc7df8-4884-4a5f-989f-d1551ec7145c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_bf80e3db-9e25-4317-ab6a-291f01c8ea91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_aecc7df8-4884-4a5f-989f-d1551ec7145c" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_bf80e3db-9e25-4317-ab6a-291f01c8ea91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_261587fa-e0e6-482f-9fc1-56e4bdde226e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_aecc7df8-4884-4a5f-989f-d1551ec7145c" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_261587fa-e0e6-482f-9fc1-56e4bdde226e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7e7041e4-0c07-4219-a2a8-6e15da4e5c75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4ea7de22-88ac-4ff6-a83e-45f2ae252af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7e7041e4-0c07-4219-a2a8-6e15da4e5c75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4ea7de22-88ac-4ff6-a83e-45f2ae252af3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_e89864a1-1e0d-4ad2-89d3-e57043284d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7e7041e4-0c07-4219-a2a8-6e15da4e5c75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_e89864a1-1e0d-4ad2-89d3-e57043284d1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8e78b70d-77a2-44af-87aa-c7ec2f4b98c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_94ef6642-04fc-41c8-bf10-bb3d970ae23a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8e78b70d-77a2-44af-87aa-c7ec2f4b98c3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_94ef6642-04fc-41c8-bf10-bb3d970ae23a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_bd76d52f-69d4-47d4-8589-25521a02a831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8e78b70d-77a2-44af-87aa-c7ec2f4b98c3" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_bd76d52f-69d4-47d4-8589-25521a02a831" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>mck-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b0c4267c-1381-4f10-888f-434d9ccb5c99,g:6c581a7b-6b71-4a88-8456-a4823e8897d4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://mckesson123.com/role/Cover" xlink:type="simple" xlink:href="mck-20211231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/Cover" xlink:type="extended" id="i5907ac90db0c411f824218de8abe3bc5_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7746f36c-0990-45d7-89ef-1c49667ed0b5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentType_7746f36c-0990-45d7-89ef-1c49667ed0b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_5fdeee57-6352-46a9-b80f-b35bd5a85dd6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentQuarterlyReport_5fdeee57-6352-46a9-b80f-b35bd5a85dd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_265c54e6-beda-4fce-b866-4ce79687ff39" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentPeriodEndDate_265c54e6-beda-4fce-b866-4ce79687ff39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_38bbd1a9-80af-458c-8f41-3ea7a7b42012" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentTransitionReport_38bbd1a9-80af-458c-8f41-3ea7a7b42012" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_06337962-5a45-47ce-bb93-a5df3a9ad455" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityFileNumber_06337962-5a45-47ce-bb93-a5df3a9ad455" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7fc83e75-e614-4163-b2ff-75500bcadf73" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityRegistrantName_7fc83e75-e614-4163-b2ff-75500bcadf73" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6b69afe1-d31e-4e4c-8919-24e5d5cc536b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6b69afe1-d31e-4e4c-8919-24e5d5cc536b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e9f1da61-1b39-4394-86f6-303fe61cb0e7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityTaxIdentificationNumber_e9f1da61-1b39-4394-86f6-303fe61cb0e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_36b8c738-303a-4435-a329-5211fd390490" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityAddressAddressLine1_36b8c738-303a-4435-a329-5211fd390490" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e3b350f4-dab9-4ced-8a71-33a9bcf9918d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityAddressCityOrTown_e3b350f4-dab9-4ced-8a71-33a9bcf9918d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_fc410f8b-f09d-4532-a6a6-cb2ceae1974a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityAddressStateOrProvince_fc410f8b-f09d-4532-a6a6-cb2ceae1974a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6656c33f-ad10-49b1-9451-68ef09d7e649" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityAddressPostalZipCode_6656c33f-ad10-49b1-9451-68ef09d7e649" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_1c480f70-97a9-4c94-bcc6-8ba0818d74d8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_CityAreaCode_1c480f70-97a9-4c94-bcc6-8ba0818d74d8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_910d6c9b-86c6-466e-aca3-3b964c234868" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_LocalPhoneNumber_910d6c9b-86c6-466e-aca3-3b964c234868" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1a82f913-c55c-4731-91b5-4ed28aa088de" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_Security12bTitle_1a82f913-c55c-4731-91b5-4ed28aa088de" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_141f9f06-3c4a-4712-a102-920f3f11d830" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_TradingSymbol_141f9f06-3c4a-4712-a102-920f3f11d830" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4d614139-3931-4e2d-82e0-8dc9642017a9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_SecurityExchangeName_4d614139-3931-4e2d-82e0-8dc9642017a9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ca218062-ce25-4a22-866e-ee8bf02f85b8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityCurrentReportingStatus_ca218062-ce25-4a22-866e-ee8bf02f85b8" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_06402934-1bb3-4822-98ef-a083b13a345f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityInteractiveDataCurrent_06402934-1bb3-4822-98ef-a083b13a345f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_0548553c-5516-4f72-a140-0ce5d8e37769" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityFilerCategory_0548553c-5516-4f72-a140-0ce5d8e37769" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_db1480c3-c5df-4799-8785-d64ea987cad4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntitySmallBusiness_db1480c3-c5df-4799-8785-d64ea987cad4" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e2143b2f-afc7-47e8-ad4f-627b9d0bb73b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityEmergingGrowthCompany_e2143b2f-afc7-47e8-ad4f-627b9d0bb73b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ebf61e70-75a8-400c-8bb4-7b13f1a7a30d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityShellCompany_ebf61e70-75a8-400c-8bb4-7b13f1a7a30d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_5f47e945-ba97-43e6-8375-3fecb9918a29" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_5f47e945-ba97-43e6-8375-3fecb9918a29" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e6a8a06b-8af5-4521-90bd-4b20d8dc24d6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityCentralIndexKey_e6a8a06b-8af5-4521-90bd-4b20d8dc24d6" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5f8788e8-eff6-4868-865d-e5ab8ab3311e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentFiscalYearFocus_5f8788e8-eff6-4868-865d-e5ab8ab3311e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3b502b00-4b91-4b9f-bc93-a5e289d9b57e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_3b502b00-4b91-4b9f-bc93-a5e289d9b57e" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_770526dd-5b26-46d9-9615-c98be295aeea" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_AmendmentFlag_770526dd-5b26-46d9-9615-c98be295aeea" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_648bc272-3271-4d73-9450-6e4cfe7c086a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_CurrentFiscalYearEndDate_648bc272-3271-4d73-9450-6e4cfe7c086a" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_870125f5-d3ea-49c1-b5d4-3933af229fdb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntitiesTable_870125f5-d3ea-49c1-b5d4-3933af229fdb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0d0b4f87-96b1-40a0-b170-f4be7e7f0ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_870125f5-d3ea-49c1-b5d4-3933af229fdb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0d0b4f87-96b1-40a0-b170-f4be7e7f0ee9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0d0b4f87-96b1-40a0-b170-f4be7e7f0ee9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0d0b4f87-96b1-40a0-b170-f4be7e7f0ee9" xlink:to="loc_us-gaap_ClassOfStockDomain_0d0b4f87-96b1-40a0-b170-f4be7e7f0ee9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0d0b4f87-96b1-40a0-b170-f4be7e7f0ee9" xlink:to="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_44b5f380-89d1-4e40-9d7f-35d1512cdfed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:to="loc_us-gaap_CommonStockMember_44b5f380-89d1-4e40-9d7f-35d1512cdfed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_7173d3ff-6357-4262-a044-4eedcdafee45" xlink:href="mck-20211231.xsd#mck_A1500NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:to="loc_mck_A1500NotesDue2025Member_7173d3ff-6357-4262-a044-4eedcdafee45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_7f00ad4b-6d33-409c-971b-11f67ee0d97c" xlink:href="mck-20211231.xsd#mck_A1625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:to="loc_mck_A1625NotesDue2026Member_7f00ad4b-6d33-409c-971b-11f67ee0d97c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_57e137ce-aae5-47c1-8549-23ee0bf70599" xlink:href="mck-20211231.xsd#mck_A3125NotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:to="loc_mck_A3125NotesDue2029Member_57e137ce-aae5-47c1-8549-23ee0bf70599" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="i1a95df357b8844a5a896ab78282a18cb_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4aa527e4-6c0e-45eb-875a-7bc349af9116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4aa527e4-6c0e-45eb-875a-7bc349af9116" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_162cf8e3-3f39-4c86-b7c8-f0f2984cd602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_SharesOutstanding_162cf8e3-3f39-4c86-b7c8-f0f2984cd602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_eacd2eb3-49b6-43f3-900c-0fb3cd511e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_TreasuryStockShares_eacd2eb3-49b6-43f3-900c-0fb3cd511e14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a35feb19-a0c4-4dc4-a4ba-43207172c832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a35feb19-a0c4-4dc4-a4ba-43207172c832" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_fab0afef-78bd-4f0e-b236-577086b9fdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_fab0afef-78bd-4f0e-b236-577086b9fdd8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7603f5c3-6898-428a-9c77-a441cbed6ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7603f5c3-6898-428a-9c77-a441cbed6ff6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_18a8e882-3d1b-4347-af49-3f658e90f3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_18a8e882-3d1b-4347-af49-3f658e90f3a3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_746eb11c-ff9e-40c2-bad7-388229cd1acb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_746eb11c-ff9e-40c2-bad7-388229cd1acb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_254f8845-c981-481e-a1ce-7c61402d25f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_254f8845-c981-481e-a1ce-7c61402d25f7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_3688f676-b8b4-46ee-bd27-087c708e3f92" xlink:href="mck-20211231.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_3688f676-b8b4-46ee-bd27-087c708e3f92" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_56e9f8ff-de2a-4628-ac7e-f861b102fa66" xlink:href="mck-20211231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_56e9f8ff-de2a-4628-ac7e-f861b102fa66" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_66fb06eb-25b6-4c05-be7e-a0c35fe51d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_66fb06eb-25b6-4c05-be7e-a0c35fe51d73" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_ae1e01c8-2dbf-43e5-90b5-835ce512de38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_ae1e01c8-2dbf-43e5-90b5-835ce512de38" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_46f38cbb-dd70-4520-a18e-c9c8f0a9116b" xlink:href="mck-20211231.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_46f38cbb-dd70-4520-a18e-c9c8f0a9116b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_7117fdf6-5847-4418-acf7-c00f0c8bd4af" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_7117fdf6-5847-4418-acf7-c00f0c8bd4af" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_7e3d33b6-b7e6-43f4-a1b0-a977409e86a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_DividendsCommonStockCash_7e3d33b6-b7e6-43f4-a1b0-a977409e86a8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_653c4883-65ab-4e76-ac45-d7253e961d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockholdersEquityOther_653c4883-65ab-4e76-ac45-d7253e961d18" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_77f23797-01ed-4da5-9cbb-e9a52442f2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_36b54cfb-2fdc-4420-b5d2-3055e50694f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e93c475d-5964-454f-bf7c-b97d38755497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_baf1f486-1e3d-4261-8387-3f23ce8e9351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4aa527e4-6c0e-45eb-875a-7bc349af9116" xlink:to="loc_us-gaap_StatementTable_baf1f486-1e3d-4261-8387-3f23ce8e9351" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eb08aa2c-dc22-4f85-96d7-9dc4eb859bc3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_baf1f486-1e3d-4261-8387-3f23ce8e9351" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eb08aa2c-dc22-4f85-96d7-9dc4eb859bc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_eb08aa2c-dc22-4f85-96d7-9dc4eb859bc3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eb08aa2c-dc22-4f85-96d7-9dc4eb859bc3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_eb08aa2c-dc22-4f85-96d7-9dc4eb859bc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fea7b84e-43a3-4ce6-8c0f-8d9b0102b88a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eb08aa2c-dc22-4f85-96d7-9dc4eb859bc3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fea7b84e-43a3-4ce6-8c0f-8d9b0102b88a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6ebff041-5a86-4bee-a123-90540be5cc6d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fea7b84e-43a3-4ce6-8c0f-8d9b0102b88a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6ebff041-5a86-4bee-a123-90540be5cc6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_4f4a7b33-cbc9-4037-989e-609fd09da162" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fea7b84e-43a3-4ce6-8c0f-8d9b0102b88a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_4f4a7b33-cbc9-4037-989e-609fd09da162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_064e04bb-43a3-4977-a457-f6fd0ff49ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_baf1f486-1e3d-4261-8387-3f23ce8e9351" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_064e04bb-43a3-4977-a457-f6fd0ff49ecc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_064e04bb-43a3-4977-a457-f6fd0ff49ecc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_064e04bb-43a3-4977-a457-f6fd0ff49ecc" xlink:to="loc_us-gaap_EquityComponentDomain_064e04bb-43a3-4977-a457-f6fd0ff49ecc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_064e04bb-43a3-4977-a457-f6fd0ff49ecc" xlink:to="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7f6963fc-8884-464b-bc6e-737671189e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_CommonStockMember_7f6963fc-8884-464b-bc6e-737671189e3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b5bcbcfa-cab4-4eb4-b01c-2f83c817a3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b5bcbcfa-cab4-4eb4-b01c-2f83c817a3d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_224f667a-e4ab-4803-99eb-8b1efe44bd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_RetainedEarningsMember_224f667a-e4ab-4803-99eb-8b1efe44bd3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_213a4dd0-bb24-4206-bf3e-208694b95550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_213a4dd0-bb24-4206-bf3e-208694b95550" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_a89d81c8-e70e-4969-82a7-c81479512ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_TreasuryStockMember_a89d81c8-e70e-4969-82a7-c81479512ff8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_87ab3bee-8ab4-4bbb-b5e6-37600530ce07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_NoncontrollingInterestMember_87ab3bee-8ab4-4bbb-b5e6-37600530ce07" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#HeldforSaleNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended" id="i877faab904c44f8cbb303df76259c597_HeldforSaleNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_8d574572-de4e-48a0-9fa9-731f75c1bc06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_8d574572-de4e-48a0-9fa9-731f75c1bc06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5b9fbf67-dce3-4e5f-8b8c-bd820fe6e34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5b9fbf67-dce3-4e5f-8b8c-bd820fe6e34c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_e7648e32-0a00-40d0-83a7-a9fc2b1455ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_e7648e32-0a00-40d0-83a7-a9fc2b1455ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_18c72d00-adac-409a-8ab8-d9dfe29208ea" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_18c72d00-adac-409a-8ab8-d9dfe29208ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_f269e2ae-22f4-4c55-8065-6754bf9d0acd" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_f269e2ae-22f4-4c55-8065-6754bf9d0acd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_71832374-4bc9-467f-9745-53d9fa4aef88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_us-gaap_AssetsNet_71832374-4bc9-467f-9745-53d9fa4aef88" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_676a66f9-a0a8-4447-86de-489c7f31df3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_676a66f9-a0a8-4447-86de-489c7f31df3e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fe6596e-2b45-46e4-95c4-e9034067e303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fe6596e-2b45-46e4-95c4-e9034067e303" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c9e8373a-9fc7-42f4-89e4-628e815622d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fe6596e-2b45-46e4-95c4-e9034067e303" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c9e8373a-9fc7-42f4-89e4-628e815622d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c9e8373a-9fc7-42f4-89e4-628e815622d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c9e8373a-9fc7-42f4-89e4-628e815622d2" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c9e8373a-9fc7-42f4-89e4-628e815622d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c9e8373a-9fc7-42f4-89e4-628e815622d2" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_e7f8d5f9-147f-4c70-bfab-a0dc76c395b1" xlink:href="mck-20211231.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_e7f8d5f9-147f-4c70-bfab-a0dc76c395b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember_5563b6c5-0952-45b8-a7a5-5f0e0c43ab44" xlink:href="mck-20211231.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:to="loc_mck_AustrianBusinessOperationsMember_5563b6c5-0952-45b8-a7a5-5f0e0c43ab44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_59aaf2c2-f379-4a4e-af55-c38ad270fa72" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_59aaf2c2-f379-4a4e-af55-c38ad270fa72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_15bbcead-1eba-4045-be08-332bd7c00501" xlink:href="mck-20211231.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_15bbcead-1eba-4045-be08-332bd7c00501" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_4274100b-d39f-43a5-b473-1d6d079f4039" xlink:href="mck-20211231.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_4274100b-d39f-43a5-b473-1d6d079f4039" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_81df8e0a-cb8f-4e18-bb0d-5d82c826313c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fe6596e-2b45-46e4-95c4-e9034067e303" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_81df8e0a-cb8f-4e18-bb0d-5d82c826313c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_81df8e0a-cb8f-4e18-bb0d-5d82c826313c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_81df8e0a-cb8f-4e18-bb0d-5d82c826313c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_81df8e0a-cb8f-4e18-bb0d-5d82c826313c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_479ec30e-e1b2-4c00-92fe-826976643cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_81df8e0a-cb8f-4e18-bb0d-5d82c826313c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_479ec30e-e1b2-4c00-92fe-826976643cb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_170713fc-4053-48e1-ad69-7eb0ae9ed40e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_479ec30e-e1b2-4c00-92fe-826976643cb3" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_170713fc-4053-48e1-ad69-7eb0ae9ed40e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8042fa83-57fc-4354-810d-17f68558e137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fe6596e-2b45-46e4-95c4-e9034067e303" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8042fa83-57fc-4354-810d-17f68558e137" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8042fa83-57fc-4354-810d-17f68558e137_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8042fa83-57fc-4354-810d-17f68558e137" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8042fa83-57fc-4354-810d-17f68558e137_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1c4b3678-9798-439f-baba-181f6b7ebbaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8042fa83-57fc-4354-810d-17f68558e137" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1c4b3678-9798-439f-baba-181f6b7ebbaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_398afc6f-0406-4564-90d2-222201c4a423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1c4b3678-9798-439f-baba-181f6b7ebbaf" xlink:to="loc_us-gaap_SubsequentEventMember_398afc6f-0406-4564-90d2-222201c4a423" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended" id="ied12428bfc134f0b93e61c88f8e71132_HeldforSaleAssetsandLiabilitiesHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19b24819-9c0b-4606-88e3-531417fc7999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19b24819-9c0b-4606-88e3-531417fc7999" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_451fe2c2-70ea-44d4-9513-20d4a0ac66b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_451fe2c2-70ea-44d4-9513-20d4a0ac66b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_380a9b53-ea53-48f1-badf-90d4e4995c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_380a9b53-ea53-48f1-badf-90d4e4995c6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e9639692-7e53-40bf-b9bb-9e8508a0cce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e9639692-7e53-40bf-b9bb-9e8508a0cce4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_9f454d61-9818-4d05-ad3f-15cd8db30265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_9f454d61-9818-4d05-ad3f-15cd8db30265" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_edbd3005-0097-4c2a-9e24-17ae15596295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_edbd3005-0097-4c2a-9e24-17ae15596295" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_1497c229-795f-4f26-b739-8190823a771f" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_1497c229-795f-4f26-b739-8190823a771f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_da247af7-7be5-4e92-8359-5cdf6a808178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_da247af7-7be5-4e92-8359-5cdf6a808178" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_4ae961ff-93d5-4731-9088-575b89005000" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_4ae961ff-93d5-4731-9088-575b89005000" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_5c0961ea-dc8f-4824-81a4-6347e6268e5d" xlink:href="mck-20211231.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_5c0961ea-dc8f-4824-81a4-6347e6268e5d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_249ec25c-1d0f-45db-9103-8db9063b2f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_249ec25c-1d0f-45db-9103-8db9063b2f11" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19b24819-9c0b-4606-88e3-531417fc7999" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_1d864aa3-809f-445e-b793-c0c9d4f07f34" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_1d864aa3-809f-445e-b793-c0c9d4f07f34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_0eca3e1a-96c0-433f-9b51-30f52c9ff111" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_0eca3e1a-96c0-433f-9b51-30f52c9ff111" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_8b074f23-f505-4374-9e18-f72ede59b642" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_8b074f23-f505-4374-9e18-f72ede59b642" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_ef713ea1-85b8-4cbb-9861-c1c290909984" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_ef713ea1-85b8-4cbb-9861-c1c290909984" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_7c7a0078-346c-4d26-9a5b-0c221a0eaca2" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_7c7a0078-346c-4d26-9a5b-0c221a0eaca2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_1a557d58-1bc9-485b-ae79-8e1a37a82ddb" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_1a557d58-1bc9-485b-ae79-8e1a37a82ddb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_c81839fa-7957-4d6d-a20a-63ef2c992b9f" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_c81839fa-7957-4d6d-a20a-63ef2c992b9f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_28d3619b-31f9-4b4c-8b89-61f6455e9524" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_28d3619b-31f9-4b4c-8b89-61f6455e9524" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fda0a826-18ea-4caf-bba1-12bcf9255f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fda0a826-18ea-4caf-bba1-12bcf9255f2b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_d3aafc2d-daa7-487a-bd9a-14dfb8625d0a" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19b24819-9c0b-4606-88e3-531417fc7999" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_d3aafc2d-daa7-487a-bd9a-14dfb8625d0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3b09633b-4c24-4a5f-bf71-429f75552ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19b24819-9c0b-4606-88e3-531417fc7999" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3b09633b-4c24-4a5f-bf71-429f75552ca0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b87f2f9c-c65e-41a9-8180-2c8c6489384e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3b09633b-4c24-4a5f-bf71-429f75552ca0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b87f2f9c-c65e-41a9-8180-2c8c6489384e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b87f2f9c-c65e-41a9-8180-2c8c6489384e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b87f2f9c-c65e-41a9-8180-2c8c6489384e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b87f2f9c-c65e-41a9-8180-2c8c6489384e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b87f2f9c-c65e-41a9-8180-2c8c6489384e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_9d814f3a-580f-48c8-9289-22dfbd79307c" xlink:href="mck-20211231.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_9d814f3a-580f-48c8-9289-22dfbd79307c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_ac3d4e54-78b0-4f0c-9e1f-3da7760a7182" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_ac3d4e54-78b0-4f0c-9e1f-3da7760a7182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_1e1abaf0-6ffe-4de6-b8a1-55fc0da3b60e" xlink:href="mck-20211231.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_1e1abaf0-6ffe-4de6-b8a1-55fc0da3b60e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_97b5b44c-7d4c-4c55-ab5b-eb633c107cbe" xlink:href="mck-20211231.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:to="loc_mck_EuroDenominatedNotesMember_97b5b44c-7d4c-4c55-ab5b-eb633c107cbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember_db7100c3-93bc-4478-a9cc-438220b98def" xlink:href="mck-20211231.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:to="loc_mck_InternallyDevelopedSoftwareMember_db7100c3-93bc-4478-a9cc-438220b98def" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3cfd1c6b-2dc8-4307-a9c6-f6622c0af8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3b09633b-4c24-4a5f-bf71-429f75552ca0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3cfd1c6b-2dc8-4307-a9c6-f6622c0af8eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3cfd1c6b-2dc8-4307-a9c6-f6622c0af8eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3cfd1c6b-2dc8-4307-a9c6-f6622c0af8eb" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3cfd1c6b-2dc8-4307-a9c6-f6622c0af8eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_08a0650d-74f0-4d50-9065-10bb2afb59ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3cfd1c6b-2dc8-4307-a9c6-f6622c0af8eb" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_08a0650d-74f0-4d50-9065-10bb2afb59ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_14a6b063-4c57-40c8-8ab3-e5d709433870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_08a0650d-74f0-4d50-9065-10bb2afb59ab" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_14a6b063-4c57-40c8-8ab3-e5d709433870" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended" id="i57e0758a6b86481599f518ab08b8eb6d_RestructuringImpairmentandRelatedChargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_2a432dd2-bd90-4c41-ad6a-a7d16570b7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_2a432dd2-bd90-4c41-ad6a-a7d16570b7bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_071d5458-0702-4479-8f57-212c1910403a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_071d5458-0702-4479-8f57-212c1910403a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_7eb580ad-df05-47d1-bc8c-65ae0c669174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_7eb580ad-df05-47d1-bc8c-65ae0c669174" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6a378ec1-8f29-4138-b80f-6ffb61b55eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:to="loc_us-gaap_RestructuringCharges_6a378ec1-8f29-4138-b80f-6ffb61b55eb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0fa46ab3-8518-48e7-b2d1-02461fdc0de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:to="loc_us-gaap_RestructuringPlanAxis_0fa46ab3-8518-48e7-b2d1-02461fdc0de3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0fa46ab3-8518-48e7-b2d1-02461fdc0de3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_0fa46ab3-8518-48e7-b2d1-02461fdc0de3" xlink:to="loc_us-gaap_RestructuringPlanDomain_0fa46ab3-8518-48e7-b2d1-02461fdc0de3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bce5757d-8a5f-408b-8494-0e0095921534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_0fa46ab3-8518-48e7-b2d1-02461fdc0de3" xlink:to="loc_us-gaap_RestructuringPlanDomain_bce5757d-8a5f-408b-8494-0e0095921534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_f3520539-657e-476d-961a-757002d43d24" xlink:href="mck-20211231.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_bce5757d-8a5f-408b-8494-0e0095921534" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_f3520539-657e-476d-961a-757002d43d24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember_063e8a81-f7b6-467a-ae9f-2730f8e18a6f" xlink:href="mck-20211231.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_bce5757d-8a5f-408b-8494-0e0095921534" xlink:to="loc_mck_OperatingModelAndCostOptimizationProgramsMember_063e8a81-f7b6-467a-ae9f-2730f8e18a6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4b787a3c-988e-4c27-8e11-4ab36a26d72d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:to="loc_srt_RangeAxis_4b787a3c-988e-4c27-8e11-4ab36a26d72d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b787a3c-988e-4c27-8e11-4ab36a26d72d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4b787a3c-988e-4c27-8e11-4ab36a26d72d" xlink:to="loc_srt_RangeMember_4b787a3c-988e-4c27-8e11-4ab36a26d72d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9883ef68-e86f-4c21-9f86-bd1caa37dfcb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4b787a3c-988e-4c27-8e11-4ab36a26d72d" xlink:to="loc_srt_RangeMember_9883ef68-e86f-4c21-9f86-bd1caa37dfcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f84403e1-57d7-42c1-ac73-f81aa794c123" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9883ef68-e86f-4c21-9f86-bd1caa37dfcb" xlink:to="loc_srt_MinimumMember_f84403e1-57d7-42c1-ac73-f81aa794c123" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e0297533-a3f6-4e95-929e-8e7b8b1aacbd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9883ef68-e86f-4c21-9f86-bd1caa37dfcb" xlink:to="loc_srt_MaximumMember_e0297533-a3f6-4e95-929e-8e7b8b1aacbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5c20b831-1e43-4858-b051-c6610a38ddd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5c20b831-1e43-4858-b051-c6610a38ddd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5c20b831-1e43-4858-b051-c6610a38ddd1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5c20b831-1e43-4858-b051-c6610a38ddd1" xlink:to="loc_us-gaap_SegmentDomain_5c20b831-1e43-4858-b051-c6610a38ddd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f6bf55fe-4190-47de-9818-de26fe7adb12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5c20b831-1e43-4858-b051-c6610a38ddd1" xlink:to="loc_us-gaap_SegmentDomain_f6bf55fe-4190-47de-9818-de26fe7adb12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_e415a5bf-eea0-46a7-a072-2d24747b6bc4" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f6bf55fe-4190-47de-9818-de26fe7adb12" xlink:to="loc_mck_InternationalSegmentMember_e415a5bf-eea0-46a7-a072-2d24747b6bc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_fcd34ec1-b2bf-4d60-a916-10f2539a10bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_fcd34ec1-b2bf-4d60-a916-10f2539a10bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_fcd34ec1-b2bf-4d60-a916-10f2539a10bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_fcd34ec1-b2bf-4d60-a916-10f2539a10bf" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_fcd34ec1-b2bf-4d60-a916-10f2539a10bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_fed1f622-f409-4e79-8ac2-a23f3f291f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_fcd34ec1-b2bf-4d60-a916-10f2539a10bf" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_fed1f622-f409-4e79-8ac2-a23f3f291f5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_a2cc8fba-4503-4439-97e6-9694f2941460" xlink:href="mck-20211231.xsd#mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_fed1f622-f409-4e79-8ac2-a23f3f291f5b" xlink:to="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_a2cc8fba-4503-4439-97e6-9694f2941460" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended" id="if744c70444034aa8b8b7ec098f465fb1_RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_e25076de-6d89-4c59-863a-b4460d416fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:to="loc_us-gaap_SeveranceCosts1_e25076de-6d89-4c59-863a-b4460d416fd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_ec37c3d3-944c-4bde-9ed9-6837eb90fef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:to="loc_us-gaap_BusinessExitCosts1_ec37c3d3-944c-4bde-9ed9-6837eb90fef2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_87682289-5f88-41b1-a952-0ccaf3791146" xlink:href="mck-20211231.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_87682289-5f88-41b1-a952-0ccaf3791146" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4770e5a4-5576-45c0-a319-2d29c6727934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:to="loc_us-gaap_RestructuringCharges_4770e5a4-5576-45c0-a319-2d29c6727934" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8682210e-04af-4423-a27e-780795e362db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8682210e-04af-4423-a27e-780795e362db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f8a5f49d-3827-4ba8-9285-fa37860bc104" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8682210e-04af-4423-a27e-780795e362db" xlink:to="loc_srt_ConsolidationItemsAxis_f8a5f49d-3827-4ba8-9285-fa37860bc104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f8a5f49d-3827-4ba8-9285-fa37860bc104_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f8a5f49d-3827-4ba8-9285-fa37860bc104" xlink:to="loc_srt_ConsolidationItemsDomain_f8a5f49d-3827-4ba8-9285-fa37860bc104_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_938d7f81-5716-4593-a3a6-03d9fa8dab02" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f8a5f49d-3827-4ba8-9285-fa37860bc104" xlink:to="loc_srt_ConsolidationItemsDomain_938d7f81-5716-4593-a3a6-03d9fa8dab02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_425b7629-d7fa-42cf-a307-553b6a6109a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_938d7f81-5716-4593-a3a6-03d9fa8dab02" xlink:to="loc_us-gaap_OperatingSegmentsMember_425b7629-d7fa-42cf-a307-553b6a6109a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f98fb473-4ba5-4cdc-bd36-1fdb167e54fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_938d7f81-5716-4593-a3a6-03d9fa8dab02" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f98fb473-4ba5-4cdc-bd36-1fdb167e54fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f69862a9-c8a2-4c71-bab0-684fbe8c3f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8682210e-04af-4423-a27e-780795e362db" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f69862a9-c8a2-4c71-bab0-684fbe8c3f19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f69862a9-c8a2-4c71-bab0-684fbe8c3f19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f69862a9-c8a2-4c71-bab0-684fbe8c3f19" xlink:to="loc_us-gaap_SegmentDomain_f69862a9-c8a2-4c71-bab0-684fbe8c3f19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f69862a9-c8a2-4c71-bab0-684fbe8c3f19" xlink:to="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_97791845-d155-44c6-babb-bba608fcfe77" xlink:href="mck-20211231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:to="loc_mck_USPharmaceuticalSegmentMember_97791845-d155-44c6-babb-bba608fcfe77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_78790f49-3c49-4716-98df-55b83f36d2d2" xlink:href="mck-20211231.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_78790f49-3c49-4716-98df-55b83f36d2d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_cd41a723-1a02-4cc1-9b5f-fead920475c0" xlink:href="mck-20211231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_cd41a723-1a02-4cc1-9b5f-fead920475c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_994e6456-96fa-4e84-8af1-0167ee347d58" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:to="loc_mck_InternationalSegmentMember_994e6456-96fa-4e84-8af1-0167ee347d58" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended" id="ie348040f8c1e42ea87e8da799b39bf7e_RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_db8c6485-4e4a-487c-84db-5d6bc8559ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_db8c6485-4e4a-487c-84db-5d6bc8559ae0" xlink:to="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_cb75cc94-0fbd-4a41-8970-91a115661c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:to="loc_us-gaap_RestructuringReserve_cb75cc94-0fbd-4a41-8970-91a115661c11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_908152d7-13bf-47aa-a4ed-ba25a9b4013c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:to="loc_us-gaap_RestructuringCharges_908152d7-13bf-47aa-a4ed-ba25a9b4013c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_56874143-0398-486f-ab6b-6f70630434f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_56874143-0398-486f-ab6b-6f70630434f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_e68a5405-fa8c-4d12-989a-52ec93cc875b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:to="loc_us-gaap_PaymentsForRestructuring_e68a5405-fa8c-4d12-989a-52ec93cc875b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_4e326fd6-2ad8-4423-86e8-8a08cdce34c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_4e326fd6-2ad8-4423-86e8-8a08cdce34c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_20bf1fa7-ebf7-4221-83e7-1629c785f28d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_40917e07-fbff-4c61-ad38-4330a285679d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_db8c6485-4e4a-487c-84db-5d6bc8559ae0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_40917e07-fbff-4c61-ad38-4330a285679d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c502e516-f40c-47f4-966b-6def59ec5f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_40917e07-fbff-4c61-ad38-4330a285679d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c502e516-f40c-47f4-966b-6def59ec5f03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c502e516-f40c-47f4-966b-6def59ec5f03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c502e516-f40c-47f4-966b-6def59ec5f03" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c502e516-f40c-47f4-966b-6def59ec5f03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_eff1effa-7655-4871-9c7c-41a3ccc97701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c502e516-f40c-47f4-966b-6def59ec5f03" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_eff1effa-7655-4871-9c7c-41a3ccc97701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_d4630bd4-290a-4617-91d5-4ba314eef69b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eff1effa-7655-4871-9c7c-41a3ccc97701" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_d4630bd4-290a-4617-91d5-4ba314eef69b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_6fdc07f7-3ba3-42e9-a341-19e721e7952a" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eff1effa-7655-4871-9c7c-41a3ccc97701" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_6fdc07f7-3ba3-42e9-a341-19e721e7952a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ab6241af-a907-4533-82c9-665961c2aa0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eff1effa-7655-4871-9c7c-41a3ccc97701" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ab6241af-a907-4533-82c9-665961c2aa0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_fb6b2b82-230c-4b0a-b52f-31fd307663e6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_40917e07-fbff-4c61-ad38-4330a285679d" xlink:to="loc_srt_ConsolidationItemsAxis_fb6b2b82-230c-4b0a-b52f-31fd307663e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_fb6b2b82-230c-4b0a-b52f-31fd307663e6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_fb6b2b82-230c-4b0a-b52f-31fd307663e6" xlink:to="loc_srt_ConsolidationItemsDomain_fb6b2b82-230c-4b0a-b52f-31fd307663e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a49b8b49-c069-4b1f-8a51-f45b97c7b610" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_fb6b2b82-230c-4b0a-b52f-31fd307663e6" xlink:to="loc_srt_ConsolidationItemsDomain_a49b8b49-c069-4b1f-8a51-f45b97c7b610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7f652f15-d4ab-42ca-a746-fa57268a21c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a49b8b49-c069-4b1f-8a51-f45b97c7b610" xlink:to="loc_us-gaap_OperatingSegmentsMember_7f652f15-d4ab-42ca-a746-fa57268a21c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c56d0c75-a073-4df0-95c2-3f7210b00eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a49b8b49-c069-4b1f-8a51-f45b97c7b610" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c56d0c75-a073-4df0-95c2-3f7210b00eac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_095bd482-42ca-4c2b-8cc3-a6493905144c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_40917e07-fbff-4c61-ad38-4330a285679d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_095bd482-42ca-4c2b-8cc3-a6493905144c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_095bd482-42ca-4c2b-8cc3-a6493905144c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_095bd482-42ca-4c2b-8cc3-a6493905144c" xlink:to="loc_us-gaap_SegmentDomain_095bd482-42ca-4c2b-8cc3-a6493905144c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_095bd482-42ca-4c2b-8cc3-a6493905144c" xlink:to="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_28658acf-9325-4625-8961-9dc630d1569a" xlink:href="mck-20211231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:to="loc_mck_USPharmaceuticalSegmentMember_28658acf-9325-4625-8961-9dc630d1569a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_5b7ac87c-542e-4070-a427-486a887c1be7" xlink:href="mck-20211231.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_5b7ac87c-542e-4070-a427-486a887c1be7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_033de4ea-c978-45eb-8749-b439de71024a" xlink:href="mck-20211231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_033de4ea-c978-45eb-8749-b439de71024a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_40990aa4-37a2-4245-b3b0-a428c36a3ec7" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:to="loc_mck_InternationalSegmentMember_40990aa4-37a2-4245-b3b0-a428c36a3ec7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="extended" id="if9097926831b41d4adf1b7dc786471b8_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cfac9d69-04c6-4035-8523-8f9fcdff21b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_056bf44c-a37a-44bb-bd72-97c0ad7d7aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cfac9d69-04c6-4035-8523-8f9fcdff21b0" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_056bf44c-a37a-44bb-bd72-97c0ad7d7aad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_98300a40-e9e8-4483-b79f-8659fb81204c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cfac9d69-04c6-4035-8523-8f9fcdff21b0" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_98300a40-e9e8-4483-b79f-8659fb81204c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_6ba4c2ef-c95e-4645-ab54-8598d010ccf9" xlink:href="mck-20211231.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cfac9d69-04c6-4035-8523-8f9fcdff21b0" xlink:to="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_6ba4c2ef-c95e-4645-ab54-8598d010ccf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3463df4d-a74d-4496-963f-b7f1f0854326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cfac9d69-04c6-4035-8523-8f9fcdff21b0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3463df4d-a74d-4496-963f-b7f1f0854326" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e182f790-afc8-4358-ba7e-d368bcd267f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3463df4d-a74d-4496-963f-b7f1f0854326" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e182f790-afc8-4358-ba7e-d368bcd267f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e182f790-afc8-4358-ba7e-d368bcd267f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e182f790-afc8-4358-ba7e-d368bcd267f3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e182f790-afc8-4358-ba7e-d368bcd267f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aee7a698-d95b-4a5c-9730-e631fbc411c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e182f790-afc8-4358-ba7e-d368bcd267f3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aee7a698-d95b-4a5c-9730-e631fbc411c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_014c6852-7412-4c74-9ecd-812d81101cd8" xlink:href="mck-20211231.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aee7a698-d95b-4a5c-9730-e631fbc411c6" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_014c6852-7412-4c74-9ecd-812d81101cd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_d8735a4c-f569-41de-ae2d-ca9b41a9eae6" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupAndAustrianBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aee7a698-d95b-4a5c-9730-e631fbc411c6" xlink:to="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_d8735a4c-f569-41de-ae2d-ca9b41a9eae6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_726cc35e-3840-4259-8c39-8c9117535490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3463df4d-a74d-4496-963f-b7f1f0854326" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_726cc35e-3840-4259-8c39-8c9117535490" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_726cc35e-3840-4259-8c39-8c9117535490_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_726cc35e-3840-4259-8c39-8c9117535490" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_726cc35e-3840-4259-8c39-8c9117535490_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d9cf173c-b067-444f-90d7-a2722a4356c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_726cc35e-3840-4259-8c39-8c9117535490" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d9cf173c-b067-444f-90d7-a2722a4356c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_9f7df1b0-cbf5-4acb-8140-0fa0c802381e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d9cf173c-b067-444f-90d7-a2722a4356c2" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_9f7df1b0-cbf5-4acb-8140-0fa0c802381e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5820cb57-9fcf-4f93-b205-2e9b157a6541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3463df4d-a74d-4496-963f-b7f1f0854326" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5820cb57-9fcf-4f93-b205-2e9b157a6541" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_5820cb57-9fcf-4f93-b205-2e9b157a6541_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5820cb57-9fcf-4f93-b205-2e9b157a6541" xlink:to="loc_us-gaap_LossContingencyNatureDomain_5820cb57-9fcf-4f93-b205-2e9b157a6541_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b3dc46b9-ccc3-42af-844a-013776237f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5820cb57-9fcf-4f93-b205-2e9b157a6541" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b3dc46b9-ccc3-42af-844a-013776237f0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_306ff8d3-0cf4-4096-b048-efb6ee5c54bc" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_b3dc46b9-ccc3-42af-844a-013776237f0c" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_306ff8d3-0cf4-4096-b048-efb6ee5c54bc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended" id="i83b501ce99d5426283f23443406c57f5_RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_077b1de8-5fcc-4878-8de2-6bbab529eda2" xlink:href="mck-20211231.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_077b1de8-5fcc-4878-8de2-6bbab529eda2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_86126ad1-2daa-41f8-b4a9-66878a6786cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_86126ad1-2daa-41f8-b4a9-66878a6786cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_592cfa5e-5ff8-4159-8ba0-0937a99d98f1" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_592cfa5e-5ff8-4159-8ba0-0937a99d98f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_a9ea73a1-492c-4c50-8079-8909190e9276" xlink:href="mck-20211231.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_PutRightValueInterestRateSpread_a9ea73a1-492c-4c50-8079-8909190e9276" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_fbe7c78c-d6bc-4cf0-81f5-7e8f52f156f4" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_fbe7c78c-d6bc-4cf0-81f5-7e8f52f156f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_663f107a-9660-4e10-abad-e3bfe779e98a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_663f107a-9660-4e10-abad-e3bfe779e98a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_185f3a08-546d-4d7e-87bb-2d36e2e03aa9" xlink:href="mck-20211231.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_185f3a08-546d-4d7e-87bb-2d36e2e03aa9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_91146bec-a0f6-4c78-872d-4636a55616bb" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_91146bec-a0f6-4c78-872d-4636a55616bb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_1b1c0863-3223-438b-9398-dda0b63e7cca" xlink:href="mck-20211231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_1b1c0863-3223-438b-9398-dda0b63e7cca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_cf7ddb37-ae9d-4cab-956b-fea3d8253db4" xlink:href="mck-20211231.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_cf7ddb37-ae9d-4cab-956b-fea3d8253db4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_b58e49cc-2418-4966-82d1-4c62b55b94c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_b58e49cc-2418-4966-82d1-4c62b55b94c2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_095b78ae-8732-4aea-9b49-3f2d2b99ac21" xlink:href="mck-20211231.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_095b78ae-8732-4aea-9b49-3f2d2b99ac21" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8d9a5ed9-8700-4da8-91cd-e7ec9579b5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8d9a5ed9-8700-4da8-91cd-e7ec9579b5c8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_be783a77-6c3b-4b5a-9196-809789616bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_be783a77-6c3b-4b5a-9196-809789616bc6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_a8ce5611-c52b-470b-acb6-bf2dc89c3025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_us-gaap_MinorityInterestTable_a8ce5611-c52b-470b-acb6-bf2dc89c3025" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_960de18e-b431-4194-8469-5c09055fb43e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_a8ce5611-c52b-470b-acb6-bf2dc89c3025" xlink:to="loc_srt_OwnershipAxis_960de18e-b431-4194-8469-5c09055fb43e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_960de18e-b431-4194-8469-5c09055fb43e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_960de18e-b431-4194-8469-5c09055fb43e" xlink:to="loc_srt_OwnershipDomain_960de18e-b431-4194-8469-5c09055fb43e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e4511eed-45cd-4db0-9460-19b56b5054df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_960de18e-b431-4194-8469-5c09055fb43e" xlink:to="loc_srt_OwnershipDomain_e4511eed-45cd-4db0-9460-19b56b5054df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_4fe97542-61e1-4786-8e8d-e290d85f71ea" xlink:href="mck-20211231.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_e4511eed-45cd-4db0-9460-19b56b5054df" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_4fe97542-61e1-4786-8e8d-e290d85f71ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_2143363a-924d-4a2f-956b-00d2ef584303" xlink:href="mck-20211231.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_e4511eed-45cd-4db0-9460-19b56b5054df" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_2143363a-924d-4a2f-956b-00d2ef584303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_25721a89-7758-45eb-ac6f-144262a064df" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_a8ce5611-c52b-470b-acb6-bf2dc89c3025" xlink:to="loc_dei_LegalEntityAxis_25721a89-7758-45eb-ac6f-144262a064df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_25721a89-7758-45eb-ac6f-144262a064df_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_25721a89-7758-45eb-ac6f-144262a064df" xlink:to="loc_dei_EntityDomain_25721a89-7758-45eb-ac6f-144262a064df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c2d1d94d-7662-405c-97da-1151b4b9e321" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_25721a89-7758-45eb-ac6f-144262a064df" xlink:to="loc_dei_EntityDomain_c2d1d94d-7662-405c-97da-1151b4b9e321" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_67e2a132-a5d6-4e21-97d8-2959d134e777" xlink:href="mck-20211231.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_c2d1d94d-7662-405c-97da-1151b4b9e321" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_67e2a132-a5d6-4e21-97d8-2959d134e777" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_073666ad-d190-4d8a-bcfd-4096a7fa50ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_a8ce5611-c52b-470b-acb6-bf2dc89c3025" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_073666ad-d190-4d8a-bcfd-4096a7fa50ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_073666ad-d190-4d8a-bcfd-4096a7fa50ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_073666ad-d190-4d8a-bcfd-4096a7fa50ce" xlink:to="loc_us-gaap_EquityComponentDomain_073666ad-d190-4d8a-bcfd-4096a7fa50ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d3993200-040e-419c-8894-5d1eb4ee18fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_073666ad-d190-4d8a-bcfd-4096a7fa50ce" xlink:to="loc_us-gaap_EquityComponentDomain_d3993200-040e-419c-8894-5d1eb4ee18fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_39ce375a-0e38-4d7d-ad9d-4dbafeff3731" xlink:href="mck-20211231.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d3993200-040e-419c-8894-5d1eb4ee18fa" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_39ce375a-0e38-4d7d-ad9d-4dbafeff3731" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e15c3b7d-7a77-4fec-bd33-e27a97d30bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d3993200-040e-419c-8894-5d1eb4ee18fa" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e15c3b7d-7a77-4fec-bd33-e27a97d30bf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ce9cbea0-203d-4a9c-a082-b04a4125b955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d3993200-040e-419c-8894-5d1eb4ee18fa" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ce9cbea0-203d-4a9c-a082-b04a4125b955" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended" id="ie01f34190e044720ac6a30cb38726560_RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_da09c715-df47-44b8-a823-b96bd3e9ba5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_da09c715-df47-44b8-a823-b96bd3e9ba5c" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_66ce73ca-f409-430f-acd2-b3b05a317522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:to="loc_us-gaap_MinorityInterest_66ce73ca-f409-430f-acd2-b3b05a317522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d4d746b6-62d7-4ca3-8d43-04a71832aa1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d4d746b6-62d7-4ca3-8d43-04a71832aa1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_7f0d4dde-6baf-4070-aadb-cca390e8a13d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_7f0d4dde-6baf-4070-aadb-cca390e8a13d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4d08513b-de41-4653-babf-bfdba183575d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4d08513b-de41-4653-babf-bfdba183575d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_0f26ba93-c419-41a1-9509-1f9df1803510" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_0f26ba93-c419-41a1-9509-1f9df1803510" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_b9f98982-e843-40b8-b336-8764a7aa7a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_da09c715-df47-44b8-a823-b96bd3e9ba5c" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_45c41dc0-ecc5-4221-b687-35ad33fd0083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_45c41dc0-ecc5-4221-b687-35ad33fd0083" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_295eb426-ef33-4cde-922f-d43901eb6a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_295eb426-ef33-4cde-922f-d43901eb6a4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_5a17a1fc-e4a4-440c-a3c7-c263692a93a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_ffa55976-8a33-4010-afb5-419e968bb094" xlink:href="mck-20211231.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_ffa55976-8a33-4010-afb5-419e968bb094" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2f7b9860-faeb-4a22-aaac-0b99bc789c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_2a7d092e-4f68-4cb1-84b8-aa67f07db601" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_2a7d092e-4f68-4cb1-84b8-aa67f07db601" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_714cc3cf-ba83-411b-8779-6c31742e67ba" xlink:href="mck-20211231.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_714cc3cf-ba83-411b-8779-6c31742e67ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_de20f520-ae79-46c4-8aa9-37dd2c45f891" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_10969847-c535-4795-a381-cc58c66f33cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_8c4ca23d-b56a-4b7c-9f47-49e39a5de83d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_da09c715-df47-44b8-a823-b96bd3e9ba5c" xlink:to="loc_us-gaap_MinorityInterestTable_8c4ca23d-b56a-4b7c-9f47-49e39a5de83d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_48fa191b-4c66-46e3-8b57-aea736ca7e79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_8c4ca23d-b56a-4b7c-9f47-49e39a5de83d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_48fa191b-4c66-46e3-8b57-aea736ca7e79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_48fa191b-4c66-46e3-8b57-aea736ca7e79_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_48fa191b-4c66-46e3-8b57-aea736ca7e79" xlink:to="loc_us-gaap_EquityComponentDomain_48fa191b-4c66-46e3-8b57-aea736ca7e79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7fc6ad85-332b-4a19-85a6-82f9d246351b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_48fa191b-4c66-46e3-8b57-aea736ca7e79" xlink:to="loc_us-gaap_EquityComponentDomain_7fc6ad85-332b-4a19-85a6-82f9d246351b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_8883c8cd-dd44-4f06-aa41-ef55649ae581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7fc6ad85-332b-4a19-85a6-82f9d246351b" xlink:to="loc_us-gaap_NoncontrollingInterestMember_8883c8cd-dd44-4f06-aa41-ef55649ae581" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_87ae3787-6a92-4d0f-80bb-6cd615a32a0c" xlink:href="mck-20211231.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7fc6ad85-332b-4a19-85a6-82f9d246351b" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_87ae3787-6a92-4d0f-80bb-6cd615a32a0c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#EarningsLossPerCommonShareDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="extended" id="ib845d5aa20a1431eaa16847e1187092e_EarningsLossPerCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3df354a9-9ec7-4230-850f-ae1bbb0fbc04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3df354a9-9ec7-4230-850f-ae1bbb0fbc04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_35165891-3ec6-424f-919c-ea61a60cdc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_35165891-3ec6-424f-919c-ea61a60cdc0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_bba0e228-2a3c-4565-9e39-ee45675a2a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_bba0e228-2a3c-4565-9e39-ee45675a2a9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_29e554e0-25f1-4b8a-9f06-1c52efc9dcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_29e554e0-25f1-4b8a-9f06-1c52efc9dcc2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dd3f6495-b01c-4b67-82d7-e97f1c52337f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_NetIncomeLoss_dd3f6495-b01c-4b67-82d7-e97f1c52337f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_803ea29d-acb3-42c3-a377-bf9055e65715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_803ea29d-acb3-42c3-a377-bf9055e65715" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4ef7a56a-48dc-4c6e-995a-fdd66bbd4364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_803ea29d-acb3-42c3-a377-bf9055e65715" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4ef7a56a-48dc-4c6e-995a-fdd66bbd4364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_4ab201b2-7513-421a-a6eb-e1c0697fff48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_803ea29d-acb3-42c3-a377-bf9055e65715" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_4ab201b2-7513-421a-a6eb-e1c0697fff48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0f7e3c9b-7472-4b43-a6a1-dfb2162c89e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_4ab201b2-7513-421a-a6eb-e1c0697fff48" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0f7e3c9b-7472-4b43-a6a1-dfb2162c89e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dbced3d3-f734-4294-8d2a-34d41c43ee22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_803ea29d-acb3-42c3-a377-bf9055e65715" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dbced3d3-f734-4294-8d2a-34d41c43ee22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fe3a64f7-4dbf-4de9-847a-faac5a1b19cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fe3a64f7-4dbf-4de9-847a-faac5a1b19cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_41d1cc40-c55f-4f49-a333-9749bff1fe34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fe3a64f7-4dbf-4de9-847a-faac5a1b19cb" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_41d1cc40-c55f-4f49-a333-9749bff1fe34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6c2bb4b1-e1ba-44b1-a8f4-a96a112501dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_41d1cc40-c55f-4f49-a333-9749bff1fe34" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6c2bb4b1-e1ba-44b1-a8f4-a96a112501dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_8130ec4c-3f02-4df7-912e-1b2375e8d7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_41d1cc40-c55f-4f49-a333-9749bff1fe34" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_8130ec4c-3f02-4df7-912e-1b2375e8d7a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8ec4263a-ca6f-45b6-8e2d-77fa0bdf9498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_41d1cc40-c55f-4f49-a333-9749bff1fe34" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8ec4263a-ca6f-45b6-8e2d-77fa0bdf9498" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_7150c971-eb70-4e79-a21e-599033ba5119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fe3a64f7-4dbf-4de9-847a-faac5a1b19cb" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_7150c971-eb70-4e79-a21e-599033ba5119" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_0f7f7d9e-f3da-4904-89e2-cabcdbeaf977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_7150c971-eb70-4e79-a21e-599033ba5119" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_0f7f7d9e-f3da-4904-89e2-cabcdbeaf977" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a4c3599f-d61e-42c6-a4c4-9b2a2b00d1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_7150c971-eb70-4e79-a21e-599033ba5119" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a4c3599f-d61e-42c6-a4c4-9b2a2b00d1a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_dea9d3a1-a51c-49f0-985b-08fc9d87b4de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_7150c971-eb70-4e79-a21e-599033ba5119" xlink:to="loc_us-gaap_EarningsPerShareBasic_dea9d3a1-a51c-49f0-985b-08fc9d87b4de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67b49eac-b873-47d7-be8d-3181e93895af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67b49eac-b873-47d7-be8d-3181e93895af" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_f4923e2a-e0cf-46b7-9b33-074916ebf493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_f4923e2a-e0cf-46b7-9b33-074916ebf493" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7d0da53c-55c6-4c0f-9781-d5a5abe2e741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_f4923e2a-e0cf-46b7-9b33-074916ebf493" xlink:to="loc_us-gaap_AwardTypeAxis_7d0da53c-55c6-4c0f-9781-d5a5abe2e741" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d0da53c-55c6-4c0f-9781-d5a5abe2e741_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7d0da53c-55c6-4c0f-9781-d5a5abe2e741" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d0da53c-55c6-4c0f-9781-d5a5abe2e741_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af856c4e-2340-477b-a731-ef933b57ca4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7d0da53c-55c6-4c0f-9781-d5a5abe2e741" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af856c4e-2340-477b-a731-ef933b57ca4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1e90f525-6d59-4b5c-a300-f34d9f4ad426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af856c4e-2340-477b-a731-ef933b57ca4e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1e90f525-6d59-4b5c-a300-f34d9f4ad426" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_50d14d38-78be-419e-a86b-2eff041175c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af856c4e-2340-477b-a731-ef933b57ca4e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_50d14d38-78be-419e-a86b-2eff041175c5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="extended" id="i396f7cb93d834df9a733d94dd55513f9_GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e4015315-11a0-45ec-8d50-de8f1df72fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_378be0b6-9edb-40dc-ade3-8136655f2458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e4015315-11a0-45ec-8d50-de8f1df72fde" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_378be0b6-9edb-40dc-ade3-8136655f2458" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2342897b-cbce-4dbf-8701-23031312d83e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e4015315-11a0-45ec-8d50-de8f1df72fde" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2342897b-cbce-4dbf-8701-23031312d83e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e4015315-11a0-45ec-8d50-de8f1df72fde" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_2dcd840f-7258-4302-b2fd-b0788e372fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_2dcd840f-7258-4302-b2fd-b0788e372fdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1a4616ae-d994-4c13-a9dd-fd206c47c302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1a4616ae-d994-4c13-a9dd-fd206c47c302" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_caf1bf42-aab7-4e36-900e-89ec56f01c55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_caf1bf42-aab7-4e36-900e-89ec56f01c55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3f479c5f-210a-4e59-bddd-fef1b01795db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3f479c5f-210a-4e59-bddd-fef1b01795db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8ee87b27-0674-4888-932c-fb3479ce1df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8ee87b27-0674-4888-932c-fb3479ce1df6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_6385fbfa-cf0f-4bea-bba1-aa875af5bae8" xlink:href="mck-20211231.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_6385fbfa-cf0f-4bea-bba1-aa875af5bae8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f83d9b59-4e92-4208-bc0b-9978a5613cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_e4015315-11a0-45ec-8d50-de8f1df72fde" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f83d9b59-4e92-4208-bc0b-9978a5613cfb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3fc76d3a-3a13-4308-a34b-da1bdc7317bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f83d9b59-4e92-4208-bc0b-9978a5613cfb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3fc76d3a-3a13-4308-a34b-da1bdc7317bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3fc76d3a-3a13-4308-a34b-da1bdc7317bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3fc76d3a-3a13-4308-a34b-da1bdc7317bd" xlink:to="loc_us-gaap_SegmentDomain_3fc76d3a-3a13-4308-a34b-da1bdc7317bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0b58213d-6164-4a8b-af7d-bf6abfc3bf20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3fc76d3a-3a13-4308-a34b-da1bdc7317bd" xlink:to="loc_us-gaap_SegmentDomain_0b58213d-6164-4a8b-af7d-bf6abfc3bf20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_9c93c2b1-6369-43a3-8d09-2e6b68f9355a" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0b58213d-6164-4a8b-af7d-bf6abfc3bf20" xlink:to="loc_mck_InternationalSegmentMember_9c93c2b1-6369-43a3-8d09-2e6b68f9355a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_93b7a927-f4ad-446d-8b98-a8049f14f5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f83d9b59-4e92-4208-bc0b-9978a5613cfb" xlink:to="loc_us-gaap_ReportingUnitAxis_93b7a927-f4ad-446d-8b98-a8049f14f5f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_93b7a927-f4ad-446d-8b98-a8049f14f5f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_93b7a927-f4ad-446d-8b98-a8049f14f5f3" xlink:to="loc_us-gaap_ReportingUnitDomain_93b7a927-f4ad-446d-8b98-a8049f14f5f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_7a5d2fda-8c5a-4cb0-b2c3-ee6db9a0dd10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_93b7a927-f4ad-446d-8b98-a8049f14f5f3" xlink:to="loc_us-gaap_ReportingUnitDomain_7a5d2fda-8c5a-4cb0-b2c3-ee6db9a0dd10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_1df9a36c-f23e-4d82-ae5d-b4f92debab0b" xlink:href="mck-20211231.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_7a5d2fda-8c5a-4cb0-b2c3-ee6db9a0dd10" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_1df9a36c-f23e-4d82-ae5d-b4f92debab0b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended" id="ie527e0cba1e6446d8cb5ac957f86c238_GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_856d60a8-8455-44b5-99fa-80d53ea1f016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_27a9fc87-47d0-4c84-9a5c-71eb6f805b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_856d60a8-8455-44b5-99fa-80d53ea1f016" xlink:to="loc_us-gaap_GoodwillRollForward_27a9fc87-47d0-4c84-9a5c-71eb6f805b05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_087e0625-b70e-4fb4-bc33-c906b6179960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_27a9fc87-47d0-4c84-9a5c-71eb6f805b05" xlink:to="loc_us-gaap_Goodwill_087e0625-b70e-4fb4-bc33-c906b6179960" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_c404dfd9-9272-41ce-b3eb-ed2610ac2fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_27a9fc87-47d0-4c84-9a5c-71eb6f805b05" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_c404dfd9-9272-41ce-b3eb-ed2610ac2fbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_399a9c52-650e-4377-8ae8-a3ef538ffcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_27a9fc87-47d0-4c84-9a5c-71eb6f805b05" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_399a9c52-650e-4377-8ae8-a3ef538ffcd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c23e0003-cf1e-40df-a4a2-3007de9477e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_02beb4b7-12f2-4aa6-9cbb-fe196144bcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_856d60a8-8455-44b5-99fa-80d53ea1f016" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_02beb4b7-12f2-4aa6-9cbb-fe196144bcd7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2051fd05-d286-4b43-825b-dc1bb47ff30e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_02beb4b7-12f2-4aa6-9cbb-fe196144bcd7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2051fd05-d286-4b43-825b-dc1bb47ff30e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2051fd05-d286-4b43-825b-dc1bb47ff30e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2051fd05-d286-4b43-825b-dc1bb47ff30e" xlink:to="loc_us-gaap_SegmentDomain_2051fd05-d286-4b43-825b-dc1bb47ff30e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2051fd05-d286-4b43-825b-dc1bb47ff30e" xlink:to="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_683e7293-7350-415f-9551-3064775ee416" xlink:href="mck-20211231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:to="loc_mck_USPharmaceuticalSegmentMember_683e7293-7350-415f-9551-3064775ee416" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_0e8729f9-fdb6-41f2-aec8-7bee2a86a743" xlink:href="mck-20211231.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_0e8729f9-fdb6-41f2-aec8-7bee2a86a743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_29b67aa0-9f49-4459-87de-5802962051b3" xlink:href="mck-20211231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_29b67aa0-9f49-4459-87de-5802962051b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_ef601298-aee3-48b5-a08b-fcbf6f5a6fbe" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:to="loc_mck_InternationalSegmentMember_ef601298-aee3-48b5-a08b-fcbf6f5a6fbe" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended" id="i947c235b5ba946e69665d253894979f8_GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_574bd2a0-6a8d-42d8-bf8c-32eb715d0bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_574bd2a0-6a8d-42d8-bf8c-32eb715d0bce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_845383b5-3851-43ae-a1cf-5e814b78a77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_845383b5-3851-43ae-a1cf-5e814b78a77f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_75397f5f-8674-48ef-b250-a38fcb180579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_75397f5f-8674-48ef-b250-a38fcb180579" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_78e0b234-abb4-4bac-915a-2b646266d7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_78e0b234-abb4-4bac-915a-2b646266d7c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4449a71c-2931-4be6-b9e3-cb51703320a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4449a71c-2931-4be6-b9e3-cb51703320a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_22462bf8-b8a0-4676-94fb-8460fb22ce37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_22462bf8-b8a0-4676-94fb-8460fb22ce37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a810bdb-1e6d-4709-a4e5-a1b3be4e56d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_22462bf8-b8a0-4676-94fb-8460fb22ce37" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a810bdb-1e6d-4709-a4e5-a1b3be4e56d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7a810bdb-1e6d-4709-a4e5-a1b3be4e56d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a810bdb-1e6d-4709-a4e5-a1b3be4e56d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7a810bdb-1e6d-4709-a4e5-a1b3be4e56d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a810bdb-1e6d-4709-a4e5-a1b3be4e56d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_02d4a04a-4505-4a97-be7f-37111b6f0029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_us-gaap_CustomerRelationshipsMember_02d4a04a-4505-4a97-be7f-37111b6f0029" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_cd769d50-92d3-4dd1-a91f-37182bce9540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_us-gaap_ServiceAgreementsMember_cd769d50-92d3-4dd1-a91f-37182bce9540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember_0bf4a410-a774-4d76-b5e2-38d003218ed1" xlink:href="mck-20211231.xsd#mck_PharmacyLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_mck_PharmacyLicensesMember_0bf4a410-a774-4d76-b5e2-38d003218ed1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_1d814c58-14a5-414c-972a-aee56a9a2d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_1d814c58-14a5-414c-972a-aee56a9a2d0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0f9c92b1-d86e-4a9c-8540-ed7a41f4f7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0f9c92b1-d86e-4a9c-8540-ed7a41f4f7ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_4cb31071-fff0-4dbd-8bdb-e76ad53f5e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_4cb31071-fff0-4dbd-8bdb-e76ad53f5e7b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ccafcba-fc13-41da-ac9f-760a8084ce47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_22462bf8-b8a0-4676-94fb-8460fb22ce37" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ccafcba-fc13-41da-ac9f-760a8084ce47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1ccafcba-fc13-41da-ac9f-760a8084ce47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ccafcba-fc13-41da-ac9f-760a8084ce47" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1ccafcba-fc13-41da-ac9f-760a8084ce47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38d134e1-0c4b-42f6-b102-1ae547f471c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ccafcba-fc13-41da-ac9f-760a8084ce47" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38d134e1-0c4b-42f6-b102-1ae547f471c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanAssetsHeldForSaleMember_7c2cadd4-2082-42a8-9bac-fe19df102c50" xlink:href="mck-20211231.xsd#mck_EuropeanAssetsHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38d134e1-0c4b-42f6-b102-1ae547f471c8" xlink:to="loc_mck_EuropeanAssetsHeldForSaleMember_7c2cadd4-2082-42a8-9bac-fe19df102c50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8e810e90-51bf-4799-a6fe-0f6b5d5d5172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_22462bf8-b8a0-4676-94fb-8460fb22ce37" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8e810e90-51bf-4799-a6fe-0f6b5d5d5172" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8e810e90-51bf-4799-a6fe-0f6b5d5d5172_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8e810e90-51bf-4799-a6fe-0f6b5d5d5172" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8e810e90-51bf-4799-a6fe-0f6b5d5d5172_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_78aa1bd0-188b-483e-be18-0b66cdf3e514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8e810e90-51bf-4799-a6fe-0f6b5d5d5172" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_78aa1bd0-188b-483e-be18-0b66cdf3e514" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8965a2dd-4b83-48eb-b971-ae427a1dab31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_78aa1bd0-188b-483e-be18-0b66cdf3e514" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8965a2dd-4b83-48eb-b971-ae427a1dab31" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended" id="ib9567a8b8a4e4f52874119537a9c37ad_DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0d201e0-141b-4f52-bff8-1af0cd366faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0d201e0-141b-4f52-bff8-1af0cd366faf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b9e4bbf1-069a-4b4b-ab49-6f9a5c451afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_LongTermDebt_b9e4bbf1-069a-4b4b-ab49-6f9a5c451afc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_9def34d7-a212-40c6-b3ef-b1938b993974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_FinanceLeaseLiability_9def34d7-a212-40c6-b3ef-b1938b993974" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_4d9a13d9-cc49-4dcd-93ac-23300e55a257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_4d9a13d9-cc49-4dcd-93ac-23300e55a257" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_12d05770-5662-4ed5-ad2b-2fb5f3a5f9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_12d05770-5662-4ed5-ad2b-2fb5f3a5f9d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5bb2ed21-8cb1-46f7-9d58-ed66637903c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5bb2ed21-8cb1-46f7-9d58-ed66637903c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_7d6aedbc-04a5-4e48-842a-509fea6d1625" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_7d6aedbc-04a5-4e48-842a-509fea6d1625" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_3536028e-d388-419c-a2a5-9aed7e92bd03" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_3536028e-d388-419c-a2a5-9aed7e92bd03" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1b45f5ec-fb64-4027-b344-0eadb69dc47b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_DebtInstrumentTable_1b45f5ec-fb64-4027-b344-0eadb69dc47b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0354e33e-8400-4bba-8f16-0f8c4ba25924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1b45f5ec-fb64-4027-b344-0eadb69dc47b" xlink:to="loc_us-gaap_DebtInstrumentAxis_0354e33e-8400-4bba-8f16-0f8c4ba25924" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0354e33e-8400-4bba-8f16-0f8c4ba25924_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0354e33e-8400-4bba-8f16-0f8c4ba25924" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0354e33e-8400-4bba-8f16-0f8c4ba25924_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0354e33e-8400-4bba-8f16-0f8c4ba25924" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_f959a6ed-3148-4c01-bb73-1dffb4a7b4a2" xlink:href="mck-20211231.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A270NotesDueDecember152022Member_f959a6ed-3148-4c01-bb73-1dffb4a7b4a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_72db654c-75a9-4e1f-879e-f2c6d242fa31" xlink:href="mck-20211231.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A285NotesDueMarch152023Member_72db654c-75a9-4e1f-879e-f2c6d242fa31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_fecf9332-810b-42d6-a75b-4c35c6dac6ef" xlink:href="mck-20211231.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A380NotesDueMarch152024Member_fecf9332-810b-42d6-a75b-4c35c6dac6ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_3424e7ef-2824-4e91-8e34-27d17c165d83" xlink:href="mck-20211231.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A090NotesDueDecember32025Member_3424e7ef-2824-4e91-8e34-27d17c165d83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_89548c5d-f6b2-4497-a5ef-d0b7422521c8" xlink:href="mck-20211231.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A130NotesDueAugust152026Member_89548c5d-f6b2-4497-a5ef-d0b7422521c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_e8026aa4-bdba-41f5-a787-34a1ec9ce66b" xlink:href="mck-20211231.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_e8026aa4-bdba-41f5-a787-34a1ec9ce66b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_fda7df0f-3f02-48cd-8dda-62d714bc1779" xlink:href="mck-20211231.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A395NotesDueFebruary162028Member_fda7df0f-3f02-48cd-8dda-62d714bc1779" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_b0c6050f-3cf0-4bf2-8c32-1ca2a64c901d" xlink:href="mck-20211231.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A475NotesDueMay302029Member_b0c6050f-3cf0-4bf2-8c32-1ca2a64c901d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_4984b95c-49f0-4457-87f5-6f1b61d2242b" xlink:href="mck-20211231.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A600NotesDueMarch12041Member_4984b95c-49f0-4457-87f5-6f1b61d2242b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_b52c07a6-fdc3-4390-97e0-e9ecb5421a16" xlink:href="mck-20211231.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A488NotesDueMarch152044Member_b52c07a6-fdc3-4390-97e0-e9ecb5421a16" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_aa08729e-1c7c-416b-b1ed-69d023e5282c" xlink:href="mck-20211231.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_aa08729e-1c7c-416b-b1ed-69d023e5282c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_6ec97c0a-93bf-4394-964b-2b9e4bda7c6a" xlink:href="mck-20211231.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_6ec97c0a-93bf-4394-964b-2b9e4bda7c6a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_642858f6-1f19-404a-ada9-4e9327dbd364" xlink:href="mck-20211231.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_642858f6-1f19-404a-ada9-4e9327dbd364" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_699b1321-79a4-4d8c-8c3a-d88d62f58d18" xlink:href="mck-20211231.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_699b1321-79a4-4d8c-8c3a-d88d62f58d18" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3013c15c-aab2-4f6e-849b-ab42f2c70f82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1b45f5ec-fb64-4027-b344-0eadb69dc47b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3013c15c-aab2-4f6e-849b-ab42f2c70f82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3013c15c-aab2-4f6e-849b-ab42f2c70f82_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3013c15c-aab2-4f6e-849b-ab42f2c70f82" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3013c15c-aab2-4f6e-849b-ab42f2c70f82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e3e5ac04-7a67-4a17-ae5c-a99ba837ef69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3013c15c-aab2-4f6e-849b-ab42f2c70f82" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e3e5ac04-7a67-4a17-ae5c-a99ba837ef69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_5388114b-a2e9-405e-941d-fdd0f8af3dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e3e5ac04-7a67-4a17-ae5c-a99ba837ef69" xlink:to="loc_us-gaap_LoansPayableMember_5388114b-a2e9-405e-941d-fdd0f8af3dc9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended" id="i9df9f8b291ff4d9cb18ff87304b51abc_DebtandFinancingActivitiesLongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_c2a6f4aa-ed29-418e-b0db-594850f6da90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_c2a6f4aa-ed29-418e-b0db-594850f6da90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_44eab399-0719-46e6-82a0-79fb624299d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_44eab399-0719-46e6-82a0-79fb624299d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_37021fbc-c438-4126-a650-f0bf696915f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_37021fbc-c438-4126-a650-f0bf696915f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ca29a975-5b2d-43e0-a983-504b5fc57209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ca29a975-5b2d-43e0-a983-504b5fc57209" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_292916ed-3dc1-4561-a161-4142a7bc1c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_292916ed-3dc1-4561-a161-4142a7bc1c7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_99af542e-176f-4044-ae3f-d4031bdaa0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_99af542e-176f-4044-ae3f-d4031bdaa0e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_39bf6f3b-d69e-46ad-b3c6-2b909e91420f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_39bf6f3b-d69e-46ad-b3c6-2b909e91420f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_8925e1c4-765b-453c-94aa-c92cf7f1a576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_8925e1c4-765b-453c-94aa-c92cf7f1a576" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_d66df734-2de5-4a54-b1d9-98debda01318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_d66df734-2de5-4a54-b1d9-98debda01318" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_59fb54b7-370a-4235-8cc6-0aca1f9fdc20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_InterestPaid_59fb54b7-370a-4235-8cc6-0aca1f9fdc20" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_a1ac683c-52e3-41bb-bced-6d5ad2fac08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_a1ac683c-52e3-41bb-bced-6d5ad2fac08e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f6c275eb-951c-4108-bcfa-0296e32a83e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f6c275eb-951c-4108-bcfa-0296e32a83e6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_fb9f588e-457d-4e93-9c25-af477b7c632e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_fb9f588e-457d-4e93-9c25-af477b7c632e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_876c6317-94ea-483c-9d09-3859d07c803a" xlink:href="mck-20211231.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_876c6317-94ea-483c-9d09-3859d07c803a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ca4f017a-e779-44c0-b9b3-2111f97189fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentTable_ca4f017a-e779-44c0-b9b3-2111f97189fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d349ac4a-f4c6-4839-a3d1-e027c75f7e98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ca4f017a-e779-44c0-b9b3-2111f97189fa" xlink:to="loc_us-gaap_DebtInstrumentAxis_d349ac4a-f4c6-4839-a3d1-e027c75f7e98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d349ac4a-f4c6-4839-a3d1-e027c75f7e98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d349ac4a-f4c6-4839-a3d1-e027c75f7e98" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d349ac4a-f4c6-4839-a3d1-e027c75f7e98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d349ac4a-f4c6-4839-a3d1-e027c75f7e98" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_3425c43c-e8e8-490a-8555-c00c893ebb89" xlink:href="mck-20211231.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A130NotesDueAugust152026Member_3425c43c-e8e8-490a-8555-c00c893ebb89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_ba7b708c-37fc-4432-b64e-3f31b56f0d49" xlink:href="mck-20211231.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_ba7b708c-37fc-4432-b64e-3f31b56f0d49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_236ef004-4833-454f-b0b2-19dcac62152d" xlink:href="mck-20211231.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A285NotesDueMarch152023Member_236ef004-4833-454f-b0b2-19dcac62152d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_b37ac902-47f0-46f7-aa31-ee3f492bb805" xlink:href="mck-20211231.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A380NotesDueMarch152024Member_b37ac902-47f0-46f7-aa31-ee3f492bb805" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_fad8d41b-2506-48fa-9f8e-e54bf58ba5a3" xlink:href="mck-20211231.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_fad8d41b-2506-48fa-9f8e-e54bf58ba5a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_6911d03e-7963-49af-bb11-0119d79e5d0c" xlink:href="mck-20211231.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A395NotesDueFebruary162028Member_6911d03e-7963-49af-bb11-0119d79e5d0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_e5639d9c-9df5-4669-8e5b-335e2f5912f9" xlink:href="mck-20211231.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A475NotesDueMay302029Member_e5639d9c-9df5-4669-8e5b-335e2f5912f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_63296b48-1cc6-436b-bde3-ff6b4854be4e" xlink:href="mck-20211231.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A600NotesDueMarch12041Member_63296b48-1cc6-436b-bde3-ff6b4854be4e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_544aa890-18c2-4a93-8093-811627e6da27" xlink:href="mck-20211231.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A488NotesDueMarch152044Member_544aa890-18c2-4a93-8093-811627e6da27" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_4f4f7e3e-36c6-4dba-884b-f96942795903" xlink:href="mck-20211231.xsd#mck_TenderOfferNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_TenderOfferNotesMember_4f4f7e3e-36c6-4dba-884b-f96942795903" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_4611b3ba-b7aa-464a-a986-7fc21e8be7d7" xlink:href="mck-20211231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_4611b3ba-b7aa-464a-a986-7fc21e8be7d7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8bba442d-e787-4cf2-ac13-a9dca21f8751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ca4f017a-e779-44c0-b9b3-2111f97189fa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8bba442d-e787-4cf2-ac13-a9dca21f8751" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8bba442d-e787-4cf2-ac13-a9dca21f8751_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bba442d-e787-4cf2-ac13-a9dca21f8751" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8bba442d-e787-4cf2-ac13-a9dca21f8751_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_387ed89c-56e3-4c2a-b4c8-7db777440b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bba442d-e787-4cf2-ac13-a9dca21f8751" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_387ed89c-56e3-4c2a-b4c8-7db777440b84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_be239eeb-d501-47af-a072-21afac6db955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_387ed89c-56e3-4c2a-b4c8-7db777440b84" xlink:to="loc_us-gaap_LoansPayableMember_be239eeb-d501-47af-a072-21afac6db955" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_d3dab703-580e-4572-a186-847a24a00132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_387ed89c-56e3-4c2a-b4c8-7db777440b84" xlink:to="loc_us-gaap_UnsecuredDebtMember_d3dab703-580e-4572-a186-847a24a00132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0033a6db-0990-4964-a828-f3fdff18fef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ca4f017a-e779-44c0-b9b3-2111f97189fa" xlink:to="loc_us-gaap_CreditFacilityAxis_0033a6db-0990-4964-a828-f3fdff18fef0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0033a6db-0990-4964-a828-f3fdff18fef0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_0033a6db-0990-4964-a828-f3fdff18fef0" xlink:to="loc_us-gaap_CreditFacilityDomain_0033a6db-0990-4964-a828-f3fdff18fef0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_93bae83c-91e2-41c1-8555-14ad5e6ed372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_0033a6db-0990-4964-a828-f3fdff18fef0" xlink:to="loc_us-gaap_CreditFacilityDomain_93bae83c-91e2-41c1-8555-14ad5e6ed372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_34545665-330e-4bd1-9a34-3badfa5f0066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_93bae83c-91e2-41c1-8555-14ad5e6ed372" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_34545665-330e-4bd1-9a34-3badfa5f0066" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended" id="i38223786477d405f8ce2a440691d701c_DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7e37c487-9ee6-45fd-ad32-47935ec8c071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7e37c487-9ee6-45fd-ad32-47935ec8c071" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_f4ae7a4d-b88b-4437-b68a-c9ddf960992a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_DebtInstrumentTerm_f4ae7a4d-b88b-4437-b68a-c9ddf960992a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c5003b32-ec2c-4b57-9720-2eff7d932689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c5003b32-ec2c-4b57-9720-2eff7d932689" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ebd3e5f8-56a4-4e66-9c09-a2cb191e0232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_LineOfCredit_ebd3e5f8-56a4-4e66-9c09-a2cb191e0232" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_a04ab172-45be-4931-b294-d5622113631e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_a04ab172-45be-4931-b294-d5622113631e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_210168a5-30a7-4ac6-a064-457a010ff5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_210168a5-30a7-4ac6-a064-457a010ff5c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_d69d3dd0-0bb0-4010-899c-420ae9ba9574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_d69d3dd0-0bb0-4010-899c-420ae9ba9574" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_340c1cf3-a14c-443e-a3a2-abc7f722c7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_d69d3dd0-0bb0-4010-899c-420ae9ba9574" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_340c1cf3-a14c-443e-a3a2-abc7f722c7a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_340c1cf3-a14c-443e-a3a2-abc7f722c7a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_340c1cf3-a14c-443e-a3a2-abc7f722c7a9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_340c1cf3-a14c-443e-a3a2-abc7f722c7a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b014bb84-cce1-42a6-abc1-b7a3290051a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_340c1cf3-a14c-443e-a3a2-abc7f722c7a9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b014bb84-cce1-42a6-abc1-b7a3290051a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_d76a93fe-036a-4a44-afa7-b6b9c92a328a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b014bb84-cce1-42a6-abc1-b7a3290051a6" xlink:to="loc_us-gaap_UnsecuredDebtMember_d76a93fe-036a-4a44-afa7-b6b9c92a328a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f249f313-3824-4f86-9c38-0fdc85a1f962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_d69d3dd0-0bb0-4010-899c-420ae9ba9574" xlink:to="loc_us-gaap_CreditFacilityAxis_f249f313-3824-4f86-9c38-0fdc85a1f962" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f249f313-3824-4f86-9c38-0fdc85a1f962_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f249f313-3824-4f86-9c38-0fdc85a1f962" xlink:to="loc_us-gaap_CreditFacilityDomain_f249f313-3824-4f86-9c38-0fdc85a1f962_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_32e541bc-d672-4018-9b87-b0e0116975ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f249f313-3824-4f86-9c38-0fdc85a1f962" xlink:to="loc_us-gaap_CreditFacilityDomain_32e541bc-d672-4018-9b87-b0e0116975ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3eea7a63-dff6-4422-b8ae-9dd32fefdde8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_32e541bc-d672-4018-9b87-b0e0116975ca" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3eea7a63-dff6-4422-b8ae-9dd32fefdde8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_41296c3b-9216-4998-a637-f94ff679e8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_32e541bc-d672-4018-9b87-b0e0116975ca" xlink:to="loc_us-gaap_LineOfCreditMember_41296c3b-9216-4998-a637-f94ff679e8f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_80315dde-2ee8-4871-b16e-70718af28add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_d69d3dd0-0bb0-4010-899c-420ae9ba9574" xlink:to="loc_us-gaap_DebtInstrumentAxis_80315dde-2ee8-4871-b16e-70718af28add" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_80315dde-2ee8-4871-b16e-70718af28add_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_80315dde-2ee8-4871-b16e-70718af28add" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_80315dde-2ee8-4871-b16e-70718af28add_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ab49cf78-c602-4e05-a8e3-002580e2d38e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_80315dde-2ee8-4871-b16e-70718af28add" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ab49cf78-c602-4e05-a8e3-002580e2d38e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_6e9b2f05-8752-4d07-92ff-c5b358fad9bc" xlink:href="mck-20211231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ab49cf78-c602-4e05-a8e3-002580e2d38e" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_6e9b2f05-8752-4d07-92ff-c5b358fad9bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_1750a99a-ec0c-4c9e-a909-9f9c7c32019f" xlink:href="mck-20211231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ab49cf78-c602-4e05-a8e3-002580e2d38e" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_1750a99a-ec0c-4c9e-a909-9f9c7c32019f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended" id="i51bd84aed9fd4032828f516c6247669b_DebtandFinancingActivitiesCommercialPaperDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b4b62990-2d1c-409e-81e7-4ad54cf1ac0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b4b62990-2d1c-409e-81e7-4ad54cf1ac0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_59a5592c-2ab6-4769-b408-1bfb24b292dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_59a5592c-2ab6-4769-b408-1bfb24b292dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_b08992f5-8757-4932-b4c6-5fe10ee14718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_b08992f5-8757-4932-b4c6-5fe10ee14718" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_b5a1e76e-cfd3-41de-8d95-1d5a6303b026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_b5a1e76e-cfd3-41de-8d95-1d5a6303b026" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_ab75a261-034b-49ef-b0b8-435ad609fbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_ab75a261-034b-49ef-b0b8-435ad609fbb2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_92be716e-eae1-4249-8159-edd14b9e94c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:to="loc_us-gaap_DebtInstrumentTable_92be716e-eae1-4249-8159-edd14b9e94c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7bf9024c-0dfd-4225-8186-d73930ac3c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_92be716e-eae1-4249-8159-edd14b9e94c3" xlink:to="loc_us-gaap_CreditFacilityAxis_7bf9024c-0dfd-4225-8186-d73930ac3c73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7bf9024c-0dfd-4225-8186-d73930ac3c73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_7bf9024c-0dfd-4225-8186-d73930ac3c73" xlink:to="loc_us-gaap_CreditFacilityDomain_7bf9024c-0dfd-4225-8186-d73930ac3c73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9affcc26-f22b-4cb2-a21d-43af7a101370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_7bf9024c-0dfd-4225-8186-d73930ac3c73" xlink:to="loc_us-gaap_CreditFacilityDomain_9affcc26-f22b-4cb2-a21d-43af7a101370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_108d3618-679a-4a31-9d9a-447d77f7d2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9affcc26-f22b-4cb2-a21d-43af7a101370" xlink:to="loc_us-gaap_CommercialPaperMember_108d3618-679a-4a31-9d9a-447d77f7d2dd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#PensionBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended" id="i1057cb5acc4f487cb6ad9704e2249f61_PensionBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b9a3415a-7cc3-47b2-bc08-30c1907611d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b9a3415a-7cc3-47b2-bc08-30c1907611d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d749aef7-6d5a-49fc-800e-882ac059409e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d749aef7-6d5a-49fc-800e-882ac059409e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_98559698-1d4e-460d-8ae8-51ac3d780e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_98559698-1d4e-460d-8ae8-51ac3d780e08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_65570d71-5aff-4ce5-b8b2-d7989fbabb7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_65570d71-5aff-4ce5-b8b2-d7989fbabb7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_14d088de-9329-4533-8d12-1c658456d2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_14d088de-9329-4533-8d12-1c658456d2f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a3011d94-710c-4544-b4db-fb69c1766025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a3011d94-710c-4544-b4db-fb69c1766025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a3011d94-710c-4544-b4db-fb69c1766025_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a3011d94-710c-4544-b4db-fb69c1766025" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a3011d94-710c-4544-b4db-fb69c1766025_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_74828503-5781-492c-8cba-63986fd562e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a3011d94-710c-4544-b4db-fb69c1766025" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_74828503-5781-492c-8cba-63986fd562e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_36c760fa-8706-40b9-af18-ef38774ce674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_74828503-5781-492c-8cba-63986fd562e9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_36c760fa-8706-40b9-af18-ef38774ce674" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2728649e-3284-4110-bdad-cee5cbffef12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2728649e-3284-4110-bdad-cee5cbffef12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2728649e-3284-4110-bdad-cee5cbffef12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2728649e-3284-4110-bdad-cee5cbffef12" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2728649e-3284-4110-bdad-cee5cbffef12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_352d1fbe-7217-4e9a-ba3c-f16caea6d859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2728649e-3284-4110-bdad-cee5cbffef12" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_352d1fbe-7217-4e9a-ba3c-f16caea6d859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f092f321-8d01-41e9-b772-90916a3c25c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_352d1fbe-7217-4e9a-ba3c-f16caea6d859" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f092f321-8d01-41e9-b772-90916a3c25c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4854789e-56fc-46a3-8d97-da94b3887c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4854789e-56fc-46a3-8d97-da94b3887c3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4854789e-56fc-46a3-8d97-da94b3887c3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4854789e-56fc-46a3-8d97-da94b3887c3b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4854789e-56fc-46a3-8d97-da94b3887c3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cea1c75e-3ac0-45a7-a8f6-d2aebd6ba5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4854789e-56fc-46a3-8d97-da94b3887c3b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cea1c75e-3ac0-45a7-a8f6-d2aebd6ba5b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_7735c005-101e-48dd-bad2-5b725a94d87d" xlink:href="mck-20211231.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cea1c75e-3ac0-45a7-a8f6-d2aebd6ba5b4" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_7735c005-101e-48dd-bad2-5b725a94d87d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_bae217bd-a262-46de-b2f5-412eb0a531e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:to="loc_us-gaap_RetirementPlanNameAxis_bae217bd-a262-46de-b2f5-412eb0a531e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_bae217bd-a262-46de-b2f5-412eb0a531e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_bae217bd-a262-46de-b2f5-412eb0a531e1" xlink:to="loc_us-gaap_RetirementPlanNameDomain_bae217bd-a262-46de-b2f5-412eb0a531e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_114d1d11-5b14-4c64-904a-5edccacc0705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_bae217bd-a262-46de-b2f5-412eb0a531e1" xlink:to="loc_us-gaap_RetirementPlanNameDomain_114d1d11-5b14-4c64-904a-5edccacc0705" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKPensionPlanMember_7d97477b-5446-41a0-99e7-38c08e657c46" xlink:href="mck-20211231.xsd#mck_UKPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_114d1d11-5b14-4c64-904a-5edccacc0705" xlink:to="loc_mck_UKPensionPlanMember_7d97477b-5446-41a0-99e7-38c08e657c46" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended" id="i5ed3281f7e8d4af4b636f924a21af650_HedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_85b648bb-da30-472d-8029-c3514afcdb72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_LongTermDebt_85b648bb-da30-472d-8029-c3514afcdb72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_abb6e780-f5aa-44cb-ad51-0b1a30fb329a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_abb6e780-f5aa-44cb-ad51-0b1a30fb329a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f8ae460a-d684-4986-8900-fd6c14489e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f8ae460a-d684-4986-8900-fd6c14489e6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_afbb887e-6c98-4352-a3de-7e471342cf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_afbb887e-6c98-4352-a3de-7e471342cf1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_eddfc5cf-4b9b-42aa-b530-f55061867f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_DebtInstrumentTerm_eddfc5cf-4b9b-42aa-b530-f55061867f5f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_9fb90ae6-f58d-4bf9-b005-5273d40b2d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_9fb90ae6-f58d-4bf9-b005-5273d40b2d1e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cd56cb5c-8420-405a-8b73-00bcabe37f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:to="loc_us-gaap_DebtInstrumentAxis_cd56cb5c-8420-405a-8b73-00bcabe37f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cd56cb5c-8420-405a-8b73-00bcabe37f71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd56cb5c-8420-405a-8b73-00bcabe37f71" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cd56cb5c-8420-405a-8b73-00bcabe37f71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5eedaa08-8823-47fd-8c75-7a48c5693efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd56cb5c-8420-405a-8b73-00bcabe37f71" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5eedaa08-8823-47fd-8c75-7a48c5693efd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_d7af727b-6fc8-4af2-8f02-4f5584354bef" xlink:href="mck-20211231.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5eedaa08-8823-47fd-8c75-7a48c5693efd" xlink:to="loc_mck_EuroDenominatedNotesMember_d7af727b-6fc8-4af2-8f02-4f5584354bef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_68a26794-9bf5-47e5-a637-a014e7888ede" xlink:href="mck-20211231.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5eedaa08-8823-47fd-8c75-7a48c5693efd" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_68a26794-9bf5-47e5-a637-a014e7888ede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2025NotesMember_40086de2-1705-41dd-827a-5fe23824c95d" xlink:href="mck-20211231.xsd#mck_A2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5eedaa08-8823-47fd-8c75-7a48c5693efd" xlink:to="loc_mck_A2025NotesMember_40086de2-1705-41dd-827a-5fe23824c95d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b5716556-10fc-4e09-a220-091dcdf16206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b5716556-10fc-4e09-a220-091dcdf16206" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b5716556-10fc-4e09-a220-091dcdf16206_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b5716556-10fc-4e09-a220-091dcdf16206" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b5716556-10fc-4e09-a220-091dcdf16206_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_317606b0-2e79-4126-bcc5-0861c904e29a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b5716556-10fc-4e09-a220-091dcdf16206" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_317606b0-2e79-4126-bcc5-0861c904e29a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_6f523aef-a1ac-4d73-9733-746baf96c013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_317606b0-2e79-4126-bcc5-0861c904e29a" xlink:to="loc_us-gaap_LoansPayableMember_6f523aef-a1ac-4d73-9733-746baf96c013" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c34a9ceb-0878-4850-b9a6-91ecd9e614f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c34a9ceb-0878-4850-b9a6-91ecd9e614f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c34a9ceb-0878-4850-b9a6-91ecd9e614f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c34a9ceb-0878-4850-b9a6-91ecd9e614f6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c34a9ceb-0878-4850-b9a6-91ecd9e614f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a7a304d7-4044-4589-a14e-45c75a6a5f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c34a9ceb-0878-4850-b9a6-91ecd9e614f6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a7a304d7-4044-4589-a14e-45c75a6a5f74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_0353aee4-cb94-42d2-8b17-a6e06523ca18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a7a304d7-4044-4589-a14e-45c75a6a5f74" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_0353aee4-cb94-42d2-8b17-a6e06523ca18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_9a5c6e2a-72ca-49fb-a1ae-ab89a37b3093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a7a304d7-4044-4589-a14e-45c75a6a5f74" xlink:to="loc_us-gaap_CashFlowHedgingMember_9a5c6e2a-72ca-49fb-a1ae-ab89a37b3093" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_057bf350-6bf1-4839-a6eb-4fc8e4e4b6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_057bf350-6bf1-4839-a6eb-4fc8e4e4b6d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_057bf350-6bf1-4839-a6eb-4fc8e4e4b6d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_057bf350-6bf1-4839-a6eb-4fc8e4e4b6d3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_057bf350-6bf1-4839-a6eb-4fc8e4e4b6d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_057bf350-6bf1-4839-a6eb-4fc8e4e4b6d3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_90c5de3c-c897-4523-92e9-1fe0209dfeab" xlink:href="mck-20211231.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_90c5de3c-c897-4523-92e9-1fe0209dfeab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_fe7e2b9a-9882-4a3c-bb76-49ba73bf1717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:to="loc_us-gaap_CurrencySwapMember_fe7e2b9a-9882-4a3c-bb76-49ba73bf1717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3b7f360a-1656-455e-aa2a-ead28e7ed7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:to="loc_us-gaap_InterestRateSwapMember_3b7f360a-1656-455e-aa2a-ead28e7ed7fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_dc6a3c33-0716-4012-b6f5-efb3f03a706f" xlink:href="mck-20211231.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:to="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_dc6a3c33-0716-4012-b6f5-efb3f03a706f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5fae1037-0cbc-4486-a56f-df62bf2b43b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:to="loc_us-gaap_HedgingDesignationAxis_5fae1037-0cbc-4486-a56f-df62bf2b43b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5fae1037-0cbc-4486-a56f-df62bf2b43b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5fae1037-0cbc-4486-a56f-df62bf2b43b2" xlink:to="loc_us-gaap_HedgingDesignationDomain_5fae1037-0cbc-4486-a56f-df62bf2b43b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b787f677-093d-40f1-a726-9673e9dbb400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5fae1037-0cbc-4486-a56f-df62bf2b43b2" xlink:to="loc_us-gaap_HedgingDesignationDomain_b787f677-093d-40f1-a726-9673e9dbb400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4f7c53a6-5fd3-46a8-bd01-b1cb71816cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b787f677-093d-40f1-a726-9673e9dbb400" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4f7c53a6-5fd3-46a8-bd01-b1cb71816cba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_a2e2cf38-3694-41d4-ac12-e6aacd89b5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b787f677-093d-40f1-a726-9673e9dbb400" xlink:to="loc_us-gaap_NondesignatedMember_a2e2cf38-3694-41d4-ac12-e6aacd89b5a0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#HedgingActivitiesDerivativeInstrumentsFairValueDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="extended" id="i62f972f1323243cea4fcc2e0ab85f6c9_HedgingActivitiesDerivativeInstrumentsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_70c09662-5450-4171-893d-26ae4fdfa5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_70c09662-5450-4171-893d-26ae4fdfa5bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_2f278ec2-bc26-407e-a10b-b93b0fecc602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_2f278ec2-bc26-407e-a10b-b93b0fecc602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_52de094f-25a3-4980-bb48-a444801edefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_52de094f-25a3-4980-bb48-a444801edefa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_ef6a7fe6-062f-468f-a201-ba436f7b2d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_ef6a7fe6-062f-468f-a201-ba436f7b2d3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4ff588d4-40e4-43f9-a5ae-ad7ac9251ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4ff588d4-40e4-43f9-a5ae-ad7ac9251ac2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d153089a-a990-4599-9036-0dd73d340374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4ff588d4-40e4-43f9-a5ae-ad7ac9251ac2" xlink:to="loc_us-gaap_HedgingDesignationAxis_d153089a-a990-4599-9036-0dd73d340374" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d153089a-a990-4599-9036-0dd73d340374_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d153089a-a990-4599-9036-0dd73d340374" xlink:to="loc_us-gaap_HedgingDesignationDomain_d153089a-a990-4599-9036-0dd73d340374_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_78e1e171-c9c4-443d-aa52-dfbbaba363de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d153089a-a990-4599-9036-0dd73d340374" xlink:to="loc_us-gaap_HedgingDesignationDomain_78e1e171-c9c4-443d-aa52-dfbbaba363de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_567bb6e8-ef33-41bd-8147-6e8022963c80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_78e1e171-c9c4-443d-aa52-dfbbaba363de" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_567bb6e8-ef33-41bd-8147-6e8022963c80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_6f977c4d-5d3c-4b8e-a624-252544030876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_78e1e171-c9c4-443d-aa52-dfbbaba363de" xlink:to="loc_us-gaap_NondesignatedMember_6f977c4d-5d3c-4b8e-a624-252544030876" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_44a28d74-b8f7-4b78-82e4-157c0527e993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4ff588d4-40e4-43f9-a5ae-ad7ac9251ac2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_44a28d74-b8f7-4b78-82e4-157c0527e993" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_44a28d74-b8f7-4b78-82e4-157c0527e993_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_44a28d74-b8f7-4b78-82e4-157c0527e993" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_44a28d74-b8f7-4b78-82e4-157c0527e993_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_167d6a51-1487-48dd-a76a-5d04e8632dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_44a28d74-b8f7-4b78-82e4-157c0527e993" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_167d6a51-1487-48dd-a76a-5d04e8632dad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_10df55dd-a3dd-4f5d-9464-110931047746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_167d6a51-1487-48dd-a76a-5d04e8632dad" xlink:to="loc_us-gaap_CurrencySwapMember_10df55dd-a3dd-4f5d-9464-110931047746" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8c2c2099-41bd-4998-a5a3-3b09d968baf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_167d6a51-1487-48dd-a76a-5d04e8632dad" xlink:to="loc_us-gaap_InterestRateSwapMember_8c2c2099-41bd-4998-a5a3-3b09d968baf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f334c5fe-24a9-4da9-9193-025cf7a9622c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_167d6a51-1487-48dd-a76a-5d04e8632dad" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f334c5fe-24a9-4da9-9193-025cf7a9622c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_45eef8af-501a-4f3d-abdf-65ecd4540d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4ff588d4-40e4-43f9-a5ae-ad7ac9251ac2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_45eef8af-501a-4f3d-abdf-65ecd4540d4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_45eef8af-501a-4f3d-abdf-65ecd4540d4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_45eef8af-501a-4f3d-abdf-65ecd4540d4d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_45eef8af-501a-4f3d-abdf-65ecd4540d4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_45eef8af-501a-4f3d-abdf-65ecd4540d4d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_8587c886-6f13-42fc-b810-2572075a4c63" xlink:href="mck-20211231.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:to="loc_mck_CurrentAssetLiabilityMember_8587c886-6f13-42fc-b810-2572075a4c63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember_9a900291-e6f1-4ef3-b31d-1261dd0f92ba" xlink:href="mck-20211231.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:to="loc_mck_NoncurrentAssetLiabilityMember_9a900291-e6f1-4ef3-b31d-1261dd0f92ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAccruedLiabilitiesMember_b783237e-bd94-4552-933e-b4e08b341c79" xlink:href="mck-20211231.xsd#mck_OtherAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:to="loc_mck_OtherAccruedLiabilitiesMember_b783237e-bd94-4552-933e-b4e08b341c79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_31250e34-10c2-4217-ac67-917744e12bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_31250e34-10c2-4217-ac67-917744e12bf4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i8baafb8c8b3343518e2c3156edf973aa_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ad23002a-4c90-44fd-9d1f-5957eb12006b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ad23002a-4c90-44fd-9d1f-5957eb12006b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_020d6afd-9b75-49a1-ad8e-f7daaf35e524" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_020d6afd-9b75-49a1-ad8e-f7daaf35e524" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_7b2bbbce-9ce6-45d1-84a8-5ba4ecc32edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_7b2bbbce-9ce6-45d1-84a8-5ba4ecc32edd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_8f5483cf-f5c9-48b6-981f-1535bca18a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_8f5483cf-f5c9-48b6-981f-1535bca18a30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_3809b992-e6b1-4bfe-bcb5-0484b184b8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:to="loc_us-gaap_RestrictedCash_3809b992-e6b1-4bfe-bcb5-0484b184b8d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98b27f64-59c0-41bc-98b9-1387a1910a11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98b27f64-59c0-41bc-98b9-1387a1910a11" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2811ddce-b92d-44bc-bcb0-93617930c4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98b27f64-59c0-41bc-98b9-1387a1910a11" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2811ddce-b92d-44bc-bcb0-93617930c4ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2811ddce-b92d-44bc-bcb0-93617930c4ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2811ddce-b92d-44bc-bcb0-93617930c4ed" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2811ddce-b92d-44bc-bcb0-93617930c4ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6516dba6-5b8a-447d-a79a-a23db78dc097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2811ddce-b92d-44bc-bcb0-93617930c4ed" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6516dba6-5b8a-447d-a79a-a23db78dc097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_92413948-d443-4909-8be3-2ffc3c65d9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6516dba6-5b8a-447d-a79a-a23db78dc097" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_92413948-d443-4909-8be3-2ffc3c65d9e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e502c417-7cae-4736-b54a-32d7fde223bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98b27f64-59c0-41bc-98b9-1387a1910a11" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e502c417-7cae-4736-b54a-32d7fde223bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e502c417-7cae-4736-b54a-32d7fde223bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e502c417-7cae-4736-b54a-32d7fde223bb" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e502c417-7cae-4736-b54a-32d7fde223bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6160fa9-4635-4170-b52a-da8bcd440ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e502c417-7cae-4736-b54a-32d7fde223bb" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6160fa9-4635-4170-b52a-da8bcd440ae6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_be682ab8-7427-481f-930d-77b1302fbaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6160fa9-4635-4170-b52a-da8bcd440ae6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_be682ab8-7427-481f-930d-77b1302fbaa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f4926bcc-f6e6-44f4-86aa-8c357f754778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6160fa9-4635-4170-b52a-da8bcd440ae6" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f4926bcc-f6e6-44f4-86aa-8c357f754778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4bb8313f-93db-4282-b34f-7ef2a4270375" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98b27f64-59c0-41bc-98b9-1387a1910a11" xlink:to="loc_srt_LitigationCaseAxis_4bb8313f-93db-4282-b34f-7ef2a4270375" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_4bb8313f-93db-4282-b34f-7ef2a4270375_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_4bb8313f-93db-4282-b34f-7ef2a4270375" xlink:to="loc_srt_LitigationCaseTypeDomain_4bb8313f-93db-4282-b34f-7ef2a4270375_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ee59fa5c-c786-4f1e-888d-e4181b948829" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_4bb8313f-93db-4282-b34f-7ef2a4270375" xlink:to="loc_srt_LitigationCaseTypeDomain_ee59fa5c-c786-4f1e-888d-e4181b948829" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_24c9c4ba-0476-4db1-b41d-f1d1c5e75d17" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ee59fa5c-c786-4f1e-888d-e4181b948829" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_24c9c4ba-0476-4db1-b41d-f1d1c5e75d17" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="extended" id="ia0943b4b62594f8eafdeb24181e127a5_FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_16c92d30-2e23-435c-8eac-c7d9b45df323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e524f68d-b742-4b03-922a-6e5a4bd6bbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_16c92d30-2e23-435c-8eac-c7d9b45df323" xlink:to="loc_us-gaap_LongTermDebt_e524f68d-b742-4b03-922a-6e5a4bd6bbdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d4d49518-8dba-4d3f-b98d-76949b769c70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_16c92d30-2e23-435c-8eac-c7d9b45df323" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d4d49518-8dba-4d3f-b98d-76949b769c70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0752650b-f3e2-4c3d-8c9a-4001fa6cf3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_16c92d30-2e23-435c-8eac-c7d9b45df323" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0752650b-f3e2-4c3d-8c9a-4001fa6cf3dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d05302b-cdf7-45c7-90a7-c686a2d1a29f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0752650b-f3e2-4c3d-8c9a-4001fa6cf3dc" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d05302b-cdf7-45c7-90a7-c686a2d1a29f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d05302b-cdf7-45c7-90a7-c686a2d1a29f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d05302b-cdf7-45c7-90a7-c686a2d1a29f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d05302b-cdf7-45c7-90a7-c686a2d1a29f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e5a6cac-2f4a-4292-ae42-3fa666a90dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d05302b-cdf7-45c7-90a7-c686a2d1a29f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e5a6cac-2f4a-4292-ae42-3fa666a90dda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_577d143a-9645-476f-a236-677bc4028f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e5a6cac-2f4a-4292-ae42-3fa666a90dda" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_577d143a-9645-476f-a236-677bc4028f8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7e77140a-c9a1-4f02-8c3f-d2ded1d3f91c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0752650b-f3e2-4c3d-8c9a-4001fa6cf3dc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7e77140a-c9a1-4f02-8c3f-d2ded1d3f91c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e77140a-c9a1-4f02-8c3f-d2ded1d3f91c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7e77140a-c9a1-4f02-8c3f-d2ded1d3f91c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e77140a-c9a1-4f02-8c3f-d2ded1d3f91c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc2ddfcd-516b-4f02-b37f-50a6e2b1462a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7e77140a-c9a1-4f02-8c3f-d2ded1d3f91c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc2ddfcd-516b-4f02-b37f-50a6e2b1462a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1e5127d3-e66b-4414-9c4f-7b530f3fd0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc2ddfcd-516b-4f02-b37f-50a6e2b1462a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1e5127d3-e66b-4414-9c4f-7b530f3fd0b3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended" id="i60bd91cd56714211a777dc29098d387f_CommitmentsandContingentLiabilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_484a0979-7cdc-4158-acda-09499e746581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_484a0979-7cdc-4158-acda-09499e746581" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_27bbd90f-7e83-4449-a8a5-5a697212518d" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberofStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberofStates_27bbd90f-7e83-4449-a8a5-5a697212518d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals_ed48bdc9-33bf-435d-afcb-a4e44d2900d5" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberofStateAttorneyGenerals_ed48bdc9-33bf-435d-afcb-a4e44d2900d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_54d37d64-a5e7-4c14-9abb-56dcaf3776d5" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_54d37d64-a5e7-4c14-9abb-56dcaf3776d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_b618a7ea-f1aa-4d76-9c41-b33226bedd17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_b618a7ea-f1aa-4d76-9c41-b33226bedd17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_c99467a1-162c-462f-8526-1eaa529d5698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_c99467a1-162c-462f-8526-1eaa529d5698" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_bf1f6f3f-9dfd-4899-91d5-2753275f7923" xlink:href="mck-20211231.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_bf1f6f3f-9dfd-4899-91d5-2753275f7923" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_4e067b96-a900-46a3-8517-a844a79dbf45" xlink:href="mck-20211231.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_4e067b96-a900-46a3-8517-a844a79dbf45" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_8d01af86-79f5-4a45-b5cc-1f495c554029" xlink:href="mck-20211231.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_8d01af86-79f5-4a45-b5cc-1f495c554029" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates_e7583010-d363-4672-9bd1-ce88185d6be1" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfEligibleStates_e7583010-d363-4672-9bd1-ce88185d6be1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfTerritories_307b1e58-cbeb-4796-856a-bbedcdae8c81" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfTerritories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfTerritories_307b1e58-cbeb-4796-856a-bbedcdae8c81" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_fd1b8bb7-b787-425d-83b0-6a7cfea28fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_fd1b8bb7-b787-425d-83b0-6a7cfea28fb2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementPaymentTerms_99c18124-3717-4c85-966f-ef7a5890555f" xlink:href="mck-20211231.xsd#mck_LossContingencySettlementPaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencySettlementPaymentTerms_99c18124-3717-4c85-966f-ef7a5890555f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_2903cd2f-6b51-404b-8a49-a5ed1ee21232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_2903cd2f-6b51-404b-8a49-a5ed1ee21232" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_77ba336d-00f7-42d0-9b39-1fd30491d6cf" xlink:href="mck-20211231.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_77ba336d-00f7-42d0-9b39-1fd30491d6cf" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7c2ea2e-442a-440c-9480-8380b37ec546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7c2ea2e-442a-440c-9480-8380b37ec546" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfInvestmentFundsThatFiledClaims_69f191e6-7a30-4d38-831a-5199aa666d64" xlink:href="mck-20211231.xsd#mck_NumberOfInvestmentFundsThatFiledClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_NumberOfInvestmentFundsThatFiledClaims_69f191e6-7a30-4d38-831a-5199aa666d64" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfRelators_2c1aaebf-69dc-4808-b73d-c160670c03ae" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfRelators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfRelators_2c1aaebf-69dc-4808-b73d-c160670c03ae" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfAdditionalDefendants_79aa75bc-2125-4b19-a642-775ca251f802" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfAdditionalDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfAdditionalDefendants_79aa75bc-2125-4b19-a642-775ca251f802" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_82ec5be2-610d-4110-ad33-67d2b13bd07f" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfStatesFiledOnBehalfOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_82ec5be2-610d-4110-ad33-67d2b13bd07f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ee64f7e0-bd1d-4904-a3e2-dd0c7b826b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_us-gaap_LitigationStatusAxis_ee64f7e0-bd1d-4904-a3e2-dd0c7b826b93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_ee64f7e0-bd1d-4904-a3e2-dd0c7b826b93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_ee64f7e0-bd1d-4904-a3e2-dd0c7b826b93" xlink:to="loc_us-gaap_LitigationStatusDomain_ee64f7e0-bd1d-4904-a3e2-dd0c7b826b93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_1d1a457f-9999-48bb-ab9f-836849eae5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_ee64f7e0-bd1d-4904-a3e2-dd0c7b826b93" xlink:to="loc_us-gaap_LitigationStatusDomain_1d1a457f-9999-48bb-ab9f-836849eae5b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_31a97602-ca45-4449-ae6a-7ce3f8e9770d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_1d1a457f-9999-48bb-ab9f-836849eae5b1" xlink:to="loc_us-gaap_PendingLitigationMember_31a97602-ca45-4449-ae6a-7ce3f8e9770d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b48c5aee-b21b-469b-a120-c2d5812c8761" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_dei_LegalEntityAxis_b48c5aee-b21b-469b-a120-c2d5812c8761" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b48c5aee-b21b-469b-a120-c2d5812c8761_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b48c5aee-b21b-469b-a120-c2d5812c8761" xlink:to="loc_dei_EntityDomain_b48c5aee-b21b-469b-a120-c2d5812c8761_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_86e222df-699e-4b3a-8537-e87c6453dc3e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b48c5aee-b21b-469b-a120-c2d5812c8761" xlink:to="loc_dei_EntityDomain_86e222df-699e-4b3a-8537-e87c6453dc3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_f9f9b339-bc99-4258-80a0-2966056e47fe" xlink:href="mck-20211231.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_86e222df-699e-4b3a-8537-e87c6453dc3e" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_f9f9b339-bc99-4258-80a0-2966056e47fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_06e0d832-0d16-4d2e-bed8-4341d8f5f41d" xlink:href="mck-20211231.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_86e222df-699e-4b3a-8537-e87c6453dc3e" xlink:to="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_06e0d832-0d16-4d2e-bed8-4341d8f5f41d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7546338e-562a-4f12-9ed4-84a1d97390ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_srt_StatementGeographicalAxis_7546338e-562a-4f12-9ed4-84a1d97390ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7546338e-562a-4f12-9ed4-84a1d97390ef_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_7546338e-562a-4f12-9ed4-84a1d97390ef" xlink:to="loc_srt_SegmentGeographicalDomain_7546338e-562a-4f12-9ed4-84a1d97390ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cc020db4-16ea-4d36-a44a-c46970024745" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_7546338e-562a-4f12-9ed4-84a1d97390ef" xlink:to="loc_srt_SegmentGeographicalDomain_cc020db4-16ea-4d36-a44a-c46970024745" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_ad19130a-8cb3-408e-881d-384e4167917a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cc020db4-16ea-4d36-a44a-c46970024745" xlink:to="loc_country_CA_ad19130a-8cb3-408e-881d-384e4167917a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_c6ba03b7-d8f7-4e66-9cfb-d2491b7ba6eb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_srt_LitigationCaseAxis_c6ba03b7-d8f7-4e66-9cfb-d2491b7ba6eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c6ba03b7-d8f7-4e66-9cfb-d2491b7ba6eb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_c6ba03b7-d8f7-4e66-9cfb-d2491b7ba6eb" xlink:to="loc_srt_LitigationCaseTypeDomain_c6ba03b7-d8f7-4e66-9cfb-d2491b7ba6eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_adf4c4da-45a7-45fd-9556-a54a513b9cb1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_c6ba03b7-d8f7-4e66-9cfb-d2491b7ba6eb" xlink:to="loc_srt_LitigationCaseTypeDomain_adf4c4da-45a7-45fd-9556-a54a513b9cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_41541b74-96e3-4490-8285-af46833ff171" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_adf4c4da-45a7-45fd-9556-a54a513b9cb1" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_41541b74-96e3-4490-8285-af46833ff171" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_68a06924-c53d-4103-862b-f36c330e60ed" xlink:href="mck-20211231.xsd#mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_adf4c4da-45a7-45fd-9556-a54a513b9cb1" xlink:to="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_68a06924-c53d-4103-862b-f36c330e60ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_17da07ca-d177-4d8a-b1e6-dc3368552282" xlink:href="mck-20211231.xsd#mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_adf4c4da-45a7-45fd-9556-a54a513b9cb1" xlink:to="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_17da07ca-d177-4d8a-b1e6-dc3368552282" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_feab5956-65d3-44e7-a28b-ce92b9cf79c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_feab5956-65d3-44e7-a28b-ce92b9cf79c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_feab5956-65d3-44e7-a28b-ce92b9cf79c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_feab5956-65d3-44e7-a28b-ce92b9cf79c5" xlink:to="loc_us-gaap_LossContingencyNatureDomain_feab5956-65d3-44e7-a28b-ce92b9cf79c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0c7049fc-8062-4535-a129-da423cba49eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_feab5956-65d3-44e7-a28b-ce92b9cf79c5" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0c7049fc-8062-4535-a129-da423cba49eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_d32de0a1-295c-49ca-9594-c81d3ebd4469" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0c7049fc-8062-4535-a129-da423cba49eb" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_d32de0a1-295c-49ca-9594-c81d3ebd4469" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_fedf0915-0573-4e24-b3f6-e42c02c92682" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_srt_CounterpartyNameAxis_fedf0915-0573-4e24-b3f6-e42c02c92682" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fedf0915-0573-4e24-b3f6-e42c02c92682_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_fedf0915-0573-4e24-b3f6-e42c02c92682" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fedf0915-0573-4e24-b3f6-e42c02c92682_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_fedf0915-0573-4e24-b3f6-e42c02c92682" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfNewYorkMember_dc3daf5c-07a4-451b-a1fa-d6a45adab1d7" xlink:href="mck-20211231.xsd#mck_StateOfNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_StateOfNewYorkMember_dc3daf5c-07a4-451b-a1fa-d6a45adab1d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfOhioMember_842aacfa-350d-40a3-97b7-53acb9d912de" xlink:href="mck-20211231.xsd#mck_StateOfOhioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_StateOfOhioMember_842aacfa-350d-40a3-97b7-53acb9d912de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember_fe66ad73-a9fd-49e7-a49c-9922c5f919f7" xlink:href="mck-20211231.xsd#mck_CherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_CherokeeNationMember_fe66ad73-a9fd-49e7-a49c-9922c5f919f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember_2f2df1f1-ba67-4a79-8250-26f9ce72fa87" xlink:href="mck-20211231.xsd#mck_GovernmentalEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_GovernmentalEntitiesMember_2f2df1f1-ba67-4a79-8250-26f9ce72fa87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_4c44b9dd-979d-4a77-b2e6-d2750473e02d" xlink:href="mck-20211231.xsd#mck_IndividualClaimantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_IndividualClaimantMember_4c44b9dd-979d-4a77-b2e6-d2750473e02d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfRhodeIslandMember_912be5a8-a6cf-467d-9a39-ecb62d5c691f" xlink:href="mck-20211231.xsd#mck_StateOfRhodeIslandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_StateOfRhodeIslandMember_912be5a8-a6cf-467d-9a39-ecb62d5c691f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfFloridaMember_10780306-8dce-406c-82eb-11caf0501a57" xlink:href="mck-20211231.xsd#mck_StateOfFloridaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_StateOfFloridaMember_10780306-8dce-406c-82eb-11caf0501a57" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_6b4c8936-d799-44fc-b910-a1e34f6a9120" xlink:href="mck-20211231.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_6b4c8936-d799-44fc-b910-a1e34f6a9120" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a9cff2c2-bec1-43d5-94cf-d749fd182f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a9cff2c2-bec1-43d5-94cf-d749fd182f19" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a9cff2c2-bec1-43d5-94cf-d749fd182f19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a9cff2c2-bec1-43d5-94cf-d749fd182f19" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a9cff2c2-bec1-43d5-94cf-d749fd182f19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a247b3fd-02c8-4061-b014-78e0399b2431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a9cff2c2-bec1-43d5-94cf-d749fd182f19" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a247b3fd-02c8-4061-b014-78e0399b2431" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9cc6dd65-a25a-4c42-bc89-677e9e7a099e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a247b3fd-02c8-4061-b014-78e0399b2431" xlink:to="loc_us-gaap_SubsequentEventMember_9cc6dd65-a25a-4c42-bc89-677e9e7a099e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended" id="i062a196c662643299f68d883ca99af93_CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f841c731-637f-4297-98b8-311a298ef5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_93659864-9a39-4cfd-85da-6e3cbfb4dce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f841c731-637f-4297-98b8-311a298ef5b9" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_93659864-9a39-4cfd-85da-6e3cbfb4dce4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_8c5b26b1-02b3-40b9-a118-10641b7d630b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f841c731-637f-4297-98b8-311a298ef5b9" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_8c5b26b1-02b3-40b9-a118-10641b7d630b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_895623b1-06e3-4ed8-8486-9192f64bca16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f841c731-637f-4297-98b8-311a298ef5b9" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_895623b1-06e3-4ed8-8486-9192f64bca16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2b495854-19d2-4612-b16c-2949e17b85fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_f841c731-637f-4297-98b8-311a298ef5b9" xlink:to="loc_us-gaap_LossContingenciesTable_2b495854-19d2-4612-b16c-2949e17b85fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_47a7982f-ed3f-475a-8262-c1472c80424a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2b495854-19d2-4612-b16c-2949e17b85fd" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_47a7982f-ed3f-475a-8262-c1472c80424a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_47a7982f-ed3f-475a-8262-c1472c80424a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_47a7982f-ed3f-475a-8262-c1472c80424a" xlink:to="loc_us-gaap_LossContingencyNatureDomain_47a7982f-ed3f-475a-8262-c1472c80424a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0a146b74-4eee-4f30-9ef7-8e40578e2747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_47a7982f-ed3f-475a-8262-c1472c80424a" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0a146b74-4eee-4f30-9ef7-8e40578e2747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_1172f8b6-8dac-4fa1-b711-2b376ff0ffc0" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0a146b74-4eee-4f30-9ef7-8e40578e2747" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_1172f8b6-8dac-4fa1-b711-2b376ff0ffc0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended" id="i95e39149a2e9407b8f892e5d23051698_StockholdersEquityDeficitNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_fb3a2419-8a46-40a5-ad2c-2857d9d9e360" xlink:href="mck-20211231.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_fb3a2419-8a46-40a5-ad2c-2857d9d9e360" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_5cff2291-469e-4468-b3e0-8ae03c2d5ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_5cff2291-469e-4468-b3e0-8ae03c2d5ed1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_5cc870a3-dff3-4d4b-a3ea-23498f2f6be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_5cc870a3-dff3-4d4b-a3ea-23498f2f6be7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_7f7946a5-a4e9-4a12-9ec1-6c757acc8a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_7f7946a5-a4e9-4a12-9ec1-6c757acc8a0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_72031902-2fd1-4fcd-9cf1-97329de6c12a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_72031902-2fd1-4fcd-9cf1-97329de6c12a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e7998da6-4999-47d7-998a-a113b22be892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e7998da6-4999-47d7-998a-a113b22be892" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_a6a41a22-8aa6-4bfb-bfc6-478d7d0c2369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_a6a41a22-8aa6-4bfb-bfc6-478d7d0c2369" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d29a5606-caa9-4d09-b505-523b86b94009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d29a5606-caa9-4d09-b505-523b86b94009" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5fe6bbea-4104-40fe-88ad-6fafbb6ecde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5fe6bbea-4104-40fe-88ad-6fafbb6ecde0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9da09481-b1ed-4c7a-afe3-dff3a4fbaa19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9da09481-b1ed-4c7a-afe3-dff3a4fbaa19" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_f759ce8d-ab53-4734-8d49-db770b9b5dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_f759ce8d-ab53-4734-8d49-db770b9b5dcf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_4f12c3bb-29b4-42b6-b1a7-2434677f9491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_f759ce8d-ab53-4734-8d49-db770b9b5dcf" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_4f12c3bb-29b4-42b6-b1a7-2434677f9491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4f12c3bb-29b4-42b6-b1a7-2434677f9491_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4f12c3bb-29b4-42b6-b1a7-2434677f9491" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4f12c3bb-29b4-42b6-b1a7-2434677f9491_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_d67b438d-7fa4-488b-b245-d97dbb2aaf27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4f12c3bb-29b4-42b6-b1a7-2434677f9491" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_d67b438d-7fa4-488b-b245-d97dbb2aaf27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_f65cc722-b648-48a0-8564-38f0ef65e369" xlink:href="mck-20211231.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_d67b438d-7fa4-488b-b245-d97dbb2aaf27" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_f65cc722-b648-48a0-8564-38f0ef65e369" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember_b38cf192-3305-4f92-aff7-4830bb8465f0" xlink:href="mck-20211231.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_d67b438d-7fa4-488b-b245-d97dbb2aaf27" xlink:to="loc_mck_OpenMarketShareRepurchaseTransactionsMember_b38cf192-3305-4f92-aff7-4830bb8465f0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended" id="i4119bcc4a7cd4bc6b14bfb02ff68a4ea_StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d289448b-29a7-4f82-af3c-4dd033e79ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d289448b-29a7-4f82-af3c-4dd033e79ef4" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdd0e0c3-2c7a-45c1-b417-f23a5805dec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdd0e0c3-2c7a-45c1-b417-f23a5805dec0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d30de58d-c069-4198-acf3-ac1ea6059ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d30de58d-c069-4198-acf3-ac1ea6059ae7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6869abd0-fe9a-4efa-96ca-215fc2092168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6869abd0-fe9a-4efa-96ca-215fc2092168" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7df23e5-67c9-454b-937d-713133498cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7df23e5-67c9-454b-937d-713133498cff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_a4e5ce06-da89-42a7-8704-8d0d77bec8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_a4e5ce06-da89-42a7-8704-8d0d77bec8dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d1c1fa81-70ae-4bdd-9dbe-82cd3b58a3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d1c1fa81-70ae-4bdd-9dbe-82cd3b58a3c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ba5b3ce8-837e-4a99-bb32-a89a680f1ea8" xlink:href="mck-20211231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ba5b3ce8-837e-4a99-bb32-a89a680f1ea8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4eec86f0-9a8c-43a5-975b-070c9bcc2a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_bbb6e446-32d7-4fca-afa9-36405afd11a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d289448b-29a7-4f82-af3c-4dd033e79ef4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_bbb6e446-32d7-4fca-afa9-36405afd11a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_6c27a86c-0427-4185-9e2b-3d32ae249cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d289448b-29a7-4f82-af3c-4dd033e79ef4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_6c27a86c-0427-4185-9e2b-3d32ae249cdb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e276ba8f-1688-49af-98ef-9aec49a4452d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_6c27a86c-0427-4185-9e2b-3d32ae249cdb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e276ba8f-1688-49af-98ef-9aec49a4452d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e276ba8f-1688-49af-98ef-9aec49a4452d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e276ba8f-1688-49af-98ef-9aec49a4452d" xlink:to="loc_us-gaap_EquityComponentDomain_e276ba8f-1688-49af-98ef-9aec49a4452d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_006ee791-a248-48bd-8451-5a4089228d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e276ba8f-1688-49af-98ef-9aec49a4452d" xlink:to="loc_us-gaap_EquityComponentDomain_006ee791-a248-48bd-8451-5a4089228d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_006ee791-a248-48bd-8451-5a4089228d2d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_ea275640-b09d-43ed-b7b8-4600ad772840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_ea275640-b09d-43ed-b7b8-4600ad772840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_64bb9032-d88c-4d1a-9dd2-64d5bc088a13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_64bb9032-d88c-4d1a-9dd2-64d5bc088a13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_d8eb559b-b04a-4a4d-be58-bfe9335c46b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_d8eb559b-b04a-4a4d-be58-bfe9335c46b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_232f7369-aef4-4f6c-bd0b-ece683b1262a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_232f7369-aef4-4f6c-bd0b-ece683b1262a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a8e6f297-b5b1-4dbc-ab98-ffabe7051012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_6c27a86c-0427-4185-9e2b-3d32ae249cdb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a8e6f297-b5b1-4dbc-ab98-ffabe7051012" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a8e6f297-b5b1-4dbc-ab98-ffabe7051012_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a8e6f297-b5b1-4dbc-ab98-ffabe7051012" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a8e6f297-b5b1-4dbc-ab98-ffabe7051012_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2530ed4e-e9e9-4217-a746-0686d36ab560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a8e6f297-b5b1-4dbc-ab98-ffabe7051012" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2530ed4e-e9e9-4217-a746-0686d36ab560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7ba26257-cfaf-45fb-b16f-e7c8bcd17fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2530ed4e-e9e9-4217-a746-0686d36ab560" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7ba26257-cfaf-45fb-b16f-e7c8bcd17fb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_39c1178d-c6a6-4bff-b3d0-4259701f44ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2530ed4e-e9e9-4217-a746-0686d36ab560" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_39c1178d-c6a6-4bff-b3d0-4259701f44ea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended" id="i9e8f9d179361478299986ac7c0d28780_SegmentsofBusinessNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_c6126fe8-70dd-4ea7-8638-ed3fa4617c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:to="loc_us-gaap_NumberOfReportableSegments_c6126fe8-70dd-4ea7-8638-ed3fa4617c4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_86637b0e-63e7-4c8a-b34d-5f5a137fca3a" xlink:href="mck-20211231.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_86637b0e-63e7-4c8a-b34d-5f5a137fca3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_615266b9-010f-4554-b78b-1a33cd7adbae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_615266b9-010f-4554-b78b-1a33cd7adbae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations_49960068-4210-4ef8-a3f6-3626b86698eb" xlink:href="mck-20211231.xsd#mck_NumberOfBusinessOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:to="loc_mck_NumberOfBusinessOperations_49960068-4210-4ef8-a3f6-3626b86698eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_d092242f-8822-44dd-9951-67e97db218c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_d092242f-8822-44dd-9951-67e97db218c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_df3fad41-5a8f-4769-993f-dea8c3a9211a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:to="loc_srt_StatementGeographicalAxis_df3fad41-5a8f-4769-993f-dea8c3a9211a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_df3fad41-5a8f-4769-993f-dea8c3a9211a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_df3fad41-5a8f-4769-993f-dea8c3a9211a" xlink:to="loc_srt_SegmentGeographicalDomain_df3fad41-5a8f-4769-993f-dea8c3a9211a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a0903703-89fc-499a-86c8-40eae7b78ca2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_df3fad41-5a8f-4769-993f-dea8c3a9211a" xlink:to="loc_srt_SegmentGeographicalDomain_a0903703-89fc-499a-86c8-40eae7b78ca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6b8eee95-db46-4bc7-b0ec-a183309d20b7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a0903703-89fc-499a-86c8-40eae7b78ca2" xlink:to="loc_country_US_6b8eee95-db46-4bc7-b0ec-a183309d20b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_ab92b77f-fd27-4272-98e0-999877406b66" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a0903703-89fc-499a-86c8-40eae7b78ca2" xlink:to="loc_srt_EuropeMember_ab92b77f-fd27-4272-98e0-999877406b66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4bb18f60-65ca-46aa-bf62-d87b15742486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4bb18f60-65ca-46aa-bf62-d87b15742486" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4bb18f60-65ca-46aa-bf62-d87b15742486_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4bb18f60-65ca-46aa-bf62-d87b15742486" xlink:to="loc_us-gaap_SegmentDomain_4bb18f60-65ca-46aa-bf62-d87b15742486_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6904b698-619d-4bbf-b2f5-27bb6f08b78e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4bb18f60-65ca-46aa-bf62-d87b15742486" xlink:to="loc_us-gaap_SegmentDomain_6904b698-619d-4bbf-b2f5-27bb6f08b78e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_b0073760-c204-4b7d-9dc0-e926774c2098" xlink:href="mck-20211231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6904b698-619d-4bbf-b2f5-27bb6f08b78e" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_b0073760-c204-4b7d-9dc0-e926774c2098" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_7eb0d751-25ae-45d3-b183-e24d6ee963d9" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6904b698-619d-4bbf-b2f5-27bb6f08b78e" xlink:to="loc_mck_InternationalSegmentMember_7eb0d751-25ae-45d3-b183-e24d6ee963d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d890fbb9-77c8-4a3f-ab69-0bb5738ad8f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:to="loc_srt_ConsolidationItemsAxis_d890fbb9-77c8-4a3f-ab69-0bb5738ad8f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d890fbb9-77c8-4a3f-ab69-0bb5738ad8f1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_d890fbb9-77c8-4a3f-ab69-0bb5738ad8f1" xlink:to="loc_srt_ConsolidationItemsDomain_d890fbb9-77c8-4a3f-ab69-0bb5738ad8f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a73eddbc-fd2f-4d4b-8559-d2c3487380de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_d890fbb9-77c8-4a3f-ab69-0bb5738ad8f1" xlink:to="loc_srt_ConsolidationItemsDomain_a73eddbc-fd2f-4d4b-8559-d2c3487380de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_91ddc8c8-ba3f-4133-ab24-c1e611287bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a73eddbc-fd2f-4d4b-8559-d2c3487380de" xlink:to="loc_us-gaap_OperatingSegmentsMember_91ddc8c8-ba3f-4133-ab24-c1e611287bab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1501bf83-c783-43bd-bfae-2f803b85d0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1501bf83-c783-43bd-bfae-2f803b85d0c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1501bf83-c783-43bd-bfae-2f803b85d0c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1501bf83-c783-43bd-bfae-2f803b85d0c7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1501bf83-c783-43bd-bfae-2f803b85d0c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b024ba9a-270f-4fc0-8032-b0bdc680f718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1501bf83-c783-43bd-bfae-2f803b85d0c7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b024ba9a-270f-4fc0-8032-b0bdc680f718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_49d2ff47-ecf2-4a81-ba61-f2d738e7bde8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b024ba9a-270f-4fc0-8032-b0bdc680f718" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_49d2ff47-ecf2-4a81-ba61-f2d738e7bde8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bef7f26a-702e-4c3c-9d26-0ae99537a430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b024ba9a-270f-4fc0-8032-b0bdc680f718" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bef7f26a-702e-4c3c-9d26-0ae99537a430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a982304c-38f3-429a-9147-ba1b68d35e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a982304c-38f3-429a-9147-ba1b68d35e3d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a982304c-38f3-429a-9147-ba1b68d35e3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a982304c-38f3-429a-9147-ba1b68d35e3d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a982304c-38f3-429a-9147-ba1b68d35e3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_32ce2a31-155f-4f59-9b4f-078e362c04d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a982304c-38f3-429a-9147-ba1b68d35e3d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_32ce2a31-155f-4f59-9b4f-078e362c04d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_87e9b125-8e5b-4fb0-888a-accfd6f8eabf" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_32ce2a31-155f-4f59-9b4f-078e362c04d8" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_87e9b125-8e5b-4fb0-888a-accfd6f8eabf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_ebb385d4-1ea2-49fb-b87e-0b5af40931e3" xlink:href="mck-20211231.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_32ce2a31-155f-4f59-9b4f-078e362c04d8" xlink:to="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_ebb385d4-1ea2-49fb-b87e-0b5af40931e3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#SegmentsofBusinessReportableoperatingsegmentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="extended" id="idbb5660eae1f43a6a5c198e5e0bbdab5_SegmentsofBusinessReportableoperatingsegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a6e4ceff-deba-4236-88b0-65f56863002a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_us-gaap_RevenuesAbstract_a6e4ceff-deba-4236-88b0-65f56863002a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0bc5ac1-f236-4ac2-9f5a-7848474a3a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a6e4ceff-deba-4236-88b0-65f56863002a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0bc5ac1-f236-4ac2-9f5a-7848474a3a3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_596a8ee8-5551-4322-a9d8-2f38c8f8378c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_596a8ee8-5551-4322-a9d8-2f38c8f8378c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f55f6477-715b-4e05-8f16-d139c74f35c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_596a8ee8-5551-4322-a9d8-2f38c8f8378c" xlink:to="loc_us-gaap_OperatingIncomeLoss_f55f6477-715b-4e05-8f16-d139c74f35c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_7d4afbbf-605f-4ec3-9c9a-fc99524a9228" xlink:href="mck-20211231.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_7d4afbbf-605f-4ec3-9c9a-fc99524a9228" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fcfcd183-99be-4e4b-886b-1f9bbcc3cbc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fcfcd183-99be-4e4b-886b-1f9bbcc3cbc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_80585587-6434-4e61-bde8-bcbeed75cb92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_us-gaap_InterestExpense_80585587-6434-4e61-bde8-bcbeed75cb92" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_642a9237-08d6-4a78-a4dc-23514733ac60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_642a9237-08d6-4a78-a4dc-23514733ac60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_931d9c2c-dedb-42c5-b116-b9d0dae9284f" xlink:href="mck-20211231.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_931d9c2c-dedb-42c5-b116-b9d0dae9284f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_08178f94-70c3-48e8-9c2f-d1f4ae46045b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_08178f94-70c3-48e8-9c2f-d1f4ae46045b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_e700f547-6987-414f-908b-3ffd18d372e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_e700f547-6987-414f-908b-3ffd18d372e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_65b5939c-1a5f-46da-b173-1461bae9fab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_65b5939c-1a5f-46da-b173-1461bae9fab1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_2c158617-c8dc-4de7-9239-4b8bee2b1713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_InventoryWriteDown_2c158617-c8dc-4de7-9239-4b8bee2b1713" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_2260ccdb-812c-49ad-b7f2-0068c6f95292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_2260ccdb-812c-49ad-b7f2-0068c6f95292" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_c852605b-3b8a-4f7c-b418-46d7d45fc686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_c852605b-3b8a-4f7c-b418-46d7d45fc686" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_84577659-fed8-44c6-b772-47b556d31b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_RestructuringCharges_84577659-fed8-44c6-b772-47b556d31b26" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_65e24aa3-76eb-4448-849b-9550a062a027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_65e24aa3-76eb-4448-849b-9550a062a027" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d5a244f0-e52c-4c1d-bce4-8d6df0279da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d5a244f0-e52c-4c1d-bce4-8d6df0279da8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_781a4ee2-d680-4598-a4eb-f4fe50f0927f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_781a4ee2-d680-4598-a4eb-f4fe50f0927f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_26a0f35c-6c58-40a6-adcc-bf76304cd689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_LitigationSettlementExpense_26a0f35c-6c58-40a6-adcc-bf76304cd689" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_98554915-5d53-42f4-9417-c045d0492c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_98554915-5d53-42f4-9417-c045d0492c9e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_61c7e6f2-0fcd-486f-b700-0e0139360349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_61c7e6f2-0fcd-486f-b700-0e0139360349" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ed20ad27-c787-486f-8204-8e2184fb0618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ed20ad27-c787-486f-8204-8e2184fb0618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ed20ad27-c787-486f-8204-8e2184fb0618_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ed20ad27-c787-486f-8204-8e2184fb0618" xlink:to="loc_us-gaap_SegmentDomain_ed20ad27-c787-486f-8204-8e2184fb0618_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ed20ad27-c787-486f-8204-8e2184fb0618" xlink:to="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_15aaaf9c-b9cf-406c-8cb7-2f4b656d6237" xlink:href="mck-20211231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:to="loc_mck_USPharmaceuticalSegmentMember_15aaaf9c-b9cf-406c-8cb7-2f4b656d6237" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_6262f875-8a0f-41bf-8e55-d3501793c8a0" xlink:href="mck-20211231.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_6262f875-8a0f-41bf-8e55-d3501793c8a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_e120bd21-2a34-4e5b-ad40-ef5d431ebf50" xlink:href="mck-20211231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_e120bd21-2a34-4e5b-ad40-ef5d431ebf50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_7347cfca-a874-40b3-8b2b-df635cfb4b0b" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:to="loc_mck_InternationalSegmentMember_7347cfca-a874-40b3-8b2b-df635cfb4b0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a80a9fe3-8ab3-4e5e-a3d4-85acafb623d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_srt_LitigationCaseAxis_a80a9fe3-8ab3-4e5e-a3d4-85acafb623d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a80a9fe3-8ab3-4e5e-a3d4-85acafb623d9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_a80a9fe3-8ab3-4e5e-a3d4-85acafb623d9" xlink:to="loc_srt_LitigationCaseTypeDomain_a80a9fe3-8ab3-4e5e-a3d4-85acafb623d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6d368646-19eb-4675-a4d5-f03ac2f51012" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_a80a9fe3-8ab3-4e5e-a3d4-85acafb623d9" xlink:to="loc_srt_LitigationCaseTypeDomain_6d368646-19eb-4675-a4d5-f03ac2f51012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AntitrustLegalSettlementsMember_2121a58b-4e9b-4faa-b29f-4e92fd4aa561" xlink:href="mck-20211231.xsd#mck_AntitrustLegalSettlementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_6d368646-19eb-4675-a4d5-f03ac2f51012" xlink:to="loc_mck_AntitrustLegalSettlementsMember_2121a58b-4e9b-4faa-b29f-4e92fd4aa561" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_caf33b2d-ab51-4a0c-938e-be6e214e86e5" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_6d368646-19eb-4675-a4d5-f03ac2f51012" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_caf33b2d-ab51-4a0c-938e-be6e214e86e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionInsuranceProceedsMember_738bd1f3-ea6e-4aaa-a013-7efd2b42e411" xlink:href="mck-20211231.xsd#mck_ShareholderDerivativeActionInsuranceProceedsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_6d368646-19eb-4675-a4d5-f03ac2f51012" xlink:to="loc_mck_ShareholderDerivativeActionInsuranceProceedsMember_738bd1f3-ea6e-4aaa-a013-7efd2b42e411" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_99cec215-4a70-4a9f-a66e-ff8526a5838c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_srt_ConsolidationItemsAxis_99cec215-4a70-4a9f-a66e-ff8526a5838c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_99cec215-4a70-4a9f-a66e-ff8526a5838c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_99cec215-4a70-4a9f-a66e-ff8526a5838c" xlink:to="loc_srt_ConsolidationItemsDomain_99cec215-4a70-4a9f-a66e-ff8526a5838c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_bd8f5fc7-c15b-49de-91e7-7247d956ca96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_99cec215-4a70-4a9f-a66e-ff8526a5838c" xlink:to="loc_srt_ConsolidationItemsDomain_bd8f5fc7-c15b-49de-91e7-7247d956ca96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_ecc6a1bf-3201-4389-b379-1c1901337256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_bd8f5fc7-c15b-49de-91e7-7247d956ca96" xlink:to="loc_us-gaap_OperatingSegmentsMember_ecc6a1bf-3201-4389-b379-1c1901337256" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_2c3be246-ced2-45fc-b001-a8351ad49039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_bd8f5fc7-c15b-49de-91e7-7247d956ca96" xlink:to="loc_us-gaap_CorporateNonSegmentMember_2c3be246-ced2-45fc-b001-a8351ad49039" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_36e19738-c32b-4ef7-a09a-c27c5978d867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_36e19738-c32b-4ef7-a09a-c27c5978d867" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_36e19738-c32b-4ef7-a09a-c27c5978d867_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_36e19738-c32b-4ef7-a09a-c27c5978d867" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_36e19738-c32b-4ef7-a09a-c27c5978d867_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c2d51a02-edc4-4149-9dfd-d2c709d06faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_36e19738-c32b-4ef7-a09a-c27c5978d867" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c2d51a02-edc4-4149-9dfd-d2c709d06faf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_475fe545-9ee4-4156-a23e-5ec88cc06994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c2d51a02-edc4-4149-9dfd-d2c709d06faf" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_475fe545-9ee4-4156-a23e-5ec88cc06994" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f835cbc0-455a-4aae-9e62-47e3708cfe00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c2d51a02-edc4-4149-9dfd-d2c709d06faf" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f835cbc0-455a-4aae-9e62-47e3708cfe00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember_af572a6c-99e3-41cd-a4ad-59a68c3f33fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c2d51a02-edc4-4149-9dfd-d2c709d06faf" xlink:to="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember_af572a6c-99e3-41cd-a4ad-59a68c3f33fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0f82ff91-1a08-4ff9-9d49-51838d2280e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0f82ff91-1a08-4ff9-9d49-51838d2280e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0f82ff91-1a08-4ff9-9d49-51838d2280e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0f82ff91-1a08-4ff9-9d49-51838d2280e7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0f82ff91-1a08-4ff9-9d49-51838d2280e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_acb12748-f516-4034-baa4-838bda94de2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0f82ff91-1a08-4ff9-9d49-51838d2280e7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_acb12748-f516-4034-baa4-838bda94de2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_1322911e-8cdb-4024-8c18-8b1bde6c3fed" xlink:href="mck-20211231.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_acb12748-f516-4034-baa4-838bda94de2e" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_1322911e-8cdb-4024-8c18-8b1bde6c3fed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_5969631e-ea61-48c7-b6cb-7fec1041f305" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_acb12748-f516-4034-baa4-838bda94de2e" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_5969631e-ea61-48c7-b6cb-7fec1041f305" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c90d199-b688-4c9d-9794-1b1c9fde2a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c90d199-b688-4c9d-9794-1b1c9fde2a63" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5c90d199-b688-4c9d-9794-1b1c9fde2a63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c90d199-b688-4c9d-9794-1b1c9fde2a63" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5c90d199-b688-4c9d-9794-1b1c9fde2a63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c90d199-b688-4c9d-9794-1b1c9fde2a63" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_e36ad766-544b-43a3-b1a0-a98cd5e18c20" xlink:href="mck-20211231.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:to="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_e36ad766-544b-43a3-b1a0-a98cd5e18c20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_2781bc0e-a823-4d57-a9c1-2a931c7a3931" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_2781bc0e-a823-4d57-a9c1-2a931c7a3931" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_002ae554-992d-4ee1-988f-b73b04b27d60" xlink:href="mck-20211231.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_002ae554-992d-4ee1-988f-b73b04b27d60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleBusinessMember_b8d75864-e95d-481e-bfb7-4d66575c2507" xlink:href="mck-20211231.xsd#mck_GermanPharmaceuticalWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:to="loc_mck_GermanPharmaceuticalWholesaleBusinessMember_b8d75864-e95d-481e-bfb7-4d66575c2507" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_85880634-3b73-4416-b607-1b9caca058e9" xlink:href="mck-20211231.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_85880634-3b73-4416-b607-1b9caca058e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_74d6591a-0066-4bde-ae4a-13ea8bfd694d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_DebtInstrumentAxis_74d6591a-0066-4bde-ae4a-13ea8bfd694d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_74d6591a-0066-4bde-ae4a-13ea8bfd694d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_74d6591a-0066-4bde-ae4a-13ea8bfd694d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_74d6591a-0066-4bde-ae4a-13ea8bfd694d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4ad17bfc-99e8-43f6-b255-23746abd605e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_74d6591a-0066-4bde-ae4a-13ea8bfd694d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4ad17bfc-99e8-43f6-b255-23746abd605e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesAndDebenturesExtinguishedFebruary72018Member_9cd94a30-eda1-4b6a-a86d-a20aa91c9213" xlink:href="mck-20211231.xsd#mck_NotesAndDebenturesExtinguishedFebruary72018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4ad17bfc-99e8-43f6-b255-23746abd605e" xlink:to="loc_mck_NotesAndDebenturesExtinguishedFebruary72018Member_9cd94a30-eda1-4b6a-a86d-a20aa91c9213" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4685fc82-d7fa-4c1b-8b88-643ff64b46fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4685fc82-d7fa-4c1b-8b88-643ff64b46fc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4685fc82-d7fa-4c1b-8b88-643ff64b46fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4685fc82-d7fa-4c1b-8b88-643ff64b46fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4685fc82-d7fa-4c1b-8b88-643ff64b46fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1e2c03db-3e74-4093-ac1c-312e4873caad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4685fc82-d7fa-4c1b-8b88-643ff64b46fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1e2c03db-3e74-4093-ac1c-312e4873caad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_eb2e5fef-ad7e-4a83-ab02-8e27715ff857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1e2c03db-3e74-4093-ac1c-312e4873caad" xlink:to="loc_us-gaap_LoansPayableMember_eb2e5fef-ad7e-4a83-ab02-8e27715ff857" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>mck-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b0c4267c-1381-4f10-888f-434d9ccb5c99,g:6c581a7b-6b71-4a88-8456-a4823e8897d4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_42535582-c7d5-49ce-9795-ba774ece4914_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized repurchase amount (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_3d25eb3d-7426-487e-80b0-c20f1aa93c41_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_6d47fc74-33ea-4e32-9b34-a9d6fcab46f2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_ce738492-6ef7-4992-8a33-23cca7e088c0_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43be9fdc-5a8f-42f5-9974-2af05be89de9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_55aa86c7-1f0e-458b-9227-7c05e54b2877_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_0ca6553f-51d6-4839-9ce9-02398b6bdc52_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_0a594095-e2fe-4e30-8742-7dea19373d7d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_58401519-b82f-466c-b464-3847855a277e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d03a176d-f6c3-42c7-a287-02132f7632bc_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_a2689cb4-9a0a-406b-9adc-5ca2db4c3024_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_555feda2-4127-42da-8b81-4efd9ee620e3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_2f3ba978-a309-44bc-9fe1-0a8e293dba61_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AntitrustLegalSettlementsMember_83c22fcf-a7cd-4da1-9676-16ea71c81526_terseLabel_en-US" xlink:label="lab_mck_AntitrustLegalSettlementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antitrust Legal Settlements</link:label>
    <link:label id="lab_mck_AntitrustLegalSettlementsMember_label_en-US" xlink:label="lab_mck_AntitrustLegalSettlementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antitrust Legal Settlements [Member]</link:label>
    <link:label id="lab_mck_AntitrustLegalSettlementsMember_documentation_en-US" xlink:label="lab_mck_AntitrustLegalSettlementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antitrust Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AntitrustLegalSettlementsMember" xlink:href="mck-20211231.xsd#mck_AntitrustLegalSettlementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AntitrustLegalSettlementsMember" xlink:to="lab_mck_AntitrustLegalSettlementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_cb139eb2-ec06-4af6-bdff-f7b1cfcfa340_terseLabel_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax expenses related to estimated litigation liability</link:label>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_label_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_documentation_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:href="mck-20211231.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:to="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_80509d22-5ab4-46ab-90ac-4c1c16b3f803_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_07739c32-364d-4ba0-b287-8a9e69d649ff_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_8c9b317a-2838-499b-85cc-7eb08dc2d04e_terseLabel_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets/liabilities</link:label>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_label_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Asset / Liability [Member]</link:label>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_documentation_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Asset / Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember" xlink:href="mck-20211231.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncurrentAssetLiabilityMember" xlink:to="lab_mck_NoncurrentAssetLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_681d47b3-53c3-473a-a57e-d4a88995133f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:to="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d27e34b7-b0ea-4698-8d55-42d37c3af142_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_cec6bb92-1539-4dea-8096-bb4ba325967b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_2b339a4b-c8a1-40ac-ad5d-cd222908ed0b_negatedTerseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax benefit recognized due to GILTI</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Global Low-Tax Income, Amount</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Global Low-Tax Income, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:href="mck-20211231.xsd#mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_03c0be5e-34ff-40a9-ae72-dc39dc299c54_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_e44de26c-6d02-48a5-a776-fbe9fbe185ba_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_4d9e6441-8ed6-48be-8373-990685d191c4_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_94b579c9-1d4f-43c3-a9fd-7fbad881ad06_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_47b1729c-c4a4-44f5-851f-57ed7ec3b175_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price percentage of principal (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5751ef55-86fe-474a-b6d4-7a9134d91b8d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_922baf2e-d325-4426-9720-76b2a8da5370_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit and other-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_93571bc2-4e70-4273-a334-ad86e55005d7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireSoftware" xlink:to="lab_us-gaap_PaymentsToAcquireSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_d71e724e-bcf8-4297-afee-aa344abe9a4d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_7287acd0-5b8b-4ee7-8491-52f11b1a0bc5_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European businesses held for sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_16dc7e48-8421-48a7-8b03-c9743e8cf457_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge for remeasurement to fair value</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_3644158d-1f5a-4210-99ac-52d1155bf154_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_fd9be34f-a1d6-426c-903b-fa8fa93a24d3_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_8d0d7281-a47b-4eb6-aebf-ee5a16a330e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_97309dc7-a43e-4e31-b5e0-67d216fe26c0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_46f6f903-98f5-437c-99b0-1954bd7f189a_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_c5139fcf-f651-422d-b6f1-61c56fc617fd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract" xlink:to="lab_us-gaap_OperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_7c345194-e168-4f13-94aa-2fac22b594be_terseLabel_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (in shares)</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_label_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_documentation_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:href="mck-20211231.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:to="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_59a185d8-b8f3-4a49-a139-ceb991c3895d_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of attorney generals that have filed claims</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of State Attorney Generals</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of State Attorney Generals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:to="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_c2211f28-d4eb-4db2-b4d7-02a9b86791fb_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_c38efd2b-8fd9-4422-9897-3fef98b232c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_29471f10-95df-4698-aeda-ced31fa0696b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized amount available for future repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_f65fe459-122d-4d8c-8bb2-7e36b5801e2a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3ad2201d-556e-4788-a0b3-8c8a8b443d2d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_c96cd1a2-d0c9-40f4-936f-9b8328bee804_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_29243041-4cda-4ece-8b66-03bac4c94934_terseLabel_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes due March 15, 2024</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_label_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024 [Member]</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_documentation_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member" xlink:href="mck-20211231.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A380NotesDueMarch152024Member" xlink:to="lab_mck_A380NotesDueMarch152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_24f3f523-89c4-45b5-8bfd-1949536d69c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember_e2b7985a-b8b0-4c6c-a7a3-f88f154e3738_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributed to Joint Venture</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_66da8e98-0188-41c6-bd2b-29b832b518e2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_1d739d37-d8cc-4061-80af-464703a926ee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_322fafa4-d3ec-472d-b6d4-6082fda1de17_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_0f6d1633-cf4a-4711-9014-c3b877c48f2f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_df667125-afe7-4055-8d30-2768cabfc5de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_2b53b973-d60d-4c4e-876d-fa21032319f1_terseLabel_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per share of common stock permitted on proposals presented to stockholders (vote)</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_label_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_documentation_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:href="mck-20211231.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:to="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_173dbd28-574d-4a20-b269-28098d9fbda3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_72e95969-ca38-4f0a-ab74-3facaa3c33ef_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_fe60e730-df8a-4cce-ad27-1d91616134ff_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3cb2a268-9032-40b2-bfb6-f751bb19cd53_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_ae4544eb-7c4c-42dd-a6e6-81c5ac209b9c_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of commercial paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_6addfc74-0ee1-4da5-a43c-110430102500_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1f7ce201-f9f9-4359-a2fc-6fd881d98b09_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7a186bd5-dc23-4587-be35-ed84fe83f60f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_4b38bfd1-9f6c-42c4-b22b-3b3f2ede862b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of businesses and investments, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses and Interests in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_d8d14d2a-65f7-4295-a825-b616c327a625_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_ee004b53-b15f-4ba7-9d37-ffedd9c56744_terseLabel_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contracts to hedge Euro against British Pound cash flows</link:label>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_label_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]</link:label>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_documentation_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:href="mck-20211231.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:to="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_f5709c13-ddee-4514-a89d-3a0bb4f52112_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_24fdb0df-342b-4330-8cb8-f078954b42d5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair values of liabilities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMay302029Member_3068e0a8-4f63-4405-8452-bab98b391acd_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due May 30, 2029</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_label_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member" xlink:href="mck-20211231.xsd#mck_A475NotesDueMay302029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMay302029Member" xlink:to="lab_mck_A475NotesDueMay302029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_b56ed8de-3ca9-422b-8b0c-f614e99cd3f0_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage (as a percent)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8ddac02d-bbfa-4491-b0ec-a1f616e7bbd8_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingent Liabilities</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0696a91b-2e77-43d6-ba51-459edf8605d9_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_646af4b0-d154-47cd-ba5b-99dd3020a332_verboseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_2214f12d-e940-4211-b334-e35ba5067021_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_15f8af6e-faff-42ca-93ef-36baeb7f347c_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_dcffe8b2-b445-470a-8279-ae98fd086aa0_terseLabel_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual recurring dividend (in euro per share)</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_label_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_documentation_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:href="mck-20211231.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:to="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_254ef591-73a3-4b48-947a-d45da6f94c23_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss in charge for remeasurement to fair value</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Loss in Charge for Remeasurement to Fair Value</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IndividualClaimantMember_67a399dd-8fcc-4a29-a52f-19a179c803c7_terseLabel_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An individual</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_label_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant [Member]</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_documentation_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember" xlink:href="mck-20211231.xsd#mck_IndividualClaimantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IndividualClaimantMember" xlink:to="lab_mck_IndividualClaimantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_5e44dfbd-9817-4ee1-85cf-7b6b32453742_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt principal redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0b820f6d-cbbf-4fad-8981-b2479fac92de_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_53fe25dc-1a2d-42b5-913f-54fc436a8afc_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_8e1e9776-4318-4caa-8c28-3f56b08763d5_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of settlement award to be used by state and local government for remediation (percent)</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_label_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:href="mck-20211231.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:to="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1eb57315-2768-4c29-b745-225d6a807a08_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_cb8d93ca-4ecd-4aa2-893c-1b62acb5786f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7e736a79-60e8-403e-ab2a-399af8fe879a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_650f2856-dcd2-4556-b435-2896561a2442_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ba13bde8-0ec5-4cd4-ad2f-9074ad878ba4_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_498eefb4-0ddf-407c-826f-131511805a6d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_d76d9461-d17a-4e20-b9cb-283bce2cc584_terseLabel_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember" xlink:href="mck-20211231.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuropeanBusinessesDisposalGroupMember" xlink:to="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_c66c024f-870e-4f1f-95f0-11102965907c_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_36053106-f470-4fcc-b45a-9a5747eb81c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_04b8a025-ca2b-4921-8532-53f8a2b2caae_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_7f131410-01c4-4e23-b01e-b972d35aaac8_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_abb766c1-e04a-4960-bcbf-31893d153a56_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complaints filed against the entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_09f83ab9-1357-4349-86ac-2da1dc41d034_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_454bf882-43bb-4ade-9141-648e9abea42a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_1a3e498c-8841-4b16-bd7e-baeed4429b0e_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreements</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ce7603de-c5e9-4d29-89f4-a846af462d2e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_659cf44e-cfca-417e-8037-b87ecc20b09a_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_4a10f570-3a12-4adf-9587-012245d6304f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_93675300-adac-41ab-9e17-72dae0ccc698_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_f6469c0a-8626-4769-9795-f193ac5140f8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_8b04ae9c-a32c-4445-a18e-d88b59ce08fe_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_68ab1c02-2508-4009-9803-9f1681f42b71_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening retained earnings adjustments: adoption of new accounting standard</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_c6aee909-41be-445a-ad33-5b7c045b2002_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_cf78a68f-a408-4cb9-98f5-0c4c305320e1_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_c96c0af2-6730-418f-a025-efb021387be0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_67ee4595-6891-482f-9376-7db58086585f_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_12e55c3d-dd85-4521-8189-6c8872e196b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_be373cc3-58ff-4a7d-abe1-f815d089b808_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_1e3fae3d-df04-44f3-a6c0-d8df290bca84_terseLabel_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of unamortized debt issuance costs and transaction fees</link:label>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_label_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Cost and Transaction Costs</link:label>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_documentation_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Cost and Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:href="mck-20211231.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:to="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_7b0eac82-2056-4cde-869e-7b4da5c862e6_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_82e2d523-fa61-4cec-8927-123cb65e6bca_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_db1460a6-7c69-421f-8f32-b23b982d385d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_33b4b0c3-6dd9-44f8-91f5-1aa1bdb93818_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_098a5a48-158d-4930-af66-b9b69b646146_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_56856bca-cefd-40cd-810c-aeb4474c700e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_b3dc6dbd-e4c0-49c1-9311-ee03d3c2f453_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of liabilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_bdfc2c52-8820-4803-9932-bf4c0cb229af_terseLabel_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes due August 15, 2026</link:label>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_label_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes Due August 15, 2026 [Member]</link:label>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_documentation_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes Due August 15, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member" xlink:href="mck-20211231.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A130NotesDueAugust152026Member" xlink:to="lab_mck_A130NotesDueAugust152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleBusinessMember_f25183de-ce7c-4cad-89c2-acbe0662d7b4_terseLabel_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Business</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleBusinessMember_label_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Business [Member]</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleBusinessMember_documentation_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleBusinessMember" xlink:href="mck-20211231.xsd#mck_GermanPharmaceuticalWholesaleBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanPharmaceuticalWholesaleBusinessMember" xlink:to="lab_mck_GermanPharmaceuticalWholesaleBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_d4957049-7fdc-4614-a6f1-a3081ad806ee_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Credit Facility</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:href="mck-20211231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_72ffc0e6-ec1a-4528-9bdf-8fe792f22640_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_f9c75596-d453-4857-8730-f6d9926fc314_negatedTerseLabel_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax benefit recognized due to temporary difference arising from buyer's excess tax basis</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_label_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_documentation_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:href="mck-20211231.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:to="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f522d8c5-39c5-45a0-834c-072a845dcf5f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_63973b1c-7515-4f4d-a681-232a4ec3c8c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_d1e79816-f77e-4078-b819-824f6763cff0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_c294ce3f-54b3-4a0f-9863-f2410f5630fe_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_6bcea743-0802-4d95-bf90-45c765241a78_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_ebcd2cda-9dcb-44c7-969d-c3b42717099e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_814b1a52-3003-4d0f-839f-935673753732_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfRhodeIslandMember_af49bb19-4b5d-4863-8bad-79b97eb7f84c_terseLabel_en-US" xlink:label="lab_mck_StateOfRhodeIslandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Rhode Island</link:label>
    <link:label id="lab_mck_StateOfRhodeIslandMember_label_en-US" xlink:label="lab_mck_StateOfRhodeIslandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Rhode Island [Member]</link:label>
    <link:label id="lab_mck_StateOfRhodeIslandMember_documentation_en-US" xlink:label="lab_mck_StateOfRhodeIslandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Rhode Island</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfRhodeIslandMember" xlink:href="mck-20211231.xsd#mck_StateOfRhodeIslandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfRhodeIslandMember" xlink:to="lab_mck_StateOfRhodeIslandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_a10dcd0f-e26a-4223-901e-2d55e95b36b2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and long-lived asset impairment charges</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_7b2475e4-f42d-44c6-8cb4-03d133c9c2f3_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f6c36373-cd4e-44bb-98a9-7e2574026539_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_7d21b362-a13a-46b7-9019-d4c2f362b748_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_0915568f-208e-4cf5-94cb-1f5f1ce01309_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_b4854f7b-cf50-4311-a095-974510158329_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_ae7ac208-65c1-4b3d-8a8d-ae121480a231_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_f8cb3b56-24dd-4028-8d01-559d31103c1c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_1447bcdd-0cdc-406d-a372-496f55c721b3_terseLabel_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_label_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions [Member]</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_documentation_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember" xlink:href="mck-20211231.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrescriptionTechnologySolutionsMember" xlink:to="lab_mck_PrescriptionTechnologySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_511d1c8d-525c-46c9-8ac1-e04fcfaf91d9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_fbaf5b5e-33ac-47af-a2f4-7b0c55508493_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would reduce income tax expense and the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_f3e008d6-48d6-4eaa-b5cf-05c020288497_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_e2d2d4a9-1622-4830-8dad-a0b1dafe7150_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_3ff7130e-ebb6-4657-ad7a-63c2f47f7bc5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward starting interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_3c8d7074-e240-4b6e-8731-ce4ed8c8ebdd_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_346f3354-1284-4a59-b0f1-8b3176cd0e8d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_079f0bb4-af56-4696-a4b5-ab6f6128b0b5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d1b51a9f-667a-417e-bc7a-fa9ce944a8e2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_304066a3-c97f-42fd-8d75-75010abd1a58_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_af848f87-a75d-47e4-a761-ed2d660c6c0b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_1bc987c6-2fe7-4f95-86e6-49d1f4d27b78_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains associated with equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_14d900cc-81ae-40d4-9fa7-828810a73369_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price of shares repurchased (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_45d5cb29-b805-4331-b269-b92a629883b8_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_af51a878-13e8-4bcb-b2af-5f8e72b443c2_verboseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_label_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:to="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b2ad6a83-72e7-4eba-b1bb-5dc261142f39_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_e9b8ca73-a932-4fdf-b279-4d5c816d88d0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_fd6252aa-f6ed-4a9e-82ed-9eb123fb7017_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_3c5ad704-7aa7-43d3-a385-c169cdc98afc_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_aa12b960-f305-437a-b70f-597d56a458bb_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_47ecbb5b-1b46-4e9e-9b75-c3818cf187a4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_98f7bb42-b44c-4164-a18e-23d6fcfdfacb_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_77f9451b-9799-4617-a180-04502aa4143e_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_97951fd8-88a0-4f2f-8714-a31135c3f2ac_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts outstanding under facility</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_dc2813a5-7023-446f-98cc-8d468313e5ed_terseLabel_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Europe Subsidiary</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_label_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_documentation_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember" xlink:href="mck-20211231.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MckessonEuropeSubsidiaryMember" xlink:to="lab_mck_MckessonEuropeSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0686c88b-b8e4-413a-bf1c-aef80f4e9d48_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_6c806c87-f64a-4d7f-ba8a-e774d9610820_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_a2150ad2-f41c-418f-8bd7-5fb11745a413_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6e3d5538-ba7e-45ad-aef2-fb3208470e90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_ad27a168-9d04-499e-9ca3-a343cbf37b91_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, distribution, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_86a668ad-5107-4942-ac6b-91c0ac60b164_terseLabel_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_label_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:href="mck-20211231.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:to="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_b0ebd316-59f6-44d6-9332-948eeb61e8b4_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_c77d4948-960e-4d29-9270-454633fe0380_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_ecc5a9fe-6bb9-4418-a9cc-24ac9b4058ec_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_c82df457-c4e5-4169-b61f-126b19cb890d_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TenderOfferNotesMember_9c39b83d-d8a4-4082-a219-e8eb9178f6bb_terseLabel_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes</link:label>
    <link:label id="lab_mck_TenderOfferNotesMember_label_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes [Member]</link:label>
    <link:label id="lab_mck_TenderOfferNotesMember_documentation_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember" xlink:href="mck-20211231.xsd#mck_TenderOfferNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TenderOfferNotesMember" xlink:to="lab_mck_TenderOfferNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_ec1d49bb-7c45-48d5-83f8-7ed66b64abc5_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_01affbfb-ee5b-42b7-a269-e14ea1bde152_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_85a0ef5e-b4b2-4491-babc-7301351d5bad_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ShareholderDerivativeActionInsuranceProceedsMember_0c320a5a-d4f6-449c-b614-ce9f2637ac39_terseLabel_en-US" xlink:label="lab_mck_ShareholderDerivativeActionInsuranceProceedsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action, Insurance Proceeds</link:label>
    <link:label id="lab_mck_ShareholderDerivativeActionInsuranceProceedsMember_label_en-US" xlink:label="lab_mck_ShareholderDerivativeActionInsuranceProceedsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action, Insurance Proceeds [Member]</link:label>
    <link:label id="lab_mck_ShareholderDerivativeActionInsuranceProceedsMember_documentation_en-US" xlink:label="lab_mck_ShareholderDerivativeActionInsuranceProceedsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action, Insurance Proceeds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionInsuranceProceedsMember" xlink:href="mck-20211231.xsd#mck_ShareholderDerivativeActionInsuranceProceedsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ShareholderDerivativeActionInsuranceProceedsMember" xlink:to="lab_mck_ShareholderDerivativeActionInsuranceProceedsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_4f306e5f-4efc-49aa-b950-f663137ad0a6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_3e67c6a2-e5ca-4f69-bd45-5bd3f70cf5d4_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_60bbf64a-c6a8-45f7-a86f-0540e2743ffd_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_fb3d484c-7e1d-4e9c-bef0-b385125b60f6_terseLabel_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes due December 3, 2025</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_label_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025 [Member]</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_documentation_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member" xlink:href="mck-20211231.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A090NotesDueDecember32025Member" xlink:to="lab_mck_A090NotesDueDecember32025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_18bfcc69-ebe2-4cf9-8518-1c0897660c32_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_d33d534e-202b-4761-b6b9-cf47612248d0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9662b2b7-4df0-4452-a0c6-c471bb4b9baa_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_68e1a7fc-68d9-4cb6-8bbd-4e9d226bbdee_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Financing Activities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_f717abe1-a42e-4e0d-a3cc-0d2f1ab4e1e2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_f8439abd-b3cf-4b9c-b4b1-744dfba543f7_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_8bf38bb6-8367-4251-9f19-07e96e4039cc_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_f0fbb1d3-9457-4ab6-82b4-a71fe68219d6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_005df13b-7651-48eb-8c56-cc3579855520_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_c554f4c2-3752-43d3-9319-2a2a609b958e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_40ba0a84-d558-4ed1-ab67-ea2e8f3e2690_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_739c36d2-a6e0-44c3-bfe3-49e0e23b4a1d_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum redemption value of redeemable noncontrolling interest</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:href="mck-20211231.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:to="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_09413c3e-c656-468a-877e-8b8acb377f61_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, by Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_3da1c97b-e5eb-413d-b5f8-5e40636f811d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_31dc68c6-bc02-4a9a-9dc9-bf1458bff6b8_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_80e74c0b-32a8-4070-8c69-608a9df88c2a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value, 800 shares authorized and 275 and 273 shares issued at December 31, 2021 and March 31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_10f9d67a-c7dd-4bfd-a929-36d4859dcd10_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_e4bb8d89-5492-4fcf-b720-3883d80bb026_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_fc8f1762-8cc8-46c0-9785-1ca680a70b79_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_e229c4a2-bed8-4cc9-8c60-737b58d50874_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b65e7e8c-2a90-4dbc-8622-1a6e8b176402_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_7b6160d8-8066-412e-8ddf-062f6e70d53a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding the fair value of derivatives on a gross basis</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c3e81f83-e284-4ed9-b670-8fdee893171c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_acbf2e43-f2a0-4a9f-9980-0c0ca9dbccc0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory impairments and excess inventory</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_38ba0549-6454-4db4-8311-16817dc3b483_terseLabel_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs</link:label>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_label_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs [Member]</link:label>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_documentation_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:href="mck-20211231.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:to="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_03788e88-0da4-400a-8dae-4fc6f0a4354b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge recorded related to Company's share of the litigation settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_8a98dcbd-726d-4d57-be92-7e4660f986c7_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember" xlink:href="mck-20211231.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseMember" xlink:to="lab_mck_AcceleratedShareRepurchaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_6018190d-4c5c-48fc-9785-155f629add66_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_14f07f90-4618-4ec1-8daa-f8fb50d9efa0_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_2216444b-c265-4ae6-ad11-365a6ea6e419_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8318baa4-b692-4410-850c-353708ebe462_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_45739bb4-1729-446e-b672-aef4f967fb67_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9cd61acb-69c2-4d9e-9cab-40121ea74e7b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_9e863c84-2971-442c-a85b-809f230c0002_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_ddd07449-0880-4cfa-94f3-d12cdf60c487_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted balance, April 1</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c7d21c88-b61a-4053-b67f-56adcc433e7e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_18c59e98-9804-4b75-9128-19be0e955165_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_7d2e920c-3c7c-497d-8410-604983df3d0e_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_0f8d2ea3-ce93-4f25-b239-f1da519dfb64_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_45dc00ef-4589-4a92-8d52-f32d1b403320_terseLabel_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:href="mck-20211231.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_1565c5fe-27d0-4401-82cc-6c97fddbdbcf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_d1805d92-9d48-4901-882c-1602c87ef1fc_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for purchase shares of McKesson Europe</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_1cbd1bca-7ee2-45df-a078-916c2f3c8272_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_ff47adb2-96cd-464c-b90a-aa9961b29aab_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_722e2ca0-8144-4b81-b252-d8ed5616c7d1_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_cac98026-5336-4438-8216-d39522310e67_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_cd95d029-6b00-40ed-b740-b9cd0389f968_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_9757cd10-fda7-4931-a931-f616598ef173_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d434621b-63c6-4444-b547-02418593d248_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4fd7c320-3ac8-48af-904d-53dfd3209922_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0de8fa70-bf9b-4769-808c-0d9e8d0d8a78_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfInvestmentFundsThatFiledClaims_3015a062-11bf-454c-b70b-032527726a61_terseLabel_en-US" xlink:label="lab_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of investment funds that filed claims</link:label>
    <link:label id="lab_mck_NumberOfInvestmentFundsThatFiledClaims_label_en-US" xlink:label="lab_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Investment Funds That Filed Claims</link:label>
    <link:label id="lab_mck_NumberOfInvestmentFundsThatFiledClaims_documentation_en-US" xlink:label="lab_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Investment Funds That Filed Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:href="mck-20211231.xsd#mck_NumberOfInvestmentFundsThatFiledClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:to="lab_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_ee4ce869-8cb9-47ee-a3a0-9e7afcd9d051_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_d9ba5122-10d4-4be0-abac-674c41e1dd55_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_3075939d-f9f9-4936-927b-92db2b19aba5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_df57d63c-29bf-4d2f-870e-91942fcb7921_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_cb4d0f25-ee20-4d5b-ae2e-443ac1b9cc1f_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_83e5eaf8-11dc-45ed-8275-15ca825968f7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_2c08ed43-b2c1-47f5-91b8-90df15a42fc2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from net investment hedges recorded within other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_5d0dd0b4-11ac-45f1-b7fd-63934a71f79f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_27c25e18-6045-4b37-a412-fb5f7cd6969b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments of Business</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_dab60bba-3ba3-4c5d-b607-4e274fe7dcd2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c012c092-99f1-4fcd-8cb5-eac718c0f752_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_1e271e1b-b997-4d9d-a0e9-ea5f2424fa07_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_fbd1d604-7500-4098-bedc-2792f991a357_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_5037a2c6-27de-4e18-ba4c-c06c869f1f82_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_108ddaf9-4351-4525-990f-26fc3d19de58_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_62880439-5980-4eba-9ef7-48df66d85b6d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_29d2ac1b-4114-4ddd-b62e-b8e4c9fdb3d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_102c31b4-e707-4a76-8bab-9a53dc2d7f0e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment, and Related Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c4222f-1ef0-4f73-a9bb-696d2d699199_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_6876bbf0-b1cc-4b44-bac0-7f5e73f088d4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_c8b1f55f-d401-42f1-a2a9-09d007eb0b74_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6283719e-5ad5-45c2-908f-2c7647b03104_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7ab01df8-06c2-4efe-9e17-e2926b1cab12_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_3100b09f-ebc2-49ee-aa29-40d5386c0055_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_ab1139f3-a05b-41e6-9e69-759bb0d6be98_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_b2d169d5-afec-4fdc-8545-9a407f731dfd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_ba6b1777-94d5-4f5b-b3ab-89f139cdc2f6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_8749d222-cdf5-4a05-9748-fced20c01b8b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_8a49aeca-a3f3-4a70-8c03-4d51ae7b6fd7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_fcf8185d-9cfe-4ae6-9b8f-aec0cae48bf0_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of eligible states</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible States</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfEligibleStates" xlink:to="lab_mck_LossContingencyNumberOfEligibleStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_030a89d3-42a3-4e2a-90ba-4cf0056cf541_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfRelators_e94065c4-9d2e-48b1-add7-7752b5a15fb4_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfRelators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Relators</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfRelators_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfRelators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Relators</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfRelators_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfRelators" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Relators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfRelators" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfRelators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfRelators" xlink:to="lab_mck_LossContingencyNumberOfRelators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_b4dda845-6773-4af9-87d4-d0c4d75366b2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional values of financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NotesAndDebenturesExtinguishedFebruary72018Member_196ee896-f1cd-4a3f-b19e-6f388eb75a5f_terseLabel_en-US" xlink:label="lab_mck_NotesAndDebenturesExtinguishedFebruary72018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and Debentures Extinguished February 7 2018</link:label>
    <link:label id="lab_mck_NotesAndDebenturesExtinguishedFebruary72018Member_label_en-US" xlink:label="lab_mck_NotesAndDebenturesExtinguishedFebruary72018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and Debentures Extinguished February 7 2018 [Member]</link:label>
    <link:label id="lab_mck_NotesAndDebenturesExtinguishedFebruary72018Member_documentation_en-US" xlink:label="lab_mck_NotesAndDebenturesExtinguishedFebruary72018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and Debentures Extinguished February72018</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesAndDebenturesExtinguishedFebruary72018Member" xlink:href="mck-20211231.xsd#mck_NotesAndDebenturesExtinguishedFebruary72018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NotesAndDebenturesExtinguishedFebruary72018Member" xlink:to="lab_mck_NotesAndDebenturesExtinguishedFebruary72018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_dee4c991-304b-45fb-a3be-df6292347dd1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0edcc37f-4ec5-4cae-8fa3-b4017d92faa4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4cb23874-59b0-4e74-8de4-84c9e96df48f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_3600cbc3-5e80-47f0-bf37-90601690da39_terseLabel_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes due March 1, 2041</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_label_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041 [Member]</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_documentation_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member" xlink:href="mck-20211231.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A600NotesDueMarch12041Member" xlink:to="lab_mck_A600NotesDueMarch12041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_65f1956c-5d19-4c8d-90b3-038c1cd0b0cc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash contributions to the plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_4f7fa542-fea5-474c-a8bd-f4988b353247_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_12897ff6-6c63-49f6-a04f-1d1034cf8677_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_658da9b5-999a-4aa8-848b-40db56508db4_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_label_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_documentation_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:href="mck-20211231.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:to="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_496d79d2-9995-41fb-8f33-93fe58061f4d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_b3c92cc6-7265-4dce-8895-ece62868fa5b_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_1c10f78d-b115-4d2d-b4b9-d0e59993b580_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt extinguishments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_5bda64c5-d41b-4df8-bac2-2e98a62c9ff2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt extinguishments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_b99d90c4-cb91-409b-85da-1b0743684510_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b0354cf7-168b-4cb3-bd8a-d9a422255cdd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_cd74c003-4dc9-48f1-9284-9e904ba5fa14_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AustrianBusinessOperationsMember_15e889eb-d637-4e6f-8985-d27bf71cf981_terseLabel_en-US" xlink:label="lab_mck_AustrianBusinessOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austrian Business Operations</link:label>
    <link:label id="lab_mck_AustrianBusinessOperationsMember_label_en-US" xlink:label="lab_mck_AustrianBusinessOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austrian Business Operations [Member]</link:label>
    <link:label id="lab_mck_AustrianBusinessOperationsMember_documentation_en-US" xlink:label="lab_mck_AustrianBusinessOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austrian Business Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember" xlink:href="mck-20211231.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AustrianBusinessOperationsMember" xlink:to="lab_mck_AustrianBusinessOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_33bd2dd8-ecd6-4c9a-940a-c0b52e0ac1e0_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_57d340a5-cc1b-42c9-98e8-9b540c34d561_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_390858f6-9875-495c-b942-44fe92dc507b_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_deabc3f8-6930-4a38-a617-1641640a8829_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_4b288c70-8559-4842-ba40-ddd9cbfb6b3a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_903076c0-3f1b-4d91-b3a4-3a3b0af25b33_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4ad32173-8f27-4b74-a437-a2a4752d6946_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_40c6373d-695d-40d4-bc76-dd014ddeaa77_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_e8c32234-ec85-495e-993e-b2c3c4040574_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_3b72fdb3-2be1-4043-b482-82605c8a6623_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_af9039e7-3343-471b-8f85-df9066555938_verboseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_33dd7d03-285a-463e-b1d3-59e231d31797_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_7eefb29d-97a9-40f8-bb56-3dacc5146c4f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4427e81d-1f06-4d52-b46c-9ea6c7109e46_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_8bc99976-72cf-4d6c-81f8-385824d68d78_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_800136fb-55f1-4d6f-8981-d662e07ee76b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate consideration of debt redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_6794f9b1-235f-4ce2-8859-b23f9b23b112_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current [Member]</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_0745a689-d7a6-4f90-afe3-6be3fad817de_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d7e7e525-7f42-4296-b1e5-d8326a4c75dc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_313339ee-4f07-4b41-a6b2-2f3b46c4f4d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1500NotesDue2025Member_cc251e07-66fe-467e-992d-169f4161cb8b_terseLabel_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_label_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_documentation_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member" xlink:href="mck-20211231.xsd#mck_A1500NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1500NotesDue2025Member" xlink:to="lab_mck_A1500NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_579d6e01-c974-49b0-9db2-5883a4c05178_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_f4e42f03-36a5-4c97-8a5f-d50562940e02_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6fe9ea41-7f2d-437c-980e-739f62240cda_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_0540522a-8a98-46a8-a1fd-eb49cc35ec32_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_043b3cea-eec7-457b-b7f0-6a98631ffc79_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_b5a1d878-e630-4210-ba3e-4efca864f63a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_72bc116b-feff-4752-861f-20775f39b838_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_4e5690ac-fb49-40d8-b620-36052feeb1fa_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_db2a39f1-631f-41c9-bfad-017a58d21f15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_e8a044a0-247d-413e-865a-83f585f35a3e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_8a00a198-744c-4879-a0de-e4818fe5a6f5_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right redemption price per share (in euros per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_c6b8c1ba-bacd-42e5-8177-8b6dbc9fdbf7_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_3513b7f5-78b5-4015-871a-41394196ad86_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_fb6a212f-c7bb-4da2-88ee-574505e4ddfc_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_f2d3de17-e546-45f3-b611-3994bf2fe56c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a1e6923d-7982-41e9-ae88-8d12c72153ba_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans, net of forfeitures (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_53a33b47-16b3-499c-85ae-826853f27272_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and other obligation</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_d685c4d7-7469-4982-a3ca-8ebc64c61772_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Contract</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfTerritories_f1f00c24-1e6d-4f9c-87fc-da2835d1e985_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfTerritories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of territories that have joined the proposed settlement agreement</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfTerritories_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfTerritories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Territories</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfTerritories_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfTerritories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Territories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfTerritories" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfTerritories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfTerritories" xlink:to="lab_mck_LossContingencyNumberOfTerritories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4f0b6252-17c9-45ca-bbaa-f674d2a911bf_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_29c38aef-33ea-4e2d-a52e-8b59ac04506e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_784b67cf-ff9b-4e71-9bb8-ac1e6c5d30c2_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_33ea5178-ecef-430a-8eae-b54c601396b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a8413554-823c-4cb5-847c-0a8b197de573_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_ceb5df4f-c2b4-4cfc-a144-dc6cf0c8e704_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_c4158eae-a218-419f-9579-762f2e3bca25_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which entity segment operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_1262cdec-c01a-43a4-9dff-1644a89d0317_negatedTerseLabel_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate income (expenses), net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_label_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_documentation_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:href="mck-20211231.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:to="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_9cf333f1-137b-4e82-b08d-631082431947_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_d1c6b349-7333-4488-a02f-a727f59339f7_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ed837a80-e59d-4557-a291-6a380c1357dc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_68e253b0-3e3f-4749-875c-e12fa8b3e92d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2c37babb-818a-4902-bcea-8bfcc5d0eeb6_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f4f2dbaf-608f-4b6b-a558-8a20028bb76e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9b5bfec6-b515-48a3-9791-4e6804a4a808_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a6a6f05b-2877-4ade-bb22-f32f693de5c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) related to continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_12727130-669c-4b71-ad55-32b63858002f_terseLabel_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_label_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:href="mck-20211231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:to="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_c57e9976-4e12-4d40-8245-7e3c8b57ce56_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_47bf91a4-a716-426b-b868-46e9aa350c5f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_2003e2d6-6241-4db2-8c41-7c6e0d5b88dd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9c5a935d-c8fc-4e1f-9d99-e452ffbb2cc2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_54b326a9-651a-43fa-8245-061e965ce86c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfNewYorkMember_3b0e9b7d-75d7-4c3b-9d7c-5f379fde27cc_terseLabel_en-US" xlink:label="lab_mck_StateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of New York</link:label>
    <link:label id="lab_mck_StateOfNewYorkMember_label_en-US" xlink:label="lab_mck_StateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of New York [Member]</link:label>
    <link:label id="lab_mck_StateOfNewYorkMember_documentation_en-US" xlink:label="lab_mck_StateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of New York</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfNewYorkMember" xlink:href="mck-20211231.xsd#mck_StateOfNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfNewYorkMember" xlink:to="lab_mck_StateOfNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0d77c58f-8235-4b41-a6e6-9bd04c4f1ee2_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_7ec5013d-c532-4a88-aca7-e24c70eb7f65_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_66058647-80c9-4f87-b48c-be0094a0d5ad_terseLabel_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures due March 1, 2027</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_label_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027 [Member]</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_documentation_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member" xlink:href="mck-20211231.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A765DebenturesDueMarch12027Member" xlink:to="lab_mck_A765DebenturesDueMarch12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_960812b1-1823-4889-b083-0bc0ecb0d152_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_196114c7-8f34-482d-9997-fb77220ec6eb_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in noncontrolling interest</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_01661d04-9f4d-411d-9a4b-5373e3ed7e7b_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercises of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:to="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNet_4ad5249c-bd24-4e99-b872-562cdd0337a6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsNet_label_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNet" xlink:to="lab_us-gaap_AssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStates_0d18e0e5-2c71-4549-b03b-e01a780c718c_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which court cases are pending</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberofStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStates" xlink:to="lab_mck_LossContingencyNumberofStates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CherokeeNationMember_1af4e174-9167-4dd5-ae8b-0a09773966ea_terseLabel_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation</link:label>
    <link:label id="lab_mck_CherokeeNationMember_label_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_CherokeeNationMember_documentation_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember" xlink:href="mck-20211231.xsd#mck_CherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CherokeeNationMember" xlink:to="lab_mck_CherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_626bb245-efe5-48f8-ab43-4fd830a3eed5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_13326938-8aeb-4982-bdb7-cde870f6bd0d_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States Filed on Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States Filed on Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States Filed on Behalf Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfStatesFiledOnBehalfOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:to="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_6bbc77ba-f6d3-4db1-b2eb-57cd018350ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_3848c044-91b5-4bec-929c-045569e46e82_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d87a260e-e846-4554-8b4e-800dfb4c0c53_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_66b41090-9587-478e-bf12-d9cdbb8a3b78_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_a857ca2a-ea45-4bfa-bab3-99e68d9c0fc0_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross purchase price</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d70c1060-997d-48f2-9947-a32670787447_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_461928f9-de53-4f21-920d-323baa705c9d_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_77eb726a-f0f7-466d-ba1c-cdc6046b6ede_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_642be572-6c5b-4d78-84f6-fb766f028a40_terseLabel_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software</link:label>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_label_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software [Member]</link:label>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_documentation_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember" xlink:href="mck-20211231.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternallyDevelopedSoftwareMember" xlink:to="lab_mck_InternallyDevelopedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ce61af19-4256-402a-b03c-5fe863c8b746_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_670e0ad6-1b88-4bf5-b534-9537d9b4c518_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_a31aab8d-722f-4246-a806-5d12614217be_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_25af822c-0734-4a83-b575-00a80b297c08_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_f737741a-6c38-4815-b48a-51f11bcbed5c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_123a0987-a75f-43c4-a5bf-fed115f6cd00_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4421a6b9-8182-48aa-b4fb-424b6b3a9143_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_7e160c5c-5194-4884-b7c7-9dd8c011fc67_terseLabel_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opioid Litigation</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_835ca0f9-b380-451f-93e2-560d581a4dee_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Dollar, British Pound Sterling, and Euros Sublimit</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:href="mck-20211231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_39223b9c-c53f-4d6e-a805-8adbae5ac3f1_terseLabel_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of national brand medical-surgical products offered (more than)</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_label_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_documentation_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:href="mck-20211231.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:to="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PharmacyLicensesMember_e8ed8928-a414-4153-82ea-146b239f0ec4_terseLabel_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy licenses</link:label>
    <link:label id="lab_mck_PharmacyLicensesMember_label_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Licenses [Member]</link:label>
    <link:label id="lab_mck_PharmacyLicensesMember_documentation_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy licenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember" xlink:href="mck-20211231.xsd#mck_PharmacyLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PharmacyLicensesMember" xlink:to="lab_mck_PharmacyLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_e9121db3-c7ac-40c8-a8c7-d09bfe09118f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_bf1e46f5-9790-42d4-9d70-3fd8e51d67a3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfFloridaMember_563b0fcf-1a5d-44cc-b7e1-dba24ec2ab32_terseLabel_en-US" xlink:label="lab_mck_StateOfFloridaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Florida</link:label>
    <link:label id="lab_mck_StateOfFloridaMember_label_en-US" xlink:label="lab_mck_StateOfFloridaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Florida [Member]</link:label>
    <link:label id="lab_mck_StateOfFloridaMember_documentation_en-US" xlink:label="lab_mck_StateOfFloridaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Florida</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfFloridaMember" xlink:href="mck-20211231.xsd#mck_StateOfFloridaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfFloridaMember" xlink:to="lab_mck_StateOfFloridaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_da5d5ef2-d85a-40e6-8bd4-47aa41532fdd_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_f5fbfeb3-615b-483d-88ab-ec361ad9acc4_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award payable under proposed framework</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_8188db3a-7fe3-49f2-a3c1-65300d21858c_terseLabel_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash classified within Assets held for sale</link:label>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_label_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</link:label>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:href="mck-20211231.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:to="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GovernmentalEntitiesMember_74125d7c-e84c-4355-bc6b-4f96f4dac139_terseLabel_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental entities</link:label>
    <link:label id="lab_mck_GovernmentalEntitiesMember_label_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Entities [Member]</link:label>
    <link:label id="lab_mck_GovernmentalEntitiesMember_documentation_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember" xlink:href="mck-20211231.xsd#mck_GovernmentalEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GovernmentalEntitiesMember" xlink:to="lab_mck_GovernmentalEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_293c7aec-4898-46ae-a6fe-ebe51a408e53_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_3605361a-46d0-471b-b75f-5013f1bcc112_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Commercial Paper, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:to="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_d19c7366-b918-455f-9d16-2703b288322e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A3125NotesDue2029Member_681a94d8-aeb2-4fa7-bf8b-7678cf9295e6_terseLabel_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_label_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_documentation_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member" xlink:href="mck-20211231.xsd#mck_A3125NotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A3125NotesDue2029Member" xlink:to="lab_mck_A3125NotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_0479a750-d854-44bd-885f-69a499af950d_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_a8f63210-3734-4a29-a2ba-f5c25c623e15_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_5344c624-98d9-467a-a048-83d97d882bac_negatedTerseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of assets of business held for sale to fair value less costs to sell</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:href="mck-20211231.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4116df6f-1017-4bb1-916d-83a87f909e89_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f7773031-7d72-42d3-89b4-49e94a1cde8c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3a1c8e0f-a9a3-46dc-8a48-47220c913ec3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_2c280065-9ab5-4d13-a122-d943737da2fc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_7119b467-db6d-4d8d-b962-f8d9f362880b_terseLabel_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan - Remote Work Transitioning</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_label_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning [Member]</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_documentation_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:href="mck-20211231.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:to="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_52070998-ca78-472b-84df-1f79fe1e78c9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_e3920e3c-e992-4281-8f21-bd030c48e31e_terseLabel_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember" xlink:href="mck-20211231.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EUBusinessesDisposalGroupMember" xlink:to="lab_mck_EUBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_7ac9a631-9937-4494-919c-dc98a29b9e24_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_95b0371d-8c0f-4f0b-91c7-8c274596ea47_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_4ceb7212-7ef6-4322-8aa3-1cf0f4740289_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_6818fe7f-8fcd-42c7-a452-34a40e206248_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_a4041162-0e54-4f4e-acde-668730fb3b06_terseLabel_en-US" xlink:label="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</link:label>
    <link:label id="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_label_en-US" xlink:label="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, No. 18 O 455/17 [Member]</link:label>
    <link:label id="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_documentation_en-US" xlink:label="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, No. 18 O 455/17</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:href="mck-20211231.xsd#mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:to="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_c2c26460-4ed4-406a-89c7-1a161da90b99_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_e2c57142-4585-4c6c-b7d1-15469f22c3c5_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_92a269e2-1d17-42a8-8ff2-c89736df0ac1_terseLabel_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_label_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_documentation_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:href="mck-20211231.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:to="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_99db66b7-03df-41ec-96b5-4cc3c1dc7d37_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_10826e8d-d1bf-4707-842e-432ab1ff744f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of computations for basic and diluted earnings per common share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_02079b59-a2ab-42b0-9af3-84347145c8e8_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9c5a1bfb-6560-40e3-8b78-2f5651d4e53c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_8bc9d4ea-264a-4c65-a86c-24e8f4d3bd95_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges recognized</link:label>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_label_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:to="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1e9f75b2-5676-4454-9455-0a5049fbeee7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e26e3548-b5c2-417a-883b-8cdc15100e71_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_ce4c2104-b3ac-451c-9dbe-4223958b1213_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_00ec7537-d9a2-455f-b97c-21d671f53c46_terseLabel_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes due October 30, 2026</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_label_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026 [Member]</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_documentation_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member" xlink:href="mck-20211231.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A163EuroNotesDueOctober302026Member" xlink:to="lab_mck_A163EuroNotesDueOctober302026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2d8fd1bf-1108-4849-a8bb-81d30ec2eaff_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_ae047ecf-18e5-4be6-af2f-a00551a4702c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_2207bcbe-f78a-422c-8714-754bb470b6ea_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_b4367fad-882f-43f9-b221-01864a20a37e_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims and litigation charges, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_e3aa9fda-adbc-463a-aa35-db8c5848917e_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on settlement proceeds</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_89f0c7e1-0643-472c-8666-51a7d4e0bd77_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_478ce7ac-0d11-4ebc-9831-a478afbf9d1d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_357b46c1-ec9d-4ba0-a0b4-7578b5c3e6ed_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected total pre-tax charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_ec5f3890-269f-45cf-aae2-f3038f5b559e_terseLabel_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_label_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_documentation_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember" xlink:href="mck-20211231.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RetailPharmacyReportingUnitMember" xlink:to="lab_mck_RetailPharmacyReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_7f6b24f9-b80f-4812-9f88-0779a33c8a1b_terseLabel_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes due March 15, 2044</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_label_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044 [Member]</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_documentation_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member" xlink:href="mck-20211231.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A488NotesDueMarch152044Member" xlink:to="lab_mck_A488NotesDueMarch152044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuropeanAssetsHeldForSaleMember_6270c891-4561-4451-adc8-a0345849ba18_terseLabel_en-US" xlink:label="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Assets Held for Sale</link:label>
    <link:label id="lab_mck_EuropeanAssetsHeldForSaleMember_label_en-US" xlink:label="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Assets Held for Sale [Member]</link:label>
    <link:label id="lab_mck_EuropeanAssetsHeldForSaleMember_documentation_en-US" xlink:label="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Assets Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanAssetsHeldForSaleMember" xlink:href="mck-20211231.xsd#mck_EuropeanAssetsHeldForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuropeanAssetsHeldForSaleMember" xlink:to="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_7915e4ff-84c0-4fd7-99f3-65aa5ba1f32b_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_176dc44a-8cee-4691-afe2-14200435fcdb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on debt instrument (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_f80aeea7-4043-41dc-b87e-e20b069c470a_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_f1ae470a-0fcf-42aa-9a18-496b500689ff_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_a78871a8-7d79-4d33-8559-cb67d8d2f16d_terseLabel_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes due February 16, 2028</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_label_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028 [Member]</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_documentation_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member" xlink:href="mck-20211231.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A395NotesDueFebruary162028Member" xlink:to="lab_mck_A395NotesDueFebruary162028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_724df7c0-2488-4d4f-ac80-1f00f9e7b6d4_terseLabel_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_label_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale [Policy Text Block]</link:label>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_documentation_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldForSalePolicyTextBlock" xlink:href="mck-20211231.xsd#mck_HeldForSalePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_HeldForSalePolicyTextBlock" xlink:to="lab_mck_HeldForSalePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5ffa8c41-860a-4876-bab9-158b74e24eff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_df09a3c3-296a-4630-aa29-f07a9dca11cb_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2021b4b1-ec16-4ab4-a207-87f5caafeebd_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_21f6eee9-9a2e-4bae-bf47-c2aa5cc48ec6_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_386ac41d-8bee-450f-9a0c-ffaa6864ade4_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_2aa68905-2677-4458-b4ed-7a877901b472_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_b2457cd7-935e-46bf-b5e8-c69361947d9d_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_3dbd9494-6bf9-421e-a40f-7057ea98c677_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_bed59985-a0e3-4b88-8273-14e901a37149_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_3d84a0e9-f0b4-4b47-a226-6a809932e52c_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_6fbeea4d-4140-4b49-b836-92cef705b498_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_fc0dbeca-6818-4abf-80bd-6166a2c65785_terseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_dce1dbc9-3295-4f26-8fd9-f0e6f1303aea_verboseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated increase in Company's ownership interest on its equity</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_label_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:href="mck-20211231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:to="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_ae3c37bc-e5d0-4485-8dca-95e5466b523f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_004a140a-4f2a-4bc3-b60e-8482be9ede09_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_178b1cf1-1e26-430a-982e-6fc2d94ba7c7_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_fdafe04f-5c77-4e2f-acc0-1e6d44bd1fc7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4d484ee3-dd4c-4a4b-baa3-2efab717c1d8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_a5996785-2030-49e9-a354-6302276237cf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar, notional amount, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_140118b6-2d2d-47ce-87fb-0696b67779db_terseLabel_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes due November 17, 2025</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_label_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025 [Member]</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_documentation_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member" xlink:href="mck-20211231.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A150EuroNotesDueNovember172025Member" xlink:to="lab_mck_A150EuroNotesDueNovember172025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a88e052d-5617-4a47-9278-73dde559b0d6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1f8dc31a-8e3c-46cf-b6d8-8663b59edd0d_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_52f3c315-c44b-46f6-845b-54f9e8c91618_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_b7b37a39-3551-4ba1-9256-7e6062d9d693_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7beea927-751b-40eb-8e7a-1f1c2d1f2e9f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b5739c8f-16a5-4fbe-a0ad-f5e73d8692f7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_cf9dce3a-9382-47ae-90bc-dba8107fe19a_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_25275506-1d7c-4f03-8f48-b9e125ec1fb6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_ad67175e-e6a9-4855-ad76-1e098021f226_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_dc527de9-731e-4af7-98d5-8e30c4841898_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2a2076b8-0b90-464a-9288-bc00108e8abf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_158659b8-50c7-4fa4-aa11-73df89146ce1_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_41379c8d-5c4e-4b70-bab8-43287cd879e5_terseLabel_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. and Austrian Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_label_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group) and Austrian Business [Member]</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_documentation_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. and Austrian Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupAndAustrianBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:to="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_5cbbed76-1702-4492-b145-a1dde8b57ba7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4713a294-fe02-467e-95f5-805eeebfda2d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_b5570882-e45b-4b5c-b200-205d36e5f9e7_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_3fe81765-fa80-4fab-9f59-95b31023ff41_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which award would be payable under proposed framework</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:href="mck-20211231.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:to="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_4aac3d87-ce90-4d3b-907a-f7aae20ab5da_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_d80ef9ed-27f0-4409-b9da-c208db6cd4c6_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares, at cost, 125 and 115 shares at December 31, 2021 and March 31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_37290914-7af1-4114-86a4-b6053805cb2f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5c1df762-3782-4c1f-a39f-97b546b08950_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_f1bd1854-c4b6-4e50-bd02-4d34bc7ec4e2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_9f079207-456a-49c2-98fb-b6c34779daf9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_d1f61358-47d3-4859-9430-0268610ac0ae_verboseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_4f0beba0-252c-40e8-ae09-c68f84b124bd_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_66859f58-5113-40a4-821e-d4bdd288db36_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_6f5d1c2d-ac8e-446f-9ee4-30c59a1d4081_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember" xlink:href="mck-20211231.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestMember" xlink:to="lab_mck_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_235b6f88-1bd2-420f-b974-75a582d0c8a7_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_1d5ed950-de10-41d6-8159-831e3f08839c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8ba51470-fe54-4c53-a2c7-2c7709b8c06e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2bbd1c28-1313-49f1-9cf5-71c66487bbe0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_6ddf03ef-c30c-4c3b-b020-3360192847d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) from sales of businesses and investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_a7cf0c02-208e-4147-8417-9cca8fc15ac5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_4706860a-0bfc-4bed-b945-f560e6644b4f_terseLabel_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Disposal Group (Disposal Group)</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UKBusinessesDisposalGroupMember" xlink:to="lab_mck_UKBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_1c37194e-23ca-40e7-bfad-ec2b5c24ff6e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_c9a32deb-ac62-4bcc-b92e-f5fa7e6512e8_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_48e0f13a-eabf-4c09-86fa-a0f515a7d0d5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UKPensionPlanMember_d125d892-39aa-4636-9ba4-33e3b5d4f3a3_terseLabel_en-US" xlink:label="lab_mck_UKPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Pension Plan</link:label>
    <link:label id="lab_mck_UKPensionPlanMember_label_en-US" xlink:label="lab_mck_UKPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Pension Plan [Member]</link:label>
    <link:label id="lab_mck_UKPensionPlanMember_documentation_en-US" xlink:label="lab_mck_UKPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKPensionPlanMember" xlink:href="mck-20211231.xsd#mck_UKPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UKPensionPlanMember" xlink:to="lab_mck_UKPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_03c730c2-d6c9-4f00-b439-8ad8b9775656_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_52f980bc-d24d-4f9a-84a4-4fb7d5df4846_terseLabel_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="mck-20211231.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_c7ac9730-5302-486d-8cda-d74a59a0f8fc_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of other national distributors named in suit</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:to="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_29a7ed4e-b1e6-4fd8-b90b-7e862607239b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_be0927f4-32ee-4fd4-b592-d2750b4947ae_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_18c1bf07-e936-4c9a-9c80-a2af12dd5438_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c0fce3db-7625-4dcd-b6f7-bb7955b322b6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dba1743d-07c2-4a90-b4d9-6b1facf8e20a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_18b8d5d6-efa5-460d-8574-ce781e21d3a9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, remainder of 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_1d91697f-5475-487c-80e8-1c91b1af34b7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_f5e5e044-26df-4a5e-8161-a1600e61caa7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment, and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_9fe76811-e6f1-4304-83d6-88a0a2d86893_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e5920fff-1859-478a-980a-e284b3dffea5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_f3e7a064-2185-4221-a3e6-3356ed8f36d8_terseLabel_en-US" xlink:label="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments</link:label>
    <link:label id="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_label_en-US" xlink:label="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments [Member]</link:label>
    <link:label id="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_documentation_en-US" xlink:label="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:href="mck-20211231.xsd#mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:to="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_9c65b552-2af9-474f-8901-94aa90631eeb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_9659ad2c-78ca-49d7-bfec-4b061c9e001c_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComparabilityOfPriorYearFinancialData_4cd0a059-745b-42b3-b02a-0048dbc7145e_terseLabel_en-US" xlink:label="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Results of Operations</link:label>
    <link:label id="lab_us-gaap_ComparabilityOfPriorYearFinancialData_label_en-US" xlink:label="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comparability of Prior Year Financial Data, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComparabilityOfPriorYearFinancialData"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:to="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_0b9fe411-d190-4785-b1a8-519ef7808220_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_c50bd017-947a-4ba2-aa30-0b6173d8a58a_terseLabel_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments and accelerated depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_label_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_documentation_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:href="mck-20211231.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:to="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_a5b72446-5d6d-415f-9a36-09040407c67a_terseLabel_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:href="mck-20211231.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_c31e4fdb-985a-4904-9e72-5f62baf60abb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Accrual Liability</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Contingencies by Contingency [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:to="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_56fdd7f3-ab17-4a54-a5fa-0753ad960110_terseLabel_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other/Other accrued liabilities</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_label_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_documentation_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember" xlink:href="mck-20211231.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CurrentAssetLiabilityMember" xlink:to="lab_mck_CurrentAssetLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_345a1ec8-1fe0-4e2c-ba11-7a973b2074e3_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_5915df27-bea6-48df-949c-45df51b07051_terseLabel_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue derived from services, percentage (less than)</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_label_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_documentation_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage" xlink:href="mck-20211231.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenueDerivedFromServicesPercentage" xlink:to="lab_mck_RevenueDerivedFromServicesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_ebc03092-cd2d-48f2-b105-ebcb3c6320cd_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f1d2c5e8-2edd-4156-bfe8-e6eb0f6a2070_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_1a306110-5d89-4a7d-8b69-1912f5993984_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_c9b269c4-8247-437a-bcc6-8f438bd8f370_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_cfef2077-7995-4bba-9075-1ea6f38fe0e9_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_db9cec98-e706-4700-9d66-7f5e29ff4a8b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_63acc6ef-47e8-4abf-93dd-56e3a9bc41a6_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_bdf02d92-1582-4fa2-be0e-c59664ab5db6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_c2e692c2-d2f1-404c-99d4-8555a8f9aeed_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_5e79c072-f17f-4e2a-9072-23664fd4b268_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_60704fea-1b23-4a32-a397-d1637d7cd9ee_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_988a2518-7b96-46d8-9fe0-b5adb0fb74a6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1625NotesDue2026Member_8cab195a-e995-49d3-8f33-ed56e8f6571d_terseLabel_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_label_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_documentation_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member" xlink:href="mck-20211231.xsd#mck_A1625NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1625NotesDue2026Member" xlink:to="lab_mck_A1625NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_c3e8fff5-fd79-43c7-91e0-7b92b64abd07_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_6a1fd7af-0ce6-413b-b10b-a03f2fcda2c4_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_de86c34f-75b9-435e-b959-f34523bad2fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_8f29aacd-3953-4d91-8da3-ca85074f158f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_2dce5b5c-c074-4ee9-b16c-14b61e487cfc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_c43e470b-7d78-4040-bc77-3e7b77362b80_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Reclassification to Liability</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Reclassification to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:to="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_5b132e84-3b15-4d21-8588-8e0edc6aeae4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transactions:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_f21c1ae7-eaec-4080-964c-a4504cc711e1_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_0425b80f-3d12-49e1-97e2-4257eec09007_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_6979433a-a320-4c7f-b626-199b22848252_terseLabel_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_label_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_documentation_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember" xlink:href="mck-20211231.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_November2018CrossCurrencySwapsMember" xlink:to="lab_mck_November2018CrossCurrencySwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_c34c619b-9379-48f5-ba0b-29eb15c52946_terseLabel_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions</link:label>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_label_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions [Member]</link:label>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_documentation_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:href="mck-20211231.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:to="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_ac3a421d-2329-4ca1-914a-961030adc153_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_fb409345-76c5-4884-abc9-df33a84965f5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0ed534a7-f7f9-4810-b9d5-fe3e83cd4e9c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to income statement</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_e94dcb42-cd53-4918-974d-d2c26f822451_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_9174d5f9-aaab-4e6f-b0d0-d57070319a08_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premiums</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_26a2b3aa-852d-4474-9e23-b142d6f24b4a_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of McKesson Europe AG redeemable noncontrolling interests</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_6ffdb102-09a0-4217-96fc-b2493493eda9_terseLabel_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of McKesson Europe redeemable noncontrolling interests</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_8578a59b-5c36-40ab-8f0c-ba3f2a49c737_negatedLabel_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of McKesson Europe redeemable noncontrolling interests</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_label_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:href="mck-20211231.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:to="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_cadaceff-c32c-4a17-8148-c28335f1a66f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_ac535b6c-534e-45fa-8334-e6a402dd754c_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and employee-related costs, net</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherAccruedLiabilitiesMember_9e263b52-a231-458c-8375-661e43b82258_terseLabel_en-US" xlink:label="lab_mck_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_mck_OtherAccruedLiabilitiesMember_label_en-US" xlink:label="lab_mck_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities [Member]</link:label>
    <link:label id="lab_mck_OtherAccruedLiabilitiesMember_documentation_en-US" xlink:label="lab_mck_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAccruedLiabilitiesMember" xlink:href="mck-20211231.xsd#mck_OtherAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherAccruedLiabilitiesMember" xlink:to="lab_mck_OtherAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_238042c4-bb74-4ee9-91f2-b925c1cb748e_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_2a2e9fb2-70bd-4cf8-8c15-c1ca04f1fa0e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_1e7b3e52-5243-488c-9b2b-7a68a1e56bda_negatedTerseLabel_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_label_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_documentation_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:href="mck-20211231.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:to="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_88e50070-6113-4dc0-8c86-8d1b41085f0d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_5056f1c2-50a7-4bc7-98bb-888db7bbfff2_totalLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_61011770-f39b-4c70-82b6-94439a7a95c3_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_cf90fac5-b2be-4440-8ead-0ab62dd5d0b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_cce25673-27c7-44ea-9b8f-26067ad14049_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_bdad6733-997d-4955-9e97-c1a368235f55_terseLabel_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation</link:label>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_label_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_documentation_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:href="mck-20211231.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:to="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_2a08442a-5566-4e44-a7b9-b1d76038f1e8_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_5379f7bd-04d3-4f2b-bc6f-b74755be9558_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_84b0c506-6031-4385-9296-adcc1dac8632_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_bd625a21-2e87-4f04-8fb2-8b63fd0a3475_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_3c075123-57ae-45e5-a406-3a85345202f8_terseLabel_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, thereafter</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="mck-20211231.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_cc1c80e1-df74-4b37-8fd4-3a005ebcea55_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_81dd0dbc-0c08-4cfe-bd09-4f83f08c04bb_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_922cab9e-c7ca-4d00-9783-ca3612e082e9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_69e174ab-9768-4d3c-b582-3567cfd01d34_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_eb45d169-ca92-4aa3-ae65-d39b12e7c60c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported income tax expense (benefit) rates (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_106bc4a6-8402-44f4-b02d-37557bfe419d_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_a3dc146a-c2b6-425b-a68b-0f7f07a43adc_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_1f1d6965-4536-48c8-8811-99517edb17b9_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_0cd7a541-a273-4f9a-9fb1-e941018b94b8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of period included in Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_bec368e7-2f9c-42ba-99a4-05c64575563f_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfOhioMember_67767c5b-b465-4115-b802-a8d17b45b6b5_terseLabel_en-US" xlink:label="lab_mck_StateOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Ohio</link:label>
    <link:label id="lab_mck_StateOfOhioMember_label_en-US" xlink:label="lab_mck_StateOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Ohio [Member]</link:label>
    <link:label id="lab_mck_StateOfOhioMember_documentation_en-US" xlink:label="lab_mck_StateOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Ohio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfOhioMember" xlink:href="mck-20211231.xsd#mck_StateOfOhioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfOhioMember" xlink:to="lab_mck_StateOfOhioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9ee6c45d-9e1a-409a-8cc4-f1af4c7bc0e1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d9c93db3-6768-42d1-a1e7-e126bf28ee35_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_106fb833-5479-4183-be0c-574d9272fd30_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_54bb0bf1-73a8-417b-b83c-1b49da018235_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_824cb61c-b255-4be1-b9b5-207adb090645_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_bb0eb321-0616-4156-b080-f45179d1d424_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_110c2404-dd11-4510-a842-d3bdc03505a8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_05bcc963-afda-4a68-bf6d-c993b09cc0d5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_1df78d3f-cc27-429e-aac5-24882a9619ac_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_e796d7fe-ddd3-4f29-925f-2980e10c5d61_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_782d7aa1-c63c-4267-bc58-8f1bc7650dce_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_e43b5879-7251-4552-852a-9443e78e7eb2_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ce5a89a2-5110-475a-9b25-949533ee8e50_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_baa67412-7f77-4bcb-8cb8-a543b7f86a03_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_20a677f0-9977-4c50-91bf-f41d3409d299_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f7df46b6-d53a-4bce-82e4-b471b3ea09dd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_17c1c83a-22f9-44a1-a2ab-13f3297353f7_terseLabel_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Business</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_label_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Joint Venture [Member]</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_documentation_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:href="mck-20211231.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:to="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_79451366-a5eb-46a7-9a23-bbb5c7761a75_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_4204da92-79f5-44cf-8368-8ede26321500_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternationalSegmentMember_6de426cb-5303-475b-94e6-14ef7b87f8ee_terseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International (1)</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_label_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_documentation_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternationalSegmentMember" xlink:to="lab_mck_InternationalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4bbc76fc-8804-4274-900f-5824800ed4c6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_351a99b2-67f8-47b3-88aa-adc8fbd83848_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_3a4b7762-0940-4456-82aa-0a3078658271_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of settlement to be paid by the Company (percent)</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_label_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:href="mck-20211231.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:to="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7c1b23cf-76b8-4d32-85c3-87fc23ed6588_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_bef77b3b-1212-44f6-9158-ba5791501ea0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_a8c5ff42-e904-4429-86f8-e1a730e37db0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_e4b1d95b-14b0-4207-a72a-e6574e4a6ab4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_9302b8de-446a-4763-aad9-9d4c4200c22c_terseLabel_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge</link:label>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_label_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge [Member]</link:label>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_documentation_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember" xlink:href="mck-20211231.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NewYorkOpioidTaxSurchargeMember" xlink:to="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_1cfe8daf-2bf4-4db2-83c9-abb7d1ba566f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_565635ec-ef3b-461e-83ea-56eb22148241_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_6ee8eb0b-b2d7-448b-9018-15e432a4760a_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al.</link:label>
    <link:label id="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_label_en-US" xlink:label="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al. [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_documentation_en-US" xlink:label="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:href="mck-20211231.xsd#mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:to="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_e2a85169-4407-4e29-b577-ef100b5bf54d_terseLabel_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_label_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_documentation_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember" xlink:href="mck-20211231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_USPharmaceuticalSegmentMember" xlink:to="lab_mck_USPharmaceuticalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7d0675b2-34e0-450a-bb1f-2138f892540c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_40408273-1c39-436e-a698-344a0cd50258_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfBusinessOperations_648d5428-3bf0-4572-9199-958634efe803_terseLabel_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business operations</link:label>
    <link:label id="lab_mck_NumberOfBusinessOperations_label_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Business Operations</link:label>
    <link:label id="lab_mck_NumberOfBusinessOperations_documentation_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Business Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations" xlink:href="mck-20211231.xsd#mck_NumberOfBusinessOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfBusinessOperations" xlink:to="lab_mck_NumberOfBusinessOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_5ce1b4a9-f5ca-481b-97e3-e78db6f61fba_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax benefit recognized due to statute of limitation expirations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_69826232-1f85-4ced-9dee-d26d021f4e7b_terseLabel_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes due February 17, 2029</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_label_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029 [Member]</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_documentation_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:href="mck-20211231.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:to="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ab902549-68cd-483f-8e4d-8ed583c838b5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_0ae0cbf6-f379-4a93-9d76-2e67f6a561cf_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_51ade860-d74c-41a0-9a9a-12458923fb32_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_1a211dc4-f807-4863-bf70-6b8f80013705_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f22c3dc3-620b-4416-b6d9-5cbbc0e2fcf2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ae4db5a3-d346-469a-8054-a39b052c386b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_e667ec85-fcda-4aaf-8f0c-c10a0154c1b2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued unpaid interest</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a1320cc7-f455-4a5e-b1e5-d946e2d26eb4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans, net of forfeitures</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_e2083695-0efc-4965-b13e-bd053d39803c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar notional amount, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A2025NotesMember_8fd1cd7a-fa95-4e3a-b003-63b6fb97d880_terseLabel_en-US" xlink:label="lab_mck_A2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes</link:label>
    <link:label id="lab_mck_A2025NotesMember_label_en-US" xlink:label="lab_mck_A2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes [Member]</link:label>
    <link:label id="lab_mck_A2025NotesMember_documentation_en-US" xlink:label="lab_mck_A2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2025NotesMember" xlink:href="mck-20211231.xsd#mck_A2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A2025NotesMember" xlink:to="lab_mck_A2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ba716eb0-0989-4fd1-b64a-62e09a64cac5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_0ea9d9bf-f9f4-4c74-9f27-6e875d2908f9_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_2bd2e26c-2f49-4674-b1d5-575fb65e3c88_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_16380519-54c0-457e-a369-d0a06b471692_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_ec389e09-4d77-4589-ab94-95dbe6731caa_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2971e7da-b392-4616-a548-bca1015df770_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ff838b59-0210-4de2-8d87-9567a4535abc_netLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding notes (up to)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_127462cb-762b-46bc-be6f-fc1fb141aad7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_a916fc71-f5ac-41ee-b816-329818689c38_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_62ce2c44-5f39-4a0e-a968-bdd63d8dd276_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_9a5bb60a-e4db-44cb-afca-6c6383e549b3_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a0950623-4bf6-4f4b-842e-42fdf50e049b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfDefendants_27392382-e776-4a00-9773-a5080b18f758_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of distributors</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfDefendants_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfDefendants" xlink:to="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_8de37123-b715-4d4c-a26c-891fe2629c10_terseLabel_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes due December 15, 2022</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_label_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022 [Member]</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_documentation_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member" xlink:href="mck-20211231.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A270NotesDueDecember152022Member" xlink:to="lab_mck_A270NotesDueDecember152022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_3ddde3b0-a417-4ac0-9212-ccebaf57370a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement payment</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_83c25486-bf38-463e-9aeb-5097fb733503_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_14700875-743e-4e7b-92a2-e98bc8eda452_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_ac7737a8-7af8-4581-9be6-551c07cc3599_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_7489a3c6-de2c-47c5-9d84-077fdf1a45c1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_69903737-78b5-4e24-b532-6035de427145_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_867f403b-34a7-4462-a110-c7b9da8bcee4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_bc705c87-d525-4f13-9a96-d055dc90b9a8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified pension liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_064ec900-c55c-4b1d-a465-2d800a0069c8_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f0e75d24-69e3-47dc-b81e-ac2b292acc56_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_f3f6adb1-b591-4205-b5f0-05333a0dbafd_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_7b17dea9-e9bb-4c97-9633-fc90636ea05d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_a56ec8ab-0c10-46a0-b8ce-af97cad6a96b_terseLabel_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes due August 17, 2021</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_label_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021 [Member]</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_documentation_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member" xlink:href="mck-20211231.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A063EuroNotesDueAugust172021Member" xlink:to="lab_mck_A063EuroNotesDueAugust172021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfAdditionalDefendants_84a3414b-d527-4a02-bb7b-cab523e42226_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional Defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfAdditionalDefendants_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional Defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfAdditionalDefendants_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfAdditionalDefendants" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfAdditionalDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfAdditionalDefendants" xlink:to="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_88dd72ba-a206-4c77-be26-0bb8c34f2389_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_77d0d290-259e-46f1-99f0-87b51288d490_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_efb5e2b8-aa01-4b84-b579-dc2a5f69d6f3_terseLabel_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business</link:label>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_label_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business [Member]</link:label>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_documentation_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:href="mck-20211231.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:to="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementPaymentTerms_8086bb54-e6ac-46da-87c9-406699262032_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment term</link:label>
    <link:label id="lab_mck_LossContingencySettlementPaymentTerms_label_en-US" xlink:label="lab_mck_LossContingencySettlementPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Payment Terms</link:label>
    <link:label id="lab_mck_LossContingencySettlementPaymentTerms_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementPaymentTerms" xlink:href="mck-20211231.xsd#mck_LossContingencySettlementPaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementPaymentTerms" xlink:to="lab_mck_LossContingencySettlementPaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_807d317d-13e4-4cf1-b010-1667a009049e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_471bbc55-0196-45ed-8d30-618f60a578ea_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_cbdb5224-b13e-4599-a6d3-8b265bdf274e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_d5ffb736-12c8-40f7-b230-1712f1cf0eae_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_d9e2d54a-bc55-4241-9190-2225ad2fa2b3_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_dafbb7c7-551f-411b-abfa-0603dae8195a_verboseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in net investment hedge, gains (losses) gross</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_2a3de2fc-c0c5-4344-a1ef-35963a5b745e_terseLabel_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes due March 15, 2023</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_label_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023 [Member]</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_documentation_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member" xlink:href="mck-20211231.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A285NotesDueMarch152023Member" xlink:to="lab_mck_A285NotesDueMarch152023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_1ab8c458-370d-469d-a77e-e05cae5f2801_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_label_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:href="mck-20211231.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:to="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_b0e71d35-a6eb-4094-a14c-92e1eafcc35a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_1dcc3185-72f8-4369-85d4-37f5dd11af34_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_efe8137f-68a8-4648-9352-dd1514ba1dea_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_ddb485c9-7ca4-4464-9256-5064dfc2486f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2c71002e-def5-44a3-8b96-51ec4305c1a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_04f76980-834b-42f9-80e1-12eeaaf8087b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's shares of legal settlements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLegalSettlements" xlink:to="lab_us-gaap_ProceedsFromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_bfeacafd-364f-475b-9de3-886045d112ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in the carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ed43f31-ba5f-474d-8cd5-a07b5e4445c2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_6704ae7e-8999-4209-b771-0f978ef8b739_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_519b3a9e-70ac-46f7-bce5-f78c6a978644_terseLabel_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right value, interest rate spread (as a percent)</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_label_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_documentation_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread" xlink:href="mck-20211231.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PutRightValueInterestRateSpread" xlink:to="lab_mck_PutRightValueInterestRateSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_d1d52724-ec26-47e4-b334-d23b78822626_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_d085c862-2bdb-4430-bf14-bd575e50d1bd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax expenses related to estimated litigation liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuroDenominatedNotesMember_43fd6f16-6499-499e-9307-c37553b8520e_terseLabel_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_label_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember" xlink:href="mck-20211231.xsd#mck_EuroDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuroDenominatedNotesMember" xlink:to="lab_mck_EuroDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_51bffb14-2026-4f35-b3a6-90400442b56e_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in put amount (in Euros per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price Increase</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_b73619f8-f81b-413f-9de3-7303d05f70b5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits associated with last-in, first-out inventory method</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_99a1adc8-195c-4741-9861-6092ca1b29dc_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax credits related to LIFO accounting</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve, Period Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>mck-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b0c4267c-1381-4f10-888f-434d9ccb5c99,g:6c581a7b-6b71-4a88-8456-a4823e8897d4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/Cover" xlink:type="simple" xlink:href="mck-20211231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_a5c0f009-a59d-41cf-9735-59fb84697bf8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_870125f5-d3ea-49c1-b5d4-3933af229fdb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a5c0f009-a59d-41cf-9735-59fb84697bf8" xlink:to="loc_dei_EntitiesTable_870125f5-d3ea-49c1-b5d4-3933af229fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0d0b4f87-96b1-40a0-b170-f4be7e7f0ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_870125f5-d3ea-49c1-b5d4-3933af229fdb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0d0b4f87-96b1-40a0-b170-f4be7e7f0ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0d0b4f87-96b1-40a0-b170-f4be7e7f0ee9" xlink:to="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_44b5f380-89d1-4e40-9d7f-35d1512cdfed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:to="loc_us-gaap_CommonStockMember_44b5f380-89d1-4e40-9d7f-35d1512cdfed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_7173d3ff-6357-4262-a044-4eedcdafee45" xlink:href="mck-20211231.xsd#mck_A1500NotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:to="loc_mck_A1500NotesDue2025Member_7173d3ff-6357-4262-a044-4eedcdafee45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_7f00ad4b-6d33-409c-971b-11f67ee0d97c" xlink:href="mck-20211231.xsd#mck_A1625NotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:to="loc_mck_A1625NotesDue2026Member_7f00ad4b-6d33-409c-971b-11f67ee0d97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_57e137ce-aae5-47c1-8549-23ee0bf70599" xlink:href="mck-20211231.xsd#mck_A3125NotesDue2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e9c9b95d-702c-4458-9759-e89c76e72207" xlink:to="loc_mck_A3125NotesDue2029Member_57e137ce-aae5-47c1-8549-23ee0bf70599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_870125f5-d3ea-49c1-b5d4-3933af229fdb" xlink:to="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7746f36c-0990-45d7-89ef-1c49667ed0b5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentType_7746f36c-0990-45d7-89ef-1c49667ed0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_5fdeee57-6352-46a9-b80f-b35bd5a85dd6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentQuarterlyReport_5fdeee57-6352-46a9-b80f-b35bd5a85dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_265c54e6-beda-4fce-b866-4ce79687ff39" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentPeriodEndDate_265c54e6-beda-4fce-b866-4ce79687ff39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_38bbd1a9-80af-458c-8f41-3ea7a7b42012" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentTransitionReport_38bbd1a9-80af-458c-8f41-3ea7a7b42012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_06337962-5a45-47ce-bb93-a5df3a9ad455" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityFileNumber_06337962-5a45-47ce-bb93-a5df3a9ad455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7fc83e75-e614-4163-b2ff-75500bcadf73" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityRegistrantName_7fc83e75-e614-4163-b2ff-75500bcadf73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6b69afe1-d31e-4e4c-8919-24e5d5cc536b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6b69afe1-d31e-4e4c-8919-24e5d5cc536b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e9f1da61-1b39-4394-86f6-303fe61cb0e7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityTaxIdentificationNumber_e9f1da61-1b39-4394-86f6-303fe61cb0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_36b8c738-303a-4435-a329-5211fd390490" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityAddressAddressLine1_36b8c738-303a-4435-a329-5211fd390490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e3b350f4-dab9-4ced-8a71-33a9bcf9918d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityAddressCityOrTown_e3b350f4-dab9-4ced-8a71-33a9bcf9918d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_fc410f8b-f09d-4532-a6a6-cb2ceae1974a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityAddressStateOrProvince_fc410f8b-f09d-4532-a6a6-cb2ceae1974a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6656c33f-ad10-49b1-9451-68ef09d7e649" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityAddressPostalZipCode_6656c33f-ad10-49b1-9451-68ef09d7e649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_1c480f70-97a9-4c94-bcc6-8ba0818d74d8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_CityAreaCode_1c480f70-97a9-4c94-bcc6-8ba0818d74d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_910d6c9b-86c6-466e-aca3-3b964c234868" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_LocalPhoneNumber_910d6c9b-86c6-466e-aca3-3b964c234868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1a82f913-c55c-4731-91b5-4ed28aa088de" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_Security12bTitle_1a82f913-c55c-4731-91b5-4ed28aa088de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_141f9f06-3c4a-4712-a102-920f3f11d830" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_TradingSymbol_141f9f06-3c4a-4712-a102-920f3f11d830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4d614139-3931-4e2d-82e0-8dc9642017a9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_SecurityExchangeName_4d614139-3931-4e2d-82e0-8dc9642017a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ca218062-ce25-4a22-866e-ee8bf02f85b8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityCurrentReportingStatus_ca218062-ce25-4a22-866e-ee8bf02f85b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_06402934-1bb3-4822-98ef-a083b13a345f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityInteractiveDataCurrent_06402934-1bb3-4822-98ef-a083b13a345f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_0548553c-5516-4f72-a140-0ce5d8e37769" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityFilerCategory_0548553c-5516-4f72-a140-0ce5d8e37769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_db1480c3-c5df-4799-8785-d64ea987cad4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntitySmallBusiness_db1480c3-c5df-4799-8785-d64ea987cad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e2143b2f-afc7-47e8-ad4f-627b9d0bb73b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityEmergingGrowthCompany_e2143b2f-afc7-47e8-ad4f-627b9d0bb73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ebf61e70-75a8-400c-8bb4-7b13f1a7a30d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityShellCompany_ebf61e70-75a8-400c-8bb4-7b13f1a7a30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_5f47e945-ba97-43e6-8375-3fecb9918a29" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_5f47e945-ba97-43e6-8375-3fecb9918a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e6a8a06b-8af5-4521-90bd-4b20d8dc24d6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_EntityCentralIndexKey_e6a8a06b-8af5-4521-90bd-4b20d8dc24d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5f8788e8-eff6-4868-865d-e5ab8ab3311e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentFiscalYearFocus_5f8788e8-eff6-4868-865d-e5ab8ab3311e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3b502b00-4b91-4b9f-bc93-a5e289d9b57e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_3b502b00-4b91-4b9f-bc93-a5e289d9b57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_770526dd-5b26-46d9-9615-c98be295aeea" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_AmendmentFlag_770526dd-5b26-46d9-9615-c98be295aeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_648bc272-3271-4d73-9450-6e4cfe7c086a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_23fed97c-7612-4bde-96a8-b6adb9d1abc0" xlink:to="loc_dei_CurrentFiscalYearEndDate_648bc272-3271-4d73-9450-6e4cfe7c086a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e9e13d9e-d28c-47d7-a452-099cd2a0e7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e9e13d9e-d28c-47d7-a452-099cd2a0e7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4d9f6ac1-472c-4bd6-850d-71487a8f8942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4d9f6ac1-472c-4bd6-850d-71487a8f8942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f2c2a218-06d6-4311-bb1b-6fe938d6a528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_GrossProfit_f2c2a218-06d6-4311-bb1b-6fe938d6a528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4f80fe82-b11f-47bc-8c83-477151cc8937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4f80fe82-b11f-47bc-8c83-477151cc8937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_8fe7ffde-6f2a-4d7f-b3a9-906d6fe57ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_8fe7ffde-6f2a-4d7f-b3a9-906d6fe57ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8f744b82-e685-49ca-83a2-520aa2367de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8f744b82-e685-49ca-83a2-520aa2367de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_9281dab4-91af-473c-a171-b1405a7bde93" xlink:href="mck-20211231.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_9281dab4-91af-473c-a171-b1405a7bde93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_249470e6-ba72-440b-a994-26cbb54fcbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_OperatingExpenses_249470e6-ba72-440b-a994-26cbb54fcbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ddf9fb16-7ccb-48b3-b821-2f28377d5298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_OperatingIncomeLoss_ddf9fb16-7ccb-48b3-b821-2f28377d5298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c14b2190-62d7-4048-8004-aba45695fb46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c14b2190-62d7-4048-8004-aba45695fb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b81f1e84-43eb-4f1b-b561-d51d4a3ca294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b81f1e84-43eb-4f1b-b561-d51d4a3ca294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_afd3c0a9-2b22-46c3-9b0e-2ff65055d785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_InterestExpense_afd3c0a9-2b22-46c3-9b0e-2ff65055d785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4990635f-2169-42ae-88d3-4cfbd27e9115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4990635f-2169-42ae-88d3-4cfbd27e9115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bcb7a537-9e64-473f-84eb-0a319b978ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bcb7a537-9e64-473f-84eb-0a319b978ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d6385ce3-7a2b-4b05-af65-7e9332d8841a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d6385ce3-7a2b-4b05-af65-7e9332d8841a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_f627b249-b917-4f9c-b261-146e9966e616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_f627b249-b917-4f9c-b261-146e9966e616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8259f7a1-6eac-436c-a0d2-ef65382b3b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_ProfitLoss_8259f7a1-6eac-436c-a0d2-ef65382b3b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e83f56a2-a892-4c8a-b60a-a19f033d0744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e83f56a2-a892-4c8a-b60a-a19f033d0744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_39ef9962-7238-48be-bc4a-eb13af283832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_NetIncomeLoss_39ef9962-7238-48be-bc4a-eb13af283832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e00fc912-efd7-4ee8-875f-f070d28bb53b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_EarningsPerShareAbstract_e00fc912-efd7-4ee8-875f-f070d28bb53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_9888ecf1-75a8-4125-8048-02de3b60f44e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e00fc912-efd7-4ee8-875f-f070d28bb53b" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_9888ecf1-75a8-4125-8048-02de3b60f44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_a22d5ba7-fad1-4c58-a8d4-e5878cd1db50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9888ecf1-75a8-4125-8048-02de3b60f44e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_a22d5ba7-fad1-4c58-a8d4-e5878cd1db50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_28914aa3-1120-4e2e-9bad-6ff942cb8451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9888ecf1-75a8-4125-8048-02de3b60f44e" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_28914aa3-1120-4e2e-9bad-6ff942cb8451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_838124d5-e83f-4e59-a209-f7fe26c0c930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9888ecf1-75a8-4125-8048-02de3b60f44e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_838124d5-e83f-4e59-a209-f7fe26c0c930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_81cdcb97-6620-4f90-8ea7-5b9cd0cc2a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e00fc912-efd7-4ee8-875f-f070d28bb53b" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_81cdcb97-6620-4f90-8ea7-5b9cd0cc2a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_95d8a842-8f8d-4e90-a4c0-977ef1e39595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_81cdcb97-6620-4f90-8ea7-5b9cd0cc2a9f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_95d8a842-8f8d-4e90-a4c0-977ef1e39595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_6e590fcc-c05b-40b3-93ec-b34cd9e02eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_81cdcb97-6620-4f90-8ea7-5b9cd0cc2a9f" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_6e590fcc-c05b-40b3-93ec-b34cd9e02eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e238d9f3-20c2-402a-b4b4-2ba5114c75f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_81cdcb97-6620-4f90-8ea7-5b9cd0cc2a9f" xlink:to="loc_us-gaap_EarningsPerShareBasic_e238d9f3-20c2-402a-b4b4-2ba5114c75f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_47089f3c-ad1e-4cea-b43a-0fb4ea83fc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fdd14bdf-b5ae-4d54-a4a8-b35899db29ad" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_47089f3c-ad1e-4cea-b43a-0fb4ea83fc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_44bd26e4-0cdb-4727-905c-0abe7ba04196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_47089f3c-ad1e-4cea-b43a-0fb4ea83fc2a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_44bd26e4-0cdb-4727-905c-0abe7ba04196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_07466de2-bc1e-40fa-9341-b8182caa514a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_47089f3c-ad1e-4cea-b43a-0fb4ea83fc2a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_07466de2-bc1e-40fa-9341-b8182caa514a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_19897faf-f572-43a1-ba12-a9fada26d63b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0aadba68-6872-44b0-9d8a-3a219c3083f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_19897faf-f572-43a1-ba12-a9fada26d63b" xlink:to="loc_us-gaap_ProfitLoss_0aadba68-6872-44b0-9d8a-3a219c3083f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_6e994bf6-cc35-4b57-910b-ea94c3fb13d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_19897faf-f572-43a1-ba12-a9fada26d63b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_6e994bf6-cc35-4b57-910b-ea94c3fb13d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8070dba8-535f-4698-aebf-6fac1f3fcf75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_6e994bf6-cc35-4b57-910b-ea94c3fb13d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8070dba8-535f-4698-aebf-6fac1f3fcf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_29dedc95-ac15-476a-879c-9059f05299dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_6e994bf6-cc35-4b57-910b-ea94c3fb13d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_29dedc95-ac15-476a-879c-9059f05299dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7659ed5a-9a7c-4446-aa7a-715d2cfacc50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_6e994bf6-cc35-4b57-910b-ea94c3fb13d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7659ed5a-9a7c-4446-aa7a-715d2cfacc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c5edd92d-6dce-4c9f-8760-4e17a0b9367d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_6e994bf6-cc35-4b57-910b-ea94c3fb13d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c5edd92d-6dce-4c9f-8760-4e17a0b9367d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5165f90a-22eb-4579-a0db-9588edced587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_19897faf-f572-43a1-ba12-a9fada26d63b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5165f90a-22eb-4579-a0db-9588edced587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cb01c5c2-e8fe-4691-9be1-7cd117e7b1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_19897faf-f572-43a1-ba12-a9fada26d63b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cb01c5c2-e8fe-4691-9be1-7cd117e7b1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4e15898f-26f2-42c5-aca3-66932d7208ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_19897faf-f572-43a1-ba12-a9fada26d63b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4e15898f-26f2-42c5-aca3-66932d7208ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ce56f57d-fbfc-48cc-9ada-4de5f916a579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f9cf0150-3c61-4abe-9993-41d7e3162eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ce56f57d-fbfc-48cc-9ada-4de5f916a579" xlink:to="loc_us-gaap_AssetsAbstract_f9cf0150-3c61-4abe-9993-41d7e3162eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_064a8755-4584-4e67-9e1a-595d52f315f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f9cf0150-3c61-4abe-9993-41d7e3162eb4" xlink:to="loc_us-gaap_AssetsCurrentAbstract_064a8755-4584-4e67-9e1a-595d52f315f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_51747653-fcef-4f18-95d8-d7b0b26f9f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_064a8755-4584-4e67-9e1a-595d52f315f4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_51747653-fcef-4f18-95d8-d7b0b26f9f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_24a29a54-408e-4986-9075-4413e0eb18fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_064a8755-4584-4e67-9e1a-595d52f315f4" xlink:to="loc_us-gaap_ReceivablesNetCurrent_24a29a54-408e-4986-9075-4413e0eb18fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b9e83cbe-0433-4448-ad10-cb09570e6c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_064a8755-4584-4e67-9e1a-595d52f315f4" xlink:to="loc_us-gaap_InventoryNet_b9e83cbe-0433-4448-ad10-cb09570e6c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_9bfd221a-4e5b-4805-8769-cfdcd7ccca21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_064a8755-4584-4e67-9e1a-595d52f315f4" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_9bfd221a-4e5b-4805-8769-cfdcd7ccca21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d80ddc9d-3ccc-4f37-8312-92e7b05011d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_064a8755-4584-4e67-9e1a-595d52f315f4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d80ddc9d-3ccc-4f37-8312-92e7b05011d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c0b40350-bfa9-41e9-a28f-d2a86782d610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_064a8755-4584-4e67-9e1a-595d52f315f4" xlink:to="loc_us-gaap_AssetsCurrent_c0b40350-bfa9-41e9-a28f-d2a86782d610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_20c58039-79de-4692-9288-b27288e26fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f9cf0150-3c61-4abe-9993-41d7e3162eb4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_20c58039-79de-4692-9288-b27288e26fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3f1d701b-2825-4767-8e70-34e981898d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f9cf0150-3c61-4abe-9993-41d7e3162eb4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3f1d701b-2825-4767-8e70-34e981898d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dec90d41-1c6f-4404-9b00-d8373ca17542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f9cf0150-3c61-4abe-9993-41d7e3162eb4" xlink:to="loc_us-gaap_Goodwill_dec90d41-1c6f-4404-9b00-d8373ca17542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8835832-d4ef-41eb-9953-29f54f5acad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f9cf0150-3c61-4abe-9993-41d7e3162eb4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8835832-d4ef-41eb-9953-29f54f5acad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5c551646-feff-4dd8-83e9-16a5f3f81dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f9cf0150-3c61-4abe-9993-41d7e3162eb4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5c551646-feff-4dd8-83e9-16a5f3f81dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1050f4dc-29a8-4bff-a280-55fb90ab57e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f9cf0150-3c61-4abe-9993-41d7e3162eb4" xlink:to="loc_us-gaap_Assets_1050f4dc-29a8-4bff-a280-55fb90ab57e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5f6e270e-f33f-4911-9db8-2e5fa7c8567c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ce56f57d-fbfc-48cc-9ada-4de5f916a579" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5f6e270e-f33f-4911-9db8-2e5fa7c8567c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_95507779-8ebe-46de-a97f-4d762da8d554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5f6e270e-f33f-4911-9db8-2e5fa7c8567c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_95507779-8ebe-46de-a97f-4d762da8d554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c1d7600b-ace9-498b-b132-12081e1c55ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_95507779-8ebe-46de-a97f-4d762da8d554" xlink:to="loc_us-gaap_AccountsPayableCurrent_c1d7600b-ace9-498b-b132-12081e1c55ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_19519966-c840-4857-af49-b588beddee33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_95507779-8ebe-46de-a97f-4d762da8d554" xlink:to="loc_us-gaap_ShortTermBorrowings_19519966-c840-4857-af49-b588beddee33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_45c2a9b6-3698-4172-b21d-d9765b70cfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_95507779-8ebe-46de-a97f-4d762da8d554" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_45c2a9b6-3698-4172-b21d-d9765b70cfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7a1b559c-9c06-4e17-8cd3-36f95e61fefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_95507779-8ebe-46de-a97f-4d762da8d554" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7a1b559c-9c06-4e17-8cd3-36f95e61fefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_7a169130-b6bf-4f46-84f5-7355332299da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_95507779-8ebe-46de-a97f-4d762da8d554" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_7a169130-b6bf-4f46-84f5-7355332299da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_678c453d-bc9a-43ad-bf63-74db9bece4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_95507779-8ebe-46de-a97f-4d762da8d554" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_678c453d-bc9a-43ad-bf63-74db9bece4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c1f28160-8470-49fe-9930-f70b6832e9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_95507779-8ebe-46de-a97f-4d762da8d554" xlink:to="loc_us-gaap_LiabilitiesCurrent_c1f28160-8470-49fe-9930-f70b6832e9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_388a35ea-9c68-4054-b326-1d12a79fcaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5f6e270e-f33f-4911-9db8-2e5fa7c8567c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_388a35ea-9c68-4054-b326-1d12a79fcaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8afa9ce5-3166-41ca-b627-b97cd7acfb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5f6e270e-f33f-4911-9db8-2e5fa7c8567c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8afa9ce5-3166-41ca-b627-b97cd7acfb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_60e94571-98c0-40ec-befb-c0b997e9d5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5f6e270e-f33f-4911-9db8-2e5fa7c8567c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_60e94571-98c0-40ec-befb-c0b997e9d5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_9d834c01-a761-4677-a100-e30c59cb6cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5f6e270e-f33f-4911-9db8-2e5fa7c8567c" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_9d834c01-a761-4677-a100-e30c59cb6cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f88db19c-31a4-4c67-b1ac-663d21816ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5f6e270e-f33f-4911-9db8-2e5fa7c8567c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f88db19c-31a4-4c67-b1ac-663d21816ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_62c6b9cc-5b14-4e12-8b7c-46a827e5a36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5f6e270e-f33f-4911-9db8-2e5fa7c8567c" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_62c6b9cc-5b14-4e12-8b7c-46a827e5a36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f002679c-b222-4f55-92c7-58cfa01cb900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5f6e270e-f33f-4911-9db8-2e5fa7c8567c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_f002679c-b222-4f55-92c7-58cfa01cb900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2d8e59a4-f3a0-40b7-9800-c85b266fb071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f002679c-b222-4f55-92c7-58cfa01cb900" xlink:to="loc_us-gaap_PreferredStockValue_2d8e59a4-f3a0-40b7-9800-c85b266fb071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8dc6d01d-2abb-471a-afa7-76eab286f247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f002679c-b222-4f55-92c7-58cfa01cb900" xlink:to="loc_us-gaap_CommonStockValue_8dc6d01d-2abb-471a-afa7-76eab286f247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_25cd84c1-ccd1-4905-aebe-cae6b8fde255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f002679c-b222-4f55-92c7-58cfa01cb900" xlink:to="loc_us-gaap_AdditionalPaidInCapital_25cd84c1-ccd1-4905-aebe-cae6b8fde255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d34acdb2-6197-43c0-bd1c-ebf30f6a2adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f002679c-b222-4f55-92c7-58cfa01cb900" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d34acdb2-6197-43c0-bd1c-ebf30f6a2adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f99178dd-dcec-43b6-be08-e3b669e9458b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f002679c-b222-4f55-92c7-58cfa01cb900" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f99178dd-dcec-43b6-be08-e3b669e9458b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_b712a247-16eb-4a32-81d2-b7c7ed7c806a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f002679c-b222-4f55-92c7-58cfa01cb900" xlink:to="loc_us-gaap_TreasuryStockValue_b712a247-16eb-4a32-81d2-b7c7ed7c806a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_038a4680-bcc6-4307-9ecc-c952f41c8705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f002679c-b222-4f55-92c7-58cfa01cb900" xlink:to="loc_us-gaap_StockholdersEquity_038a4680-bcc6-4307-9ecc-c952f41c8705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_605d9eaf-94ea-4c91-a2bb-b7f16627775c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f002679c-b222-4f55-92c7-58cfa01cb900" xlink:to="loc_us-gaap_MinorityInterest_605d9eaf-94ea-4c91-a2bb-b7f16627775c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_da3e9cca-9676-4f2a-aa8b-c779adc108b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f002679c-b222-4f55-92c7-58cfa01cb900" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_da3e9cca-9676-4f2a-aa8b-c779adc108b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_be3e701e-bc5f-44df-bee5-bdcc6db7cead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5f6e270e-f33f-4911-9db8-2e5fa7c8567c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_be3e701e-bc5f-44df-bee5-bdcc6db7cead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7f9c3793-d6a5-4672-8407-1641ddb73d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6052c561-cfb9-457c-a0cd-03c416a4e27f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7f9c3793-d6a5-4672-8407-1641ddb73d17" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6052c561-cfb9-457c-a0cd-03c416a4e27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_72d43542-5ca8-425b-8a9b-26860ae794f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6052c561-cfb9-457c-a0cd-03c416a4e27f" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_72d43542-5ca8-425b-8a9b-26860ae794f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f81228df-908e-43ef-8b6a-191a6586fdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6052c561-cfb9-457c-a0cd-03c416a4e27f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f81228df-908e-43ef-8b6a-191a6586fdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_85c2999f-44a4-4a94-88f7-158bff64d418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6052c561-cfb9-457c-a0cd-03c416a4e27f" xlink:to="loc_us-gaap_PreferredStockSharesIssued_85c2999f-44a4-4a94-88f7-158bff64d418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_049329dc-62c5-4858-8adf-7892838567e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6052c561-cfb9-457c-a0cd-03c416a4e27f" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_049329dc-62c5-4858-8adf-7892838567e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_131d8448-56f9-455d-8e3c-c7e516e9f72e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6052c561-cfb9-457c-a0cd-03c416a4e27f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_131d8448-56f9-455d-8e3c-c7e516e9f72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4763f3f7-9886-40f8-b08c-9b3a180dd2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6052c561-cfb9-457c-a0cd-03c416a4e27f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4763f3f7-9886-40f8-b08c-9b3a180dd2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9e9a2131-0dfa-4924-a329-fea55f3ab18e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6052c561-cfb9-457c-a0cd-03c416a4e27f" xlink:to="loc_us-gaap_CommonStockSharesIssued_9e9a2131-0dfa-4924-a329-fea55f3ab18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_34e0eb71-c396-48d1-a8f8-d12108cb5538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6052c561-cfb9-457c-a0cd-03c416a4e27f" xlink:to="loc_us-gaap_TreasuryStockShares_34e0eb71-c396-48d1-a8f8-d12108cb5538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a6a52427-8756-427c-81ea-8a43604d70ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_baf1f486-1e3d-4261-8387-3f23ce8e9351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a6a52427-8756-427c-81ea-8a43604d70ff" xlink:to="loc_us-gaap_StatementTable_baf1f486-1e3d-4261-8387-3f23ce8e9351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eb08aa2c-dc22-4f85-96d7-9dc4eb859bc3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_baf1f486-1e3d-4261-8387-3f23ce8e9351" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eb08aa2c-dc22-4f85-96d7-9dc4eb859bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fea7b84e-43a3-4ce6-8c0f-8d9b0102b88a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eb08aa2c-dc22-4f85-96d7-9dc4eb859bc3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fea7b84e-43a3-4ce6-8c0f-8d9b0102b88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6ebff041-5a86-4bee-a123-90540be5cc6d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fea7b84e-43a3-4ce6-8c0f-8d9b0102b88a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6ebff041-5a86-4bee-a123-90540be5cc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_4f4a7b33-cbc9-4037-989e-609fd09da162" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fea7b84e-43a3-4ce6-8c0f-8d9b0102b88a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_4f4a7b33-cbc9-4037-989e-609fd09da162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_064e04bb-43a3-4977-a457-f6fd0ff49ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_baf1f486-1e3d-4261-8387-3f23ce8e9351" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_064e04bb-43a3-4977-a457-f6fd0ff49ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_064e04bb-43a3-4977-a457-f6fd0ff49ecc" xlink:to="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7f6963fc-8884-464b-bc6e-737671189e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_CommonStockMember_7f6963fc-8884-464b-bc6e-737671189e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b5bcbcfa-cab4-4eb4-b01c-2f83c817a3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b5bcbcfa-cab4-4eb4-b01c-2f83c817a3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_224f667a-e4ab-4803-99eb-8b1efe44bd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_RetainedEarningsMember_224f667a-e4ab-4803-99eb-8b1efe44bd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_213a4dd0-bb24-4206-bf3e-208694b95550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_213a4dd0-bb24-4206-bf3e-208694b95550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_a89d81c8-e70e-4969-82a7-c81479512ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_TreasuryStockMember_a89d81c8-e70e-4969-82a7-c81479512ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_87ab3bee-8ab4-4bbb-b5e6-37600530ce07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0710c848-57d9-40cb-9900-304163e9fc12" xlink:to="loc_us-gaap_NoncontrollingInterestMember_87ab3bee-8ab4-4bbb-b5e6-37600530ce07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4aa527e4-6c0e-45eb-875a-7bc349af9116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_baf1f486-1e3d-4261-8387-3f23ce8e9351" xlink:to="loc_us-gaap_StatementLineItems_4aa527e4-6c0e-45eb-875a-7bc349af9116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4aa527e4-6c0e-45eb-875a-7bc349af9116" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_162cf8e3-3f39-4c86-b7c8-f0f2984cd602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_SharesOutstanding_162cf8e3-3f39-4c86-b7c8-f0f2984cd602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_eacd2eb3-49b6-43f3-900c-0fb3cd511e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_TreasuryStockShares_eacd2eb3-49b6-43f3-900c-0fb3cd511e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a35feb19-a0c4-4dc4-a4ba-43207172c832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a35feb19-a0c4-4dc4-a4ba-43207172c832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_fab0afef-78bd-4f0e-b236-577086b9fdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_fab0afef-78bd-4f0e-b236-577086b9fdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7603f5c3-6898-428a-9c77-a441cbed6ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_7603f5c3-6898-428a-9c77-a441cbed6ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_18a8e882-3d1b-4347-af49-3f658e90f3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_18a8e882-3d1b-4347-af49-3f658e90f3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_746eb11c-ff9e-40c2-bad7-388229cd1acb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_746eb11c-ff9e-40c2-bad7-388229cd1acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_254f8845-c981-481e-a1ce-7c61402d25f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_254f8845-c981-481e-a1ce-7c61402d25f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_3688f676-b8b4-46ee-bd27-087c708e3f92" xlink:href="mck-20211231.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_3688f676-b8b4-46ee-bd27-087c708e3f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_56e9f8ff-de2a-4628-ac7e-f861b102fa66" xlink:href="mck-20211231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_56e9f8ff-de2a-4628-ac7e-f861b102fa66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_66fb06eb-25b6-4c05-be7e-a0c35fe51d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_66fb06eb-25b6-4c05-be7e-a0c35fe51d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_ae1e01c8-2dbf-43e5-90b5-835ce512de38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_ae1e01c8-2dbf-43e5-90b5-835ce512de38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_46f38cbb-dd70-4520-a18e-c9c8f0a9116b" xlink:href="mck-20211231.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_46f38cbb-dd70-4520-a18e-c9c8f0a9116b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_7117fdf6-5847-4418-acf7-c00f0c8bd4af" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_7117fdf6-5847-4418-acf7-c00f0c8bd4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_7e3d33b6-b7e6-43f4-a1b0-a977409e86a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_DividendsCommonStockCash_7e3d33b6-b7e6-43f4-a1b0-a977409e86a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_653c4883-65ab-4e76-ac45-d7253e961d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockholdersEquityOther_653c4883-65ab-4e76-ac45-d7253e961d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_77f23797-01ed-4da5-9cbb-e9a52442f2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_SharesOutstanding_77f23797-01ed-4da5-9cbb-e9a52442f2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_36b54cfb-2fdc-4420-b5d2-3055e50694f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_TreasuryStockShares_36b54cfb-2fdc-4420-b5d2-3055e50694f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e93c475d-5964-454f-bf7c-b97d38755497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b9d2408-b57b-4258-8c94-98aed138481f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e93c475d-5964-454f-bf7c-b97d38755497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3954ea55-0ea7-4310-b378-fb769a02d84e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_12aa1853-3a7e-46bc-bd05-110a9f77e97e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3954ea55-0ea7-4310-b378-fb769a02d84e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_12aa1853-3a7e-46bc-bd05-110a9f77e97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20211231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4a6f7b80-bc6b-441f-ac01-f3aa09850820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ec41ce68-28b1-480c-9c06-1939e353d96d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4a6f7b80-bc6b-441f-ac01-f3aa09850820" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ec41ce68-28b1-480c-9c06-1939e353d96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_91f8baf8-5ee8-4771-8cbe-3ec82237e034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ec41ce68-28b1-480c-9c06-1939e353d96d" xlink:to="loc_us-gaap_ProfitLoss_91f8baf8-5ee8-4771-8cbe-3ec82237e034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ec41ce68-28b1-480c-9c06-1939e353d96d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_2dc038e4-6bb1-4a28-8b03-c5cdf149effe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:to="loc_us-gaap_Depreciation_2dc038e4-6bb1-4a28-8b03-c5cdf149effe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_38871bdb-a696-49e9-8237-890e4bd2b45c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:to="loc_us-gaap_AdjustmentForAmortization_38871bdb-a696-49e9-8237-890e4bd2b45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_0381e6b7-3888-408b-993e-ea4de0bd0317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_0381e6b7-3888-408b-993e-ea4de0bd0317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3760afb9-011b-4035-978e-3e41d561bef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3760afb9-011b-4035-978e-3e41d561bef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_31e4328f-e57c-4284-9f95-4af59ed4a996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_31e4328f-e57c-4284-9f95-4af59ed4a996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_59eb738a-3b56-44bf-b79b-5acb930a353d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:to="loc_us-gaap_OperatingLeaseExpense_59eb738a-3b56-44bf-b79b-5acb930a353d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_4b2ffd22-c720-43fd-b7ed-76a2da4e1d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_4b2ffd22-c720-43fd-b7ed-76a2da4e1d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_13cc7bfe-c914-442b-80b3-1cd79cabb080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_13cc7bfe-c914-442b-80b3-1cd79cabb080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_bf2b9426-d8dd-4117-8801-ad67ac78044c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_bf2b9426-d8dd-4117-8801-ad67ac78044c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_6005b4d2-a97d-44f2-a91b-01d32ea760b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_956a05e0-9dec-4dba-ba91-ba346014aedd" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_6005b4d2-a97d-44f2-a91b-01d32ea760b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_e74a4883-f8d0-4feb-86c8-a5622f6af294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_6005b4d2-a97d-44f2-a91b-01d32ea760b9" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_e74a4883-f8d0-4feb-86c8-a5622f6af294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c6e86f1f-2f33-4053-bf3d-27d9d7c512ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_6005b4d2-a97d-44f2-a91b-01d32ea760b9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c6e86f1f-2f33-4053-bf3d-27d9d7c512ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5ff48e04-7e30-4761-9d0f-d082025a1d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_6005b4d2-a97d-44f2-a91b-01d32ea760b9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5ff48e04-7e30-4761-9d0f-d082025a1d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_fb0163d5-9e31-452d-82db-fd05796b3dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_6005b4d2-a97d-44f2-a91b-01d32ea760b9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_fb0163d5-9e31-452d-82db-fd05796b3dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_1506cf6d-74d8-45d3-a947-8d1011763d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_6005b4d2-a97d-44f2-a91b-01d32ea760b9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_1506cf6d-74d8-45d3-a947-8d1011763d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_4f91fb54-dab9-42bc-8738-594e4e09dcff" xlink:href="mck-20211231.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_6005b4d2-a97d-44f2-a91b-01d32ea760b9" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_4f91fb54-dab9-42bc-8738-594e4e09dcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_cbbd857d-ca1c-4ac6-8535-5fa3a8e74455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_6005b4d2-a97d-44f2-a91b-01d32ea760b9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_cbbd857d-ca1c-4ac6-8535-5fa3a8e74455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2a3a0f90-c179-4055-bb79-1c7c75b3eb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ec41ce68-28b1-480c-9c06-1939e353d96d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2a3a0f90-c179-4055-bb79-1c7c75b3eb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1049a4be-6027-4752-a140-08b3663ecd53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4a6f7b80-bc6b-441f-ac01-f3aa09850820" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1049a4be-6027-4752-a140-08b3663ecd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_61eedca2-6669-4c70-9a8c-e6051bf9f233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1049a4be-6027-4752-a140-08b3663ecd53" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_61eedca2-6669-4c70-9a8c-e6051bf9f233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_882c1421-d6a4-4dc6-a25e-b77870ed407b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1049a4be-6027-4752-a140-08b3663ecd53" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_882c1421-d6a4-4dc6-a25e-b77870ed407b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7b913ad5-5f04-4081-9067-422c50fbbc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1049a4be-6027-4752-a140-08b3663ecd53" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7b913ad5-5f04-4081-9067-422c50fbbc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_9808666d-d59c-4146-8330-ae6d38cb2840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1049a4be-6027-4752-a140-08b3663ecd53" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_9808666d-d59c-4146-8330-ae6d38cb2840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6967144b-8112-4608-85ea-9633cc3cf712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1049a4be-6027-4752-a140-08b3663ecd53" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6967144b-8112-4608-85ea-9633cc3cf712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12570c23-5890-4264-b5b3-797f6df011cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1049a4be-6027-4752-a140-08b3663ecd53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12570c23-5890-4264-b5b3-797f6df011cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4a6f7b80-bc6b-441f-ac01-f3aa09850820" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_01436c61-47ba-45a4-9378-893aad808c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_01436c61-47ba-45a4-9378-893aad808c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_50c109a1-7dff-4246-89a5-37d3d882e94d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_50c109a1-7dff-4246-89a5-37d3d882e94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_dc153c5c-5463-46ad-b480-ec408e38d762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_dc153c5c-5463-46ad-b480-ec408e38d762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_c860fcee-b4fc-4a1a-9c0e-00985c23ee00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_c860fcee-b4fc-4a1a-9c0e-00985c23ee00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_f8bd2966-3946-4e76-b73b-b1ddab960d66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_f8bd2966-3946-4e76-b73b-b1ddab960d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_6f1a9d74-b10e-45b1-8da2-13ece705c869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_6f1a9d74-b10e-45b1-8da2-13ece705c869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a2a52a71-8bbd-48a3-aaa6-f60307e2ebbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_6f1a9d74-b10e-45b1-8da2-13ece705c869" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a2a52a71-8bbd-48a3-aaa6-f60307e2ebbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_bd6f7b1a-95b1-47b2-a3a4-77ee9ba967dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_6f1a9d74-b10e-45b1-8da2-13ece705c869" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_bd6f7b1a-95b1-47b2-a3a4-77ee9ba967dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8b560b70-830d-41dd-ab53-aa49b1afc700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8b560b70-830d-41dd-ab53-aa49b1afc700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_57d1e0ff-83e1-47fa-8c6a-d4f2df3f1816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_57d1e0ff-83e1-47fa-8c6a-d4f2df3f1816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_19fc2f25-5fd6-49d5-8484-52661247b001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_19fc2f25-5fd6-49d5-8484-52661247b001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2ce72ad1-2bcb-4385-a010-420874fc7038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d668456a-e73b-4a2f-b80d-a33be4f4552a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2ce72ad1-2bcb-4385-a010-420874fc7038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b9138b8f-98e6-4099-b713-0f0beaa9640b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4a6f7b80-bc6b-441f-ac01-f3aa09850820" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b9138b8f-98e6-4099-b713-0f0beaa9640b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_d0c14a5e-2cdf-431b-8dcb-279eb5b66c0f" xlink:href="mck-20211231.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4a6f7b80-bc6b-441f-ac01-f3aa09850820" xlink:to="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_d0c14a5e-2cdf-431b-8dcb-279eb5b66c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_91efb9cb-145c-4475-a163-e689952ce2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4a6f7b80-bc6b-441f-ac01-f3aa09850820" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_91efb9cb-145c-4475-a163-e689952ce2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_24e6ec47-b5b3-430a-aff2-8908ce584675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4a6f7b80-bc6b-441f-ac01-f3aa09850820" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_24e6ec47-b5b3-430a-aff2-8908ce584675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f34f99a1-c5ac-4c27-b868-86ece4cbfefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4a6f7b80-bc6b-441f-ac01-f3aa09850820" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f34f99a1-c5ac-4c27-b868-86ece4cbfefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_94e7d16a-1f8b-46ee-9b09-e5c8bfd46ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4a6f7b80-bc6b-441f-ac01-f3aa09850820" xlink:to="loc_us-gaap_RestrictedCashCurrent_94e7d16a-1f8b-46ee-9b09-e5c8bfd46ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_80f5cce4-4673-47b5-b567-97b49ec2130b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4a6f7b80-bc6b-441f-ac01-f3aa09850820" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_80f5cce4-4673-47b5-b567-97b49ec2130b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20211231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_eae758fc-ad62-40d2-9bbe-3f4530ba2f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_a0ad316f-d2ca-4381-a039-528c8cedabe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eae758fc-ad62-40d2-9bbe-3f4530ba2f9e" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_a0ad316f-d2ca-4381-a039-528c8cedabe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20211231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9a0b8f5c-1fd1-49b4-bdbb-cb2ff3165f53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_d3ac6307-3965-40bb-89d1-d3e4be393732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a0b8f5c-1fd1-49b4-bdbb-cb2ff3165f53" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_d3ac6307-3965-40bb-89d1-d3e4be393732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a63b3586-7b75-4bd2-8f7f-392e6f2ad990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a0b8f5c-1fd1-49b4-bdbb-cb2ff3165f53" xlink:to="loc_us-gaap_UseOfEstimates_a63b3586-7b75-4bd2-8f7f-392e6f2ad990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComparabilityOfPriorYearFinancialData_7ef5fbc6-0a8e-4103-b11b-2b86c5b8db30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComparabilityOfPriorYearFinancialData"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a0b8f5c-1fd1-49b4-bdbb-cb2ff3165f53" xlink:to="loc_us-gaap_ComparabilityOfPriorYearFinancialData_7ef5fbc6-0a8e-4103-b11b-2b86c5b8db30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_d0e866ee-512e-4d87-8788-a23b81be2317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a0b8f5c-1fd1-49b4-bdbb-cb2ff3165f53" xlink:to="loc_us-gaap_FiscalPeriod_d0e866ee-512e-4d87-8788-a23b81be2317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_228e05c5-52e1-402c-ad8e-049c8364a0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a0b8f5c-1fd1-49b4-bdbb-cb2ff3165f53" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_228e05c5-52e1-402c-ad8e-049c8364a0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b33e302e-eb68-4204-ac72-279b9009c76d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a0b8f5c-1fd1-49b4-bdbb-cb2ff3165f53" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b33e302e-eb68-4204-ac72-279b9009c76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldForSalePolicyTextBlock_670a625e-5aac-41b2-9ec3-48ec92465455" xlink:href="mck-20211231.xsd#mck_HeldForSalePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a0b8f5c-1fd1-49b4-bdbb-cb2ff3165f53" xlink:to="loc_mck_HeldForSalePolicyTextBlock_670a625e-5aac-41b2-9ec3-48ec92465455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_15e8a786-d9c3-45a1-92d3-9e4ff83eca31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a0b8f5c-1fd1-49b4-bdbb-cb2ff3165f53" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_15e8a786-d9c3-45a1-92d3-9e4ff83eca31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_01048fd5-c0c7-4c8b-a28f-fb727c4042ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_cbf318b2-abcc-407e-bfcf-34f35e718312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_01048fd5-c0c7-4c8b-a28f-fb727c4042ae" xlink:to="loc_us-gaap_NumberOfReportableSegments_cbf318b2-abcc-407e-bfcf-34f35e718312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20211231.xsd#HeldforSale"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c9a9ce2a-b849-422d-9446-a4efa49c94b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_317b8342-86b4-4a03-a63d-07d9e7defa08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c9a9ce2a-b849-422d-9446-a4efa49c94b2" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_317b8342-86b4-4a03-a63d-07d9e7defa08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20211231.xsd#HeldforSaleTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4de49cdd-a181-4aa7-b860-be90b25ee537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_653a1a5f-843e-4063-aa34-85002e8f93c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4de49cdd-a181-4aa7-b860-be90b25ee537" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_653a1a5f-843e-4063-aa34-85002e8f93c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#HeldforSaleNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a682e26a-dd43-48ac-ab37-3847f8c82661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fe6596e-2b45-46e4-95c4-e9034067e303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a682e26a-dd43-48ac-ab37-3847f8c82661" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fe6596e-2b45-46e4-95c4-e9034067e303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c9e8373a-9fc7-42f4-89e4-628e815622d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fe6596e-2b45-46e4-95c4-e9034067e303" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c9e8373a-9fc7-42f4-89e4-628e815622d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c9e8373a-9fc7-42f4-89e4-628e815622d2" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_e7f8d5f9-147f-4c70-bfab-a0dc76c395b1" xlink:href="mck-20211231.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_e7f8d5f9-147f-4c70-bfab-a0dc76c395b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember_5563b6c5-0952-45b8-a7a5-5f0e0c43ab44" xlink:href="mck-20211231.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:to="loc_mck_AustrianBusinessOperationsMember_5563b6c5-0952-45b8-a7a5-5f0e0c43ab44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_59aaf2c2-f379-4a4e-af55-c38ad270fa72" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_59aaf2c2-f379-4a4e-af55-c38ad270fa72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_15bbcead-1eba-4045-be08-332bd7c00501" xlink:href="mck-20211231.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_15bbcead-1eba-4045-be08-332bd7c00501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_4274100b-d39f-43a5-b473-1d6d079f4039" xlink:href="mck-20211231.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0483726-dde7-4256-8e75-49493e408d83" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_4274100b-d39f-43a5-b473-1d6d079f4039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_81df8e0a-cb8f-4e18-bb0d-5d82c826313c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fe6596e-2b45-46e4-95c4-e9034067e303" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_81df8e0a-cb8f-4e18-bb0d-5d82c826313c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_479ec30e-e1b2-4c00-92fe-826976643cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_81df8e0a-cb8f-4e18-bb0d-5d82c826313c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_479ec30e-e1b2-4c00-92fe-826976643cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_170713fc-4053-48e1-ad69-7eb0ae9ed40e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_479ec30e-e1b2-4c00-92fe-826976643cb3" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_170713fc-4053-48e1-ad69-7eb0ae9ed40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8042fa83-57fc-4354-810d-17f68558e137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fe6596e-2b45-46e4-95c4-e9034067e303" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8042fa83-57fc-4354-810d-17f68558e137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1c4b3678-9798-439f-baba-181f6b7ebbaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8042fa83-57fc-4354-810d-17f68558e137" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1c4b3678-9798-439f-baba-181f6b7ebbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_398afc6f-0406-4564-90d2-222201c4a423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1c4b3678-9798-439f-baba-181f6b7ebbaf" xlink:to="loc_us-gaap_SubsequentEventMember_398afc6f-0406-4564-90d2-222201c4a423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fe6596e-2b45-46e4-95c4-e9034067e303" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_8d574572-de4e-48a0-9fa9-731f75c1bc06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_8d574572-de4e-48a0-9fa9-731f75c1bc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5b9fbf67-dce3-4e5f-8b8c-bd820fe6e34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5b9fbf67-dce3-4e5f-8b8c-bd820fe6e34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_e7648e32-0a00-40d0-83a7-a9fc2b1455ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_e7648e32-0a00-40d0-83a7-a9fc2b1455ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_18c72d00-adac-409a-8ab8-d9dfe29208ea" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_18c72d00-adac-409a-8ab8-d9dfe29208ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_f269e2ae-22f4-4c55-8065-6754bf9d0acd" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_f269e2ae-22f4-4c55-8065-6754bf9d0acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_71832374-4bc9-467f-9745-53d9fa4aef88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_us-gaap_AssetsNet_71832374-4bc9-467f-9745-53d9fa4aef88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_676a66f9-a0a8-4447-86de-489c7f31df3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c3e2a157-96af-4512-8985-c3380dd837c8" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_676a66f9-a0a8-4447-86de-489c7f31df3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6d9d2140-4c0a-4a19-90ee-44a1e61dd04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3b09633b-4c24-4a5f-bf71-429f75552ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6d9d2140-4c0a-4a19-90ee-44a1e61dd04c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3b09633b-4c24-4a5f-bf71-429f75552ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b87f2f9c-c65e-41a9-8180-2c8c6489384e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3b09633b-4c24-4a5f-bf71-429f75552ca0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b87f2f9c-c65e-41a9-8180-2c8c6489384e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b87f2f9c-c65e-41a9-8180-2c8c6489384e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_9d814f3a-580f-48c8-9289-22dfbd79307c" xlink:href="mck-20211231.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_9d814f3a-580f-48c8-9289-22dfbd79307c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_ac3d4e54-78b0-4f0c-9e1f-3da7760a7182" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_ac3d4e54-78b0-4f0c-9e1f-3da7760a7182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_1e1abaf0-6ffe-4de6-b8a1-55fc0da3b60e" xlink:href="mck-20211231.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_1e1abaf0-6ffe-4de6-b8a1-55fc0da3b60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_97b5b44c-7d4c-4c55-ab5b-eb633c107cbe" xlink:href="mck-20211231.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:to="loc_mck_EuroDenominatedNotesMember_97b5b44c-7d4c-4c55-ab5b-eb633c107cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember_db7100c3-93bc-4478-a9cc-438220b98def" xlink:href="mck-20211231.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac589b63-3f97-4a3b-a91e-34f72b73c684" xlink:to="loc_mck_InternallyDevelopedSoftwareMember_db7100c3-93bc-4478-a9cc-438220b98def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3cfd1c6b-2dc8-4307-a9c6-f6622c0af8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3b09633b-4c24-4a5f-bf71-429f75552ca0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3cfd1c6b-2dc8-4307-a9c6-f6622c0af8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_08a0650d-74f0-4d50-9065-10bb2afb59ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3cfd1c6b-2dc8-4307-a9c6-f6622c0af8eb" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_08a0650d-74f0-4d50-9065-10bb2afb59ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_14a6b063-4c57-40c8-8ab3-e5d709433870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_08a0650d-74f0-4d50-9065-10bb2afb59ab" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_14a6b063-4c57-40c8-8ab3-e5d709433870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19b24819-9c0b-4606-88e3-531417fc7999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3b09633b-4c24-4a5f-bf71-429f75552ca0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19b24819-9c0b-4606-88e3-531417fc7999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19b24819-9c0b-4606-88e3-531417fc7999" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_451fe2c2-70ea-44d4-9513-20d4a0ac66b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_451fe2c2-70ea-44d4-9513-20d4a0ac66b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_380a9b53-ea53-48f1-badf-90d4e4995c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_380a9b53-ea53-48f1-badf-90d4e4995c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e9639692-7e53-40bf-b9bb-9e8508a0cce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e9639692-7e53-40bf-b9bb-9e8508a0cce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_9f454d61-9818-4d05-ad3f-15cd8db30265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_9f454d61-9818-4d05-ad3f-15cd8db30265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_edbd3005-0097-4c2a-9e24-17ae15596295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_edbd3005-0097-4c2a-9e24-17ae15596295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_1497c229-795f-4f26-b739-8190823a771f" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_1497c229-795f-4f26-b739-8190823a771f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_da247af7-7be5-4e92-8359-5cdf6a808178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_da247af7-7be5-4e92-8359-5cdf6a808178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_4ae961ff-93d5-4731-9088-575b89005000" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_4ae961ff-93d5-4731-9088-575b89005000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_5c0961ea-dc8f-4824-81a4-6347e6268e5d" xlink:href="mck-20211231.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_5c0961ea-dc8f-4824-81a4-6347e6268e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_249ec25c-1d0f-45db-9103-8db9063b2f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_2de7a8bb-1ceb-457d-bdee-5c7c34970b06" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_249ec25c-1d0f-45db-9103-8db9063b2f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19b24819-9c0b-4606-88e3-531417fc7999" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_1d864aa3-809f-445e-b793-c0c9d4f07f34" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_1d864aa3-809f-445e-b793-c0c9d4f07f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_0eca3e1a-96c0-433f-9b51-30f52c9ff111" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_0eca3e1a-96c0-433f-9b51-30f52c9ff111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_8b074f23-f505-4374-9e18-f72ede59b642" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_8b074f23-f505-4374-9e18-f72ede59b642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_ef713ea1-85b8-4cbb-9861-c1c290909984" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_ef713ea1-85b8-4cbb-9861-c1c290909984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_7c7a0078-346c-4d26-9a5b-0c221a0eaca2" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_7c7a0078-346c-4d26-9a5b-0c221a0eaca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_1a557d58-1bc9-485b-ae79-8e1a37a82ddb" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_1a557d58-1bc9-485b-ae79-8e1a37a82ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_c81839fa-7957-4d6d-a20a-63ef2c992b9f" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_c81839fa-7957-4d6d-a20a-63ef2c992b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_28d3619b-31f9-4b4c-8b89-61f6455e9524" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_28d3619b-31f9-4b4c-8b89-61f6455e9524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fda0a826-18ea-4caf-bba1-12bcf9255f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_d12a663f-47bb-4329-8c81-4ad4f78b20a4" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fda0a826-18ea-4caf-bba1-12bcf9255f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_d3aafc2d-daa7-487a-bd9a-14dfb8625d0a" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19b24819-9c0b-4606-88e3-531417fc7999" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_d3aafc2d-daa7-487a-bd9a-14dfb8625d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20211231.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c1ce1ef0-5b1c-446a-8681-e92f41c9b720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_85322024-3eef-4129-9d95-668e1e146667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c1ce1ef0-5b1c-446a-8681-e92f41c9b720" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_85322024-3eef-4129-9d95-668e1e146667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20211231.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a3d8e083-84f1-4448-98e2-a9cd0cf6595c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5a7743a2-c939-44ca-9902-5c7b008e8126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a3d8e083-84f1-4448-98e2-a9cd0cf6595c" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5a7743a2-c939-44ca-9902-5c7b008e8126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_ebfae1a8-3d52-4652-9f2f-633c1277cfe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a3d8e083-84f1-4448-98e2-a9cd0cf6595c" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_ebfae1a8-3d52-4652-9f2f-633c1277cfe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0016a60e-6703-4c55-8f6a-8e1ca0b033bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0016a60e-6703-4c55-8f6a-8e1ca0b033bf" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0fa46ab3-8518-48e7-b2d1-02461fdc0de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:to="loc_us-gaap_RestructuringPlanAxis_0fa46ab3-8518-48e7-b2d1-02461fdc0de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bce5757d-8a5f-408b-8494-0e0095921534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_0fa46ab3-8518-48e7-b2d1-02461fdc0de3" xlink:to="loc_us-gaap_RestructuringPlanDomain_bce5757d-8a5f-408b-8494-0e0095921534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_f3520539-657e-476d-961a-757002d43d24" xlink:href="mck-20211231.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_bce5757d-8a5f-408b-8494-0e0095921534" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_f3520539-657e-476d-961a-757002d43d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember_063e8a81-f7b6-467a-ae9f-2730f8e18a6f" xlink:href="mck-20211231.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_bce5757d-8a5f-408b-8494-0e0095921534" xlink:to="loc_mck_OperatingModelAndCostOptimizationProgramsMember_063e8a81-f7b6-467a-ae9f-2730f8e18a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4b787a3c-988e-4c27-8e11-4ab36a26d72d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:to="loc_srt_RangeAxis_4b787a3c-988e-4c27-8e11-4ab36a26d72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9883ef68-e86f-4c21-9f86-bd1caa37dfcb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4b787a3c-988e-4c27-8e11-4ab36a26d72d" xlink:to="loc_srt_RangeMember_9883ef68-e86f-4c21-9f86-bd1caa37dfcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f84403e1-57d7-42c1-ac73-f81aa794c123" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9883ef68-e86f-4c21-9f86-bd1caa37dfcb" xlink:to="loc_srt_MinimumMember_f84403e1-57d7-42c1-ac73-f81aa794c123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e0297533-a3f6-4e95-929e-8e7b8b1aacbd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9883ef68-e86f-4c21-9f86-bd1caa37dfcb" xlink:to="loc_srt_MaximumMember_e0297533-a3f6-4e95-929e-8e7b8b1aacbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5c20b831-1e43-4858-b051-c6610a38ddd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5c20b831-1e43-4858-b051-c6610a38ddd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f6bf55fe-4190-47de-9818-de26fe7adb12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5c20b831-1e43-4858-b051-c6610a38ddd1" xlink:to="loc_us-gaap_SegmentDomain_f6bf55fe-4190-47de-9818-de26fe7adb12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_e415a5bf-eea0-46a7-a072-2d24747b6bc4" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f6bf55fe-4190-47de-9818-de26fe7adb12" xlink:to="loc_mck_InternationalSegmentMember_e415a5bf-eea0-46a7-a072-2d24747b6bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_fcd34ec1-b2bf-4d60-a916-10f2539a10bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_fcd34ec1-b2bf-4d60-a916-10f2539a10bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_fed1f622-f409-4e79-8ac2-a23f3f291f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_fcd34ec1-b2bf-4d60-a916-10f2539a10bf" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_fed1f622-f409-4e79-8ac2-a23f3f291f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_a2cc8fba-4503-4439-97e6-9694f2941460" xlink:href="mck-20211231.xsd#mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_fed1f622-f409-4e79-8ac2-a23f3f291f5b" xlink:to="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_a2cc8fba-4503-4439-97e6-9694f2941460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97057e8b-601b-4a57-823d-2b47a45bcad5" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_2a432dd2-bd90-4c41-ad6a-a7d16570b7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_2a432dd2-bd90-4c41-ad6a-a7d16570b7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_071d5458-0702-4479-8f57-212c1910403a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_071d5458-0702-4479-8f57-212c1910403a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_7eb580ad-df05-47d1-bc8c-65ae0c669174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_7eb580ad-df05-47d1-bc8c-65ae0c669174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6a378ec1-8f29-4138-b80f-6ffb61b55eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5504f136-e950-4f89-ab26-92965bd9bb65" xlink:to="loc_us-gaap_RestructuringCharges_6a378ec1-8f29-4138-b80f-6ffb61b55eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c853ff7d-4414-4114-b6d3-39b06db69cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8682210e-04af-4423-a27e-780795e362db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c853ff7d-4414-4114-b6d3-39b06db69cbb" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8682210e-04af-4423-a27e-780795e362db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f8a5f49d-3827-4ba8-9285-fa37860bc104" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8682210e-04af-4423-a27e-780795e362db" xlink:to="loc_srt_ConsolidationItemsAxis_f8a5f49d-3827-4ba8-9285-fa37860bc104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_938d7f81-5716-4593-a3a6-03d9fa8dab02" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f8a5f49d-3827-4ba8-9285-fa37860bc104" xlink:to="loc_srt_ConsolidationItemsDomain_938d7f81-5716-4593-a3a6-03d9fa8dab02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_425b7629-d7fa-42cf-a307-553b6a6109a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_938d7f81-5716-4593-a3a6-03d9fa8dab02" xlink:to="loc_us-gaap_OperatingSegmentsMember_425b7629-d7fa-42cf-a307-553b6a6109a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f98fb473-4ba5-4cdc-bd36-1fdb167e54fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_938d7f81-5716-4593-a3a6-03d9fa8dab02" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f98fb473-4ba5-4cdc-bd36-1fdb167e54fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f69862a9-c8a2-4c71-bab0-684fbe8c3f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8682210e-04af-4423-a27e-780795e362db" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f69862a9-c8a2-4c71-bab0-684fbe8c3f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f69862a9-c8a2-4c71-bab0-684fbe8c3f19" xlink:to="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_97791845-d155-44c6-babb-bba608fcfe77" xlink:href="mck-20211231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:to="loc_mck_USPharmaceuticalSegmentMember_97791845-d155-44c6-babb-bba608fcfe77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_78790f49-3c49-4716-98df-55b83f36d2d2" xlink:href="mck-20211231.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_78790f49-3c49-4716-98df-55b83f36d2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_cd41a723-1a02-4cc1-9b5f-fead920475c0" xlink:href="mck-20211231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_cd41a723-1a02-4cc1-9b5f-fead920475c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_994e6456-96fa-4e84-8af1-0167ee347d58" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cae237de-c2a4-42c6-81a9-8e5b26679471" xlink:to="loc_mck_InternationalSegmentMember_994e6456-96fa-4e84-8af1-0167ee347d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8682210e-04af-4423-a27e-780795e362db" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_e25076de-6d89-4c59-863a-b4460d416fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:to="loc_us-gaap_SeveranceCosts1_e25076de-6d89-4c59-863a-b4460d416fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_ec37c3d3-944c-4bde-9ed9-6837eb90fef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:to="loc_us-gaap_BusinessExitCosts1_ec37c3d3-944c-4bde-9ed9-6837eb90fef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_87682289-5f88-41b1-a952-0ccaf3791146" xlink:href="mck-20211231.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_87682289-5f88-41b1-a952-0ccaf3791146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4770e5a4-5576-45c0-a319-2d29c6727934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2a3266ce-8b95-4f21-8094-98c5c7c28c00" xlink:to="loc_us-gaap_RestructuringCharges_4770e5a4-5576-45c0-a319-2d29c6727934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bc4bd092-49f8-4a85-87e6-b5aca3c4bd44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_40917e07-fbff-4c61-ad38-4330a285679d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bc4bd092-49f8-4a85-87e6-b5aca3c4bd44" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_40917e07-fbff-4c61-ad38-4330a285679d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c502e516-f40c-47f4-966b-6def59ec5f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_40917e07-fbff-4c61-ad38-4330a285679d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c502e516-f40c-47f4-966b-6def59ec5f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_eff1effa-7655-4871-9c7c-41a3ccc97701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c502e516-f40c-47f4-966b-6def59ec5f03" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_eff1effa-7655-4871-9c7c-41a3ccc97701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_d4630bd4-290a-4617-91d5-4ba314eef69b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eff1effa-7655-4871-9c7c-41a3ccc97701" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_d4630bd4-290a-4617-91d5-4ba314eef69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_6fdc07f7-3ba3-42e9-a341-19e721e7952a" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eff1effa-7655-4871-9c7c-41a3ccc97701" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_6fdc07f7-3ba3-42e9-a341-19e721e7952a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ab6241af-a907-4533-82c9-665961c2aa0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eff1effa-7655-4871-9c7c-41a3ccc97701" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ab6241af-a907-4533-82c9-665961c2aa0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_fb6b2b82-230c-4b0a-b52f-31fd307663e6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_40917e07-fbff-4c61-ad38-4330a285679d" xlink:to="loc_srt_ConsolidationItemsAxis_fb6b2b82-230c-4b0a-b52f-31fd307663e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a49b8b49-c069-4b1f-8a51-f45b97c7b610" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_fb6b2b82-230c-4b0a-b52f-31fd307663e6" xlink:to="loc_srt_ConsolidationItemsDomain_a49b8b49-c069-4b1f-8a51-f45b97c7b610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7f652f15-d4ab-42ca-a746-fa57268a21c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a49b8b49-c069-4b1f-8a51-f45b97c7b610" xlink:to="loc_us-gaap_OperatingSegmentsMember_7f652f15-d4ab-42ca-a746-fa57268a21c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c56d0c75-a073-4df0-95c2-3f7210b00eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a49b8b49-c069-4b1f-8a51-f45b97c7b610" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c56d0c75-a073-4df0-95c2-3f7210b00eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_095bd482-42ca-4c2b-8cc3-a6493905144c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_40917e07-fbff-4c61-ad38-4330a285679d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_095bd482-42ca-4c2b-8cc3-a6493905144c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_095bd482-42ca-4c2b-8cc3-a6493905144c" xlink:to="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_28658acf-9325-4625-8961-9dc630d1569a" xlink:href="mck-20211231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:to="loc_mck_USPharmaceuticalSegmentMember_28658acf-9325-4625-8961-9dc630d1569a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_5b7ac87c-542e-4070-a427-486a887c1be7" xlink:href="mck-20211231.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_5b7ac87c-542e-4070-a427-486a887c1be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_033de4ea-c978-45eb-8749-b439de71024a" xlink:href="mck-20211231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_033de4ea-c978-45eb-8749-b439de71024a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_40990aa4-37a2-4245-b3b0-a428c36a3ec7" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_156af029-f1a0-4fb6-b199-162d91ac06c4" xlink:to="loc_mck_InternationalSegmentMember_40990aa4-37a2-4245-b3b0-a428c36a3ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_db8c6485-4e4a-487c-84db-5d6bc8559ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_40917e07-fbff-4c61-ad38-4330a285679d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_db8c6485-4e4a-487c-84db-5d6bc8559ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_db8c6485-4e4a-487c-84db-5d6bc8559ae0" xlink:to="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_cb75cc94-0fbd-4a41-8970-91a115661c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:to="loc_us-gaap_RestructuringReserve_cb75cc94-0fbd-4a41-8970-91a115661c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_908152d7-13bf-47aa-a4ed-ba25a9b4013c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:to="loc_us-gaap_RestructuringCharges_908152d7-13bf-47aa-a4ed-ba25a9b4013c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_56874143-0398-486f-ab6b-6f70630434f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_56874143-0398-486f-ab6b-6f70630434f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_e68a5405-fa8c-4d12-989a-52ec93cc875b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:to="loc_us-gaap_PaymentsForRestructuring_e68a5405-fa8c-4d12-989a-52ec93cc875b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_4e326fd6-2ad8-4423-86e8-8a08cdce34c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_4e326fd6-2ad8-4423-86e8-8a08cdce34c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_20bf1fa7-ebf7-4221-83e7-1629c785f28d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0fc46427-d46d-49d7-989d-c91920c22369" xlink:to="loc_us-gaap_RestructuringReserve_20bf1fa7-ebf7-4221-83e7-1629c785f28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_88004b82-d29b-4be0-8422-423478308fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_fe3080db-b698-457c-bda5-99a5e020ac0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_88004b82-d29b-4be0-8422-423478308fd1" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_fe3080db-b698-457c-bda5-99a5e020ac0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c96a7082-60ff-43cc-9552-c5de90fda3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_40165b01-2cd9-4984-b389-7127466c26a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c96a7082-60ff-43cc-9552-c5de90fda3b9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_40165b01-2cd9-4984-b389-7127466c26a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_114c25c6-7eba-434a-a585-c6ba5de76b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c96a7082-60ff-43cc-9552-c5de90fda3b9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_114c25c6-7eba-434a-a585-c6ba5de76b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3463df4d-a74d-4496-963f-b7f1f0854326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c96a7082-60ff-43cc-9552-c5de90fda3b9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3463df4d-a74d-4496-963f-b7f1f0854326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e182f790-afc8-4358-ba7e-d368bcd267f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3463df4d-a74d-4496-963f-b7f1f0854326" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e182f790-afc8-4358-ba7e-d368bcd267f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aee7a698-d95b-4a5c-9730-e631fbc411c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e182f790-afc8-4358-ba7e-d368bcd267f3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aee7a698-d95b-4a5c-9730-e631fbc411c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_014c6852-7412-4c74-9ecd-812d81101cd8" xlink:href="mck-20211231.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aee7a698-d95b-4a5c-9730-e631fbc411c6" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_014c6852-7412-4c74-9ecd-812d81101cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_d8735a4c-f569-41de-ae2d-ca9b41a9eae6" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupAndAustrianBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aee7a698-d95b-4a5c-9730-e631fbc411c6" xlink:to="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_d8735a4c-f569-41de-ae2d-ca9b41a9eae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_726cc35e-3840-4259-8c39-8c9117535490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3463df4d-a74d-4496-963f-b7f1f0854326" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_726cc35e-3840-4259-8c39-8c9117535490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d9cf173c-b067-444f-90d7-a2722a4356c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_726cc35e-3840-4259-8c39-8c9117535490" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d9cf173c-b067-444f-90d7-a2722a4356c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_9f7df1b0-cbf5-4acb-8140-0fa0c802381e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d9cf173c-b067-444f-90d7-a2722a4356c2" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_9f7df1b0-cbf5-4acb-8140-0fa0c802381e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5820cb57-9fcf-4f93-b205-2e9b157a6541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3463df4d-a74d-4496-963f-b7f1f0854326" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5820cb57-9fcf-4f93-b205-2e9b157a6541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b3dc46b9-ccc3-42af-844a-013776237f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5820cb57-9fcf-4f93-b205-2e9b157a6541" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b3dc46b9-ccc3-42af-844a-013776237f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_306ff8d3-0cf4-4096-b048-efb6ee5c54bc" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_b3dc46b9-ccc3-42af-844a-013776237f0c" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_306ff8d3-0cf4-4096-b048-efb6ee5c54bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cfac9d69-04c6-4035-8523-8f9fcdff21b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3463df4d-a74d-4496-963f-b7f1f0854326" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cfac9d69-04c6-4035-8523-8f9fcdff21b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_056bf44c-a37a-44bb-bd72-97c0ad7d7aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cfac9d69-04c6-4035-8523-8f9fcdff21b0" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_056bf44c-a37a-44bb-bd72-97c0ad7d7aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_98300a40-e9e8-4483-b79f-8659fb81204c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cfac9d69-04c6-4035-8523-8f9fcdff21b0" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_98300a40-e9e8-4483-b79f-8659fb81204c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_6ba4c2ef-c95e-4645-ab54-8598d010ccf9" xlink:href="mck-20211231.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cfac9d69-04c6-4035-8523-8f9fcdff21b0" xlink:to="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_6ba4c2ef-c95e-4645-ab54-8598d010ccf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_3ef435ac-4508-4575-82da-661d3becb9d7" xlink:href="mck-20211231.xsd#mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c96a7082-60ff-43cc-9552-c5de90fda3b9" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount_3ef435ac-4508-4575-82da-661d3becb9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_3db5c9ce-3cbb-4b33-ac1b-8e421e5e06dc" xlink:href="mck-20211231.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c96a7082-60ff-43cc-9552-c5de90fda3b9" xlink:to="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_3db5c9ce-3cbb-4b33-ac1b-8e421e5e06dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_9a5a0e1f-e626-4d7e-adc4-23998afe5844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c96a7082-60ff-43cc-9552-c5de90fda3b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_9a5a0e1f-e626-4d7e-adc4-23998afe5844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b6514c4c-ac66-4e9c-9217-c8d6b713e14d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c96a7082-60ff-43cc-9552-c5de90fda3b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b6514c4c-ac66-4e9c-9217-c8d6b713e14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_5eeb25f2-220b-4110-ba0c-013da84d15af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c96a7082-60ff-43cc-9552-c5de90fda3b9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_5eeb25f2-220b-4110-ba0c-013da84d15af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20211231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_4440ca9a-26c1-44da-9af8-f08dd87c182c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_17109c08-ac51-43a0-b7d0-dda7f48fba05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_4440ca9a-26c1-44da-9af8-f08dd87c182c" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_17109c08-ac51-43a0-b7d0-dda7f48fba05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20211231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_ed9b1f15-93f6-48d9-a380-ccf8b662550d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_2899e2de-7a65-4dbc-be58-9cf516f4a193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_ed9b1f15-93f6-48d9-a380-ccf8b662550d" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_2899e2de-7a65-4dbc-be58-9cf516f4a193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_4903286c-c802-4f6c-a89c-775de3218e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_a8ce5611-c52b-470b-acb6-bf2dc89c3025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_4903286c-c802-4f6c-a89c-775de3218e0a" xlink:to="loc_us-gaap_MinorityInterestTable_a8ce5611-c52b-470b-acb6-bf2dc89c3025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_960de18e-b431-4194-8469-5c09055fb43e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_a8ce5611-c52b-470b-acb6-bf2dc89c3025" xlink:to="loc_srt_OwnershipAxis_960de18e-b431-4194-8469-5c09055fb43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e4511eed-45cd-4db0-9460-19b56b5054df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_960de18e-b431-4194-8469-5c09055fb43e" xlink:to="loc_srt_OwnershipDomain_e4511eed-45cd-4db0-9460-19b56b5054df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_4fe97542-61e1-4786-8e8d-e290d85f71ea" xlink:href="mck-20211231.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_e4511eed-45cd-4db0-9460-19b56b5054df" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_4fe97542-61e1-4786-8e8d-e290d85f71ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_2143363a-924d-4a2f-956b-00d2ef584303" xlink:href="mck-20211231.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_e4511eed-45cd-4db0-9460-19b56b5054df" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_2143363a-924d-4a2f-956b-00d2ef584303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_25721a89-7758-45eb-ac6f-144262a064df" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_a8ce5611-c52b-470b-acb6-bf2dc89c3025" xlink:to="loc_dei_LegalEntityAxis_25721a89-7758-45eb-ac6f-144262a064df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c2d1d94d-7662-405c-97da-1151b4b9e321" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_25721a89-7758-45eb-ac6f-144262a064df" xlink:to="loc_dei_EntityDomain_c2d1d94d-7662-405c-97da-1151b4b9e321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_67e2a132-a5d6-4e21-97d8-2959d134e777" xlink:href="mck-20211231.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c2d1d94d-7662-405c-97da-1151b4b9e321" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_67e2a132-a5d6-4e21-97d8-2959d134e777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_073666ad-d190-4d8a-bcfd-4096a7fa50ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_a8ce5611-c52b-470b-acb6-bf2dc89c3025" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_073666ad-d190-4d8a-bcfd-4096a7fa50ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d3993200-040e-419c-8894-5d1eb4ee18fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_073666ad-d190-4d8a-bcfd-4096a7fa50ce" xlink:to="loc_us-gaap_EquityComponentDomain_d3993200-040e-419c-8894-5d1eb4ee18fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_39ce375a-0e38-4d7d-ad9d-4dbafeff3731" xlink:href="mck-20211231.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d3993200-040e-419c-8894-5d1eb4ee18fa" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_39ce375a-0e38-4d7d-ad9d-4dbafeff3731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e15c3b7d-7a77-4fec-bd33-e27a97d30bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d3993200-040e-419c-8894-5d1eb4ee18fa" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e15c3b7d-7a77-4fec-bd33-e27a97d30bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ce9cbea0-203d-4a9c-a082-b04a4125b955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d3993200-040e-419c-8894-5d1eb4ee18fa" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ce9cbea0-203d-4a9c-a082-b04a4125b955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_a8ce5611-c52b-470b-acb6-bf2dc89c3025" xlink:to="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_077b1de8-5fcc-4878-8de2-6bbab529eda2" xlink:href="mck-20211231.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_077b1de8-5fcc-4878-8de2-6bbab529eda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_86126ad1-2daa-41f8-b4a9-66878a6786cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_86126ad1-2daa-41f8-b4a9-66878a6786cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_592cfa5e-5ff8-4159-8ba0-0937a99d98f1" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_592cfa5e-5ff8-4159-8ba0-0937a99d98f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_a9ea73a1-492c-4c50-8079-8909190e9276" xlink:href="mck-20211231.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_PutRightValueInterestRateSpread_a9ea73a1-492c-4c50-8079-8909190e9276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_fbe7c78c-d6bc-4cf0-81f5-7e8f52f156f4" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_fbe7c78c-d6bc-4cf0-81f5-7e8f52f156f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_663f107a-9660-4e10-abad-e3bfe779e98a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_663f107a-9660-4e10-abad-e3bfe779e98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_185f3a08-546d-4d7e-87bb-2d36e2e03aa9" xlink:href="mck-20211231.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_185f3a08-546d-4d7e-87bb-2d36e2e03aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_91146bec-a0f6-4c78-872d-4636a55616bb" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_91146bec-a0f6-4c78-872d-4636a55616bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_1b1c0863-3223-438b-9398-dda0b63e7cca" xlink:href="mck-20211231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_1b1c0863-3223-438b-9398-dda0b63e7cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_cf7ddb37-ae9d-4cab-956b-fea3d8253db4" xlink:href="mck-20211231.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_cf7ddb37-ae9d-4cab-956b-fea3d8253db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_b58e49cc-2418-4966-82d1-4c62b55b94c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_b58e49cc-2418-4966-82d1-4c62b55b94c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_095b78ae-8732-4aea-9b49-3f2d2b99ac21" xlink:href="mck-20211231.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_095b78ae-8732-4aea-9b49-3f2d2b99ac21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8d9a5ed9-8700-4da8-91cd-e7ec9579b5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8d9a5ed9-8700-4da8-91cd-e7ec9579b5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_be783a77-6c3b-4b5a-9196-809789616bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_b4becd22-e6d6-4ba3-82e8-2344cf2c3024" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_be783a77-6c3b-4b5a-9196-809789616bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_57436724-10a3-4ce8-9586-1848dd261f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_8c4ca23d-b56a-4b7c-9f47-49e39a5de83d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_57436724-10a3-4ce8-9586-1848dd261f10" xlink:to="loc_us-gaap_MinorityInterestTable_8c4ca23d-b56a-4b7c-9f47-49e39a5de83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_48fa191b-4c66-46e3-8b57-aea736ca7e79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_8c4ca23d-b56a-4b7c-9f47-49e39a5de83d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_48fa191b-4c66-46e3-8b57-aea736ca7e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7fc6ad85-332b-4a19-85a6-82f9d246351b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_48fa191b-4c66-46e3-8b57-aea736ca7e79" xlink:to="loc_us-gaap_EquityComponentDomain_7fc6ad85-332b-4a19-85a6-82f9d246351b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_8883c8cd-dd44-4f06-aa41-ef55649ae581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7fc6ad85-332b-4a19-85a6-82f9d246351b" xlink:to="loc_us-gaap_NoncontrollingInterestMember_8883c8cd-dd44-4f06-aa41-ef55649ae581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_87ae3787-6a92-4d0f-80bb-6cd615a32a0c" xlink:href="mck-20211231.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7fc6ad85-332b-4a19-85a6-82f9d246351b" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_87ae3787-6a92-4d0f-80bb-6cd615a32a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_da09c715-df47-44b8-a823-b96bd3e9ba5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_8c4ca23d-b56a-4b7c-9f47-49e39a5de83d" xlink:to="loc_us-gaap_MinorityInterestLineItems_da09c715-df47-44b8-a823-b96bd3e9ba5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_da09c715-df47-44b8-a823-b96bd3e9ba5c" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_66ce73ca-f409-430f-acd2-b3b05a317522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:to="loc_us-gaap_MinorityInterest_66ce73ca-f409-430f-acd2-b3b05a317522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d4d746b6-62d7-4ca3-8d43-04a71832aa1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d4d746b6-62d7-4ca3-8d43-04a71832aa1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_7f0d4dde-6baf-4070-aadb-cca390e8a13d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_7f0d4dde-6baf-4070-aadb-cca390e8a13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4d08513b-de41-4653-babf-bfdba183575d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4d08513b-de41-4653-babf-bfdba183575d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_0f26ba93-c419-41a1-9509-1f9df1803510" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_0f26ba93-c419-41a1-9509-1f9df1803510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_b9f98982-e843-40b8-b336-8764a7aa7a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f08b326d-13e0-4d32-bf40-fb04d5080735" xlink:to="loc_us-gaap_MinorityInterest_b9f98982-e843-40b8-b336-8764a7aa7a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_da09c715-df47-44b8-a823-b96bd3e9ba5c" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_45c41dc0-ecc5-4221-b687-35ad33fd0083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_45c41dc0-ecc5-4221-b687-35ad33fd0083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_295eb426-ef33-4cde-922f-d43901eb6a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_295eb426-ef33-4cde-922f-d43901eb6a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_5a17a1fc-e4a4-440c-a3c7-c263692a93a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_5a17a1fc-e4a4-440c-a3c7-c263692a93a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_ffa55976-8a33-4010-afb5-419e968bb094" xlink:href="mck-20211231.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_ffa55976-8a33-4010-afb5-419e968bb094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2f7b9860-faeb-4a22-aaac-0b99bc789c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2f7b9860-faeb-4a22-aaac-0b99bc789c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_2a7d092e-4f68-4cb1-84b8-aa67f07db601" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_2a7d092e-4f68-4cb1-84b8-aa67f07db601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_714cc3cf-ba83-411b-8779-6c31742e67ba" xlink:href="mck-20211231.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_714cc3cf-ba83-411b-8779-6c31742e67ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_de20f520-ae79-46c4-8aa9-37dd2c45f891" xlink:href="mck-20211231.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_de20f520-ae79-46c4-8aa9-37dd2c45f891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_10969847-c535-4795-a381-cc58c66f33cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2ee6cff2-f28a-4d73-afe5-55889972f97f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_10969847-c535-4795-a381-cc58c66f33cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="simple" xlink:href="mck-20211231.xsd#EarningsLossPerCommonShare"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ae6d52b8-0ca5-43cc-8708-37a8e9de62c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_889bf5a7-b90c-4203-a56d-dfeeddf76e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ae6d52b8-0ca5-43cc-8708-37a8e9de62c7" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_889bf5a7-b90c-4203-a56d-dfeeddf76e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="simple" xlink:href="mck-20211231.xsd#EarningsLossPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cb2502ee-383c-443f-a1e6-ebfddb35aff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_aa21e840-414f-4ac1-b6b3-a78e7dcbdef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cb2502ee-383c-443f-a1e6-ebfddb35aff3" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_aa21e840-414f-4ac1-b6b3-a78e7dcbdef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#EarningsLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d727d0b0-f79f-4553-9c43-9e2a7f7cca20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_f4923e2a-e0cf-46b7-9b33-074916ebf493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d727d0b0-f79f-4553-9c43-9e2a7f7cca20" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_f4923e2a-e0cf-46b7-9b33-074916ebf493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7d0da53c-55c6-4c0f-9781-d5a5abe2e741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_f4923e2a-e0cf-46b7-9b33-074916ebf493" xlink:to="loc_us-gaap_AwardTypeAxis_7d0da53c-55c6-4c0f-9781-d5a5abe2e741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af856c4e-2340-477b-a731-ef933b57ca4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7d0da53c-55c6-4c0f-9781-d5a5abe2e741" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af856c4e-2340-477b-a731-ef933b57ca4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1e90f525-6d59-4b5c-a300-f34d9f4ad426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af856c4e-2340-477b-a731-ef933b57ca4e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1e90f525-6d59-4b5c-a300-f34d9f4ad426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_50d14d38-78be-419e-a86b-2eff041175c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af856c4e-2340-477b-a731-ef933b57ca4e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_50d14d38-78be-419e-a86b-2eff041175c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_f4923e2a-e0cf-46b7-9b33-074916ebf493" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3df354a9-9ec7-4230-850f-ae1bbb0fbc04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3df354a9-9ec7-4230-850f-ae1bbb0fbc04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_35165891-3ec6-424f-919c-ea61a60cdc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_35165891-3ec6-424f-919c-ea61a60cdc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_bba0e228-2a3c-4565-9e39-ee45675a2a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_bba0e228-2a3c-4565-9e39-ee45675a2a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_29e554e0-25f1-4b8a-9f06-1c52efc9dcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_29e554e0-25f1-4b8a-9f06-1c52efc9dcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dd3f6495-b01c-4b67-82d7-e97f1c52337f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_NetIncomeLoss_dd3f6495-b01c-4b67-82d7-e97f1c52337f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_803ea29d-acb3-42c3-a377-bf9055e65715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_803ea29d-acb3-42c3-a377-bf9055e65715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4ef7a56a-48dc-4c6e-995a-fdd66bbd4364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_803ea29d-acb3-42c3-a377-bf9055e65715" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4ef7a56a-48dc-4c6e-995a-fdd66bbd4364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_4ab201b2-7513-421a-a6eb-e1c0697fff48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_803ea29d-acb3-42c3-a377-bf9055e65715" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_4ab201b2-7513-421a-a6eb-e1c0697fff48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0f7e3c9b-7472-4b43-a6a1-dfb2162c89e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_4ab201b2-7513-421a-a6eb-e1c0697fff48" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0f7e3c9b-7472-4b43-a6a1-dfb2162c89e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dbced3d3-f734-4294-8d2a-34d41c43ee22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_803ea29d-acb3-42c3-a377-bf9055e65715" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dbced3d3-f734-4294-8d2a-34d41c43ee22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fe3a64f7-4dbf-4de9-847a-faac5a1b19cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fe3a64f7-4dbf-4de9-847a-faac5a1b19cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_41d1cc40-c55f-4f49-a333-9749bff1fe34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fe3a64f7-4dbf-4de9-847a-faac5a1b19cb" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_41d1cc40-c55f-4f49-a333-9749bff1fe34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6c2bb4b1-e1ba-44b1-a8f4-a96a112501dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_41d1cc40-c55f-4f49-a333-9749bff1fe34" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6c2bb4b1-e1ba-44b1-a8f4-a96a112501dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_8130ec4c-3f02-4df7-912e-1b2375e8d7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_41d1cc40-c55f-4f49-a333-9749bff1fe34" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_8130ec4c-3f02-4df7-912e-1b2375e8d7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8ec4263a-ca6f-45b6-8e2d-77fa0bdf9498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_41d1cc40-c55f-4f49-a333-9749bff1fe34" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8ec4263a-ca6f-45b6-8e2d-77fa0bdf9498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_7150c971-eb70-4e79-a21e-599033ba5119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fe3a64f7-4dbf-4de9-847a-faac5a1b19cb" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_7150c971-eb70-4e79-a21e-599033ba5119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_0f7f7d9e-f3da-4904-89e2-cabcdbeaf977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_7150c971-eb70-4e79-a21e-599033ba5119" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_0f7f7d9e-f3da-4904-89e2-cabcdbeaf977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a4c3599f-d61e-42c6-a4c4-9b2a2b00d1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_7150c971-eb70-4e79-a21e-599033ba5119" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a4c3599f-d61e-42c6-a4c4-9b2a2b00d1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_dea9d3a1-a51c-49f0-985b-08fc9d87b4de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_7150c971-eb70-4e79-a21e-599033ba5119" xlink:to="loc_us-gaap_EarningsPerShareBasic_dea9d3a1-a51c-49f0-985b-08fc9d87b4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67b49eac-b873-47d7-be8d-3181e93895af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_449c4872-7ce0-45a7-b650-afcc639b1d93" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67b49eac-b873-47d7-be8d-3181e93895af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20211231.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b7152eec-c456-44cb-bdc8-e9665806269c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a983bafb-08ba-4090-b0bd-8e730251becd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b7152eec-c456-44cb-bdc8-e9665806269c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a983bafb-08ba-4090-b0bd-8e730251becd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20211231.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dd14b683-3a46-450e-8405-a398c1801b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_1c5e701b-22ff-4de9-96c3-372a72b4896f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dd14b683-3a46-450e-8405-a398c1801b30" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_1c5e701b-22ff-4de9-96c3-372a72b4896f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_83636f75-e5de-45f4-8e42-442cd68fb519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dd14b683-3a46-450e-8405-a398c1801b30" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_83636f75-e5de-45f4-8e42-442cd68fb519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2d33afc6-7875-4680-9c33-4bb2c7e82656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f83d9b59-4e92-4208-bc0b-9978a5613cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2d33afc6-7875-4680-9c33-4bb2c7e82656" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f83d9b59-4e92-4208-bc0b-9978a5613cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3fc76d3a-3a13-4308-a34b-da1bdc7317bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f83d9b59-4e92-4208-bc0b-9978a5613cfb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3fc76d3a-3a13-4308-a34b-da1bdc7317bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0b58213d-6164-4a8b-af7d-bf6abfc3bf20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3fc76d3a-3a13-4308-a34b-da1bdc7317bd" xlink:to="loc_us-gaap_SegmentDomain_0b58213d-6164-4a8b-af7d-bf6abfc3bf20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_9c93c2b1-6369-43a3-8d09-2e6b68f9355a" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0b58213d-6164-4a8b-af7d-bf6abfc3bf20" xlink:to="loc_mck_InternationalSegmentMember_9c93c2b1-6369-43a3-8d09-2e6b68f9355a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_93b7a927-f4ad-446d-8b98-a8049f14f5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f83d9b59-4e92-4208-bc0b-9978a5613cfb" xlink:to="loc_us-gaap_ReportingUnitAxis_93b7a927-f4ad-446d-8b98-a8049f14f5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_7a5d2fda-8c5a-4cb0-b2c3-ee6db9a0dd10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_93b7a927-f4ad-446d-8b98-a8049f14f5f3" xlink:to="loc_us-gaap_ReportingUnitDomain_7a5d2fda-8c5a-4cb0-b2c3-ee6db9a0dd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_1df9a36c-f23e-4d82-ae5d-b4f92debab0b" xlink:href="mck-20211231.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_7a5d2fda-8c5a-4cb0-b2c3-ee6db9a0dd10" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_1df9a36c-f23e-4d82-ae5d-b4f92debab0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e4015315-11a0-45ec-8d50-de8f1df72fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f83d9b59-4e92-4208-bc0b-9978a5613cfb" xlink:to="loc_us-gaap_GoodwillLineItems_e4015315-11a0-45ec-8d50-de8f1df72fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_378be0b6-9edb-40dc-ade3-8136655f2458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e4015315-11a0-45ec-8d50-de8f1df72fde" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_378be0b6-9edb-40dc-ade3-8136655f2458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2342897b-cbce-4dbf-8701-23031312d83e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e4015315-11a0-45ec-8d50-de8f1df72fde" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2342897b-cbce-4dbf-8701-23031312d83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e4015315-11a0-45ec-8d50-de8f1df72fde" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_2dcd840f-7258-4302-b2fd-b0788e372fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_2dcd840f-7258-4302-b2fd-b0788e372fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1a4616ae-d994-4c13-a9dd-fd206c47c302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1a4616ae-d994-4c13-a9dd-fd206c47c302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_caf1bf42-aab7-4e36-900e-89ec56f01c55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_caf1bf42-aab7-4e36-900e-89ec56f01c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3f479c5f-210a-4e59-bddd-fef1b01795db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3f479c5f-210a-4e59-bddd-fef1b01795db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8ee87b27-0674-4888-932c-fb3479ce1df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8ee87b27-0674-4888-932c-fb3479ce1df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_6385fbfa-cf0f-4bea-bba1-aa875af5bae8" xlink:href="mck-20211231.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_9d29ddbf-f5ae-4da7-b1a1-0a77d825d1ac" xlink:to="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_6385fbfa-cf0f-4bea-bba1-aa875af5bae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_92438db4-5fa9-40f7-993e-04350eee3741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_02beb4b7-12f2-4aa6-9cbb-fe196144bcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_92438db4-5fa9-40f7-993e-04350eee3741" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_02beb4b7-12f2-4aa6-9cbb-fe196144bcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2051fd05-d286-4b43-825b-dc1bb47ff30e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_02beb4b7-12f2-4aa6-9cbb-fe196144bcd7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2051fd05-d286-4b43-825b-dc1bb47ff30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2051fd05-d286-4b43-825b-dc1bb47ff30e" xlink:to="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_683e7293-7350-415f-9551-3064775ee416" xlink:href="mck-20211231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:to="loc_mck_USPharmaceuticalSegmentMember_683e7293-7350-415f-9551-3064775ee416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_0e8729f9-fdb6-41f2-aec8-7bee2a86a743" xlink:href="mck-20211231.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_0e8729f9-fdb6-41f2-aec8-7bee2a86a743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_29b67aa0-9f49-4459-87de-5802962051b3" xlink:href="mck-20211231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_29b67aa0-9f49-4459-87de-5802962051b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_ef601298-aee3-48b5-a08b-fcbf6f5a6fbe" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3dbe581-a718-4d47-803b-a6f6473a1073" xlink:to="loc_mck_InternationalSegmentMember_ef601298-aee3-48b5-a08b-fcbf6f5a6fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_856d60a8-8455-44b5-99fa-80d53ea1f016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_02beb4b7-12f2-4aa6-9cbb-fe196144bcd7" xlink:to="loc_us-gaap_GoodwillLineItems_856d60a8-8455-44b5-99fa-80d53ea1f016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_27a9fc87-47d0-4c84-9a5c-71eb6f805b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_856d60a8-8455-44b5-99fa-80d53ea1f016" xlink:to="loc_us-gaap_GoodwillRollForward_27a9fc87-47d0-4c84-9a5c-71eb6f805b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_087e0625-b70e-4fb4-bc33-c906b6179960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_27a9fc87-47d0-4c84-9a5c-71eb6f805b05" xlink:to="loc_us-gaap_Goodwill_087e0625-b70e-4fb4-bc33-c906b6179960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_c404dfd9-9272-41ce-b3eb-ed2610ac2fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_27a9fc87-47d0-4c84-9a5c-71eb6f805b05" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_c404dfd9-9272-41ce-b3eb-ed2610ac2fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_399a9c52-650e-4377-8ae8-a3ef538ffcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_27a9fc87-47d0-4c84-9a5c-71eb6f805b05" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_399a9c52-650e-4377-8ae8-a3ef538ffcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c23e0003-cf1e-40df-a4a2-3007de9477e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_27a9fc87-47d0-4c84-9a5c-71eb6f805b05" xlink:to="loc_us-gaap_Goodwill_c23e0003-cf1e-40df-a4a2-3007de9477e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4511ee98-5ed1-4277-b4ad-4be77c6ee61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_22462bf8-b8a0-4676-94fb-8460fb22ce37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4511ee98-5ed1-4277-b4ad-4be77c6ee61a" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_22462bf8-b8a0-4676-94fb-8460fb22ce37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a810bdb-1e6d-4709-a4e5-a1b3be4e56d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_22462bf8-b8a0-4676-94fb-8460fb22ce37" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a810bdb-1e6d-4709-a4e5-a1b3be4e56d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a810bdb-1e6d-4709-a4e5-a1b3be4e56d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_02d4a04a-4505-4a97-be7f-37111b6f0029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_us-gaap_CustomerRelationshipsMember_02d4a04a-4505-4a97-be7f-37111b6f0029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_cd769d50-92d3-4dd1-a91f-37182bce9540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_us-gaap_ServiceAgreementsMember_cd769d50-92d3-4dd1-a91f-37182bce9540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember_0bf4a410-a774-4d76-b5e2-38d003218ed1" xlink:href="mck-20211231.xsd#mck_PharmacyLicensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_mck_PharmacyLicensesMember_0bf4a410-a774-4d76-b5e2-38d003218ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_1d814c58-14a5-414c-972a-aee56a9a2d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_1d814c58-14a5-414c-972a-aee56a9a2d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0f9c92b1-d86e-4a9c-8540-ed7a41f4f7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0f9c92b1-d86e-4a9c-8540-ed7a41f4f7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_4cb31071-fff0-4dbd-8bdb-e76ad53f5e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cfd2b859-6baf-4548-9b40-c1930a9a25cf" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_4cb31071-fff0-4dbd-8bdb-e76ad53f5e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ccafcba-fc13-41da-ac9f-760a8084ce47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_22462bf8-b8a0-4676-94fb-8460fb22ce37" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ccafcba-fc13-41da-ac9f-760a8084ce47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38d134e1-0c4b-42f6-b102-1ae547f471c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ccafcba-fc13-41da-ac9f-760a8084ce47" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38d134e1-0c4b-42f6-b102-1ae547f471c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanAssetsHeldForSaleMember_7c2cadd4-2082-42a8-9bac-fe19df102c50" xlink:href="mck-20211231.xsd#mck_EuropeanAssetsHeldForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38d134e1-0c4b-42f6-b102-1ae547f471c8" xlink:to="loc_mck_EuropeanAssetsHeldForSaleMember_7c2cadd4-2082-42a8-9bac-fe19df102c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8e810e90-51bf-4799-a6fe-0f6b5d5d5172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_22462bf8-b8a0-4676-94fb-8460fb22ce37" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8e810e90-51bf-4799-a6fe-0f6b5d5d5172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_78aa1bd0-188b-483e-be18-0b66cdf3e514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8e810e90-51bf-4799-a6fe-0f6b5d5d5172" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_78aa1bd0-188b-483e-be18-0b66cdf3e514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8965a2dd-4b83-48eb-b971-ae427a1dab31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_78aa1bd0-188b-483e-be18-0b66cdf3e514" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8965a2dd-4b83-48eb-b971-ae427a1dab31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_22462bf8-b8a0-4676-94fb-8460fb22ce37" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_574bd2a0-6a8d-42d8-bf8c-32eb715d0bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_574bd2a0-6a8d-42d8-bf8c-32eb715d0bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_845383b5-3851-43ae-a1cf-5e814b78a77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_845383b5-3851-43ae-a1cf-5e814b78a77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_75397f5f-8674-48ef-b250-a38fcb180579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_75397f5f-8674-48ef-b250-a38fcb180579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_78e0b234-abb4-4bac-915a-2b646266d7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_78e0b234-abb4-4bac-915a-2b646266d7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4449a71c-2931-4be6-b9e3-cb51703320a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_55fe148b-b87c-46da-964c-c0d5c9cbea48" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4449a71c-2931-4be6-b9e3-cb51703320a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bfb4e65e-4fe9-4686-94d2-c046a686fe90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_ec19837d-5005-400f-b420-ae81ccfe776a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bfb4e65e-4fe9-4686-94d2-c046a686fe90" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_ec19837d-5005-400f-b420-ae81ccfe776a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8d029cf9-a0d5-409c-8dca-fff13db71d80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_9d33bfce-63b5-4ff0-af40-27c39ccbb8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8d029cf9-a0d5-409c-8dca-fff13db71d80" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_9d33bfce-63b5-4ff0-af40-27c39ccbb8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_74454929-dfd0-4094-9b28-a368168f44fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1b45f5ec-fb64-4027-b344-0eadb69dc47b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_74454929-dfd0-4094-9b28-a368168f44fe" xlink:to="loc_us-gaap_DebtInstrumentTable_1b45f5ec-fb64-4027-b344-0eadb69dc47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0354e33e-8400-4bba-8f16-0f8c4ba25924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b45f5ec-fb64-4027-b344-0eadb69dc47b" xlink:to="loc_us-gaap_DebtInstrumentAxis_0354e33e-8400-4bba-8f16-0f8c4ba25924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0354e33e-8400-4bba-8f16-0f8c4ba25924" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_f959a6ed-3148-4c01-bb73-1dffb4a7b4a2" xlink:href="mck-20211231.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A270NotesDueDecember152022Member_f959a6ed-3148-4c01-bb73-1dffb4a7b4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_72db654c-75a9-4e1f-879e-f2c6d242fa31" xlink:href="mck-20211231.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A285NotesDueMarch152023Member_72db654c-75a9-4e1f-879e-f2c6d242fa31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_fecf9332-810b-42d6-a75b-4c35c6dac6ef" xlink:href="mck-20211231.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A380NotesDueMarch152024Member_fecf9332-810b-42d6-a75b-4c35c6dac6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_3424e7ef-2824-4e91-8e34-27d17c165d83" xlink:href="mck-20211231.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A090NotesDueDecember32025Member_3424e7ef-2824-4e91-8e34-27d17c165d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_89548c5d-f6b2-4497-a5ef-d0b7422521c8" xlink:href="mck-20211231.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A130NotesDueAugust152026Member_89548c5d-f6b2-4497-a5ef-d0b7422521c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_e8026aa4-bdba-41f5-a787-34a1ec9ce66b" xlink:href="mck-20211231.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_e8026aa4-bdba-41f5-a787-34a1ec9ce66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_fda7df0f-3f02-48cd-8dda-62d714bc1779" xlink:href="mck-20211231.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A395NotesDueFebruary162028Member_fda7df0f-3f02-48cd-8dda-62d714bc1779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_b0c6050f-3cf0-4bf2-8c32-1ca2a64c901d" xlink:href="mck-20211231.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A475NotesDueMay302029Member_b0c6050f-3cf0-4bf2-8c32-1ca2a64c901d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_4984b95c-49f0-4457-87f5-6f1b61d2242b" xlink:href="mck-20211231.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A600NotesDueMarch12041Member_4984b95c-49f0-4457-87f5-6f1b61d2242b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_b52c07a6-fdc3-4390-97e0-e9ecb5421a16" xlink:href="mck-20211231.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A488NotesDueMarch152044Member_b52c07a6-fdc3-4390-97e0-e9ecb5421a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_aa08729e-1c7c-416b-b1ed-69d023e5282c" xlink:href="mck-20211231.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_aa08729e-1c7c-416b-b1ed-69d023e5282c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_6ec97c0a-93bf-4394-964b-2b9e4bda7c6a" xlink:href="mck-20211231.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_6ec97c0a-93bf-4394-964b-2b9e4bda7c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_642858f6-1f19-404a-ada9-4e9327dbd364" xlink:href="mck-20211231.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_642858f6-1f19-404a-ada9-4e9327dbd364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_699b1321-79a4-4d8c-8c3a-d88d62f58d18" xlink:href="mck-20211231.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_aa2713dd-d978-4bea-a44b-2e4646290caa" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_699b1321-79a4-4d8c-8c3a-d88d62f58d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3013c15c-aab2-4f6e-849b-ab42f2c70f82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b45f5ec-fb64-4027-b344-0eadb69dc47b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3013c15c-aab2-4f6e-849b-ab42f2c70f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e3e5ac04-7a67-4a17-ae5c-a99ba837ef69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3013c15c-aab2-4f6e-849b-ab42f2c70f82" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e3e5ac04-7a67-4a17-ae5c-a99ba837ef69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_5388114b-a2e9-405e-941d-fdd0f8af3dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e3e5ac04-7a67-4a17-ae5c-a99ba837ef69" xlink:to="loc_us-gaap_LoansPayableMember_5388114b-a2e9-405e-941d-fdd0f8af3dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b45f5ec-fb64-4027-b344-0eadb69dc47b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0d201e0-141b-4f52-bff8-1af0cd366faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0d201e0-141b-4f52-bff8-1af0cd366faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b9e4bbf1-069a-4b4b-ab49-6f9a5c451afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_LongTermDebt_b9e4bbf1-069a-4b4b-ab49-6f9a5c451afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_9def34d7-a212-40c6-b3ef-b1938b993974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_FinanceLeaseLiability_9def34d7-a212-40c6-b3ef-b1938b993974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_4d9a13d9-cc49-4dcd-93ac-23300e55a257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_4d9a13d9-cc49-4dcd-93ac-23300e55a257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_12d05770-5662-4ed5-ad2b-2fb5f3a5f9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_12d05770-5662-4ed5-ad2b-2fb5f3a5f9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5bb2ed21-8cb1-46f7-9d58-ed66637903c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5bb2ed21-8cb1-46f7-9d58-ed66637903c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_7d6aedbc-04a5-4e48-842a-509fea6d1625" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_7d6aedbc-04a5-4e48-842a-509fea6d1625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_3536028e-d388-419c-a2a5-9aed7e92bd03" xlink:href="mck-20211231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a624c36c-1c66-4eda-81d2-d42d504c1fe9" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_3536028e-d388-419c-a2a5-9aed7e92bd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_03f12b0d-2121-4783-b11d-cbb73ae73198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ca4f017a-e779-44c0-b9b3-2111f97189fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_03f12b0d-2121-4783-b11d-cbb73ae73198" xlink:to="loc_us-gaap_DebtInstrumentTable_ca4f017a-e779-44c0-b9b3-2111f97189fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d349ac4a-f4c6-4839-a3d1-e027c75f7e98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca4f017a-e779-44c0-b9b3-2111f97189fa" xlink:to="loc_us-gaap_DebtInstrumentAxis_d349ac4a-f4c6-4839-a3d1-e027c75f7e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d349ac4a-f4c6-4839-a3d1-e027c75f7e98" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_3425c43c-e8e8-490a-8555-c00c893ebb89" xlink:href="mck-20211231.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A130NotesDueAugust152026Member_3425c43c-e8e8-490a-8555-c00c893ebb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_ba7b708c-37fc-4432-b64e-3f31b56f0d49" xlink:href="mck-20211231.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_ba7b708c-37fc-4432-b64e-3f31b56f0d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_236ef004-4833-454f-b0b2-19dcac62152d" xlink:href="mck-20211231.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A285NotesDueMarch152023Member_236ef004-4833-454f-b0b2-19dcac62152d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_b37ac902-47f0-46f7-aa31-ee3f492bb805" xlink:href="mck-20211231.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A380NotesDueMarch152024Member_b37ac902-47f0-46f7-aa31-ee3f492bb805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_fad8d41b-2506-48fa-9f8e-e54bf58ba5a3" xlink:href="mck-20211231.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_fad8d41b-2506-48fa-9f8e-e54bf58ba5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_6911d03e-7963-49af-bb11-0119d79e5d0c" xlink:href="mck-20211231.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A395NotesDueFebruary162028Member_6911d03e-7963-49af-bb11-0119d79e5d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_e5639d9c-9df5-4669-8e5b-335e2f5912f9" xlink:href="mck-20211231.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A475NotesDueMay302029Member_e5639d9c-9df5-4669-8e5b-335e2f5912f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_63296b48-1cc6-436b-bde3-ff6b4854be4e" xlink:href="mck-20211231.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A600NotesDueMarch12041Member_63296b48-1cc6-436b-bde3-ff6b4854be4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_544aa890-18c2-4a93-8093-811627e6da27" xlink:href="mck-20211231.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_A488NotesDueMarch152044Member_544aa890-18c2-4a93-8093-811627e6da27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_4f4f7e3e-36c6-4dba-884b-f96942795903" xlink:href="mck-20211231.xsd#mck_TenderOfferNotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_TenderOfferNotesMember_4f4f7e3e-36c6-4dba-884b-f96942795903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_4611b3ba-b7aa-464a-a986-7fc21e8be7d7" xlink:href="mck-20211231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b08f6d1f-b6c8-4bb5-b1b0-4ca1fe8150b1" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_4611b3ba-b7aa-464a-a986-7fc21e8be7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8bba442d-e787-4cf2-ac13-a9dca21f8751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca4f017a-e779-44c0-b9b3-2111f97189fa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8bba442d-e787-4cf2-ac13-a9dca21f8751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_387ed89c-56e3-4c2a-b4c8-7db777440b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bba442d-e787-4cf2-ac13-a9dca21f8751" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_387ed89c-56e3-4c2a-b4c8-7db777440b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_be239eeb-d501-47af-a072-21afac6db955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_387ed89c-56e3-4c2a-b4c8-7db777440b84" xlink:to="loc_us-gaap_LoansPayableMember_be239eeb-d501-47af-a072-21afac6db955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_d3dab703-580e-4572-a186-847a24a00132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_387ed89c-56e3-4c2a-b4c8-7db777440b84" xlink:to="loc_us-gaap_UnsecuredDebtMember_d3dab703-580e-4572-a186-847a24a00132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0033a6db-0990-4964-a828-f3fdff18fef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca4f017a-e779-44c0-b9b3-2111f97189fa" xlink:to="loc_us-gaap_CreditFacilityAxis_0033a6db-0990-4964-a828-f3fdff18fef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_93bae83c-91e2-41c1-8555-14ad5e6ed372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_0033a6db-0990-4964-a828-f3fdff18fef0" xlink:to="loc_us-gaap_CreditFacilityDomain_93bae83c-91e2-41c1-8555-14ad5e6ed372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_34545665-330e-4bd1-9a34-3badfa5f0066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_93bae83c-91e2-41c1-8555-14ad5e6ed372" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_34545665-330e-4bd1-9a34-3badfa5f0066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca4f017a-e779-44c0-b9b3-2111f97189fa" xlink:to="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_c2a6f4aa-ed29-418e-b0db-594850f6da90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_c2a6f4aa-ed29-418e-b0db-594850f6da90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_44eab399-0719-46e6-82a0-79fb624299d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_44eab399-0719-46e6-82a0-79fb624299d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_37021fbc-c438-4126-a650-f0bf696915f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_37021fbc-c438-4126-a650-f0bf696915f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ca29a975-5b2d-43e0-a983-504b5fc57209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ca29a975-5b2d-43e0-a983-504b5fc57209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_292916ed-3dc1-4561-a161-4142a7bc1c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_292916ed-3dc1-4561-a161-4142a7bc1c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_99af542e-176f-4044-ae3f-d4031bdaa0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_99af542e-176f-4044-ae3f-d4031bdaa0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_39bf6f3b-d69e-46ad-b3c6-2b909e91420f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_39bf6f3b-d69e-46ad-b3c6-2b909e91420f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_8925e1c4-765b-453c-94aa-c92cf7f1a576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_8925e1c4-765b-453c-94aa-c92cf7f1a576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_d66df734-2de5-4a54-b1d9-98debda01318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_d66df734-2de5-4a54-b1d9-98debda01318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_59fb54b7-370a-4235-8cc6-0aca1f9fdc20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_InterestPaid_59fb54b7-370a-4235-8cc6-0aca1f9fdc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_a1ac683c-52e3-41bb-bced-6d5ad2fac08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_a1ac683c-52e3-41bb-bced-6d5ad2fac08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f6c275eb-951c-4108-bcfa-0296e32a83e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f6c275eb-951c-4108-bcfa-0296e32a83e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_fb9f588e-457d-4e93-9c25-af477b7c632e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_fb9f588e-457d-4e93-9c25-af477b7c632e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_876c6317-94ea-483c-9d09-3859d07c803a" xlink:href="mck-20211231.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74cd58fe-0298-41e6-a3b3-31702112a7ca" xlink:to="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_876c6317-94ea-483c-9d09-3859d07c803a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_19771f44-eb67-4bf9-9c40-5758bb0e1f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_d69d3dd0-0bb0-4010-899c-420ae9ba9574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_19771f44-eb67-4bf9-9c40-5758bb0e1f92" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_d69d3dd0-0bb0-4010-899c-420ae9ba9574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_340c1cf3-a14c-443e-a3a2-abc7f722c7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_d69d3dd0-0bb0-4010-899c-420ae9ba9574" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_340c1cf3-a14c-443e-a3a2-abc7f722c7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b014bb84-cce1-42a6-abc1-b7a3290051a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_340c1cf3-a14c-443e-a3a2-abc7f722c7a9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b014bb84-cce1-42a6-abc1-b7a3290051a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_d76a93fe-036a-4a44-afa7-b6b9c92a328a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b014bb84-cce1-42a6-abc1-b7a3290051a6" xlink:to="loc_us-gaap_UnsecuredDebtMember_d76a93fe-036a-4a44-afa7-b6b9c92a328a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f249f313-3824-4f86-9c38-0fdc85a1f962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_d69d3dd0-0bb0-4010-899c-420ae9ba9574" xlink:to="loc_us-gaap_CreditFacilityAxis_f249f313-3824-4f86-9c38-0fdc85a1f962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_32e541bc-d672-4018-9b87-b0e0116975ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f249f313-3824-4f86-9c38-0fdc85a1f962" xlink:to="loc_us-gaap_CreditFacilityDomain_32e541bc-d672-4018-9b87-b0e0116975ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3eea7a63-dff6-4422-b8ae-9dd32fefdde8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_32e541bc-d672-4018-9b87-b0e0116975ca" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3eea7a63-dff6-4422-b8ae-9dd32fefdde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_41296c3b-9216-4998-a637-f94ff679e8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_32e541bc-d672-4018-9b87-b0e0116975ca" xlink:to="loc_us-gaap_LineOfCreditMember_41296c3b-9216-4998-a637-f94ff679e8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_80315dde-2ee8-4871-b16e-70718af28add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_d69d3dd0-0bb0-4010-899c-420ae9ba9574" xlink:to="loc_us-gaap_DebtInstrumentAxis_80315dde-2ee8-4871-b16e-70718af28add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ab49cf78-c602-4e05-a8e3-002580e2d38e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_80315dde-2ee8-4871-b16e-70718af28add" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ab49cf78-c602-4e05-a8e3-002580e2d38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_6e9b2f05-8752-4d07-92ff-c5b358fad9bc" xlink:href="mck-20211231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ab49cf78-c602-4e05-a8e3-002580e2d38e" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_6e9b2f05-8752-4d07-92ff-c5b358fad9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_1750a99a-ec0c-4c9e-a909-9f9c7c32019f" xlink:href="mck-20211231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ab49cf78-c602-4e05-a8e3-002580e2d38e" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_1750a99a-ec0c-4c9e-a909-9f9c7c32019f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_d69d3dd0-0bb0-4010-899c-420ae9ba9574" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7e37c487-9ee6-45fd-ad32-47935ec8c071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7e37c487-9ee6-45fd-ad32-47935ec8c071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_f4ae7a4d-b88b-4437-b68a-c9ddf960992a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_DebtInstrumentTerm_f4ae7a4d-b88b-4437-b68a-c9ddf960992a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c5003b32-ec2c-4b57-9720-2eff7d932689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c5003b32-ec2c-4b57-9720-2eff7d932689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ebd3e5f8-56a4-4e66-9c09-a2cb191e0232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_LineOfCredit_ebd3e5f8-56a4-4e66-9c09-a2cb191e0232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_a04ab172-45be-4931-b294-d5622113631e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_a04ab172-45be-4931-b294-d5622113631e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_210168a5-30a7-4ac6-a064-457a010ff5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6a22127d-616c-4fbc-b7ff-c0ac06b39d14" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_210168a5-30a7-4ac6-a064-457a010ff5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2508381b-297b-4943-965f-8a3d56f3f4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_92be716e-eae1-4249-8159-edd14b9e94c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2508381b-297b-4943-965f-8a3d56f3f4a7" xlink:to="loc_us-gaap_DebtInstrumentTable_92be716e-eae1-4249-8159-edd14b9e94c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7bf9024c-0dfd-4225-8186-d73930ac3c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_92be716e-eae1-4249-8159-edd14b9e94c3" xlink:to="loc_us-gaap_CreditFacilityAxis_7bf9024c-0dfd-4225-8186-d73930ac3c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9affcc26-f22b-4cb2-a21d-43af7a101370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_7bf9024c-0dfd-4225-8186-d73930ac3c73" xlink:to="loc_us-gaap_CreditFacilityDomain_9affcc26-f22b-4cb2-a21d-43af7a101370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_108d3618-679a-4a31-9d9a-447d77f7d2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9affcc26-f22b-4cb2-a21d-43af7a101370" xlink:to="loc_us-gaap_CommercialPaperMember_108d3618-679a-4a31-9d9a-447d77f7d2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_92be716e-eae1-4249-8159-edd14b9e94c3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b4b62990-2d1c-409e-81e7-4ad54cf1ac0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b4b62990-2d1c-409e-81e7-4ad54cf1ac0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_59a5592c-2ab6-4769-b408-1bfb24b292dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_59a5592c-2ab6-4769-b408-1bfb24b292dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_b08992f5-8757-4932-b4c6-5fe10ee14718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_b08992f5-8757-4932-b4c6-5fe10ee14718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_b5a1e76e-cfd3-41de-8d95-1d5a6303b026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_b5a1e76e-cfd3-41de-8d95-1d5a6303b026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_ab75a261-034b-49ef-b0b8-435ad609fbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd02c28d-55bf-4d8c-9a33-035f7fee50f3" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_ab75a261-034b-49ef-b0b8-435ad609fbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20211231.xsd#PensionBenefits"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e0791de5-9ea3-440f-b270-1a0ddec08e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f01467a5-ada2-4ad4-8640-4dfce11b11cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e0791de5-9ea3-440f-b270-1a0ddec08e1e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f01467a5-ada2-4ad4-8640-4dfce11b11cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#PensionBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_be6088e5-09de-4844-97c5-3fb53eab0e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_be6088e5-09de-4844-97c5-3fb53eab0e09" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a3011d94-710c-4544-b4db-fb69c1766025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a3011d94-710c-4544-b4db-fb69c1766025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_74828503-5781-492c-8cba-63986fd562e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a3011d94-710c-4544-b4db-fb69c1766025" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_74828503-5781-492c-8cba-63986fd562e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_36c760fa-8706-40b9-af18-ef38774ce674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_74828503-5781-492c-8cba-63986fd562e9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_36c760fa-8706-40b9-af18-ef38774ce674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2728649e-3284-4110-bdad-cee5cbffef12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2728649e-3284-4110-bdad-cee5cbffef12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_352d1fbe-7217-4e9a-ba3c-f16caea6d859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2728649e-3284-4110-bdad-cee5cbffef12" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_352d1fbe-7217-4e9a-ba3c-f16caea6d859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f092f321-8d01-41e9-b772-90916a3c25c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_352d1fbe-7217-4e9a-ba3c-f16caea6d859" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f092f321-8d01-41e9-b772-90916a3c25c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4854789e-56fc-46a3-8d97-da94b3887c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4854789e-56fc-46a3-8d97-da94b3887c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cea1c75e-3ac0-45a7-a8f6-d2aebd6ba5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4854789e-56fc-46a3-8d97-da94b3887c3b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cea1c75e-3ac0-45a7-a8f6-d2aebd6ba5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_7735c005-101e-48dd-bad2-5b725a94d87d" xlink:href="mck-20211231.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cea1c75e-3ac0-45a7-a8f6-d2aebd6ba5b4" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_7735c005-101e-48dd-bad2-5b725a94d87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_bae217bd-a262-46de-b2f5-412eb0a531e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:to="loc_us-gaap_RetirementPlanNameAxis_bae217bd-a262-46de-b2f5-412eb0a531e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_114d1d11-5b14-4c64-904a-5edccacc0705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_bae217bd-a262-46de-b2f5-412eb0a531e1" xlink:to="loc_us-gaap_RetirementPlanNameDomain_114d1d11-5b14-4c64-904a-5edccacc0705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKPensionPlanMember_7d97477b-5446-41a0-99e7-38c08e657c46" xlink:href="mck-20211231.xsd#mck_UKPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_114d1d11-5b14-4c64-904a-5edccacc0705" xlink:to="loc_mck_UKPensionPlanMember_7d97477b-5446-41a0-99e7-38c08e657c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_716bda41-5ab3-4291-a5fa-d675a5b520b2" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b9a3415a-7cc3-47b2-bc08-30c1907611d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b9a3415a-7cc3-47b2-bc08-30c1907611d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d749aef7-6d5a-49fc-800e-882ac059409e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d749aef7-6d5a-49fc-800e-882ac059409e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_98559698-1d4e-460d-8ae8-51ac3d780e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_98559698-1d4e-460d-8ae8-51ac3d780e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_65570d71-5aff-4ce5-b8b2-d7989fbabb7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_65570d71-5aff-4ce5-b8b2-d7989fbabb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_14d088de-9329-4533-8d12-1c658456d2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_af2c3bfb-3d9d-4d7c-a23e-a09abea1c7a2" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_14d088de-9329-4533-8d12-1c658456d2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20211231.xsd#HedgingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5bf195ed-cc50-442f-b08a-1d999338126d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_535f45b4-b624-44c1-867d-68b4ca620245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5bf195ed-cc50-442f-b08a-1d999338126d" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_535f45b4-b624-44c1-867d-68b4ca620245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20211231.xsd#HedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_746da497-acd6-4580-aabf-72c6bdc68386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_4c2f0224-2e9e-4fc3-9c10-f034f53dcf58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_746da497-acd6-4580-aabf-72c6bdc68386" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_4c2f0224-2e9e-4fc3-9c10-f034f53dcf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f269bbd1-4b46-4ae9-9342-41789d33b2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f269bbd1-4b46-4ae9-9342-41789d33b2d0" xlink:to="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cd56cb5c-8420-405a-8b73-00bcabe37f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:to="loc_us-gaap_DebtInstrumentAxis_cd56cb5c-8420-405a-8b73-00bcabe37f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5eedaa08-8823-47fd-8c75-7a48c5693efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd56cb5c-8420-405a-8b73-00bcabe37f71" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5eedaa08-8823-47fd-8c75-7a48c5693efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_d7af727b-6fc8-4af2-8f02-4f5584354bef" xlink:href="mck-20211231.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5eedaa08-8823-47fd-8c75-7a48c5693efd" xlink:to="loc_mck_EuroDenominatedNotesMember_d7af727b-6fc8-4af2-8f02-4f5584354bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_68a26794-9bf5-47e5-a637-a014e7888ede" xlink:href="mck-20211231.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5eedaa08-8823-47fd-8c75-7a48c5693efd" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_68a26794-9bf5-47e5-a637-a014e7888ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2025NotesMember_40086de2-1705-41dd-827a-5fe23824c95d" xlink:href="mck-20211231.xsd#mck_A2025NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5eedaa08-8823-47fd-8c75-7a48c5693efd" xlink:to="loc_mck_A2025NotesMember_40086de2-1705-41dd-827a-5fe23824c95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b5716556-10fc-4e09-a220-091dcdf16206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b5716556-10fc-4e09-a220-091dcdf16206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_317606b0-2e79-4126-bcc5-0861c904e29a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b5716556-10fc-4e09-a220-091dcdf16206" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_317606b0-2e79-4126-bcc5-0861c904e29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_6f523aef-a1ac-4d73-9733-746baf96c013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_317606b0-2e79-4126-bcc5-0861c904e29a" xlink:to="loc_us-gaap_LoansPayableMember_6f523aef-a1ac-4d73-9733-746baf96c013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c34a9ceb-0878-4850-b9a6-91ecd9e614f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c34a9ceb-0878-4850-b9a6-91ecd9e614f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a7a304d7-4044-4589-a14e-45c75a6a5f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c34a9ceb-0878-4850-b9a6-91ecd9e614f6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a7a304d7-4044-4589-a14e-45c75a6a5f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_0353aee4-cb94-42d2-8b17-a6e06523ca18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a7a304d7-4044-4589-a14e-45c75a6a5f74" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_0353aee4-cb94-42d2-8b17-a6e06523ca18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_9a5c6e2a-72ca-49fb-a1ae-ab89a37b3093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a7a304d7-4044-4589-a14e-45c75a6a5f74" xlink:to="loc_us-gaap_CashFlowHedgingMember_9a5c6e2a-72ca-49fb-a1ae-ab89a37b3093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_057bf350-6bf1-4839-a6eb-4fc8e4e4b6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_057bf350-6bf1-4839-a6eb-4fc8e4e4b6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_057bf350-6bf1-4839-a6eb-4fc8e4e4b6d3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_90c5de3c-c897-4523-92e9-1fe0209dfeab" xlink:href="mck-20211231.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_90c5de3c-c897-4523-92e9-1fe0209dfeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_fe7e2b9a-9882-4a3c-bb76-49ba73bf1717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:to="loc_us-gaap_CurrencySwapMember_fe7e2b9a-9882-4a3c-bb76-49ba73bf1717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3b7f360a-1656-455e-aa2a-ead28e7ed7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:to="loc_us-gaap_InterestRateSwapMember_3b7f360a-1656-455e-aa2a-ead28e7ed7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_dc6a3c33-0716-4012-b6f5-efb3f03a706f" xlink:href="mck-20211231.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dff44089-1347-452d-bb4a-78d55016514d" xlink:to="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_dc6a3c33-0716-4012-b6f5-efb3f03a706f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5fae1037-0cbc-4486-a56f-df62bf2b43b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:to="loc_us-gaap_HedgingDesignationAxis_5fae1037-0cbc-4486-a56f-df62bf2b43b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b787f677-093d-40f1-a726-9673e9dbb400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5fae1037-0cbc-4486-a56f-df62bf2b43b2" xlink:to="loc_us-gaap_HedgingDesignationDomain_b787f677-093d-40f1-a726-9673e9dbb400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4f7c53a6-5fd3-46a8-bd01-b1cb71816cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b787f677-093d-40f1-a726-9673e9dbb400" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4f7c53a6-5fd3-46a8-bd01-b1cb71816cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_a2e2cf38-3694-41d4-ac12-e6aacd89b5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b787f677-093d-40f1-a726-9673e9dbb400" xlink:to="loc_us-gaap_NondesignatedMember_a2e2cf38-3694-41d4-ac12-e6aacd89b5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e27dcc47-7640-4ddf-b2fc-686593c82c29" xlink:to="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_85b648bb-da30-472d-8029-c3514afcdb72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_LongTermDebt_85b648bb-da30-472d-8029-c3514afcdb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_abb6e780-f5aa-44cb-ad51-0b1a30fb329a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_abb6e780-f5aa-44cb-ad51-0b1a30fb329a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f8ae460a-d684-4986-8900-fd6c14489e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f8ae460a-d684-4986-8900-fd6c14489e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_afbb887e-6c98-4352-a3de-7e471342cf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_afbb887e-6c98-4352-a3de-7e471342cf1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_eddfc5cf-4b9b-42aa-b530-f55061867f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_DebtInstrumentTerm_eddfc5cf-4b9b-42aa-b530-f55061867f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_9fb90ae6-f58d-4bf9-b005-5273d40b2d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_02623ece-8a28-41e8-bcac-4054f60789d9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_9fb90ae6-f58d-4bf9-b005-5273d40b2d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#HedgingActivitiesDerivativeInstrumentsFairValueDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_509fd04c-877a-41d8-911c-4a8bbab8d139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4ff588d4-40e4-43f9-a5ae-ad7ac9251ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_509fd04c-877a-41d8-911c-4a8bbab8d139" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4ff588d4-40e4-43f9-a5ae-ad7ac9251ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d153089a-a990-4599-9036-0dd73d340374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4ff588d4-40e4-43f9-a5ae-ad7ac9251ac2" xlink:to="loc_us-gaap_HedgingDesignationAxis_d153089a-a990-4599-9036-0dd73d340374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_78e1e171-c9c4-443d-aa52-dfbbaba363de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d153089a-a990-4599-9036-0dd73d340374" xlink:to="loc_us-gaap_HedgingDesignationDomain_78e1e171-c9c4-443d-aa52-dfbbaba363de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_567bb6e8-ef33-41bd-8147-6e8022963c80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_78e1e171-c9c4-443d-aa52-dfbbaba363de" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_567bb6e8-ef33-41bd-8147-6e8022963c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_6f977c4d-5d3c-4b8e-a624-252544030876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_78e1e171-c9c4-443d-aa52-dfbbaba363de" xlink:to="loc_us-gaap_NondesignatedMember_6f977c4d-5d3c-4b8e-a624-252544030876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_44a28d74-b8f7-4b78-82e4-157c0527e993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4ff588d4-40e4-43f9-a5ae-ad7ac9251ac2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_44a28d74-b8f7-4b78-82e4-157c0527e993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_167d6a51-1487-48dd-a76a-5d04e8632dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_44a28d74-b8f7-4b78-82e4-157c0527e993" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_167d6a51-1487-48dd-a76a-5d04e8632dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_10df55dd-a3dd-4f5d-9464-110931047746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_167d6a51-1487-48dd-a76a-5d04e8632dad" xlink:to="loc_us-gaap_CurrencySwapMember_10df55dd-a3dd-4f5d-9464-110931047746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8c2c2099-41bd-4998-a5a3-3b09d968baf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_167d6a51-1487-48dd-a76a-5d04e8632dad" xlink:to="loc_us-gaap_InterestRateSwapMember_8c2c2099-41bd-4998-a5a3-3b09d968baf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f334c5fe-24a9-4da9-9193-025cf7a9622c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_167d6a51-1487-48dd-a76a-5d04e8632dad" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f334c5fe-24a9-4da9-9193-025cf7a9622c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_45eef8af-501a-4f3d-abdf-65ecd4540d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4ff588d4-40e4-43f9-a5ae-ad7ac9251ac2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_45eef8af-501a-4f3d-abdf-65ecd4540d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_45eef8af-501a-4f3d-abdf-65ecd4540d4d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_8587c886-6f13-42fc-b810-2572075a4c63" xlink:href="mck-20211231.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:to="loc_mck_CurrentAssetLiabilityMember_8587c886-6f13-42fc-b810-2572075a4c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember_9a900291-e6f1-4ef3-b31d-1261dd0f92ba" xlink:href="mck-20211231.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:to="loc_mck_NoncurrentAssetLiabilityMember_9a900291-e6f1-4ef3-b31d-1261dd0f92ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAccruedLiabilitiesMember_b783237e-bd94-4552-933e-b4e08b341c79" xlink:href="mck-20211231.xsd#mck_OtherAccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:to="loc_mck_OtherAccruedLiabilitiesMember_b783237e-bd94-4552-933e-b4e08b341c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_31250e34-10c2-4217-ac67-917744e12bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b97a62c4-86e2-453a-8f21-a0cf92cea47c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_31250e34-10c2-4217-ac67-917744e12bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4ff588d4-40e4-43f9-a5ae-ad7ac9251ac2" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_70c09662-5450-4171-893d-26ae4fdfa5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_70c09662-5450-4171-893d-26ae4fdfa5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_2f278ec2-bc26-407e-a10b-b93b0fecc602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_2f278ec2-bc26-407e-a10b-b93b0fecc602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_52de094f-25a3-4980-bb48-a444801edefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_52de094f-25a3-4980-bb48-a444801edefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_ef6a7fe6-062f-468f-a201-ba436f7b2d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_645e6c85-e2ab-4ebf-a3c6-ab07758cac73" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_ef6a7fe6-062f-468f-a201-ba436f7b2d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20211231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3b740760-1975-4e7d-a9a1-2d7f9cb51c06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_5830deeb-d8a8-4266-8337-79ee390299fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3b740760-1975-4e7d-a9a1-2d7f9cb51c06" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_5830deeb-d8a8-4266-8337-79ee390299fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mck-20211231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c359099f-df05-4cea-985b-5482df4efa9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_c8c77e22-8b74-4170-9cca-69f92a497f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c359099f-df05-4cea-985b-5482df4efa9d" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_c8c77e22-8b74-4170-9cca-69f92a497f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5907ed74-ad28-4478-b375-df6d1e380177" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98b27f64-59c0-41bc-98b9-1387a1910a11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5907ed74-ad28-4478-b375-df6d1e380177" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98b27f64-59c0-41bc-98b9-1387a1910a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2811ddce-b92d-44bc-bcb0-93617930c4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98b27f64-59c0-41bc-98b9-1387a1910a11" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2811ddce-b92d-44bc-bcb0-93617930c4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6516dba6-5b8a-447d-a79a-a23db78dc097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2811ddce-b92d-44bc-bcb0-93617930c4ed" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6516dba6-5b8a-447d-a79a-a23db78dc097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_92413948-d443-4909-8be3-2ffc3c65d9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6516dba6-5b8a-447d-a79a-a23db78dc097" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_92413948-d443-4909-8be3-2ffc3c65d9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e502c417-7cae-4736-b54a-32d7fde223bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98b27f64-59c0-41bc-98b9-1387a1910a11" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e502c417-7cae-4736-b54a-32d7fde223bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6160fa9-4635-4170-b52a-da8bcd440ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e502c417-7cae-4736-b54a-32d7fde223bb" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6160fa9-4635-4170-b52a-da8bcd440ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_be682ab8-7427-481f-930d-77b1302fbaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6160fa9-4635-4170-b52a-da8bcd440ae6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_be682ab8-7427-481f-930d-77b1302fbaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f4926bcc-f6e6-44f4-86aa-8c357f754778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6160fa9-4635-4170-b52a-da8bcd440ae6" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f4926bcc-f6e6-44f4-86aa-8c357f754778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4bb8313f-93db-4282-b34f-7ef2a4270375" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98b27f64-59c0-41bc-98b9-1387a1910a11" xlink:to="loc_srt_LitigationCaseAxis_4bb8313f-93db-4282-b34f-7ef2a4270375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ee59fa5c-c786-4f1e-888d-e4181b948829" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_4bb8313f-93db-4282-b34f-7ef2a4270375" xlink:to="loc_srt_LitigationCaseTypeDomain_ee59fa5c-c786-4f1e-888d-e4181b948829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_24c9c4ba-0476-4db1-b41d-f1d1c5e75d17" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ee59fa5c-c786-4f1e-888d-e4181b948829" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_24c9c4ba-0476-4db1-b41d-f1d1c5e75d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98b27f64-59c0-41bc-98b9-1387a1910a11" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ad23002a-4c90-44fd-9d1f-5957eb12006b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ad23002a-4c90-44fd-9d1f-5957eb12006b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_020d6afd-9b75-49a1-ad8e-f7daaf35e524" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_020d6afd-9b75-49a1-ad8e-f7daaf35e524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_7b2bbbce-9ce6-45d1-84a8-5ba4ecc32edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_7b2bbbce-9ce6-45d1-84a8-5ba4ecc32edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_8f5483cf-f5c9-48b6-981f-1535bca18a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_8f5483cf-f5c9-48b6-981f-1535bca18a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_3809b992-e6b1-4bfe-bcb5-0484b184b8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e45ac1c1-2422-4ac7-a3d3-28b3b6d77306" xlink:to="loc_us-gaap_RestrictedCash_3809b992-e6b1-4bfe-bcb5-0484b184b8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c0f3e60c-3043-47f1-8efd-cea22759a662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0752650b-f3e2-4c3d-8c9a-4001fa6cf3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c0f3e60c-3043-47f1-8efd-cea22759a662" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0752650b-f3e2-4c3d-8c9a-4001fa6cf3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d05302b-cdf7-45c7-90a7-c686a2d1a29f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0752650b-f3e2-4c3d-8c9a-4001fa6cf3dc" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d05302b-cdf7-45c7-90a7-c686a2d1a29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e5a6cac-2f4a-4292-ae42-3fa666a90dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d05302b-cdf7-45c7-90a7-c686a2d1a29f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e5a6cac-2f4a-4292-ae42-3fa666a90dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_577d143a-9645-476f-a236-677bc4028f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e5a6cac-2f4a-4292-ae42-3fa666a90dda" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_577d143a-9645-476f-a236-677bc4028f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7e77140a-c9a1-4f02-8c3f-d2ded1d3f91c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0752650b-f3e2-4c3d-8c9a-4001fa6cf3dc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7e77140a-c9a1-4f02-8c3f-d2ded1d3f91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc2ddfcd-516b-4f02-b37f-50a6e2b1462a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7e77140a-c9a1-4f02-8c3f-d2ded1d3f91c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc2ddfcd-516b-4f02-b37f-50a6e2b1462a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1e5127d3-e66b-4414-9c4f-7b530f3fd0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc2ddfcd-516b-4f02-b37f-50a6e2b1462a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1e5127d3-e66b-4414-9c4f-7b530f3fd0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_16c92d30-2e23-435c-8eac-c7d9b45df323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0752650b-f3e2-4c3d-8c9a-4001fa6cf3dc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_16c92d30-2e23-435c-8eac-c7d9b45df323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e524f68d-b742-4b03-922a-6e5a4bd6bbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_16c92d30-2e23-435c-8eac-c7d9b45df323" xlink:to="loc_us-gaap_LongTermDebt_e524f68d-b742-4b03-922a-6e5a4bd6bbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d4d49518-8dba-4d3f-b98d-76949b769c70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_16c92d30-2e23-435c-8eac-c7d9b45df323" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d4d49518-8dba-4d3f-b98d-76949b769c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20211231.xsd#CommitmentsandContingentLiabilities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2b542163-c986-46e8-9483-632af0077202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f9043191-b21a-4ffe-b111-2eef114bab9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2b542163-c986-46e8-9483-632af0077202" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f9043191-b21a-4ffe-b111-2eef114bab9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables" xlink:type="simple" xlink:href="mck-20211231.xsd#CommitmentsandContingentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ac9271c9-d601-4f7c-8561-33992cff38a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_c3d56779-fba9-4e42-ae6e-ddaca772545f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ac9271c9-d601-4f7c-8561-33992cff38a0" xlink:to="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_c3d56779-fba9-4e42-ae6e-ddaca772545f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c19edca4-80fb-42a3-bfad-458c57882206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c19edca4-80fb-42a3-bfad-458c57882206" xlink:to="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ee64f7e0-bd1d-4904-a3e2-dd0c7b826b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_us-gaap_LitigationStatusAxis_ee64f7e0-bd1d-4904-a3e2-dd0c7b826b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_1d1a457f-9999-48bb-ab9f-836849eae5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_ee64f7e0-bd1d-4904-a3e2-dd0c7b826b93" xlink:to="loc_us-gaap_LitigationStatusDomain_1d1a457f-9999-48bb-ab9f-836849eae5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_31a97602-ca45-4449-ae6a-7ce3f8e9770d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_1d1a457f-9999-48bb-ab9f-836849eae5b1" xlink:to="loc_us-gaap_PendingLitigationMember_31a97602-ca45-4449-ae6a-7ce3f8e9770d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b48c5aee-b21b-469b-a120-c2d5812c8761" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_dei_LegalEntityAxis_b48c5aee-b21b-469b-a120-c2d5812c8761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_86e222df-699e-4b3a-8537-e87c6453dc3e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b48c5aee-b21b-469b-a120-c2d5812c8761" xlink:to="loc_dei_EntityDomain_86e222df-699e-4b3a-8537-e87c6453dc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_f9f9b339-bc99-4258-80a0-2966056e47fe" xlink:href="mck-20211231.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_86e222df-699e-4b3a-8537-e87c6453dc3e" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_f9f9b339-bc99-4258-80a0-2966056e47fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_06e0d832-0d16-4d2e-bed8-4341d8f5f41d" xlink:href="mck-20211231.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_86e222df-699e-4b3a-8537-e87c6453dc3e" xlink:to="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_06e0d832-0d16-4d2e-bed8-4341d8f5f41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7546338e-562a-4f12-9ed4-84a1d97390ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_srt_StatementGeographicalAxis_7546338e-562a-4f12-9ed4-84a1d97390ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cc020db4-16ea-4d36-a44a-c46970024745" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_7546338e-562a-4f12-9ed4-84a1d97390ef" xlink:to="loc_srt_SegmentGeographicalDomain_cc020db4-16ea-4d36-a44a-c46970024745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_ad19130a-8cb3-408e-881d-384e4167917a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cc020db4-16ea-4d36-a44a-c46970024745" xlink:to="loc_country_CA_ad19130a-8cb3-408e-881d-384e4167917a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_c6ba03b7-d8f7-4e66-9cfb-d2491b7ba6eb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_srt_LitigationCaseAxis_c6ba03b7-d8f7-4e66-9cfb-d2491b7ba6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_adf4c4da-45a7-45fd-9556-a54a513b9cb1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_c6ba03b7-d8f7-4e66-9cfb-d2491b7ba6eb" xlink:to="loc_srt_LitigationCaseTypeDomain_adf4c4da-45a7-45fd-9556-a54a513b9cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_41541b74-96e3-4490-8285-af46833ff171" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_adf4c4da-45a7-45fd-9556-a54a513b9cb1" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_41541b74-96e3-4490-8285-af46833ff171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_68a06924-c53d-4103-862b-f36c330e60ed" xlink:href="mck-20211231.xsd#mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_adf4c4da-45a7-45fd-9556-a54a513b9cb1" xlink:to="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_68a06924-c53d-4103-862b-f36c330e60ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_17da07ca-d177-4d8a-b1e6-dc3368552282" xlink:href="mck-20211231.xsd#mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_adf4c4da-45a7-45fd-9556-a54a513b9cb1" xlink:to="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_17da07ca-d177-4d8a-b1e6-dc3368552282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_feab5956-65d3-44e7-a28b-ce92b9cf79c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_feab5956-65d3-44e7-a28b-ce92b9cf79c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0c7049fc-8062-4535-a129-da423cba49eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_feab5956-65d3-44e7-a28b-ce92b9cf79c5" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0c7049fc-8062-4535-a129-da423cba49eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_d32de0a1-295c-49ca-9594-c81d3ebd4469" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0c7049fc-8062-4535-a129-da423cba49eb" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_d32de0a1-295c-49ca-9594-c81d3ebd4469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_fedf0915-0573-4e24-b3f6-e42c02c92682" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_srt_CounterpartyNameAxis_fedf0915-0573-4e24-b3f6-e42c02c92682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_fedf0915-0573-4e24-b3f6-e42c02c92682" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfNewYorkMember_dc3daf5c-07a4-451b-a1fa-d6a45adab1d7" xlink:href="mck-20211231.xsd#mck_StateOfNewYorkMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_StateOfNewYorkMember_dc3daf5c-07a4-451b-a1fa-d6a45adab1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfOhioMember_842aacfa-350d-40a3-97b7-53acb9d912de" xlink:href="mck-20211231.xsd#mck_StateOfOhioMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_StateOfOhioMember_842aacfa-350d-40a3-97b7-53acb9d912de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember_fe66ad73-a9fd-49e7-a49c-9922c5f919f7" xlink:href="mck-20211231.xsd#mck_CherokeeNationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_CherokeeNationMember_fe66ad73-a9fd-49e7-a49c-9922c5f919f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember_2f2df1f1-ba67-4a79-8250-26f9ce72fa87" xlink:href="mck-20211231.xsd#mck_GovernmentalEntitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_GovernmentalEntitiesMember_2f2df1f1-ba67-4a79-8250-26f9ce72fa87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_4c44b9dd-979d-4a77-b2e6-d2750473e02d" xlink:href="mck-20211231.xsd#mck_IndividualClaimantMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_IndividualClaimantMember_4c44b9dd-979d-4a77-b2e6-d2750473e02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfRhodeIslandMember_912be5a8-a6cf-467d-9a39-ecb62d5c691f" xlink:href="mck-20211231.xsd#mck_StateOfRhodeIslandMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_StateOfRhodeIslandMember_912be5a8-a6cf-467d-9a39-ecb62d5c691f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfFloridaMember_10780306-8dce-406c-82eb-11caf0501a57" xlink:href="mck-20211231.xsd#mck_StateOfFloridaMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_StateOfFloridaMember_10780306-8dce-406c-82eb-11caf0501a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_6b4c8936-d799-44fc-b910-a1e34f6a9120" xlink:href="mck-20211231.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1944b2e0-0303-4226-ab9e-de1ab6c5a24f" xlink:to="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_6b4c8936-d799-44fc-b910-a1e34f6a9120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a9cff2c2-bec1-43d5-94cf-d749fd182f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a9cff2c2-bec1-43d5-94cf-d749fd182f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a247b3fd-02c8-4061-b014-78e0399b2431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a9cff2c2-bec1-43d5-94cf-d749fd182f19" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a247b3fd-02c8-4061-b014-78e0399b2431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9cc6dd65-a25a-4c42-bc89-677e9e7a099e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a247b3fd-02c8-4061-b014-78e0399b2431" xlink:to="loc_us-gaap_SubsequentEventMember_9cc6dd65-a25a-4c42-bc89-677e9e7a099e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1fee1069-e093-4169-bcb0-f26eaf949a37" xlink:to="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_484a0979-7cdc-4158-acda-09499e746581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_484a0979-7cdc-4158-acda-09499e746581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_27bbd90f-7e83-4449-a8a5-5a697212518d" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberofStates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberofStates_27bbd90f-7e83-4449-a8a5-5a697212518d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals_ed48bdc9-33bf-435d-afcb-a4e44d2900d5" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberofStateAttorneyGenerals_ed48bdc9-33bf-435d-afcb-a4e44d2900d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_54d37d64-a5e7-4c14-9abb-56dcaf3776d5" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_54d37d64-a5e7-4c14-9abb-56dcaf3776d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_b618a7ea-f1aa-4d76-9c41-b33226bedd17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_b618a7ea-f1aa-4d76-9c41-b33226bedd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_c99467a1-162c-462f-8526-1eaa529d5698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_c99467a1-162c-462f-8526-1eaa529d5698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_bf1f6f3f-9dfd-4899-91d5-2753275f7923" xlink:href="mck-20211231.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_bf1f6f3f-9dfd-4899-91d5-2753275f7923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_4e067b96-a900-46a3-8517-a844a79dbf45" xlink:href="mck-20211231.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_4e067b96-a900-46a3-8517-a844a79dbf45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_8d01af86-79f5-4a45-b5cc-1f495c554029" xlink:href="mck-20211231.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_8d01af86-79f5-4a45-b5cc-1f495c554029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates_e7583010-d363-4672-9bd1-ce88185d6be1" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfEligibleStates_e7583010-d363-4672-9bd1-ce88185d6be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfTerritories_307b1e58-cbeb-4796-856a-bbedcdae8c81" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfTerritories"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfTerritories_307b1e58-cbeb-4796-856a-bbedcdae8c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_fd1b8bb7-b787-425d-83b0-6a7cfea28fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_fd1b8bb7-b787-425d-83b0-6a7cfea28fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementPaymentTerms_99c18124-3717-4c85-966f-ef7a5890555f" xlink:href="mck-20211231.xsd#mck_LossContingencySettlementPaymentTerms"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencySettlementPaymentTerms_99c18124-3717-4c85-966f-ef7a5890555f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_2903cd2f-6b51-404b-8a49-a5ed1ee21232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_2903cd2f-6b51-404b-8a49-a5ed1ee21232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_77ba336d-00f7-42d0-9b39-1fd30491d6cf" xlink:href="mck-20211231.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_77ba336d-00f7-42d0-9b39-1fd30491d6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7c2ea2e-442a-440c-9480-8380b37ec546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7c2ea2e-442a-440c-9480-8380b37ec546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfInvestmentFundsThatFiledClaims_69f191e6-7a30-4d38-831a-5199aa666d64" xlink:href="mck-20211231.xsd#mck_NumberOfInvestmentFundsThatFiledClaims"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_NumberOfInvestmentFundsThatFiledClaims_69f191e6-7a30-4d38-831a-5199aa666d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfRelators_2c1aaebf-69dc-4808-b73d-c160670c03ae" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfRelators"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfRelators_2c1aaebf-69dc-4808-b73d-c160670c03ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfAdditionalDefendants_79aa75bc-2125-4b19-a642-775ca251f802" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfAdditionalDefendants"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfAdditionalDefendants_79aa75bc-2125-4b19-a642-775ca251f802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_82ec5be2-610d-4110-ad33-67d2b13bd07f" xlink:href="mck-20211231.xsd#mck_LossContingencyNumberOfStatesFiledOnBehalfOf"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c97507b0-c20b-4ac8-8ca6-11415bd97889" xlink:to="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_82ec5be2-610d-4110-ad33-67d2b13bd07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_de1f239a-5f47-4c3a-8c06-61e02b231183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2b495854-19d2-4612-b16c-2949e17b85fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_de1f239a-5f47-4c3a-8c06-61e02b231183" xlink:to="loc_us-gaap_LossContingenciesTable_2b495854-19d2-4612-b16c-2949e17b85fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_47a7982f-ed3f-475a-8262-c1472c80424a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2b495854-19d2-4612-b16c-2949e17b85fd" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_47a7982f-ed3f-475a-8262-c1472c80424a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0a146b74-4eee-4f30-9ef7-8e40578e2747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_47a7982f-ed3f-475a-8262-c1472c80424a" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0a146b74-4eee-4f30-9ef7-8e40578e2747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_1172f8b6-8dac-4fa1-b711-2b376ff0ffc0" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0a146b74-4eee-4f30-9ef7-8e40578e2747" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_1172f8b6-8dac-4fa1-b711-2b376ff0ffc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f841c731-637f-4297-98b8-311a298ef5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2b495854-19d2-4612-b16c-2949e17b85fd" xlink:to="loc_us-gaap_LossContingenciesLineItems_f841c731-637f-4297-98b8-311a298ef5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_93659864-9a39-4cfd-85da-6e3cbfb4dce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f841c731-637f-4297-98b8-311a298ef5b9" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_93659864-9a39-4cfd-85da-6e3cbfb4dce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_8c5b26b1-02b3-40b9-a118-10641b7d630b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f841c731-637f-4297-98b8-311a298ef5b9" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_8c5b26b1-02b3-40b9-a118-10641b7d630b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_895623b1-06e3-4ed8-8486-9192f64bca16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f841c731-637f-4297-98b8-311a298ef5b9" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_895623b1-06e3-4ed8-8486-9192f64bca16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="mck-20211231.xsd#StockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d88f184f-aabd-428f-9c4e-4131f0bab261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6fd9ea1a-d6f1-416b-ba75-966ac73e4d64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d88f184f-aabd-428f-9c4e-4131f0bab261" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6fd9ea1a-d6f1-416b-ba75-966ac73e4d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="simple" xlink:href="mck-20211231.xsd#StockholdersEquityDeficitTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_816a88af-6ee6-432d-89bf-87771a88589e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_389f598e-4a65-4a0f-97ad-a649c9b18e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_816a88af-6ee6-432d-89bf-87771a88589e" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_389f598e-4a65-4a0f-97ad-a649c9b18e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_eb36960c-77b2-429f-8000-b7bd5831b620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_f759ce8d-ab53-4734-8d49-db770b9b5dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_eb36960c-77b2-429f-8000-b7bd5831b620" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_f759ce8d-ab53-4734-8d49-db770b9b5dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_4f12c3bb-29b4-42b6-b1a7-2434677f9491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_f759ce8d-ab53-4734-8d49-db770b9b5dcf" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_4f12c3bb-29b4-42b6-b1a7-2434677f9491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_d67b438d-7fa4-488b-b245-d97dbb2aaf27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4f12c3bb-29b4-42b6-b1a7-2434677f9491" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_d67b438d-7fa4-488b-b245-d97dbb2aaf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_f65cc722-b648-48a0-8564-38f0ef65e369" xlink:href="mck-20211231.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_d67b438d-7fa4-488b-b245-d97dbb2aaf27" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_f65cc722-b648-48a0-8564-38f0ef65e369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember_b38cf192-3305-4f92-aff7-4830bb8465f0" xlink:href="mck-20211231.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_d67b438d-7fa4-488b-b245-d97dbb2aaf27" xlink:to="loc_mck_OpenMarketShareRepurchaseTransactionsMember_b38cf192-3305-4f92-aff7-4830bb8465f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_f759ce8d-ab53-4734-8d49-db770b9b5dcf" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_fb3a2419-8a46-40a5-ad2c-2857d9d9e360" xlink:href="mck-20211231.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_fb3a2419-8a46-40a5-ad2c-2857d9d9e360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_5cff2291-469e-4468-b3e0-8ae03c2d5ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_5cff2291-469e-4468-b3e0-8ae03c2d5ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_5cc870a3-dff3-4d4b-a3ea-23498f2f6be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_5cc870a3-dff3-4d4b-a3ea-23498f2f6be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_7f7946a5-a4e9-4a12-9ec1-6c757acc8a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_7f7946a5-a4e9-4a12-9ec1-6c757acc8a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_72031902-2fd1-4fcd-9cf1-97329de6c12a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_72031902-2fd1-4fcd-9cf1-97329de6c12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e7998da6-4999-47d7-998a-a113b22be892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e7998da6-4999-47d7-998a-a113b22be892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_a6a41a22-8aa6-4bfb-bfc6-478d7d0c2369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_a6a41a22-8aa6-4bfb-bfc6-478d7d0c2369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d29a5606-caa9-4d09-b505-523b86b94009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d29a5606-caa9-4d09-b505-523b86b94009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5fe6bbea-4104-40fe-88ad-6fafbb6ecde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5fe6bbea-4104-40fe-88ad-6fafbb6ecde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9da09481-b1ed-4c7a-afe3-dff3a4fbaa19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_efc764ed-2017-4163-804f-9c9aed7f326a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9da09481-b1ed-4c7a-afe3-dff3a4fbaa19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7dc07d2f-f5bb-4f2a-ba9c-73d79daba152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_6c27a86c-0427-4185-9e2b-3d32ae249cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7dc07d2f-f5bb-4f2a-ba9c-73d79daba152" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_6c27a86c-0427-4185-9e2b-3d32ae249cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e276ba8f-1688-49af-98ef-9aec49a4452d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_6c27a86c-0427-4185-9e2b-3d32ae249cdb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e276ba8f-1688-49af-98ef-9aec49a4452d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_006ee791-a248-48bd-8451-5a4089228d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e276ba8f-1688-49af-98ef-9aec49a4452d" xlink:to="loc_us-gaap_EquityComponentDomain_006ee791-a248-48bd-8451-5a4089228d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_006ee791-a248-48bd-8451-5a4089228d2d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_ea275640-b09d-43ed-b7b8-4600ad772840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_ea275640-b09d-43ed-b7b8-4600ad772840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_64bb9032-d88c-4d1a-9dd2-64d5bc088a13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_64bb9032-d88c-4d1a-9dd2-64d5bc088a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_d8eb559b-b04a-4a4d-be58-bfe9335c46b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_d8eb559b-b04a-4a4d-be58-bfe9335c46b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_232f7369-aef4-4f6c-bd0b-ece683b1262a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a987d452-4dab-4e57-b2a8-a8b3d6dd9168" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_232f7369-aef4-4f6c-bd0b-ece683b1262a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a8e6f297-b5b1-4dbc-ab98-ffabe7051012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_6c27a86c-0427-4185-9e2b-3d32ae249cdb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a8e6f297-b5b1-4dbc-ab98-ffabe7051012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2530ed4e-e9e9-4217-a746-0686d36ab560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a8e6f297-b5b1-4dbc-ab98-ffabe7051012" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2530ed4e-e9e9-4217-a746-0686d36ab560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7ba26257-cfaf-45fb-b16f-e7c8bcd17fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2530ed4e-e9e9-4217-a746-0686d36ab560" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7ba26257-cfaf-45fb-b16f-e7c8bcd17fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_39c1178d-c6a6-4bff-b3d0-4259701f44ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2530ed4e-e9e9-4217-a746-0686d36ab560" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_39c1178d-c6a6-4bff-b3d0-4259701f44ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d289448b-29a7-4f82-af3c-4dd033e79ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_6c27a86c-0427-4185-9e2b-3d32ae249cdb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d289448b-29a7-4f82-af3c-4dd033e79ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d289448b-29a7-4f82-af3c-4dd033e79ef4" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdd0e0c3-2c7a-45c1-b417-f23a5805dec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdd0e0c3-2c7a-45c1-b417-f23a5805dec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d30de58d-c069-4198-acf3-ac1ea6059ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d30de58d-c069-4198-acf3-ac1ea6059ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6869abd0-fe9a-4efa-96ca-215fc2092168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6869abd0-fe9a-4efa-96ca-215fc2092168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7df23e5-67c9-454b-937d-713133498cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7df23e5-67c9-454b-937d-713133498cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_a4e5ce06-da89-42a7-8704-8d0d77bec8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_a4e5ce06-da89-42a7-8704-8d0d77bec8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d1c1fa81-70ae-4bdd-9dbe-82cd3b58a3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d1c1fa81-70ae-4bdd-9dbe-82cd3b58a3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ba5b3ce8-837e-4a99-bb32-a89a680f1ea8" xlink:href="mck-20211231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ba5b3ce8-837e-4a99-bb32-a89a680f1ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4eec86f0-9a8c-43a5-975b-070c9bcc2a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3cdc7d56-b523-4883-804c-57bacea8a4eb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4eec86f0-9a8c-43a5-975b-070c9bcc2a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_bbb6e446-32d7-4fca-afa9-36405afd11a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d289448b-29a7-4f82-af3c-4dd033e79ef4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_bbb6e446-32d7-4fca-afa9-36405afd11a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20211231.xsd#SegmentsofBusiness"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7ec1bc69-6c74-47df-9aea-e934a8e634cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_2b5c8f95-33ba-46f1-b40c-0c60df759854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7ec1bc69-6c74-47df-9aea-e934a8e634cb" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_2b5c8f95-33ba-46f1-b40c-0c60df759854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20211231.xsd#SegmentsofBusinessTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_83f34d58-0946-454d-8caa-630f8db6ec6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_c228b5fd-9c7c-4749-9461-06b34261620a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_83f34d58-0946-454d-8caa-630f8db6ec6a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_c228b5fd-9c7c-4749-9461-06b34261620a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7277e554-c16b-483e-8fd8-275ec14e5100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7277e554-c16b-483e-8fd8-275ec14e5100" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_df3fad41-5a8f-4769-993f-dea8c3a9211a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:to="loc_srt_StatementGeographicalAxis_df3fad41-5a8f-4769-993f-dea8c3a9211a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a0903703-89fc-499a-86c8-40eae7b78ca2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_df3fad41-5a8f-4769-993f-dea8c3a9211a" xlink:to="loc_srt_SegmentGeographicalDomain_a0903703-89fc-499a-86c8-40eae7b78ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6b8eee95-db46-4bc7-b0ec-a183309d20b7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a0903703-89fc-499a-86c8-40eae7b78ca2" xlink:to="loc_country_US_6b8eee95-db46-4bc7-b0ec-a183309d20b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_ab92b77f-fd27-4272-98e0-999877406b66" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a0903703-89fc-499a-86c8-40eae7b78ca2" xlink:to="loc_srt_EuropeMember_ab92b77f-fd27-4272-98e0-999877406b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4bb18f60-65ca-46aa-bf62-d87b15742486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4bb18f60-65ca-46aa-bf62-d87b15742486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6904b698-619d-4bbf-b2f5-27bb6f08b78e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4bb18f60-65ca-46aa-bf62-d87b15742486" xlink:to="loc_us-gaap_SegmentDomain_6904b698-619d-4bbf-b2f5-27bb6f08b78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_b0073760-c204-4b7d-9dc0-e926774c2098" xlink:href="mck-20211231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6904b698-619d-4bbf-b2f5-27bb6f08b78e" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_b0073760-c204-4b7d-9dc0-e926774c2098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_7eb0d751-25ae-45d3-b183-e24d6ee963d9" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6904b698-619d-4bbf-b2f5-27bb6f08b78e" xlink:to="loc_mck_InternationalSegmentMember_7eb0d751-25ae-45d3-b183-e24d6ee963d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d890fbb9-77c8-4a3f-ab69-0bb5738ad8f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:to="loc_srt_ConsolidationItemsAxis_d890fbb9-77c8-4a3f-ab69-0bb5738ad8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a73eddbc-fd2f-4d4b-8559-d2c3487380de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_d890fbb9-77c8-4a3f-ab69-0bb5738ad8f1" xlink:to="loc_srt_ConsolidationItemsDomain_a73eddbc-fd2f-4d4b-8559-d2c3487380de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_91ddc8c8-ba3f-4133-ab24-c1e611287bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a73eddbc-fd2f-4d4b-8559-d2c3487380de" xlink:to="loc_us-gaap_OperatingSegmentsMember_91ddc8c8-ba3f-4133-ab24-c1e611287bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1501bf83-c783-43bd-bfae-2f803b85d0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1501bf83-c783-43bd-bfae-2f803b85d0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b024ba9a-270f-4fc0-8032-b0bdc680f718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1501bf83-c783-43bd-bfae-2f803b85d0c7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b024ba9a-270f-4fc0-8032-b0bdc680f718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_49d2ff47-ecf2-4a81-ba61-f2d738e7bde8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b024ba9a-270f-4fc0-8032-b0bdc680f718" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_49d2ff47-ecf2-4a81-ba61-f2d738e7bde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bef7f26a-702e-4c3c-9d26-0ae99537a430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b024ba9a-270f-4fc0-8032-b0bdc680f718" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bef7f26a-702e-4c3c-9d26-0ae99537a430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a982304c-38f3-429a-9147-ba1b68d35e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a982304c-38f3-429a-9147-ba1b68d35e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_32ce2a31-155f-4f59-9b4f-078e362c04d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a982304c-38f3-429a-9147-ba1b68d35e3d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_32ce2a31-155f-4f59-9b4f-078e362c04d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_87e9b125-8e5b-4fb0-888a-accfd6f8eabf" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_32ce2a31-155f-4f59-9b4f-078e362c04d8" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_87e9b125-8e5b-4fb0-888a-accfd6f8eabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_ebb385d4-1ea2-49fb-b87e-0b5af40931e3" xlink:href="mck-20211231.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_32ce2a31-155f-4f59-9b4f-078e362c04d8" xlink:to="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_ebb385d4-1ea2-49fb-b87e-0b5af40931e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f49bdf0e-2e59-47a8-a580-2d3517f6c89a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_c6126fe8-70dd-4ea7-8638-ed3fa4617c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:to="loc_us-gaap_NumberOfReportableSegments_c6126fe8-70dd-4ea7-8638-ed3fa4617c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_86637b0e-63e7-4c8a-b34d-5f5a137fca3a" xlink:href="mck-20211231.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_86637b0e-63e7-4c8a-b34d-5f5a137fca3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_615266b9-010f-4554-b78b-1a33cd7adbae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_615266b9-010f-4554-b78b-1a33cd7adbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations_49960068-4210-4ef8-a3f6-3626b86698eb" xlink:href="mck-20211231.xsd#mck_NumberOfBusinessOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:to="loc_mck_NumberOfBusinessOperations_49960068-4210-4ef8-a3f6-3626b86698eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_d092242f-8822-44dd-9951-67e97db218c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9e38b6d0-6911-4142-b48a-dbb21cb34a85" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_d092242f-8822-44dd-9951-67e97db218c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="simple" xlink:href="mck-20211231.xsd#SegmentsofBusinessReportableoperatingsegmentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2eec28d8-2969-4fa8-9a0a-08a4e88e5b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2eec28d8-2969-4fa8-9a0a-08a4e88e5b98" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ed20ad27-c787-486f-8204-8e2184fb0618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ed20ad27-c787-486f-8204-8e2184fb0618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ed20ad27-c787-486f-8204-8e2184fb0618" xlink:to="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_15aaaf9c-b9cf-406c-8cb7-2f4b656d6237" xlink:href="mck-20211231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:to="loc_mck_USPharmaceuticalSegmentMember_15aaaf9c-b9cf-406c-8cb7-2f4b656d6237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_6262f875-8a0f-41bf-8e55-d3501793c8a0" xlink:href="mck-20211231.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_6262f875-8a0f-41bf-8e55-d3501793c8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_e120bd21-2a34-4e5b-ad40-ef5d431ebf50" xlink:href="mck-20211231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_e120bd21-2a34-4e5b-ad40-ef5d431ebf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_7347cfca-a874-40b3-8b2b-df635cfb4b0b" xlink:href="mck-20211231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e1949562-90e7-4bd0-8eb1-2e8d7cb0a728" xlink:to="loc_mck_InternationalSegmentMember_7347cfca-a874-40b3-8b2b-df635cfb4b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a80a9fe3-8ab3-4e5e-a3d4-85acafb623d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_srt_LitigationCaseAxis_a80a9fe3-8ab3-4e5e-a3d4-85acafb623d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6d368646-19eb-4675-a4d5-f03ac2f51012" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_a80a9fe3-8ab3-4e5e-a3d4-85acafb623d9" xlink:to="loc_srt_LitigationCaseTypeDomain_6d368646-19eb-4675-a4d5-f03ac2f51012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AntitrustLegalSettlementsMember_2121a58b-4e9b-4faa-b29f-4e92fd4aa561" xlink:href="mck-20211231.xsd#mck_AntitrustLegalSettlementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_6d368646-19eb-4675-a4d5-f03ac2f51012" xlink:to="loc_mck_AntitrustLegalSettlementsMember_2121a58b-4e9b-4faa-b29f-4e92fd4aa561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_caf33b2d-ab51-4a0c-938e-be6e214e86e5" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_6d368646-19eb-4675-a4d5-f03ac2f51012" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_caf33b2d-ab51-4a0c-938e-be6e214e86e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionInsuranceProceedsMember_738bd1f3-ea6e-4aaa-a013-7efd2b42e411" xlink:href="mck-20211231.xsd#mck_ShareholderDerivativeActionInsuranceProceedsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_6d368646-19eb-4675-a4d5-f03ac2f51012" xlink:to="loc_mck_ShareholderDerivativeActionInsuranceProceedsMember_738bd1f3-ea6e-4aaa-a013-7efd2b42e411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_99cec215-4a70-4a9f-a66e-ff8526a5838c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_srt_ConsolidationItemsAxis_99cec215-4a70-4a9f-a66e-ff8526a5838c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_bd8f5fc7-c15b-49de-91e7-7247d956ca96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_99cec215-4a70-4a9f-a66e-ff8526a5838c" xlink:to="loc_srt_ConsolidationItemsDomain_bd8f5fc7-c15b-49de-91e7-7247d956ca96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_ecc6a1bf-3201-4389-b379-1c1901337256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_bd8f5fc7-c15b-49de-91e7-7247d956ca96" xlink:to="loc_us-gaap_OperatingSegmentsMember_ecc6a1bf-3201-4389-b379-1c1901337256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_2c3be246-ced2-45fc-b001-a8351ad49039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_bd8f5fc7-c15b-49de-91e7-7247d956ca96" xlink:to="loc_us-gaap_CorporateNonSegmentMember_2c3be246-ced2-45fc-b001-a8351ad49039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_36e19738-c32b-4ef7-a09a-c27c5978d867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_36e19738-c32b-4ef7-a09a-c27c5978d867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c2d51a02-edc4-4149-9dfd-d2c709d06faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_36e19738-c32b-4ef7-a09a-c27c5978d867" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c2d51a02-edc4-4149-9dfd-d2c709d06faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_475fe545-9ee4-4156-a23e-5ec88cc06994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c2d51a02-edc4-4149-9dfd-d2c709d06faf" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_475fe545-9ee4-4156-a23e-5ec88cc06994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f835cbc0-455a-4aae-9e62-47e3708cfe00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c2d51a02-edc4-4149-9dfd-d2c709d06faf" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f835cbc0-455a-4aae-9e62-47e3708cfe00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember_af572a6c-99e3-41cd-a4ad-59a68c3f33fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c2d51a02-edc4-4149-9dfd-d2c709d06faf" xlink:to="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember_af572a6c-99e3-41cd-a4ad-59a68c3f33fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0f82ff91-1a08-4ff9-9d49-51838d2280e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0f82ff91-1a08-4ff9-9d49-51838d2280e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_acb12748-f516-4034-baa4-838bda94de2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0f82ff91-1a08-4ff9-9d49-51838d2280e7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_acb12748-f516-4034-baa4-838bda94de2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_1322911e-8cdb-4024-8c18-8b1bde6c3fed" xlink:href="mck-20211231.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_acb12748-f516-4034-baa4-838bda94de2e" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_1322911e-8cdb-4024-8c18-8b1bde6c3fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_5969631e-ea61-48c7-b6cb-7fec1041f305" xlink:href="mck-20211231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_acb12748-f516-4034-baa4-838bda94de2e" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_5969631e-ea61-48c7-b6cb-7fec1041f305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c90d199-b688-4c9d-9794-1b1c9fde2a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c90d199-b688-4c9d-9794-1b1c9fde2a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c90d199-b688-4c9d-9794-1b1c9fde2a63" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_e36ad766-544b-43a3-b1a0-a98cd5e18c20" xlink:href="mck-20211231.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:to="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_e36ad766-544b-43a3-b1a0-a98cd5e18c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_2781bc0e-a823-4d57-a9c1-2a931c7a3931" xlink:href="mck-20211231.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_2781bc0e-a823-4d57-a9c1-2a931c7a3931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_002ae554-992d-4ee1-988f-b73b04b27d60" xlink:href="mck-20211231.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_002ae554-992d-4ee1-988f-b73b04b27d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleBusinessMember_b8d75864-e95d-481e-bfb7-4d66575c2507" xlink:href="mck-20211231.xsd#mck_GermanPharmaceuticalWholesaleBusinessMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:to="loc_mck_GermanPharmaceuticalWholesaleBusinessMember_b8d75864-e95d-481e-bfb7-4d66575c2507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_85880634-3b73-4416-b607-1b9caca058e9" xlink:href="mck-20211231.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4f3d8c98-c400-4e1a-ba92-ce27bab1801d" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_85880634-3b73-4416-b607-1b9caca058e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_74d6591a-0066-4bde-ae4a-13ea8bfd694d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_DebtInstrumentAxis_74d6591a-0066-4bde-ae4a-13ea8bfd694d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4ad17bfc-99e8-43f6-b255-23746abd605e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_74d6591a-0066-4bde-ae4a-13ea8bfd694d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4ad17bfc-99e8-43f6-b255-23746abd605e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesAndDebenturesExtinguishedFebruary72018Member_9cd94a30-eda1-4b6a-a86d-a20aa91c9213" xlink:href="mck-20211231.xsd#mck_NotesAndDebenturesExtinguishedFebruary72018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4ad17bfc-99e8-43f6-b255-23746abd605e" xlink:to="loc_mck_NotesAndDebenturesExtinguishedFebruary72018Member_9cd94a30-eda1-4b6a-a86d-a20aa91c9213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4685fc82-d7fa-4c1b-8b88-643ff64b46fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4685fc82-d7fa-4c1b-8b88-643ff64b46fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1e2c03db-3e74-4093-ac1c-312e4873caad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4685fc82-d7fa-4c1b-8b88-643ff64b46fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1e2c03db-3e74-4093-ac1c-312e4873caad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_eb2e5fef-ad7e-4a83-ab02-8e27715ff857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1e2c03db-3e74-4093-ac1c-312e4873caad" xlink:to="loc_us-gaap_LoansPayableMember_eb2e5fef-ad7e-4a83-ab02-8e27715ff857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_57a03fab-f27f-44fa-b027-79d3edeefe6f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a6e4ceff-deba-4236-88b0-65f56863002a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_us-gaap_RevenuesAbstract_a6e4ceff-deba-4236-88b0-65f56863002a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0bc5ac1-f236-4ac2-9f5a-7848474a3a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a6e4ceff-deba-4236-88b0-65f56863002a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0bc5ac1-f236-4ac2-9f5a-7848474a3a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_596a8ee8-5551-4322-a9d8-2f38c8f8378c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_596a8ee8-5551-4322-a9d8-2f38c8f8378c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f55f6477-715b-4e05-8f16-d139c74f35c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_596a8ee8-5551-4322-a9d8-2f38c8f8378c" xlink:to="loc_us-gaap_OperatingIncomeLoss_f55f6477-715b-4e05-8f16-d139c74f35c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_7d4afbbf-605f-4ec3-9c9a-fc99524a9228" xlink:href="mck-20211231.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_7d4afbbf-605f-4ec3-9c9a-fc99524a9228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fcfcd183-99be-4e4b-886b-1f9bbcc3cbc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fcfcd183-99be-4e4b-886b-1f9bbcc3cbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_80585587-6434-4e61-bde8-bcbeed75cb92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_us-gaap_InterestExpense_80585587-6434-4e61-bde8-bcbeed75cb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_642a9237-08d6-4a78-a4dc-23514733ac60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c7ca0040-66e9-4054-9f09-f284e45133a8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_642a9237-08d6-4a78-a4dc-23514733ac60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_931d9c2c-dedb-42c5-b116-b9d0dae9284f" xlink:href="mck-20211231.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_931d9c2c-dedb-42c5-b116-b9d0dae9284f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_08178f94-70c3-48e8-9c2f-d1f4ae46045b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_08178f94-70c3-48e8-9c2f-d1f4ae46045b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_e700f547-6987-414f-908b-3ffd18d372e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_e700f547-6987-414f-908b-3ffd18d372e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_65b5939c-1a5f-46da-b173-1461bae9fab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_65b5939c-1a5f-46da-b173-1461bae9fab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_2c158617-c8dc-4de7-9239-4b8bee2b1713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_InventoryWriteDown_2c158617-c8dc-4de7-9239-4b8bee2b1713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_2260ccdb-812c-49ad-b7f2-0068c6f95292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_2260ccdb-812c-49ad-b7f2-0068c6f95292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_c852605b-3b8a-4f7c-b418-46d7d45fc686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_c852605b-3b8a-4f7c-b418-46d7d45fc686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_84577659-fed8-44c6-b772-47b556d31b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_RestructuringCharges_84577659-fed8-44c6-b772-47b556d31b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_65e24aa3-76eb-4448-849b-9550a062a027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_65e24aa3-76eb-4448-849b-9550a062a027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d5a244f0-e52c-4c1d-bce4-8d6df0279da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d5a244f0-e52c-4c1d-bce4-8d6df0279da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_781a4ee2-d680-4598-a4eb-f4fe50f0927f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_781a4ee2-d680-4598-a4eb-f4fe50f0927f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_26a0f35c-6c58-40a6-adcc-bf76304cd689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_LitigationSettlementExpense_26a0f35c-6c58-40a6-adcc-bf76304cd689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_98554915-5d53-42f4-9417-c045d0492c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_98554915-5d53-42f4-9417-c045d0492c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_61c7e6f2-0fcd-486f-b700-0e0139360349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ee03bc8b-d7ad-459d-892e-550ae6cdc7e0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_61c7e6f2-0fcd-486f-b700-0e0139360349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>mck-20211231_g1.jpg
<DESCRIPTION>LOGO
<TEXT>
begin 644 mck-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ^ 9@# 2(  A$! Q$!_\0
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M?$#XA>(?$4S;FU&]DG'7A2QV@>V,5CE& CC:DO:?"C;/,RGE].*I?$S]#O\
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MOK:UCTK71)/(L2EH(P,DX!^_ZFOJ^&430I(O1E##Z&OPG\+C_BIM(_Z^XO\
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MD5^IL,R7$*2QL'C<!E93D$'H:^+QV"G@JG)+;H?H&6YC3S"ESQW6Z/&/CO\
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M6=^U=\!E^/OPRETJV=(=;L9/M>G3/]WS ""C'L&!(]N#VKP\'..$QL7/9/\
MX!]%CJ<L;E\E36LDG^I^/)]J_3W]AOXP?#MOA%H_ANTO;+1O$-HI2^M+EEBD
MGDW$F4$_?#9_#IVK\V_%W@W6O .NW&CZ_IT^F:C VUH;A"I//4'N#CJ*QU9D
M8.I*L#D$'!'N*_0<;A89A145+[C\PP.,GE==S<;O;4_>F.2.959&5E89#*<@
MUD>*/!>A>-M->PUW2;35;1Q@Q740<<^F>GX5^-?@OX^?$/X?R1G0_%VIVB(>
M(&G,D1QZHV01]17T]\)/^"E6M6%Q;V7Q!TF'4[1B%;5--7RYD]6:/[K?\!V]
M#P:^0KY)BJ'O4W?\S[K#\0X/$>Y6CR_D?>'@3P+HWPW\,VOA_0+3[%I=J7,4
M.XMMW,6/)]V-?GQ_P4TGN6^*WAR.0$6Z:83%Z9\P[C_*OT*\%^-M%^(?ARSU
MW0+^+4=,NEWQS1'\P1V([@UX1^VQ^SA=?'#P9;:EH2J_B;10SP0DX^TQ$9:+
M/9N 1[\=ZXLMKK#XQ3K'?FU!XG ..'/RFXSDC-?KK^R[\8OASXD^&>@Z7X<U
M"QTZZM+2.*?2Y&6*:.0* Q*G[V3D[AUS7Y*ZQHU_X?U&>PU.SFT^]@;;);W"
M%'4@]""*KPS26\JR1.T<BG*NA((]P:^ZQV"CF$$E*UC\YR[,)Y95;<+G[TAE
M;!&#7,>.OAAX7^)6EO8>)-$L]5@8;1YT8+K[JW4?A7Y$>"?VE_B;\/9$_L?Q
M?J"1)TM[F3SXOQ1P17U5\&?^"E#7%Y;Z;\1]*B@1R%&L:6"%7MF2(D\>ZG_@
M(KY"MDN+P_OTW>W;<^YP^?8+%6IU5:_?8^X_#?AVQ\)Z#8:-ID/V?3[&%8((
MLD[448 _*OAG_@IS\1)8Y/"W@BWE*QR(^IW<8/W@&V19'ID2'\!7W7H>N6/B
M/2[;4M-NH[VQN4$D,\+;E=2."#7Y;_\ !0[46OOVD;V%BQ%IIMK"N[I@AI./
M;+G]:RR:G[3&KGZ&V?5?9X!JGL[(^9_I7ZK_ +'/[,>D_"CP+IFO:M8Q7/C#
M4H%N9YI5#&T5AE8DST(!&XCJ<]J_,_X7Z3'KWQ*\*:=,H:&ZU6UBD5N 5,JA
MA^(S7[B0Q+#"B*,*J@ 5[7$&(G",*,79,^?X9PD*DIUYJ]MA)(8Y$:-T5D88
M*D<$5^>W[?W[,NE^%+.+XA^&+-+&WDF6'4[.!=L89N$E51TYX...17Z&UY7^
MU)HT.O?L\_$"WG7<L>CW%T!_M1(95/YH*^8R_$SP^(C*+TZGV&:82GB<+-26
MJ6A^,O\ .OUR_8C^(TWQ$^ >BO=R&6^TPMI\S,<L1'@(3]5Q^5?D;7Z+_P#!
M+^ZD?P#XP@+9C34T91Z$Q+G^0K[//J:GA>?JF? \-U94\;R=&CSO_@I]_P E
M%\(?]@Q__1K5\6JK.P5069C@*.2<\  5]H_\%/O^2B>$/^P8_P#Z--?(_@E0
MWC/0 >0=0MQ_Y%6NK*I<N @^R9Q9Q'FS&<>[,9D96*L"K*<%3P1Z@^]?H1_P
M3F^/@U'2;CX:ZS<YNK/-QI+R-R\)Y>(>ZGYA[,?05X9^W-\!3\)_B4-;TVW*
M>'/$!:>+:/E@N.LD9]CG</8D?PUX)X)\8ZE\/_%FE^(=(E,-_I\ZSQMG@X/*
MGV(R/QHKPIYKA+QW>WJ&&J5<GQMI=-_0_53]NK_DVWQ+]8?_ $8*_)"OT]_:
M+^)6G?%S]BF]\4Z8P,%]#"SQYR8I!(%>-O=6!'X#US7YA5QY#&4*$XRZ,[^(
MZD:N(A..S1^O'[#_ /R:[X(_ZY7'_I5+11^P_P#\FN^"/^N5Q_Z52T5\-BO]
MXJ>K_,_1L#_NM/T1C?\ !0+_ )-MUG_KZMO_ $8*_)^OU@_X*!?\FVZS_P!?
M5M_Z,%?D_7W&0?[J_4_.^)O]\7HC[_\ BU\/?^$R_P""??A'5(8M][X?M8;]
M"HR?*W%)1] K;O\ @ KX*TW4)M)U&UOK=MEQ;2K-&PX(92"/U K]>/@#X?M_
M%7[*/AK1KM!+:W^B&VD1NA5PRD?D:_)+Q7X>N/"7B?5=%NE*W&GW4EL^>"=C
M$9_$ ?G3RBMSRK4'T;(SK#NG&AB(]8K\"UX\\9ZA\0O%VJ>(M48-?ZA*9I=O
M0' &![ "ONC]@7X>_P!C_ KQSXNN(R+C64FMX&8?\L(8V&1]79_^^17Y_6EK
M)?7<%M"N^:9Q&B^K,0 /S(K]FO!O@>+X;_L]VWAV-0K6.B.DG&"9/*)<GW+$
MTLZK*C1A0CI=_@BL@H.O7G7GK9?BS\9+K_CZF_WV_F:_0O\ X)=_\BCXX_Z_
M;?\ ]%M7YZW7_'U/_P!=&_F:_0K_ ()=_P#(H^.?^OVW_P#1;5OG/^XOY'/D
M/_(RC\SZC^-?PCTCXV^ ;_PSJP,:S#?!=* 7MY1RKCZ']":_)#XP_ GQ;\$]
M>GL/$&FRBU$A6#4HD+6\ZY.TJW8D#[IYZU^T&IZM::+9O=7US%:6Z_>EF8*H
M^I-<MJGCKP)K5G)::CJVCWUK(-KPW$D<B,/0@Y&*^%PF>PRN7)4FK/HW8_0<
MPR'^U5SPB^9=4KGXG6&J7>E3":RNY[27KO@D9&XY'(J_K'C+7_$"!-3UK4+]
M%& MQ<O(/I@FOU+UKX'_ +-^O3/)=:'X<B=^3]CN3:C\!$ZX_"I=#^"_[.?A
M^9);30_#+NF-OVN87(^N)6;FO:?%N52U;5_5?YGS:X1S./NINWS_ ,AW[#_Q
M2G^)7P-TQ;PN^H:.W]G32,#\ZH!L;/?Y<#CTKYX_X*A?\C)X(_Z];C_T):^]
M?#,FCR:3#_87V0:<ORQBR"B,8[#;Q7P5_P %0O\ D9?!'_7M<?\ H2URY56A
MB,PC5I_"[GJ9Q1J8?*W2J.\E8^*=%M([[6;"UESY4UQ'&VW@[68 X/K@UZ)^
MT1\#-1^!/CIM*G#S:3=I]HTZ\8<31=P3_>4G!_ ]ZX'PO_R,ND?]?D/_ *&M
M?KW^T%\"M.^/7PK;1KA$CU6",3Z=>$?-#,%XY_NL/E(]#["OKL=COJ=>G?X7
MN?$Y=EWU[#U7'XE:Q^57P;^+VM_!/QQ9>(]$F.Z-@ES:L2$N82?FC;V/;T(!
MK]A/A/\ %#1?B_X)T_Q-H<_FVMROSQD_/#(,;HW'8@G^1[U^*GB/P[?^$]=O
M]&U6W:TU&QF:">%Q@JRG!'TKUW]E7]HZ_P#@#XV5IGDG\+Z@RQZC9@D[><"9
M1_>4?F,USYKE\<935:C\7YG5DV:2P%7V%;X7^!^P'\J^0?\ @I?_ ,D;T?\
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M/!(K8XW*\B,,^N%4_P# A7=?\$P/"%Q)KGC+Q2T96TB@BTV.0YP[LPD=0?\
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M)?LB,Z_1F!(KNU4*-H  [ "N;$<0RE&U&%KG5A>%XQES8B=_)''?"/X6Z/\
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HTLX+"W2"UACMH%^['$H51WX Z45\G5G[6<I]V?:T:?L*4:6]E8__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334697863576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">McKESSON CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3207296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555 State Hwy 161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irving<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">446-4800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">149,798,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member', window );">1.500% Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.500% Notes due 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member', window );">1.625% Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Notes due 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member', window );">3.125% Notes Due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334699146616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 68,614<span></span>
</td>
<td class="nump">$ 62,599<span></span>
</td>
<td class="nump">$ 197,864<span></span>
</td>
<td class="nump">$ 179,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(65,186)<span></span>
</td>
<td class="num">(59,448)<span></span>
</td>
<td class="num">(188,052)<span></span>
</td>
<td class="num">(170,235)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,428<span></span>
</td>
<td class="nump">3,151<span></span>
</td>
<td class="nump">9,812<span></span>
</td>
<td class="nump">8,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, distribution, general, and administrative expenses</a></td>
<td class="num">(3,105)<span></span>
</td>
<td class="num">(2,291)<span></span>
</td>
<td class="num">(8,006)<span></span>
</td>
<td class="num">(6,625)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Claims and litigation charges, net</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(8,067)<span></span>
</td>
<td class="num">(193)<span></span>
</td>
<td class="num">(7,936)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RestructuringImpairmentandOtherRelatedCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
<td class="num">(271)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(3,130)<span></span>
</td>
<td class="num">(10,513)<span></span>
</td>
<td class="num">(8,407)<span></span>
</td>
<td class="num">(14,901)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">298<span></span>
</td>
<td class="num">(7,362)<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
<td class="num">(6,050)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="nump">277<span></span>
</td>
<td class="num">(7,363)<span></span>
</td>
<td class="nump">1,281<span></span>
</td>
<td class="num">(6,063)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(238)<span></span>
</td>
<td class="nump">1,189<span></span>
</td>
<td class="num">(396)<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">39<span></span>
</td>
<td class="num">(6,174)<span></span>
</td>
<td class="nump">885<span></span>
</td>
<td class="num">(5,052)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">39<span></span>
</td>
<td class="num">(6,174)<span></span>
</td>
<td class="nump">882<span></span>
</td>
<td class="num">(5,053)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(136)<span></span>
</td>
<td class="num">(152)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (6,226)<span></span>
</td>
<td class="nump">$ 746<span></span>
</td>
<td class="num">$ (5,205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in usd per share)</a></td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 4.81<span></span>
</td>
<td class="num">$ (32.28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="num">(0.04)<span></span>
</td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">4.79<span></span>
</td>
<td class="num">(32.29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in usd per share)</a></td>
<td class="num">(0.04)<span></span>
</td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">4.87<span></span>
</td>
<td class="num">(32.28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 4.85<span></span>
</td>
<td class="num">$ (32.29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in usd per share)</a></td>
<td class="nump">151.6<span></span>
</td>
<td class="nump">159.5<span></span>
</td>
<td class="nump">155.8<span></span>
</td>
<td class="nump">161.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">151.6<span></span>
</td>
<td class="nump">159.5<span></span>
</td>
<td class="nump">154.0<span></span>
</td>
<td class="nump">161.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RestructuringImpairmentandOtherRelatedCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Impairment and Other Related Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RestructuringImpairmentandOtherRelatedCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334699136600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="num">$ (6,174)<span></span>
</td>
<td class="nump">$ 882<span></span>
</td>
<td class="num">$ (5,053)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gains (losses) on cash flow hedges</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Changes in retirement-related benefit plans</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">47<span></span>
</td>
<td class="num">(6,055)<span></span>
</td>
<td class="nump">878<span></span>
</td>
<td class="num">(4,892)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (6,132)<span></span>
</td>
<td class="nump">$ 741<span></span>
</td>
<td class="num">$ (5,005)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334700121992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,754<span></span>
</td>
<td class="nump">$ 6,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">18,355<span></span>
</td>
<td class="nump">19,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">19,024<span></span>
</td>
<td class="nump">19,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">5,534<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">831<span></span>
</td>
<td class="nump">665<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">46,498<span></span>
</td>
<td class="nump">45,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">2,064<span></span>
</td>
<td class="nump">2,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,581<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,462<span></span>
</td>
<td class="nump">9,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">2,130<span></span>
</td>
<td class="nump">2,878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">1,973<span></span>
</td>
<td class="nump">2,581<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">63,708<span></span>
</td>
<td class="nump">65,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">37,183<span></span>
</td>
<td class="nump">38,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">372<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Long-term Debt and Lease Obligation, Current</a></td>
<td class="nump">438<span></span>
</td>
<td class="nump">742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">4,833<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">4,332<span></span>
</td>
<td class="nump">3,987<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">47,452<span></span>
</td>
<td class="nump">44,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">5,518<span></span>
</td>
<td class="nump">6,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">1,369<span></span>
</td>
<td class="nump">1,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,391<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">7,153<span></span>
</td>
<td class="nump">8,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,612<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, 800 shares authorized and 275 and 273 shares issued at December 31, 2021 and March 31, 2021, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">7,411<span></span>
</td>
<td class="nump">6,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">8,734<span></span>
</td>
<td class="nump">8,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,655)<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares, at cost, 125 and 115 shares at December 31, 2021 and March 31, 2021, respectively</a></td>
<td class="num">(15,766)<span></span>
</td>
<td class="num">(13,670)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total McKesson Corporation stockholders&#8217; deficit</a></td>
<td class="num">(1,274)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">487<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity (deficit)</a></td>
<td class="num">(787)<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</a></td>
<td class="nump">$ 63,708<span></span>
</td>
<td class="nump">$ 65,015<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334703815592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">275,000,000<span></span>
</td>
<td class="nump">273,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">125,000,000<span></span>
</td>
<td class="nump">115,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334691553000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
<th class="th"><div>Opening retained earnings adjustments: adoption of new accounting standard</div></th>
<th class="th">
<div>Opening retained earnings adjustments: adoption of new accounting standard </div>
<div>Retained Earnings</div>
</th>
<th class="th"><div>Adjusted balance, April 1</div></th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Additional Paid-in Capital</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Retained Earnings</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Accumulated Other Comprehensive Loss</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Treasury</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Noncontrolling Interests</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 13,022<span></span>
</td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 5,296<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 13,009<span></span>
</td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans, net of forfeitures (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="num">(5,085)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="num">(277)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,847<span></span>
</td>
<td class="nump">7,595<span></span>
</td>
<td class="num">(1,503)<span></span>
</td>
<td class="num">$ (13,418)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Sep. 30, 2020</a></td>
<td class="nump">6,090<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,780<span></span>
</td>
<td class="nump">13,890<span></span>
</td>
<td class="num">(1,597)<span></span>
</td>
<td class="num">$ (13,185)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="num">(6,185)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="num">$ (277)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,847<span></span>
</td>
<td class="nump">7,595<span></span>
</td>
<td class="num">(1,503)<span></span>
</td>
<td class="num">$ (13,418)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Mar. 31, 2021</a></td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,925<span></span>
</td>
<td class="nump">8,202<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
<td class="num">$ (13,670)<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans, net of forfeitures (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(2,008)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,029)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(211)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(211)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Dec. 31, 2021</a></td>
<td class="num">(125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="num">$ (787)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">7,411<span></span>
</td>
<td class="nump">8,734<span></span>
</td>
<td class="num">(1,655)<span></span>
</td>
<td class="num">$ (15,766)<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Sep. 30, 2021</a></td>
<td class="num">(87)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">7,311<span></span>
</td>
<td class="nump">8,812<span></span>
</td>
<td class="num">(1,665)<span></span>
</td>
<td class="num">$ (15,031)<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Dec. 31, 2021</a></td>
<td class="num">(125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="num">$ (787)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 7,411<span></span>
</td>
<td class="nump">$ 8,734<span></span>
</td>
<td class="num">$ (1,655)<span></span>
</td>
<td class="num">$ (15,766)<span></span>
</td>
<td class="nump">$ 487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease from Reclassification to Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseFromReclassificationToLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334699222088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 23, 2021</div></th>
<th class="th"><div>Jul. 22, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334699967832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 882<span></span>
</td>
<td class="num">$ (5,053)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Goodwill and long-lived asset impairment charges</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="nump">12<span></span>
</td>
<td class="num">(1,520)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Loss (gain) from sales of businesses and investments</a></td>
<td class="num">(117)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(1,925)<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(1,659)<span></span>
</td>
<td class="num">(2,046)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Drafts and accounts payable</a></td>
<td class="nump">1,612<span></span>
</td>
<td class="num">(1,240)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(276)<span></span>
</td>
<td class="num">(291)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Taxes</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncreaseDecreaseInLitigationReserve', window );">Litigation liabilities</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">8,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,547<span></span>
</td>
<td class="nump">1,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments for property, plant, and equipment</a></td>
<td class="num">(253)<span></span>
</td>
<td class="num">(293)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireSoftware', window );">Capitalized software expenditures</a></td>
<td class="num">(127)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates', window );">Proceeds from sales of businesses and investments, net</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(83)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(272)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">3,642<span></span>
</td>
<td class="nump">5,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of short-term borrowings</a></td>
<td class="num">(3,270)<span></span>
</td>
<td class="num">(5,303)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuances of long-term debt</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(1,646)<span></span>
</td>
<td class="num">(1,030)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="num">(184)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract', window );"><strong>Common stock transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Issuances</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchases</a></td>
<td class="num">(1,986)<span></span>
</td>
<td class="num">(500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(206)<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="num">(1,031)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(323)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(4,332)<span></span>
</td>
<td class="num">(1,176)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">35<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease', window );">Cash, cash equivalents, and restricted cash classified within Assets held for sale</a></td>
<td class="num">(215)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(3,237)<span></span>
</td>
<td class="num">(291)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">6,396<span></span>
</td>
<td class="nump">4,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">3,159<span></span>
</td>
<td class="nump">3,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Less: Restricted cash at end of period included in Prepaid expenses and other</a></td>
<td class="num">(405)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 2,754<span></span>
</td>
<td class="nump">$ 3,577<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseInLitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Litigation Reserve</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseInLitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702237704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations in healthcare to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic. As COVID-19 further evolves, the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and nine months ended December 31, 2021 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, previously filed with the SEC on May&#160;12, 2021 (&#8220;2021 Annual Report&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702404648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Held for Sale</a></td>
<td class="text">Held for Sale<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe. Assets and liabilities of certain European businesses to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. Assets and liabilities that have met the classification of held for sale were $5.5 billion and $4.8 billion, respectively, at December 31, 2021 and $12 million and $9 million, respectively, at March 31, 2021. The amounts at December 31, 2021 primarily consisted of disposal groups related to the Company&#8217;s European divestiture activities, as discussed below. During the three and nine months ended December 31, 2021, the Company recorded charges totaling $879&#160;million and $1.4&#160;billion, respectively, primarily to remeasure the assets and liabilities of the disposal groups related to European divestiture activities discussed below to the lower of their carrying value or fair value less costs to sell. These charges were largely driven by declines in the British pound sterling and the Euro. During the three and nine months ended December 31, 2020, the Company recorded losses of $47&#160;million and $57&#160;million, respectively, related to the contribution of its German pharmaceutical wholesale business to the joint venture with Walgreens Boots Alliance which was completed on November 1, 2020. The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#8220;E.U.&#8221;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;1.2 billion (or, approximately $1.4 billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. The transaction is anticipated to close within the first half of fiscal year 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable. As of December 31, 2021, the E.U. disposal group, consisting of $3.1 billion of assets and $2.3 billion of liabilities primarily within the Company&#8217;s International segment, was classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2021, the Company recorded charges totaling $26&#160;million and $517&#160;million, respectively, to remeasure the E.U. disposal group to the lower of its carrying value or fair value less costs to sell. These charges also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole. The remeasurement adjustment includes net losses of $230 million related to the accumulated other comprehensive income balances associated with the E.U. disposal group, driven by declines in the Euro. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,321&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2021, the Company announced an agreement to sell its retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;325&#160;million (or, approximately $440&#160;million), subject to certain adjustments. As of December 31, 2021, the U.K. disposal group, consisting of $1.9&#160;billion of assets and $2.3&#160;billion of liabilities primarily within the Company&#8217;s International segment, was classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheet. The transaction is expected to close in the fourth quarter of 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2021, the Company recorded charges totaling $823&#160;million to remeasure the U.K. disposal group to the lower of its carrying value or fair value less costs to sell. The remeasurement adjustment includes a $731&#160;million loss related to the accumulated other comprehensive income balances associated with the U.K. disposal group, driven by declines in the British pound sterling. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the U.K. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the U.K. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2021, the Company announced an agreement with Quadrifolia Management GmbH for a management-led buyout of its Austrian business for a purchase price of &#8364;226&#160;million (or, approximately $257&#160;million), subject to certain adjustments. At December 31, 2021, the net assets of the Austrian business of $290&#160;million, primarily within the Company&#8217;s International segment, were classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale&#8221; in the Condensed Consolidated Balance Sheet. The transaction closed on January 31, 2022. In the three and nine months ended December 31, 2021, the Company recognized a loss of $30&#160;million to remeasure the assets and liabilities of the business to the lower of its carrying value or fair value less costs to sell. The charge was recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702238424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring, Impairment, and Related Charges</a></td>
<td class="text">Restructuring, Impairment, and Related ChargesThe Company recorded restructuring, impairment, and related charges of $18 million and $208 million during the three and nine months ended December 31, 2021, respectively, and $155 million and $271 million during the three and nine months ended December 31, 2020, respectively. These charges are included in &#8220;Restructuring, impairment, and related charges&#8221; in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives were included in &#8220;Cost of sales&#8221; in the Condensed Consolidated Statement of Operations and were not material for the nine months ended December 31, 2020.<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily includes the rationalization of the Company&#8217;s office space in North America. Where it determines to cease using office space, the Company plans to exit the portion of the facility no longer used. It also may retain and repurpose certain other office locations. The Company expects to incur total charges of approximately $140 million&#160;to $180 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments. The Company recorded charges of $5 million and $115 million, respectively, in the three and nine months ended December 31, 2021. Charges primarily relate to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative is anticipated to be substantially complete in 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative included reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Charges incurred for this initiative were not material for the three and nine months ended December 31, 2021 and were $9 million and $50 million for the three and nine months ended December 31, 2020, respectively, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. This initiative was substantially complete in the third quarter of 2022, and remaining costs the Company expects to record under this initiative are not material.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2021 consisted of the following: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs related to optimization programs in Canada as well as the transition to a partial remote work model and the U.K. operating model and cost optimization efforts both described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2020 consisted of the following: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with an operating model and cost optimization initiative and with the relocation of the Company&#8217;s corporate headquarters. Both of these initiatives were substantially completed in the year ended March 31, 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above, and an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with an operating model and cost optimization initiative and with the relocation of the Company&#8217;s corporate headquarters. Both of these initiatives were substantially completed in the year ended March 31, 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the nine months ended December 31, 2021:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#8220;Other accrued liabilities&#8221; and $52 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of December 31, 2021, the total reserve balance was $144 million, of which $52 million was recorded in &#8220;Other accrued liabilities,&#8221; $44 million was recorded in &#8220;Liabilities held for sale,&#8221; and $48 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Asset Impairments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company recognized charges of $115&#160;million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach (a discounted cash flow (&#8220;DCF&#8221;) method) and a market approach to estimate the fair value of the long-lived assets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the long-lived assets is considered a Level 3 fair value measurement due to the significance of unobservable inputs developed using company specific information. Refer to Financial Note 11, &#8220;Fair Value Measurements,&#8221; for more information on nonrecurring fair value measurements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334700510008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021 and 2020, the Company recorded income tax expense of $238 million and an income tax benefit of $1.2 billion, respectively. During the nine months ended December 31, 2021 and 2020, the Company recorded income tax expense of $396 million and an income tax benefit of $1.0 billion, respectively. The Company&#8217;s reported income tax expense rate was 85.9% and an income tax benefit rate of 16.1% for the three months ended December 31, 2021 and 2020, respectively, and an income tax expense rate of 30.9% and an income tax benefit rate of 16.7% for the nine months ended December 31, 2021 and 2020, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to non-cash charges related to remeasuring the value of its E.U. and U.K disposal groups held for sale to the lower of its carrying value or fair value less costs to sell, changes in the mix of earnings between various taxing jurisdictions, and discrete items recognized in the quarters.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended December 31, 2021, the Company recorded non-cash pre-tax charges of $517 million primarily to remeasure the E.U. disposal group to the lower of its carrying value or fair value less costs to sell, and, during the three and nine months ended December 31, 2021, the Company recorded non-cash pre-tax charges of $853 million to remeasure the U.K. disposal group and the Austrian business to the lower of carrying value or fair value less costs to sell, as described in Financial Note 2, &#8220;Held for Sale.&#8221; The Company&#8217;s reported income tax rates for the three and nine months ended December 31, 2021 were unfavorably impacted by the non-deductible nature of the majority of these charges for income tax purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rates for the nine months ended December 31, 2021 and 2020 were impacted by the charges for opioid-related claims of $193 million ($160 million after-tax) and $8.1 billion ($6.7 billion after-tax), respectively, as described further in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company recognized a net discrete tax benefit of $42 million primarily related to a decrease in the income recognized pursuant to the global intangible low-tax income (&#8220;GILTI&#8221;) regime in its 2021 U.S. Federal income tax return and the statute of limitation expirations in various taxing jurisdictions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended December 31, 2020, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gain was eliminated upon consolidation. The acquiring entity of the intellectual property is entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; a discrete tax benefit of $105 million was recognized with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#8217;s excess tax basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had $1.6 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate if recognized. During the nine months ended December 31, 2021, the Company recognized a net discrete tax benefit of $115 million related to statute of limitation expirations in various taxing jurisdictions. During the next twelve months, the Company does not anticipate any material reduction in its unrecognized tax benefits. However, this may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702239432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text">Redeemable Noncontrolling Interests and Noncontrolling Interests<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million during the three months ended June 30, 2021, and $11 million and $32 million during the three and nine months ended December 31, 2020, respectively. All amounts were recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). Subsequent to the Domination Agreement&#8217;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#8220;Appraisal Proceedings&#8221;) with the Stuttgart Regional Court (the &#8220;Court&#8221;) to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified in the Domination Agreement. On September 19, 2018, the Court ruled that the Put Amount shall be increased by &#8364;0.51 resulting in an adjusted Put Amount of &#8364;23.50. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount shall remain &#8364;22.99, thereby rejecting the lower court&#8217;s increase, and the recurring compensation remained at &#8364;0.83 per share.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended December 31, 2021 and 2020, the Company paid $1.0 billion and $49&#160;million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $983 million and $49 million, respectively, for the nine months ended December 31, 2021 and 2020, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $178&#160;million and $3&#160;million, respectively, as an increase to McKesson stockholders&#8217; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; in the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. Prior to expiration of the Put Right, the balance of the redeemable noncontrolling interests was reported as the greater of its carrying value or its maximum redemption value at each reporting date. At March 31, 2021, the carrying value of $1.3&#160;billion exceeded the maximum redemption value of $1.2 billion and the Company owned approximately 78% of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021 noncontrolling interests also represent minority shareholder equity interests in McKesson Europe. At December 31, 2021, the Company owned approximately 95%, of McKesson Europe&#8217;s outstanding common shares. The Company&#8217;s noncontrolling interest in McKesson Europe will be included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#8220;Held for Sale.&#8221; The Company allocated $46 million and $128 million of net income to noncontrolling interests during the three and nine months ended December 31, 2021, respectively, and $41 million and $120 million during the three and nine months ended December 31, 2020, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2020 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702195720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Common Share</a></td>
<td class="text">Earnings (Loss) Per Common ShareBasic earnings (loss) per common share are computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Diluted loss per common share for the three months ended December 31, 2021 and the three and nine months ended December 31, 2020 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Less than 1&#160;million of potentially dilutive securities for the nine months ended December 31, 2021 were excluded from the computation of diluted earnings per common share as they were anti-dilutive.<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,052)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,204)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.79&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.29)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units, performance-based restricted stock units, and performance-based stock units.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334700481752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text">Goodwill and Intangible Assets, Net <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the Company implemented a new segment reporting structure which prompted changes in multiple reporting units across the Company. As a result, goodwill included in the impacted reporting units was reallocated using a relative fair value approach and assessed for impairment before and after the reallocation. The Company recorded a goodwill impairment charge of $69 million in the nine months ended December 31, 2020 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of this reporting unit within the International segment. This impairment charge is included in &#8220;Goodwill impairment charges&#8221; in the Condensed Consolidated Statement of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist. The annual impairment testing performed for 2022 and 2021 did not indicate any impairment of goodwill.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:26.212%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.681%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Remaining goodwill for this segment primarily relates to the McKesson Canada reporting unit.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,718)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,061&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,931)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,130&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,768)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes net intangible assets of approximately $452 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; This amount was included under the caption &#8220;Assets held for sale&#8221; in the Condensed Consolidated Balance Sheet as of December 31, 2021. Amortization of these assets ceased upon classification as Assets held for sale in the second and third quarters of 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $80 million and $262 million during the three and nine months ended December 31, 2021, respectively, and $108 million and $320 million during the three and nine months ended December 31, 2020, respectively. Estimated amortization expense of these assets is as follows: $70 million, $226 million, $215 million, $209 million, and $177 million for the remainder of 2022 and each of the succeeding years through 2026, respectively, and $1.2 billion thereafter. All intangible assets were subject to amortization as of December 31, 2021 and March 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334700502728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt and Financing Activities</a></td>
<td class="text">Debt and Financing Activities<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,518&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,406&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term debt of approximately $5 million and $12 million, respectively, as of December 31, 2021 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Condensed Consolidated Balance Sheet as of December 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $6.0 billion and $7.1 billion at December 31, 2021 and March 31, 2021, respectively, of which $438 million and $742 million, respectively, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021, the Company completed a public offering of 1.30% Notes due August 15, 2026 (the &#8220;2026 Notes&#8221;) in a principal amount of $500&#160;million. Interest on the 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on February 15, 2022. Proceeds received from this note issuance, net of discounts and offering expenses, were $495&#160;million. The Company utilized the net proceeds from this note for general corporate purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2026 Notes, which constitutes a &#8220;Series,&#8221; are an unsecured and unsubordinated obligation of the Company and rank equally with all of the Company&#8217;s existing, and from time-to-time, future unsecured and unsubordinated indebtedness outstanding. The 2026 Notes are governed by materially similar indentures and officers&#8217; certificates as those of other Series issued by the Company. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#8217;s Investors Service, Inc. and Standard &amp; Poor&#8217;s Ratings Services within a specified period, an offer must be made to purchase the 2026 Notes from the holders at a price equal to 101% of the then outstanding principal amount of the 2026 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#8217; certificate for the 2026 Note, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without lenders&#8217; consent. The indentures also contain customary events of default provisions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 17, 2021, the Company redeemed its 0.63% &#8364;600 million (or, approximately $709 million) total principal Euro-denominated notes, originally due on August 17, 2021, prior to maturity. The notes were redeemed at par value using cash on hand.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tender Offer</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) 2.85% Notes due 2023, (ii) 3.80% Notes due 2024, (iii) 7.65% Debentures due 2027, (iv) 3.95% Notes due 2028, (v) 4.75% Notes due 2029, (vi) 6.00% Notes due 2041, and (vii) 4.88% Notes due 2044 (collectively referred to herein as the &#8220;Tender Offer Notes&#8221;). In connection with the tender offer, the Company paid an aggregate consideration of $1.1&#160;billion to redeem $922&#160;million principal amount of the notes at a redemption price equal to 100% of the principal amount and premiums of $182&#160;million, plus accrued and unpaid interest of $14&#160;million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $191&#160;million in the nine months ended December 31, 2021, which included premiums of $182&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $9&#160;million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Credit Agreement, dated as of September 25, 2019 (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had no borrowings during the three and nine months ended December 31, 2021 and 2020 and no amounts outstanding as of December 31, 2021 and March 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At December 31, 2021, the Company was in compliance with all covenants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $7 million and an uncommitted amount of $114 million as of December 31, 2021. Borrowings and repayments were not material during the three and nine months ended December 31, 2021 and 2020. Amounts outstanding under these credit lines were not material as of December 31, 2021 and March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During the nine months ended December 31, 2021, the Company borrowed $3.6 billion and repaid $3.3 billion under the program. During the nine months ended December 31, 2020, the Company borrowed $5.5 billion and repaid $5.3 billion under the program. At December 31, 2021 there were $372 million commercial paper notes outstanding at a weighted average interest rate of 0.29%. At March 31, 2021, there were no commercial paper notes outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702188760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Benefits</a></td>
<td class="text">Pension Benefits<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was approximately $2 million and $4 million for the three and nine months ended December 31, 2021, respectively, and $4 million and $17 million for the three and nine months ended December 31, 2020, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash contributions to these plans were $18 million and $35 million for the three and nine months ended December 31, 2021, respectively, and $8 million and $19 million for the three and nine months ended December 31, 2020, respectively. The cash contributions for the three and nine months ended December 31, 2021 included a $17&#160;million payment to a U.K. pension plan. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale,&#8221; pension assets of $52&#160;million and pension liabilities of $148&#160;million were included under the captions &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Condensed Consolidated Balance Sheet as of December 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702193192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Hedging Activities</a></td>
<td class="text">Hedging Activities<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021 and March 31, 2021, the Company had &#8364;1.1 billion and &#8364;1.7 billion, respectively, of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from net investment hedges recorded within Other comprehensive income were gains of $23 million and $34 million during the three and nine months ended December 31, 2021, respectively, and losses of $84 million and $201 million during the three and nine months ended December 31, 2020, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three and nine months ended December 31, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021 and March 31, 2021, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $500 million Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the three and nine months ended December 31, 2021 and 2020. The remaining cross-currency swaps will mature in November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $2 million and gains of $3 million during the three and nine months ended December 31, 2021, respectively, and losses of $45 million and $108 million during the three and nine months ended December 31, 2020, respectively. There was no ineffectiveness in the Company&#8217;s cross-currency swap hedges for the three and nine months ended December 31, 2021 and 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;450 million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At December 31, 2021 and March 31, 2021, the Company had cross-currency swaps with total gross notional amounts of approximately $1.8 billion and $2.6 billion, respectively, which are designated as cash flow hedges. These swaps will mature between December 2022 and January 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500 million and &#8364;600 million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;600 million swaps. The $500 million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and is being amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes. The &#8364;600 million swaps were terminated in the second quarter of 2022 and the loss on termination of the swaps recorded in interest expense was not material for the nine months ended December 31, 2021. Refer to Financial Note 8, &#8220;Debt and Financing Activities,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From September 20, 2021 to November 4, 2021, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with a combined notional amount of $500 million, to hedge the variability of future benchmark interest rates on a planned bond issuance. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $8 million and gains of $3 million during the three and nine months ended December 31, 2021 and losses of $14 million and $42 million during the three and nine months ended December 31, 2020, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations were not material in the three and nine months ended December 31, 2021 and 2020. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the three and nine months ended December 31, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At December 31, 2021 and March 31, 2021, the total gross notional amounts of these contracts were $5 million and $39 million, respectively. These contracts matured between October 2021 and January 2022 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material in the three and nine months ended December 31, 2021 and 2020. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.206%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/></tr></table></div>Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702259000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at December 31, 2021 and March 31, 2021 included investments in money market funds of $1.1 billion and $1.6 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#8217;s marketable securities were not material at December 31, 2021 and March 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps, foreign currency forward contracts, and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $358 million and $269 million, respectively, at December 31, 2021 and March 31, 2021. These investments primarily consist of equity securities without readily determinable fair values and are included in &#8220;Other non-current assets&#8221; in the Condensed Consolidated Balance Sheets. During the nine months ended December 31, 2021 and 2020, certain of the Company&#8217;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities. Additionally, during the nine months ended December 31, 2020, certain of the Company&#8217;s investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. Net gains related to the Company&#8217;s investments in these equity securities, primarily representing unrealized gains on the securities discussed above, were $104 million for the nine months ended December 31, 2021 and $28 million and $87 million for the three and nine months ended December 31, 2020, respectively. These net gains were recorded in &#8220;Other income, net,&#8221; in the Condensed Consolidated Statements of Operations. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the assets and liabilities associated with the disposal groups in Europe held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale." At December 31, 2021 and 2020, assets measured at fair value on a nonrecurring basis included long-lived assets associated with the Company&#8217;s restructuring initiatives as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges.&#8221; Assets measured at fair value on a nonrecurring basis as of December 31, 2020 included long-lived assets in the Company&#8217;s International segment and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment. Refer to Financial Note 7, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information. At March 31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s International segment and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other liabilities measured at fair value on a nonrecurring basis at December 31, 2021 and March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021 and March 31, 2021, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.903%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within &#8220;Prepaid expenses and other&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets as of December 31, 2021, primarily consists of $354&#160;million held in escrow related to the initial payment under the proposed settlement agreement for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221; Additionally, restricted cash as of December 31, 2021 and March 31, 2021 includes funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. These amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities and corresponding deposit liabilities associated with these funds have been recorded by the Company within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets as of December 31, 2021 and March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of reporting units.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702234824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingent Liabilities</a></td>
<td class="text">Commitments and Contingent Liabilities<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765321000039/mck-20210331.htm#i08f9baf810c0412e93ea6effc6d22995_214" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 19 to the Company&#8217;s 2021 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statement of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#8220;MDL&#8221;) in the United States District Court for the Northern District of Ohio captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 17-md-2804. At present, there are approximately 2,800 cases under the jurisdiction of the MDL court.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also named in approximately 350 similar state court cases pending in 40 states plus Puerto Rico, along with 4 cases in Canada. These include actions filed by 23 state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trial in the case brought by the Washington attorney general began on November 15, 2021. Trial in the case brought by the Alabama attorney general was postponed until April 18, 2022, and the parties continue to engage in settlement negotiations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2021, the Company and the two other national pharmaceutical distributors announced that they had negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. If the proposed settlement agreement and settlement process leads to final settlement, the three distributors would pay up to approximately $21 billion over 18 years, with up to $7.9 billion to be paid by the Company for its 38.1% portion; a minimum of 85% of such payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed agreement would also establish a clearinghouse that would consolidate controlled-substance distribution data from the three largest U.S. distributors, which will be available to the settling states to use as part of their anti-diversion efforts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed agreement only addresses the claims of U.S. state attorneys general and political subdivisions in participating states. The West Virginia subdivisions and Native American tribes are not part of this settlement process. The proposed agreement is subject to contingencies and will not become effective unless the Company determines that a sufficient number of states and political subdivisions, including those that have not sued, have agreed to be bound by the agreement (or otherwise had their claims foreclosed).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 4, 2021, the Company announced that 42 of 49 eligible states had affirmatively signed on to the proposed agreement. Since that time, the attorneys general of Georgia, Nevada, New Mexico, and Rhode Island have announced that they will join, bringing the state total to 46 out of 49 eligible states, all 5 U.S. territories, and Washington, DC. The attorneys general of Alabama, Oklahoma, and Washington have not joined the proposed settlement. Beginning on September 4, 2021, each participating state offered its political subdivisions, including those that have not sued, the opportunity to participate in the settlement. That period concluded on January 26, 2022. Under the agreement, the participating states have until February 7, 2022 to determine whether there is sufficient participation in the settlement by political subdivisions to proceed to implementation. After the conclusion of this period, the Company will have until February 25, 2022 to determine whether a sufficient number of states and political subdivisions have joined for the settlement to proceed to implementation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exact amount that would be due under the proposed agreement depends on several factors, including the participation rate of states and political subdivisions, the extent to which states take action to foreclose opioid lawsuits by political subdivisions, and the extent to which political subdivisions in settling states file additional opioid lawsuits against the Company after the proposed agreement becomes effective. The proposed agreement contemplates that if certain governmental entities do not agree to a settlement under the framework, but the distributors nonetheless conclude that there is sufficient participation to warrant the settlement, there would be a corresponding reduction in the amount due from the Company to account for the unresolved claims of the governmental entities that do not participate. Those non-participating governmental entities could continue to pursue their claims against the Company and other defendants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the terms of the proposed agreement, the Company placed its first annual payment of approximately $354&#160;million, into escrow on September 30, 2021. Those escrow amounts were presented as restricted cash within &#8220;Prepaid expenses and other&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheet as of December 31, 2021. On January 25, 2022, the Company placed approximately $19&#160;million into escrow to reflect the participation of Georgia, New Mexico, and Nevada. The amounts placed into escrow exclude the proportionate allocation under the proposed settlement for each non-participating state and would be disbursed when and if the proposed agreement becomes effective. Subsequent annual payments would be due on July 15 of each year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2021, the Company announced that it and the two other national pharmaceutical distributors had agreed to pay up to $1.2&#160;billion, of which the Company&#8217;s portion would be 38.1% (or, approximately $450&#160;million), in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that New York and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#8217; fees and costs. If the broad settlement is finalized, New York and its participating subdivisions will become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2021, the Company and the two other national pharmaceutical distributors reached an agreement with the state of Ohio and its participating subdivisions and agreed to pay $881&#160;million, of which the Company&#8217;s portion would be 38.1% (or, approximately $336&#160;million), to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that Ohio and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#8217; fees and costs. If the broad settlement is finalized, Ohio and its participating subdivisions will become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 24, 2022, the Company and two other national pharmaceutical distributors reached an agreement with the state of Rhode Island and its participating subdivisions and agreed to pay approximately $91&#160;million, of which the Company&#8217;s portion would be 38.1% (or, approximately $35&#160;million), plus certain attorneys&#8217; fees and costs, to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that Rhode Island and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#8217; fees and costs. If the broad settlement is finalized, Rhode Island and its participating subdivisions will become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 28, 2022, the Company and two other national pharmaceutical distributors reached an agreement with the state of Florida and its participating subdivisions and agreed to pay approximately $1.4&#160;billion, of which the Company&#8217;s portion would be 38.1% (or, approximately $530&#160;million), to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that Florida and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework. If the broad settlement is finalized, Florida and its participating subdivisions will become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2021, the Company announced that it and the two other national distributors had reached an agreement with the Cherokee Nation to pay approximately $75&#160;million over 6.5 years to resolve opioid-related claims, of which the Company&#8217;s portion would be 38.1% (or, approximately $29&#160;million).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also negotiated a broad resolution of opioid-related claims brought by Native American tribes. Under the proposed agreement, which has been endorsed by the leadership committee of counsel representing the tribes, the Company and the two other national distributors would pay the Native American tribes other than the Cherokee Nation approximately $440&#160;million over 6 years, of which the Company&#8217;s portion would be 38.1% (or, approximately $167&#160;million). This broad resolution is contingent on the participation of a substantial majority of the Native American tribes that have brought opioid-related claims against the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the West Virginia subdivisions, trial in the case of Cabell County and City of Huntington, occurred in the U.S. District Court for the Southern District of West Virginia, and concluded on July 28, 2021. The outcome of that trial is pending. The claims of certain other West Virginia subdivisions are pending in the federal MDL and before the state Mass Litigation Panel. On September 30, 2021, the Mass Litigation Panel issued an order scheduling a liability-only trial on the public nuisance claims of certain political subdivisions against the Company and the two other national pharmaceutical distributors for July 5, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that a broad settlement of opioid claims by governmental entities is probable, and that the loss related thereto can be reasonably estimated. The Company recorded a charge of $8.1 billion ($6.8 billion after-tax) in the fiscal year ended March 31, 2021 related to its share of the global settlement as well as claims of West Virginia municipalities and the Native American tribes. In connection with the matters described above, the Company recorded additional charges of $193&#160;million ($160&#160;million after-tax) in the nine months ended December 31, 2021 within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statements of Operations, in connection with the proposed settlement agreement and other opioid related settlement accruals.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for opioid-related claims of governmental entities is as follows as of December 31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This amount, recorded in &#8220;Other accrued liabilities&#8221; in the Condensed Consolidated Balance Sheet, is the amount estimated to be paid prior to December 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a broad settlement is not reached under the proposed agreement, litigation will continue. The Company continues to prepare for trial in these pending matters, and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private entities generally, are not included in the settlement framework for governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court seeks to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CE19-00472. Trial in that case is scheduled to begin on March 21, 2022. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any potential settlement arrangement or other resolution of all of these opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2017, two investment funds holding shares in Celesio AG filed a complaint against McKesson Europe Holdings (formerly known as &#8220;Dragonfly GmbH &amp; Co KGaA&#8221;), a subsidiary of the Company, in a German court in Stuttgart, Germany, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 18 O 455/17. On December 30, 2017, four investment funds, which had allegedly entered into swap transactions regarding shares in Celesio AG that would have enabled them to decide whether to accept McKesson Europe Holdings&#8217;s takeover offer in its acquisition of Celesio AG, filed a complaint, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson Kempner International (BVI) Ltd. et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No.16 O 475/17. The complaints allege that the public tender offer document published by McKesson Europe in its acquisition of Celesio AG incorrectly stated that McKesson Europe&#8217;s acquisition of convertible bonds would not be treated as a relevant acquisition of shares for the purposes of triggering minimum pricing considerations under Section 4 of the German Takeover Offer Ordinance. On May 11, 2018, the court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dismissed the claims against McKesson Europe. Plaintiffs appealed this ruling and, on December 19, 2018, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. On November 23, 2021, the Federal Court of Justice (Bundesgerichtshof) rejected the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plaintiffs&#8217; further appeal. On March 15, 2019, the lower court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> similarly dismissed the case. Plaintiffs appealed this ruling and, on October 9, 2019, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. On November 23, 2021, the Federal Court of Justice (Bundesgerichtshof) rejected the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plaintiffs&#8217; further appeal. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2013, the Company&#8217;s subsidiary, U.S. Oncology, Inc. (&#8220;USON&#8221;), was served with a third amended qui tam complaint filed in the United States District Court for the Eastern District of New York by two relators, purportedly on behalf of the United States, 21 states and the District of Columbia, against USON and five other defendants, alleging that USON solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Piacentile v. Amgen Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 30, 2013, the court granted the United States&#8217; motion to dismiss the claims pled against Amgen. On September 17, 2018, the court granted USON&#8217;s motion to dismiss the claims pled against it, with leave to amend. On November 16, 2018, the relators filed a fourth amended complaint; that complaint was dismissed with prejudice on December 1, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2016, the Belgian Competition Authority carried out inspections at the premises of several Belgian wholesalers, including Belmedis SA, which was subsequently acquired by the Company. Pharma Belgium NV was also part of the investigation. On April 23, 2021, the Company received correspondence from the Belgian Competition Authority seeking civil penalties. The Company was fully reserved related to this matter for the third quarter of 2022, and the outcome will have no significant impact to the financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702378072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity (Deficit)</a></td>
<td class="text">Stockholders' Equity (Deficit) <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company raised its quarterly dividend from $0.42 to $0.47 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.2 million shares at an average price per share of $193.22. The Company received 4.3 million shares as the initial share settlement, and in August 2021 the Company received an additional 0.9 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021, the Company repurchased 3.3 million of the Company&#8217;s shares for $728 million through open market transactions at an average price per share of $223.89, of which $30 million was accrued at December 31, 2021 within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheet for share repurchases executed in late December and settled in early January. Additionally, during the three months ended September 30, 2021, the Company repurchased 1.4 million of the Company&#8217;s shares for $280 million through open market transactions at an average price per share of $203.20. There were no open market share repurchases during the three months ended June 30, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 8, 2021, the Company announced that the Board approved an increase of $4.0&#160;billion in the authorization for repurchase of McKesson&#8217;s common stock. The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at December 31, 2021 was $4.8 billion.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2020, the Company repurchased 1.5&#160;million of the Company&#8217;s shares for $231&#160;million through open market transactions at an average price per share of $151.12. During the three months ended September 30, 2020, the Company repurchased 1.8&#160;million of the Company&#8217;s shares for $269&#160;million through open market transactions at an average price per share of $151.23. There were no share repurchases during the three months ended June 30, 2020.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss) </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss), including noncontrolling interests and redeemable noncontrolling interests, by components for the three and nine months ended December 31, 2021 and 2020 are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,557)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,665)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,555)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,655)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the three months ended December 31, 2021 include gains of $23&#160;million related to net investment hedges from Euro-denominated notes and losses of $2&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $5 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,555)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,655)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the nine months ended December 31, 2021 include gains of $34&#160;million related to net investment hedges from Euro-denominated notes and gains of $3&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $10 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,597)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the three months ended December 31, 2020 include losses of $84&#160;million related to net investment hedges from Euro-denominated notes and losses of $45&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $33&#160;million.</span></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the nine months ended December 31, 2020 include losses of $201&#160;million related to net investment hedges from Euro-denominated notes and losses of $108&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $80&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702248920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments of Business</a></td>
<td class="text">Segments of Business<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment unifies the solutions and services of CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation to serve biopharma and life sciences partners and patients. By combining automation and expert navigation of the healthcare ecosystem, RxTS connects pharmacies, providers, payers, and biopharma to address patients&#8217; medication access, adherence, and affordability challenges to help people get the medicine they need to live healthier lives. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 275,000 national brand medical-surgical products as well as McKesson&#8217;s own line of products through a network of distribution centers within the United States.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 12 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. In the second quarter of 2022, the Company entered into an agreement to sell the E.U. disposal group and in the third quarter of 2022, the Company announced agreements to sell the U.K. disposal group and its Austrian business. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.260%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,614&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,864&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,086&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(668)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,363)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,063)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 40% of the RxTS segment&#8217;s total revenues, less than 4% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than 8% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three and nine months ended December 31, 2021 includes $33 million and $79 million, respectively, and for the three and nine months ended December 31, 2020 includes $11 million and $115 million, respectively, of credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. The nine months ended December 31, 2021 includes $46 million of cash receipts for the Company&#8217;s share of antitrust legal settlements. The nine months ended December 31, 2020 includes a charge of $50 million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s Opioid Stewardship Act.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the nine months ended December 31, 2021 includes $164 million, and for the three and nine months ended December 31, 2020 includes $35 million and $49 million, respectively, of inventory charges on certain personal protective equipment and other related products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three and nine months ended December 31, 2021 includes charges of $787 million to remeasure assets and liabilities of the U.K. disposal group to the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; The three and nine months ended December 31, 2021 includes charges of $58 million and $400 million to remeasure assets and liabilities of the E.U. disposal group to the lower of carrying value or fair value less costs to sell and to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; The nine months ended December 31, 2021 also includes a gain of $59 million related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business. Operating loss for the three and nine months ended December 31, 2020 includes restructuring, impairment, and related charges of $131 million and $189 million, respectively, driven largely by long-lived asset impairment charges of $115 million primarily related to retail pharmacy businesses in Canada and Europe as well as costs associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and a second quarter goodwill impairment charge of $69 million related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 7, &#8220;Goodwill and Intangible Assets, Net.&#8221; The three and nine months ended December 31, 2020 also includes charges of $47 million and $57 million, respectively, to remeasure to the lower of carrying value or fair value less costs to sell the assets and liabilities of the Company&#8217;s German pharmaceutical wholesale business which was contributed to a joint venture.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the three and nine months ended December 31, 2021 includes credits of $32 million and charges of $117 million primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; Corporate expenses, net for the nine months ended December 31, 2021 also includes charges of $193 million related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221; The three and nine months ended December 31, 2021 includes $33 million and $104 million, respectively, and the three and nine months ended December 31, 2020 includes $34 million and $118 million, respectively, of opioid-related costs, primarily litigation expenses. Corporate expenses, net for the three and nine months ended December 31, 2020 includes a charge of $8.1 billion related to the estimated liability for opioid-related claims, as discussed in more detail in Financial </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, &#8220;Commitments and Contingent Liabilities.&#8221; The nine months ended December 31, 2020 also includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for the nine months ended December 31, 2021 includes $104 million and for the three and nine months ended December 31, 2020 includes $30 million and $89 million, respectively, of net gains associated with certain of the Company&#8217;s equity investments.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for the nine months ended December 31, 2021 consists of a charge of $191 million on debt extinguishment related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 8, &#8220;Debt and Financing Activities.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334703820312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic. As COVID-19 further evolves, the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComparabilityOfPriorYearFinancialData', window );">Results of Operations</a></td>
<td class="text">The results of operations for the three and nine months ended December 31, 2021 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, previously filed with the SEC on May&#160;12, 2021 (&#8220;2021 Annual Report&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Period</a></td>
<td class="text">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text">Certain prior year amounts have been reclassified to conform to the current year presentation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_HeldForSalePolicyTextBlock', window );">Held for Sale</a></td>
<td class="text">Assets and liabilities of certain European businesses to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765321000039/mck-20210331.htm#i08f9baf810c0412e93ea6effc6d22995_214" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 19 to the Company&#8217;s 2021 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statement of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_HeldForSalePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Held for Sale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_HeldForSalePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComparabilityOfPriorYearFinancialData">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting any exceptions to the  comparability of prior year financial data with data shown for the most recent accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124429468&amp;loc=d3e288-107754<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComparabilityOfPriorYearFinancialData</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702265688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and Liabilities Held for Sale</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,321&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the U.K. disposal group that have met the classification of held for sale in the Company&#8217;s Condensed Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702369752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring, Impairment, and Related Costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2021 consisted of the following: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs related to optimization programs in Canada as well as the transition to a partial remote work model and the U.K. operating model and cost optimization efforts both described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2020 consisted of the following: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with an operating model and cost optimization initiative and with the relocation of the Company&#8217;s corporate headquarters. Both of these initiatives were substantially completed in the year ended March 31, 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above, and an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with an operating model and cost optimization initiative and with the relocation of the Company&#8217;s corporate headquarters. Both of these initiatives were substantially completed in the year ended March 31, 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring and Asset Impairment Charges</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the nine months ended December 31, 2021:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#8220;Other accrued liabilities&#8221; and $52 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of December 31, 2021, the total reserve balance was $144 million, of which $52 million was recorded in &#8220;Other accrued liabilities,&#8221; $44 million was recorded in &#8220;Liabilities held for sale,&#8221; and $48 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702413192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2021 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2020 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702265688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computations for basic and diluted earnings per common share</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,052)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,204)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.79&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.29)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units, performance-based restricted stock units, and performance-based stock units.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334697820664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of changes in the carrying amount of goodwill</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:26.212%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.681%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Remaining goodwill for this segment primarily relates to the McKesson Canada reporting unit.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of information regarding intangible assets</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,718)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,061&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,931)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,130&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,768)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes net intangible assets of approximately $452 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; This amount was included under the caption &#8220;Assets held for sale&#8221; in the Condensed Consolidated Balance Sheet as of December 31, 2021. Amortization of these assets ceased upon classification as Assets held for sale in the second and third quarters of 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702236264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,518&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,406&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term debt of approximately $5 million and $12 million, respectively, as of December 31, 2021 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Condensed Consolidated Balance Sheet as of December 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702383576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of information regarding the fair value of derivatives on a gross basis</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.206%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702265128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.903%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334700473432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock', window );">Schedule of Estimated Accrual Liability</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for opioid-related claims of governmental entities is as follows as of December 31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This amount, recorded in &#8220;Other accrued liabilities&#8221; in the Condensed Consolidated Balance Sheet, is the amount estimated to be paid prior to December 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14472-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14453-108349<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14394-108349<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334787110552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss), including noncontrolling interests and redeemable noncontrolling interests, by components for the three and nine months ended December 31, 2021 and 2020 are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,557)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,665)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,555)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,655)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the three months ended December 31, 2021 include gains of $23&#160;million related to net investment hedges from Euro-denominated notes and losses of $2&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $5 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,555)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,655)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the nine months ended December 31, 2021 include gains of $34&#160;million related to net investment hedges from Euro-denominated notes and gains of $3&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $10 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,597)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the three months ended December 31, 2020 include losses of $84&#160;million related to net investment hedges from Euro-denominated notes and losses of $45&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $33&#160;million.</span></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8317;&#178;&#8318;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts recorded in the nine months ended December 31, 2020 include losses of $201&#160;million related to net investment hedges from Euro-denominated notes and losses of $108&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $80&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702381640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.260%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,614&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,864&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,086&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(668)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,363)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,063)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 40% of the RxTS segment&#8217;s total revenues, less than 4% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than 8% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three and nine months ended December 31, 2021 includes $33 million and $79 million, respectively, and for the three and nine months ended December 31, 2020 includes $11 million and $115 million, respectively, of credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. The nine months ended December 31, 2021 includes $46 million of cash receipts for the Company&#8217;s share of antitrust legal settlements. The nine months ended December 31, 2020 includes a charge of $50 million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s Opioid Stewardship Act.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the nine months ended December 31, 2021 includes $164 million, and for the three and nine months ended December 31, 2020 includes $35 million and $49 million, respectively, of inventory charges on certain personal protective equipment and other related products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three and nine months ended December 31, 2021 includes charges of $787 million to remeasure assets and liabilities of the U.K. disposal group to the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; The three and nine months ended December 31, 2021 includes charges of $58 million and $400 million to remeasure assets and liabilities of the E.U. disposal group to the lower of carrying value or fair value less costs to sell and to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; The nine months ended December 31, 2021 also includes a gain of $59 million related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business. Operating loss for the three and nine months ended December 31, 2020 includes restructuring, impairment, and related charges of $131 million and $189 million, respectively, driven largely by long-lived asset impairment charges of $115 million primarily related to retail pharmacy businesses in Canada and Europe as well as costs associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and a second quarter goodwill impairment charge of $69 million related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 7, &#8220;Goodwill and Intangible Assets, Net.&#8221; The three and nine months ended December 31, 2020 also includes charges of $47 million and $57 million, respectively, to remeasure to the lower of carrying value or fair value less costs to sell the assets and liabilities of the Company&#8217;s German pharmaceutical wholesale business which was contributed to a joint venture.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the three and nine months ended December 31, 2021 includes credits of $32 million and charges of $117 million primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; Corporate expenses, net for the nine months ended December 31, 2021 also includes charges of $193 million related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221; The three and nine months ended December 31, 2021 includes $33 million and $104 million, respectively, and the three and nine months ended December 31, 2020 includes $34 million and $118 million, respectively, of opioid-related costs, primarily litigation expenses. Corporate expenses, net for the three and nine months ended December 31, 2020 includes a charge of $8.1 billion related to the estimated liability for opioid-related claims, as discussed in more detail in Financial </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, &#8220;Commitments and Contingent Liabilities.&#8221; The nine months ended December 31, 2020 also includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for the nine months ended December 31, 2021 includes $104 million and for the three and nine months ended December 31, 2020 includes $30 million and $89 million, respectively, of net gains associated with certain of the Company&#8217;s equity investments.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for the nine months ended December 31, 2021 consists of a charge of $191 million on debt extinguishment related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 8, &#8220;Debt and Financing Activities.&#8221;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334702350728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334694558104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale - Narrative (Details)<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 20, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 20, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Nov. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 01, 2021 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Jul. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 05, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">$ 5,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">4,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="nump">879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember', window );">Austrian Business Operations | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected', window );">Gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 257<span></span>
</td>
<td class="nump">&#8364; 226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net assets held for sale</a></td>
<td class="nump">290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Disposal Group (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="nump">823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected', window );">Gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 440<span></span>
</td>
<td class="nump">&#163; 325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue', window );">Accumulated other comprehensive loss in charge for remeasurement to fair value</a></td>
<td class="nump">731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember', window );">German Pharmaceutical Wholesale Business | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected', window );">Gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">&#8364; 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue', window );">Accumulated other comprehensive loss in charge for remeasurement to fair value</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Expected</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334698966696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale - Assets and Liabilities Held for Sale (Details) - Held-for-sale<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities', window );">Long-term debt</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Disposal Group (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net</a></td>
<td class="nump">1,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="nump">698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant, and equipment, net</a></td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent', window );">Operating lease right-of-use assets</a></td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent', window );">Other non-current assets</a></td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of business held for sale to fair value less costs to sell</a></td>
<td class="num">(822)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="nump">1,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">1,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent', window );">Other non-current liabilities</a></td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="nump">2,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net</a></td>
<td class="nump">1,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="nump">913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant, and equipment, net</a></td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent', window );">Operating lease right-of-use assets</a></td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent', window );">Other non-current assets</a></td>
<td class="nump">348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of business held for sale to fair value less costs to sell</a></td>
<td class="num">(387)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="nump">3,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">1,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities', window );">Current portion of long-term debt</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities', window );">Long-term debt</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent', window );">Other non-current liabilities</a></td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="nump">2,321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember', window );">Internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware', window );">Impairment charge</a></td>
<td class="nump">$ 113<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334691412328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Restructuring, impairment, and related charges recognized</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">$ 271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment, Long-Lived Asset, Held-for-Use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember', window );">Restructuring Plan - Remote Work Transitioning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember', window );">Restructuring Plan - Remote Work Transitioning | Minimum | Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember', window );">Restructuring Plan - Remote Work Transitioning | Maximum | Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember', window );">Operating Model and Cost Optimization Programs | International (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334693698552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges, Including Accelerated Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetImpairmentChargesIncludingAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334694120632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other accrued liabilities, noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334694441864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit) related to continuing operations</a></td>
<td class="nump">$ 238<span></span>
</td>
<td class="num">$ (1,189)<span></span>
</td>
<td class="nump">$ 396<span></span>
</td>
<td class="num">$ (1,011)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Reported income tax expense (benefit) rates (percent)</a></td>
<td class="nump">85.90%<span></span>
</td>
<td class="nump">16.10%<span></span>
</td>
<td class="nump">30.90%<span></span>
</td>
<td class="nump">16.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,271<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount', window );">Discrete tax benefit recognized due to GILTI</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncomeTaxExpenseBenefitDiscreteItems', window );">Discrete tax benefit recognized due to temporary difference arising from buyer's excess tax basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would reduce income tax expense and the effective tax rate</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Discrete tax benefit recognized due to statute of limitation expirations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax', window );">After-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">$ 6,700<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="nump">879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupAndAustrianBusinessMember', window );">U.K. and Austrian Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="nump">$ 853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Global Low-Tax Income, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeTaxExpenseBenefitDiscreteItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit) Discrete Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeTaxExpenseBenefitDiscreteItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupAndAustrianBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupAndAustrianBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334695055768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 12, 2021 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 19, 2018 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right redemption price per share (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 23.50<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PutRightValueInterestRateSpread', window );">Put right value, interest rate spread (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePriceIncrease', window );">Increase in put amount (in Euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments for purchase shares of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,031,000,000<span></span>
</td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,271,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">46,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="nump">136,000,000<span></span>
</td>
<td class="nump">152,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Decrease in noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">983,000,000<span></span>
</td>
<td class="nump">49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,292,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,292,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,271,000,000<span></span>
</td>
<td class="nump">$ 1,265,000,000<span></span>
</td>
<td class="nump">$ 1,402,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">$ 46,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000,000<span></span>
</td>
<td class="nump">128,000,000<span></span>
</td>
<td class="nump">120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests', window );">Annual recurring dividend (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments for purchase shares of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased', window );">Shares purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.5<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue', window );">Maximum redemption value of redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage (as a percent)</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember', window );">Vantage and ClarusOne Sourcing Services LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">$ 46,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,000,000<span></span>
</td>
<td class="nump">$ 128,000,000<span></span>
</td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Recurring Compensation Per Share to Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PutRightValueInterestRateSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Put Right Value, Interest Rate Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PutRightValueInterestRateSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interests, Maximum Redemption Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334693889928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">484<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">487<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercises of Put Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,292<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,292<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) Due to Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestIncreaseDecreaseDuetoOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationofTemporaryEquitytoLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationofTemporaryEquitytoLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334694398904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="num">$ (6,174)<span></span>
</td>
<td class="nump">$ 885<span></span>
</td>
<td class="num">$ (5,052)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations attributable to McKesson Corporation</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(6,226)<span></span>
</td>
<td class="nump">749<span></span>
</td>
<td class="num">(5,204)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (6,226)<span></span>
</td>
<td class="nump">$ 746<span></span>
</td>
<td class="num">$ (5,205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">151.6<span></span>
</td>
<td class="nump">159.5<span></span>
</td>
<td class="nump">154.0<span></span>
</td>
<td class="nump">161.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">151.6<span></span>
</td>
<td class="nump">159.5<span></span>
</td>
<td class="nump">155.8<span></span>
</td>
<td class="nump">161.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in usd per share)</a></td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 4.81<span></span>
</td>
<td class="num">$ (32.28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="num">(0.04)<span></span>
</td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">4.79<span></span>
</td>
<td class="num">(32.29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in usd per share)</a></td>
<td class="num">(0.04)<span></span>
</td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">4.87<span></span>
</td>
<td class="num">(32.28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 4.85<span></span>
</td>
<td class="num">$ (32.29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Restricted stock units (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Restricted stock units (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334691522328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible assets</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Estimated annual amortization expense, remainder of 2022</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2023</a></td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2024</a></td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2025</a></td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2026</a></td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Estimated annual amortization expense, thereafter</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1) | Retail Pharmacy Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334691403096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 9,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">9,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">3,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">3,942<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">1,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 1,525<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334698013880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 5,061<span></span>
</td>
<td class="nump">$ 6,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,931)<span></span>
</td>
<td class="num">(3,768)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">2,130<span></span>
</td>
<td class="nump">2,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanAssetsHeldForSaleMember', window );">European Assets Held for Sale | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">$ 452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,842<span></span>
</td>
<td class="nump">3,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,718)<span></span>
</td>
<td class="num">(2,269)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,124<span></span>
</td>
<td class="nump">1,470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Service agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,083<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(558)<span></span>
</td>
<td class="num">(513)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember', window );">Pharmacy licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(244)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 816<span></span>
</td>
<td class="nump">925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(371)<span></span>
</td>
<td class="num">(394)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 445<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 128<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(113)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 192<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanAssetsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanAssetsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334694156136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 12, 2021</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
<th class="th"><div>Jul. 17, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Lease and other obligation</a></td>
<td class="nump">$ 253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="nump">5,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current portion</a></td>
<td class="nump">438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">$ 5,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member', window );">2.70% Notes due December 15, 2022 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member', window );">0.90% Notes due December 3, 2025 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member', window );">1.30% Notes due August 15, 2026 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member', window );">0.63% Euro Notes due August 17, 2021 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member', window );">1.50% Euro Notes due November 17, 2025 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member', window );">1.63% Euro Notes due October 30, 2026 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member', window );">3.13% Sterling Notes due February 17, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="nump">$ 618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 627<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334694836968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Long-Term Debt Narrative (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 12, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 23, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 17, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 17, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,956,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,956,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,148,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Long-term Debt and Lease Obligation, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 742,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 191,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member', window );">1.30% Notes due August 15, 2026 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt principal amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt issuance</a></td>
<td class="nump">$ 495,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price percentage of principal (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member', window );">0.63% Euro Notes due August 17, 2021 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt principal redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 709,000,000<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember', window );">Tender Offer Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price percentage of principal (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt principal redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 922,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Aggregate consideration of debt redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Accrued unpaid interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts', window );">Write-off of unamortized debt issuance costs and transaction fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember', window );">The 2020 Credit Facility | Unsecured Debt | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of Deferred Debt Issuance Cost and Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334698030264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Revolving Credit Facilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases', window );">Committed balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Uncommitted balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | The 2020 Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Syndicated senior unsecured revolving credit facility term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amounts outstanding under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | Canadian Dollar, British Pound Sterling, and Euros Sublimit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334694083256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Commercial Paper (Details) - Commercial Paper - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Outstanding notes (up to)</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Proceeds from issuance of commercial paper</a></td>
<td class="nump">3,600,000,000<span></span>
</td>
<td class="nump">$ 5,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of commercial paper</a></td>
<td class="nump">3,300,000,000<span></span>
</td>
<td class="nump">$ 5,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermCommercialPaperCurrent', window );">Commercial paper</a></td>
<td class="nump">$ 372,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">0.29%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermCommercialPaperCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermCommercialPaperCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334694407080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Narrative (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Cash contributions to the plans</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedPercentage', window );">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.K. Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Cash contributions to the plans</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Held-for-sale | European Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation', window );">Reclassified pension liabilities</a></td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of plan assets to benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as defined benefit plan benefit obligations attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=mck_UKPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=mck_UKPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334694574568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Narrative (Details)<br> &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Nov. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gains (losses) on cash flow hedges</a></td>
<td class="num">$ (6,000,000)<span></span>
</td>
<td class="num">$ (12,000,000)<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="num">$ (36,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) from net investment hedges recorded within other comprehensive income</a></td>
<td class="nump">23,000,000<span></span>
</td>
<td class="num">(84,000,000)<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="num">(201,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember', window );">Forward contracts to hedge Euro against British Pound cash flows | Derivatives not designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Derivatives used in net investment hedge, gains (losses) gross</a></td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="num">(45,000,000)<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="num">(108,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | November 2018 Cross Currency Swaps | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gains (losses) on cash flow hedges</a></td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="num">$ (14,000,000)<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="num">$ (42,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency swap | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward starting interest rate swaps | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">&#8364; 600,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A2025NotesMember', window );">2025 Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334693903080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Derivative Instruments Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Prepaid expenses and other/Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">570<span></span>
</td>
<td class="nump">826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Other non-current assets/liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">2,205<span></span>
</td>
<td class="nump">2,663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Forward starting interest rate swaps | Other non-current assets/liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar, notional amount, liability</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Forward starting interest rate swaps | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar, notional amount, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting | Foreign Exchange Contract | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar, notional amount, liability</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting | Foreign Exchange Contract | Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_NoncurrentAssetLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_NoncurrentAssetLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_OtherAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_OtherAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334701042232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 358,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gain (loss) on equity investments</a></td>
<td class="nump">$ 28,000,000<span></span>
</td>
<td class="nump">104,000,000<span></span>
</td>
<td class="nump">$ 87,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair value, inputs, level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Investments in money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334703721272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details) - Recurring - Fair value, inputs, level 2 - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount of liabilities</a></td>
<td class="nump">$ 5,956<span></span>
</td>
<td class="nump">$ 7,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of liabilities</a></td>
<td class="nump">$ 6,376<span></span>
</td>
<td class="nump">$ 7,785<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334688359128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 28, 2022 </div>
<div>USD ($) </div>
<div>distributor</div>
</th>
<th class="th">
<div>Jan. 25, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 24, 2022 </div>
<div>USD ($) </div>
<div>distributor</div>
</th>
<th class="th">
<div>Sep. 28, 2021 </div>
<div>USD ($) </div>
<div>distributor</div>
</th>
<th class="th">
<div>Sep. 20, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 21, 2021 </div>
<div>USD ($) </div>
<div>distributor</div>
</th>
<th class="th">
<div>Jul. 20, 2021 </div>
<div>USD ($) </div>
<div>distributor</div>
</th>
<th class="th">
<div>Apr. 16, 2013 </div>
<div>state </div>
<div>relator </div>
<div>defendant</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>case </div>
<div>state </div>
<div>stateAttorney</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 26, 2022 </div>
<div>territory </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 04, 2021 </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>investmentFund</div>
</th>
<th class="th">
<div>Dec. 29, 2017 </div>
<div>investmentFund</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax', window );">After-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">$ 6,700<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Total litigation liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStates', window );">Number of states in which court cases are pending | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other national distributors named in suit | distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfDefendants', window );">Number of distributors | distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment', window );">Portion of settlement award to be used by state and local government for remediation (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfEligibleStates', window );">Number of eligible states | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Settlement payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStates', window );">Number of states in which court cases are pending | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfEligibleStates', window );">Number of eligible states | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfTerritories', window );">Number of territories that have joined the proposed settlement agreement | territory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Settlement payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | State of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other national distributors named in suit | distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | State of Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other national distributors named in suit | distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other national distributors named in suit | distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementPaymentTerms', window );">Payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | State of Rhode Island | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other national distributors named in suit | distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | State of Florida | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other national distributors named in suit | distributor</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="nump">$ 530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other national distributors named in suit | distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementPaymentTerms', window );">Payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member', window );">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfInvestmentFundsThatFiledClaims', window );">Number of investment funds that filed claims | investmentFund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember', window );">United States ex rel. Piacentile v. Amgen Inc., et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfRelators', window );">Loss Contingency Number of Relators | relator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfAdditionalDefendants', window );">Loss Contingency, Number of Additional Defendants | defendant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfStatesFiledOnBehalfOf', window );">Loss Contingency, Number of States Filed on Behalf Of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation | Governmental entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation | An individual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember', window );">Three Largest U.S. Pharmaceutical Distributors | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Period over which award would be payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | State of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | State of Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | State of Rhode Island | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | State of Florida | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember', window );">Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStates', window );">Number of states in which court cases are pending | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStateAttorneyGenerals', window );">Number of attorney generals that have filed claims | stateAttorney</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Award Amount To Be Used by State and Local Government</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfAdditionalDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Additional Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfAdditionalDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfEligibleStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Eligible States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfEligibleStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfOtherDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Other Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfOtherDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfRelators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Relators</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfRelators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfStatesFiledOnBehalfOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States Filed on Behalf Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfStatesFiledOnBehalfOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfTerritories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Territories</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfTerritories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStateAttorneyGenerals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of State Attorney Generals</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStateAttorneyGenerals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Award Payment Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementAwardPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement, Payment Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfInvestmentFundsThatFiledClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Investment Funds That Filed Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfInvestmentFundsThatFiledClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of defendants named in a legal action.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfOhioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfOhioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_CherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_CherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfRhodeIslandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfRhodeIslandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfFloridaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfFloridaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_GovernmentalEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_GovernmentalEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_IndividualClaimantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_IndividualClaimantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334704928312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details) - National Prescription Opioid Litigation<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueCurrent', window );">Current litigation liabilities</a></td>
<td class="nump">$ 1,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">7,153<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Total litigation liabilities</a></td>
<td class="nump">$ 8,213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334694972488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 23, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 22, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 08, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare', window );">Number of votes per share of common stock permitted on proposals presented to stockholders (vote) | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 728,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,008,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized repurchase amount (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Authorized amount available for future repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,332,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,332,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,987,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember', window );">Accelerated Share Repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Share repurchases (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price of shares repurchased (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember', window );">Open Market Share Repurchase Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price of shares repurchased (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223.89<span></span>
</td>
<td class="nump">$ 203.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151.12<span></span>
</td>
<td class="nump">$ 151.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 728,000,000<span></span>
</td>
<td class="nump">$ 280,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231,000,000<span></span>
</td>
<td class="nump">$ 269,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockVotingRightsNumberofVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334694049400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">$ (87)<span></span>
</td>
<td class="nump">$ 6,090<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 5,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to income statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(787)<span></span>
</td>
<td class="num">(277)<span></span>
</td>
<td class="num">(787)<span></span>
</td>
<td class="num">(277)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,665)<span></span>
</td>
<td class="num">(1,597)<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to income statement</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,655)<span></span>
</td>
<td class="num">(1,503)<span></span>
</td>
<td class="num">(1,655)<span></span>
</td>
<td class="num">(1,503)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,557)<span></span>
</td>
<td class="num">(1,512)<span></span>
</td>
<td class="num">(1,361)<span></span>
</td>
<td class="num">(1,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="nump">363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to income statement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,555)<span></span>
</td>
<td class="num">(1,329)<span></span>
</td>
<td class="num">(1,555)<span></span>
</td>
<td class="num">(1,329)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(25)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(96)<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="num">(229)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to income statement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(96)<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="num">(229)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(96)<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(84)<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="num">(201)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax | Cross Currency Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to income statement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(104)<span></span>
</td>
<td class="num">(116)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to income statement</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (106)<span></span>
</td>
<td class="num">$ (97)<span></span>
</td>
<td class="num">$ (106)<span></span>
</td>
<td class="num">$ (97)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334699067768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Narrative (Details)<br> product in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment </div>
<div>business_operation </div>
<div>product </div>
<div>country</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1) | Operating Segments | Disposed of by sale | Canadian Health Benefit Claims Management and Plan Administrative Services Business</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Pre-tax gain on sale of business | $</a></td>
<td class="nump">$ 59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfNationalBrandMedicalSurgicalProducts', window );">Number of national brand medical-surgical products offered (more than) | product</a></td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe | International (1)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which entity segment operates | country</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfBusinessOperations', window );">Number of business operations | business_operation</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfBusinessOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Business Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfBusinessOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfNationalBrandMedicalSurgicalProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of National Brand Medical-Surgical Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfNationalBrandMedicalSurgicalProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140334692506456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Reportable operating segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 68,614<span></span>
</td>
<td class="nump">$ 62,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197,864<span></span>
</td>
<td class="nump">$ 179,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">298<span></span>
</td>
<td class="num">(7,362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
<td class="num">(6,050)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate income (expenses), net</a></td>
<td class="num">(195)<span></span>
</td>
<td class="num">(8,246)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(858)<span></span>
</td>
<td class="num">(8,462)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="nump">277<span></span>
</td>
<td class="num">(7,363)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,281<span></span>
</td>
<td class="num">(6,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Net gain on settlement proceeds</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(8,067)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(193)<span></span>
</td>
<td class="num">(7,936)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_NotesAndDebenturesExtinguishedFebruary72018Member', window );">Notes and Debentures Extinguished February 7 2018 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | U.K. Disposal Group (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="nump">823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | European Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="nump">879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,465<span></span>
</td>
<td class="nump">2,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Gains associated with equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_ShareholderDerivativeActionInsuranceProceedsMember', window );">Shareholder Derivative Action, Insurance Proceeds | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Net gain on settlement proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">55,041<span></span>
</td>
<td class="nump">49,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,471<span></span>
</td>
<td class="nump">142,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">744<span></span>
</td>
<td class="nump">635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,186<span></span>
</td>
<td class="nump">1,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments | New York Opioid Tax Surcharge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Antitrust Legal Settlements | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Company's shares of legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,031<span></span>
</td>
<td class="nump">777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,844<span></span>
</td>
<td class="nump">2,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 361<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">3,082<span></span>
</td>
<td class="nump">3,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,734<span></span>
</td>
<td class="nump">7,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 679<span></span>
</td>
<td class="nump">536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory impairments and excess inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">9,460<span></span>
</td>
<td class="nump">9,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,815<span></span>
</td>
<td class="nump">27,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment, Long-Lived Asset, Held-for-Use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1) | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="num">(668)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (761)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1) | Operating Segments | Held-for-sale | U.K. Disposal Group (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="nump">787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1) | Operating Segments | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1) | Operating Segments | Disposed of by sale | Canadian Health Benefit Claims Management and Plan Administrative Services Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Pre-tax gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International (1) | Operating Segments | Contributed to Joint Venture | German Pharmaceutical Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CorporateOperatingExpenseandOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expense and Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CorporateOperatingExpenseandOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenueDerivedFromServicesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Derived From Services, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenueDerivedFromServicesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_NotesAndDebenturesExtinguishedFebruary72018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_NotesAndDebenturesExtinguishedFebruary72018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_ShareholderDerivativeActionInsuranceProceedsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_ShareholderDerivativeActionInsuranceProceedsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_AntitrustLegalSettlementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_AntitrustLegalSettlementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanPharmaceuticalWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanPharmaceuticalWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>mck-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mck="http://mckesson123.com/20211231"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mck-20211231.xsd" xlink:type="simple"/>
    <context id="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i42c76eb99b0a4559a5de3adcd86f6edd_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6b63e34ea5fd40c091185d9028f7ce9e_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i88eff9c3909e492a8890b0de1ca7a9a6_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i653ff56b96724c2aad5d2fedce9f8538_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i489f4fe3b29441a9ac0c65293e1fd406_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icea0af673fff48e587087205a66d4ec0_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58ce6c4148614409980f63a506b7650f_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iafc802238be540dba818f29ae266827f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i439966e71d2144ef842f55e3776ff357_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8436ab31a1f04277a0978cc5082487d6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i700f01544539495e9ffcc43f6df2519a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1be4875f550d4562b96d61a975ce1384_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ida99689579c54617a262daa0e8430ed6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i68c571fe607348cdab2a44a5f011467b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib1ad330dab834c37a1beaf31343ccddc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic47507086542449a87995a47b6731b7a_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b2766918b80463a9b60d65600e7b809_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2b8216d3c52941658551f660f72d6248_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icd7e5ba6748444768519a57ab6d455e1_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i51890ebfb4e6484b85eee1fcde455801_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iccaf4a3f07d140fa8a374c7d818db2c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2dc60e1226cd4fcfbed4ac8715e43490_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib041b764acbd496ba6cd257448c9a6ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i954d5ded78d141c1aab9b2f0e240b4e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic820959a12ab4a0bae3278102cbe3604_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0187d0ab0c2b497ba13eb86f09ee7b1d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icea0e96cfe3d44cabedc838f2e613c8f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia38d606928fc4b3db6f2c28bb6975efc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9bf3b3d119214ddc994b0fa424595480_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5708808d3fca428a8db75e932c0ab1ed_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6da59171484d4afba5f49534b2709456_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7b44821ac2c64fd7ab23957aaf69ef0e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i29dac400581c4ad0a015f1f22afc419d_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i395b68d034cb497d9e909bd37a723bb3_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie535baeb0dd347cd978917e66bf4f610_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id8bdea9022ea4c33963371f1d4922ff7_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c35edcf7a034a8083f41df320050fd4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic093d490b58f4f6da8f7e05176f1fcb5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i44427056526c458db776d32cda88d623_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i19c25b891e2446a6bab4b8ee69b28057_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d421e0224fb47f8b7a8dc9b60947bdb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i64318d5dd9f1472c90248ebb8e0becbf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i92b029a90e9640e6a41de2c763149aec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iacce3d46e1114af0a96f49bb08fb9657_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1d4a47e592514d34b5bd2a736f25f14e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i140e091483a24a50921565a4f50f0bc6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibd1f982f3f4042c9badc91a36fff0cc1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id250b6c030544199b7220d3a2aca9cc0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic0d467e35eb14c31bcba781b26964717_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if543dc69884c4140a12003d1148abf8b_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8b0c099b1c004a6c8a540a2430721bbb_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic9f93739e19b4aafadc89d067d383156_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i178f7de2928e404a940f4fec020ed2b2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6f5ef3a9f2864706b17af4a3663282d5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i196e981a1d044679b7aa89e65f24dc73_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iebc1818efd944fffbeda92744ddd19d5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9df402b98dd84868a1686daf16596424_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i805c937398e343ddbade7f441c4786b9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3cd3b8f0b9fb4e3b80f26f6a286a8c4c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i608ff3c7e46a422da1a3bca44aba8bb7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i746a7ab451924975842c08464b7c24d1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i705e588d2f514ff7bd717969c76affb2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3486e22c3b4e49d2a3c85ce54a4b1ef6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0bcf0ae780a4416aab58b011355b0f70_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i646e69bc99874247b6c06d6a96b329e7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0ec61b139f8d42da8e958f556f58020e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id7cfe7694bf045d993d3e0e6ac8a85dd_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib8d647cddebc42c3a78ef89fe06d1cfa_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i49683251f292481d9201d661f7720626_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4c6fe05296e94ff8845fee715825c659_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia8d1cfbcdd084d568e496e899582fa21_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie2db64a62c8943349987209b0adb60c1_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i309bd0e5ce434017a3985a239297e197_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if55a1f085e0849c78909dea0bbe21536_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9e504a0e274543e69fed9f79303ad80e_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibe12fecbb15d4762ad018564eb3bf31a_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4bc2bdbef58a40d19661323d7b54990c_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iddc5a92071754307af41a34bc9c1f1ea_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i64c3f8f2f25f4734b8e1b0d9bbbae72c_I20210705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-05</instant>
        </period>
    </context>
    <context id="i10a2699ec09f4c4a92c66ae680e3c440_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5b4ca1a6e16e4bbeb9da4a62c3265a52_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if374ea59631143b09b6e3e2a5671193c_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f779261e3804b478a035d030ffeb926_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8aadd60f8b644a8ba5a20fae10cb7b86_I20211101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-01</instant>
        </period>
    </context>
    <context id="i6c2657ec4fc04232a99ae16e23e0f399_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a2ecac161104759a17bcb76d94a2b91_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b6587768d5e4ba2b267df62494974ef_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icf6948803676498cbf4f702d46fd11ac_I20211220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-20</instant>
        </period>
    </context>
    <context id="i0914720c662a4ad59b56ab30f003e13e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i90d1e84fd58d41a08c7559556cfa6e5e_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0e0e546ae1e249039d79b3c361e64a24_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i082db05a184a45abb24328a6c95b59c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i890b4a0eb5514ad49a5ab0eda1744e3e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i278171a6be044601b82b45db97c44012_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i67f5dae20f6d49a8b3c72b65242baec8_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7ef12d06d22b408b9631eede48f318c6_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if17bd5af058345ef8f80c5f477b1769a_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6255fa153b8b446d9bdaa92a69dc6082_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie95102b563614313b48519acd3293019_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3742a9e3c767428ca709e210fa6bad34_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic0a87db44d0d4d4182e198de1c5b21c4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8294a77ec53f4808af02d30170fb109a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iaf0b19c69df049fa808f63371bd26ec9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i05d03e41b9ee4dcd81af0575a30e3f45_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7bd134a4f3094ace932c748910dea417_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa2ddeb82199484c81ead365111b0450_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80e1a134cedf416a93e2147fb33ab4a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id8490ed3cfc74500b6dec809af6c38fb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic0f61357f5234a798f4dce41029f5202_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5673a7452c840fab96c68406dedc263_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3a02716128214d2eb9f7820b420c8182_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia211c26831c34274a5c1964a280c0daf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i74ddcf1aa661488db155891acc773561_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i009f49e0941d419aa250d05631fa2fba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c351ccf073b47a9b3c10a8e07901940_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i53948167a7da4f68be6121c6d4840331_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i262128f4e5f940ada5343a7bf5fe0a97_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupAndAustrianBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f49b1ee7cfe4b72a4014ddd42947be3_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupAndAustrianBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6b6bcdc79602464fb68d237e91f2c420_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i96393cf84f184dd1a34604191f7e8463_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i45576a15c2784ff6aa60281bbbd7fc94_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i36b8a9d0b6414497bb8f44ec79a79e4f_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i36e918c6183c4f78895df724b9cd04c0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6ba029fe46a542dfbd04dc832ae15366_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifd6ba103380e4fe88bf3646afc1959fd_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i29833bf67ca6476e970b86ed97f2e301_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i74388bba79ec4594ae5515983a877ddf_I20180919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2018-09-19</instant>
        </period>
    </context>
    <context id="i92bc310247354b8c924fe8c7f5b5b506_I20210412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-04-12</instant>
        </period>
    </context>
    <context id="ic3993b3a21a449f38c8b6792da95b13e_I20210412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-12</instant>
        </period>
    </context>
    <context id="ic547f16da1eb490b8049506b5f0658f0_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a074287e0774fecbde0c96584206770_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4eb5d4844c44421d8fe111518bf52e1d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib9fe220da3a84c2a9f05f0cdd2906fd0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id82faee2169b4c03851f9e48fd63456a_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaa26af6e2fc04c6da537c566605c6805_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd14b94896e64108be04ae3457f1a609_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i13af6ba5a424438aa3988581a89555a8_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6c40279fd2ae42f882d256f241b6eeb9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icfbf1847be9645d4a2fcb3f516d062d2_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i00c5c61ba79d490583932b1ea0ae6fee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i966a1c60d7794ac19c4b0482afbd9d63_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie38d6747b6b2440cb19da83a637e8e0c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie23170f25899482c8fb14218e9b36811_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iad4dcc2e71484863b95577492db41418_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f407b53967e488c8979843a9f2e0587_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i31bf4f7d1a23482c831cafb66e4eeb11_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia20f2ae234824563aaf020230203bc95_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i85920522622d4e87a1778b8915896cd9_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i429c33e0c248436d9d40564788aef7cc_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i17e68fc5432d42999abbd9cfb84788b2_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibd7d6c6918264060a11449cce87c8a74_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c44d406842b4dfd9be43d9417c45d16_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5aad64ed07e840d48b824f939696d040_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic4a94e99c27749f9bb0cdf58b9fb0d21_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic904723c4ba64a05ae420a0be5054017_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1152c87f165d4441a106e92fb010eee7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia5b0a5563e78433e81c99f7828894e50_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idd869a8aa917470b91d673083a1c9728_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifcceb81b10094fe38a52a708698e8e26_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id4fff6966c2f4bf68a5a99a525be017b_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id8581c40a6994c56adbfa16cef30adce_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibbe27bfd9e2c41d58630861c22b41289_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i32326b7bf53a4dd384901e9903f9bba5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd6a711404a649daa658dfed92674336_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d3dae03307347b1aaa7f9adb1a1146e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c38b50f2e6d4df48e12878cd04a1f29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5940c64b0f72408a95d2a120f5c0cb9d_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib25c56b1dc1542b8b6cba0c5909ee061_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f9282a1be1949719baad2d71826d505_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i74ed405c42b74c4389c3f91f5005ff7a_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id5ddfbf05bb24ccba4c97a3aa8391604_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec8b0c080d464091895e0a8629dc3b8f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4867f847dac14e859a18453f84be838e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie340410ba12c44e9911705e385d3b53b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icb766b9c9d944af29da2f7e212da9b0f_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6350e24aa5bc4ecdb728677b7257e206_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e6e140e0372458c969bb39e40eb721e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iaa5fb8b105594c8e8a3005b94b561d93_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iabb0392b7148487bb4a2f65bf6026803_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93c95e7a4b934ef38d46deb03522e7e9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7552b3f9fefa4753841e20f4ee183f59_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib39a321c4bcc4b6cb3698d1b56855f45_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i373201c35c334793a8e487531dd13808_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia5f3b27c39db4b379168925a74818f88_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanAssetsHeldForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8746bc225334425396ca59f548e37a0b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e16308e8f8a44b0b56714da70bdba87_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3131096ca12e4ff79f710ef33e1fad9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4460ad7ee7034da6ab6577545bb4e0db_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia93f81c5e6b04232b2292683ca038221_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if114852dcd424e71925af80e34de7a6c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if3719b3f8d244ac494c2824c0832d07e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9174bf78e06c4f3d84ca5ac5c9b2aba5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1f726c763f9a479b8e540f1c1a4b7bfe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icfaf4e782dc9445ab195eab4ffe8ab10_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8f67c3e22d524b2bb83fd6759a331308_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia28dcbf6b06649eb9dff2cfa25450e96_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1e57c87f990a465aa51e7b583931c71c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i88366d3c093b4dc49a21a6e0db895a8d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i02cb6f0f6a454110948073b47a98653b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i586efb75ab5d463cb59b296f08231f94_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icc040bd3b61f4ac2897cb464802aff8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1d47528c190644909c718b0fb28a8991_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i18921a55bfdb4914912bf2fcd15ae90c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i109f3a112c2942a89945755f920801f5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic9237fc120ce474f8df6c1ab559748c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idce1a776f3f4491eaecf73c69740b2c1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib02bd64fd220450cb919b052658bd225_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i980877648a26404c9f3f88facfab3a12_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i594a4fdaee3b4bb29cfb65eb877bdf18_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd138e409b7b4f81be9450bcf3b931dd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i40926358e8e740acb1b20bcaef8dbb44_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ca68483b5e748d296466ae242322a5b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i792e3f3cd2194564994f887fa0311091_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i069e5020023e41c2aedab80fbb7726b6_I20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="i8dde3db75bc9423db7d08caf0b284aa7_D20210812-20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="i6122fb9648ed4fbf9da45b3e8dd631d2_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i31809c12d9a9402ea8b76662fed12284_I20210717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-17</instant>
        </period>
    </context>
    <context id="icd10c718453c405e97d6ad84b80e8fc1_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i64f43622e576465e9b38ab4c248303f2_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ia80e8f219b104e7b8095a386e548a730_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ibfb5001dc67f4f8a896d6c6104d869ab_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i610e62fc020849aaa1514bb64ecea83d_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i04a21be0ee8945e1bc0d1cb119b3e6dd_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i8fbbaa7c754d4333bc9a4584cc99c906_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="icbb3c18dcf864424ae20c2a6f59a05a6_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="i41cdbb2354254500bac2539b51ef63ea_I20190925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-25</instant>
        </period>
    </context>
    <context id="i4fde2411c1644621b3365876316b4cbf_D20190925-20190925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-25</startDate>
            <endDate>2019-09-25</endDate>
        </period>
    </context>
    <context id="i8665153941be4bb7b02bd203a47d4f00_I20190925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-25</instant>
        </period>
    </context>
    <context id="ia0f0596aa0084e20afa89597288e93c4_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b04286cc90b410990ef32577b13b1cf_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5854b4d082a04d84aa8c864577be8b31_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i07aa03a3cf46464cbc26feec1d3d32c1_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6953458f6f674d6ab890f86f4cd4f38e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0dafe850daa44ba092c57047f0ce2877_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i89b9210a5ce84d4c8f57ef708a9e06d0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibb82d8e0e0254d2e8fef071a792829d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if95be6cfe924456c8da8cea9e5d5e974_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ief157ea0a56249a692efe8e3d4607fa5_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie1fc9c20fe7d4693bf05d2692768da1f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3f3051bdb38143259288f549f974a0e9_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i090754fc8e614e6bbad26c7f79ea2655_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3fd478d8076c43f6abb4a6dd08e769d8_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4730e8d997974abd8395c6ed22b656fe_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if2d4d8bd24764afda92f5b33e18eec02_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:UKPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2b06140a4e4b45c08325af13b9477bc5_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:UKPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i96f5c70408574f04b15b2f7ec7679bb4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a47389171bb414193fe6314b964f7fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e8c8f89b9ff413690a3a67eb1468bb1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7ed6b36701e4a04bfe99fe455ef93a9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic3f95e7d8ccb40f9b9eb2820e1c96850_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib56a0acb015f42a9b6db7d566e4d694a_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id0fb12228284472bb3616ebca5add51a_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c56745c1ad842ad90cf4a2cd11ebec9_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i306448d022c44df8b4a9d9a3a303bd36_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4fd28eaef6c94a969cb3718719b09b86_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id80470ece115487a90c8e9f0d8fa5909_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0562d50847594e68a2ad757563e23331_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if413ab2045f7407d94fd20c0c60e1710_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i096c4c0268604806b329bdf3f18855cc_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if0efacf445fc46d1b3325b78010882fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab7a4eb1e70b4fa1b361a9b44cd85bf4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29742682b8ef4a26affbcf74cb0801e1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i65f089e2f1a9456e92ea3681ece4ea46_I20200427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-27</instant>
        </period>
    </context>
    <context id="ic0079095dff44d82a99df4fa0de3968c_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A2025NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i759ece90e4a84418bd88eef741535d3a_I20211104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-04</instant>
        </period>
    </context>
    <context id="i32ba2d1a45c445c583e6de9a264e133b_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i17d15431fbc54c0ca88b62ba4fa8a2af_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieddd952970aa4ffdac4cb0616cd91e55_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib0f2aab0d3e545aeb80528ab93b0610b_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3cccab8b5e8e4f7eb85e366050dd0c6e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i31ea48b5b7c94d91be10ded715dc2ed7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i91a4aa2234e64d5492f8ae8c66bf803a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i952999021b6746f7bb3d33905898d07e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if9e7d0745bdf49c39fe6e13e746c332d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i61fc3b32631340948c814ea6d7f2e4bd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i24f081c15f3b4160a10acf6eb389de1b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i319b6b970e834bb696c416ea5807f857_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1586fe22fd6646a0a008cea296ca2866_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i90925257b3bd4257846aefcd6879fc30_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i44441409ce5e4ca6988aff06c61dae4f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie3caf14c9bd64234ba322f53161f25e5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1e6556feb6b14585bc7a63dbc68b457d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1fcadcad601441e0af45b696a5ae82cb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i547bb2984de34a9496536b9a8f7fb1d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieac471f0e5ea44638e9f45f235e28103_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i63bb1d026acc4fe6bdcd0573dcf77353_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i57cdcb90e9d24ccb8237b2d0adc78da8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie81c569998f846eabdd329f198f8fb80_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if71186c9249547a6bb4645f7ef5e00bc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i058558a97c0745aaadbecc089580e6ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5fd50078c2b473ba6fa21c1d3fc3a83_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia57f313fd26c4d74b79a639aec5953e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic780468f2c1a40329586136abdfe217f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3b6ebdeadc4946d3be80756e21be72d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic4f1a5ddaf4d4944b94efda2a00dba4b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if18621054cc940498e59d84996888935_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c8b3f7cefb949109e7eb1c36b7d7bc5_I20210721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-21</instant>
        </period>
    </context>
    <context id="i29032cc93762461290c629af975e89f1_D20210721-20210721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-21</startDate>
            <endDate>2021-07-21</endDate>
        </period>
    </context>
    <context id="iccc8e044a04f4f06a7102fd769862177_D20210721-20210721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-21</startDate>
            <endDate>2021-07-21</endDate>
        </period>
    </context>
    <context id="i63ddda3383cb497a8aa380352d746509_I20210904">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-04</instant>
        </period>
    </context>
    <context id="ie1bd51abcbd045cd983975696083a0d4_I20220126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-26</instant>
        </period>
    </context>
    <context id="i4c5fee0b311f4c85ad63d103f1e8aa63_D20210920-20210920">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-20</startDate>
            <endDate>2021-09-20</endDate>
        </period>
    </context>
    <context id="i649beb76d86943469243e3ece439fa07_D20220125-20220125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-25</startDate>
            <endDate>2022-01-25</endDate>
        </period>
    </context>
    <context id="i6421afdc7756406892c7733f92c74bf9_I20210720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-20</instant>
        </period>
    </context>
    <context id="i9571ebfcfb4243d4b7416b6bf1f52242_D20210720-20210720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-20</startDate>
            <endDate>2021-07-20</endDate>
        </period>
    </context>
    <context id="if2de5ab2204a4239a0132d31018e9977_D20210720-20210720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-20</startDate>
            <endDate>2021-07-20</endDate>
        </period>
    </context>
    <context id="iad569f2cde004174b037e2447153313c_I20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOhioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="i4cac7c85628448f5aeb6a8aa1a8dd896_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOhioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="i5dccdea006cd4f81805e1bde772196ee_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfOhioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="i82197fca02554991b73acbc4d68ccac2_I20220124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfRhodeIslandMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-24</instant>
        </period>
    </context>
    <context id="ic684bd89db914674b6775e7c4d69f963_D20220124-20220124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfRhodeIslandMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-24</startDate>
            <endDate>2022-01-24</endDate>
        </period>
    </context>
    <context id="i643abe1e48c24a8aa9d02dfbe10b9c8c_D20220124-20220124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfRhodeIslandMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-24</startDate>
            <endDate>2022-01-24</endDate>
        </period>
    </context>
    <context id="i7c604a712f64457faf00ef87a115fbda_I20220128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfFloridaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-28</instant>
        </period>
    </context>
    <context id="i2df648f57fa54b56a5008f3783b93493_D20220128-20220128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfFloridaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-28</startDate>
            <endDate>2022-01-28</endDate>
        </period>
    </context>
    <context id="if78131496b944f1cae74e5708bfd519c_D20220128-20220128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfFloridaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-28</startDate>
            <endDate>2022-01-28</endDate>
        </period>
    </context>
    <context id="icdab83fc6b78425a832a4ba53f78811c_I20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="if72c9e5652044d418c8a4b5883f5f283_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="ibd87c8cd4564444caf1bfeedc9bedcad_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="id6b31bd1cab64e2aa516e6a01c17aabb_I20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="i6a960216fc5047ae9856d959b0a6c287_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="i7eaaa89dea4740b0bc8eb0ada92ff0b3_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="i85eff5aee4c3446698c4907a3978d21b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a2ded36405146879cf86872b0b24b1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16fa32e7eb8c4c528a92f587159347b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:GovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ca435af43514f1eac1c81fefbc999f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b789596251942f2bfcd923a95ccdf00_I20171229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-29</instant>
        </period>
    </context>
    <context id="ie3c0a2798de8485c9bfc70f3983c4ff0_I20171230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-30</instant>
        </period>
    </context>
    <context id="i2e0bc32bb6704e56a7596ad34859790f_D20130416-20130416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelPiacentileVAmgenIncEtAlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-04-16</startDate>
            <endDate>2013-04-16</endDate>
        </period>
    </context>
    <context id="i4e3b4356f92241a79cba33c2ed751c94_D20210722-20210722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-07-22</startDate>
            <endDate>2021-07-22</endDate>
        </period>
    </context>
    <context id="i5dfc838eb1ac450fa9327128ad95b9f4_D20210723-20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="i4651daec0fcd4008b8fbcb1cba4827c1_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i843f7e95b9d346549a854382391ff392_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="ib17c7ffbc55e498aa48c293d6f774907_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if205d6ef74be40cfa4f1e33f2e553e47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ed2ad6a9a9245ffb0210d01707cf604_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0933f1ae15e649a1b3f3599aeed9843f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1f96be18861e4831bbe49116594b08c3_I20211208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-12-08</instant>
        </period>
    </context>
    <context id="i540273ce247f4e77bcb256bd6ff2edea_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i054b314a3e2a4b9d9bc83711755c16c6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6b65ae2097be4ee9b04fbfebc350aa5c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iea19c1464fd3431fbfd6ec399c1e71c7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8f08193bb90c44f6ae9ec36df03a265a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia35d1f63c33540bea2b1ae396c7e4d9d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2a19c7ce388247dd9c4fff8563e46afd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id5033f6f00844a00b920db06167d72c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieb80f013f5b04877be046df73b8ea013_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica87d626efb840368fbbe575e025eb74_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9f90b71776b5462a8d1be5c313a0e1c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7225d41e4b98447f94299cb918d544af_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3ed06ba2cb5a4c79824d9a614fb48e1f_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5ec1ab358f1c44c4b1d28bfe361d9694_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2a7350f891f34c389f5314b093c80f47_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic4cae94d5a4343dea4571122ba91a7dd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifc95fc7008f24256bb487870b5b105be_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i884c5bc5307442deb92721feb1328c24_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iddd5269e4982442faf5d718821e185be_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idac086104fd949cabcf4563c6be329c2_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i213dfc02855e4772998e42a0ea099c76_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i70cfadc2fd5f4b4a9277df704a122f06_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i13b43080a3b24a16ae2b97ea91852b4c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic5cec83dac43442fb28746e2671aa4ef_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9f84efb755fb430185527dfc44d3694e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73ca4490ab994f9aab3a6fe25a21c69c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f489db5b4e04093bf6487d97631d28a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb666f100afe4890aa66b7e618e14266_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8ce0eeffaae46c29688d5a5b4ce0c65_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e495f371886450bba3a39c61d7905dd_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia33af281a8774481b036a38c796706ec_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76a341aced7248cd9123b95a14c8a92e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4c22952abf9142609c8c89682fe068ff_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2e78796fe5fa418093c4d5c12a166c69_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if03813c6358648a394e5872d25a93782_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1cfcd79590b140b1936d216597d97299_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic8f475edd8834ac5b7034c3816c08c6b_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5e50b6a1f79d4e56ac4b54c8d2eae50e_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice5d0a8bd1a546f9bd990cd472b21d74_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i196f51a7ced74f518fa05fcb8b2e53bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9da13a8ac8824096b8684170e319eb8c_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0a3c9d231a79420980fb15fd08fb296f_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6926dac9087a4729876428bc63b1680e_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id99d6b8c9b1d4b43b119e8ff00e3fdf7_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i538bea40557c484aac444eeb523f853a_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d5729dcafe64c6b8bf4d8ca0546c7a2_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id4d53e061fc145b591fc79c6361e5475_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if9752827ca2c41efadc1fd4270e49ff3_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27ff3ca362ce4d138f3855742853ed06_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieefe2d7dc09b481daf49a5152e7f4971_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8e45b6151afc4cf1bed1110c1034f5c6_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia429fdc9639444a39fdf735d731eed0d_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i70cbdd4364d74ecbb61747d6ff39ba0f_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i924634ae29da4f73998a60b0bbcf1083_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0c361f72849a4e38a3998abb4c3cd3d1_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i10248887c7a5482389fdac7a1610cf69_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i535080de97454a9fac988b095055839e_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:AntitrustLegalSettlementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic7b7e620d7a14950b39e853f79b975ee_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3eda82f8d025454abf73c560d50c29b3_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i826a607678f54e2a86f5a30f297b657c_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id15b966c53f8432785b54e03b4585bb3_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i83044c196239439998e7c6a17739816c_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia091e797b3e14a3f9b725a69bf843a92_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic9c32c72ede24d538c9aaaa3b64848d1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3e5e6c1fd605455eab552c5ec9e5d777_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i987a6d37125a48a0a90ff128963d4df6_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0cf49f518ed74829b2b4b51a44b670a5_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4e881354ecc94f77a5d413d65a33f8b8_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i24f8b8a283c34dc597297cbaa2899171_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifd5e0dbe10d64b948193be43501d890e_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i74f39cabd47c4d089eb231a7347761c6_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2be96b105bae4665a5c985276d810148_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5eb76a4477ee48c8a318ceb3d69a0f20_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7173dc2a4c04d2f81bcc70922723445_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ShareholderDerivativeActionInsuranceProceedsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iec63485adeb64ac4b82621f5ef551144_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesAndDebenturesExtinguishedFebruary72018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>mck:segment</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="case">
        <measure>mck:case</measure>
    </unit>
    <unit id="state">
        <measure>mck:state</measure>
    </unit>
    <unit id="stateattorney">
        <measure>mck:stateAttorney</measure>
    </unit>
    <unit id="distributor">
        <measure>mck:distributor</measure>
    </unit>
    <unit id="territory">
        <measure>mck:territory</measure>
    </unit>
    <unit id="investmentfund">
        <measure>mck:investmentFund</measure>
    </unit>
    <unit id="relator">
        <measure>mck:relator</measure>
    </unit>
    <unit id="defendant">
        <measure>mck:defendant</measure>
    </unit>
    <unit id="vote">
        <measure>mck:vote</measure>
    </unit>
    <unit id="product">
        <measure>mck:product</measure>
    </unit>
    <unit id="country">
        <measure>mck:country</measure>
    </unit>
    <unit id="business_operation">
        <measure>mck:business_operation</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80L2ZyYWc6NDljMmY4NGViNjI4NGU0M2FmZjFlZWE5ODZmMmE4MWUvdGFibGU6M2U3NjVjMTgxYTllNDhhYzhjNzQxMGNiZGM3YzIxY2EvdGFibGVyYW5nZTozZTc2NWMxODFhOWU0OGFjOGM3NDEwY2JkYzdjMjFjYV8zLTItMS0xLTQ3Mjg0_2035bfc4-e0f5-4856-873d-2387499c755d">0000927653</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80L2ZyYWc6NDljMmY4NGViNjI4NGU0M2FmZjFlZWE5ODZmMmE4MWUvdGFibGU6M2U3NjVjMTgxYTllNDhhYzhjNzQxMGNiZGM3YzIxY2EvdGFibGVyYW5nZTozZTc2NWMxODFhOWU0OGFjOGM3NDEwY2JkYzdjMjFjYV80LTQtMS0xLTQ3Mjg0_9561dd20-a794-4451-80f8-5ceb1a99c431">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80L2ZyYWc6NDljMmY4NGViNjI4NGU0M2FmZjFlZWE5ODZmMmE4MWUvdGFibGU6M2U3NjVjMTgxYTllNDhhYzhjNzQxMGNiZGM3YzIxY2EvdGFibGVyYW5nZTozZTc2NWMxODFhOWU0OGFjOGM3NDEwY2JkYzdjMjFjYV8xMS0yLTEtMS00NzI4NA_c90ac5eb-1914-4d87-91b5-5201fc6d110f">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80L2ZyYWc6NDljMmY4NGViNjI4NGU0M2FmZjFlZWE5ODZmMmE4MWUvdGFibGU6M2U3NjVjMTgxYTllNDhhYzhjNzQxMGNiZGM3YzIxY2EvdGFibGVyYW5nZTozZTc2NWMxODFhOWU0OGFjOGM3NDEwY2JkYzdjMjFjYV8xMi0yLTEtMS00NzI4NA_52b4c80a-100d-4f77-96e4-8f73f8456f78">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80L2ZyYWc6NDljMmY4NGViNjI4NGU0M2FmZjFlZWE5ODZmMmE4MWUvdGFibGU6M2U3NjVjMTgxYTllNDhhYzhjNzQxMGNiZGM3YzIxY2EvdGFibGVyYW5nZTozZTc2NWMxODFhOWU0OGFjOGM3NDEwY2JkYzdjMjFjYV8xMy0yLTEtMS00NzI4NA_8f979932-bcf3-4b3f-9f56-6555e9eb8d5e">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ5_2bd2ea44-e7de-4dcb-9cc1-1262ee9bbc91">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NGNhYjJkYzVjODAzNDgwYmIzYzQxZWI1NGU5ZjQ2M2UvdGFibGVyYW5nZTo0Y2FiMmRjNWM4MDM0ODBiYjNjNDFlYjU0ZTlmNDYzZV8wLTAtMS0xLTQ3Mjg0_a80761b7-6690-4cf5-b0da-11f6de63bd65">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18xMDk5NTExNjI5OTc4_db930471-8205-41e7-96f1-60888df446cd">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NjZkZDQ5ZWIwMWM0NGVmOThiYmRlZTBiYjE4M2RiZDkvdGFibGVyYW5nZTo2NmRkNDllYjAxYzQ0ZWY5OGJiZGVlMGJiMTgzZGJkOV8wLTAtMS0xLTQ3Mjg0_90e4204c-2e23-4121-817c-474139de0662">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQy_55f37f18-4754-4d17-97da-484b055b0011">1-13252</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ2_d8cb374b-f2e5-445b-9150-0bef4976b61d">McKESSON CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NGMwNjY5Nzk2MTZlNDM1YWExMDhlMTFmMjZkZDkxNzcvdGFibGVyYW5nZTo0YzA2Njk3OTYxNmU0MzVhYTEwOGUxMWYyNmRkOTE3N18wLTAtMS0xLTQ3Mjg0_8c31e30b-ecf5-4f34-ae01-5c148cfcb04f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NGMwNjY5Nzk2MTZlNDM1YWExMDhlMTFmMjZkZDkxNzcvdGFibGVyYW5nZTo0YzA2Njk3OTYxNmU0MzVhYTEwOGUxMWYyNmRkOTE3N18wLTItMS0xLTQ3Mjg0_22333edc-c8e3-46e5-867a-4f7c3135d350">94-3207296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQz_7098b0bd-9832-490c-b387-ca29bb332f60">6555 State Hwy 161</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ0_7865809e-b00f-42de-ac12-d1cb815802c4">Irving</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTUw_0ce21753-1073-49e5-8e9e-46c0b583b71a">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ1_653c09ed-c9e5-4f89-94b7-762f00a0e220">75039</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ3_84fbdbb9-29b6-4d5c-a658-c6f7a5b4140e">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTM4_f5a0440c-7fce-4913-a8f7-e9fbe7187f30">446-4800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i42c76eb99b0a4559a5de3adcd86f6edd_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8xLTAtMS0xLTQ3Mjg0_eb887261-af24-4dce-b4db-c755227b83a7">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i42c76eb99b0a4559a5de3adcd86f6edd_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8xLTEtMS0xLTQ3Mjg0_dbf117ef-c8fc-490a-afdf-f3ab4634b3d2">MCK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i42c76eb99b0a4559a5de3adcd86f6edd_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8xLTItMS0xLTQ3Mjg0_c1c59316-fb67-4c5c-9deb-aa39a369b842">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i6b63e34ea5fd40c091185d9028f7ce9e_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8yLTAtMS0xLTQ3Mjg0_f5feb609-c9cb-484a-95aa-90ee464faec7">1.500% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6b63e34ea5fd40c091185d9028f7ce9e_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8yLTEtMS0xLTQ3Mjg0_ff8746e7-f895-447d-b8e5-7aa40f212da4">MCK25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6b63e34ea5fd40c091185d9028f7ce9e_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8yLTItMS0xLTQ3Mjg0_8181f070-e442-4307-865d-2fcb2ba6cfa6">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i88eff9c3909e492a8890b0de1ca7a9a6_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8zLTAtMS0xLTQ3Mjg0_949af8b0-595a-424f-94ec-b62043bda40a">1.625% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i88eff9c3909e492a8890b0de1ca7a9a6_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8zLTEtMS0xLTQ3Mjg0_4b9901e8-e350-4989-b3ad-10ee3a5860e0">MCK26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i88eff9c3909e492a8890b0de1ca7a9a6_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF8zLTItMS0xLTQ3Mjg0_e830d31e-c83b-4601-98a0-9e63660facf0">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i653ff56b96724c2aad5d2fedce9f8538_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF80LTAtMS0xLTQ3Mjg0_fec4b129-6f5a-406f-b890-9b5f3a9ed397">3.125% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i653ff56b96724c2aad5d2fedce9f8538_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF80LTEtMS0xLTQ3Mjg0_2527e468-fdbd-4821-98aa-388fc3d36d39">MCK29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i653ff56b96724c2aad5d2fedce9f8538_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6NWJhMDE0NmYyMzA2NDc5YWI4ZTZhNTQ3Y2NjOTZmNWQvdGFibGVyYW5nZTo1YmEwMTQ2ZjIzMDY0NzlhYjhlNmE1NDdjY2M5NmY1ZF80LTItMS0xLTQ3Mjg0_029ab1b9-533c-410b-8276-7f89453254e6">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTM5_93293f30-b401-491b-817a-e5454a783d21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQw_a74f677e-656b-4120-93d9-67480e136f91">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6MTc3NWU4OWRiZmE2NDQ5YWFhZWUwNmUxZmY3NWM5NWUvdGFibGVyYW5nZToxNzc1ZTg5ZGJmYTY0NDlhYWFlZTA2ZTFmZjc1Yzk1ZV8wLTAtMS0xLTQ3Mjg0_b2f958ea-3d19-4379-a354-8ad0d9a10ff3">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6MTc3NWU4OWRiZmE2NDQ5YWFhZWUwNmUxZmY3NWM5NWUvdGFibGVyYW5nZToxNzc1ZTg5ZGJmYTY0NDlhYWFlZTA2ZTFmZjc1Yzk1ZV8xLTYtMS0xLTQ3Mjg0_b886cf4f-d833-4663-bef4-0437f1b3544f">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGFibGU6MTc3NWU4OWRiZmE2NDQ5YWFhZWUwNmUxZmY3NWM5NWUvdGFibGVyYW5nZToxNzc1ZTg5ZGJmYTY0NDlhYWFlZTA2ZTFmZjc1Yzk1ZV8yLTYtMS0xLTQ3Mjg0_c075d42d-ea81-4cc8-b803-a13e5d1f1acd">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMTQ4_87fa46e6-ce76-424d-8682-cc2629b4c96e">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xL2ZyYWc6Y2ZmODhiMWFiMzZiNDc2ZGIwNjNiYmNhNTg1ODg2NmMvdGV4dHJlZ2lvbjpjZmY4OGIxYWIzNmI0NzZkYjA2M2JiY2E1ODU4ODY2Y18yMDcy_535abef5-b18b-46ae-8761-387814aa461c"
      unitRef="shares">149798378</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMi0xLTEtMS00NzI4NA_238d73c6-b777-4c52-b761-42444eb686f6"
      unitRef="usd">68614000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMi0zLTEtMS00NzI4NA_01321167-a8a9-4afa-a05f-82693761eede"
      unitRef="usd">62599000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMi01LTEtMS00NzI4NA_3b19c3f1-10d3-4a39-b4e7-5c1f63326a88"
      unitRef="usd">197864000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMi03LTEtMS00NzI4NA_7b8da9ea-5908-4402-920a-d479e8f1002e"
      unitRef="usd">179086000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMy0xLTEtMS00NzI4NA_f6f5a46e-4c58-439d-9e49-0d693671a7b0"
      unitRef="usd">65186000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMy0zLTEtMS00NzI4NA_ff3ce8f5-3d75-4441-97cd-efcdef9967b0"
      unitRef="usd">59448000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMy01LTEtMS00NzI4NA_0679cd5b-672d-4a96-96d3-61a9894f8421"
      unitRef="usd">188052000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMy03LTEtMS00NzI4NA_95288156-5ec4-49c9-91f8-2c601d476b7b"
      unitRef="usd">170235000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNC0xLTEtMS00NzI4NA_0fd261c9-db27-48bb-9c45-65c98ffca4ce"
      unitRef="usd">3428000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNC0zLTEtMS00NzI4NA_132c7a79-784d-4720-946f-de6beeb5aefe"
      unitRef="usd">3151000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNC01LTEtMS00NzI4NA_061f8576-577e-4b86-bd5e-ae41e2ce79b4"
      unitRef="usd">9812000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNC03LTEtMS00NzI4NA_4a8013db-e0ee-4736-97a3-4862be429c36"
      unitRef="usd">8851000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNS0xLTEtMS00NzI4NA_72312112-d847-4e23-be1c-1699347d36ce"
      unitRef="usd">3105000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNS0zLTEtMS00NzI4NA_454d36db-bad1-4dc4-a677-e1d508d26a76"
      unitRef="usd">2291000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNS01LTEtMS00NzI4NA_b025069e-f674-4ef5-bbcc-f6c460d382ed"
      unitRef="usd">8006000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNS03LTEtMS00NzI4NA_c3d13ac6-0dfc-45bf-8892-a136bd4c4e2b"
      unitRef="usd">6625000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNi0xLTEtMS00NzI4NA_6449b9ef-9039-426a-9dff-7d92ade681d6"
      unitRef="usd">-7000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNi0zLTEtMS00NzI4NA_288aa1d9-e585-4fdd-a11d-732b1787ffba"
      unitRef="usd">-8067000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNi01LTEtMS00NzI4NA_e2de7b6e-e5a5-4f13-ae10-55eb89e1a7cc"
      unitRef="usd">-193000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNi03LTEtMS00NzI4NA_7bf3103d-16ae-4752-ad87-bdef120824b1"
      unitRef="usd">-7936000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNy0xLTEtMS00NzI4NA_643630e9-0741-40d6-baa9-7696f75a8de2"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNy0zLTEtMS00NzI4NA_3e47fbd6-2341-4763-90cf-e215c0c6ddcf"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNy01LTEtMS00NzI4NA_841f213c-0deb-4479-8b91-d8085f40dbf0"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfNy03LTEtMS00NzI4NA_15860233-13d1-447d-a102-ac268a29c588"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOC0xLTEtMS00NzI4NA_54b1ae3c-6197-44b9-8d0f-e0d0a33c25dc"
      unitRef="usd">18000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOC0zLTEtMS00NzI4NA_75175188-35d1-4200-87c2-75af8574c249"
      unitRef="usd">155000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOC01LTEtMS00NzI4NA_298973f1-8ace-41c0-b8f2-a1403028e2bf"
      unitRef="usd">208000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOC03LTEtMS00NzI4NA_d7c59dd8-24a0-440b-9a47-5060f51bb9b9"
      unitRef="usd">271000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <us-gaap:OperatingExpenses
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOS0xLTEtMS00NzI4NA_6574eb38-33d3-4a90-bd58-269044d97504"
      unitRef="usd">3130000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOS0zLTEtMS00NzI4NA_0156c6af-7f18-429b-bd41-7129226d9f76"
      unitRef="usd">10513000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOS01LTEtMS00NzI4NA_a57f56ed-3325-4a4e-b1dd-8234ce113b37"
      unitRef="usd">8407000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfOS03LTEtMS00NzI4NA_64852b83-e5ec-46c7-80ca-8d6672b52701"
      unitRef="usd">14901000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTAtMS0xLTEtNDcyODQ_88f15218-30b9-4e02-91a7-ec7116e2d480"
      unitRef="usd">298000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTAtMy0xLTEtNDcyODQ_ddb4594a-3d92-465f-ac97-76e2cff20a66"
      unitRef="usd">-7362000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTAtNS0xLTEtNDcyODQ_0eafde85-b612-4fb0-9629-b7b48f9ec0db"
      unitRef="usd">1405000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTAtNy0xLTEtNDcyODQ_bbff9c59-7d05-4b3e-9174-efb09429de65"
      unitRef="usd">-6050000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTEtMS0xLTEtNDcyODQ_883e4d23-a89b-4aa2-bc5f-6b34191cf20c"
      unitRef="usd">20000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTEtMy0xLTEtNDcyODQ_0580916d-2211-44ef-863c-eabc9c7273bc"
      unitRef="usd">54000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTEtNS0xLTEtNDcyODQ_ac3ea19f-b317-49eb-9d76-30cc2d67bc8d"
      unitRef="usd">202000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTEtNy0xLTEtNDcyODQ_4daf8d4c-bb67-4e5c-884f-785f42d1941c"
      unitRef="usd">152000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTItMS0xLTEtNDcyODQ_39007049-d274-4656-ba43-f8dcca155ce7"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTItMy0xLTEtNDcyODQ_67e7c3b2-c6e3-46e5-9ca1-781ed417040f"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTItNS0xLTEtNDcyODQ_00d4e35f-7566-46b5-bb6a-c9091ce0c932"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTItNy0xLTEtNDcyODQ_73efcb8c-64d5-460f-8302-d907023d65ce"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpense
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTQtMS0xLTEtNDcyODQ_e7fb7fa6-1b4a-4810-a26f-77e39b242953"
      unitRef="usd">41000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTQtMy0xLTEtNDcyODQ_1c69eb09-5b5c-4229-8bc9-c47ec60fefcb"
      unitRef="usd">55000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTQtNS0xLTEtNDcyODQ_f427b8ad-f908-49c0-a0c2-7c3911f2629b"
      unitRef="usd">135000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTQtNy0xLTEtNDcyODQ_50318fb8-d284-4002-a208-40c35766b8b5"
      unitRef="usd">165000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTUtMS0xLTEtNDcyODQ_7d75793c-9da0-41f0-90ab-0304627587d2"
      unitRef="usd">277000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTUtMy0xLTEtNDcyODQ_6e2da3a5-5120-4d9f-82da-4ade6e64839c"
      unitRef="usd">-7363000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTUtNS0xLTEtNDcyODQ_4e174ec1-37e9-4219-81bf-7ccac94e4df9"
      unitRef="usd">1281000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTUtNy0xLTEtNDcyODQ_0940ae3c-d420-473d-9ed1-06825be89e6a"
      unitRef="usd">-6063000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTYtMS0xLTEtNDcyODQ_3ae96190-d3a8-4226-b76b-0e550617d5c7"
      unitRef="usd">238000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTYtMy0xLTEtNDcyODQ_63eb641b-c260-43bc-ba5b-5615dde49e3b"
      unitRef="usd">-1189000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTYtNS0xLTEtNDcyODQ_24d71596-5585-459c-991c-7544f6183b0b"
      unitRef="usd">396000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTYtNy0xLTEtNDcyODQ_2aa049b6-4b38-4ebd-833f-e6c58a88da5d"
      unitRef="usd">-1011000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTctMS0xLTEtNDcyODQ_87c07a14-bc99-4f9f-9e0a-8efc2656b5f0"
      unitRef="usd">39000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTctMy0xLTEtNDcyODQ_a5f78eea-47bd-438e-b85a-0c78985789e1"
      unitRef="usd">-6174000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTctNS0xLTEtNDcyODQ_4eceb1df-a94d-4f95-8154-e4ac2a486d6e"
      unitRef="usd">885000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTctNy0xLTEtNDcyODQ_201c74b5-b2f9-4062-99e3-28c6394f53d2"
      unitRef="usd">-5052000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTgtMS0xLTEtNDcyODQ_cfbbdacd-f97a-4874-8f30-c397f64893dd"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTgtMy0xLTEtNDcyODQ_83fa9e89-ae59-4e45-b4e8-59645807bdcc"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTgtNS0xLTEtNDcyODQ_025d8e19-5b36-41ae-8845-6daba1a55392"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTgtNy0xLTEtNDcyODQ_b5667315-ff36-4447-b6c7-ef7e29dc726d"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTktMS0xLTEtNDcyODQ_5a9b2c0c-ac77-4cb4-a41c-803e3b73033c"
      unitRef="usd">39000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTktMy0xLTEtNDcyODQ_59beedac-5510-4466-be2e-8129b0e01b9b"
      unitRef="usd">-6174000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTktNS0xLTEtNDcyODQ_10c4ff1a-08f9-4410-a5c4-a711e2e4877d"
      unitRef="usd">882000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMTktNy0xLTEtNDcyODQ_b6832923-8a7b-46e2-b336-778bcd523833"
      unitRef="usd">-5053000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjAtMS0xLTEtNDcyODQ_e7d17c6b-b4d3-43d4-bb2a-28e31d1a2e83"
      unitRef="usd">46000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjAtMy0xLTEtNDcyODQ_45748771-5d23-4c91-8e75-4ccb910350f5"
      unitRef="usd">52000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjAtNS0xLTEtNDcyODQ_8e5f665c-2456-417f-8253-c37271ec16e4"
      unitRef="usd">136000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjAtNy0xLTEtNDcyODQ_14773e81-7c10-4f13-a1ea-8742673836e4"
      unitRef="usd">152000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjEtMS0xLTEtNDcyODQ_125708f5-24cd-4436-8779-1cea9fc93f2c"
      unitRef="usd">-7000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjEtMy0xLTEtNDcyODQ_01b6a654-13e9-47b0-b7a9-aeddcdc23620"
      unitRef="usd">-6226000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjEtNS0xLTEtNDcyODQ_8fb23b2a-5a4f-49e8-8d12-ce90aeaba4b2"
      unitRef="usd">746000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjEtNy0xLTEtNDcyODQ_8781f394-2961-48d6-b253-8342e0c8a183"
      unitRef="usd">-5205000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjUtMS0xLTEtNDcyODQ_ea51b969-8e9f-4403-8684-bca3961cd020"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjUtMy0xLTEtNDcyODQ_bd249b49-ca8b-4b7d-835d-128e60c05d8d"
      unitRef="usdPerShare">-39.03</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjUtNS0xLTEtNDcyODQ_aaeabba9-2609-4c5e-9da9-9b0a04f66095"
      unitRef="usdPerShare">4.81</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjUtNy0xLTEtNDcyODQ_6c232c61-35e6-4b73-b9ae-487b1c9b6afd"
      unitRef="usdPerShare">-32.28</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjYtMS0xLTEtNDcyODQ_d67f52e1-5094-42aa-9328-126ebc620ec1"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjYtMy0xLTEtNDcyODQ_6dfdc0c7-1c27-4635-9023-0d00a72a3c38"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjYtNS0xLTEtNDcyODQ_05f9fbd2-a2c3-42b4-a199-6777980b2067"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjYtNy0xLTEtNDcyODQ_99a9eebb-b44f-4667-a7dd-f8b422169f65"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjctMS0xLTEtNDcyODQ_dba34460-bf2e-4f00-814f-5abad97ff800"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjctMy0xLTEtNDcyODQ_69faf159-8115-42ac-b240-306f05453cb2"
      unitRef="usdPerShare">-39.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjctNS0xLTEtNDcyODQ_34e07c30-7f8f-4e89-a323-fd339aabfb46"
      unitRef="usdPerShare">4.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjctNy0xLTEtNDcyODQ_1a57a25c-1b89-4372-bc36-d3a23dc1c987"
      unitRef="usdPerShare">-32.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjktMS0xLTEtNDcyODQ_6582c668-2354-4a0d-bfbc-476d9ea48b8b"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjktMy0xLTEtNDcyODQ_7eb4a1f5-99a8-4b1f-ad6b-81d758ffb036"
      unitRef="usdPerShare">-39.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjktNS0xLTEtNDcyODQ_1c7913b4-648e-45ec-b184-c046dad71c71"
      unitRef="usdPerShare">4.87</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMjktNy0xLTEtNDcyODQ_4538274e-e912-4977-8785-f79127bdd8d2"
      unitRef="usdPerShare">-32.28</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzAtMS0xLTEtNDcyODQ_8a3fe01c-43cd-49f2-a548-6d9d3a1cc0ff"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzAtMy0xLTEtNDcyODQ_d45205a1-5c50-43de-b897-9ac27fc55359"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzAtNS0xLTEtNDcyODQ_15f67d18-7ea5-40a6-8f5f-bc1eb11006cc"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzAtNy0xLTEtNDcyODQ_325673c8-8ea5-46b0-8f86-87c896b83393"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzEtMS0xLTEtNDcyODQ_6f087b9f-897d-4ffd-8af4-32338a3ce72d"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzEtMy0xLTEtNDcyODQ_3a128334-16f8-4042-b607-91ab31bc6147"
      unitRef="usdPerShare">-39.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzEtNS0xLTEtNDcyODQ_c28a3448-d588-4bd8-b38c-a86dbc725789"
      unitRef="usdPerShare">4.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzEtNy0xLTEtNDcyODQ_372c50fc-ada4-4f5f-bf6a-ffe6f129a6e1"
      unitRef="usdPerShare">-32.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzQtMS0xLTEtNDcyODQ_56a88764-0e1e-4ea2-a4fa-ae832992ef19"
      unitRef="shares">151600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzQtMy0xLTEtNDcyODQ_a8a85c6f-d0ef-4d97-876e-34ee89e7e5ad"
      unitRef="shares">159500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzQtNS0xLTEtNDcyODQ_6a918d8c-d1e6-423f-a8b9-18c55e37b009"
      unitRef="shares">155800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzQtNy0xLTEtNDcyODQ_e5715295-fc93-415f-91b5-f070a26d26f1"
      unitRef="shares">161200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzUtMS0xLTEtNDcyODQ_6be5b585-d984-49c1-8a6b-e4045f3814d4"
      unitRef="shares">151600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzUtMy0xLTEtNDcyODQ_43ccc1f0-5c4c-46b8-be1b-a830436b339f"
      unitRef="shares">159500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzUtNS0xLTEtNDcyODQ_24ec0839-5ceb-4cbd-aea9-68aee0b80147"
      unitRef="shares">154000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xMy9mcmFnOmMzYzc5NmU2NDgwYTQ5MDk4Y2RmY2YyNDZiN2EyZjQ0L3RhYmxlOmY0OWQ3MGRjZTQzMjQyYTBiOWIxOGU2N2JiMTA5MDA4L3RhYmxlcmFuZ2U6ZjQ5ZDcwZGNlNDMyNDJhMGI5YjE4ZTY3YmIxMDkwMDhfMzUtNy0xLTEtNDcyODQ_f6ff93c8-496f-4007-bfd6-bfe54e998356"
      unitRef="shares">161200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMi0xLTEtMS00NzI4NA_8eb02ef4-7c0a-4b82-bef5-40c63e4c8cf5"
      unitRef="usd">39000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMi0zLTEtMS00NzI4NA_b910637b-1fd8-4320-bc8d-90c675442742"
      unitRef="usd">-6174000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMi01LTEtMS00NzI4NA_b8d7998b-d57e-4ba7-bc96-f7c464820a42"
      unitRef="usd">882000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMi03LTEtMS00NzI4NA_a14a4116-9dbc-46ee-9465-62bc4ba14ade"
      unitRef="usd">-5053000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNS0xLTEtMS00NzI4NA_9c0f83d4-d3f5-4440-b457-eac72c67b5b5"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNS0zLTEtMS00NzI4NA_ef78aad2-d04c-4ed9-a0a5-f270f028adbe"
      unitRef="usd">107000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNS01LTEtMS00NzI4NA_4207ab8a-1ebc-407a-9789-67471b08db9d"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNS03LTEtMS00NzI4NA_70a45dea-295b-4254-a434-17e5fbe58658"
      unitRef="usd">181000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNi0xLTEtMS00NzI4NA_6299f2d0-eb4d-4eda-b3fc-8b1cb221ebbb"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNi0zLTEtMS00NzI4NA_fbd2a539-cbcd-4724-8a6f-0c7fcfa1c047"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNi01LTEtMS00NzI4NA_41c580c6-dd26-44bb-ac0c-0094ed9cf399"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNi03LTEtMS00NzI4NA_2dd9bb16-51be-48d3-a876-31393a976dbd"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNy0xLTEtMS00NzI4NA_206cdec0-9e1a-4dfe-a2c1-94484195ff0b"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNy0zLTEtMS00NzI4NA_7d000715-bce0-4d8c-ae8d-51ededa476a9"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNy01LTEtMS00NzI4NA_5a24b56f-709f-4779-8a3f-9b2bb9a9bedb"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfNy03LTEtMS00NzI4NA_2ac8e774-df2a-4cab-983e-6c3c884ae5e9"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfOC0xLTEtMS00NzI4NA_e9c8967e-b0cc-4240-a12b-58762619c011"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfOC0zLTEtMS00NzI4NA_43f165b5-0400-4782-8932-10b7cbbffae1"
      unitRef="usd">119000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfOC01LTEtMS00NzI4NA_7901dafb-04de-4735-b97d-53670ae71c0c"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfOC03LTEtMS00NzI4NA_099ff21e-0ecb-42c8-8aae-33e767fe95e6"
      unitRef="usd">161000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTAtMS0xLTEtNDcyODQ_36bca4ad-5f9e-47da-910b-1b676c2f4886"
      unitRef="usd">47000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTAtMy0xLTEtNDcyODQ_1c372d78-0854-4fed-b0c6-717b76ea39b2"
      unitRef="usd">-6055000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTAtNS0xLTEtNDcyODQ_06615cc7-f761-4dc8-afcc-18b075fddf2b"
      unitRef="usd">878000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTAtNy0xLTEtNDcyODQ_d4467abf-c1a2-4660-a0bd-a709923fc521"
      unitRef="usd">-4892000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTEtMS0xLTEtNDcyODQ_5ba8f033-19a0-418c-94df-8f830bf6494b"
      unitRef="usd">44000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTEtMy0xLTEtNDcyODQ_4932b50e-a248-4317-9c1e-b18c7fcaaa23"
      unitRef="usd">77000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTEtNS0xLTEtNDcyODQ_3892b415-6396-4fe4-964f-273bfdf4f584"
      unitRef="usd">137000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTEtNy0xLTEtNDcyODQ_791db15f-7d00-465a-bcf2-40f5d4eedff3"
      unitRef="usd">113000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTItMS0xLTEtNDcyODQ_25eadbc6-caba-4ba0-ba8c-29e6c6212a5c"
      unitRef="usd">3000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTItMy0xLTEtNDcyODQ_ed04e2bc-eba8-4744-9cc4-f03638f7f96a"
      unitRef="usd">-6132000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTItNS0xLTEtNDcyODQ_3375a56b-7673-4b23-a590-808087f58390"
      unitRef="usd">741000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xNi9mcmFnOjIyNTE2ZmNkM2QyMjRmMzNiOWM0MGNhYTJkOGYyMWY5L3RhYmxlOmRlZGY0YmM2YTdiNzRkMDc4MzlhNjUyNGEwZWMxYWQ4L3RhYmxlcmFuZ2U6ZGVkZjRiYzZhN2I3NGQwNzgzOWE2NTI0YTBlYzFhZDhfMTItNy0xLTEtNDcyODQ_416e2e02-5322-4d5e-aa73-d4fcbf5fc8fc"
      unitRef="usd">-5005000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMy0xLTEtMS00NzI4NA_d63dde59-49b7-4719-8842-df78f237c0b0"
      unitRef="usd">2754000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMy0zLTEtMS00NzI4NA_2a905c89-7bf5-4bde-b188-1f2ffe6e0cec"
      unitRef="usd">6278000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNC0xLTEtMS00NzI4NA_727fa6fa-43c3-423c-9497-3765b8e48ba9"
      unitRef="usd">18355000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNC0zLTEtMS00NzI4NA_9721a996-a778-47eb-9d84-08a58dc24950"
      unitRef="usd">19181000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNS0xLTEtMS00NzI4NA_e9ad5319-6027-436e-9ff5-41691b201076"
      unitRef="usd">19024000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNS0zLTEtMS00NzI4NA_993a1f95-fdf9-4b74-8368-7887581f5b63"
      unitRef="usd">19246000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNi0xLTEtMS00NzI4NA_8a4eaa4d-8e84-42ff-af93-69e64ccba324"
      unitRef="usd">5534000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNi0zLTEtMS00NzI4NA_14f3932e-02d1-44b1-885e-853924a9ee97"
      unitRef="usd">12000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNy0xLTEtMS00NzI4NA_adb93899-cad8-4b38-8d4a-d59edca44d4f"
      unitRef="usd">831000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNy0zLTEtMS00NzI4NA_859ac446-23af-443c-bd54-603ff43a2eb8"
      unitRef="usd">665000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfOC0xLTEtMS00NzI4NA_c058efb5-0997-414a-bc56-929251bd27f4"
      unitRef="usd">46498000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfOC0zLTEtMS00NzI4NA_e78f6958-7d55-4734-b976-d050bf5507b1"
      unitRef="usd">45382000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfOS0xLTEtMS00NzI4NA_8a063fc3-0ab1-4893-a855-bcec66d71e4c"
      unitRef="usd">2064000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfOS0zLTEtMS00NzI4NA_cd51430d-17d7-4630-803c-0d8569236093"
      unitRef="usd">2581000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTAtMS0xLTEtNDcyODQ_cdfebef4-2272-40b0-9d1b-e2ec7873b1c1"
      unitRef="usd">1581000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTAtMy0xLTEtNDcyODQ_5f0114d4-e7f2-4190-bebf-d3008fb2cc8f"
      unitRef="usd">2100000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTEtMS0xLTEtNDcyODQ_a78d60df-fec8-44e1-9e8a-7a65ebcd9429"
      unitRef="usd">9462000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTEtMy0xLTEtNDcyODQ_e6990466-bbeb-4d7d-9832-01238cdd6502"
      unitRef="usd">9493000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTItMS0xLTEtNDcyODQ_4c89fc4b-0d13-4331-9154-b2154c6a250d"
      unitRef="usd">2130000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTItMy0xLTEtNDcyODQ_79dea4f3-ba7e-49bd-b4f7-54f176160fc1"
      unitRef="usd">2878000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTQtMS0xLTEtNDcyODQ_b95bd24a-fc23-463e-8a79-105101a3c383"
      unitRef="usd">1973000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTQtMy0xLTEtNDcyODQ_ad264afd-879d-49f7-8393-f7aa968d316a"
      unitRef="usd">2581000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTUtMS0xLTEtNDcyODQ_1e3ee774-0b7a-429e-b0b9-0c0e758609dc"
      unitRef="usd">63708000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTUtMy0xLTEtNDcyODQ_6c6d7154-dbc9-4fe3-9fb6-4e93e140030b"
      unitRef="usd">65015000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTktMS0xLTEtNDcyODQ_3ab4f25e-9a95-4163-af45-1482037a9419"
      unitRef="usd">37183000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMTktMy0xLTEtNDcyODQ_fb9a627c-9af6-4a45-9b57-b4df8dc491fd"
      unitRef="usd">38975000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjAtMS0xLTEtNDcyODQ_33dd44d4-3cfc-4fff-b503-fc23d5f8a7cc"
      unitRef="usd">372000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjAtMy0xLTEtNDcyODQ_8e881951-1a82-48a0-a7cc-77d2835e667b"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjEtMS0xLTEtNDcyODQ_3bc1a21b-6756-43df-9e80-4bd5c6b1722a"
      unitRef="usd">438000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjEtMy0xLTEtNDcyODQ_8581eff0-b4ea-4c42-803a-32d9b3759839"
      unitRef="usd">742000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjItMS0xLTEtNDcyODQ_a5627218-7063-49bc-bca0-b58924a50d72"
      unitRef="usd">294000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjItMy0xLTEtNDcyODQ_f0a87d0b-bd09-4b1e-ae94-43a0d215cf49"
      unitRef="usd">390000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjMtMS0xLTEtNDcyODQ_db4bc84c-45cc-4e48-a255-325dc6e58de2"
      unitRef="usd">4833000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjMtMy0xLTEtNDcyODQ_c2e4ee4f-1d1f-402f-a3a2-e44a4ff75cef"
      unitRef="usd">9000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjQtMS0xLTEtNDcyODQ_b2fcfd69-c200-4ff7-9588-74d8a74d9f84"
      unitRef="usd">4332000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjQtMy0xLTEtNDcyODQ_161ef465-bfac-4350-996b-7be7fc6f2a5a"
      unitRef="usd">3987000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjUtMS0xLTEtNDcyODQ_7e9f6be6-fcfc-49ad-9a52-e27c7f9a70bb"
      unitRef="usd">47452000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjUtMy0xLTEtNDcyODQ_057066b2-574c-4e69-ab57-20e4ed8b4100"
      unitRef="usd">44103000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjYtMS0xLTEtNDcyODQ_85a10295-a242-4ef8-8089-42f8f392f734"
      unitRef="usd">5518000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjYtMy0xLTEtNDcyODQ_565b8d0f-7f30-43a1-bc8a-25ffdc6adb37"
      unitRef="usd">6406000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjctMS0xLTEtNDcyODQ_538f4b86-8e2f-45e6-a9e2-9bb90b34e5a2"
      unitRef="usd">1369000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjctMy0xLTEtNDcyODQ_35f8359b-60f5-4ddd-8e76-0d9d394e3cd0"
      unitRef="usd">1411000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjgtMS0xLTEtNDcyODQ_3204f4d1-d48e-4a36-ac43-5950b3753476"
      unitRef="usd">1391000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjgtMy0xLTEtNDcyODQ_56c4e535-7780-4f98-a040-38b2b9560306"
      unitRef="usd">1867000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjktMS0xLTEtNDcyODQ_ebc63202-588f-4752-a5a6-33d1fd108c45"
      unitRef="usd">7153000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMjktMy0xLTEtNDcyODQ_7d4ee3f8-ff1a-4050-97a2-ec3a497df97b"
      unitRef="usd">8067000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzAtMS0xLTEtNDcyODQ_157a7aec-f645-4bdb-821c-a27af847f54f"
      unitRef="usd">1612000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzAtMy0xLTEtNDcyODQ_a00bb303-466c-4efe-b7f1-f5890bffbff0"
      unitRef="usd">1715000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzEtMS0xLTEtNDcyODQ_8319ab7d-0159-46c1-bf47-03b996c2bc05"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzEtMy0xLTEtNDcyODQ_39af3cdb-ac82-436b-ae75-bde409a00d4f"
      unitRef="usd">1271000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N18yMQ_801ae82b-7356-4cbd-ad4f-ed93c2cc8479"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N18yMQ_b2670a3f-a4bb-4357-a71d-0de7ff771549"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N18zNQ_6f834177-ed7d-426c-9e33-327e8d2ed102"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N18zNQ_77b41a9f-a47a-47a8-992f-9ee311851392"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N181Nw_6cc17ca3-513c-4cdb-836c-34804fb1b1cb"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N181Nw_a379f0d1-6103-4388-85a3-ed30a8989fe2"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N181Nw_b6782544-f515-41b9-a06e-0561b6395f19"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1YmQyZDc4MzA4NmU0NjQzODY0MWUwYjhkMzExY2I3N181Nw_cd1af9a2-43fa-4212-aeff-2cd089b05dbd"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMS0xLTEtNDcyODQ_10d2c87c-cc53-4820-a9b2-ae600931b403"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzMtMy0xLTEtNDcyODQ_333399f4-c261-4ebf-bc66-66e41a46b5c0"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF8xOA_8f757c35-3d2a-4826-9ca8-9235129d1853"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF8xOA_978e7e6d-202a-44c5-89db-5174e2f818bf"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF8zMg_044b3516-4b2a-4970-8215-a5c4d4c16fa4"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF8zMg_bbce8676-9c6c-4757-80b5-0336cf6902fe"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF81Nw_50e212d7-006a-400b-ab7f-ce3f75aa2872"
      unitRef="shares">275000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpjNjFiZGExMTY1N2M0MjQwOTFmMzBjNDY4NzNlMGFjZF82NA_bbe9669f-72a0-4540-97d7-93a36965d217"
      unitRef="shares">273000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMS0xLTEtNDcyODQ_979f911f-9d80-4f8e-b5ce-11da2cace20f"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzQtMy0xLTEtNDcyODQ_002f4aef-fd38-4086-acd3-38b0e278fdc9"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzUtMS0xLTEtNDcyODQ_4eaca4d1-7b3c-433c-82b0-6771129e31b6"
      unitRef="usd">7411000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzUtMy0xLTEtNDcyODQ_eca83892-51f0-4947-bd7f-e400cf2ec7dc"
      unitRef="usd">6925000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzYtMS0xLTEtNDcyODQ_297071a1-da8c-4ff0-ba02-8da74dc976df"
      unitRef="usd">8734000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzYtMy0xLTEtNDcyODQ_cd893dda-f778-4ab2-8203-9e0e18f74892"
      unitRef="usd">8202000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzctMS0xLTEtNDcyODQ_0fe0c6ed-fc2f-41ac-8ea3-32a01ad96b6c"
      unitRef="usd">-1655000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzctMy0xLTEtNDcyODQ_2560f0c4-adae-4142-a280-67c4d4fb6ab0"
      unitRef="usd">-1480000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzktMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo0NTUzNjI2Yjg2ODM0MTE5Yjg1MmUwYzMxYmMxMzEyZV8zMA_6d4750b3-b7f4-4516-b177-352892fcd1b8"
      unitRef="shares">125000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzktMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo0NTUzNjI2Yjg2ODM0MTE5Yjg1MmUwYzMxYmMxMzEyZV8zNw_795c710a-b2fa-4ac0-9f9f-6d7e019e5362"
      unitRef="shares">115000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzktMS0xLTEtNDcyODQ_af4d987c-004c-4f0d-9102-b0f462f1a16a"
      unitRef="usd">15766000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfMzktMy0xLTEtNDcyODQ_7b6cce7c-989f-4809-b1ef-46e8c661ec96"
      unitRef="usd">13670000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDAtMS0xLTEtNDcyODQ_88213b09-691d-4bbf-ac91-a6f8ca6ff343"
      unitRef="usd">-1274000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDAtMy0xLTEtNDcyODQ_71046014-e91e-4907-9bf4-2f18648a94c7"
      unitRef="usd">-21000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDEtMS0xLTEtNDcyODQ_e5286501-908f-4802-a100-f4ee7a0f997c"
      unitRef="usd">487000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDEtMy0xLTEtNDcyODQ_cc851e3f-dbb0-4eb9-83c1-59a16b1f3e4a"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDItMS0xLTEtNDcyODQ_ed1f368b-49a9-4128-85f1-5356d780faab"
      unitRef="usd">-787000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDItMy0xLTEtNDcyODQ_2ad02e92-e444-4303-8dcd-5c99182e6a6c"
      unitRef="usd">175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDMtMS0xLTEtNDcyODQ_fe8174bf-3551-4dd9-a77d-700e4f2d395b"
      unitRef="usd">63708000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8xOS9mcmFnOjkyZGZiOGFkMDA1NDRjYTFiZDI5ZmQxYzU3MjY1OTUzL3RhYmxlOjE3Njg3NjVkOGZlNzQ5YmE5Nzc3ODY3ZmVjNmUyZjExL3RhYmxlcmFuZ2U6MTc2ODc2NWQ4ZmU3NDliYTk3Nzc4NjdmZWM2ZTJmMTFfNDMtMy0xLTEtNDcyODQ_b259376d-0453-477e-aeeb-759763c872c1"
      unitRef="usd">65015000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i439966e71d2144ef842f55e3776ff357_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xLTEtMS00NzI4NA_5939d470-0dbd-468a-bc88-ef949d6ae638"
      unitRef="shares">275000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i439966e71d2144ef842f55e3776ff357_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0zLTEtMS00NzI4NA_e97cb1f5-840c-4e82-83cb-f546e5b16c3b"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8436ab31a1f04277a0978cc5082487d6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy01LTEtMS00NzI4NA_3bb92cd0-f46d-4ea6-85bf-a6653934b390"
      unitRef="usd">7311000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i700f01544539495e9ffcc43f6df2519a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy05LTEtMS00NzI4NA_33ee7bc4-6677-4097-bc51-6ef016be00fb"
      unitRef="usd">8812000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1be4875f550d4562b96d61a975ce1384_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xMS0xLTEtNDcyODQ_16094244-2efb-42e6-a1a0-92c224d95428"
      unitRef="usd">-1665000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ida99689579c54617a262daa0e8430ed6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xMy0xLTEtNDcyODQ_69f2b826-d354-42cd-abf2-4f9b8ff570e7"
      unitRef="shares">122000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida99689579c54617a262daa0e8430ed6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xNS0xLTEtNDcyODQ_8aaa5388-1c91-46e0-a3e2-0cc491587b4f"
      unitRef="usd">-15031000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i68c571fe607348cdab2a44a5f011467b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xNy0xLTEtNDcyODQ_e0c0bb9b-be9b-425d-be51-66bf81c70dbc"
      unitRef="usd">484000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1ad330dab834c37a1beaf31343ccddc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMy0xOS0xLTEtNDcyODQ_1e4f0cb7-7c5b-467c-a495-057fecb7bfec"
      unitRef="usd">-87000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ic47507086542449a87995a47b6731b7a_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNC01LTEtMS00NzI4NA_93986b89-1a14-4d11-95ed-68332515c4cf"
      unitRef="usd">63000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i7b2766918b80463a9b60d65600e7b809_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNC0xNS0xLTEtNDcyODQ_4e5a3623-0be9-4705-9c4d-7905cba9aa94"
      unitRef="usd">-7000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNC0xOS0xLTEtNDcyODQ_911f91da-0bbd-4f26-81ff-c791e6bd270d"
      unitRef="usd">56000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic47507086542449a87995a47b6731b7a_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNS01LTEtMS00NzI4NA_73900f4e-0001-4997-a448-9e085d55f5c8"
      unitRef="usd">36000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNS0xOS0xLTEtNDcyODQ_2fe46997-665e-4de4-b979-a98eb00a6ca9"
      unitRef="usd">36000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNi0xNy0xLTEtNDcyODQ_c2e3a413-531f-4b4d-bfc2-85e3f805a9b9"
      unitRef="usd">38000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNi0xOS0xLTEtNDcyODQ_d3ebc6c2-7014-4745-a2e2-cbfc439f81dd"
      unitRef="usd">38000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNy0xMS0xLTEtNDcyODQ_fe2c3697-963c-4a05-a698-75de93bf98d3"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNy0xNy0xLTEtNDcyODQ_610e7290-1190-4258-92ce-69aa0dfaa8d3"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfNy0xOS0xLTEtNDcyODQ_fac578dd-4dfa-4263-ac6e-431685ff1a4d"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="icd7e5ba6748444768519a57ab6d455e1_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOC05LTEtMS00NzI4NA_28d3c462-7f09-4da9-8ffc-7acaf942dba5"
      unitRef="usd">-7000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOC0xNy0xLTEtNDcyODQ_4379b474-ab72-41e5-b3ed-1584cdb9c867"
      unitRef="usd">46000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOC0xOS0xLTEtNDcyODQ_33eb8aa6-b300-49c1-ac75-68f8b75264a7"
      unitRef="usd">39000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i7b2766918b80463a9b60d65600e7b809_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOS0xMy0xLTEtNDcyODQ_136d2fde-de09-4af7-be0a-d00deb59438d"
      unitRef="shares">3000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i7b2766918b80463a9b60d65600e7b809_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOS0xNS0xLTEtNDcyODQ_bc2795e1-4ed6-47cf-9e99-eae2df8abb8a"
      unitRef="usd">728000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfOS0xOS0xLTEtNDcyODQ_b67c1715-4816-4524-a8d6-48c0d558bdbb"
      unitRef="usd">728000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTItMTctMS0xLTQ3Mjg0_1fbdca44-60cf-4b58-a3f6-4ce8ca849cf8"
      unitRef="usd">3000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTItMTktMS0xLTQ3Mjg0_bf843a17-1fdb-4c8a-8b8e-4d58bc306010"
      unitRef="usd">3000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo3YjcxOTA2MzQ0OTI0YTUwYjVlNDJkMDVmOWNmNjY1Yl8yOQ_a80b2318-c023-44ee-ab76-3b910985bd14"
      unitRef="usdPerShare">0.47</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="icd7e5ba6748444768519a57ab6d455e1_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTMtOS0xLTEtNDcyODQ_0321e5f9-d853-40ca-b33d-b179c8bc75a5"
      unitRef="usd">72000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTMtMTktMS0xLTQ3Mjg0_fa32cf86-a271-4ee9-838f-30bee7457166"
      unitRef="usd">72000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="ic47507086542449a87995a47b6731b7a_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTQtNS0xLTEtNDcyODQ_5ea06d95-3bcd-4825-8917-43fc5d2d2ac4"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="icd7e5ba6748444768519a57ab6d455e1_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTQtOS0xLTEtNDcyODQ_ae06062c-36f5-4642-b12f-70d844544a80"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTQtMTktMS0xLTQ3Mjg0_13247c2c-5388-4d50-ab3a-aac36f85510e"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i51890ebfb4e6484b85eee1fcde455801_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMS0xLTEtNDcyODQ_181aae56-951d-43cc-8fec-4f8349c4748a"
      unitRef="shares">275000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i51890ebfb4e6484b85eee1fcde455801_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMy0xLTEtNDcyODQ_ea7c0261-7d1d-43a9-9a8a-1448cdc7b7cd"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iccaf4a3f07d140fa8a374c7d818db2c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtNS0xLTEtNDcyODQ_3dac77dc-249b-455e-9e1c-72e4e62123a0"
      unitRef="usd">7411000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2dc60e1226cd4fcfbed4ac8715e43490_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtOS0xLTEtNDcyODQ_b2439be7-3b42-4f74-92c4-cf69087e3d7b"
      unitRef="usd">8734000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib041b764acbd496ba6cd257448c9a6ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMTEtMS0xLTQ3Mjg0_274a4c28-8dd9-4255-997d-c45d95b4838a"
      unitRef="usd">-1655000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i954d5ded78d141c1aab9b2f0e240b4e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMTMtMS0xLTQ3Mjg0_59269c3e-2a4c-4c4b-9528-278397e6e188"
      unitRef="shares">125000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i954d5ded78d141c1aab9b2f0e240b4e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMTUtMS0xLTQ3Mjg0_e9459fc2-0dfd-457a-9b71-ba1f26d5f53c"
      unitRef="usd">-15766000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic820959a12ab4a0bae3278102cbe3604_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMTctMS0xLTQ3Mjg0_84a9daa0-ba39-4a13-8004-5ff208683840"
      unitRef="usd">487000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOmZjY2Q4ZTYzZjA4NDQ4M2JhMDdhMGY1YzQ2NzhiMjQ1L3RhYmxlcmFuZ2U6ZmNjZDhlNjNmMDg0NDgzYmEwN2EwZjVjNDY3OGIyNDVfMTUtMTktMS0xLTQ3Mjg0_e5531ba4-014a-4192-8b54-8b054e31f861"
      unitRef="usd">-787000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i0187d0ab0c2b497ba13eb86f09ee7b1d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xLTEtMS00NzI4NA_43a21e18-04b5-4c6e-a2fe-dcb8832f542d"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0187d0ab0c2b497ba13eb86f09ee7b1d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0zLTEtMS00NzI4NA_1187d9eb-260a-41a3-9a08-e31a95d2272a"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icea0e96cfe3d44cabedc838f2e613c8f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy01LTEtMS00NzI4NA_dc73080b-a482-4e02-88ea-15b480ee0a6c"
      unitRef="usd">6780000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia38d606928fc4b3db6f2c28bb6975efc_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy05LTEtMS00NzI4NA_be250db6-0405-4504-8345-a23388e38ed6"
      unitRef="usd">13890000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9bf3b3d119214ddc994b0fa424595480_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xMS0xLTEtNDcyODQ_498f0d68-834a-4972-a350-caeb29a0314c"
      unitRef="usd">-1597000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i5708808d3fca428a8db75e932c0ab1ed_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xMy0xLTEtNDcyODQ_621ebdd2-3332-457c-8ad3-e70fbe722149"
      unitRef="shares">112000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5708808d3fca428a8db75e932c0ab1ed_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xNS0xLTEtNDcyODQ_5115b963-69c8-4d6d-b2e0-5a98558f71df"
      unitRef="usd">-13185000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6da59171484d4afba5f49534b2709456_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xNy0xLTEtNDcyODQ_759ee0cd-03fc-4dcf-a56d-da60a5c630d1"
      unitRef="usd">200000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b44821ac2c64fd7ab23957aaf69ef0e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMy0xOS0xLTEtNDcyODQ_8696de6c-860a-4e47-bdc2-86e7a6b074b8"
      unitRef="usd">6090000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i29dac400581c4ad0a015f1f22afc419d_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNC01LTEtMS00NzI4NA_4da64041-51ae-42d4-9f6a-69a023021cdc"
      unitRef="usd">16000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i395b68d034cb497d9e909bd37a723bb3_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNC0xNS0xLTEtNDcyODQ_218fa09d-caa9-4826-89d4-4c4952414cac"
      unitRef="usd">-2000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNC0xOS0xLTEtNDcyODQ_8e3ddeed-01f7-4d6b-a164-1573f8d7ee44"
      unitRef="usd">14000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i29dac400581c4ad0a015f1f22afc419d_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNS01LTEtMS00NzI4NA_f1bcd6c5-f79d-4ea9-9450-86af4520fbdb"
      unitRef="usd">51000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNS0xOS0xLTEtNDcyODQ_c8108e06-6f7c-40ee-bc0b-33c8dd1cc583"
      unitRef="usd">51000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNi0xNy0xLTEtNDcyODQ_9d7ea056-58f0-471e-8cae-fa11b8a5ad5d"
      unitRef="usd">41000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNi0xOS0xLTEtNDcyODQ_78c14e76-913c-4d99-a057-b1cf5d3e04f8"
      unitRef="usd">41000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie535baeb0dd347cd978917e66bf4f610_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNy0xMS0xLTEtNDcyODQ_a958f43e-abe6-4b09-b7e6-015e53d3337c"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfNy0xOS0xLTEtNDcyODQ_d443d63a-a362-4008-a026-752b9445903f"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="id8bdea9022ea4c33963371f1d4922ff7_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOC05LTEtMS00NzI4NA_1b6b7173-05b6-4a44-8bcf-f4c08954938d"
      unitRef="usd">-6226000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOC0xNy0xLTEtNDcyODQ_1f677182-5f19-46be-a4d8-fbbf20be1577"
      unitRef="usd">41000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOC0xOS0xLTEtNDcyODQ_b3e9fcc7-d1ca-4bcc-aca0-28f336bcd40e"
      unitRef="usd">-6185000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i395b68d034cb497d9e909bd37a723bb3_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOS0xMy0xLTEtNDcyODQ_09113d85-b01d-4ec6-81f5-fcd984e5ca02"
      unitRef="shares">2000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i395b68d034cb497d9e909bd37a723bb3_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOS0xNS0xLTEtNDcyODQ_dd7755a7-b4e8-4c55-b661-5766c10c5c05"
      unitRef="usd">231000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfOS0xOS0xLTEtNDcyODQ_f631a180-14c5-4cb7-ba69-812f551d901c"
      unitRef="usd">231000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTEtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo2YzM1OWIzNmMxODA0MjE3YWRkNzM2Nzc5MWY2NzM4ZV8yOQ_0bbdf373-e2dd-44cc-bacb-a62702baa023"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="id8bdea9022ea4c33963371f1d4922ff7_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTEtOS0xLTEtNDcyODQ_fa917568-8ca8-49d2-8da1-b6551f5f3789"
      unitRef="usd">67000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTEtMTktMS0xLTQ3Mjg0_a61755a6-d02f-4372-ac27-47ccfdf33bd0"
      unitRef="usd">67000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="id8bdea9022ea4c33963371f1d4922ff7_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTItOS0xLTEtNDcyODQ_b7490ffa-bde0-42bb-a968-45334d8b0f49"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTItMTktMS0xLTQ3Mjg0_b6ea6bc9-d58c-4a32-8e5c-850aac7d8680"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i1c35edcf7a034a8083f41df320050fd4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMS0xLTEtNDcyODQ_bacc33a3-0a88-4601-98e0-b6e2eb4af64a"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1c35edcf7a034a8083f41df320050fd4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMy0xLTEtNDcyODQ_a5b0c431-1dcb-4be2-a78d-d052d9d8b4f1"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic093d490b58f4f6da8f7e05176f1fcb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtNS0xLTEtNDcyODQ_2be61387-9067-4282-b504-4b43ad613f2b"
      unitRef="usd">6847000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i44427056526c458db776d32cda88d623_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtOS0xLTEtNDcyODQ_14aa04c5-d123-41bc-948c-382228cfed15"
      unitRef="usd">7595000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19c25b891e2446a6bab4b8ee69b28057_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMTEtMS0xLTQ3Mjg0_4db6b15f-4f32-477b-82c2-0d46f604ee43"
      unitRef="usd">-1503000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i0d421e0224fb47f8b7a8dc9b60947bdb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMTMtMS0xLTQ3Mjg0_0fa9af86-5ff8-4835-b5fe-fd2d954b5946"
      unitRef="shares">114000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0d421e0224fb47f8b7a8dc9b60947bdb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMTUtMS0xLTQ3Mjg0_a1eb9ca4-679e-4654-bcb0-b22922d38078"
      unitRef="usd">-13418000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64318d5dd9f1472c90248ebb8e0becbf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMTctMS0xLTQ3Mjg0_693059ea-09f5-4f42-bf3d-9112f391f2f8"
      unitRef="usd">200000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92b029a90e9640e6a41de2c763149aec_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yMi9mcmFnOjBlZTc5YTZkOWNkZDRmNDI4ZGFiMjE0M2M1M2I2OGQ4L3RhYmxlOjc2NGI5YWJjY2U3ZTQ1ZTg5Njk5MDIxY2E1NGNlNjVhL3RhYmxlcmFuZ2U6NzY0YjlhYmNjZTdlNDVlODk2OTkwMjFjYTU0Y2U2NWFfMTMtMTktMS0xLTQ3Mjg0_695dc70d-e3e1-4a85-81ad-bb0ed6d40b56"
      unitRef="usd">-277000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="iacce3d46e1114af0a96f49bb08fb9657_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xLTEtMS00NzI4NA_ac3834ba-30d5-4e09-b07f-8f6aabdca22d"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iacce3d46e1114af0a96f49bb08fb9657_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0zLTEtMS00NzI4NA_6a90756d-ee9e-4947-a2bb-018ee9707e5d"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d4a47e592514d34b5bd2a736f25f14e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy01LTEtMS00NzI4NA_de2198b1-cdd2-4e7f-847a-628f4347aa8f"
      unitRef="usd">6925000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i140e091483a24a50921565a4f50f0bc6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy05LTEtMS00NzI4NA_527f93da-0959-4022-bfed-a47a2a7c8a74"
      unitRef="usd">8202000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd1f982f3f4042c9badc91a36fff0cc1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xMS0xLTEtNDcyODQ_69fb11a4-ce42-4f56-849e-0a9d2a10b26f"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="id250b6c030544199b7220d3a2aca9cc0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xMy0xLTEtNDcyODQ_44f2ade6-b4ff-4851-b17d-f738ba5e2cc7"
      unitRef="shares">115000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id250b6c030544199b7220d3a2aca9cc0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xNS0xLTEtNDcyODQ_547ffd8b-00d2-4b11-8f9f-19b3ec1ac973"
      unitRef="usd">-13670000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0d467e35eb14c31bcba781b26964717_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xNy0xLTEtNDcyODQ_bb84a684-b31a-4c5e-ba59-9259fd481413"
      unitRef="usd">196000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMy0xOS0xLTEtNDcyODQ_8654d4ad-75de-4e1f-9342-3930da984276"
      unitRef="usd">175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if543dc69884c4140a12003d1148abf8b_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNC0xLTEtMS00NzI4NA_8540fe4e-d168-4ce4-b293-15fc9b64ef86"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNC01LTEtMS00NzI4NA_997e1a37-0b3d-4ab7-8105-0e0f8e780565"
      unitRef="usd">174000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i8b0c099b1c004a6c8a540a2430721bbb_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNC0xNS0xLTEtNDcyODQ_8351fbae-e004-4652-bbbf-b8dbc198e6dd"
      unitRef="usd">-67000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNC0xOS0xLTEtNDcyODQ_431366d7-0ea8-47ae-b3d6-2746f2f635f0"
      unitRef="usd">107000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNS01LTEtMS00NzI4NA_1c01d2e1-2f69-4313-a48c-cd0e0a202c1b"
      unitRef="usd">112000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNS0xOS0xLTEtNDcyODQ_3127f1a4-b1db-4595-ad36-e4512b63be22"
      unitRef="usd">112000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNi0xNy0xLTEtNDcyODQ_853ab27c-5579-44b3-85fb-f499558c2448"
      unitRef="usd">117000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNi0xOS0xLTEtNDcyODQ_f97d9d00-ab1d-4f72-bad5-b42a15617612"
      unitRef="usd">117000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNy0xMS0xLTEtNDcyODQ_6bc5a1fc-0c66-4259-a8d4-48c41b6d4fc1"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNy0xNy0xLTEtNDcyODQ_050fb580-daef-417a-b5a4-df474acb5b7b"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfNy0xOS0xLTEtNDcyODQ_42af46fa-7d35-49f1-9b1a-2fad2f58078e"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ic9f93739e19b4aafadc89d067d383156_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOC05LTEtMS00NzI4NA_64b9ba9c-a60e-454a-820c-ef38a5fa15dc"
      unitRef="usd">746000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOC0xNy0xLTEtNDcyODQ_5817b4d9-3a40-4f88-b47f-a08c512462e5"
      unitRef="usd">128000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOC0xOS0xLTEtNDcyODQ_106ba0a0-b249-49c0-886b-bc18212d75ea"
      unitRef="usd">874000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOS01LTEtMS00NzI4NA_8e389df6-1d2a-42a4-9dd5-c7c614709562"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOS0xMS0xLTEtNDcyODQ_41c68e51-d4db-46df-ae17-737cb05b61b1"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfOS0xOS0xLTEtNDcyODQ_9b99eab3-4eb6-44d5-a63e-5230d1ea4133"
      unitRef="usd">8000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTAtNS0xLTEtNDcyODQ_19306347-060f-4eb0-a924-d104695acee7"
      unitRef="usd">-21000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i8b0c099b1c004a6c8a540a2430721bbb_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTAtMTMtMS0xLTQ3Mjg0_68c41fff-d650-4ebf-b74b-2eece65c6c6f"
      unitRef="shares">10000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i8b0c099b1c004a6c8a540a2430721bbb_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTAtMTUtMS0xLTQ3Mjg0_2dcbda25-aecb-45e3-a7ff-5b0d445e948c"
      unitRef="usd">2029000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTAtMTktMS0xLTQ3Mjg0_f10d455e-17e8-4871-b606-a01a57b3b144"
      unitRef="usd">2008000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTEtMTctMS0xLTQ3Mjg0_58834409-d24e-4718-920d-c51e2757806c"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTEtMTktMS0xLTQ3Mjg0_f54484b1-1941-412c-abbb-23aa9f835a64"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTItMTctMS0xLTQ3Mjg0_64a78c7f-206d-404d-a7e5-ec27e3c3be66"
      unitRef="usd">5000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTItMTktMS0xLTQ3Mjg0_0c428b1e-bd82-42d7-b6a3-b4118bd3a26c"
      unitRef="usd">5000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjozMjVkNWY0YzBhMzM0OWRkODczOGM4OGJjOTkzMDdkNV8yOQ_834c9146-3634-48e3-97fc-fe14c9724795"
      unitRef="usdPerShare">1.36</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic9f93739e19b4aafadc89d067d383156_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTMtOS0xLTEtNDcyODQ_a5e441e2-5caa-4900-b7ce-e0c9e487cb7b"
      unitRef="usd">211000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTMtMTktMS0xLTQ3Mjg0_3ba1f223-91f8-4e3d-a17a-fb19f1a25386"
      unitRef="usd">211000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTQtNS0xLTEtNDcyODQ_6881a7b2-49d1-4c4e-b124-d8defea01827"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ic9f93739e19b4aafadc89d067d383156_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTQtOS0xLTEtNDcyODQ_ba80c52a-0ac2-4446-a346-c66a1a217d5b"
      unitRef="usd">3000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTQtMTktMS0xLTQ3Mjg0_4fe7c225-70d4-453d-a88c-8818334056d8"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i51890ebfb4e6484b85eee1fcde455801_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMS0xLTEtNDcyODQ_3089954a-7c38-4c34-8c89-637634e044b9"
      unitRef="shares">275000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i51890ebfb4e6484b85eee1fcde455801_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMy0xLTEtNDcyODQ_e2c26624-bbe1-4d27-9a91-fc37ab64e719"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iccaf4a3f07d140fa8a374c7d818db2c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtNS0xLTEtNDcyODQ_c344afd6-6429-41ed-922a-f31aafd304ea"
      unitRef="usd">7411000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2dc60e1226cd4fcfbed4ac8715e43490_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtOS0xLTEtNDcyODQ_fc666c57-a9d7-4001-bc24-a99b3abb3d26"
      unitRef="usd">8734000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib041b764acbd496ba6cd257448c9a6ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMTEtMS0xLTQ3Mjg0_0eeaa282-0cb2-4c23-94b7-b1eb1ad542d0"
      unitRef="usd">-1655000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i954d5ded78d141c1aab9b2f0e240b4e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMTMtMS0xLTQ3Mjg0_8d264038-ebf8-4617-8479-264633fa8daf"
      unitRef="shares">125000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i954d5ded78d141c1aab9b2f0e240b4e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMTUtMS0xLTQ3Mjg0_379d99b6-b983-4541-a728-f3dc010dce4c"
      unitRef="usd">-15766000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic820959a12ab4a0bae3278102cbe3604_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMTctMS0xLTQ3Mjg0_8237ecfb-a70f-4cad-a4bb-da0a6cf98f94"
      unitRef="usd">487000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOjUyYjFjZmEzMjgyZTQ0YmNhNTczMzYzYTRiMTFhOWIyL3RhYmxlcmFuZ2U6NTJiMWNmYTMyODJlNDRiY2E1NzMzNjNhNGIxMWE5YjJfMTUtMTktMS0xLTQ3Mjg0_9a7cc511-16c2-403d-b315-477f5db32b85"
      unitRef="usd">-787000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i178f7de2928e404a940f4fec020ed2b2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xLTEtMS00NzI4NA_1552dbe0-0a15-44df-a2bc-cddc2939c8a9"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i178f7de2928e404a940f4fec020ed2b2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0zLTEtMS00NzI4NA_a6e4e53a-0e82-4042-a2cd-c7e233fd40f6"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f5ef3a9f2864706b17af4a3663282d5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy01LTEtMS00NzI4NA_41a88f6a-8dea-4b8c-ab3c-f2d790f147b2"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i196e981a1d044679b7aa89e65f24dc73_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy05LTEtMS00NzI4NA_e8e0aca7-3d5b-4cad-91b2-20e330a12885"
      unitRef="usd">13022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iebc1818efd944fffbeda92744ddd19d5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xMS0xLTEtNDcyODQ_7dce64b3-f78d-4bbe-a22f-0a169b7ee992"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i9df402b98dd84868a1686daf16596424_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xMy0xLTEtNDcyODQ_6b01c3c6-1587-4037-9b19-303428dd45fb"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9df402b98dd84868a1686daf16596424_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xNS0xLTEtNDcyODQ_bae9db72-e1c1-447d-98be-5934be134d26"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i805c937398e343ddbade7f441c4786b9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xNy0xLTEtNDcyODQ_5340d916-b555-4968-8391-834fa290a063"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3cd3b8f0b9fb4e3b80f26f6a286a8c4c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMy0xOS0xLTEtNDcyODQ_1207b56c-3782-4747-bba3-5389424614a9"
      unitRef="usd">5309000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i608ff3c7e46a422da1a3bca44aba8bb7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNC05LTEtMS00NzI4NA_d86f4726-7da2-4e75-97ba-550be3a3eddd"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i746a7ab451924975842c08464b7c24d1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNC0xOS0xLTEtNDcyODQ_5b94cd40-1531-494c-b169-49bdc5a0cbb2"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i705e588d2f514ff7bd717969c76affb2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xLTEtMS00NzI4NA_85a7fd07-b6e0-4c8e-9539-3d5c855a5097"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i705e588d2f514ff7bd717969c76affb2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0zLTEtMS00NzI4NA_4d872b35-26ff-4b48-ab23-1a1e6296f479"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3486e22c3b4e49d2a3c85ce54a4b1ef6_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS01LTEtMS00NzI4NA_f82df57f-c69f-444b-a19a-e86dba5977a5"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0bcf0ae780a4416aab58b011355b0f70_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS05LTEtMS00NzI4NA_847d7f89-c6ca-4dec-b93f-4b9d2f330cb4"
      unitRef="usd">13009000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i646e69bc99874247b6c06d6a96b329e7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xMS0xLTEtNDcyODQ_0d028b0b-3278-48d7-b4c3-330e09e51612"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i0ec61b139f8d42da8e958f556f58020e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xMy0xLTEtNDcyODQ_7e40b765-2733-4126-bb19-0c5f5e000260"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ec61b139f8d42da8e958f556f58020e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xNS0xLTEtNDcyODQ_d0314b2b-d2f2-4799-86c3-4b28b8a8a980"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id7cfe7694bf045d993d3e0e6ac8a85dd_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xNy0xLTEtNDcyODQ_5f366707-cd36-48e8-a4ea-9419ee99ff44"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8d647cddebc42c3a78ef89fe06d1cfa_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNS0xOS0xLTEtNDcyODQ_e9c119d9-e5dd-4fe0-a1e4-24229af58e3f"
      unitRef="usd">5296000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i49683251f292481d9201d661f7720626_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNi0xLTEtMS00NzI4NA_74a7fa29-4efc-4b37-a5dd-8e3edf63c5db"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNi01LTEtMS00NzI4NA_e6c87637-aeb7-4a33-a9dd-3b466cef3306"
      unitRef="usd">55000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4c6fe05296e94ff8845fee715825c659_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNi0xNS0xLTEtNDcyODQ_aab45830-a824-4731-be34-3d9826aaa270"
      unitRef="usd">-26000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNi0xOS0xLTEtNDcyODQ_f790c9b9-cb6e-4ea7-894b-1f0fb8dd0ec5"
      unitRef="usd">29000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNy01LTEtMS00NzI4NA_82c01f47-0226-4903-b8c3-64ca0f454533"
      unitRef="usd">110000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfNy0xOS0xLTEtNDcyODQ_ed286a21-2520-4535-93c1-d42c33b424b6"
      unitRef="usd">110000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfOC0xNy0xLTEtNDcyODQ_efa52b0a-65e3-4eee-ab4b-a9c180f8c652"
      unitRef="usd">134000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfOC0xOS0xLTEtNDcyODQ_cbb3f731-b609-432a-8ad8-77cd325ebc81"
      unitRef="usd">134000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia8d1cfbcdd084d568e496e899582fa21_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfOS0xMS0xLTEtNDcyODQ_a61f0d0d-5b16-443c-97be-265020ef5205"
      unitRef="usd">200000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfOS0xOS0xLTEtNDcyODQ_e3c02268-d8bc-44f1-b663-8f70277aa863"
      unitRef="usd">200000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ie2db64a62c8943349987209b0adb60c1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTAtOS0xLTEtNDcyODQ_128a4f2e-2eac-485c-bb94-da31d4686ee9"
      unitRef="usd">-5205000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTAtMTctMS0xLTQ3Mjg0_e542a8d4-a8ec-464c-a3ca-97a2e6c4204c"
      unitRef="usd">120000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTAtMTktMS0xLTQ3Mjg0_d91eaa6b-07f0-4dc6-aeda-9018825787f2"
      unitRef="usd">-5085000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTEtNS0xLTEtNDcyODQ_8a2d3128-d66f-452a-b380-f24c1be01cb1"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTEtMTktMS0xLTQ3Mjg0_934cc600-a7a2-492e-9c03-cf3fb7044e6e"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i4c6fe05296e94ff8845fee715825c659_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTItMTMtMS0xLTQ3Mjg0_a11adb8a-bbce-4013-bfdf-9d21fd51c240"
      unitRef="shares">4000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i4c6fe05296e94ff8845fee715825c659_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTItMTUtMS0xLTQ3Mjg0_b04696ea-430d-4be1-846b-8b35215bfe31"
      unitRef="usd">500000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTItMTktMS0xLTQ3Mjg0_d11714b9-4902-4b0b-8c48-6a510ff95514"
      unitRef="usd">500000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo3ZGZjMjc0MWJkOGQ0NDI1OGVmMjJkNzI3OTQ1OTRlNF8yOQ_5fb6bb19-4770-483f-9698-77bf6d5a85ae"
      unitRef="usdPerShare">1.25</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ie2db64a62c8943349987209b0adb60c1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTQtOS0xLTEtNDcyODQ_ab3f91e4-daad-4980-a775-1b53be2c1ed7"
      unitRef="usd">203000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTQtMTktMS0xLTQ3Mjg0_1b6cfc7c-9fa3-4225-973f-c468acd56dac"
      unitRef="usd">203000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTUtNS0xLTEtNDcyODQ_69c91c80-e266-4754-8815-f8d05f604e18"
      unitRef="usd">-16000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ie2db64a62c8943349987209b0adb60c1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTUtOS0xLTEtNDcyODQ_f32c8f4d-ba3c-4a03-976f-e7d4babf4043"
      unitRef="usd">6000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTUtMTctMS0xLTQ3Mjg0_5b4ccad7-7688-497b-9a65-c66a4b9f3f0c"
      unitRef="usd">3000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTUtMTktMS0xLTQ3Mjg0_6247abb4-d146-4d7b-a394-8e97d3c477c8"
      unitRef="usd">-7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i1c35edcf7a034a8083f41df320050fd4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMS0xLTEtNDcyODQ_20ceffe8-da69-4fbc-989b-b4f04ecb7ea7"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1c35edcf7a034a8083f41df320050fd4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMy0xLTEtNDcyODQ_300cdeec-d37a-48d7-b722-93aad5ae28d0"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic093d490b58f4f6da8f7e05176f1fcb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtNS0xLTEtNDcyODQ_016566c5-eb61-4174-a826-69e8a5c48aba"
      unitRef="usd">6847000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i44427056526c458db776d32cda88d623_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtOS0xLTEtNDcyODQ_2c7f625c-5197-4cfa-b24b-f0baa7e22a21"
      unitRef="usd">7595000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19c25b891e2446a6bab4b8ee69b28057_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMTEtMS0xLTQ3Mjg0_aa67b8ad-c2f0-40df-b4c8-72ac1c160b4c"
      unitRef="usd">-1503000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i0d421e0224fb47f8b7a8dc9b60947bdb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMTMtMS0xLTQ3Mjg0_49519865-644c-4004-a71e-7031449a8645"
      unitRef="shares">114000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0d421e0224fb47f8b7a8dc9b60947bdb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMTUtMS0xLTQ3Mjg0_2a69bc67-60bb-44df-8f31-685ea6231011"
      unitRef="usd">-13418000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64318d5dd9f1472c90248ebb8e0becbf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMTctMS0xLTQ3Mjg0_516b3bf1-b4ee-4733-b8ca-e33d73cd21dd"
      unitRef="usd">200000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92b029a90e9640e6a41de2c763149aec_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yNS9mcmFnOjI5MzRlNGU4MmNhZDQ1NWI5Mjg0NDA5YTU3MzI0MzZhL3RhYmxlOmUyODlmNWNmYzA1MjQzYzM4OTM0MWZmZWQ3NzlkYzY5L3RhYmxlcmFuZ2U6ZTI4OWY1Y2ZjMDUyNDNjMzg5MzQxZmZlZDc3OWRjNjlfMTYtMTktMS0xLTQ3Mjg0_90c7e2e9-04f4-4155-9941-0e24ea9fc0ca"
      unitRef="usd">-277000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMy0xLTEtMS00NzI4NA_afdd1156-43a9-4281-91d7-f424d1a63c47"
      unitRef="usd">882000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMy0zLTEtMS00NzI4NA_2548815d-dd04-407b-8414-d03934d153ea"
      unitRef="usd">-5053000000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNS0xLTEtMS00NzI4NA_0981479e-e215-42a0-9573-6051351ce169"
      unitRef="usd">215000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNS0zLTEtMS00NzI4NA_7493be1f-e9fc-418b-9b5d-15606bbf2726"
      unitRef="usd">237000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNi0xLTEtMS00NzI4NA_a56c6e3d-a6f4-43b4-8df1-c7c9940226e7"
      unitRef="usd">383000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNi0zLTEtMS00NzI4NA_33899b91-feb2-463d-99bc-6c52c71553ba"
      unitRef="usd">429000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNy0xLTEtMS00NzI4NA_0d74c42d-f93a-474b-8e14-217593037c15"
      unitRef="usd">128000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNy0zLTEtMS00NzI4NA_6d4af2db-e878-4e7a-bb58-d95ba28bbb3e"
      unitRef="usd">236000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfOS0xLTEtMS00NzI4NA_a0b6a359-40db-43bd-b909-cb7b1582da8d"
      unitRef="usd">-12000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfOS0zLTEtMS00NzI4NA_9d2221d7-97ac-4cfc-bdba-2e3b66d7bd83"
      unitRef="usd">1520000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTAtMS0xLTEtNDcyODQ_56e7a92b-261c-493e-9d0f-54c5ee910ee6"
      unitRef="usd">-79000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTAtMy0xLTEtNDcyODQ_a9490120-5693-4007-b993-627eb121142d"
      unitRef="usd">-115000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:OperatingLeaseExpense
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTEtMS0xLTEtNDcyODQ_efde1a4c-c3a1-44aa-81ea-2f6389336e79"
      unitRef="usd">198000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTEtMy0xLTEtNDcyODQ_9225d23b-b864-41ba-8604-bd4de6e680b3"
      unitRef="usd">264000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTItMS0xLTEtNDcyODQ_1de29969-ba2e-4056-a5e1-07fceb0f26dd"
      unitRef="usd">117000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTItMy0xLTEtNDcyODQ_f31c85b9-b5da-4329-b0b2-3028de31c0ff"
      unitRef="usd">-50000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTMtMS0xLTEtNDcyODQ_ba45fef5-f0cc-424a-9e32-6451c12d5140"
      unitRef="usd">1271000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTMtMy0xLTEtNDcyODQ_ba37a9be-cd1c-4f34-82bf-9921589c82ac"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTQtMS0xLTEtNDcyODQ_35cbcb53-605b-45c0-afa1-8cf78299d747"
      unitRef="usd">-452000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTQtMy0xLTEtNDcyODQ_8d4bce20-fe29-4d7b-99ad-6fc3eeb4ba44"
      unitRef="usd">-67000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTYtMS0xLTEtNDcyODQ_24715bcb-35eb-4ed3-98b9-edffcdc48322"
      unitRef="usd">1925000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTYtMy0xLTEtNDcyODQ_f50b3dea-39d1-45aa-b17e-18b44b035d7d"
      unitRef="usd">-1500000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTctMS0xLTEtNDcyODQ_1a54efa9-e8d5-4dba-aad7-8ba7be0cc285"
      unitRef="usd">1659000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTctMy0xLTEtNDcyODQ_754ba64d-0625-45ef-b9f4-abce809d9975"
      unitRef="usd">2046000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTgtMS0xLTEtNDcyODQ_ff9250af-9bc0-41c9-9f68-f23913864f69"
      unitRef="usd">1612000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTgtMy0xLTEtNDcyODQ_2e2fa3df-f64e-43a5-87a9-ca80f1abc6ac"
      unitRef="usd">-1240000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTktMS0xLTEtNDcyODQ_ab6fee7c-0943-4220-9f84-d47cd432f3fb"
      unitRef="usd">-276000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMTktMy0xLTEtNDcyODQ_c85e325d-34ea-4728-9046-2c2404ff87a1"
      unitRef="usd">-291000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjAtMS0xLTEtNDcyODQ_e3804951-bdb0-4f56-8cdb-ebbb8313160e"
      unitRef="usd">176000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjAtMy0xLTEtNDcyODQ_1767a507-f46d-4349-9e98-9beb24c4bf8f"
      unitRef="usd">184000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjEtMS0xLTEtNDcyODQ_aa0b164f-3f5c-4c16-939f-8cd938f9f9cd"
      unitRef="usd">146000000</mck:IncreaseDecreaseInLitigationReserve>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjEtMy0xLTEtNDcyODQ_3411f144-2067-4ab9-b27a-219929a03d98"
      unitRef="usd">8067000000</mck:IncreaseDecreaseInLitigationReserve>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjItMS0xLTEtNDcyODQ_0fd514d7-3fd1-428d-889d-742d2e0f0eb8"
      unitRef="usd">-128000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjItMy0xLTEtNDcyODQ_8fbfce65-543f-4ee7-8dce-9e6b6b195ee3"
      unitRef="usd">-403000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjMtMS0xLTEtNDcyODQ_31b67bc0-ee2e-447c-87de-c8b5d0322244"
      unitRef="usd">1547000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjMtMy0xLTEtNDcyODQ_e5f13703-ecd9-482c-b397-d0859060d217"
      unitRef="usd">1172000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjYtMS0xLTEtNDcyODQ_25589a87-a56e-4f81-9ce2-746e94884403"
      unitRef="usd">253000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjYtMy0xLTEtNDcyODQ_67dd82ea-4fc8-4f5b-a61f-517b769d3320"
      unitRef="usd">293000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjctMS0xLTEtNDcyODQ_3be7449f-d627-48e0-be78-fb3776d392e3"
      unitRef="usd">127000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjctMy0xLTEtNDcyODQ_ef1dc6c8-d0c8-4959-a596-f84db6593d60"
      unitRef="usd">134000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjgtMS0xLTEtNDcyODQ_7b377ce8-d330-4847-9223-4c8d970d5d49"
      unitRef="usd">6000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjgtMy0xLTEtNDcyODQ_61988dd5-f20a-4cb3-8315-727d91f62968"
      unitRef="usd">33000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjktMS0xLTEtNDcyODQ_23a11162-abe1-4442-b48c-2a51e4f959c4"
      unitRef="usd">197000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMjktMy0xLTEtNDcyODQ_0551ae0e-dbbf-43fc-9a22-0d9f32847a37"
      unitRef="usd">325000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzAtMS0xLTEtNDcyODQ_51447257-e60c-4828-8729-408575fdd723"
      unitRef="usd">83000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzAtMy0xLTEtNDcyODQ_0c819f8b-20c1-48ca-b100-ab5842047fc8"
      unitRef="usd">75000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzEtMS0xLTEtNDcyODQ_295d387a-efac-49fc-90ea-95b1193b6f5c"
      unitRef="usd">-272000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzEtMy0xLTEtNDcyODQ_9b5d429e-4aff-420e-ab01-30118c21357a"
      unitRef="usd">-210000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzQtMS0xLTEtNDcyODQ_5763eac9-b59e-4926-8831-6cf86dc8dc73"
      unitRef="usd">3642000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzQtMy0xLTEtNDcyODQ_9a220388-0258-4a6d-8828-6bf21883c067"
      unitRef="usd">5455000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzgtMS0xLTEtNDcyODQ_cc4fd4a8-5055-4525-adda-7e63c02b3b0c"
      unitRef="usd">3270000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzgtMy0xLTEtNDcyODQ_859c7a70-4b40-4311-9bd5-525ee7627c7c"
      unitRef="usd">5303000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzktMS0xLTEtNDcyODQ_988c5bde-32b7-4b05-8e08-38ec7d86d5f3"
      unitRef="usd">498000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfMzktMy0xLTEtNDcyODQ_9db8b2c3-3e58-4f1b-9b02-21e4dd7c3725"
      unitRef="usd">500000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDAtMS0xLTEtNDcyODQ_834ab430-5c7f-4229-93f3-e3cc730610cf"
      unitRef="usd">1646000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDAtMy0xLTEtNDcyODQ_f4ada092-3176-4811-aef7-7f83c7afa0dd"
      unitRef="usd">1030000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDEtMS0xLTEtNDcyODQ_4a1c5fcd-d8e0-478c-9797-8cadb5fe0b56"
      unitRef="usd">184000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDEtMy0xLTEtNDcyODQ_2cdecdbf-5a5d-4882-a4e5-edbffb686c9c"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDMtMS0xLTEtNDcyODQ_b8e5b1b9-76d4-467a-bf8e-54281ed45057"
      unitRef="usd">174000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDMtMy0xLTEtNDcyODQ_3227703f-cef1-4daa-b036-46d0e9f731d9"
      unitRef="usd">55000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDQtMS0xLTEtNDcyODQ_5e935a7a-e2fa-4717-b173-c6c609a5139b"
      unitRef="usd">1986000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDQtMy0xLTEtNDcyODQ_08ed7e6e-a6d3-47d0-93ee-dcb52c032f6b"
      unitRef="usd">500000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDUtMS0xLTEtNDcyODQ_c2f2f41b-79ae-4de8-8630-f0da79cb9c92"
      unitRef="usd">206000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDUtMy0xLTEtNDcyODQ_f464891b-a622-4494-b9a4-244e4e3b8b3e"
      unitRef="usd">209000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDYtMS0xLTEtNDcyODQ_8c4722d3-d872-4013-b194-9eecd6f77db1"
      unitRef="usd">1031000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDYtMy0xLTEtNDcyODQ_452670d2-6fdf-471d-b220-007aab08763f"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDctMS0xLTEtNDcyODQ_b64bf8b2-8861-43e1-90ba-50df6854875d"
      unitRef="usd">-323000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDctMy0xLTEtNDcyODQ_b4d63b82-835a-4038-9663-30a4e8ae4263"
      unitRef="usd">-95000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDgtMS0xLTEtNDcyODQ_b49dd416-84c0-4922-b455-66ca53c143ec"
      unitRef="usd">-4332000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDgtMy0xLTEtNDcyODQ_0cfc2b7f-b725-4cd6-bf77-b852f31ac873"
      unitRef="usd">-1176000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDktMS0xLTEtNDcyODQ_c41a0174-858f-4a19-8b0e-9f52786d5244"
      unitRef="usd">35000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNDktMy0xLTEtNDcyODQ_d086eece-0c6e-40f9-b89b-b02d9a84b31a"
      unitRef="usd">-77000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTAtMS0xLTEtNTM3MjA_7b3aa86c-11ed-48a9-9dd8-77cec0ecab30"
      unitRef="usd">-215000000</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTAtMy0xLTEtNTM3MjA_63b6d921-ff4f-4e80-8aee-cdbf80a45086"
      unitRef="usd">0</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTAtMS0xLTEtNDcyODQ_c65e5b7c-e8b3-49b5-b7f9-33e41537e43d"
      unitRef="usd">-3237000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTAtMy0xLTEtNDcyODQ_6f545269-da92-4983-8f76-2f0b8dcdcd48"
      unitRef="usd">-291000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTEtMS0xLTEtNDcyODQ_9a39bcde-7857-42ae-bddc-d1d46328fc19"
      unitRef="usd">6396000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3cd3b8f0b9fb4e3b80f26f6a286a8c4c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTEtMy0xLTEtNDcyODQ_8af227a5-de5e-4ad3-ae20-ad26a01d5810"
      unitRef="usd">4023000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTItMS0xLTEtNDcyODQ_ca9586af-6d18-4191-a16d-929238d00354"
      unitRef="usd">3159000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i92b029a90e9640e6a41de2c763149aec_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTItMy0xLTEtNDcyODQ_fdc7fdbe-1742-4947-b02d-ee4bbcc9751c"
      unitRef="usd">3732000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTMtMS0xLTEtNDcyODQ_5bf7e09c-52ad-4e6c-ba0b-c0b4698ae35d"
      unitRef="usd">405000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i92b029a90e9640e6a41de2c763149aec_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTMtMy0xLTEtNDcyODQ_218c5f9d-d8e6-4e15-affc-6337ea2fbf16"
      unitRef="usd">155000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTUtMS0xLTEtNDcyODQ_a918fd6c-c8b8-4396-99d5-5ec7b383b232"
      unitRef="usd">2754000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i92b029a90e9640e6a41de2c763149aec_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8yOC9mcmFnOjliNjk4ZjliOTIwMDRjN2Q5OWE5ZjMwZTJhNjMxN2JhL3RhYmxlOjZhMTE5YmYzYWM1MTRjNGI4MWRjMzllODc3MDc0MzJkL3RhYmxlcmFuZ2U6NmExMTliZjNhYzUxNGM0YjgxZGMzOWU4NzcwNzQzMmRfNTUtMy0xLTEtNDcyODQ_1e50e691-a8d7-4b75-b8f6-bb80512afcec"
      unitRef="usd">3577000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY2OA_538a51ba-966c-4521-afb8-a376feb7deec">Significant Accounting Policies&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: McKesson Corporation (&#x201c;McKesson,&#x201d; or the &#x201c;Company,&#x201d;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations in healthcare to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#x201c;RxTS&#x201d;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#x201c;Segments of Business,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S.&#x201d;) of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) pandemic. As COVID-19 further evolves, the Company&#x2019;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three and nine months ended December 31, 2021 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, previously filed with the SEC on May&#160;12, 2021 (&#x201c;2021 Annual Report&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, the Company prospectively adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNTcx_463d7fc6-8d21-4d8d-b29d-45115b5bdf9c"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY4NA_448b9c6a-8d5c-4383-9d72-9ac39aa3fd5e">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S.&#x201d;) of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY5OA_f54b7431-7898-4b06-a448-bef0ce51cb11">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) pandemic. As COVID-19 further evolves, the Company&#x2019;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</us-gaap:UseOfEstimates>
    <us-gaap:ComparabilityOfPriorYearFinancialData
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY3OQ_60374c9e-bed0-442f-ba09-1f6194d0c6c0">The results of operations for the three and nine months ended December 31, 2021 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, previously filed with the SEC on May&#160;12, 2021 (&#x201c;2021 Annual Report&#x201d;).</us-gaap:ComparabilityOfPriorYearFinancialData>
    <us-gaap:FiscalPeriod
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY4Ng_dd8793e8-1a53-40e8-907b-2f0bc6893fb9">The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.</us-gaap:FiscalPeriod>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY5MA_bee877ca-4194-4a5c-810d-b507f5e505e6">Certain prior year amounts have been reclassified to conform to the current year presentation.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNC9mcmFnOjlmMjJiZjFkYTEyYjQ4OWZhYmVhMGUxYWZhODNkN2Y0L3RleHRyZWdpb246OWYyMmJmMWRhMTJiNDg5ZmFiZWEwZTFhZmE4M2Q3ZjRfNDY4Mw_f3da760e-04cb-4835-a80c-389eb4e931c3">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, the Company prospectively adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfNTA0NQ_98dfb516-2c64-48f0-8844-30e3d8f0d21c">Held for Sale&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company announced its intention to exit its businesses in Europe. Assets and liabilities of certain European businesses to be disposed of by sale (&#x201c;disposal groups&#x201d;) are classified as &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. Assets and liabilities that have met the classification of held for sale were $5.5 billion and $4.8 billion, respectively, at December 31, 2021 and $12 million and $9 million, respectively, at March 31, 2021. The amounts at December 31, 2021 primarily consisted of disposal groups related to the Company&#x2019;s European divestiture activities, as discussed below. During the three and nine months ended December 31, 2021, the Company recorded charges totaling $879&#160;million and $1.4&#160;billion, respectively, primarily to remeasure the assets and liabilities of the disposal groups related to European divestiture activities discussed below to the lower of their carrying value or fair value less costs to sell. These charges were largely driven by declines in the British pound sterling and the Euro. During the three and nine months ended December 31, 2020, the Company recorded losses of $47&#160;million and $57&#160;million, respectively, related to the contribution of its German pharmaceutical wholesale business to the joint venture with Walgreens Boots Alliance which was completed on November 1, 2020. The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;European Divestiture Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#x201c;E.U.&#x201d;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#x201c;E.U. disposal group&#x201d;) to the PHOENIX Group for a purchase price of &#x20ac;1.2 billion (or, approximately $1.4 billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;) at the transaction closing date. The transaction is anticipated to close within the first half of fiscal year 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable. As of December 31, 2021, the E.U. disposal group, consisting of $3.1 billion of assets and $2.3 billion of liabilities primarily within the Company&#x2019;s International segment, was classified as &#x201c;Assets held for sale&#x201d; and &#x201c;Liabilities held for sale,&#x201d; respectively, in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended December 31, 2021, the Company recorded charges totaling $26&#160;million and $517&#160;million, respectively, to remeasure the E.U. disposal group to the lower of its carrying value or fair value less costs to sell. These charges also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole. The remeasurement adjustment includes net losses of $230 million related to the accumulated other comprehensive income balances associated with the E.U. disposal group, driven by declines in the Euro. The charges were recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations. The Company&#x2019;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Excludes charges related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2021, the Company announced an agreement to sell its retail and distribution businesses in the United Kingdom (&#x201c;U.K. disposal group&#x201d;) to Aurelius Elephant Limited for a purchase price of &#xa3;325&#160;million (or, approximately $440&#160;million), subject to certain adjustments. As of December 31, 2021, the U.K. disposal group, consisting of $1.9&#160;billion of assets and $2.3&#160;billion of liabilities primarily within the Company&#x2019;s International segment, was classified as &#x201c;Assets held for sale&#x201d; and &#x201c;Liabilities held for sale,&#x201d; respectively, in the Condensed Consolidated Balance Sheet. The transaction is expected to close in the fourth quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended December 31, 2021, the Company recorded charges totaling $823&#160;million to remeasure the U.K. disposal group to the lower of its carrying value or fair value less costs to sell. The remeasurement adjustment includes a $731&#160;million loss related to the accumulated other comprehensive income balances associated with the U.K. disposal group, driven by declines in the British pound sterling. The charges were recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations. The Company&#x2019;s measurement of the fair value of the U.K. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the U.K. disposal group that have met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 20, 2021, the Company announced an agreement with Quadrifolia Management GmbH for a management-led buyout of its Austrian business for a purchase price of &#x20ac;226&#160;million (or, approximately $257&#160;million), subject to certain adjustments. At December 31, 2021, the net assets of the Austrian business of $290&#160;million, primarily within the Company&#x2019;s International segment, were classified as &#x201c;Assets held for sale&#x201d; and &#x201c;Liabilities held for sale&#x201d; in the Condensed Consolidated Balance Sheet. The transaction closed on January 31, 2022. In the three and nine months ended December 31, 2021, the Company recognized a loss of $30&#160;million to remeasure the assets and liabilities of the business to the lower of its carrying value or fair value less costs to sell. The charge was recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <mck:HeldForSalePolicyTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfNTA0Ng_b73344ec-7e2f-4e17-8802-cce9ea7dd3a3">Assets and liabilities of certain European businesses to be disposed of by sale (&#x201c;disposal groups&#x201d;) are classified as &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group.</mck:HeldForSalePolicyTextBlock>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i309bd0e5ce434017a3985a239297e197_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA1NQ_f1ba2af1-b4fd-4806-ab6e-f3a2fdfac114"
      unitRef="usd">5500000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i309bd0e5ce434017a3985a239297e197_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA2Mg_37728971-d4b6-4b66-94b1-c7a967df5ae9"
      unitRef="usd">4800000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="if55a1f085e0849c78909dea0bbe21536_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5MA_5a8f2052-383b-42b5-8cc5-ccf3d620762a"
      unitRef="usd">12000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="if55a1f085e0849c78909dea0bbe21536_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5Nw_f9d1dbd5-002a-4ab0-a220-1a1a0b1094b1"
      unitRef="usd">9000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i9e504a0e274543e69fed9f79303ad80e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1MTA3Ng_7112d60c-6770-449e-8e22-21d74d3b717f"
      unitRef="usd">879000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ibe12fecbb15d4762ad018564eb3bf31a_D20210401-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1MTA5MA_d91f9334-8414-449d-a910-f52542f20b28"
      unitRef="usd">1400000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i4bc2bdbef58a40d19661323d7b54990c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1MTAyMg_0450b368-8326-417f-9462-e51f8b0874c8"
      unitRef="usd">47000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="iddc5a92071754307af41a34bc9c1f1ea_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1MTA1NQ_0906cba0-a800-42f2-9192-c87e6b1028d5"
      unitRef="usd">57000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i64c3f8f2f25f4734b8e1b0d9bbbae72c_I20210705"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDIzNQ_8877ebe5-f9bb-4cc4-8285-9b8506b4f08b"
      unitRef="eur">1200000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i64c3f8f2f25f4734b8e1b0d9bbbae72c_I20210705"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDIyNQ_df5a5f1d-603d-41c6-8f89-4ab30aa2fa7b"
      unitRef="usd">1400000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMjM0NQ_9ce348c0-322a-415f-9c16-d0cfe1a11434"
      unitRef="usd">3100000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMjM2Mg_610bc4b2-6376-4f86-b21d-ccf631976d52"
      unitRef="usd">2300000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i5b4ca1a6e16e4bbeb9da4a62c3265a52_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1MjI5MQ_33a8da34-e338-4d25-b9d7-2fbead7c34ce"
      unitRef="usd">26000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="if374ea59631143b09b6e3e2a5671193c_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMjYzMQ_9a26cc4a-6705-48c9-9b69-f004e0a49505"
      unitRef="usd">517000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue
      contextRef="if374ea59631143b09b6e3e2a5671193c_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMjk3Ng_e8b8c63c-9ea3-4a02-b7cf-7baa0e43c116"
      unitRef="usd">230000000</mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue>
    <mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue
      contextRef="i5b4ca1a6e16e4bbeb9da4a62c3265a52_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMjk3Ng_efbec70b-50ce-4aa6-b7d2-1dcd7e616c23"
      unitRef="usd">230000000</mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfNTA0Mw_771fc291-c15c-4d67-aa11-6828d13e63c5">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Excludes charges related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the U.K. disposal group that have met the classification of held for sale in the Company&#x2019;s Condensed Consolidated Balance Sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMy0xLTEtMS00NzI4NA_20866763-29ef-4662-9a21-3ebed43cd120"
      unitRef="usd">1346000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfNC0xLTEtMS00NzI4NA_012d83f3-318a-4d5c-861a-0d52761bdd94"
      unitRef="usd">913000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfNS0xLTEtMS00NzI4NA_840fbed0-3cc8-4489-b7fb-aae48b4ac694"
      unitRef="usd">75000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfNi0xLTEtMS00NzI4NA_afa20dee-6fc1-4043-a9d4-68cddac36204"
      unitRef="usd">296000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfNy0xLTEtMS00NzI4NA_c141a84b-2803-4f5f-bc52-6400d4999f80"
      unitRef="usd">221000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfOC0xLTEtMS00NzI4NA_4162f4aa-9811-4379-bf3d-0b2c179cb77f"
      unitRef="usd">274000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfOS0xLTEtMS00NzI4NA_4020a185-8529-45e2-a1e9-7961622a5553"
      unitRef="usd">348000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTAtMS0xLTEtNDcyODQ_b2eee9cf-7b68-4489-a534-544375d02cd3"
      unitRef="usd">387000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTEtMS0xLTEtNDcyODQ_050e3a29-d59f-4e69-8021-0fab9d237068"
      unitRef="usd">3086000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTUtMS0xLTEtNDcyODQ_ba118ab4-a5cb-428e-abee-e28a3bc21d17"
      unitRef="usd">1433000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTYtMS0xLTEtNDcyODQ_b521e732-ded5-4c90-9a40-8ffbe64e8436"
      unitRef="usd">5000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTctMS0xLTEtNDcyODQ_eacb7dc7-bd9a-4928-b461-650a8ce5ec8f"
      unitRef="usd">32000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTgtMS0xLTEtNDcyODQ_37d5b994-4ed3-4053-a89d-7c731c0ac034"
      unitRef="usd">440000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMTktMS0xLTEtNDcyODQ_dd1fc9db-f882-4390-a1d3-6fbc91ab46e7"
      unitRef="usd">12000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMjAtMS0xLTEtNDcyODQ_5a2516a6-dfe3-4071-8265-f60f404dc339"
      unitRef="usd">47000000</mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMjEtMS0xLTEtNDcyODQ_158615ed-5e82-4d26-aaf9-557ab9743ef4"
      unitRef="usd">187000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMjItMS0xLTEtNDcyODQ_ae83d35e-f336-4b07-9009-0a2413486704"
      unitRef="usd">165000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i10a2699ec09f4c4a92c66ae680e3c440_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmU2MDE3NjAyODZmMTRkNzQ4MGViMzFiZmMwODI1ZTU1L3RhYmxlcmFuZ2U6ZTYwMTc2MDI4NmYxNGQ3NDgwZWIzMWJmYzA4MjVlNTVfMjMtMS0xLTEtNDcyODQ_e3ced062-d193-4cab-9cd1-62c7d3f0a23c"
      unitRef="usd">2321000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware
      contextRef="i6f779261e3804b478a035d030ffeb926_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMzc4OQ_0bd62298-56ff-40e5-b5ba-74c343a9d289"
      unitRef="usd">113000000</mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i8aadd60f8b644a8ba5a20fae10cb7b86_I20211101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDI3MA_358458aa-c64a-45c4-b361-b942b8af1339"
      unitRef="gbp">325000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i8aadd60f8b644a8ba5a20fae10cb7b86_I20211101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDI3Nw_933dc2e7-d18b-4ca8-954f-38da71e5724d"
      unitRef="usd">440000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDI1MQ_ca4d1b3a-8d91-4fc2-a527-e544c5c3c7fd"
      unitRef="usd">1900000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDI1Nw_3ef5e8e2-ba06-4ebd-a241-3276398d270b"
      unitRef="usd">2300000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i7a2ecac161104759a17bcb76d94a2b91_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTYzNjI5MQ_cbea14f1-9edb-4012-9985-819bbce44d99"
      unitRef="usd">823000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i7b6587768d5e4ba2b267df62494974ef_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTYzNjI5MQ_d4b85730-318c-44e0-b2ee-f949b73d3942"
      unitRef="usd">823000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue
      contextRef="i7a2ecac161104759a17bcb76d94a2b91_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTYzNjMwNQ_f62d3c0d-7004-4182-9d61-7712275ef58f"
      unitRef="usd">731000000</mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue>
    <mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue
      contextRef="i7b6587768d5e4ba2b267df62494974ef_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTYzNjMwNQ_f77a8146-1787-429b-b740-41412d5e2350"
      unitRef="usd">731000000</mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMy0xLTEtMS01NDU3OQ_d939ea0b-65dc-468b-a0b6-ff4e57ec6529"
      unitRef="usd">206000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMy0xLTEtMS00ODc4OQ_4cb28b95-b59c-48b8-87cf-494f8b9c293a"
      unitRef="usd">1212000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfNC0xLTEtMS00ODc4OQ_b49bab5f-47ab-43f7-87fc-143e374dce6a"
      unitRef="usd">698000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfNS0xLTEtMS00ODc4OQ_f8be62d5-e499-4758-8399-6fafdd15468a"
      unitRef="usd">76000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfNi0xLTEtMS00ODc4OQ_aa16dd61-2ec6-45fd-a19d-82aef318d294"
      unitRef="usd">91000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfNy0xLTEtMS00ODc4OQ_d5c526a4-f5e3-4f75-b165-dd0661b2794c"
      unitRef="usd">259000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfOC0xLTEtMS00ODc4OQ_52e574e7-79ff-454b-b1d2-985bb430133c"
      unitRef="usd">120000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfOS0xLTEtMS00ODc4OQ_0ac2e91b-0b30-4d83-8439-a56de0f87eaf"
      unitRef="usd">78000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMTAtMS0xLTEtNDg3ODk_b3c9f737-7ce6-43ac-927f-386ef70c4285"
      unitRef="usd">822000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMTEtMS0xLTEtNDg3ODk_6397d54e-7e59-45a4-956d-4a416222d365"
      unitRef="usd">1918000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMTUtMS0xLTEtNDg3ODk_c75e281a-6e5e-4e8f-842e-5966da693883"
      unitRef="usd">1756000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMTctMS0xLTEtNDg3ODk_0ee02ab3-5c62-4032-98b0-19be529786db"
      unitRef="usd">51000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMTgtMS0xLTEtNDg3ODk_1dfdc43e-59b5-4aa0-9e18-bfd387a42299"
      unitRef="usd">141000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMjEtMS0xLTEtNDg3ODk_5d79c552-4153-4313-a488-3faab0aba924"
      unitRef="usd">269000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMjItMS0xLTEtNDg3ODk_d57dc624-c967-4a85-8ae5-3119691619cf"
      unitRef="usd">57000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i6c2657ec4fc04232a99ae16e23e0f399_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RhYmxlOmZjN2JjNjhmZWM1OTRiMDA4NWVjZjk1YTMzMmU3NGJjL3RhYmxlcmFuZ2U6ZmM3YmM2OGZlYzU5NGIwMDg1ZWNmOTVhMzMyZTc0YmNfMjMtMS0xLTEtNDg3ODk_faf71233-ff32-4c77-ba61-455112ae2c61"
      unitRef="usd">2274000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="icf6948803676498cbf4f702d46fd11ac_I20211220"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ2Njc4Mw_38d4e832-de58-48b1-ba0a-4f58ec6da849"
      unitRef="eur">226000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="icf6948803676498cbf4f702d46fd11ac_I20211220"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ2Njc5Nw_7bfd3ed5-007c-4013-8dd9-b8116189de35"
      unitRef="usd">257000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <us-gaap:AssetsNet
      contextRef="i0914720c662a4ad59b56ab30f003e13e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTY0OTI2NzQ1MDM0Nw_502ce08a-a007-4ce3-8658-f4419f6eaaaa"
      unitRef="usd">290000000</us-gaap:AssetsNet>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i90d1e84fd58d41a08c7559556cfa6e5e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1NjkwNw_233ff5b0-37dd-4a07-abac-abf7ac309949"
      unitRef="usd">30000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i0e0e546ae1e249039d79b3c361e64a24_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV8zNy9mcmFnOjNlNDQyMzc5NTE5YzRlZDZhM2U2NjdjNGVjZjAwY2U4L3RleHRyZWdpb246M2U0NDIzNzk1MTljNGVkNmEzZTY2N2M0ZWNmMDBjZThfMTA5OTUxMTY1NjkwNw_aff591a2-996d-4097-b7c5-2bddbfa22fef"
      unitRef="usd">30000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDkxMQ_d5ea832a-3b2f-4aeb-8ff6-cf68f5e84f60">Restructuring, Impairment, and Related ChargesThe Company recorded restructuring, impairment, and related charges of $18 million and $208 million during the three and nine months ended December 31, 2021, respectively, and $155 million and $271 million during the three and nine months ended December 31, 2020, respectively. These charges are included in &#x201c;Restructuring, impairment, and related charges&#x201d; in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives were included in &#x201c;Cost of sales&#x201d; in the Condensed Consolidated Statement of Operations and were not material for the nine months ended December 31, 2020.&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Initiatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily includes the rationalization of the Company&#x2019;s office space in North America. Where it determines to cease using office space, the Company plans to exit the portion of the facility no longer used. It also may retain and repurpose certain other office locations. The Company expects to incur total charges of approximately $140 million&#160;to $180 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments. The Company recorded charges of $5 million and $115 million, respectively, in the three and nine months ended December 31, 2021. Charges primarily relate to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative is anticipated to be substantially complete in 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#x201c;U.K.&#x201d;), which is included in the Company&#x2019;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative included reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Charges incurred for this initiative were not material for the three and nine months ended December 31, 2021 and were $9 million and $50 million for the three and nine months ended December 31, 2020, respectively, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. This initiative was substantially complete in the third quarter of 2022, and remaining costs the Company expects to record under this initiative are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and nine months ended December 31, 2021 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Costs primarily relate to the transition to the partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs related to optimization programs in Canada as well as the transition to a partial remote work model and the U.K. operating model and cost optimization efforts both described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and nine months ended December 31, 2020 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with an operating model and cost optimization initiative and with the relocation of the Company&#x2019;s corporate headquarters. Both of these initiatives were substantially completed in the year ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above, and an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with an operating model and cost optimization initiative and with the relocation of the Company&#x2019;s corporate headquarters. Both of these initiatives were substantially completed in the year ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the nine months ended December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#x201c;Other accrued liabilities&#x201d; and $52 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of December 31, 2021, the total reserve balance was $144 million, of which $52 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $44 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $48 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Lived Asset Impairments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company recognized charges of $115&#160;million to impair certain long-lived assets within the Company&#x2019;s International segment. These charges primarily related to long-lived assets associated with the Company&#x2019;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach (a discounted cash flow (&#x201c;DCF&#x201d;) method) and a market approach to estimate the fair value of the long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the long-lived assets is considered a Level 3 fair value measurement due to the significance of unobservable inputs developed using company specific information. Refer to Financial Note 11, &#x201c;Fair Value Measurements,&#x201d; for more information on nonrecurring fair value measurements.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfODM_fa767fbf-a001-45f8-b0e6-0ffbb36172a0"
      unitRef="usd">18000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfOTA_1b284a85-d714-4cc0-842e-a19eed5708cc"
      unitRef="usd">208000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMTI2_db30fd78-acb2-450a-b46c-d719a8e0a93c"
      unitRef="usd">155000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMTMz_09638ab5-603f-4216-92d8-5be12b8eb1fe"
      unitRef="usd">271000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i082db05a184a45abb24328a6c95b59c7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfOTkw_2c2fa927-a723-456f-8390-c72ae9a5a68f"
      unitRef="usd">140000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i890b4a0eb5514ad49a5ab0eda1744e3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfOTk2_cc1e9522-f855-4398-bac2-5899aed97670"
      unitRef="usd">180000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringCharges
      contextRef="i278171a6be044601b82b45db97c44012_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMTE4Mw_dcb67157-6c54-48e5-9a81-2453ddd75208"
      unitRef="usd">5000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i67f5dae20f6d49a8b3c72b65242baec8_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMTE5MA_9cb01722-377d-4a75-aa2e-947ecf2a2466"
      unitRef="usd">115000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7ef12d06d22b408b9631eede48f318c6_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMjA5MA_d9e429df-d1d3-4871-8661-3a16b977ff2d"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if17bd5af058345ef8f80c5f477b1769a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMjA5Nw_263e0a7c-64b3-4ab0-a32f-f6f1916a53f0"
      unitRef="usd">50000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNzE0NjgyNTU4ODY1MA_cc028c5b-3b73-407c-b5f6-2fc51ce2ec7b">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and nine months ended December 31, 2021 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Costs primarily relate to the transition to the partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs related to optimization programs in Canada as well as the transition to a partial remote work model and the U.K. operating model and cost optimization efforts both described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and nine months ended December 31, 2020 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with an operating model and cost optimization initiative and with the relocation of the Company&#x2019;s corporate headquarters. Both of these initiatives were substantially completed in the year ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above, and an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with an operating model and cost optimization initiative and with the relocation of the Company&#x2019;s corporate headquarters. Both of these initiatives were substantially completed in the year ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi0xLTEtMS00NzI4NA_cce215d4-20fa-4d1d-afe2-40f2b7941bc5"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi0zLTEtMS00NzI4NA_dea8bcc5-af31-4016-8660-a8333c3737c1"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi01LTEtMS00NzI4NA_1122dd07-7d7d-4c00-9196-e098484326d5"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi03LTEtMS00NzI4NA_e7cf5c0b-5e73-4b68-b3c5-0f573bef1414"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i6255fa153b8b446d9bdaa92a69dc6082_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi05LTEtMS00NzI4NA_09266f39-ee70-46b7-9a0c-8e7c0b2ff28f"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMi0xMS0xLTEtNDcyODQ_3ff00c10-a15b-4b8c-888f-882042358397"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy0xLTEtMS00NzI4NA_bd9b0c28-d949-48d2-ae3c-a95ca02bf7a8"
      unitRef="usd">3000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy0zLTEtMS00NzI4NA_f2347c21-489e-435d-8763-2389ef92b5b9"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy01LTEtMS00NzI4NA_ddd465fe-912d-4714-a60c-d0c3a8b71699"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy03LTEtMS00NzI4NA_7ac8840b-6747-4788-813f-577e62d94e31"
      unitRef="usd">6000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i6255fa153b8b446d9bdaa92a69dc6082_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy05LTEtMS00NzI4NA_9ce7db68-c928-4603-8ff9-bba7db4c3fac"
      unitRef="usd">6000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfMy0xMS0xLTEtNDcyODQ_67434f82-d709-4204-accd-e47a5353222c"
      unitRef="usd">16000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC0xLTEtMS00NzI4NA_fe4de353-1ff7-40dc-a6c9-07707da22013"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC0zLTEtMS00NzI4NA_7e54757e-91bb-4add-81cc-06413aa888f9"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC01LTEtMS00NzI4NA_28e0a0c4-0c89-4283-bb22-822d01cec97a"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC03LTEtMS00NzI4NA_5af9c37d-790d-4de9-88a5-1b8a887e8cef"
      unitRef="usd">-1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i6255fa153b8b446d9bdaa92a69dc6082_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC05LTEtMS00NzI4NA_6588f4cf-027a-4adc-bd61-60418392e63b"
      unitRef="usd">2000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNC0xMS0xLTEtNDcyODQ_8759d22c-aa4a-4a29-875f-6677b2f14e9a"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS0xLTEtMS00NzI4NA_21bc12ed-8044-4720-b120-d0033dcf648c"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS0zLTEtMS00NzI4NA_1b20391b-efe4-4aef-a27f-74e8dad28836"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS01LTEtMS00NzI4NA_514a043c-54c5-4eb2-8923-5a60344275d0"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS03LTEtMS00NzI4NA_9aa74558-677b-4b09-93e6-806b86b96ee0"
      unitRef="usd">5000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6255fa153b8b446d9bdaa92a69dc6082_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS05LTEtMS00NzI4NA_e10ca9c6-0098-4d76-84f5-edf53f4b0aa6"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjk0NjE3Y2VlODJhYzQxZjhhYWQyMzBlOWE2ZWViYTA5L3RhYmxlcmFuZ2U6OTQ2MTdjZWU4MmFjNDFmOGFhZDIzMGU5YTZlZWJhMDlfNS0xMS0xLTEtNDcyODQ_68351941-8638-49aa-b1e3-d7d36523e241"
      unitRef="usd">18000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi0xLTEtMS00NzI4NA_d03470e9-8dff-4479-8982-5ba742386435"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi0zLTEtMS00NzI4NA_080c064f-13fc-4307-a1ad-2ff435e97bc6"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi01LTEtMS00NzI4NA_e51c1688-9e67-477b-9656-6de99acd8c6d"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi03LTEtMS00NzI4NA_d5f179dc-8c41-4701-9e53-f92cf441c299"
      unitRef="usd">10000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi05LTEtMS00NzI4NA_385598f0-7376-412e-9b5a-50dba839f67e"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMi0xMS0xLTEtNDcyODQ_dc293104-02a2-43a8-bc43-00af0166e3f2"
      unitRef="usd">14000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy0xLTEtMS00NzI4NA_d9627435-d889-41c4-8260-c04cad241f1a"
      unitRef="usd">7000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy0zLTEtMS00NzI4NA_45921e7d-df7e-4855-9d10-082a5d9cedf3"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy01LTEtMS00NzI4NA_df3117c9-70fb-4382-9cbe-e709018ca072"
      unitRef="usd">3000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy03LTEtMS00NzI4NA_7e257cea-50d1-43e3-87a7-addc0def2ec7"
      unitRef="usd">21000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy05LTEtMS00NzI4NA_1614ea6f-373a-47b8-ac8c-878ceb9beaad"
      unitRef="usd">33000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfMy0xMS0xLTEtNDcyODQ_74c23d41-572a-4387-b9e3-3b5bd1cac286"
      unitRef="usd">66000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC0xLTEtMS00NzI4NA_2f83c874-6c11-45fe-9ca0-0302a6cc390a"
      unitRef="usd">16000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC0zLTEtMS00NzI4NA_7d617949-eeda-4501-9951-c394d6aeb9e2"
      unitRef="usd">17000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC01LTEtMS00NzI4NA_ad8e4b71-647c-4434-aabd-9e929963c0d4"
      unitRef="usd">5000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC03LTEtMS00NzI4NA_d733ed40-41e8-4ae6-b907-e0cff00f1347"
      unitRef="usd">35000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC05LTEtMS00NzI4NA_4c428d73-0f35-4b92-b3b2-d3b3029d33b4"
      unitRef="usd">55000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNC0xMS0xLTEtNDcyODQ_85993b49-63e3-464f-aa6a-0a41841616d7"
      unitRef="usd">128000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS0xLTEtMS00NzI4NA_faed0162-5467-4e70-9eaf-a66b7075b1f7"
      unitRef="usd">25000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS0zLTEtMS00NzI4NA_885f696a-6c49-47d7-9a80-359e41c675c0"
      unitRef="usd">18000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS01LTEtMS00NzI4NA_2ebf9a25-8993-4cb6-b039-d9280146fa93"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS03LTEtMS00NzI4NA_a9ef0e8c-d450-4fc2-b24b-57621ca36602"
      unitRef="usd">66000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS05LTEtMS00NzI4NA_f0127312-a647-49ea-ad72-2cccf31d8637"
      unitRef="usd">90000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjgyMjhiNmI3OGNiYjQ1ODQ5YjYzNGU4ZmFhZjMyZDQ5L3RhYmxlcmFuZ2U6ODIyOGI2Yjc4Y2JiNDU4NDliNjM0ZThmYWFmMzJkNDlfNS0xMS0xLTEtNDcyODQ_d378e51d-e7b2-465b-be27-1a8c38d65078"
      unitRef="usd">208000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi0xLTEtMS00NzI4NA_4de7af2a-088d-4d4b-8784-09bd3a2862d5"
      unitRef="usd">3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi0zLTEtMS00NzI4NA_431a9ba9-88f0-407a-b3a8-7f628788c86d"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi01LTEtMS00NzI4NA_94dcb014-4af5-4adf-8fad-4482e248060a"
      unitRef="usd">-3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi03LTEtMS00NzI4NA_a7d9a340-cd2d-4028-8a5c-78d528ab1c6e"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi05LTEtMS00NzI4NA_8eeedfe4-06a4-4937-a0e6-8fc151e188fd"
      unitRef="usd">7000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMi0xMS0xLTEtNDcyODQ_bd274653-d09a-40c1-9dff-c8616ec4b898"
      unitRef="usd">9000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy0xLTEtMS00NzI4NA_4ce54fbb-baa8-4186-8315-ea8ee2f00c96"
      unitRef="usd">3000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy0zLTEtMS00NzI4NA_8f0bbe84-b704-429e-8bf5-81aa8e992e7b"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy01LTEtMS00NzI4NA_6a3e797d-e7d8-43fc-b94c-b5ab3c54dc88"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy03LTEtMS00NzI4NA_89c07d08-3074-41a9-9e3e-6f8da230654d"
      unitRef="usd">5000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy05LTEtMS00NzI4NA_ea7cebfc-325e-4585-b9f5-d5aa8471073a"
      unitRef="usd">6000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfMy0xMS0xLTEtNDcyODQ_2d58397f-d20a-4072-a04a-6bc07ae95198"
      unitRef="usd">15000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC0xLTEtMS00NzI4NA_3a91caae-92ef-4356-8ca3-7ca1a4c67b60"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC0zLTEtMS00NzI4NA_161019cb-a9b3-4c0e-842d-40d3228e071a"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC01LTEtMS00NzI4NA_e02a9201-b138-43dd-bebb-aef60c5cf6e4"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC03LTEtMS00NzI4NA_467d030a-2569-4ea6-9adf-6ab209e98478"
      unitRef="usd">9000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC05LTEtMS00NzI4NA_fbc3d3d2-13c1-4083-a9fc-5017488238da"
      unitRef="usd">7000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNC0xMS0xLTEtNDcyODQ_9f20a42b-0c66-4ae6-b2f9-468c62669278"
      unitRef="usd">16000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS0xLTEtMS00NzI4NA_f21b19e3-96f0-4dc6-b6c8-a473fb6d5814"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS0zLTEtMS00NzI4NA_1a196fec-d853-4f06-b36a-17b8a7995d76"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS01LTEtMS00NzI4NA_049b132a-d647-49b4-840d-b8444b7485fc"
      unitRef="usd">-2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS03LTEtMS00NzI4NA_0f191a83-abd9-4e32-8cca-b3599d6507af"
      unitRef="usd">16000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS05LTEtMS00NzI4NA_f426ae8f-51ba-465d-b286-1ffcc9506020"
      unitRef="usd">20000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOmNmMmIzNGUyZTg5NDQ4ZDQ5YjU1ZTVhNDRhNGM1MzViL3RhYmxlcmFuZ2U6Y2YyYjM0ZTJlODk0NDhkNDliNTVlNWE0NGE0YzUzNWJfNS0xMS0xLTEtNDcyODQ_c8e72e42-003d-445c-92b9-a1ae76d00e7b"
      unitRef="usd">40000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi0xLTEtMS00NzI4NA_50c4dc24-16eb-45ae-8060-1306319c5b47"
      unitRef="usd">10000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi0zLTEtMS00NzI4NA_04ab3008-43ce-4411-9c1f-b9e25d556e12"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi01LTEtMS00NzI4NA_ea1fe7b7-f654-4320-ae9a-95a659b6f1bf"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi03LTEtMS00NzI4NA_20ef510c-b835-4267-8b34-e6c666da56e9"
      unitRef="usd">22000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi05LTEtMS00NzI4NA_1d0c5ce8-9150-4142-9433-03c225663c3c"
      unitRef="usd">31000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMi0xMS0xLTEtNDcyODQ_d0fae2cc-e5db-4e81-9aa7-180a36a38cd1"
      unitRef="usd">63000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy0xLTEtMS00NzI4NA_67037302-162d-4fd4-b044-46641d7b8870"
      unitRef="usd">8000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy0zLTEtMS00NzI4NA_4c230f02-b5f3-4801-9d88-2e63de2179b2"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy01LTEtMS00NzI4NA_e0c38116-6249-4505-a925-1bb2b2aec7f1"
      unitRef="usd">3000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy03LTEtMS00NzI4NA_77b82759-ad8f-46e8-832a-b0737bcafdf3"
      unitRef="usd">12000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy05LTEtMS00NzI4NA_8c11a95c-8b19-4171-a444-a56c9d4d1383"
      unitRef="usd">20000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfMy0xMS0xLTEtNDcyODQ_40bb3922-ce2b-4bb3-9543-1a501a4d06d6"
      unitRef="usd">43000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC0xLTEtMS00NzI4NA_38bc2d64-3c9f-47fe-8778-6b8cdb900ec5"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC0zLTEtMS00NzI4NA_45c422a5-871f-437e-b4ee-f7f11329a2a0"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC01LTEtMS00NzI4NA_293f4484-8902-4041-abae-a89dda4e56c7"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC03LTEtMS00NzI4NA_3deef6db-9d19-4cf3-a569-6596536eaaeb"
      unitRef="usd">40000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC05LTEtMS00NzI4NA_c15c835c-312c-4087-b538-f3c00f4e9ff0"
      unitRef="usd">9000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNC0xMS0xLTEtNDcyODQ_6e160929-707c-4fbc-b2fc-c05d533f3e0b"
      unitRef="usd">50000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS0xLTEtMS00NzI4NA_0ee8390d-0992-43df-9327-25012d3668ba"
      unitRef="usd">18000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS0zLTEtMS00NzI4NA_76e2cd15-1725-4f11-91a2-51cf4b5d7a8a"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS01LTEtMS00NzI4NA_86cf1247-813e-47a2-a001-4d7c9cda8e3e"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS03LTEtMS00NzI4NA_63c91732-6693-4465-8b5f-d35716974ebd"
      unitRef="usd">74000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS05LTEtMS00NzI4NA_fa4cd0bd-35fd-414e-823d-6d530c3673bb"
      unitRef="usd">60000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjBlZmJmMGY3NWEyMTRlOTA5ZGU3MmUzNDZhN2QzZmFjL3RhYmxlcmFuZ2U6MGVmYmYwZjc1YTIxNGU5MDlkZTcyZTM0NmE3ZDNmYWNfNS0xMS0xLTEtNDcyODQ_9b369804-5f03-4c2f-b6b9-06a20264a144"
      unitRef="usd">156000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNzE0NjgyNTU4ODY1MQ_2f3a19f4-455c-4e4e-9d90-1fb2f5fd97c7">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the nine months ended December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#x201c;Other accrued liabilities&#x201d; and $52 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of December 31, 2021, the total reserve balance was $144 million, of which $52 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $44 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $48 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i3742a9e3c767428ca709e210fa6bad34_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS0xLTEtMS00NzI4NA_72ad49df-d52d-412f-96cd-605e6b9c55c8"
      unitRef="usd">19000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic0a87db44d0d4d4182e198de1c5b21c4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS0zLTEtMS00NzI4NA_e7b12359-bb6f-4960-bdd6-418d9ecb7ef0"
      unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8294a77ec53f4808af02d30170fb109a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS01LTEtMS00NzI4NA_fc80393a-ffe8-4d0b-bd0e-1d96f6f1d5d2"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iaf0b19c69df049fa808f63371bd26ec9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS03LTEtMS00NzI4NA_3e9dbc05-a660-4b23-9b6d-b90ea3c25ed2"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i05d03e41b9ee4dcd81af0575a30e3f45_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS05LTEtMS00NzI4NA_fa82031d-6a57-47f3-accf-ee24f3d3fcc9"
      unitRef="usd">59000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMS0xMS0xLTEtNDcyODQ_a02e874b-4b4c-4194-84e7-0e9f136dab97"
      unitRef="usd">151000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi0xLTEtMS00NzI4NA_af831fe3-eba5-4c9a-af07-9d75c1b725bc"
      unitRef="usd">25000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi0zLTEtMS00NzI4NA_2103a950-9a14-4730-abbb-7f195dee7179"
      unitRef="usd">18000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi01LTEtMS00NzI4NA_dfc496eb-fef7-4b54-9c4a-64e9134da69f"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi03LTEtMS00NzI4NA_dc7440a0-4a68-4b0e-a391-2d87e5adcbcd"
      unitRef="usd">66000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi05LTEtMS00NzI4NA_1b6e4c17-5a97-4a88-b7fb-aac58f6e9e0a"
      unitRef="usd">90000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMi0xMS0xLTEtNDcyODQ_bab09bc3-d47a-4372-bfaa-dec66489f503"
      unitRef="usd">208000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy0xLTEtMS00NzI4NA_cf07fa52-e344-42d8-9bfd-a06ccd71141a"
      unitRef="usd">16000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy0zLTEtMS00NzI4NA_10783241-b62b-42b5-a1e7-e0cb0b4e13ed"
      unitRef="usd">17000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy01LTEtMS00NzI4NA_acf0b7a9-a76a-49ae-a0e3-497198797ad1"
      unitRef="usd">5000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy03LTEtMS00NzI4NA_71781db9-1835-454b-9336-1223ce9c7d7e"
      unitRef="usd">35000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy05LTEtMS00NzI4NA_18dde85b-a3f4-497f-9476-4d18b52314c0"
      unitRef="usd">55000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfMy0xMS0xLTEtNDcyODQ_9dd39077-a37d-4c52-b7ff-8bcfb6ae43cf"
      unitRef="usd">128000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC0xLTEtMS00NzI4NA_816a1720-3a79-478b-afff-4a5f56fede59"
      unitRef="usd">15000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC0zLTEtMS00NzI4NA_824889df-c540-4291-8823-18d1beb8e9d3"
      unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC01LTEtMS00NzI4NA_ea946a97-01b3-4c53-ba7e-1a8c47fbda21"
      unitRef="usd">5000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC03LTEtMS00NzI4NA_c8973b74-bf37-4020-8383-54bc3a7f1922"
      unitRef="usd">22000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC05LTEtMS00NzI4NA_bf6832d6-80f1-4785-989e-91890a0afd07"
      unitRef="usd">26000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNC0xMS0xLTEtNDcyODQ_e8ab5221-e363-4242-9482-51708316029c"
      unitRef="usd">69000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS0xLTEtMS00NzI4NA_5eda7f3f-181c-4e0e-adb0-af2d01f4ccd9"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS0zLTEtMS00NzI4NA_32effd0b-d1ac-4ff7-98d1-f2c1fca2dff6"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS01LTEtMS00NzI4NA_1d2154e3-4ace-46a5-9238-fa7862d3c722"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS03LTEtMS00NzI4NA_a21e1c23-5d3a-42b4-94b3-a3323aeaa028"
      unitRef="usd">-11000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS05LTEtMS00NzI4NA_603cdcb7-4e63-4a9f-9039-88f6257dca37"
      unitRef="usd">-7000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNS0xMS0xLTEtNDcyODQ_e7fa2419-34ec-40b2-bc32-34bbba79dd7b"
      unitRef="usd">-18000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i7bd134a4f3094ace932c748910dea417_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi0xLTEtMS00NzI4NA_412e9f46-c4e7-4bc7-afc3-f8bfaa5eed71"
      unitRef="usd">13000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ifa2ddeb82199484c81ead365111b0450_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi0zLTEtMS00NzI4NA_9b359af6-0a30-446a-8de5-b81319b67d0c"
      unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i80e1a134cedf416a93e2147fb33ab4a7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi01LTEtMS00NzI4NA_713441ce-3293-4317-a827-635a21406653"
      unitRef="usd">2000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id8490ed3cfc74500b6dec809af6c38fb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi03LTEtMS00NzI4NA_c2ec6623-fad7-434c-ac38-fb312c695b5b"
      unitRef="usd">64000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic0f61357f5234a798f4dce41029f5202_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi05LTEtMS00NzI4NA_0d6fcff1-e337-4d81-81e5-61e2dfb299ee"
      unitRef="usd">61000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RhYmxlOjhiYTAzYjYzZjg0MzQwOTJhYWJhNmRhMjE5MDY0MTFjL3RhYmxlcmFuZ2U6OGJhMDNiNjNmODQzNDA5MmFhYmE2ZGEyMTkwNjQxMWNfNi0xMS0xLTEtNDcyODQ_bdf4db8d-8346-456b-8fe5-c8c6427d7a40"
      unitRef="usd">144000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDYxNg_435f627f-bbde-4069-a84e-5757857b02b5"
      unitRef="usd">151000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib5673a7452c840fab96c68406dedc263_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDYyOQ_568e4014-7cc9-424a-8ee0-99f01dc4c029"
      unitRef="usd">99000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3a02716128214d2eb9f7820b420c8182_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDY1Nw_0518c148-e2fa-45a9-884c-2a3cca79ab19"
      unitRef="usd">52000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDc2Nw_7395ee10-d55b-47ee-9c69-5b32d2d01aed"
      unitRef="usd">144000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia211c26831c34274a5c1964a280c0daf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDc4MA_9b9346d7-814b-471e-b2cc-eb34c54c8e42"
      unitRef="usd">52000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i74ddcf1aa661488db155891acc773561_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDgwNQ_dbc72818-a60a-4e14-a404-d61b7993f60b"
      unitRef="usd">44000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i009f49e0941d419aa250d05631fa2fba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfNDgzNA_311d756f-f866-460d-87c4-17c9efdf9b9d"
      unitRef="usd">48000000</us-gaap:RestructuringReserve>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i4c351ccf073b47a9b3c10a8e07901940_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80MC9mcmFnOmIyZTc4ZTliOTM0MDQ5MWE4ODkyZWRhNzBiMThmYzc3L3RleHRyZWdpb246YjJlNzhlOWI5MzQwNDkxYTg4OTJlZGE3MGIxOGZjNzdfMjk2ODY4MTM5NjE5ODA_eacee2f5-87b1-451d-8db7-9439d01fdb06"
      unitRef="usd">115000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMzM1NA_ad11fd0e-2327-4095-b049-f87fc2afa960">Income Taxes &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended December 31, 2021 and 2020, the Company recorded income tax expense of $238 million and an income tax benefit of $1.2 billion, respectively. During the nine months ended December 31, 2021 and 2020, the Company recorded income tax expense of $396 million and an income tax benefit of $1.0 billion, respectively. The Company&#x2019;s reported income tax expense rate was 85.9% and an income tax benefit rate of 16.1% for the three months ended December 31, 2021 and 2020, respectively, and an income tax expense rate of 30.9% and an income tax benefit rate of 16.7% for the nine months ended December 31, 2021 and 2020, respectively. Fluctuations in the Company&#x2019;s reported income tax rates are primarily due to non-cash charges related to remeasuring the value of its E.U. and U.K disposal groups held for sale to the lower of its carrying value or fair value less costs to sell, changes in the mix of earnings between various taxing jurisdictions, and discrete items recognized in the quarters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended December 31, 2021, the Company recorded non-cash pre-tax charges of $517 million primarily to remeasure the E.U. disposal group to the lower of its carrying value or fair value less costs to sell, and, during the three and nine months ended December 31, 2021, the Company recorded non-cash pre-tax charges of $853 million to remeasure the U.K. disposal group and the Austrian business to the lower of carrying value or fair value less costs to sell, as described in Financial Note 2, &#x201c;Held for Sale.&#x201d; The Company&#x2019;s reported income tax rates for the three and nine months ended December 31, 2021 were unfavorably impacted by the non-deductible nature of the majority of these charges for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reported income tax rates for the nine months ended December 31, 2021 and 2020 were impacted by the charges for opioid-related claims of $193 million ($160 million after-tax) and $8.1 billion ($6.7 billion after-tax), respectively, as described further in Financial Note 12, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2022, the Company recognized a net discrete tax benefit of $42 million primarily related to a decrease in the income recognized pursuant to the global intangible low-tax income (&#x201c;GILTI&#x201d;) regime in its 2021 U.S. Federal income tax return and the statute of limitation expirations in various taxing jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended December 31, 2020, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gain was eliminated upon consolidation. The acquiring entity of the intellectual property is entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#x201c;Intra-Entity Transfers of Assets Other Than Inventory,&#x201d; a discrete tax benefit of $105 million was recognized with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#x2019;s excess tax basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the Company had $1.6 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate if recognized. During the nine months ended December 31, 2021, the Company recognized a net discrete tax benefit of $115 million related to statute of limitation expirations in various taxing jurisdictions. During the next twelve months, the Company does not anticipate any material reduction in its unrecognized tax benefits. However, this may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 12, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#x201c;IRS&#x201d;) is currently examining the Company&#x2019;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjIxOA_1a731332-1f9c-49d2-be26-f9e5532d4483"
      unitRef="usd">238000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjIyNQ_056721ba-2706-4f59-87e8-003f4cdcef60"
      unitRef="usd">-1200000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjIzMg_8f85f4ed-c01b-4d15-8e0d-532eb1749073"
      unitRef="usd">396000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjI0Mg_0467ab58-ae9e-4672-81c3-2a9d8c2f44d2"
      unitRef="usd">-1000000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjI1Mw_3e9a3610-d4f9-45a8-a6e7-67c4b2d24a6b"
      unitRef="number">0.859</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjI1Nw_1f40d39b-c73a-4084-854b-502d6e23a125"
      unitRef="number">0.161</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjI2MQ_3e70a230-f41c-4cf1-b0d3-cbab4fd5443d"
      unitRef="number">0.309</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjI2NQ_b2c6d511-74e8-4fa8-a994-701804f9f943"
      unitRef="number">0.167</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i53948167a7da4f68be6121c6d4840331_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfNzcy_f5533b8a-55a2-4e8a-b1af-4d8bd916306c"
      unitRef="usd">517000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i262128f4e5f940ada5343a7bf5fe0a97_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjM3OQ_43affdd0-a03f-4509-b439-4927794d351e"
      unitRef="usd">853000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i6f49b1ee7cfe4b72a4014ddd42947be3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMjM3OQ_9a3f28be-8801-4a1c-866e-91fa8f144131"
      unitRef="usd">853000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i6b6bcdc79602464fb68d237e91f2c420_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMzQwNw_206f7b06-99e6-440c-9932-bd0af31d5150"
      unitRef="usd">193000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="i6b6bcdc79602464fb68d237e91f2c420_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMzM4OQ_f9d2fc0f-0cd4-48fb-970e-db5248481b8d"
      unitRef="usd">160000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i96393cf84f184dd1a34604191f7e8463_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMzM1Mw_247f30ed-c3e9-4151-bb50-4aa4949e0d71"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="i45576a15c2784ff6aa60281bbbd7fc94_D20200401-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTA5OTUxMTYzMzM3MQ_4338fa19-49ce-4a27-96e5-a189653762ad"
      unitRef="usd">6700000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <mck:EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTE5MQ_8daee0c2-1571-4779-8f79-d6b55673f256"
      unitRef="usd">-42000000</mck:EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount>
    <mck:IncomeTaxExpenseBenefitDiscreteItems
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMTkwNA_2513c169-2e0b-4de0-b1ca-a086841b7c44"
      unitRef="usd">-105000000</mck:IncomeTaxExpenseBenefitDiscreteItems>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMjIwNQ_5ad5b66e-68af-48ca-b105-893672f8987c"
      unitRef="usd">1600000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMjI0Nw_d1565a04-acf2-4176-9937-f451a8e1846c"
      unitRef="usd">1300000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80My9mcmFnOmY2MmFkMjhmMmJiNzRlMzM4OWZmMDc2MGU5MzBjZGM0L3RleHRyZWdpb246ZjYyYWQyOGYyYmI3NGUzMzg5ZmYwNzYwZTkzMGNkYzRfMjQwOA_1ec5ccf9-0027-4f28-8f3f-ff124f2b4a22"
      unitRef="usd">115000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDYwOQ_70e236ef-97d8-4be1-b57d-5e099275493b">Redeemable Noncontrolling Interests and Noncontrolling Interests&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million during the three months ended June 30, 2021, and $11 million and $32 million during the three and nine months ended December 31, 2020, respectively. All amounts were recorded in &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Company&#x2019;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;). Subsequent to the Domination Agreement&#x2019;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#x201c;Appraisal Proceedings&#x201d;) with the Stuttgart Regional Court (the &#x201c;Court&#x201d;) to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified in the Domination Agreement. On September 19, 2018, the Court ruled that the Put Amount shall be increased by &#x20ac;0.51 resulting in an adjusted Put Amount of &#x20ac;23.50. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount shall remain &#x20ac;22.99, thereby rejecting the lower court&#x2019;s increase, and the recurring compensation remained at &#x20ac;0.83 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended December 31, 2021 and 2020, the Company paid $1.0 billion and $49&#160;million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $983 million and $49 million, respectively, for the nine months ended December 31, 2021 and 2020, and the Company recorded the associated effect of the increase in the Company&#x2019;s ownership interest of $178&#160;million and $3&#160;million, respectively, as an increase to McKesson stockholders&#x2019; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#x201c;Redeemable noncontrolling interests&#x201d; to &#x201c;Noncontrolling interests&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. Prior to expiration of the Put Right, the balance of the redeemable noncontrolling interests was reported as the greater of its carrying value or its maximum redemption value at each reporting date. At March 31, 2021, the carrying value of $1.3&#160;billion exceeded the maximum redemption value of $1.2 billion and the Company owned approximately 78% of McKesson Europe&#x2019;s outstanding common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021 noncontrolling interests also represent minority shareholder equity interests in McKesson Europe. At December 31, 2021, the Company owned approximately 95%, of McKesson Europe&#x2019;s outstanding common shares. The Company&#x2019;s noncontrolling interest in McKesson Europe will be included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#x201c;Held for Sale.&#x201d; The Company allocated $46 million and $128 million of net income to noncontrolling interests during the three and nine months ended December 31, 2021, respectively, and $41 million and $120 million during the three and nine months ended December 31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="i36b8a9d0b6414497bb8f44ec79a79e4f_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMzg4_70ec4ce1-c945-4d8d-b3ed-16e19b4bf5b4"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i36e918c6183c4f78895df724b9cd04c0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNTI3_4ecdcb66-a23e-4369-b6d2-69e5ec08a13e"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i6ba029fe46a542dfbd04dc832ae15366_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNTc5_973129d6-af21-49cb-8a48-356be618d82a"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ifd6ba103380e4fe88bf3646afc1959fd_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNTg2_d3ae683d-db6c-4d04-ae81-5b04a1b63398"
      unitRef="usd">32000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i29833bf67ca6476e970b86ed97f2e301_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfOTgx_047658f3-b76a-44d4-9acc-46586c809e52"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:PutRightValueInterestRateSpread
      contextRef="i29833bf67ca6476e970b86ed97f2e301_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMTA0NA_7cf51ce0-74e9-45dc-ba0b-e757b8d9aa8d"
      unitRef="number">0.05</mck:PutRightValueInterestRateSpread>
    <mck:NoncontrollingInterestsPutRightExercisePriceIncrease
      contextRef="i74388bba79ec4594ae5515983a877ddf_I20180919"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMTc5Mg_a2b85d6c-d34e-4219-9666-8969f468066b"
      unitRef="eurPerShare">0.51</mck:NoncontrollingInterestsPutRightExercisePriceIncrease>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i74388bba79ec4594ae5515983a877ddf_I20180919"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMTgzNA_2e4ce109-a250-4e96-8b7e-f412ccc8fc2a"
      unitRef="eurPerShare">23.50</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i92bc310247354b8c924fe8c7f5b5b506_I20210412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjE5Mw_042612c8-d4e3-49f5-b376-86078ac728bb"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="ic3993b3a21a449f38c8b6792da95b13e_I20210412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjI4Ng_16a4f102-5a9e-45c5-9f84-990b850e2a6a"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="ic547f16da1eb490b8049506b5f0658f0_D20210401-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjM1NQ_285a9eee-88a4-41ec-b300-5bf881752146"
      unitRef="usd">1000000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="ifd6ba103380e4fe88bf3646afc1959fd_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjM2Mg_bdbc3d37-e3c9-4ef4-b77a-b43090373312"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="ic547f16da1eb490b8049506b5f0658f0_D20210401-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjM5Mg_c286c9c0-cc19-4656-8045-66c37cb07d30"
      unitRef="shares">34500000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="ifd6ba103380e4fe88bf3646afc1959fd_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjM5OQ_0d899292-1300-44c6-a65e-0a972cfbbf31"
      unitRef="shares">1800000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjU4Mw_2299da69-6a42-457d-86ef-2a1a7dc78aea"
      unitRef="usd">983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjU5MA_b52ee408-c59a-4cf0-ac44-48982fde7b20"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="iee4cc431a99b43be8fffd219ba74bac3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjc0NQ_8e389df6-1d2a-42a4-9dd5-c7c614709562"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i5c27a38c8e7740469e94feb27cbef36a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjc1Mg_8a2d3128-d66f-452a-b380-f24c1be01cb1"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMjk3Nw_0e7e3021-7092-437d-a021-4025bab551b9"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i4eb5d4844c44421d8fe111518bf52e1d_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMzUxMw_bc859323-2dff-45bf-a5a7-3a43be7aad18"
      unitRef="usd">1300000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue
      contextRef="i4eb5d4844c44421d8fe111518bf52e1d_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMzU1Nw_86fd8b1f-34cc-4c74-931a-af8a317b60fa"
      unitRef="usd">1200000000</mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i4eb5d4844c44421d8fe111518bf52e1d_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfMzU5Ng_1e5ad389-0283-4d71-a9db-be9985f81e9b"
      unitRef="number">0.78</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="ib9fe220da3a84c2a9f05f0cdd2906fd0_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDA0Mg_e3811332-53a9-425e-8f38-9c4af19e32a6"
      unitRef="number">0.95</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id82faee2169b4c03851f9e48fd63456a_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDI2Ng_af08426e-f12d-47ab-99e1-3bb28be272c9"
      unitRef="usd">46000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iaa26af6e2fc04c6da537c566605c6805_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDI3Mw_a8f570d6-bff2-41b0-8514-527384f6ab5e"
      unitRef="usd">128000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="idd14b94896e64108be04ae3457f1a609_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDM1MQ_cc0c5c8a-2a61-499d-9e6b-1036a814578d"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i13af6ba5a424438aa3988581a89555a8_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDM1OA_121d05ca-a4c2-4771-ac75-125371f00ff2"
      unitRef="usd">120000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RleHRyZWdpb246NmExM2Y0MjQ2MTExNGU1NWJjZDAwNTBkMDhjOTNkNWJfNDYxNw_837f85c1-93c9-4cbf-8c2a-dbf8112b6c93">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <us-gaap:MinorityInterest
      contextRef="i68c571fe607348cdab2a44a5f011467b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMS0yLTEtMS00NzI4NA_cd6dea3d-b263-49b0-bcf1-2e4bc38a9789"
      unitRef="usd">484000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i6c40279fd2ae42f882d256f241b6eeb9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMS00LTEtMS00NzI4NA_94501300-74a4-413a-a53b-565431c1ce43"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMi0yLTEtMS00NzI4NA_1fd11318-93ca-49c8-a951-370b43c3dee3"
      unitRef="usd">46000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="icfbf1847be9645d4a2fcb3f516d062d2_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMi00LTEtMS00NzI4NA_8019d0f9-991e-4995-ac44-4315ab329b13"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMy0yLTEtMS00NzI4NA_f501ba6d-6072-46a3-8b26-5efe12784e37"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="icfbf1847be9645d4a2fcb3f516d062d2_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfMy00LTEtMS00NzI4NA_4e133a97-0259-44fe-9d98-f46c6e154888"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfNC0yLTEtMS00NzI4NA_e2eeefcb-088e-4f2c-b5c4-68553b0b92d1"
      unitRef="usd">3000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="icfbf1847be9645d4a2fcb3f516d062d2_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfNC00LTEtMS00NzI4NA_d9a51bad-88b8-4311-842e-5420002b4e77"
      unitRef="usd">0</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic327903ae3c04d0ba43ca064d3a93bcc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfNS0yLTEtMS00NzI4NA_4fbc4795-26a1-49ae-9577-d33b65b072b4"
      unitRef="usd">38000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="icfbf1847be9645d4a2fcb3f516d062d2_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfNS00LTEtMS00NzI4NA_c990d61d-3c2a-4b02-82f5-ea8f6d8b6c18"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterest
      contextRef="ic820959a12ab4a0bae3278102cbe3604_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfOS0yLTEtMS00NzI4NA_d23e2959-ec0c-4016-8f01-4edb6866897f"
      unitRef="usd">487000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i00c5c61ba79d490583932b1ea0ae6fee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk4YjcwNzZjMTYyYTRkNjhiYzkxMzkzZWVmZDdiZTYyL3RhYmxlcmFuZ2U6OThiNzA3NmMxNjJhNGQ2OGJjOTEzOTNlZWZkN2JlNjJfOS00LTEtMS00NzI4NA_f52ef355-6aa2-41da-bd5a-18840e280ff9"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:MinorityInterest
      contextRef="ic0d467e35eb14c31bcba781b26964717_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMS0xLTEtMS00NzI4NA_de0e6f54-53c4-4cbd-8b75-e0598b0bd28a"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i966a1c60d7794ac19c4b0482afbd9d63_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMS0zLTEtMS00NzI4NA_d5662c73-8b1a-4884-9692-5cb7732b6790"
      unitRef="usd">1271000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMi0xLTEtMS00NzI4NA_17889623-58e9-4f34-a9a1-26065cec1ef9"
      unitRef="usd">128000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMi0zLTEtMS00NzI4NA_7a01d3f8-14cc-44cc-b02c-52120c1fbdef"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMy0xLTEtMS00NzI4NA_6571d242-c03c-4df0-baa2-5cfbc1564760"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfMy0zLTEtMS00NzI4NA_09bfaa65-f400-45ca-860e-70760fc72570"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNC0xLTEtMS00NzI4NA_97871cd5-c585-42d1-ab48-398e27a48c93"
      unitRef="usd">5000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNC0zLTEtMS00NzI4NA_04ee16ba-5a12-44a2-a928-45d16571370a"
      unitRef="usd">8000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNS0xLTEtMS00NzI4NA_b0a0231e-d008-47de-8817-8649bac7c70d"
      unitRef="usd">117000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNS0zLTEtMS00NzI4NA_e082bbe6-98bb-4bac-8554-5b43bf632227"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNi0zLTEtMS00NzI4NA_2299da69-6a42-457d-86ef-2a1a7dc78aea"
      unitRef="usd">983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNy0xLTEtMS00NzI4NA_0e7e3021-7092-437d-a021-4025bab551b9"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfNy0zLTEtMS00NzI4NA_71c3f04e-ebf6-4937-97b5-127944fedada"
      unitRef="usd">287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="ie1e263c576304574aedc5247ad0fe15e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfOC0xLTEtMS00NzI4NA_d1ca0295-689e-4731-b53b-4f4291f653d7"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i5939e2f9285a40cb852a4c8e240b60e3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfOC0zLTEtMS00NzI4NA_12e044e8-1e70-4382-8720-0d39599fe9b5"
      unitRef="usd">-4000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="ic820959a12ab4a0bae3278102cbe3604_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfOS0xLTEtMS00NzI4NA_9396ff4e-4d1f-4290-bd78-9df1ded55d80"
      unitRef="usd">487000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i00c5c61ba79d490583932b1ea0ae6fee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmY5ZjVmMDllMDFhZjQzNmU4ZTQzNTY1NGNlNDZlNjAxL3RhYmxlcmFuZ2U6ZjlmNWYwOWUwMWFmNDM2ZThlNDM1NjU0Y2U0NmU2MDFfOS0zLTEtMS00NzI4NA_0f4978aa-7a66-4a7f-9ea6-b24ce6678688"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:MinorityInterest
      contextRef="i6da59171484d4afba5f49534b2709456_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMS0yLTEtMS00NzI4NA_b20f20d5-5114-47fd-89a6-354a8a763257"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ie38d6747b6b2440cb19da83a637e8e0c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMS00LTEtMS00NzI4NA_253eba48-6e81-4e7d-b7dc-1f734f2f77a4"
      unitRef="usd">1265000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMi0yLTEtMS00NzI4NA_ff03cebd-f6dc-48db-b4b1-185366ae8bdb"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ie23170f25899482c8fb14218e9b36811_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMi00LTEtMS00NzI4NA_25d46ec6-0095-422d-ae9d-a6eebffa53bd"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMy0yLTEtMS00NzI4NA_96d297f1-009c-46be-9577-2cc44c920489"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie23170f25899482c8fb14218e9b36811_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfMy00LTEtMS00NzI4NA_c076f699-c72e-46aa-8921-06c93623c3b5"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ie23170f25899482c8fb14218e9b36811_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfNC00LTEtMS00NzI4NA_745b3baa-e41f-4952-ade3-6d84a3bba12f"
      unitRef="usd">11000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfNS0yLTEtMS00NzI4NA_681e31ff-b16f-4f97-90a8-2aebd2bf26bb"
      unitRef="usd">41000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie23170f25899482c8fb14218e9b36811_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfNS00LTEtMS00NzI4NA_98f086e4-9893-43e4-90da-33476d96dc30"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i8002925b860440d8b89e06b95588dbc0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfNy0yLTEtMS00NzI4NA_a825ecf0-3569-42b1-bab3-9ae742b23107"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="ie23170f25899482c8fb14218e9b36811_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfNy00LTEtMS00NzI4NA_9105bd5f-12dd-47fd-9f54-5633f09a743e"
      unitRef="usd">2000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i64318d5dd9f1472c90248ebb8e0becbf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfOC0yLTEtMS00NzI4NA_ee57769a-04b2-40a5-a2b8-29a4600c3e49"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="iad4dcc2e71484863b95577492db41418_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOjk1YjI3MGJhNTQ5ZjQ5ZDc4ZDAzMjIxYzFlZWZkMDM1L3RhYmxlcmFuZ2U6OTViMjcwYmE1NDlmNDlkNzhkMDMyMjFjMWVlZmQwMzVfOC00LTEtMS00NzI4NA_d388e9b7-6c50-4f6f-b84a-6a6145db4f19"
      unitRef="usd">1292000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:MinorityInterest
      contextRef="i805c937398e343ddbade7f441c4786b9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMS0yLTEtMS00NzI4NA_d9c13b0e-03be-484a-aa17-0b51d8199f88"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i5f407b53967e488c8979843a9f2e0587_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMS00LTEtMS00NzI4NA_adab4494-4133-4a5d-91b9-a5b6659cec84"
      unitRef="usd">1402000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMi0yLTEtMS00NzI4NA_784899b8-5a32-43cd-8b3d-1a44465bd44d"
      unitRef="usd">120000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMi00LTEtMS00NzI4NA_fcda1a81-cd72-42dc-8ebe-7456cea92593"
      unitRef="usd">32000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMy0yLTEtMS00NzI4NA_4322086b-b811-49ae-bcce-e179f53792d4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfMy00LTEtMS00NzI4NA_2ad2452e-e86b-419f-b27e-81874c93e972"
      unitRef="usd">-65000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNC00LTEtMS00NzI4NA_a08980e7-0b4b-4df2-a0e6-85b16e0b1748"
      unitRef="usd">32000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNS0yLTEtMS00NzI4NA_69902c45-4f2c-4292-9f06-3e670b56c72d"
      unitRef="usd">134000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNS00LTEtMS00NzI4NA_079d0a79-3b0d-4dae-a7f6-25423b1652f0"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNi00LTEtMS00NzI4NA_b52ee408-c59a-4cf0-ac44-48982fde7b20"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i46f0afa2f7454a6490e3e9d95346d416_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNy0yLTEtMS00NzI4NA_46bfa2a5-305f-4c96-a327-8e249d0ce8ed"
      unitRef="usd">-3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i8a074287e0774fecbde0c96584206770_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfNy00LTEtMS00NzI4NA_264a567e-9d27-40de-bdfd-30fa3819c103"
      unitRef="usd">4000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i64318d5dd9f1472c90248ebb8e0becbf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfOC0yLTEtMS00NzI4NA_4dc7fa9f-d619-482f-9267-3a195ff32420"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="iad4dcc2e71484863b95577492db41418_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80Ni9mcmFnOjZhMTNmNDI0NjExMTRlNTViY2QwMDUwZDA4YzkzZDViL3RhYmxlOmM4N2I0YWM3N2Y0MTRmZWQ5Y2QzZmMyMDMzYzNlNTQ0L3RhYmxlcmFuZ2U6Yzg3YjRhYzc3ZjQxNGZlZDljZDNmYzIwMzNjM2U1NDRfOC00LTEtMS00NzI4NA_5cad19f0-27fd-43e6-b35c-18d30cda9992"
      unitRef="usd">1292000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RleHRyZWdpb246ZmUyNTE4ZmE4OGMxNDAyNmJmOTUzZjFmNTJiOGZiMWRfMTEzNA_b581455f-7157-4bd2-89c2-245ab19b4d0e">Earnings (Loss) Per Common ShareBasic earnings (loss) per common share are computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Diluted loss per common share for the three months ended December 31, 2021 and the three and nine months ended December 31, 2020 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Less than 1&#160;million of potentially dilutive securities for the nine months ended December 31, 2021 were excluded from the computation of diluted earnings per common share as they were anti-dilutive.&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units, performance-based restricted stock units, and performance-based stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RleHRyZWdpb246ZmUyNTE4ZmE4OGMxNDAyNmJmOTUzZjFmNTJiOGZiMWRfNjQw_da143cdf-1088-4582-bff7-14be546ee59a"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RleHRyZWdpb246ZmUyNTE4ZmE4OGMxNDAyNmJmOTUzZjFmNTJiOGZiMWRfMTE1Mw_508baaea-96f8-4a7c-89de-d32489e50e23">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units, performance-based restricted stock units, and performance-based stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMi0xLTEtMS00NzI4NA_c6b961fb-85ae-4dbe-87e2-6917372ebf1d"
      unitRef="usd">39000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMi0zLTEtMS00NzI4NA_1a7e9779-51a5-4365-aebc-626a80436e39"
      unitRef="usd">-6174000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMi01LTEtMS00NzI4NA_bff6ba88-8a63-4f33-98a9-4ed46842410c"
      unitRef="usd">885000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMi03LTEtMS00NzI4NA_61035d7a-6c87-4f6e-8dc6-e61b2394028a"
      unitRef="usd">-5052000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMy0xLTEtMS00NzI4NA_e7d17c6b-b4d3-43d4-bb2a-28e31d1a2e83"
      unitRef="usd">46000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMy0zLTEtMS00NzI4NA_45748771-5d23-4c91-8e75-4ccb910350f5"
      unitRef="usd">52000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMy01LTEtMS00NzI4NA_8e5f665c-2456-417f-8253-c37271ec16e4"
      unitRef="usd">136000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMy03LTEtMS00NzI4NA_14773e81-7c10-4f13-a1ea-8742673836e4"
      unitRef="usd">152000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNC0xLTEtMS00NzI4NA_82accfaa-22c0-4029-b3e3-08dc8b669c0b"
      unitRef="usd">-7000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNC0zLTEtMS00NzI4NA_6955c30a-44f9-482a-896f-12e18459200d"
      unitRef="usd">-6226000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNC01LTEtMS00NzI4NA_9cd7998b-11a6-458a-bd74-2481d9c6e789"
      unitRef="usd">749000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNC03LTEtMS00NzI4NA_248e4463-48ff-4de9-a695-ee1721309e50"
      unitRef="usd">-5204000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNS0xLTEtMS00NzI4NA_10923f6e-313a-4ade-8ff2-9a110cd058c8"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNS0zLTEtMS00NzI4NA_afe2c330-9455-4998-ac5a-09013a315ece"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNS01LTEtMS00NzI4NA_3d5ca656-534b-4c83-82e2-cb0f4fda0943"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNS03LTEtMS00NzI4NA_33531c41-2cc3-4bef-835e-54e5040eb31d"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNi0xLTEtMS00NzI4NA_e680c7e8-ace9-4506-b475-0be2218da121"
      unitRef="usd">-7000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNi0zLTEtMS00NzI4NA_fd86f906-5353-4913-abf8-ab2853eb7349"
      unitRef="usd">-6226000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNi01LTEtMS00NzI4NA_25a3f642-96cf-4a9a-98f9-26d0b46b879a"
      unitRef="usd">746000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfNi03LTEtMS00NzI4NA_165d8d4f-f707-4804-9f07-7a673ef4048e"
      unitRef="usd">-5205000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfOS0xLTEtMS00NzI4NA_6be5b585-d984-49c1-8a6b-e4045f3814d4"
      unitRef="shares">151600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfOS0zLTEtMS00NzI4NA_43ccc1f0-5c4c-46b8-be1b-a830436b339f"
      unitRef="shares">159500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfOS01LTEtMS00NzI4NA_24ec0839-5ceb-4cbd-aea9-68aee0b80147"
      unitRef="shares">154000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfOS03LTEtMS00NzI4NA_f6ff93c8-496f-4007-bfd6-bfe54e998356"
      unitRef="shares">161200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i31bf4f7d1a23482c831cafb66e4eeb11_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTEtMS0xLTEtNDcyODQ_c4dddb0d-e9f5-4d0b-8121-f2a6a742348a"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia20f2ae234824563aaf020230203bc95_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTEtMy0xLTEtNDcyODQ_2abc39a7-5499-4cd7-80f8-7ca0041f9aa3"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i85920522622d4e87a1778b8915896cd9_D20210401-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTEtNS0xLTEtNDcyODQ_fbd821d3-162a-4496-9ef5-39f06f0ea36c"
      unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i429c33e0c248436d9d40564788aef7cc_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTEtNy0xLTEtNDcyODQ_07fd1527-8ad6-4d5f-a44e-adb8afa515cd"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i17e68fc5432d42999abbd9cfb84788b2_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTItMS0xLTEtNDcyODQ_147c8532-77c7-4d88-9c32-a32524c74e7e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibd7d6c6918264060a11449cce87c8a74_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTItMy0xLTEtNDcyODQ_bd20dd1f-5e8f-463a-b992-cf5845364ccf"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1c44d406842b4dfd9be43d9417c45d16_D20210401-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTItNS0xLTEtNDcyODQ_c93a2196-c4df-41ba-80f1-1d81bd1ea726"
      unitRef="shares">1600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5aad64ed07e840d48b824f939696d040_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTItNy0xLTEtNDcyODQ_8afc19f9-cfc7-4a17-b40b-ae15299d6709"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTMtMS0xLTEtNDcyODQ_74bcf668-11d6-46c9-a235-cfc82192540d"
      unitRef="shares">151600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTMtMy0xLTEtNDcyODQ_7232c952-06ce-43b6-b860-a27a980f38f2"
      unitRef="shares">159500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTMtNS0xLTEtNDcyODQ_49e8cfb3-5793-467c-b8c6-c0e334ab8f98"
      unitRef="shares">155800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTMtNy0xLTEtNDcyODQ_4c7010cd-9574-4082-be47-d499574d24de"
      unitRef="shares">161200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTctMS0xLTEtNDcyODQ_ea51b969-8e9f-4403-8684-bca3961cd020"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTctMy0xLTEtNDcyODQ_bd249b49-ca8b-4b7d-835d-128e60c05d8d"
      unitRef="usdPerShare">-39.03</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTctNS0xLTEtNDcyODQ_aaeabba9-2609-4c5e-9da9-9b0a04f66095"
      unitRef="usdPerShare">4.81</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTctNy0xLTEtNDcyODQ_6c232c61-35e6-4b73-b9ae-487b1c9b6afd"
      unitRef="usdPerShare">-32.28</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTgtMS0xLTEtNDcyODQ_d67f52e1-5094-42aa-9328-126ebc620ec1"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTgtMy0xLTEtNDcyODQ_6dfdc0c7-1c27-4635-9023-0d00a72a3c38"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTgtNS0xLTEtNDcyODQ_05f9fbd2-a2c3-42b4-a199-6777980b2067"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTgtNy0xLTEtNDcyODQ_99a9eebb-b44f-4667-a7dd-f8b422169f65"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTktMS0xLTEtNDcyODQ_3bf635b0-ea5f-4c09-bd53-a512d656835a"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTktMy0xLTEtNDcyODQ_3e1b2ef7-887c-4447-a1c6-7beb32a0eae6"
      unitRef="usdPerShare">-39.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTktNS0xLTEtNDcyODQ_ee2bbc3d-8dc8-4e9e-be4a-82f61d519028"
      unitRef="usdPerShare">4.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMTktNy0xLTEtNDcyODQ_67b4614c-8ff1-44df-92ed-613f2bb79461"
      unitRef="usdPerShare">-32.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjEtMS0xLTEtNDcyODQ_6582c668-2354-4a0d-bfbc-476d9ea48b8b"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjEtMy0xLTEtNDcyODQ_7eb4a1f5-99a8-4b1f-ad6b-81d758ffb036"
      unitRef="usdPerShare">-39.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjEtNS0xLTEtNDcyODQ_1c7913b4-648e-45ec-b184-c046dad71c71"
      unitRef="usdPerShare">4.87</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjEtNy0xLTEtNDcyODQ_4538274e-e912-4977-8785-f79127bdd8d2"
      unitRef="usdPerShare">-32.28</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjItMS0xLTEtNDcyODQ_8a3fe01c-43cd-49f2-a548-6d9d3a1cc0ff"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjItMy0xLTEtNDcyODQ_d45205a1-5c50-43de-b897-9ac27fc55359"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjItNS0xLTEtNDcyODQ_15f67d18-7ea5-40a6-8f5f-bc1eb11006cc"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjItNy0xLTEtNDcyODQ_325673c8-8ea5-46b0-8f86-87c896b83393"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjMtMS0xLTEtNDcyODQ_4fc3fbcd-7449-45be-9a7e-f198c7dd8222"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjMtMy0xLTEtNDcyODQ_0a2e35f0-d6eb-40a8-8787-c6dd64628fdd"
      unitRef="usdPerShare">-39.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjMtNS0xLTEtNDcyODQ_7f3e4c1d-7b6d-485d-98d9-b5116b5aeb4d"
      unitRef="usdPerShare">4.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV80OS9mcmFnOmZlMjUxOGZhODhjMTQwMjZiZjk1M2YxZjUyYjhmYjFkL3RhYmxlOjY3OThhOTc1ZTJkMjQ2NjhhYTQ0Mjc0YTkyOWM3M2JkL3RhYmxlcmFuZ2U6Njc5OGE5NzVlMmQyNDY2OGFhNDQyNzRhOTI5YzczYmRfMjMtNy0xLTEtNDcyODQ_7d0bf09d-76ee-4eb0-98dd-87b92b78cd37"
      unitRef="usdPerShare">-32.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTU4NA_9cc4a2d8-e9e4-49ba-b4b5-6fda8f5df112">Goodwill and Intangible Assets, Net &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2021, the Company implemented a new segment reporting structure which prompted changes in multiple reporting units across the Company. As a result, goodwill included in the impacted reporting units was reallocated using a relative fair value approach and assessed for impairment before and after the reallocation. The Company recorded a goodwill impairment charge of $69 million in the nine months ended December 31, 2020 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of this reporting unit within the International segment. This impairment charge is included in &#x201c;Goodwill impairment charges&#x201d; in the Condensed Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist. The annual impairment testing performed for 2022 and 2021 did not indicate any impairment of goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Remaining goodwill for this segment primarily relates to the McKesson Canada reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes net intangible assets of approximately $452 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; This amount was included under the caption &#x201c;Assets held for sale&#x201d; in the Condensed Consolidated Balance Sheet as of December 31, 2021. Amortization of these assets ceased upon classification as Assets held for sale in the second and third quarters of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense of intangible assets was $80 million and $262 million during the three and nine months ended December 31, 2021, respectively, and $108 million and $320 million during the three and nine months ended December 31, 2020, respectively. Estimated amortization expense of these assets is as follows: $70 million, $226 million, $215 million, $209 million, and $177 million for the remainder of 2022 and each of the succeeding years through 2026, respectively, and $1.2 billion thereafter. All intangible assets were subject to amortization as of December 31, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic4a94e99c27749f9bb0cdf58b9fb0d21_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfNDA1_380cd640-b8a5-4f8c-8ed5-53f944d1985a"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic4a94e99c27749f9bb0cdf58b9fb0d21_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfNDA1_457e753b-bf5a-4155-878f-0abe97d1d50a"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTU2NA_9d719544-4b92-456f-9abd-5143d8b05ee0">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Remaining goodwill for this segment primarily relates to the McKesson Canada reporting unit.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ic904723c4ba64a05ae420a0be5054017_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMS0xLTEtMS00NzI4NA_ea92a9df-08e1-4008-a76b-683e3f9ab77c"
      unitRef="usd">3963000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1152c87f165d4441a106e92fb010eee7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMS0zLTEtMS00NzI4NA_1abe4bf3-745c-4203-b451-d2c6d5dc1c4e"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia5b0a5563e78433e81c99f7828894e50_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMS01LTEtMS00NzI4NA_87ab18ff-6174-4f50-a16a-e111ad70c143"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idd869a8aa917470b91d673083a1c9728_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMS03LTEtMS00NzI4NA_9d98c365-6351-4b64-a863-0daed13ad086"
      unitRef="usd">1535000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMS05LTEtMS00NzI4NA_050f81cc-8c18-45c7-a2ee-9a9567288f7c"
      unitRef="usd">9493000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ifcceb81b10094fe38a52a708698e8e26_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMi0xLTEtMS00NzI4NA_ff66f593-30e2-4db9-8452-90301c0e88ef"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id4fff6966c2f4bf68a5a99a525be017b_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMi0zLTEtMS00NzI4NA_4ed341a6-8e9a-4493-b8da-909aef0a7b5e"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id8581c40a6994c56adbfa16cef30adce_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMi01LTEtMS00NzI4NA_285fb652-d8bc-4e20-a416-0d6392bd42ff"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ibbe27bfd9e2c41d58630861c22b41289_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMi03LTEtMS00NzI4NA_1f88a844-bf12-4609-ab70-d71ffe0ca109"
      unitRef="usd">5000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfMi05LTEtMS00NzI4NA_b57aed07-efdd-44df-a8d1-19c6d95818ef"
      unitRef="usd">5000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ifcceb81b10094fe38a52a708698e8e26_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNi0xLTEtMS00NzI4NA_a36f2217-c5cf-4166-8880-bc655079bea0"
      unitRef="usd">-21000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id4fff6966c2f4bf68a5a99a525be017b_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNi0zLTEtMS00NzI4NA_65f729fb-6d22-40d4-b721-b9f8ca781a35"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id8581c40a6994c56adbfa16cef30adce_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNi01LTEtMS00NzI4NA_d6f181f2-b981-4e25-9a16-32999e555202"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ibbe27bfd9e2c41d58630861c22b41289_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNi03LTEtMS00NzI4NA_4c38f4cf-348f-4e76-a05c-b2ee3ce28368"
      unitRef="usd">-15000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNi05LTEtMS00NzI4NA_8c105b29-4f47-4918-b978-1843a26a46d2"
      unitRef="usd">-36000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i32326b7bf53a4dd384901e9903f9bba5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNy0xLTEtMS00NzI4NA_26e14b4b-471d-4c2f-8053-df9b0c2b8b50"
      unitRef="usd">3942000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idd6a711404a649daa658dfed92674336_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNy0zLTEtMS00NzI4NA_a8b032b4-1d2c-419f-8c09-86e80d6b76a2"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7d3dae03307347b1aaa7f9adb1a1146e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNy01LTEtMS00NzI4NA_59c9fd86-646a-439c-866f-71906ec4aed4"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7c38b50f2e6d4df48e12878cd04a1f29_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNy03LTEtMS00NzI4NA_8c8b7280-c78d-449b-9435-9a7be93b7285"
      unitRef="usd">1525000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOjViMGQ3ZmU0OTNiMTQ4OWViYzZmZWMyZDI1ZjMzMmJkL3RhYmxlcmFuZ2U6NWIwZDdmZTQ5M2IxNDg5ZWJjNmZlYzJkMjVmMzMyYmRfNy05LTEtMS00NzI4NA_b67a9712-a194-4095-9c41-62c1176aa79d"
      unitRef="usd">9462000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTU3NQ_460e39e0-329b-4902-9421-ba2e5b90eb66">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes net intangible assets of approximately $452 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; This amount was included under the caption &#x201c;Assets held for sale&#x201d; in the Condensed Consolidated Balance Sheet as of December 31, 2021. Amortization of these assets ceased upon classification as Assets held for sale in the second and third quarters of 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i5940c64b0f72408a95d2a120f5c0cb9d_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi0xLTEtMS00NzI4NA_b161de19-f7a8-446f-b463-167022cac786">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib25c56b1dc1542b8b6cba0c5909ee061_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi0zLTEtMS00NzI4NA_9c058b04-b1e8-4f77-939c-d12e0a751216"
      unitRef="usd">2842000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib25c56b1dc1542b8b6cba0c5909ee061_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi01LTEtMS00NzI4NA_1c478be9-8032-49e3-b13d-b5a3d5261489"
      unitRef="usd">1718000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib25c56b1dc1542b8b6cba0c5909ee061_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi03LTEtMS00NzI4NA_cd9ef3f8-4a41-4204-9944-9292c736aa1e"
      unitRef="usd">1124000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8f9282a1be1949719baad2d71826d505_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi05LTEtMS00NzI4NA_28334aa5-cc0e-4fd8-a9ba-ef041fe931ee"
      unitRef="usd">3739000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8f9282a1be1949719baad2d71826d505_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi0xMS0xLTEtNDcyODQ_1e436aee-e938-439b-a385-730fd3251b6d"
      unitRef="usd">2269000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8f9282a1be1949719baad2d71826d505_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMi0xMy0xLTEtNDcyODQ_0d3a5258-9450-4e8e-bbe6-5d6af4830b5d"
      unitRef="usd">1470000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i74ed405c42b74c4389c3f91f5005ff7a_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy0xLTEtMS00NzI4NA_0a25cdd0-da40-469a-9a2d-002dd9c7761d">P9Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id5ddfbf05bb24ccba4c97a3aa8391604_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy0zLTEtMS00NzI4NA_202e1da7-63e5-48ab-870a-4e6beb485a16"
      unitRef="usd">1083000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id5ddfbf05bb24ccba4c97a3aa8391604_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy01LTEtMS00NzI4NA_b5e4f06e-3095-46a6-81a1-a6f28b10b0ae"
      unitRef="usd">558000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id5ddfbf05bb24ccba4c97a3aa8391604_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy03LTEtMS00NzI4NA_c5eedb36-15fb-48fd-af4d-7779d73884b3"
      unitRef="usd">525000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iec8b0c080d464091895e0a8629dc3b8f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy05LTEtMS00NzI4NA_7a96f3f4-b4c8-40f2-b04c-1fa7b12ae340"
      unitRef="usd">1081000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iec8b0c080d464091895e0a8629dc3b8f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy0xMS0xLTEtNDcyODQ_21b90f13-530f-47a3-9050-fa2bb2a45398"
      unitRef="usd">513000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iec8b0c080d464091895e0a8629dc3b8f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfMy0xMy0xLTEtNDcyODQ_0a3f79a0-a3af-4068-b32b-85800b0f8154"
      unitRef="usd">568000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4867f847dac14e859a18453f84be838e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC0zLTEtMS00NzI4NA_2bb8d815-4067-409e-983d-fd8c5c44f4f3"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4867f847dac14e859a18453f84be838e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC01LTEtMS00NzI4NA_cf4308b0-cfb1-4c55-b829-964a91ab7a39"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4867f847dac14e859a18453f84be838e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC03LTEtMS00NzI4NA_db3a1c4d-6857-4230-aee4-3fa56ab51ba3"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie340410ba12c44e9911705e385d3b53b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC05LTEtMS00NzI4NA_a623971b-9eab-43ff-aa73-62184483b51e"
      unitRef="usd">497000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie340410ba12c44e9911705e385d3b53b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC0xMS0xLTEtNDcyODQ_86158638-79e8-4abc-8689-34e5248984b9"
      unitRef="usd">244000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie340410ba12c44e9911705e385d3b53b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNC0xMy0xLTEtNDcyODQ_e2e1d468-ef39-4a5b-b57b-a5660f323029"
      unitRef="usd">253000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="icb766b9c9d944af29da2f7e212da9b0f_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS0xLTEtMS00NzI4NA_e1e3648d-3cf4-4ec9-8e46-1a7d7fede416">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6350e24aa5bc4ecdb728677b7257e206_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS0zLTEtMS00NzI4NA_96869f9a-5e34-45dd-94ee-a79d9c768139"
      unitRef="usd">816000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6350e24aa5bc4ecdb728677b7257e206_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS01LTEtMS00NzI4NA_7eb3bd3c-99a7-41c1-b49f-d8036b7a6560"
      unitRef="usd">371000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6350e24aa5bc4ecdb728677b7257e206_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS03LTEtMS00NzI4NA_46ec2405-d1f6-4673-9e54-2f55be000909"
      unitRef="usd">445000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7e6e140e0372458c969bb39e40eb721e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS05LTEtMS00NzI4NA_31fd6fa0-e9e6-47be-bfed-50aba37a976e"
      unitRef="usd">925000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7e6e140e0372458c969bb39e40eb721e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS0xMS0xLTEtNDcyODQ_4fcf0088-e5a4-41fe-8891-6f96b02c102a"
      unitRef="usd">394000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7e6e140e0372458c969bb39e40eb721e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNS0xMy0xLTEtNDcyODQ_5ced770b-3a79-4c74-98a4-da7cd30feced"
      unitRef="usd">531000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="iaa5fb8b105594c8e8a3005b94b561d93_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi0xLTEtMS00NzI4NA_18f4c572-0308-427d-8acc-49822a8ccb9e">P2Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iabb0392b7148487bb4a2f65bf6026803_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi0zLTEtMS00NzI4NA_c55f4068-07d0-41f7-ae1d-3d8381f7b04f"
      unitRef="usd">128000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iabb0392b7148487bb4a2f65bf6026803_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi01LTEtMS00NzI4NA_ab346ca6-84e8-4070-a0a9-ee46a352749d"
      unitRef="usd">113000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iabb0392b7148487bb4a2f65bf6026803_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi03LTEtMS00NzI4NA_bf8f9261-459e-42b1-a4ae-c720aeb8b5c0"
      unitRef="usd">15000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i93c95e7a4b934ef38d46deb03522e7e9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi05LTEtMS00NzI4NA_7806b278-1d91-4648-8c9c-3288a7ef1f47"
      unitRef="usd">150000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i93c95e7a4b934ef38d46deb03522e7e9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi0xMS0xLTEtNDcyODQ_0ae09fcd-69bf-47f8-a3aa-a500ee407f95"
      unitRef="usd">122000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i93c95e7a4b934ef38d46deb03522e7e9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNi0xMy0xLTEtNDcyODQ_3e8cab6f-1a59-4d02-970f-71d49ad75d35"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i7552b3f9fefa4753841e20f4ee183f59_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy0xLTEtMS00NzI4NA_0cac0fab-3ca3-4e90-a21b-1de1ddc94041">P8Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib39a321c4bcc4b6cb3698d1b56855f45_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy0zLTEtMS00NzI4NA_592ebf84-bbcc-40c7-beed-77dbcd630f58"
      unitRef="usd">192000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib39a321c4bcc4b6cb3698d1b56855f45_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy01LTEtMS00NzI4NA_023a507f-92a7-4a07-8826-61c10ee4c9b6"
      unitRef="usd">171000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib39a321c4bcc4b6cb3698d1b56855f45_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy03LTEtMS00NzI4NA_ed36868b-e970-480f-b60f-7a426f12a9a7"
      unitRef="usd">21000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i373201c35c334793a8e487531dd13808_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy05LTEtMS00NzI4NA_f57372a8-46f2-4d7e-b511-eb2f777f64ac"
      unitRef="usd">254000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i373201c35c334793a8e487531dd13808_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy0xMS0xLTEtNDcyODQ_0260b706-a4c0-4af5-97d1-cf51de1508f2"
      unitRef="usd">226000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i373201c35c334793a8e487531dd13808_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfNy0xMy0xLTEtNDcyODQ_339207a3-7a44-4ca3-ad6e-7b44469a8334"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC0zLTEtMS00NzI4NA_69095b18-95b1-4430-b8df-40a54195c468"
      unitRef="usd">5061000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC01LTEtMS00NzI4NA_6b982a5c-a962-4cf1-8f52-22768c47031a"
      unitRef="usd">2931000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC03LTEtMS00NzI4NA_dbf62572-5da7-4c27-8d09-bdcba7146026"
      unitRef="usd">2130000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC05LTEtMS00NzI4NA_16476058-085e-4291-a1aa-8e3a62c8980f"
      unitRef="usd">6646000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC0xMS0xLTEtNDcyODQ_1a71fb67-2ab8-4dea-b904-136ff5ea0381"
      unitRef="usd">3768000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RhYmxlOmI3Nzk5YjQ5M2YzODRiNTE4ZGQwMzVjZWI1MjYxNDA3L3RhYmxlcmFuZ2U6Yjc3OTliNDkzZjM4NGI1MThkZDAzNWNlYjUyNjE0MDdfOC0xMy0xLTEtNDcyODQ_d88ff0f9-2f07-4a63-bfa6-ff99e077fb65"
      unitRef="usd">2878000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="ia5f3b27c39db4b379168925a74818f88_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTA5OTUxMTYyOTczMg_df61d600-2722-4081-ac30-4d6ed484a783"
      unitRef="usd">452000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTIzOQ_f889eb3f-d12b-48fc-8d9f-06e58cb77e46"
      unitRef="usd">80000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTI0Ng_9f0e7d23-9baa-4754-8711-15a3ef3dc8a2"
      unitRef="usd">262000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTI4Mg_1e8e1fc6-ac33-4cf9-82d5-33ab20c71823"
      unitRef="usd">108000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTI4OQ_ef888db4-1f30-4c84-b4cd-91b02e1364ff"
      unitRef="usd">320000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTM4Mw_62b54915-cdc7-43b7-a9f1-5bc39c641429"
      unitRef="usd">70000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTM4Nw_09d68f69-e985-466a-ad5d-469e38759a14"
      unitRef="usd">226000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTM5MQ_efc5427a-f2d0-496c-97c9-430b1dd12d67"
      unitRef="usd">215000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTM5NQ_2001a0f7-47a7-497b-b697-9f0545df6a12"
      unitRef="usd">209000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTQwMw_03cb42f5-ae4d-4b1d-ad7b-bacc8f1407cb"
      unitRef="usd">177000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81Mi9mcmFnOmJkNTRmZGRlMjYwOTRkNzJhOWJkMmM4NTk4MzZkZTEwL3RleHRyZWdpb246YmQ1NGZkZGUyNjA5NGQ3MmE5YmQyYzg1OTgzNmRlMTBfMTQ3OA_3ae358eb-3811-4c79-b3d2-1d4ede2ee4f0"
      unitRef="usd">1200000000</mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjA5Mw_5202ce7f-4b1a-4128-9cc8-3c9f5abbee54">Debt and Financing Activities&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30% Notes due August 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes current and long-term debt of approximately $5 million and $12 million, respectively, as of December 31, 2021 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Liabilities held for sale&#x201d; in the Condensed Consolidated Balance Sheet as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $6.0 billion and $7.1 billion at December 31, 2021 and March 31, 2021, respectively, of which $438 million and $742 million, respectively, was included under the caption &#x201c;Current portion of long-term debt&#x201d; within the Company&#x2019;s Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 12, 2021, the Company completed a public offering of 1.30% Notes due August 15, 2026 (the &#x201c;2026 Notes&#x201d;) in a principal amount of $500&#160;million. Interest on the 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on February 15, 2022. Proceeds received from this note issuance, net of discounts and offering expenses, were $495&#160;million. The Company utilized the net proceeds from this note for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2026 Notes, which constitutes a &#x201c;Series,&#x201d; are an unsecured and unsubordinated obligation of the Company and rank equally with all of the Company&#x2019;s existing, and from time-to-time, future unsecured and unsubordinated indebtedness outstanding. The 2026 Notes are governed by materially similar indentures and officers&#x2019; certificates as those of other Series issued by the Company. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#x2019;s Investors Service, Inc. and Standard &amp;amp; Poor&#x2019;s Ratings Services within a specified period, an offer must be made to purchase the 2026 Notes from the holders at a price equal to 101% of the then outstanding principal amount of the 2026 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#x2019; certificate for the 2026 Note, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without lenders&#x2019; consent. The indentures also contain customary events of default provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 17, 2021, the Company redeemed its 0.63% &#x20ac;600 million (or, approximately $709 million) total principal Euro-denominated notes, originally due on August 17, 2021, prior to maturity. The notes were redeemed at par value using cash on hand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tender Offer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) 2.85% Notes due 2023, (ii) 3.80% Notes due 2024, (iii) 7.65% Debentures due 2027, (iv) 3.95% Notes due 2028, (v) 4.75% Notes due 2029, (vi) 6.00% Notes due 2041, and (vii) 4.88% Notes due 2044 (collectively referred to herein as the &#x201c;Tender Offer Notes&#x201d;). In connection with the tender offer, the Company paid an aggregate consideration of $1.1&#160;billion to redeem $922&#160;million principal amount of the notes at a redemption price equal to 100% of the principal amount and premiums of $182&#160;million, plus accrued and unpaid interest of $14&#160;million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $191&#160;million in the nine months ended December 31, 2021, which included premiums of $182&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $9&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a Credit Agreement, dated as of September 25, 2019 (the &#x201c;2020 Credit Facility&#x201d;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had no borrowings during the three and nine months ended December 31, 2021 and 2020 and no amounts outstanding as of December 31, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At December 31, 2021, the Company was in compliance with all covenants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $7 million and an uncommitted amount of $114 million as of December 31, 2021. Borrowings and repayments were not material during the three and nine months ended December 31, 2021 and 2020. Amounts outstanding under these credit lines were not material as of December 31, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During the nine months ended December 31, 2021, the Company borrowed $3.6 billion and repaid $3.3 billion under the program. During the nine months ended December 31, 2020, the Company borrowed $5.5 billion and repaid $5.3 billion under the program. At December 31, 2021 there were $372 million commercial paper notes outstanding at a weighted average interest rate of 0.29%. At March 31, 2021, there were no commercial paper notes outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjA5OA_6fed3a99-d273-47b1-b548-62e1ead4498a">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30% Notes due August 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes current and long-term debt of approximately $5 million and $12 million, respectively, as of December 31, 2021 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Liabilities held for sale&#x201d; in the Condensed Consolidated Balance Sheet as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8746bc225334425396ca59f548e37a0b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMi0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjU4ZjIwYjU0YTA0ZTQxNWU5YWM0ZjQ4NTdlMDczZjg3XzQ_cf3e34d3-6155-49a3-adad-0841b4d18254"
      unitRef="number">0.0270</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i8746bc225334425396ca59f548e37a0b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMi0xLTEtMS00NzI4NA_ced8ec26-c09f-497c-87b8-8e09366f1154"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9e16308e8f8a44b0b56714da70bdba87_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMi0zLTEtMS00NzI4NA_d0ee4923-d90f-4bcc-a5a6-b1b2b3d0af9d"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3131096ca12e4ff79f710ef33e1fad9f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMy0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjVjMTFhY2ZiNWEzMzQ1YzVhZDc5ZTM1YjBlNDc4NmU3XzQ_22ea5843-9c4d-4f98-b141-cb75012c2378"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3131096ca12e4ff79f710ef33e1fad9f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMy0xLTEtMS00NzI4NA_63bee7c6-7836-44c1-9995-ceb1178fcef3"
      unitRef="usd">360000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4460ad7ee7034da6ab6577545bb4e0db_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMy0zLTEtMS00NzI4NA_e203d72b-8142-43dd-9559-25a7a99041d5"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia93f81c5e6b04232b2292683ca038221_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNC0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjM5YTkyNzk1YTUxYjRmZWI4OTgyNGZiZmQwMTM0ZTM4XzQ_c9d9b0f9-6a41-486d-b5fd-fb3603337a2c"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia93f81c5e6b04232b2292683ca038221_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNC0xLTEtMS00NzI4NA_e2dcde5d-d85b-4935-ab3d-238753cac598"
      unitRef="usd">918000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if114852dcd424e71925af80e34de7a6c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNC0zLTEtMS00NzI4NA_64c72276-93c4-4067-853c-4f95fe0414a3"
      unitRef="usd">1100000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if3719b3f8d244ac494c2824c0832d07e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNS0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOmUwMWE3MTg3NmMxMzQwYmZhMzdiZTg4NWZlNDdhYmE1XzQ_74091bce-eafe-43b4-a407-d26d9b2a347c"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if3719b3f8d244ac494c2824c0832d07e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNS0xLTEtMS00NzI4NA_e3cc1b96-2f82-4366-a416-1192c53a5f5d"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9174bf78e06c4f3d84ca5ac5c9b2aba5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNS0zLTEtMS00NzI4NA_828ca38a-8376-42d3-9a69-a7c4c1d22e15"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1f726c763f9a479b8e540f1c1a4b7bfe_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNi0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjA5MTg0MzcwNzMzYjQyNTE5NDAzZTc2MTY4MWEzNjgxXzQ_e82864b6-a602-42a6-bf66-436cced0ace1"
      unitRef="number">0.0130</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1f726c763f9a479b8e540f1c1a4b7bfe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNi0xLTEtMS00NzI4NA_21855c83-a071-4720-bafe-958342266bdb"
      unitRef="usd">498000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icfaf4e782dc9445ab195eab4ffe8ab10_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNi0zLTEtMS00NzI4NA_8d6f6c69-90b4-4d69-82d4-43541ecd3a6f"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8f67c3e22d524b2bb83fd6759a331308_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNy0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjA3N2MyYTljNTIxZDQ5Y2NiNTA4Mzc3OTYxMTA2ZTg5XzQ_5bcd4a6c-5eea-4f1d-b8f3-0d8aee7ddafc"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i8f67c3e22d524b2bb83fd6759a331308_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNy0xLTEtMS00NzI4NA_bbd41dcf-f73d-40ba-ad54-e341298b1236"
      unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia28dcbf6b06649eb9dff2cfa25450e96_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfNy0zLTEtMS00NzI4NA_7bc90ad3-3332-46bb-b006-a88641a4d0d8"
      unitRef="usd">167000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1e57c87f990a465aa51e7b583931c71c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOC0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjQzMDYyZTNmMjg4MzRiMzVhYmUwMTE0MDA0ZjkyMzkxXzQ_a6d02020-34a0-4ad4-93a3-26837ca1e78b"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1e57c87f990a465aa51e7b583931c71c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOC0xLTEtMS00NzI4NA_397f245b-0de0-4f0f-9481-fd4c75ecb923"
      unitRef="usd">343000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i88366d3c093b4dc49a21a6e0db895a8d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOC0zLTEtMS00NzI4NA_b84ec5d4-191c-4894-a82b-f7894f1a5cc1"
      unitRef="usd">600000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i02cb6f0f6a454110948073b47a98653b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOS0wLTEtMS00NzI4NC90ZXh0cmVnaW9uOjdmM2NkMjlmMWViNzRlNjliYmM2MDcyZmEwYTNhNjc5XzQ_a2d2189b-eeef-4f5f-8b1d-163633f79dd9"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i02cb6f0f6a454110948073b47a98653b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOS0xLTEtMS00NzI4NA_7d1cbab5-4b72-43c6-8b35-09cf2a8c5703"
      unitRef="usd">196000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i586efb75ab5d463cb59b296f08231f94_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfOS0zLTEtMS00NzI4NA_09a5bc30-79f8-445b-a742-88b188343248"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icc040bd3b61f4ac2897cb464802aff8a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTAtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo1ZTYzYmMwYTRjN2M0NzVkYmViMmIxZWI5NjkxZWUzZF80_ab4e130d-ac7e-4a05-b739-dfbefa105b96"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="icc040bd3b61f4ac2897cb464802aff8a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTAtMS0xLTEtNDcyODQ_7382d3d7-3492-4935-8ea1-b5ddedb9ccf0"
      unitRef="usd">217000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1d47528c190644909c718b0fb28a8991_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTAtMy0xLTEtNDcyODQ_c2659220-825a-4d6b-9e80-92d6780ecafd"
      unitRef="usd">282000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i18921a55bfdb4914912bf2fcd15ae90c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTEtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo5ZDc5NDYyZGY0N2I0YzJlYjYwZmVlMjUxZjgzZmQ0OF80_efc1221d-5a57-490d-8b02-a23c308ecba3"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i18921a55bfdb4914912bf2fcd15ae90c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTEtMS0xLTEtNDcyODQ_ac90a03f-3f1a-4acc-8740-c5331f6856f0"
      unitRef="usd">255000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i109f3a112c2942a89945755f920801f5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTEtMy0xLTEtNDcyODQ_3f27ec5b-b6b3-47d5-8af8-7af5176baf2b"
      unitRef="usd">411000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic9237fc120ce474f8df6c1ab559748c0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTMtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo3NGZjNzAxNWE2MGU0NWQwYmNjNmM5MTExOWEwMTIyNV80_ac0aabd4-6729-459d-bdce-4d6053179186"
      unitRef="number">0.0063</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ic9237fc120ce474f8df6c1ab559748c0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTMtMS0xLTEtNDcyODQ_25fb02cc-653c-4445-828c-75e782dce3b0"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="idce1a776f3f4491eaecf73c69740b2c1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTMtMy0xLTEtNDcyODQ_dc0c9872-57a4-42b3-8e31-92cf93a5ab8b"
      unitRef="usd">704000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib02bd64fd220450cb919b052658bd225_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTQtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjpiMDc0ZDcxNjJhNGI0OTc1Yjc1OWMxMTMxYmY1MTRkYl80_2ac499e1-485c-4fac-91d8-8245b8fa1de1"
      unitRef="number">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib02bd64fd220450cb919b052658bd225_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTQtMS0xLTEtNDcyODQ_be1fbe88-46dd-4e17-a78d-0e642a700ca8"
      unitRef="usd">680000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i980877648a26404c9f3f88facfab3a12_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTQtMy0xLTEtNDcyODQ_8dcf5ba8-c9f9-4289-ad9a-fc1844f4a1f4"
      unitRef="usd">700000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i594a4fdaee3b4bb29cfb65eb877bdf18_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTUtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo4OGNlYzg5ZDUzN2Y0NmM0ODA2MTc4ZTU5ZGU4OTZhN180_92111cd9-fe6c-4eea-b04b-dbaeb1e70358"
      unitRef="number">0.0163</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i594a4fdaee3b4bb29cfb65eb877bdf18_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTUtMS0xLTEtNDcyODQ_d18e44e1-9bb7-4909-806a-412f76931690"
      unitRef="usd">568000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibd138e409b7b4f81be9450bcf3b931dd_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTUtMy0xLTEtNDcyODQ_40add0e6-4a3a-4253-9ab6-355a78d3ec65"
      unitRef="usd">587000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i40926358e8e740acb1b20bcaef8dbb44_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTYtMC0xLTEtNDcyODQvdGV4dHJlZ2lvbjo5ZTliYzE1MjViMzc0Nzk3OWQ3ODY4YzZlMWYwMTFiNV80_a01bddef-d8db-4844-aaf3-beca29f71e34"
      unitRef="number">0.0313</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i40926358e8e740acb1b20bcaef8dbb44_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTYtMS0xLTEtNDcyODQ_b4468e1d-3917-48c6-8c78-908e05bc049b"
      unitRef="usd">618000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6ca68483b5e748d296466ae242322a5b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTYtMy0xLTEtNDcyODQ_3a2bc7c9-06cf-4111-89aa-8d38636da934"
      unitRef="usd">627000000</us-gaap:LongTermDebt>
    <us-gaap:FinanceLeaseLiability
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTgtMS0xLTEtNDcyODQ_0cc23a42-2008-4eba-8a96-16026e3ba1d5"
      unitRef="usd">253000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTgtMy0xLTEtNDcyODQ_c4029351-5a46-4c56-b167-d13f7cd97032"
      unitRef="usd">270000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTktMS0xLTEtNDcyODQ_37ac301b-c799-4aba-b124-5b87d4189f23"
      unitRef="usd">5956000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMTktMy0xLTEtNDcyODQ_20d5edf0-f6dd-4bc6-ba51-cc856b5f83ca"
      unitRef="usd">7148000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMjAtMS0xLTEtNDcyODQ_d7396880-4e29-414a-b367-838af593d2df"
      unitRef="usd">438000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMjAtMy0xLTEtNDcyODQ_70a84ee5-2fc3-41d6-9ed4-589c793ef861"
      unitRef="usd">742000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMjEtMS0xLTEtNDcyODQ_a39ac37e-6b67-480a-91b4-8d11800e999b"
      unitRef="usd">5518000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RhYmxlOmM1NDEzZTM1N2E5MTQyZmQ5Y2I5NGNhNTNmODNjNThlL3RhYmxlcmFuZ2U6YzU0MTNlMzU3YTkxNDJmZDljYjk0Y2E1M2Y4M2M1OGVfMjEtMy0xLTEtNDcyODQ_afcd2374-ff17-4ae8-aa49-805626661401"
      unitRef="usd">6406000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities
      contextRef="i792e3f3cd2194564994f887fa0311091_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMTA5OTUxMTYzNDA4Mg_eaf8ef9b-6f7b-4396-a20a-e0e5b2afd716"
      unitRef="usd">5000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities
      contextRef="i792e3f3cd2194564994f887fa0311091_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMTA5OTUxMTYzNDA4Ng_87421931-9635-4e23-b7a0-6fa4e65abb36"
      unitRef="usd">12000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjYy_84566d44-22ea-4099-a6c8-1fd6338a8fbb"
      unitRef="usd">6000000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjY5_26a3b011-00f8-4df8-96a3-1e245b4ff0e8"
      unitRef="usd">7100000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNzA5_640b5d1f-8618-49d6-a60a-a9f66b37114f"
      unitRef="usd">438000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNzE2_0010c3e9-b92e-4cf8-bbef-eed7e3df6ba4"
      unitRef="usd">742000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i069e5020023e41c2aedab80fbb7726b6_I20210812"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfODkz_bd741356-bf9d-4a77-824a-399feddea31d"
      unitRef="number">0.0130</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i069e5020023e41c2aedab80fbb7726b6_I20210812"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfOTY2_09de43bc-e858-4fc4-bd98-24828953911c"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i8dde3db75bc9423db7d08caf0b284aa7_D20210812-20210812"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMTE5MA_9cf0e44f-3921-493c-90a7-40f2904183d9"
      unitRef="usd">495000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i6122fb9648ed4fbf9da45b3e8dd631d2_D20210401-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMjE5OQ_2854098f-9167-413c-afea-9bc2604c2bb9"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i31809c12d9a9402ea8b76662fed12284_I20210717"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMjgxMA_87fc077c-3634-44ca-9d01-1be3e3240cc7"
      unitRef="number">0.0063</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i31809c12d9a9402ea8b76662fed12284_I20210717"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMjgxMw_31075461-8b3a-4f21-bd70-bf03fa278039"
      unitRef="eur">600000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i31809c12d9a9402ea8b76662fed12284_I20210717"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMjgzNQ_d6869644-e9e9-4d49-b534-93476321267e"
      unitRef="usd">709000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icd10c718453c405e97d6ad84b80e8fc1_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzEwOQ_a1a396f6-aff8-46ab-b9de-41d058371aa6"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i64f43622e576465e9b38ab4c248303f2_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzEzMw_868b13fc-483d-4842-9d0f-cf1dfdb96f82"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia80e8f219b104e7b8095a386e548a730_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzE1OA_e1231de2-df1b-4c83-9bce-754be3ed6231"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibfb5001dc67f4f8a896d6c6104d869ab_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzE4Nw_493e6371-1149-44aa-9962-82384a9c9668"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i610e62fc020849aaa1514bb64ecea83d_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzIxMA_6aee04f9-347c-4030-b81d-3740d4a3767e"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i04a21be0ee8945e1bc0d1cb119b3e6dd_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzIzNA_74f6938e-d7d9-477f-a0fc-f723aed1aab8"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8fbbaa7c754d4333bc9a4584cc99c906_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzI2Mw_e3a0b244-e0d3-4774-a9ba-86fd0b84222c"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="icbb3c18dcf864424ae20c2a6f59a05a6_I20210723"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzQyOA_f10a2fc2-5809-4b95-978d-461d92d8a3e0"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="icbb3c18dcf864424ae20c2a6f59a05a6_I20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzQ0MQ_c6200274-50d0-48ba-9c8d-689ecd8ec633"
      unitRef="usd">922000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzUwNQ_8ccb46ef-ef89-46be-b8a9-0560733ce361"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzU0OA_944bd5ce-416b-4f06-80be-1a58ca9ba087"
      unitRef="usd">182000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:InterestPaid
      contextRef="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzU4OA_5ab72215-290a-415a-9992-2bfea2a529a7"
      unitRef="usd">14000000</us-gaap:InterestPaid>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzc3MA_ea6bbd8e-e3e5-49e3-aca5-5d606cc3874f"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="icbb3c18dcf864424ae20c2a6f59a05a6_I20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzgwMQ_c7a0936e-c00a-4b67-bc99-e89c6f8a38a2"
      unitRef="usd">182000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts
      contextRef="ie1750bb90c1145e3b9cc2012621306a0_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMzkwMw_d1d1e832-8b4c-437e-8d39-b64d329eea8c"
      unitRef="usd">9000000</mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i41cdbb2354254500bac2539b51ef63ea_I20190925"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDA2MA_9704642c-2dbe-4809-aea2-f5d274a682cc"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i4fde2411c1644621b3365876316b4cbf_D20190925-20190925"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjA4Nw_b24ee3e7-c243-42a8-b384-b924dc5c50f2">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8665153941be4bb7b02bd203a47d4f00_I20190925"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDExMQ_fccaf705-1655-4394-b3ec-88880161794f"
      unitRef="usd">3600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ia0f0596aa0084e20afa89597288e93c4_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU0MA_0e9daa8b-1056-4016-bd69-abf0245c6477"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i6b04286cc90b410990ef32577b13b1cf_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU0MA_c4025aca-cfb2-4d7f-a8e6-4b5164d1a39d"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i5854b4d082a04d84aa8c864577be8b31_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU0MA_e60f231c-5ebf-4f8b-bffc-a08fcc43302a"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i07aa03a3cf46464cbc26feec1d3d32c1_D20210401-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU0MA_fb3e0c39-4396-45d9-93b6-9edd9c1cc4ed"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i6953458f6f674d6ab890f86f4cd4f38e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU4Mg_55004fd9-4e18-425e-87c1-b61864624b71"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i0dafe850daa44ba092c57047f0ce2877_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNDU4Mg_774c2523-b2c6-4c1e-83a5-e2120b5ca978"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
      contextRef="i89b9210a5ce84d4c8f57ef708a9e06d0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTQwOA_2936aa2b-e6ea-4b11-a91d-8cb56376d704"
      unitRef="usd">7000000</us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i89b9210a5ce84d4c8f57ef708a9e06d0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTQ0MA_b5873c9b-6968-4f52-930b-c809ebca0772"
      unitRef="usd">114000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ibb82d8e0e0254d2e8fef071a792829d2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTgwNQ_cdb453c9-0b94-476b-a2ef-29616e58e7b8"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="if95be6cfe924456c8da8cea9e5d5e974_D20210401-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTg5OQ_f27ec612-1ed5-4058-bf18-b9e073b0f39f"
      unitRef="usd">3600000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="if95be6cfe924456c8da8cea9e5d5e974_D20210401-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTkxMw_3e7fabd5-0d93-4e07-b86d-32a0c858f347"
      unitRef="usd">3300000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="ief157ea0a56249a692efe8e3d4607fa5_D20200401-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNTk4Nw_121bba89-5593-4c91-9d12-ff23b26477e8"
      unitRef="usd">5500000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="ief157ea0a56249a692efe8e3d4607fa5_D20200401-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjAwMQ_0def5b5b-93ef-43f4-b581-3da287f00347"
      unitRef="usd">5300000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="ibb82d8e0e0254d2e8fef071a792829d2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMTA5OTUxMTYzMzkzMQ_f58abbe4-9879-4d61-afce-406042e92949"
      unitRef="usd">372000000</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="ibb82d8e0e0254d2e8fef071a792829d2_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfMTA5OTUxMTYzNDAzOQ_cbe805c0-548b-4d7b-aff6-3156481b64f1"
      unitRef="number">0.0029</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="ie1fc9c20fe7d4693bf05d2692768da1f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81NS9mcmFnOmEzMmM1N2JjZjMzNzQ3NzE5MDg0ODU3MDExMmQ2YTRhL3RleHRyZWdpb246YTMyYzU3YmNmMzM3NDc3MTkwODQ4NTcwMTEyZDZhNGFfNjA0OA_4c56da82-823d-4345-954b-9b05bd38f4df"
      unitRef="usd">0</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfODY2_02378a10-730c-41e4-8746-43ca80f08607">Pension Benefits&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net periodic expense for defined benefit pension plans was approximately $2 million and $4 million for the three and nine months ended December 31, 2021, respectively, and $4 million and $17 million for the three and nine months ended December 31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash contributions to these plans were $18 million and $35 million for the three and nine months ended December 31, 2021, respectively, and $8 million and $19 million for the three and nine months ended December 31, 2020, respectively. The cash contributions for the three and nine months ended December 31, 2021 included a $17&#160;million payment to a U.K. pension plan. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#x2019; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale,&#x201d; pension assets of $52&#160;million and pension liabilities of $148&#160;million were included under the captions &#x201c;Assets held for sale&#x201d; and &#x201c;Liabilities held for sale,&#x201d; respectively, in the Condensed Consolidated Balance Sheet as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3f3051bdb38143259288f549f974a0e9_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfODk_3b81a626-1ebd-4413-a8de-b837f31d4c07"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i090754fc8e614e6bbad26c7f79ea2655_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTA5OTUxMTYyODY2Mg_b5f776d8-6d93-49ad-a478-98d9746f7f90"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3fd478d8076c43f6abb4a6dd08e769d8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTA3_3d198711-2dd1-4f6f-9308-b7fb7d62e6c3"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i4730e8d997974abd8395c6ed22b656fe_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTE0_9d61a636-078f-4af3-b8f8-1bd33ba36388"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i3f3051bdb38143259288f549f974a0e9_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTgy_4c42e230-a1e9-44c1-b03a-d416d019b189"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i090754fc8e614e6bbad26c7f79ea2655_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTg5_b6444a42-a8e7-4cb4-94dc-d06714cd38bd"
      unitRef="usd">35000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i3fd478d8076c43f6abb4a6dd08e769d8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMjIy_ac8196d3-1631-4260-b82d-5d5aef5de510"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i4730e8d997974abd8395c6ed22b656fe_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMjI5_edc5b14d-2d44-49b2-9d46-c05e675fedc5"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="if2d4d8bd24764afda92f5b33e18eec02_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTY0OTI2NzQ0MjgwOA_283e5609-bbb3-4560-b7de-271caec9c99c"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i2b06140a4e4b45c08325af13b9477bc5_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTY0OTI2NzQ0MjgwOA_dbb4c0e7-25ea-42ed-b5ee-dceed7ff6bc4"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanFundedPercentage
      contextRef="i96f5c70408574f04b15b2f7ec7679bb4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfNDQx_22f0539f-18d7-42ee-8843-20b42deff5a3"
      unitRef="number">0.10</us-gaap:DefinedBenefitPlanFundedPercentage>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1a47389171bb414193fe6314b964f7fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfMTY0OTI2NzQ0Mjg2MQ_d7570984-7c58-4937-9c5c-5e87c274dc4f"
      unitRef="usd">52000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation
      contextRef="i1a47389171bb414193fe6314b964f7fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV81OC9mcmFnOjhhOTlmNWRhM2JjMDQwNDNhZjU2MWI0YzNkYjZlZTkyL3RleHRyZWdpb246OGE5OWY1ZGEzYmMwNDA0M2FmNTYxYjRjM2RiNmVlOTJfNzY4_9fd435b3-7030-4dc5-af0d-dcb2f0f7402b"
      unitRef="usd">148000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfOTg0NA_2af08ef6-50f3-4b11-9b3e-0ed9b65ec7ba">Hedging Activities&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#x2019;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Exchange Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#x2019;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Derivative Instruments Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021 and March 31, 2021, the Company had &#x20ac;1.1 billion and &#x20ac;1.7 billion, respectively, of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#x2019;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#x201c;Accumulated other comprehensive loss&#x201d; in the Condensed Consolidated Statements of Stockholders&#x2019; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from net investment hedges recorded within Other comprehensive income were gains of $23 million and $34 million during the three and nine months ended December 31, 2021, respectively, and losses of $84 million and $201 million during the three and nine months ended December 31, 2020, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three and nine months ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021 and March 31, 2021, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $500 million Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#x2019;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#x201c;Accumulated other comprehensive loss&#x201d; in the Condensed Consolidated Statements of Stockholders&#x2019; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#x2019;s net investment hedges for the three and nine months ended December 31, 2021 and 2020. The remaining cross-currency swaps will mature in November 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from the Company&#x2019;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $2 million and gains of $3 million during the three and nine months ended December 31, 2021, respectively, and losses of $45 million and $108 million during the three and nine months ended December 31, 2020, respectively. There was no ineffectiveness in the Company&#x2019;s cross-currency swap hedges for the three and nine months ended December 31, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#xa3;450 million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#xa3;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At December 31, 2021 and March 31, 2021, the Company had cross-currency swaps with total gross notional amounts of approximately $1.8 billion and $2.6 billion, respectively, which are designated as cash flow hedges. These swaps will mature between December 2022 and January 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500 million and &#x20ac;600 million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#x201c;EURIBOR&#x201d;) for the &#x20ac;600 million swaps. The $500 million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and is being amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes. The &#x20ac;600 million swaps were terminated in the second quarter of 2022 and the loss on termination of the swaps recorded in interest expense was not material for the nine months ended December 31, 2021. Refer to Financial Note 8, &#x201c;Debt and Financing Activities,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From September 20, 2021 to November 4, 2021, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with a combined notional amount of $500 million, to hedge the variability of future benchmark interest rates on a planned bond issuance. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $8 million and gains of $3 million during the three and nine months ended December 31, 2021 and losses of $14 million and $42 million during the three and nine months ended December 31, 2020, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations were not material in the three and nine months ended December 31, 2021 and 2020. There was no ineffectiveness in the Company&#x2019;s cash flow hedges for the three and nine months ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Not Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At December 31, 2021 and March 31, 2021, the total gross notional amounts of these contracts were $5 million and $39 million, respectively. These contracts matured between October 2021 and January 2022 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material in the three and nine months ended December 31, 2021 and 2020. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.481%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i9e8c8f89b9ff413690a3a67eb1468bb1_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMTUwMQ_764c82ef-c62f-46df-b41b-da12b2fbd6c8"
      unitRef="eur">1100000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib7ed6b36701e4a04bfe99fe455ef93a9_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMTUwOA_a7e99da4-27da-49a5-8aff-c7494038a1bc"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic3f95e7d8ccb40f9b9eb2820e1c96850_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjU3OQ_528e4541-61c7-4383-bba3-30933f1204e2"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib56a0acb015f42a9b6db7d566e4d694a_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjU4Ng_a3b5d2b1-30de-4f73-b5c3-c2ca88f9ec0c"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="id0fb12228284472bb3616ebca5add51a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjYzMg_82caeed4-99f4-4fee-a645-f5930b283e8c"
      unitRef="usd">-84000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9c56745c1ad842ad90cf4a2cd11ebec9_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjYzOQ_e3e731c8-ab48-4de2-a129-6377209341f4"
      unitRef="usd">-201000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i306448d022c44df8b4a9d9a3a303bd36_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjkxMw_3a048555-7278-445a-8bf1-83260d218909"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4fd28eaef6c94a969cb3718719b09b86_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMjkxMw_6caafb3a-fc40-4a91-ad05-0b7f4a88fa76"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="id80470ece115487a90c8e9f0d8fa5909_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNDM5Nw_83b29576-d200-4cec-aff5-f8da236d5429"
      unitRef="usd">-2000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i0562d50847594e68a2ad757563e23331_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNDQwNA_6f30fe90-cbcb-4163-883e-a12513b75d16"
      unitRef="usd">3000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="if413ab2045f7407d94fd20c0c60e1710_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNDQ1MA_ef3df82a-9628-48e0-b2c4-7f312afc8738"
      unitRef="usd">-45000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i096c4c0268604806b329bdf3f18855cc_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNDQ1Nw_094b31c9-b03b-4f71-a371-8cac6fc03f36"
      unitRef="usd">-108000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:LongTermDebt
      contextRef="if0efacf445fc46d1b3325b78010882fa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNDY5Nw_cc13afb1-12a1-4330-97a5-bf5564ceff80"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if0efacf445fc46d1b3325b78010882fa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNTA0OQ_cc13afb1-12a1-4330-97a5-bf5564ceff80"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iab7a4eb1e70b4fa1b361a9b44cd85bf4_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNjI3Mg_4ef04221-0921-4e18-a033-3986258e570d"
      unitRef="usd">1800000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i29742682b8ef4a26affbcf74cb0801e1_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNjI3OQ_6c2f4dff-2608-42e6-95a6-e0c477c2cebc"
      unitRef="usd">2600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNjkxNA_28f2ce5c-21e9-43e4-b2ae-630a59668bff"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNjkyMQ_2a733d77-c86a-40eb-bd83-502c4a98a897"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNzE1MA_28f2ce5c-21e9-43e4-b2ae-630a59668bff"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNzM3NQ_2a733d77-c86a-40eb-bd83-502c4a98a897"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNzM4OQ_28f2ce5c-21e9-43e4-b2ae-630a59668bff"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="ic0079095dff44d82a99df4fa0de3968c_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfOTg0Ng_d9ccd05e-0c76-452d-a07b-7dc5c9ffb16c">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i65f089e2f1a9456e92ea3681ece4ea46_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNzYzMQ_2a733d77-c86a-40eb-bd83-502c4a98a897"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i759ece90e4a84418bd88eef741535d3a_I20211104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfNzk5Mw_c84cb153-0a93-48c2-805a-7976744228fc"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i759ece90e4a84418bd88eef741535d3a_I20211104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfODIyMw_c84cb153-0a93-48c2-805a-7976744228fc"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i32ba2d1a45c445c583e6de9a264e133b_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfMTA5OTUxMTYzODAxMA_0b7f64e7-6348-4296-9339-706c62f2928a"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i17d15431fbc54c0ca88b62ba4fa8a2af_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfODM5OA_815d8e0f-e4a2-4bbc-b712-aece5ce7b424"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ieddd952970aa4ffdac4cb0616cd91e55_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfODQyOQ_4324cf42-6563-495e-827e-4b79b3e07b4a"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib0f2aab0d3e545aeb80528ab93b0610b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfODQzNg_246890c5-c5ce-4d85-8bf2-9e362b5468bf"
      unitRef="usd">-42000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3cccab8b5e8e4f7eb85e366050dd0c6e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfOTEzOQ_e30ad1b0-a255-44b3-b42a-165f61fff9cd"
      unitRef="usd">5000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i31ea48b5b7c94d91be10ded715dc2ed7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfOTE0Ng_37714e86-8976-435a-8465-103b6a07bee9"
      unitRef="usd">39000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RleHRyZWdpb246ZWVlMGZkMjg4NzRlNDc1NmI4N2JkMjJlNzBkOGY4MGZfOTg0MQ_33699f3d-0902-4acf-8c4d-2972d31f4e70">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.481%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i91a4aa2234e64d5492f8ae8c66bf803a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS0yLTEtMS00NzI4NA_aa479ffa-71cf-4ee8-9259-e7fddec0129d"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i91a4aa2234e64d5492f8ae8c66bf803a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS00LTEtMS00NzI4NA_50521412-d10a-4432-8dea-37392c2f0a2a"
      unitRef="usd">28000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i91a4aa2234e64d5492f8ae8c66bf803a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS01LTEtMS00NzI4NA_73666f34-7566-4245-856d-b3efe9f963e4"
      unitRef="usd">570000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i952999021b6746f7bb3d33905898d07e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS03LTEtMS00NzI4NA_1f95226d-0079-4745-bca0-8d9d33cee92b"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i952999021b6746f7bb3d33905898d07e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS05LTEtMS00NzI4NA_618af7f4-eb1a-41d8-abae-3954bee79950"
      unitRef="usd">47000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i952999021b6746f7bb3d33905898d07e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNS0xMC0xLTEtNDcyODQ_6c29a7a1-0bca-4684-a7d5-300cf9cb6e0e"
      unitRef="usd">826000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if9e7d0745bdf49c39fe6e13e746c332d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi0yLTEtMS00NzI4NA_d863e1ac-abe6-4781-9271-3c7bfc3e884d"
      unitRef="usd">66000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if9e7d0745bdf49c39fe6e13e746c332d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi00LTEtMS00NzI4NA_3de98d31-f408-44de-837b-2d2ba1043f1d"
      unitRef="usd">56000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if9e7d0745bdf49c39fe6e13e746c332d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi01LTEtMS00NzI4NA_5a4796cc-09f4-4736-990d-6e0b03d49ab2"
      unitRef="usd">2205000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i61fc3b32631340948c814ea6d7f2e4bd_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi03LTEtMS00NzI4NA_5baa9e43-16ab-4acc-9bca-0eef4240343e"
      unitRef="usd">72000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i61fc3b32631340948c814ea6d7f2e4bd_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi05LTEtMS00NzI4NA_93cfb6c4-bfdf-4819-a508-e474852245d1"
      unitRef="usd">92000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i61fc3b32631340948c814ea6d7f2e4bd_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNi0xMC0xLTEtNDcyODQ_91767ebb-96fe-4e9e-9681-f4faf5f8dc72"
      unitRef="usd">2663000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i24f081c15f3b4160a10acf6eb389de1b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy0yLTEtMS00NzI4NA_af1fe2de-5f49-470e-b660-895092283388"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i24f081c15f3b4160a10acf6eb389de1b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy00LTEtMS00NzI4NA_dc144924-4403-4144-8119-cb9ec5c1eab1"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i24f081c15f3b4160a10acf6eb389de1b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy01LTEtMS00NzI4NA_2e2b3bb6-1b01-4051-afcf-a90e7d3e1c6f"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i319b6b970e834bb696c416ea5807f857_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy03LTEtMS00NzI4NA_b89c0f3f-2a89-4dcf-8712-ffa281b21502"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i319b6b970e834bb696c416ea5807f857_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy05LTEtMS00NzI4NA_07e13bca-abb9-4a74-a6cc-47d3318fa901"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i319b6b970e834bb696c416ea5807f857_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfNy0xMC0xLTEtNDcyODQ_a29f1ec8-a707-4f32-a3cb-f6605adef77a"
      unitRef="usd">704000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1586fe22fd6646a0a008cea296ca2866_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC0yLTEtMS00NzI4NA_a5cce0bf-ab7f-47d8-90e4-7658f9acd63d"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1586fe22fd6646a0a008cea296ca2866_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC00LTEtMS00NzI4NA_60bed5a0-c77d-4756-bce6-a4b81e0a146c"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i1586fe22fd6646a0a008cea296ca2866_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC01LTEtMS00NzI4NA_3072615a-1de8-4d55-9704-c7b4bfd6ee1b"
      unitRef="usd">500000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i90925257b3bd4257846aefcd6879fc30_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC03LTEtMS00NzI4NA_bd964cd5-1916-4450-aa39-663f5b086d73"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i90925257b3bd4257846aefcd6879fc30_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC05LTEtMS00NzI4NA_8a3c5557-0316-41ce-8f9b-4e786bfea9e1"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i90925257b3bd4257846aefcd6879fc30_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOC0xMC0xLTEtNDcyODQ_75ab1ddf-2442-46c9-a27a-30c55b457960"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i44441409ce5e4ca6988aff06c61dae4f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOS0yLTEtMS00NzI4NA_7ba71d8e-13ac-4789-a7b3-796e91bd4a6e"
      unitRef="usd">69000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i44441409ce5e4ca6988aff06c61dae4f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOS00LTEtMS00NzI4NA_9ce3000b-f84c-4762-8190-54d3203acf18"
      unitRef="usd">86000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie3caf14c9bd64234ba322f53161f25e5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOS03LTEtMS00NzI4NA_0bfe67e3-7f4f-4309-abb1-4d18909a7597"
      unitRef="usd">76000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie3caf14c9bd64234ba322f53161f25e5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfOS05LTEtMS00NzI4NA_adcd35f1-2709-43e6-9185-f914e3eeae6f"
      unitRef="usd">146000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1e6556feb6b14585bc7a63dbc68b457d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtMi0xLTEtNDcyODQ_bcc32cb5-6dcc-45eb-8bcf-de1acee255ba"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1e6556feb6b14585bc7a63dbc68b457d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtNC0xLTEtNDcyODQ_875c3549-4d33-4d0b-93fa-3af9007bb3cc"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i1e6556feb6b14585bc7a63dbc68b457d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtNS0xLTEtNDcyODQ_389dc7b9-7ee7-437e-9f18-35d4137da75b"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1fcadcad601441e0af45b696a5ae82cb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtNy0xLTEtNDcyODQ_e6c37cf8-394c-4de2-b25c-aea2ec46bbfb"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1fcadcad601441e0af45b696a5ae82cb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtOS0xLTEtNDcyODQ_8d65cea3-74e3-42db-8736-f2357821c834"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i1fcadcad601441e0af45b696a5ae82cb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTEtMTAtMS0xLTQ3Mjg0_7add724b-d105-4d32-a65a-aecf76c76274"
      unitRef="usd">29000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i547bb2984de34a9496536b9a8f7fb1d6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItMi0xLTEtNDcyODQ_a79d6396-0d56-4d30-af8f-533c043b9b32"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i547bb2984de34a9496536b9a8f7fb1d6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItNC0xLTEtNDcyODQ_bfae85d0-2ad7-4a96-ab39-0b36f90cb18f"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i547bb2984de34a9496536b9a8f7fb1d6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItNS0xLTEtNDcyODQ_e9ee57ae-bad0-4bf7-ae3c-608e7d36a51c"
      unitRef="usd">5000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ieac471f0e5ea44638e9f45f235e28103_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItNy0xLTEtNDcyODQ_b1fa06d3-a6b1-463a-9270-b2fe674034c8"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ieac471f0e5ea44638e9f45f235e28103_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItOS0xLTEtNDcyODQ_d535449f-0deb-424c-aa85-74124e375c35"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ieac471f0e5ea44638e9f45f235e28103_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTItMTAtMS0xLTQ3Mjg0_f5f0b0c4-0942-4515-82c5-edb3818399cc"
      unitRef="usd">10000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i63bb1d026acc4fe6bdcd0573dcf77353_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTMtMi0xLTEtNDcyODQ_e0806c24-9196-45b1-acd2-ff7d00bbdfc8"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i63bb1d026acc4fe6bdcd0573dcf77353_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTMtNC0xLTEtNDcyODQ_0578d9af-c5ea-4ad3-b83f-16aba1903fb5"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i57cdcb90e9d24ccb8237b2d0adc78da8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTMtNy0xLTEtNDcyODQ_e41e3f93-fc22-4f7a-8f14-e82c8dab19c0"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i57cdcb90e9d24ccb8237b2d0adc78da8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82MS9mcmFnOmVlZTBmZDI4ODc0ZTQ3NTZiODdiZDIyZTcwZDhmODBmL3RhYmxlOjhlNTVkY2Y5ZDg4NjQ3MTRiYjhiMTY1OGJkM2JlODEzL3RhYmxlcmFuZ2U6OGU1NWRjZjlkODg2NDcxNGJiOGIxNjU4YmQzYmU4MTNfMTMtOS0xLTEtNDcyODQ_a4735f46-5292-4673-8ecc-2fe177d3ce5e"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfODM1MQ_0bd478cd-e6b3-4484-8699-182b7bc13609">Fair Value Measurements&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - significant other observable market-based inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents at December 31, 2021 and March 31, 2021 included investments in money market funds of $1.1 billion and $1.6 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#x2019;s marketable securities were not material at December 31, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of the Company&#x2019;s interest rate swaps, foreign currency forward contracts, and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#x201c;Hedging Activities,&#x201d; for fair value and other information on the Company&#x2019;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $358 million and $269 million, respectively, at December 31, 2021 and March 31, 2021. These investments primarily consist of equity securities without readily determinable fair values and are included in &#x201c;Other non-current assets&#x201d; in the Condensed Consolidated Balance Sheets. During the nine months ended December 31, 2021 and 2020, certain of the Company&#x2019;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities. Additionally, during the nine months ended December 31, 2020, certain of the Company&#x2019;s investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. Net gains related to the Company&#x2019;s investments in these equity securities, primarily representing unrealized gains on the securities discussed above, were $104 million for the nine months ended December 31, 2021 and $28 million and $87 million for the three and nine months ended December 31, 2020, respectively. These net gains were recorded in &#x201c;Other income, net,&#x201d; in the Condensed Consolidated Statements of Operations. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#x2019;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021, the assets and liabilities associated with the disposal groups in Europe held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale." At December 31, 2021 and 2020, assets measured at fair value on a nonrecurring basis included long-lived assets associated with the Company&#x2019;s restructuring initiatives as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges.&#x201d; Assets measured at fair value on a nonrecurring basis as of December 31, 2020 included long-lived assets in the Company&#x2019;s International segment and goodwill of the Company&#x2019;s Europe Retail Pharmacy reporting unit within the International segment. Refer to Financial Note 7, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for more information. At March 31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#x2019;s International segment and goodwill of the Company&#x2019;s Europe Retail Pharmacy reporting unit within the International segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no other liabilities measured at fair value on a nonrecurring basis at December 31, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Fair Value Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021 and March 31, 2021, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.903%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash, included within &#x201c;Prepaid expenses and other&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheets as of December 31, 2021, primarily consists of $354&#160;million held in escrow related to the initial payment under the proposed settlement agreement for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 12, &#x201c;Commitments and Contingent Liabilities.&#x201d; Additionally, restricted cash as of December 31, 2021 and March 31, 2021 includes funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. These amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities and corresponding deposit liabilities associated with these funds have been recorded by the Company within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheets as of December 31, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of reporting units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie81c569998f846eabdd329f198f8fb80_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfNzY4_8e517191-0e7b-4ccd-9709-fe73643b1bb7"
      unitRef="usd">1100000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if71186c9249547a6bb4645f7ef5e00bc_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfNzc1_e578c7dc-c98d-4be9-b9cd-7ee97d11b390"
      unitRef="usd">1600000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfMjE2Nw_7b85f1a4-483b-47d5-8192-ef4d92a09904"
      unitRef="usd">358000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iafc802238be540dba818f29ae266827f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfMjE3NA_cbf44504-aedf-40cb-bb24-c7706162a880"
      unitRef="usd">269000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfMjk1OA_d96aca2e-1625-44b2-920d-6e9dd98eadae"
      unitRef="usd">104000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfMzg0ODI5MDcwNTU3OQ_61ed76fd-7397-4374-95ec-3a91f6698f2a"
      unitRef="usd">28000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfMzg0ODI5MDcwNTU4NA_0f339941-4408-4aa1-8d99-5b0a6768a951"
      unitRef="usd">87000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i058558a97c0745aaadbecc089580e6ca_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfNTEwOA_6eee0583-1815-4377-85f1-ed213efbf3ef"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib5fd50078c2b473ba6fa21c1d3fc3a83_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfNTEwOA_7daa3be0-ab10-4df5-91f7-cf5919eb4518"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfODM1MA_8a8c1d88-b354-4016-8061-fcef8bcfa5f4">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.903%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ia57f313fd26c4d74b79a639aec5953e7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RhYmxlOmE3ZGE1YjVlZDMwZTQyZGE4ZDVmMzY2OTUwOTEwMmYxL3RhYmxlcmFuZ2U6YTdkYTViNWVkMzBlNDJkYThkNWYzNjY5NTA5MTAyZjFfMi0xLTEtMS00NzI4NA_1f3831c2-4306-4f04-86dc-67a070fbec91"
      unitRef="usd">5956000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia57f313fd26c4d74b79a639aec5953e7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RhYmxlOmE3ZGE1YjVlZDMwZTQyZGE4ZDVmMzY2OTUwOTEwMmYxL3RhYmxlcmFuZ2U6YTdkYTViNWVkMzBlNDJkYThkNWYzNjY5NTA5MTAyZjFfMi0zLTEtMS00NzI4NA_2668003c-3177-42b9-aeb1-e6bf06f84e36"
      unitRef="usd">6376000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="ic780468f2c1a40329586136abdfe217f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RhYmxlOmE3ZGE1YjVlZDMwZTQyZGE4ZDVmMzY2OTUwOTEwMmYxL3RhYmxlcmFuZ2U6YTdkYTViNWVkMzBlNDJkYThkNWYzNjY5NTA5MTAyZjFfMi01LTEtMS00NzI4NA_497bb5f0-ba9f-4ae3-80db-eb7fd6411d27"
      unitRef="usd">7148000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic780468f2c1a40329586136abdfe217f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RhYmxlOmE3ZGE1YjVlZDMwZTQyZGE4ZDVmMzY2OTUwOTEwMmYxL3RhYmxlcmFuZ2U6YTdkYTViNWVkMzBlNDJkYThkNWYzNjY5NTA5MTAyZjFfMi03LTEtMS00NzI4NA_4ebdbc8c-5d79-481b-85cb-b162e9d5e048"
      unitRef="usd">7785000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:RestrictedCash
      contextRef="i3b6ebdeadc4946d3be80756e21be72d2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82NC9mcmFnOjU2Y2RmMzk1OGFjZDRhYTdiOGI0YWNhNzJkMjcyZWU3L3RleHRyZWdpb246NTZjZGYzOTU4YWNkNGFhN2I4YjRhY2E3MmQyNzJlZTdfNjM3MQ_7cf57b0d-8b0e-4382-b714-213c9087f4e7"
      unitRef="usd">354000000</us-gaap:RestrictedCash>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTk5Mzc_429d5b16-7d9f-42b4-93ee-2441fa302ad6">Commitments and Contingent Liabilities&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765321000039/mck-20210331.htm#i08f9baf810c0412e93ea6effc6d22995_214" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 19 to the Company&#x2019;s 2021 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#x201c;Claims and litigation charges, net&#x201d; in the Condensed Consolidated Statement of Operations consist of estimated loss contingencies related to opioid-related litigation matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;I. Litigation and Claims Involving Distribution of Controlled Substances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), state and federal controlled substances laws, and other statutes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#x201c;MDL&#x201d;) in the United States District Court for the Northern District of Ohio captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re: National Prescription Opiate Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Case No. 17-md-2804. At present, there are approximately 2,800 cases under the jurisdiction of the MDL court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also named in approximately 350 similar state court cases pending in 40 states plus Puerto Rico, along with 4 cases in Canada. These include actions filed by 23 state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trial in the case brought by the Washington attorney general began on November 15, 2021. Trial in the case brought by the Alabama attorney general was postponed until April 18, 2022, and the parties continue to engage in settlement negotiations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 21, 2021, the Company and the two other national pharmaceutical distributors announced that they had negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. If the proposed settlement agreement and settlement process leads to final settlement, the three distributors would pay up to approximately $21 billion over 18 years, with up to $7.9 billion to be paid by the Company for its 38.1% portion; a minimum of 85% of such payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#x2019; attorneys&#x2019; fees and costs, and would be payable over a shorter time period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The proposed agreement would also establish a clearinghouse that would consolidate controlled-substance distribution data from the three largest U.S. distributors, which will be available to the settling states to use as part of their anti-diversion efforts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The proposed agreement only addresses the claims of U.S. state attorneys general and political subdivisions in participating states. The West Virginia subdivisions and Native American tribes are not part of this settlement process. The proposed agreement is subject to contingencies and will not become effective unless the Company determines that a sufficient number of states and political subdivisions, including those that have not sued, have agreed to be bound by the agreement (or otherwise had their claims foreclosed).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 4, 2021, the Company announced that 42 of 49 eligible states had affirmatively signed on to the proposed agreement. Since that time, the attorneys general of Georgia, Nevada, New Mexico, and Rhode Island have announced that they will join, bringing the state total to 46 out of 49 eligible states, all 5 U.S. territories, and Washington, DC. The attorneys general of Alabama, Oklahoma, and Washington have not joined the proposed settlement. Beginning on September 4, 2021, each participating state offered its political subdivisions, including those that have not sued, the opportunity to participate in the settlement. That period concluded on January 26, 2022. Under the agreement, the participating states have until February 7, 2022 to determine whether there is sufficient participation in the settlement by political subdivisions to proceed to implementation. After the conclusion of this period, the Company will have until February 25, 2022 to determine whether a sufficient number of states and political subdivisions have joined for the settlement to proceed to implementation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The exact amount that would be due under the proposed agreement depends on several factors, including the participation rate of states and political subdivisions, the extent to which states take action to foreclose opioid lawsuits by political subdivisions, and the extent to which political subdivisions in settling states file additional opioid lawsuits against the Company after the proposed agreement becomes effective. The proposed agreement contemplates that if certain governmental entities do not agree to a settlement under the framework, but the distributors nonetheless conclude that there is sufficient participation to warrant the settlement, there would be a corresponding reduction in the amount due from the Company to account for the unresolved claims of the governmental entities that do not participate. Those non-participating governmental entities could continue to pursue their claims against the Company and other defendants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with the terms of the proposed agreement, the Company placed its first annual payment of approximately $354&#160;million, into escrow on September 30, 2021. Those escrow amounts were presented as restricted cash within &#x201c;Prepaid expenses and other&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheet as of December 31, 2021. On January 25, 2022, the Company placed approximately $19&#160;million into escrow to reflect the participation of Georgia, New Mexico, and Nevada. The amounts placed into escrow exclude the proportionate allocation under the proposed settlement for each non-participating state and would be disbursed when and if the proposed agreement becomes effective. Subsequent annual payments would be due on July 15 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 20, 2021, the Company announced that it and the two other national pharmaceutical distributors had agreed to pay up to $1.2&#160;billion, of which the Company&#x2019;s portion would be 38.1% (or, approximately $450&#160;million), in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that New York and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#x2019; fees and costs. If the broad settlement is finalized, New York and its participating subdivisions will become part of that broader agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2021, the Company and the two other national pharmaceutical distributors reached an agreement with the state of Ohio and its participating subdivisions and agreed to pay $881&#160;million, of which the Company&#x2019;s portion would be 38.1% (or, approximately $336&#160;million), to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that Ohio and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#x2019; fees and costs. If the broad settlement is finalized, Ohio and its participating subdivisions will become part of that broader agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 24, 2022, the Company and two other national pharmaceutical distributors reached an agreement with the state of Rhode Island and its participating subdivisions and agreed to pay approximately $91&#160;million, of which the Company&#x2019;s portion would be 38.1% (or, approximately $35&#160;million), plus certain attorneys&#x2019; fees and costs, to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that Rhode Island and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#x2019; fees and costs. If the broad settlement is finalized, Rhode Island and its participating subdivisions will become part of that broader agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 28, 2022, the Company and two other national pharmaceutical distributors reached an agreement with the state of Florida and its participating subdivisions and agreed to pay approximately $1.4&#160;billion, of which the Company&#x2019;s portion would be 38.1% (or, approximately $530&#160;million), to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that Florida and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework. If the broad settlement is finalized, Florida and its participating subdivisions will become part of that broader agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2021, the Company announced that it and the two other national distributors had reached an agreement with the Cherokee Nation to pay approximately $75&#160;million over 6.5 years to resolve opioid-related claims, of which the Company&#x2019;s portion would be 38.1% (or, approximately $29&#160;million).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has also negotiated a broad resolution of opioid-related claims brought by Native American tribes. Under the proposed agreement, which has been endorsed by the leadership committee of counsel representing the tribes, the Company and the two other national distributors would pay the Native American tribes other than the Cherokee Nation approximately $440&#160;million over 6 years, of which the Company&#x2019;s portion would be 38.1% (or, approximately $167&#160;million). This broad resolution is contingent on the participation of a substantial majority of the Native American tribes that have brought opioid-related claims against the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to the West Virginia subdivisions, trial in the case of Cabell County and City of Huntington, occurred in the U.S. District Court for the Southern District of West Virginia, and concluded on July 28, 2021. The outcome of that trial is pending. The claims of certain other West Virginia subdivisions are pending in the federal MDL and before the state Mass Litigation Panel. On September 30, 2021, the Mass Litigation Panel issued an order scheduling a liability-only trial on the public nuisance claims of certain political subdivisions against the Company and the two other national pharmaceutical distributors for July 5, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that a broad settlement of opioid claims by governmental entities is probable, and that the loss related thereto can be reasonably estimated. The Company recorded a charge of $8.1 billion ($6.8 billion after-tax) in the fiscal year ended March 31, 2021 related to its share of the global settlement as well as claims of West Virginia municipalities and the Native American tribes. In connection with the matters described above, the Company recorded additional charges of $193&#160;million ($160&#160;million after-tax) in the nine months ended December 31, 2021 within &#x201c;Claims and litigation charges, net&#x201d; in the Condensed Consolidated Statements of Operations, in connection with the proposed settlement agreement and other opioid related settlement accruals.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimated accrued liability for opioid-related claims of governmental entities is as follows as of December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This amount, recorded in &#x201c;Other accrued liabilities&#x201d; in the Condensed Consolidated Balance Sheet, is the amount estimated to be paid prior to December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a broad settlement is not reached under the proposed agreement, litigation will continue. The Company continues to prepare for trial in these pending matters, and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private entities generally, are not included in the settlement framework for governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court seeks to recover for damages allegedly arising from their family members&#x2019; abuse of prescription opioids. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Poppell v. Cardinal Health, Inc. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CE19-00472. Trial in that case is scheduled to begin on March 21, 2022. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the many uncertainties associated with any potential settlement arrangement or other resolution of all of these opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#x2019;s financial position, cash flows or liquidity, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;II. Other Litigation and Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 29, 2017, two investment funds holding shares in Celesio AG filed a complaint against McKesson Europe Holdings (formerly known as &#x201c;Dragonfly GmbH &amp;amp; Co KGaA&#x201d;), a subsidiary of the Company, in a German court in Stuttgart, Germany, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 18 O 455/17. On December 30, 2017, four investment funds, which had allegedly entered into swap transactions regarding shares in Celesio AG that would have enabled them to decide whether to accept McKesson Europe Holdings&#x2019;s takeover offer in its acquisition of Celesio AG, filed a complaint, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Davidson Kempner International (BVI) Ltd. et al. v. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No.16 O 475/17. The complaints allege that the public tender offer document published by McKesson Europe in its acquisition of Celesio AG incorrectly stated that McKesson Europe&#x2019;s acquisition of convertible bonds would not be treated as a relevant acquisition of shares for the purposes of triggering minimum pricing considerations under Section 4 of the German Takeover Offer Ordinance. On May 11, 2018, the court in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Polygon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; dismissed the claims against McKesson Europe. Plaintiffs appealed this ruling and, on December 19, 2018, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Polygon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; matter. On November 23, 2021, the Federal Court of Justice (Bundesgerichtshof) rejected the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Polygon &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;plaintiffs&#x2019; further appeal. On March 15, 2019, the lower court in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Davidson&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; similarly dismissed the case. Plaintiffs appealed this ruling and, on October 9, 2019, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Davidson&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; matter. On November 23, 2021, the Federal Court of Justice (Bundesgerichtshof) rejected the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Davidson &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;plaintiffs&#x2019; further appeal. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 16, 2013, the Company&#x2019;s subsidiary, U.S. Oncology, Inc. (&#x201c;USON&#x201d;), was served with a third amended qui tam complaint filed in the United States District Court for the Eastern District of New York by two relators, purportedly on behalf of the United States, 21 states and the District of Columbia, against USON and five other defendants, alleging that USON solicited and received illegal &#x201c;kickbacks&#x201d; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Piacentile v. Amgen Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 30, 2013, the court granted the United States&#x2019; motion to dismiss the claims pled against Amgen. On September 17, 2018, the court granted USON&#x2019;s motion to dismiss the claims pled against it, with leave to amend. On November 16, 2018, the relators filed a fourth amended complaint; that complaint was dismissed with prejudice on December 1, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;III.&#160;Government Subpoenas and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 21, 2016, the Belgian Competition Authority carried out inspections at the premises of several Belgian wholesalers, including Belmedis SA, which was subsequently acquired by the Company. Pharma Belgium NV was also part of the investigation. On April 23, 2021, the Company received correspondence from the Belgian Competition Authority seeking civil penalties. The Company was fully reserved related to this matter for the third quarter of 2022, and the outcome will have no significant impact to the financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTk5MzI_b5cb6176-4dc2-423a-8fe5-c4f2a8dbb059">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765321000039/mck-20210331.htm#i08f9baf810c0412e93ea6effc6d22995_214" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 19 to the Company&#x2019;s 2021 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#x201c;Claims and litigation charges, net&#x201d; in the Condensed Consolidated Statement of Operations consist of estimated loss contingencies related to opioid-related litigation matters.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i3b6ebdeadc4946d3be80756e21be72d2_I20211231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMzc0Mg_ab41bbbe-ffa7-482f-8825-f0f467fdfd3f"
      unitRef="case">2800</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ic4f1a5ddaf4d4944b94efda2a00dba4b_I20211231"
      decimals="-1"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMzgzNQ_9eb15852-8c8d-4378-bb34-f5023c1d041c"
      unitRef="case">350</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofStates
      contextRef="ic4f1a5ddaf4d4944b94efda2a00dba4b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMzg3NQ_fe88de99-8714-4998-90a7-014ba1a6e78c"
      unitRef="state">40</mck:LossContingencyNumberofStates>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if18621054cc940498e59d84996888935_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMzkxNA_3a533d92-22b7-4b62-8546-49dab88cf4ae"
      unitRef="case">4</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofStateAttorneyGenerals
      contextRef="ic4f1a5ddaf4d4944b94efda2a00dba4b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMzk2NQ_e4890cd0-e083-4148-b473-5c55914633e2"
      unitRef="stateattorney">23</mck:LossContingencyNumberofStateAttorneyGenerals>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="i2c8b3f7cefb949109e7eb1c36b7d7bc5_I20210721"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNDc3OQ_4e8dccf4-3aa7-4590-a0a1-e1ea04886075"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <us-gaap:LossContingencyNumberOfDefendants
      contextRef="i29032cc93762461290c629af975e89f1_D20210721-20210721"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTE2MQ_7803f0ed-a362-4fe3-a1d4-9a941ac9c703"
      unitRef="distributor">3</us-gaap:LossContingencyNumberOfDefendants>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="iccc8e044a04f4f06a7102fd769862177_D20210721-20210721"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTIwNw_685513d2-3f02-4874-a8a7-464a3e08d43c"
      unitRef="usd">21000000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="iccc8e044a04f4f06a7102fd769862177_D20210721-20210721"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTIxNQ_5d448093-cff6-4b74-8ee3-ae78a0516a95">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i29032cc93762461290c629af975e89f1_D20210721-20210721"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTIzMA_0ad19d75-8a8b-41ee-be6c-9ef28b0fd491"
      unitRef="usd">7900000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i2c8b3f7cefb949109e7eb1c36b7d7bc5_I20210721"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTI2Nw_734ae8b4-a08c-4bc2-8c73-e5a0e91e2163"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment
      contextRef="i2c8b3f7cefb949109e7eb1c36b7d7bc5_I20210721"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTI5Mg_c78ff411-3320-4572-90b2-95705e01e502"
      unitRef="number">0.85</mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment>
    <us-gaap:LossContingencyNumberOfDefendants
      contextRef="i29032cc93762461290c629af975e89f1_D20210721-20210721"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNTY2Mw_7c97bd21-5c5e-4f96-8dce-85478d9b9848"
      unitRef="distributor">3</us-gaap:LossContingencyNumberOfDefendants>
    <mck:LossContingencyNumberofStates
      contextRef="i63ddda3383cb497a8aa380352d746509_I20210904"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MjU1Mg_208e1f70-e512-4c9e-a978-ad18511a5a85"
      unitRef="state">42</mck:LossContingencyNumberofStates>
    <mck:LossContingencyNumberOfEligibleStates
      contextRef="i63ddda3383cb497a8aa380352d746509_I20210904"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MjU1Ng_4405d8da-9fc9-4ffc-a9b1-cd89f30610f5"
      unitRef="state">49</mck:LossContingencyNumberOfEligibleStates>
    <mck:LossContingencyNumberofStates
      contextRef="ie1bd51abcbd045cd983975696083a0d4_I20220126"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ2MjA3Mg_4b67f866-e7a0-4a71-93a8-749767dad01b"
      unitRef="state">46</mck:LossContingencyNumberofStates>
    <mck:LossContingencyNumberOfEligibleStates
      contextRef="ie1bd51abcbd045cd983975696083a0d4_I20220126"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ2MjA4NQ_ea581503-8449-4cac-a852-94b178d4f6bc"
      unitRef="state">49</mck:LossContingencyNumberOfEligibleStates>
    <mck:LossContingencyNumberOfTerritories
      contextRef="ie1bd51abcbd045cd983975696083a0d4_I20220126"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfNjQzNw_ae6521ff-71b4-428d-9e66-901798524ac0"
      unitRef="territory">5</mck:LossContingencyNumberOfTerritories>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i4c5fee0b311f4c85ad63d103f1e8aa63_D20210920-20210920"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfODMzMQ_3fef9c95-f60d-4a38-9eb4-26008092d709"
      unitRef="usd">354000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i649beb76d86943469243e3ece439fa07_D20220125-20220125"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MTk0MQ_0636dd2b-d2b0-4574-9d15-1b787444091f"
      unitRef="usd">19000000</us-gaap:PaymentsForLegalSettlements>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="i6421afdc7756406892c7733f92c74bf9_I20210720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfODgwOQ_cee7e8a0-45d7-4441-a6a3-f980787a79f6"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i9571ebfcfb4243d4b7416b6bf1f52242_D20210720-20210720"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfODg3OQ_3c57e6cf-d059-4509-a12b-a684a3ab801e"
      unitRef="usd">1200000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i6421afdc7756406892c7733f92c74bf9_I20210720"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfODkyMw_77085d22-fd19-4703-b4a9-d1053880d871"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="if2de5ab2204a4239a0132d31018e9977_D20210720-20210720"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MjY5NA_464d8ef5-99df-4565-84f3-c1301ffcf434"
      unitRef="usd">450000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="iad569f2cde004174b037e2447153313c_I20210928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfOTc4Mw_2f9845f7-c06e-4330-86b8-2eb3ad366c22"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i4cac7c85628448f5aeb6a8aa1a8dd896_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfOTkyNg_b1bd57b3-2b02-48b5-9970-a280b2ab1663"
      unitRef="usd">881000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="iad569f2cde004174b037e2447153313c_I20210928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2NTY0Mg_b34e3cd1-e8db-419a-bc29-d92c15c82de1"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i5dccdea006cd4f81805e1bde772196ee_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3Mjc0Ng_211bf09c-201c-4943-891f-101b38eb8cc0"
      unitRef="usd">336000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="i82197fca02554991b73acbc4d68ccac2_I20220124"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ2ODM2Mg_1309b531-820d-4526-bb1a-575364706d63"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ic684bd89db914674b6775e7c4d69f963_D20220124-20220124"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2NTE3MQ_88e38bb0-c336-4189-b9a4-ef7ac6706e8d"
      unitRef="usd">91000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i82197fca02554991b73acbc4d68ccac2_I20220124"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2NTcwNg_60ea9226-5f3e-4917-9a72-7f8dabdc0c1b"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i643abe1e48c24a8aa9d02dfbe10b9c8c_D20220124-20220124"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MjgwNA_622d7cab-f5c4-4180-948d-cf4c82deafbe"
      unitRef="usd">35000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="i7c604a712f64457faf00ef87a115fbda_I20220128"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ2ODM2MQ_b5344753-8355-4196-9b2b-9fc77eea5ae8"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i2df648f57fa54b56a5008f3783b93493_D20220128-20220128"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2NTc0Mw_4244592c-8929-45ec-afce-0a9d87940ac0"
      unitRef="usd">1400000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i7c604a712f64457faf00ef87a115fbda_I20220128"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTE2MjU_330e1f86-dd8d-4ba0-9023-491d775f072b"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="if78131496b944f1cae74e5708bfd519c_D20220128-20220128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3Mjg4MQ_c9499fb9-14c0-4d47-9e7e-44b016b6239d"
      unitRef="usd">530000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="icdab83fc6b78425a832a4ba53f78811c_I20210928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA0NjI_4a97de9d-c02c-470d-a01b-91ff118554ba"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="if72c9e5652044d418c8a4b5883f5f283_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA1NjQ_4d0d0fc4-b3ce-46d3-a072-828b529ff788"
      unitRef="usd">75000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementPaymentTerms
      contextRef="ibd87c8cd4564444caf1bfeedc9bedcad_D20210928-20210928"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ4MzE3Mw_67985888-dc64-4b52-9f93-4ec1e53e740b">P6Y6M</mck:LossContingencySettlementPaymentTerms>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="icdab83fc6b78425a832a4ba53f78811c_I20210928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA2NTU_42c3480d-f34b-4706-a393-8957c30f570e"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ibd87c8cd4564444caf1bfeedc9bedcad_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MzAwMw_dc638dda-1cbf-4de5-9a56-e839c1bb4e83"
      unitRef="usd">29000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="id6b31bd1cab64e2aa516e6a01c17aabb_I20210928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTE2MzE_605d7667-b5f4-4bb2-a28f-f6c546d9f431"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i6a960216fc5047ae9856d959b0a6c287_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2OTI0Mw_ed412d70-81a2-4b76-83c1-55d2e8130dd4"
      unitRef="usd">440000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementPaymentTerms
      contextRef="i7eaaa89dea4740b0bc8eb0ada92ff0b3_D20210928-20210928"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2OTI5Mg_91176e1f-def2-4b95-9a04-71b55627ca1d">P6Y</mck:LossContingencySettlementPaymentTerms>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="id6b31bd1cab64e2aa516e6a01c17aabb_I20210928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2OTIzNg_c83f57ab-778b-41fe-82f7-fa2da652cb08"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i7eaaa89dea4740b0bc8eb0ada92ff0b3_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY3MzA4Ng_173329a9-e893-479d-9986-1f9eeeeffc9e"
      unitRef="usd">167000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i96393cf84f184dd1a34604191f7e8463_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTE2Mjg_247f30ed-c3e9-4151-bb50-4aa4949e0d71"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="i96393cf84f184dd1a34604191f7e8463_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTA5OTUxMTY2Mzk3OA_95cf6aa5-25d1-4ab8-8bbd-f8182272ab00"
      unitRef="usd">6800000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i6b6bcdc79602464fb68d237e91f2c420_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ3NzMwNw_206f7b06-99e6-440c-9932-bd0af31d5150"
      unitRef="usd">193000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="i6b6bcdc79602464fb68d237e91f2c420_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ3NzMxNQ_f9d2fc0f-0cd4-48fb-970e-db5248481b8d"
      unitRef="usd">160000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTk5MzY_2060225b-5423-4c66-8439-4a625ff33549">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimated accrued liability for opioid-related claims of governmental entities is as follows as of December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This amount, recorded in &#x201c;Other accrued liabilities&#x201d; in the Condensed Consolidated Balance Sheet, is the amount estimated to be paid prior to December 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="i85eff5aee4c3446698c4907a3978d21b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RhYmxlOmNjZTk4OTk3NGMwMTQwN2ViMGVhNzgzOTRjYjExOWQ4L3RhYmxlcmFuZ2U6Y2NlOTg5OTc0YzAxNDA3ZWIwZWE3ODM5NGNiMTE5ZDhfMS0xLTEtMS00NzI4NA_2684fc68-2dde-4554-a95d-008d48d4657b"
      unitRef="usd">1060000000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="i85eff5aee4c3446698c4907a3978d21b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RhYmxlOmNjZTk4OTk3NGMwMTQwN2ViMGVhNzgzOTRjYjExOWQ4L3RhYmxlcmFuZ2U6Y2NlOTg5OTc0YzAxNDA3ZWIwZWE3ODM5NGNiMTE5ZDhfMi0xLTEtMS00NzI4NA_78900e3b-5ab8-4041-8854-415da8779611"
      unitRef="usd">7153000000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i85eff5aee4c3446698c4907a3978d21b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RhYmxlOmNjZTk4OTk3NGMwMTQwN2ViMGVhNzgzOTRjYjExOWQ4L3RhYmxlcmFuZ2U6Y2NlOTg5OTc0YzAxNDA3ZWIwZWE3ODM5NGNiMTE5ZDhfNC0xLTEtMS00NzI4NA_592a9a39-914d-436a-978a-404cd960e4d1"
      unitRef="usd">8213000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i9a2ded36405146879cf86872b0b24b1c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTMwMTg_4b4cb030-55d2-4436-99f6-1c66f3425e9e"
      unitRef="case">4</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i16fa32e7eb8c4c528a92f587159347b8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTMwNDY_e4bb76c3-2bba-4f66-be2d-98ee71b9c038"
      unitRef="case">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i5ca435af43514f1eac1c81fefbc999f1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTMwODg_57a96d24-5619-4f2d-b5ea-341e2ca3ee8a"
      unitRef="case">1</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:NumberOfInvestmentFundsThatFiledClaims
      contextRef="i4b789596251942f2bfcd923a95ccdf00_I20171229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTI0MDQ_c806e149-de32-4846-ad75-da2dc21dec69"
      unitRef="investmentfund">2</mck:NumberOfInvestmentFundsThatFiledClaims>
    <mck:NumberOfInvestmentFundsThatFiledClaims
      contextRef="ie3c0a2798de8485c9bfc70f3983c4ff0_I20171230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTI0MDc_e6b59282-8bad-48e3-bd4c-4009b454d37a"
      unitRef="investmentfund">4</mck:NumberOfInvestmentFundsThatFiledClaims>
    <mck:LossContingencyNumberOfRelators
      contextRef="i2e0bc32bb6704e56a7596ad34859790f_D20130416-20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTMzNjc_75cb8990-7f98-44b3-a4bc-718ab8c39c78"
      unitRef="relator">2</mck:LossContingencyNumberOfRelators>
    <mck:LossContingencyNumberOfStatesFiledOnBehalfOf
      contextRef="i2e0bc32bb6704e56a7596ad34859790f_D20130416-20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMTY0OTI2NzQ3NzMwMg_51fe37b7-962a-4213-a6ca-5afc59e0c85e"
      unitRef="state">21</mck:LossContingencyNumberOfStatesFiledOnBehalfOf>
    <mck:LossContingencyNumberOfAdditionalDefendants
      contextRef="i2e0bc32bb6704e56a7596ad34859790f_D20130416-20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV82Ny9mcmFnOjcwNjliMGEyOWNiNzQxMTBhNjIzNjg5N2I3YjFiYWY0L3RleHRyZWdpb246NzA2OWIwYTI5Y2I3NDExMGE2MjM2ODk3YjdiMWJhZjRfMjk2ODY4MTM5OTMzNjg_e55abb24-a8ae-44e2-9a6e-80297a9fc846"
      unitRef="defendant">5</mck:LossContingencyNumberOfAdditionalDefendants>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDY0OA_dedca418-c8de-41c6-84c0-dc8c749cc83f">Stockholders' Equity (Deficit) &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of the Company&#x2019;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 23, 2021, the Company raised its quarterly dividend from $0.42 to $0.47 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#x201c;ASR&#x201d;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#x2019;s stock price, corporate and regulatory requirements, restrictions under the Company&#x2019;s debt obligations, and other market and economic conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#x2019;s common stock. The total number of shares repurchased under this ASR program was 5.2 million shares at an average price per share of $193.22. The Company received 4.3 million shares as the initial share settlement, and in August 2021 the Company received an additional 0.9 million shares upon the completion of this ASR program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended December 31, 2021, the Company repurchased 3.3 million of the Company&#x2019;s shares for $728 million through open market transactions at an average price per share of $223.89, of which $30 million was accrued at December 31, 2021 within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheet for share repurchases executed in late December and settled in early January. Additionally, during the three months ended September 30, 2021, the Company repurchased 1.4 million of the Company&#x2019;s shares for $280 million through open market transactions at an average price per share of $203.20. There were no open market share repurchases during the three months ended June 30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 8, 2021, the Company announced that the Board approved an increase of $4.0&#160;billion in the authorization for repurchase of McKesson&#x2019;s common stock. The total remaining authorization outstanding for repurchases of the Company&#x2019;s common stock at December 31, 2021 was $4.8 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended December 31, 2020, the Company repurchased 1.5&#160;million of the Company&#x2019;s shares for $231&#160;million through open market transactions at an average price per share of $151.12. During the three months ended September 30, 2020, the Company repurchased 1.8&#160;million of the Company&#x2019;s shares for $269&#160;million through open market transactions at an average price per share of $151.23. There were no share repurchases during the three months ended June 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss), including noncontrolling interests and redeemable noncontrolling interests, by components for the three and nine months ended December 31, 2021 and 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded in the three months ended December 31, 2021 include gains of $23&#160;million related to net investment hedges from Euro-denominated notes and losses of $2&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $5 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded in the nine months ended December 31, 2021 include gains of $34&#160;million related to net investment hedges from Euro-denominated notes and gains of $3&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $10 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded in the three months ended December 31, 2020 include losses of $84&#160;million related to net investment hedges from Euro-denominated notes and losses of $45&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $33&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded in the nine months ended December 31, 2020 include losses of $201&#160;million related to net investment hedges from Euro-denominated notes and losses of $108&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $80&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <mck:CommonStockVotingRightsNumberofVotesPerCommonShare
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNzk_18c35eec-0e9f-4845-ba60-03c966345ada"
      unitRef="vote">1</mck:CommonStockVotingRightsNumberofVotesPerCommonShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i4e3b4356f92241a79cba33c2ed751c94_D20210722-20210722"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzAy_3c6dc11e-8424-4395-8830-338dec5b8dc4"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5dfc838eb1ac450fa9327128ad95b9f4_D20210723-20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzA4_630de847-2894-425c-b7ef-0b6f342296a1"
      unitRef="usdPerShare">0.47</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i4651daec0fcd4008b8fbcb1cba4827c1_D20210501-20210531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTQ1MQ_13bdc400-0997-49ff-ae20-99fe37ee14d1"
      unitRef="usd">1000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i4651daec0fcd4008b8fbcb1cba4827c1_D20210501-20210531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTU1MQ_fd0d0c80-ccc0-477a-aa02-477a78734fa7"
      unitRef="shares">5200000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i4651daec0fcd4008b8fbcb1cba4827c1_D20210501-20210531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTU5NA_d3f90d53-0107-4860-a2af-71ede6cc95c0"
      unitRef="usdPerShare">193.22</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i4651daec0fcd4008b8fbcb1cba4827c1_D20210501-20210531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTYxOQ_34fb57a6-9575-4558-8255-0df3a2aa5504"
      unitRef="shares">4300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i843f7e95b9d346549a854382391ff392_D20210801-20210831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTcxNg_4ba624db-68cf-43f3-8055-c3491ed15a26"
      unitRef="shares">900000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib17c7ffbc55e498aa48c293d6f774907_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMyOTY5OA_fb6ed07b-0bd9-4544-9f0e-6683a1936d1b"
      unitRef="shares">3300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ib17c7ffbc55e498aa48c293d6f774907_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMyOTczMA_cfc9bc74-90cf-4b30-bcfa-8596b9e64e5f"
      unitRef="usd">728000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ib17c7ffbc55e498aa48c293d6f774907_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMyOTgwMA_4545afbf-f786-4d0d-b28d-cab2d0d2d5b4"
      unitRef="usdPerShare">223.89</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="if205d6ef74be40cfa4f1e33f2e553e47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTA5OTUxMTYzNDEyNg_0f6afdb2-f2c8-4971-b03d-02bb5bdb4d3e"
      unitRef="usd">30000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1ed2ad6a9a9245ffb0210d01707cf604_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTA5OTUxMTYzMzU3Mg_36b34845-98aa-4bb0-8bdc-b5415ced09db"
      unitRef="shares">1400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i1ed2ad6a9a9245ffb0210d01707cf604_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTA5OTUxMTYzMzU5Mg_285889b6-5343-4cb5-b242-edb48faeb7d8"
      unitRef="usd">280000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i1ed2ad6a9a9245ffb0210d01707cf604_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTA5OTUxMTYzMzYwNw_ac748988-2efa-4a46-b04f-edf4bebd1350"
      unitRef="usdPerShare">203.20</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0933f1ae15e649a1b3f3599aeed9843f_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjk2ODY4MTM5NTc0Mjk_b8fa95a3-e831-448a-9615-42da4a49b1df"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i1f96be18861e4831bbe49116594b08c3_I20211208"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMTA5OTUxMTYzMzcyMg_a3690955-a7aa-4f9b-84e8-c8133568d99e"
      unitRef="usd">4000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i489f4fe3b29441a9ac0c65293e1fd406_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjIzMA_19bfa6ad-a8a5-438d-b111-59fc621c85da"
      unitRef="usd">4800000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i540273ce247f4e77bcb256bd6ff2edea_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMzMDMzNA_ab354645-abe3-4af5-b894-e00914e0e6ec"
      unitRef="shares">1500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i540273ce247f4e77bcb256bd6ff2edea_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMzMDM0Nw_74110c49-b15b-4e03-a922-b2a705a20b2c"
      unitRef="usd">231000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i540273ce247f4e77bcb256bd6ff2edea_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDk0NzgwMjMzMDM2MQ_04d6773c-83fe-4fa0-be90-9dd13ee1d8cc"
      unitRef="usdPerShare">151.12</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i054b314a3e2a4b9d9bc83711755c16c6_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjMwOA_317ac6c2-3b85-482b-ab4d-ff61ca58edc7"
      unitRef="shares">1800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i054b314a3e2a4b9d9bc83711755c16c6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjMzOQ_94950e0f-736f-4967-b782-590acff140ca"
      unitRef="usd">269000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i054b314a3e2a4b9d9bc83711755c16c6_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjQwOA_3437a336-86c3-4421-89ea-6693286abf13"
      unitRef="usdPerShare">151.23</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6b65ae2097be4ee9b04fbfebc350aa5c_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMjYyNg_cdbcf3c8-8a39-4b56-8fb6-c2e67a7eb01c"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDYzMQ_1938ad34-233b-4b9c-bee9-07903988eb54">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss), including noncontrolling interests and redeemable noncontrolling interests, by components for the three and nine months ended December 31, 2021 and 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded in the three months ended December 31, 2021 include gains of $23&#160;million related to net investment hedges from Euro-denominated notes and losses of $2&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $5 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded in the nine months ended December 31, 2021 include gains of $34&#160;million related to net investment hedges from Euro-denominated notes and gains of $3&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax expense of $10 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded in the three months ended December 31, 2020 include losses of $84&#160;million related to net investment hedges from Euro-denominated notes and losses of $45&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $33&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x207d;&#xb2;&#x207e;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts recorded in the nine months ended December 31, 2020 include losses of $201&#160;million related to net investment hedges from Euro-denominated notes and losses of $108&#160;million related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit of $80&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea19c1464fd3431fbfd6ec399c1e71c7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMi0xLTEtMS00NzI4NA_617ac710-cf71-4d95-9a45-89f353494f47"
      unitRef="usd">-1557000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f08193bb90c44f6ae9ec36df03a265a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMi0zLTEtMS00NzI4NA_61bd69d9-923d-4a83-8b72-2c8351a9c54f"
      unitRef="usd">-25000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia35d1f63c33540bea2b1ae396c7e4d9d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMi01LTEtMS00NzI4NA_ba02f7df-82c8-4101-8bf0-742b73ee301e"
      unitRef="usd">21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2a19c7ce388247dd9c4fff8563e46afd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMi03LTEtMS00NzI4NA_bdc9cb3b-be8a-4d39-ba69-97ddf186f947"
      unitRef="usd">-104000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1be4875f550d4562b96d61a975ce1384_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMi05LTEtMS00NzI4NA_b7adc45b-c60b-4aa3-86a0-ed3d019fc745"
      unitRef="usd">-1665000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMy0xLTEtMS00NzI4NA_e5de4f37-5b7f-4d4a-afa4-edea78c97671"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMy0zLTEtMS00NzI4NA_5d8ec7c9-5f32-4e3d-8a22-39e271913cb5"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMy01LTEtMS00NzI4NA_1f08ea2d-c299-4af8-a420-96e3b9eac5d1"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMy03LTEtMS00NzI4NA_72792876-0d7e-423c-b0ec-e737a27febab"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfMy05LTEtMS00NzI4NA_f5e1c31d-848d-44a5-8265-87afb66bdb73"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNC0xLTEtMS00NzI4NA_323fee97-3ba0-40d6-8399-a1688611497f"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNC0zLTEtMS00NzI4NA_ee0c6632-d401-45c5-906e-d5aefaa79550"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNC01LTEtMS00NzI4NA_436ee599-24e5-489b-b7d7-0b37a5ebe059"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNC03LTEtMS00NzI4NA_ce5acfe5-4bc3-4205-8115-5e8ac6dccfdf"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNC05LTEtMS00NzI4NA_c300acd4-34b7-43ae-b359-46b554187b12"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNS0xLTEtMS00NzI4NA_73594e8a-8bd2-43ae-a125-4f69d14a9495"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNS0zLTEtMS00NzI4NA_30bd7b4d-21af-4ee6-b8dc-18b72deff048"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNS01LTEtMS00NzI4NA_7dfd7437-7337-44c7-b658-105df3b4f8a1"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNS03LTEtMS00NzI4NA_bbca8cf3-f56d-46ba-8f67-e1d8b7062b21"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNS05LTEtMS00NzI4NA_90cc280a-bc4d-46e6-8e2f-57f37eb5af81"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNi0xLTEtMS00NzI4NA_f955f11e-9420-4b8d-9a99-45a7ebe70bce"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNi0zLTEtMS00NzI4NA_b4b2993f-3a32-4b33-ae25-5d48d1581ab7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNi01LTEtMS00NzI4NA_48543f18-2f7f-424e-b0a6-9b19667fec7c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNi03LTEtMS00NzI4NA_5140157b-90e1-4e0c-a778-a789cbd460f9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNi05LTEtMS00NzI4NA_7a3b871e-7fde-4ee9-8107-1db3f454195b"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaae030e0b21c4189aaf56ec07f3cf26a_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNy0xLTEtMS00NzI4NA_2e7414bf-7e95-4472-8f7f-b7bf2d591de6"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNy0zLTEtMS00NzI4NA_a7285ae7-80bc-48a4-9369-028ecf32b306"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie176d4824ab34e3ab68ea9d7f14c25e8_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNy01LTEtMS00NzI4NA_490e9456-2bbd-42b7-b6b6-343fbe5a3595"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icad1e3e0426249429fc0d7e9b54a29cb_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNy03LTEtMS00NzI4NA_e221417c-bcf0-4b31-b8bd-6fc388723028"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2b8216d3c52941658551f660f72d6248_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfNy05LTEtMS00NzI4NA_cf80c94d-e67c-4644-9a6e-d171b419bfc1"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5033f6f00844a00b920db06167d72c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfOS0xLTEtMS00NzI4NA_6e569161-35f6-4a46-a0cc-42175e4c9940"
      unitRef="usd">-1555000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb80f013f5b04877be046df73b8ea013_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfOS0zLTEtMS00NzI4NA_095f29bb-880a-4530-ba5f-b72c3266e954"
      unitRef="usd">-9000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ica87d626efb840368fbbe575e025eb74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfOS01LTEtMS00NzI4NA_41939645-effd-44fc-8835-2788cf3335bd"
      unitRef="usd">15000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f90b71776b5462a8d1be5c313a0e1c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfOS03LTEtMS00NzI4NA_d504fa8c-706a-4c03-ab16-dbd0097467a4"
      unitRef="usd">-106000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib041b764acbd496ba6cd257448c9a6ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjM4ZWFkMDBkZGU3MzQ1YzE5NWZmMDQzYWE1ZDRjYzI2L3RhYmxlcmFuZ2U6MzhlYWQwMGRkZTczNDVjMTk1ZmYwNDNhYTVkNGNjMjZfOS05LTEtMS00NzI4NA_eb85aece-c1c2-456b-8c02-92a089dce213"
      unitRef="usd">-1655000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7225d41e4b98447f94299cb918d544af_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzE3Ng_ee8a95b5-83ce-4f01-905b-7735d4df6a80"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3ed06ba2cb5a4c79824d9a614fb48e1f_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzI1Nw_fc60f6f0-a7c2-4520-99c9-f25390f78028"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i7c456e22a2764fe19ec5b005b0cb3b72_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzM2NA_4079c993-6da7-47b3-acd5-66ab823813f4"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ec1ab358f1c44c4b1d28bfe361d9694_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMi0xLTEtMS00NzI4NA_d08d57e6-10bf-477c-b2a4-27593535a423"
      unitRef="usd">-1361000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2a7350f891f34c389f5314b093c80f47_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMi0zLTEtMS00NzI4NA_98b59810-2059-456e-aec6-cf4ed5f5662f"
      unitRef="usd">-36000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic4cae94d5a4343dea4571122ba91a7dd_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMi01LTEtMS00NzI4NA_b54d4ef0-15d7-4fd1-92c5-5646b61c7f0c"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifc95fc7008f24256bb487870b5b105be_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMi03LTEtMS00NzI4NA_86b2cd35-0b97-4564-bb4c-25170a032ae4"
      unitRef="usd">-96000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd1f982f3f4042c9badc91a36fff0cc1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMi05LTEtMS00NzI4NA_a33ff243-fc15-47dc-ade3-e3d153981589"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMy0xLTEtMS00NzI4NA_62f775e8-8ad6-439c-bc1c-41673b60348e"
      unitRef="usd">-47000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMy0zLTEtMS00NzI4NA_e9903887-13ea-4d7d-ae03-71faecc8a70d"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMy01LTEtMS00NzI4NA_5184f66e-8b94-4544-bd38-698c47b3aa4e"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMy03LTEtMS00NzI4NA_f2de1bc5-d3f9-4a31-8099-7d4f557208b2"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfMy05LTEtMS00NzI4NA_9f6516f3-99ca-4d4d-842c-292b514677b0"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNC0xLTEtMS00NzI4NA_c5360fb8-a34a-4389-925b-87d54536bcfb"
      unitRef="usd">-18000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNC0zLTEtMS00NzI4NA_f0a229d6-1e27-4ae2-a521-bc113e4d0c7f"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNC01LTEtMS00NzI4NA_a6c525a2-c4ba-4f29-a95e-595fcb7de212"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNC03LTEtMS00NzI4NA_969683a1-03ed-49bf-b9c7-62cb3d738b01"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNC05LTEtMS00NzI4NA_6b56c1b9-56ee-4cb1-8898-873e79ed166a"
      unitRef="usd">-20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNS0xLTEtMS00NzI4NA_d8c38f6a-ce5e-4bd6-87ae-ea73f4b0b5c2"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNS0zLTEtMS00NzI4NA_d8247145-6faf-4ce6-8d6e-114c52fc2bd0"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNS01LTEtMS00NzI4NA_e0a83486-08f0-4e30-bc51-a525658f7608"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNS03LTEtMS00NzI4NA_23d3410c-a006-4e4c-ae39-a1151eb2cba2"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNS05LTEtMS00NzI4NA_ddec8b7b-c0b8-4a90-836b-15fc154f2447"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNi0xLTEtMS00NzI4NA_88640c41-61f8-4788-89d3-d4a8be078360"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNi0zLTEtMS00NzI4NA_60e6b7c3-4b40-4e81-b4d0-24bf946c43cd"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNi01LTEtMS00NzI4NA_09d85c94-8468-47bd-a208-07e25a273c00"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNi03LTEtMS00NzI4NA_a3c7e687-538f-4a87-9b5d-df391225c19a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNi05LTEtMS00NzI4NA_28d9351c-ed5c-4280-8b0c-b67817fd1d5c"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNy0xLTEtMS00NzI4NA_2ab12db7-de12-4ebd-93a3-b03e69394136"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNy0zLTEtMS00NzI4NA_c946c2fd-9329-432f-98bf-d6fb1ac3b1e5"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNy01LTEtMS00NzI4NA_2c55e6c3-7a3c-485c-878f-90de87d68e39"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNy03LTEtMS00NzI4NA_f9038d54-0c36-4577-9e9f-8e58dcc61f84"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfNy05LTEtMS00NzI4NA_e7deb3a9-3ca7-414f-940f-f7ffd3cac06f"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ib1ce27e638984ad398ce2fe398f9d3f6_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOC0xLTEtMS00NzI4NA_62a5b56a-4d84-4200-967d-2acb42a09fdb"
      unitRef="usd">-158000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOC0zLTEtMS00NzI4NA_52c0e49a-726d-46c6-b4e6-1f1e4aef75ff"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i884c5bc5307442deb92721feb1328c24_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOC01LTEtMS00NzI4NA_6890a807-9bf3-4cf5-b7d2-dd43aa1169c8"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="iddd5269e4982442faf5d718821e185be_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOC03LTEtMS00NzI4NA_840d5731-bc53-442f-88ca-b633178e43a4"
      unitRef="usd">-12000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="iaf4b37b1b5444287b5c85ef0de230957_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOC05LTEtMS00NzI4NA_10a166e1-1e59-4f73-aa76-9de031c33620"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5033f6f00844a00b920db06167d72c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOS0xLTEtMS00NzI4NA_b5c16b2d-546c-4c02-ac65-1f1cf6b79420"
      unitRef="usd">-1555000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb80f013f5b04877be046df73b8ea013_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOS0zLTEtMS00NzI4NA_4be4809d-0dc1-4115-b08d-459350422d88"
      unitRef="usd">-9000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ica87d626efb840368fbbe575e025eb74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOS01LTEtMS00NzI4NA_87a3fc8a-2a2d-42f1-a5fc-e6c801eb98db"
      unitRef="usd">15000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f90b71776b5462a8d1be5c313a0e1c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOS03LTEtMS00NzI4NA_61191603-2a4d-4435-8cbc-109feec96fa0"
      unitRef="usd">-106000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib041b764acbd496ba6cd257448c9a6ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOjFhNDQ0NzFjYjJmZDQ0ZTU4NWE2Yjc2NDkzYTA4YTVlL3RhYmxlcmFuZ2U6MWE0NDQ3MWNiMmZkNDRlNTg1YTZiNzY0OTNhMDhhNWVfOS05LTEtMS00NzI4NA_bee72483-e751-4510-ac3b-58a534e4ebc8"
      unitRef="usd">-1655000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="idac086104fd949cabcf4563c6be329c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzU5NQ_68196ea4-9e6f-439c-a823-c2e6bba3456a"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i213dfc02855e4772998e42a0ea099c76_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzY3Ng_95f609e0-40e7-4540-b6b5-c3137ff79ba3"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="id3a4f7dc2a0a46eabc4f22f09772a6df_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfMzc4Mw_dddeaa56-5014-465e-bdd5-c136a92d66cf"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70cfadc2fd5f4b4a9277df704a122f06_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMi0xLTEtMS00NzI4NA_1c77bc03-21a3-41ce-be35-91a60e6fd024"
      unitRef="usd">-1512000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i13b43080a3b24a16ae2b97ea91852b4c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMi0zLTEtMS00NzI4NA_cf52db28-3271-4300-850f-92bae0f51c7a"
      unitRef="usd">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5cec83dac43442fb28746e2671aa4ef_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMi01LTEtMS00NzI4NA_52155c38-3978-484f-8876-e337f3f1a748"
      unitRef="usd">25000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f84efb755fb430185527dfc44d3694e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMi03LTEtMS00NzI4NA_d9dfcb18-c9f7-4264-86d1-0a4e3c15bf52"
      unitRef="usd">-116000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9bf3b3d119214ddc994b0fa424595480_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMi05LTEtMS00NzI4NA_a59122ed-b016-457c-a49a-a919a2dabb0a"
      unitRef="usd">-1597000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMy0xLTEtMS00NzI4NA_8005fd6a-0ff7-404d-96be-07a7c742b796"
      unitRef="usd">156000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMy0zLTEtMS00NzI4NA_6d7ed921-b995-495a-a431-f754d82bcdf1"
      unitRef="usd">-96000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMy01LTEtMS00NzI4NA_e7f29417-0fcd-468b-99d2-84d7a8c329d3"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMy03LTEtMS00NzI4NA_5b6efda0-b788-4422-a251-dde3ba6bb0fc"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfMy05LTEtMS00NzI4NA_3403bf09-25ef-4397-bf66-c92205df68e5"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNC0xLTEtMS00NzI4NA_80f37431-2bd9-4637-959d-a5d7f499552d"
      unitRef="usd">-47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNC0zLTEtMS00NzI4NA_5f048072-63ce-4f08-8cb8-f45337277b2c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNC01LTEtMS00NzI4NA_2d9e6f54-628a-4661-87ad-d3d69c4211fb"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNC03LTEtMS00NzI4NA_08eee8a4-2148-4b01-a0c8-a6a76682cecc"
      unitRef="usd">-22000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNC05LTEtMS00NzI4NA_a63c31d7-a7b7-4c11-98f1-5b32bbdce858"
      unitRef="usd">-69000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNS0xLTEtMS00NzI4NA_a700f89d-d710-41e3-a49d-2d5e7a1b650f"
      unitRef="usd">203000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNS0zLTEtMS00NzI4NA_8b945a18-5543-4689-bc11-dfb24e0de788"
      unitRef="usd">-96000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNS01LTEtMS00NzI4NA_fc2d579c-61b4-4f99-b838-9408a4b5afd5"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNS03LTEtMS00NzI4NA_21c4a485-c57e-4e3c-bd2a-53ae0261c44a"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNS05LTEtMS00NzI4NA_f51644de-c2e0-4eb0-85a7-53e7e20853c4"
      unitRef="usd">119000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNi0xLTEtMS00NzI4NA_44ae2da6-c174-494d-bce4-3daa73c16b04"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNi0zLTEtMS00NzI4NA_5bfa626d-1d7f-4158-a858-d4ab6f8fd111"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNi01LTEtMS00NzI4NA_4f07e573-0f0d-4131-9315-857608e9ba2b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNi03LTEtMS00NzI4NA_6144cd1e-81c3-40cd-b79b-1d1e279aae39"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNi05LTEtMS00NzI4NA_6e1fe2d6-ec4f-48fa-964a-867e001fc146"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i88a3c98bab5c484eb594f4f392356279_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNy0xLTEtMS00NzI4NA_bf6919dd-3dee-417f-998d-8975d180b8d2"
      unitRef="usd">183000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNy0zLTEtMS00NzI4NA_2efb2cf1-bb74-4016-9b8e-dd4e54b8013f"
      unitRef="usd">-96000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0634d98c6d3c4a8a89cb86265297be3e_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNy01LTEtMS00NzI4NA_922eaf0c-b33f-4cdf-b195-08f25dd42ed4"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie59df3e4cb994fa6941efa3a47ff5488_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNy03LTEtMS00NzI4NA_15d008ce-24bb-4ac4-b21f-2dc81c432c18"
      unitRef="usd">19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfNy05LTEtMS00NzI4NA_effc0fab-7f08-4a8a-bc7d-125e5d8d1abb"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73ca4490ab994f9aab3a6fe25a21c69c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfOC0xLTEtMS00NzI4NA_c81eddfc-a37d-46d5-8996-e4303ed2a859"
      unitRef="usd">-1329000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f489db5b4e04093bf6487d97631d28a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfOC0zLTEtMS00NzI4NA_f8c7fda2-aafd-46cf-82d0-c62d64c312fa"
      unitRef="usd">-90000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb666f100afe4890aa66b7e618e14266_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfOC01LTEtMS00NzI4NA_02a6f792-c688-48ac-b814-5dd4f0974aab"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia8ce0eeffaae46c29688d5a5b4ce0c65_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfOC03LTEtMS00NzI4NA_888796ba-67fe-4a55-a129-fa44050b1ac4"
      unitRef="usd">-97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19c25b891e2446a6bab4b8ee69b28057_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmY2MDMzNDNmZTFlMjRkODRiOTI3YjA5NTNhMmY1Y2NkL3RhYmxlcmFuZ2U6ZjYwMzM0M2ZlMWUyNGQ4NGI5MjdiMDk1M2EyZjVjY2RfOC05LTEtMS00NzI4NA_e265e872-75d8-44cd-9b85-3651818182e8"
      unitRef="usd">-1503000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1e495f371886450bba3a39c61d7905dd_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDAxNA_0eab93f4-c86a-4a7e-aad1-a70b7fd743e2"
      unitRef="usd">-84000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia33af281a8774481b036a38c796706ec_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDA5Ng_4546787b-654d-4283-9c45-d9228fd82c23"
      unitRef="usd">-45000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="iee8d1edafa2940a19544e2aa0dbfc5c4_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDIwNg_c0938b59-b251-4fc7-8d63-6f1b4cb64588"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i76a341aced7248cd9123b95a14c8a92e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMi0xLTEtMS00NzI4NA_5f6f3424-cc0c-4b29-9172-e7d2aeaec263"
      unitRef="usd">-1780000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c22952abf9142609c8c89682fe068ff_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMi0zLTEtMS00NzI4NA_02a33485-487a-4b12-8969-b7b406f9a9fb"
      unitRef="usd">138000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e78796fe5fa418093c4d5c12a166c69_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMi01LTEtMS00NzI4NA_d8686c0d-7e1e-498b-b848-5f2d66b0662e"
      unitRef="usd">49000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if03813c6358648a394e5872d25a93782_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMi03LTEtMS00NzI4NA_d4da7fd6-4395-4027-9c97-fbd8e9bc7bb3"
      unitRef="usd">-110000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iebc1818efd944fffbeda92744ddd19d5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMi05LTEtMS00NzI4NA_1c8d5f93-7d13-4c86-aeb3-58199d11fead"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1cfcd79590b140b1936d216597d97299_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMy0xLTEtMS00NzI4NA_2fe78567-6271-43a7-9f67-1f654cc3af65"
      unitRef="usd">363000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMy0zLTEtMS00NzI4NA_1b9998b4-7274-4e2f-9bd5-a40e6c4e14a7"
      unitRef="usd">-229000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMy01LTEtMS00NzI4NA_108e0bf7-f262-4cff-9520-27e7b0265f62"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMy03LTEtMS00NzI4NA_105ea7b4-57e6-4f80-b521-e6c45cc58faa"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfMy05LTEtMS00NzI4NA_4bbaf48d-8ce0-4a2e-bca7-31c70e620d74"
      unitRef="usd">90000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1cfcd79590b140b1936d216597d97299_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNC0xLTEtMS00NzI4NA_05772d13-bc55-403d-ae97-8894b5b9796b"
      unitRef="usd">-47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNC0zLTEtMS00NzI4NA_eec996e0-3338-4229-83e8-eb6bb66978d5"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNC01LTEtMS00NzI4NA_44152aed-fb69-4d12-bffc-63dcd2a81757"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNC03LTEtMS00NzI4NA_91e3e8a5-382b-4916-befe-f29a484d8bab"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNC05LTEtMS00NzI4NA_7827e564-3731-4548-a138-3d4ed1266515"
      unitRef="usd">-71000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1cfcd79590b140b1936d216597d97299_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNS0xLTEtMS00NzI4NA_50cc5574-6f31-4a45-bb05-a093c057cfae"
      unitRef="usd">410000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNS0zLTEtMS00NzI4NA_9835f19d-de5e-4482-bc4b-5daf268dccca"
      unitRef="usd">-229000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNS01LTEtMS00NzI4NA_6c59aeff-1722-46cc-b978-80f0badb630b"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNS03LTEtMS00NzI4NA_9e389ea3-3570-4ba9-b517-ac9df9872836"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNS05LTEtMS00NzI4NA_b3fa046a-3aec-45be-946b-80a2c05421ac"
      unitRef="usd">161000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i1cfcd79590b140b1936d216597d97299_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNi0xLTEtMS00NzI4NA_175ee7f5-7cd1-4564-90df-0385bcd9671c"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNi0zLTEtMS00NzI4NA_84169ac7-273b-4142-8fa5-1a8fdbc7b9ab"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNi01LTEtMS00NzI4NA_d40c1839-2cde-4d28-86fe-09326c1245e0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNi03LTEtMS00NzI4NA_f7713acd-5166-47f6-b336-13c243b9feaa"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNi05LTEtMS00NzI4NA_3f40c558-5da3-4ea8-b2ad-117a969386a6"
      unitRef="usd">-39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1cfcd79590b140b1936d216597d97299_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNy0xLTEtMS00NzI4NA_11c26096-a720-4a2f-8311-93d3420b33b2"
      unitRef="usd">451000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNy0zLTEtMS00NzI4NA_fe1cceb1-ec5c-48f6-be37-49cd28eaf4b0"
      unitRef="usd">-228000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id46be97bd43a4ec39d60058477ce959e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNy01LTEtMS00NzI4NA_168ae13e-d810-4249-86ed-4f080864b8b6"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id55e37d2478b47c7af3b6dd00b669ad4_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNy03LTEtMS00NzI4NA_ff0ae0ee-86ed-4995-addc-65cf526fa79c"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfNy05LTEtMS00NzI4NA_93281423-2dda-4951-bb16-cb0e972bad40"
      unitRef="usd">200000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73ca4490ab994f9aab3a6fe25a21c69c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfOC0xLTEtMS00NzI4NA_4f6ea674-d6c6-420d-94ce-de97f00a2719"
      unitRef="usd">-1329000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f489db5b4e04093bf6487d97631d28a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfOC0zLTEtMS00NzI4NA_cc5b2f8f-8365-46f7-a3c1-42ffaa8a3a60"
      unitRef="usd">-90000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb666f100afe4890aa66b7e618e14266_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfOC01LTEtMS00NzI4NA_e6d6443b-3a55-4c99-a356-e03fae829842"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia8ce0eeffaae46c29688d5a5b4ce0c65_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfOC03LTEtMS00NzI4NA_d8152e5f-4538-48d2-8d54-9e310f2b3714"
      unitRef="usd">-97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19c25b891e2446a6bab4b8ee69b28057_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RhYmxlOmQ1YmFkNmRmZmVmMDQ1NDE4NGNhMDlkYjQyOGMzODhmL3RhYmxlcmFuZ2U6ZDViYWQ2ZGZmZWYwNDU0MTg0Y2EwOWRiNDI4YzM4OGZfOC05LTEtMS00NzI4NA_2e1db228-b2af-49ef-9cf2-961c475bb8a3"
      unitRef="usd">-1503000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic8f475edd8834ac5b7034c3816c08c6b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDQzNw_a41786aa-e5ce-4547-8742-200039fe90de"
      unitRef="usd">-201000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5e50b6a1f79d4e56ac4b54c8d2eae50e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDUxOQ_4a36257c-be6e-4a90-8c4b-6671b56bd906"
      unitRef="usd">-108000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i0e98c8e9038c4bb8bc3309d12045eed1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83MC9mcmFnOjQ0OTE3ZGU5NmZiZTRlOWRiN2U2NGFkZmJjZmFkYmVhL3RleHRyZWdpb246NDQ5MTdkZTk2ZmJlNGU5ZGI3ZTY0YWRmYmNmYWRiZWFfNDYyOQ_bdef1f8e-92c1-4e44-b838-b7aa9f538953"
      unitRef="usd">80000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjg2OQ_a85eb811-c8bd-432b-baea-aa792832f853">Segments of Business&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RxTS segment unifies the solutions and services of CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation to serve biopharma and life sciences partners and patients. By combining automation and expert navigation of the healthcare ecosystem, RxTS connects pharmacies, providers, payers, and biopharma to address patients&#x2019; medication access, adherence, and affordability challenges to help people get the medicine they need to live healthier lives. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 275,000 national brand medical-surgical products as well as McKesson&#x2019;s own line of products through a network of distribution centers within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The International segment includes the Company&#x2019;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#x2019;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 12 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#x2019;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. In the second quarter of 2022, the Company entered into an agreement to sell the E.U. disposal group and in the third quarter of 2022, the Company announced agreements to sell the U.K. disposal group and its Austrian business. Refer to Financial Note 2, &#x201c;Held for Sale,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(858)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 40% of the RxTS segment&#x2019;s total revenues, less than 4% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and less than 8% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#x2019;s reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for the three and nine months ended December 31, 2021 includes $33 million and $79 million, respectively, and for the three and nine months ended December 31, 2020 includes $11 million and $115 million, respectively, of credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories. The nine months ended December 31, 2021 includes $46 million of cash receipts for the Company&#x2019;s share of antitrust legal settlements. The nine months ended December 31, 2020 includes a charge of $50 million recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s Opioid Stewardship Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for the nine months ended December 31, 2021 includes $164 million, and for the three and nine months ended December 31, 2020 includes $35 million and $49 million, respectively, of inventory charges on certain personal protective equipment and other related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for the three and nine months ended December 31, 2021 includes charges of $787 million to remeasure assets and liabilities of the U.K. disposal group to the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; The three and nine months ended December 31, 2021 includes charges of $58 million and $400 million to remeasure assets and liabilities of the E.U. disposal group to the lower of carrying value or fair value less costs to sell and to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; The nine months ended December 31, 2021 also includes a gain of $59 million related to the sale of the Company&#x2019;s Canadian health benefit claims management and plan administrative services business. Operating loss for the three and nine months ended December 31, 2020 includes restructuring, impairment, and related charges of $131 million and $189 million, respectively, driven largely by long-lived asset impairment charges of $115 million primarily related to retail pharmacy businesses in Canada and Europe as well as costs associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges,&#x201d; and a second quarter goodwill impairment charge of $69 million related to one of the Company&#x2019;s reporting units in Europe, as discussed in more detail in Financial Note 7, &#x201c;Goodwill and Intangible Assets, Net.&#x201d; The three and nine months ended December 31, 2020 also includes charges of $47 million and $57 million, respectively, to remeasure to the lower of carrying value or fair value less costs to sell the assets and liabilities of the Company&#x2019;s German pharmaceutical wholesale business which was contributed to a joint venture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net for the three and nine months ended December 31, 2021 includes credits of $32 million and charges of $117 million primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; Corporate expenses, net for the nine months ended December 31, 2021 also includes charges of $193 million related to the Company&#x2019;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#x201c;Commitments and Contingent Liabilities.&#x201d; The three and nine months ended December 31, 2021 includes $33 million and $104 million, respectively, and the three and nine months ended December 31, 2020 includes $34 million and $118 million, respectively, of opioid-related costs, primarily litigation expenses. Corporate expenses, net for the three and nine months ended December 31, 2020 includes a charge of $8.1 billion related to the estimated liability for opioid-related claims, as discussed in more detail in Financial &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Note 12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &#x201c;Commitments and Contingent Liabilities.&#x201d; The nine months ended December 31, 2020 also includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program. Corporate expenses, net, for the nine months ended December 31, 2021 includes $104 million and for the three and nine months ended December 31, 2020 includes $30 million and $89 million, respectively, of net gains associated with certain of the Company&#x2019;s equity investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Loss on debt extinguishment for the nine months ended December 31, 2021 consists of a charge of $191 million on debt extinguishment related to the Company&#x2019;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 8, &#x201c;Debt and Financing Activities.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNTc_ae83d28c-f37e-45a1-afb6-66cea11258bd"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <mck:NumberOfNationalBrandMedicalSurgicalProducts
      contextRef="ice5d0a8bd1a546f9bd990cd472b21d74_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMjEyMw_68c8fc64-cfec-4ae4-a3ea-9beb791ed462"
      unitRef="product">275000</mck:NumberOfNationalBrandMedicalSurgicalProducts>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="i196f51a7ced74f518fa05fcb8b2e53bb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMjU5OQ_93bc7db8-e68e-45ab-894a-47119b1d4d95"
      unitRef="country">12</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <mck:NumberOfBusinessOperations
      contextRef="i196f51a7ced74f518fa05fcb8b2e53bb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMjcwNA_afa2d7bd-c06f-49db-bfb4-1bac3ec37b00"
      unitRef="business_operation">2</mck:NumberOfBusinessOperations>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjg2OA_2fc7fd9a-e2db-4ddc-b3d1-c2dffbe52e33">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(858)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 40% of the RxTS segment&#x2019;s total revenues, less than 4% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and less than 8% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#x2019;s reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for the three and nine months ended December 31, 2021 includes $33 million and $79 million, respectively, and for the three and nine months ended December 31, 2020 includes $11 million and $115 million, respectively, of credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories. The nine months ended December 31, 2021 includes $46 million of cash receipts for the Company&#x2019;s share of antitrust legal settlements. The nine months ended December 31, 2020 includes a charge of $50 million recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s Opioid Stewardship Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for the nine months ended December 31, 2021 includes $164 million, and for the three and nine months ended December 31, 2020 includes $35 million and $49 million, respectively, of inventory charges on certain personal protective equipment and other related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for the three and nine months ended December 31, 2021 includes charges of $787 million to remeasure assets and liabilities of the U.K. disposal group to the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; The three and nine months ended December 31, 2021 includes charges of $58 million and $400 million to remeasure assets and liabilities of the E.U. disposal group to the lower of carrying value or fair value less costs to sell and to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; The nine months ended December 31, 2021 also includes a gain of $59 million related to the sale of the Company&#x2019;s Canadian health benefit claims management and plan administrative services business. Operating loss for the three and nine months ended December 31, 2020 includes restructuring, impairment, and related charges of $131 million and $189 million, respectively, driven largely by long-lived asset impairment charges of $115 million primarily related to retail pharmacy businesses in Canada and Europe as well as costs associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges,&#x201d; and a second quarter goodwill impairment charge of $69 million related to one of the Company&#x2019;s reporting units in Europe, as discussed in more detail in Financial Note 7, &#x201c;Goodwill and Intangible Assets, Net.&#x201d; The three and nine months ended December 31, 2020 also includes charges of $47 million and $57 million, respectively, to remeasure to the lower of carrying value or fair value less costs to sell the assets and liabilities of the Company&#x2019;s German pharmaceutical wholesale business which was contributed to a joint venture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net for the three and nine months ended December 31, 2021 includes credits of $32 million and charges of $117 million primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; Corporate expenses, net for the nine months ended December 31, 2021 also includes charges of $193 million related to the Company&#x2019;s estimated liability for opioid-related claims, as discussed in more detail in Financial Note 12, &#x201c;Commitments and Contingent Liabilities.&#x201d; The three and nine months ended December 31, 2021 includes $33 million and $104 million, respectively, and the three and nine months ended December 31, 2020 includes $34 million and $118 million, respectively, of opioid-related costs, primarily litigation expenses. Corporate expenses, net for the three and nine months ended December 31, 2020 includes a charge of $8.1 billion related to the estimated liability for opioid-related claims, as discussed in more detail in Financial &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Note 12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &#x201c;Commitments and Contingent Liabilities.&#x201d; The nine months ended December 31, 2020 also includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program. Corporate expenses, net, for the nine months ended December 31, 2021 includes $104 million and for the three and nine months ended December 31, 2020 includes $30 million and $89 million, respectively, of net gains associated with certain of the Company&#x2019;s equity investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Loss on debt extinguishment for the nine months ended December 31, 2021 consists of a charge of $191 million on debt extinguishment related to the Company&#x2019;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 8, &#x201c;Debt and Financing Activities.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9da13a8ac8824096b8684170e319eb8c_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMy0xLTEtMS00NzI4NA_148e887d-1c8d-4870-ad98-9406e676f610"
      unitRef="usd">55041000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a3c9d231a79420980fb15fd08fb296f_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMy0zLTEtMS00NzI4NA_9c6a2ef0-1bd0-4be7-b400-28addeb1ba7e"
      unitRef="usd">49495000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifcceb81b10094fe38a52a708698e8e26_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMy01LTEtMS00NzI4NA_615eef6b-ec17-415f-8dce-0ae6145f2a56"
      unitRef="usd">158471000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6926dac9087a4729876428bc63b1680e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMy03LTEtMS00NzI4NA_a3a2c135-85b8-43ce-a00e-6eb22aa911cd"
      unitRef="usd">142232000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id99d6b8c9b1d4b43b119e8ff00e3fdf7_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNC0xLTEtMS00NzI4NA_49685d89-bb41-4eac-8254-089aafb61fcd"
      unitRef="usd">1031000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i538bea40557c484aac444eeb523f853a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNC0zLTEtMS00NzI4NA_740e780e-125c-4c6c-b478-8b7654624afa"
      unitRef="usd">777000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4fff6966c2f4bf68a5a99a525be017b_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNC01LTEtMS00NzI4NA_58f720c5-e2df-4c6b-847d-463a23e708ed"
      unitRef="usd">2844000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d5729dcafe64c6b8bf4d8ca0546c7a2_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNC03LTEtMS00NzI4NA_705340df-8be1-4b28-b572-ad42f19273e8"
      unitRef="usd">2101000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4d53e061fc145b591fc79c6361e5475_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNS0xLTEtMS00NzI4NA_1aa5ac71-d290-4ee6-bfdc-f378baa3c2e7"
      unitRef="usd">3082000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9752827ca2c41efadc1fd4270e49ff3_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNS0zLTEtMS00NzI4NA_33217f8a-5d69-4e1e-adc9-8b61f4fb00fe"
      unitRef="usd">3054000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8581c40a6994c56adbfa16cef30adce_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNS01LTEtMS00NzI4NA_6201661a-7e63-49c8-9f0b-6a1d41040bef"
      unitRef="usd">8734000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27ff3ca362ce4d138f3855742853ed06_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNS03LTEtMS00NzI4NA_fcaa0241-cd6d-4fed-918a-eb78a5d6c8ee"
      unitRef="usd">7388000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieefe2d7dc09b481daf49a5152e7f4971_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNi0xLTEtMS00NzI4NA_7449fbad-26d0-433c-a5aa-749d850e1758"
      unitRef="usd">9460000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c351ccf073b47a9b3c10a8e07901940_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNi0zLTEtMS00NzI4NA_9c5d5333-2827-4e15-9957-c1aa237262a5"
      unitRef="usd">9273000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbe27bfd9e2c41d58630861c22b41289_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNi01LTEtMS00NzI4NA_42b82c4f-2485-4ba1-ad52-3f9e3bcd6cc3"
      unitRef="usd">27815000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e45b6151afc4cf1bed1110c1034f5c6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfNi03LTEtMS00NzI4NA_918d5028-bb4f-43d5-8d23-8d83a698a94d"
      unitRef="usd">27365000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfOC0xLTEtMS00NzI4NA_6084696a-83d3-4b44-b62c-7fc2a0542751"
      unitRef="usd">68614000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfOC0zLTEtMS00NzI4NA_134f308d-b7c9-4249-8f56-bd82d4e1b829"
      unitRef="usd">62599000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfOC01LTEtMS00NzI4NA_ddbd2916-2ae6-4912-9e33-1dad6ebd307d"
      unitRef="usd">197864000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfOC03LTEtMS00NzI4NA_b071ceb9-4c02-4f37-9a70-0fb0657882d3"
      unitRef="usd">179086000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTEtMS0xLTEtNDcyODQ_239d34af-2db2-4023-ac0a-f6b00a70b6c2"
      unitRef="usd">744000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTEtMy0xLTEtNDcyODQ_e43aa4e5-9037-4a50-be2a-dbfc9ce1cd8f"
      unitRef="usd">635000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTEtNS0xLTEtNDcyODQ_aa3b2efb-0afd-417f-b2a4-67425a74a044"
      unitRef="usd">2186000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTEtNy0xLTEtNDcyODQ_02e8b4a9-92db-413f-a4a1-bf9054074740"
      unitRef="usd">1871000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie564ac6fb72740e38846a99095bad10b_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTItMS0xLTEtNDcyODQ_02c38bcf-c035-4239-9f3e-54ae1cd10816"
      unitRef="usd">129000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5bde396cb2ad4723957c6bacf93f699c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTItMy0xLTEtNDcyODQ_d70ae688-9399-462d-867b-eb0fe6dd1732"
      unitRef="usd">114000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTItNS0xLTEtNDcyODQ_464d1a3a-4ebb-4cf1-9360-c58d3f2871d1"
      unitRef="usd">361000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibf35e3a77f4447d7903bfc8d5df347e6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTItNy0xLTEtNDcyODQ_b83dc6aa-9d67-46d4-89da-2236b4c80ed0"
      unitRef="usd">270000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8dfdf9e02b494474a257438da042e87e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTMtMS0xLTEtNDcyODQ_2f136f1f-1584-4adb-a13e-c8180717016a"
      unitRef="usd">308000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTMtMy0xLTEtNDcyODQ_4adb888d-3786-4650-8e14-1af6184cf05e"
      unitRef="usd">260000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTMtNS0xLTEtNDcyODQ_20fb9dad-3367-457e-a6f8-b670c8782d3c"
      unitRef="usd">679000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTMtNy0xLTEtNDcyODQ_c31f184c-57ea-463e-b2e0-ac23d893da94"
      unitRef="usd">536000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id4cb0cc677a14470acf93a50bf6feed0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTQtMS0xLTEtNDcyODQ_720c857d-d6b6-4205-9e73-575ba01f6110"
      unitRef="usd">-668000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i46b48dcfcfdd45abb8847e524723a266_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTQtMy0xLTEtNDcyODQ_48d1bba9-7a6c-4184-8a46-cf06aabb6ca7"
      unitRef="usd">-71000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTQtNS0xLTEtNDcyODQ_99b1ce7c-2549-441a-bc9a-aefecd933515"
      unitRef="usd">-761000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib088fe2e07304e999dae5b80075fca10_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTQtNy0xLTEtNDcyODQ_164ce65b-c155-48de-9632-6fcc919d8dd6"
      unitRef="usd">-113000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia429fdc9639444a39fdf735d731eed0d_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTYtMS0xLTEtNDcyODQ_38f1a97b-2d23-41a3-a457-e284a1f66e4e"
      unitRef="usd">513000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i70cbdd4364d74ecbb61747d6ff39ba0f_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTYtMy0xLTEtNDcyODQ_894c858d-eb32-4139-9bd9-152d6b134b5e"
      unitRef="usd">938000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i924634ae29da4f73998a60b0bbcf1083_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTYtNS0xLTEtNDcyODQ_5ec355f1-d8ba-49d1-b073-d8edfb659e9c"
      unitRef="usd">2465000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0c361f72849a4e38a3998abb4c3cd3d1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTYtNy0xLTEtNDcyODQ_7d6c91ff-79ee-444e-94c2-093aafb432d0"
      unitRef="usd">2564000000</us-gaap:OperatingIncomeLoss>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTctMS0xLTEtNDcyODQ_ac817936-9736-4a88-98e3-0145ba9abbf1"
      unitRef="usd">195000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTctMy0xLTEtNDcyODQ_5530536e-30c3-406c-91ee-6a8a9adeeb88"
      unitRef="usd">8246000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTctNS0xLTEtNDcyODQ_90cdfd76-6b35-4c3a-be3f-ad832524d5c8"
      unitRef="usd">858000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTctNy0xLTEtNDcyODQ_dcf2e527-e87e-46b9-966d-4a0033c39696"
      unitRef="usd">8462000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTgtMS0xLTEtNDcyODQ_e6914fd6-087f-4cf5-8ab0-c20b4f512049"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTgtMy0xLTEtNDcyODQ_8406ab95-677c-4ec8-881a-4b8776d2c68e"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTgtNS0xLTEtNDcyODQ_778f39fb-c1cd-404a-835a-852775d6913f"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTgtNy0xLTEtNDcyODQ_8c2c1bf1-c595-41b0-b265-be74c188b0dd"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpense
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTktMS0xLTEtNDcyODQ_9d40a1c8-52ff-438b-9af0-64e398220214"
      unitRef="usd">41000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTktMy0xLTEtNDcyODQ_69468796-1fb2-4715-bbe4-710e5c713d40"
      unitRef="usd">55000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTktNS0xLTEtNDcyODQ_a1c81638-b0b2-43d0-8f4f-586925ffa228"
      unitRef="usd">135000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMTktNy0xLTEtNDcyODQ_8908fad0-5ced-483c-ac31-d2e328ae9b51"
      unitRef="usd">165000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icea0af673fff48e587087205a66d4ec0_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMjAtMS0xLTEtNDcyODQ_7df6f3fc-7d68-4b6c-89fc-7b37d503b579"
      unitRef="usd">277000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifaba465936154095b5d4ba8b30a84938_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMjAtMy0xLTEtNDcyODQ_c4d8601d-0859-45be-9c65-0c32aabe2b51"
      unitRef="usd">-7363000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMjAtNS0xLTEtNDcyODQ_a74d3e24-ebef-4865-a8a2-8447b51adb24"
      unitRef="usd">1281000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i58ce6c4148614409980f63a506b7650f_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RhYmxlOmI4MmJlYzNmNGMyNDQ1MjA5OTM3NjNmYTVkYTZmYWQ3L3RhYmxlcmFuZ2U6YjgyYmVjM2Y0YzI0NDUyMDk5Mzc2M2ZhNWRhNmZhZDdfMjAtNy0xLTEtNDcyODQ_6cd95f1f-11b8-4341-bced-0bd0b4cbd790"
      unitRef="usd">-6063000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMzQ0MA_5536a51a-8a46-40f5-8daa-dcb848b0190b"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i9ed56a267f0b4bf3aa290c989ff068dc_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMzUwNg_fd5d84c0-1a99-4a0f-9135-d9c38b901711"
      unitRef="number">0.40</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMzU1Nw_4219060c-60b7-4085-9d99-aacf9e026502"
      unitRef="number">0.04</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ie91a3f56d79b42dc8c3b915205a6c2c9_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMzYzNA_dcf75a17-47f2-45ee-ae97-046476a94f1f"
      unitRef="number">0.08</mck:RevenueDerivedFromServicesPercentage>
    <us-gaap:NumberOfReportableSegments
      contextRef="i10248887c7a5482389fdac7a1610cf69_D20210401-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMjk2ODY4MTM5NjI5NDg_0f3712c3-c80b-45ce-9a80-bb7e573c4ae3"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i94fdb1f2c2a947ac844d70ebe0e7856f_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDA0Mg_85a40ce1-0bad-4f67-8e05-342f65eefa79"
      unitRef="usd">33000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i9b93cd32972e406da425d6abeb3973b3_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDA0OQ_6846bb80-0b5f-471b-8c4e-c4cb16b755c7"
      unitRef="usd">79000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i88e11efe78994e7dbc17a05d28563c13_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDA5MQ_cd88c2ab-ba05-4183-83c7-309316150669"
      unitRef="usd">11000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ie95102b563614313b48519acd3293019_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDA5OA_653e4d54-97df-4d0b-8404-edee9827bc22"
      unitRef="usd">115000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i535080de97454a9fac988b095055839e_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDIzMQ_447c520e-ad5f-4c98-bad2-ded99775f8e5"
      unitRef="usd">46000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ic7b7e620d7a14950b39e853f79b975ee_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDM1NQ_2d082492-3ef3-4b75-ba30-6edc44d91d02"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:InventoryWriteDown
      contextRef="i40948811af614a1a960a7eb0c8c1edb0_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMTk3Mg_e7d5e306-5068-4f17-90bf-29f1240e1c9a"
      unitRef="usd">164000000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i9d2234ce5407484e9110cf5f4c10de25_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMTk4Nw_8f87ba0b-a3e5-4569-b157-76069affbe38"
      unitRef="usd">35000000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="ic7340ae6a76d4f16a82f2b9e5aa51fd5_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMTk5MQ_050d630e-19d6-48e0-bbc1-6429c8fbd0a9"
      unitRef="usd">49000000</us-gaap:InventoryWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i3eda82f8d025454abf73c560d50c29b3_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzM1OA_09dd6605-c8c1-481c-a6e5-0e381f67bdaa"
      unitRef="usd">787000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i826a607678f54e2a86f5a30f297b657c_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzM1OA_862a8d50-8d54-449d-b486-919d1e7cded1"
      unitRef="usd">787000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="id15b966c53f8432785b54e03b4585bb3_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzNzM0NQ_8813d59f-67e2-400f-98cd-b60468e04a5d"
      unitRef="usd">58000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i83044c196239439998e7c6a17739816c_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDc5Ng_d8c3129e-5a57-49a6-a5ea-7c310565dcb1"
      unitRef="usd">400000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ia091e797b3e14a3f9b725a69bf843a92_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNTEwNg_144b1894-5539-4246-af1a-ff55dd696d0f"
      unitRef="usd">59000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:RestructuringCharges
      contextRef="i4c351ccf073b47a9b3c10a8e07901940_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMTA5OTUxMTYzOTUwNw_4736a6bd-7e7e-48ba-aa60-f7cc8a5f04c1"
      unitRef="usd">131000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8e45b6151afc4cf1bed1110c1034f5c6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMTA5OTUxMTYzOTUxNQ_3bd4f6a4-18af-4937-968a-55831919decd"
      unitRef="usd">189000000</us-gaap:RestructuringCharges>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i8e45b6151afc4cf1bed1110c1034f5c6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzc3MQ_14fdd42c-721f-43b0-bea7-cf892ea862de"
      unitRef="usd">115000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i4c351ccf073b47a9b3c10a8e07901940_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzc3MQ_81f4c11d-7f7f-4bff-89ec-2db168c911d9"
      unitRef="usd">115000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic9c32c72ede24d538c9aaaa3b64848d1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNTUxOA_95a8623d-b050-4860-92d1-ed6df6f6203a"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i3e5e6c1fd605455eab552c5ec9e5d777_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMjg1NQ_20ded5d6-c6d0-47b4-94a6-a29376495fb6"
      unitRef="usd">47000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i987a6d37125a48a0a90ff128963d4df6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMjg2OQ_83f82b78-ffc0-4f5e-af51-5a052b5c62a1"
      unitRef="usd">57000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i0cf49f518ed74829b2b4b51a44b670a5_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzNzM3Mw_e502bdf4-3b28-4c29-bd6f-155430b7cc9e"
      unitRef="usd">-32000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i4e881354ecc94f77a5d413d65a33f8b8_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNTY4Ng_75e3c1d3-378e-4a18-8b22-eb498ff150b8"
      unitRef="usd">117000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i24f8b8a283c34dc597297cbaa2899171_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNTkxNQ_e5650e67-2a89-48fd-a5c2-709a2057e422"
      unitRef="usd">193000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:LitigationSettlementExpense
      contextRef="ifd5e0dbe10d64b948193be43501d890e_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjA3Mg_63e7fd37-f350-4cde-a4c6-21dae48e021d"
      unitRef="usd">33000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i74f39cabd47c4d089eb231a7347761c6_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjA3OQ_9166e237-4544-489f-aeef-c857292ad9f1"
      unitRef="usd">104000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i2be96b105bae4665a5c985276d810148_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjExNw_bdaf15ea-bba6-4898-86c0-706e777a8390"
      unitRef="usd">34000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i5eb76a4477ee48c8a318ceb3d69a0f20_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjEyNA_bc9fb17b-9d0b-4359-8577-1ede5bebd64d"
      unitRef="usd">118000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i5eb76a4477ee48c8a318ceb3d69a0f20_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzY3Nw_939ebbdf-3236-43ce-af0c-44c56a9d9673"
      unitRef="usd">-8100000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i2be96b105bae4665a5c985276d810148_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNDk0NzgwMjMzMzY3Nw_fd4768d2-fb41-4b9c-969a-78c7bfed3b1c"
      unitRef="usd">-8100000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ic7173dc2a4c04d2f81bcc70922723445_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjI1Ng_56d5c6bd-0ed3-4319-b2cd-93e4bddad55d"
      unitRef="usd">131000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="if0795bca19b544c29c3573a9b4270afa_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjUyNA_abd2064e-5767-4891-8538-d9fe00278de3"
      unitRef="usd">104000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ic28dacd462654b9da21ceaf161a65b64_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjU2Ng_793583b7-3b57-48bf-9d06-356c51c1bb2b"
      unitRef="usd">30000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i845b8f54c2384b069835a503f7a9157a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfNjU3Mw_64919de5-aee9-4c81-a59c-7c6155396428"
      unitRef="usd">89000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iec63485adeb64ac4b82621f5ef551144_D20210401-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMmI0NjVjMjg4MzRkYzlhODg2NGU4ZjVmOWEzZDlhL3NlYzo0YTJiNDY1YzI4ODM0ZGM5YTg4NjRlOGY1ZjlhM2Q5YV83My9mcmFnOjNkZWE1YzYxMzU2ZDQyNjM4ZDQ2ZGE3MmVjOTExOTY3L3RleHRyZWdpb246M2RlYTVjNjEzNTZkNDI2MzhkNDZkYTcyZWM5MTE5NjdfMTA5OTUxMTYzNjc4Ng_36be89f0-d306-414c-9320-f987719a8ecb"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>74
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M8M-?'WXC"^ZE$FY:%<H:I>+QDQP]/UL=RR8;Z)U'%J)S=N?@<PE.2Y@0^]E
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M$&:15Z^4JB/9KKR&KYB$2WW93.%E1[@"P/<-8_*UHP(T;\7I_U!+ P04
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M:Q%Z56D(AC1(GO%O$TW:)BXB=T;I\[V[O?31*A]02;$MVA2V5; =E@T- @W
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MXHEZ=4B85MZM</Z#9]".7/#YFFKJ44RNKW4%X&!"Z,(>>0I%O'*7.H81,7N
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MJYQ*P#=7&+>6Q@4XA6H"O[F9VF)53;6W/5^!_O9!=U\0"0\:@L.%1\724*/
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M:MQIR51)QBMKA*/\='">_/AZG\_' _]1M/*]WX(CF5O[!U]<9*>#"3M$FM+
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M6SEE%B(4A'^.2)0UNL3H"F!#Y9Q<AX^0)N,?DV$4>6/+I31KM$IJ'0NH6G=
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MZ>35^[:<+U'.HW@S>?5D-JN[;YN4GHBP0&@D*I/+&^OD'*6A8"]E _-U79<
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M9H*=POUZ&=S2,B: IOWIS4KGC?!:C)DT[:80;O(;1>.&W]XS>8<]3Z%+L=+
M7^T(V6X<Q3Y8NX-)% ^X-8S&B1](HW3,"&]Z?]OCA,2!2G^D\F?MZ S<@7\R
M:? GO=H]W\?OY/_E%_*VYL<.O D'I(57E3ODQZZS<?M<_+Y3=./ 9&=>T0E/
MKZ3-$EN*Y^8* H;JF#_!1/X7W?SIZ4.B;UU(^VOW?;K#S/VKQO(M1;EP]6]'
MVX?3N_!>>%D>7EVWPLPE\2AP1J)Q=#+J@ DOF=!Q>NE?#U/MZ"WBFPMZ_*'A
M!30_TW3*U1W>H'U.7OP#4$L#!!0    ( ".-0E0\SDXH)@<   T1   9
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M>2?"^M]F^#>E*?CW$$M3HFSQRXU"L;)$@,]7!B*'-W1!\P.9M_\#4$L#!!0
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MODT[*Y$HPXV@!WS*9!\HPS7MHL!02 #WQ#%F#E:"ZA$[E!]@,:<##_\,8EY
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M_BNH7'8KJ9)E2[9C9Y*9*L>9))Z9Q*EX7NKJZCY )"1A3)$*0<KQ_OI[NAL
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MK9JYRZG@.,+1!(R/%1P7?M &BY<97_P/4$L#!!0    ( ".-0E0;H/H!&PX
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M8@;]3*-(HMK@ E0QA5S58&#"&=,F4<G]NO7@[J W6%A%!"&?=(*$.#UY^?M
M4GIO]:KWB=I]E/CFXB5^B$HE1YV-37 YL?C'3EEV+FRVA/7=*#N9<+#I+0I1
M#9=%+R!<6R>YRCFQD5LE5DJU0M4:!8.Y0(;!\#J[G^0EV2:DQ\8<$[[6?B/4
M]Q[N%HV"-XGL%IHJ\O#5X#=FI4NX3&B/^EN1E:*)(*^ LD1#5WA,YB8)4B %
M7Q-O>&X#^V\-IV>Z;K:*6DJQB52FC&7M#)SF%/V7[_B--?UZ Z&AC3!@9T,
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M2?22!N>BQHE>P9G")R5M;N"=3#'=U^^13UO'HM:QB^@@X!4F78C##D3]*#R
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M_A:_5KPD"K(U2C0=M:TC5R"0V "T&_M3E9U6!EN_(O+X6EHF5YQ\:TX;B/$
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MN:8V#@U/H.]+K=UNP LTC>'L7U!+ P04    "  CC4)4=3Z\*10%   _"P
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M0@J8/ZKI)\6 ^MET< \=52KJ&V%_0!]1/X$^[=!/TQB'3R(TTY"F?7+0?)%
MZ<B)=<!#&RO10Z6Z0V,$6J38FYCBR_(WX1S GS'-.,/UQE@?E#5:^M$+M5OL
M:[?XZ=J5NOU9:#OTFED>+,E['K'(HZ<*]V4C%S^GF!"2AS7[./ _5%'_'$^9
MC8RX+^XOL7<+_HK>6^,<G91E4S<AKCPVP*=/SV)WAK&8@J"IDAM'29O=><QR
M/QG.DOD@YCE)\U@'LVP1;M)A.EVT-_EL0DMAO\L2CJVM$+'F:(&KR3RC?E%
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MQH/2\;/"A"ML>(#[E4%&NTTPL)^9C_\%4$L#!!0    ( ".-0E2L "[.F00
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MV,<Y*K.=!'&P7W@OB]+YA7 ZWH@"E^@^;NXL2V&'DLL*-4FCP>)Z$LSBZ_G
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M,2YX;6R55&UOVC 0_BNG;)I:B1$(4"@#I$)7K=(J56W7?9CVP2078M4OF>U
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M')T>1V#:4=9NG*[#^%AH1\,H+"N:_FB\ =TOM7:;C2?H_D_&OP%02P,$%
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M<)\)<3LA=G9[1<[*7[CEKU]JM6*:1D,:G3A7W6P8)VM:E NK\51BGGU](>:
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MRXZL#X,L'?5.D)'<+*CZ"^1YLY,(9D%4)5-@AM5H=A%G<[? UI:B9<;];-D
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M(5B0?%Q2XE*N!.3]1\;$YD(](/WUP^0_4$L#!!0    ( ".-0E3,0SB/O04
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M1BG$:6(WQVC-PH8$GD'*AF#/) 54&HUA5M.&U=3)ZCJ7E.?E>$4I>N]_<.C
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M+"L/MS1:4UX U._WC,FGDZ) \]''_']02P,$%     @ (XU"5*C7:HZ3!@
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M')AA/9W!;^8&WSXX?*$"I87#B1R2$.-#3D^-=G0"P  S!D 7%SBA/@\8M<D
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M\;2X7#'=<HK<0/^^X%R]#/($U2>Z\?]02P,$%     @ (XU"5,=<EF%M!@
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M %8"F*K]H5BJTC>!"!;S+'T"6=%:1BL.U' IM"QPF!3,NA>9O!I*G%C<\*4
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M4PA<<VUJ.RH;8.:7TKRK5<<N4'\M3/X#4$L#!!0    ( ".-0E0X&C3KJ@,
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MU87 7@/9J"0;7:I2P']@*KB4NK.%H.G\!<@=V>BS=X)N"%L ^JSGL]2.2+H
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MM 6YNN&P=2$--U_(*@LZ65G>W">N<#B,7<@@;+BY159:T.G2HBG_QD,MLH*
M6A4$9 4!75P0D&_:%XDX61"0%034BB @W[0OV+H06,\66T' ?D%X8]'D Y9J
M"/CC>;XFJ;XZY:D29*[.G*K8"@&&;18;MN,;^_\:.J/8"H^^]'DAATPK_RJ=
M._^]Q89?UX :2%.Q60W ?@WXC:F*:YXQCAF[$-@48"L$V"\$E^V/YG^!?'5K
M%0!'K3:('?MX</$&&;Q><C[((5.K&_A<W?"7V^O:X84<LK7:@?W:<=X#;>$T
M\I%U(6ATQ#:HO&0P;WANB5BQ5(*8+K51V!WHK8K\I4E^H/@F>^_PR)7B2?9S
M38F.L0'HZTO.U?[ O,HH7UU-_@=02P,$%     @ (XU"5-8W<S6! P  5PP
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M97!,+HP!K  F4_*5LV<NN.5@MN61$GR]'R IM.9RZ:WNE-3UPB4SW) _OV(
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MCC-1*KHSZR]8U=/U?)E1+GQA7>4V(\A*1Z:HP*R@D'KS%T^5#SN 5F</(*D
MR4<![0K0#H5NE(6RQH)$.K!F#=9G,YL?!&\"FJN1VI_BA"RO2L91>BFDA0>A
M2H0;%*ZTR$=$#HYAPA<F+Q6"F<&UT?/C;V@+&..40#JXP\S8'',0!.>%L21_
M<S RCN!PC"2D<D=,PFFEM5+/>1RV6OFM&B#ULB37 (4K5)#PZOUD#(<'1W#
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M+CBP/H'V%\;@)O!#UU^9Q2]02P,$%     @ (XU"5-H*M>M+!0  YQ<  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3DN>&ULO5AM;Z,X$/XK5K32M=)MP"8O
M9)5&:IN^;M_4WMY].-T'%YS&*F 6FW1[NA]_-A @8%RJWEX_- &>>3R/9SPS
M8?["DF>^)D2 'V$0\8/!6HCXBV5Q;TU"S(<L)I%\LF))B(6\3)XL'B<$^YE1
M&%C(MB=6B&DT6,RS>W?)8LY2$="(W"6 IV&(D]<C$K"7@P$<;&_<TZ>U4#>L
MQ3S&3^2!B&_Q72*OK)+%IR&).&412,CJ8' (O]PB6QEDB-\I>>&U[T!)>63L
M65U<^ <#6WE$ N()18'EQX8<DR!03-*/[P7IH%Q3&=:_;]E/,_%2S"/FY)@%
M?U!?K \&[@#X9(730-RSEW-2"!HK/H\%//L/7@JL/0!>R@4+"V/I04BC_!/_
M*#:B9H!&'0:H,$!]#9S"P&D:=+DT*@Q&#0-GTF$P+@S&#8,1[#"8% :3Y@K3
M#H-I83#MJ\$M#-R^*\P*@UE? VAO(V?W=0J6P6Y&VQEWF6S##9OQ=KHV%VX#
M#EL1[S39AAPV8]YML@UZGO!6GO'9<5EB@1?SA+V 1.$EG_J2G;G,7IX2&JGR
M\" 2^91*.[%X$,Q[7K/ )PG_!9Q\3ZEX!7M+LJ(>%?O@,[C!28+5$59W!:8!
MWY];0JZL["VO6.4H7P5UK'*9!D. G%\!LA'\!"S US@A7$-TW(<(]2!:FHD.
MTZ<A<&!.U$ER8B:YQJ\EQ[>')=C[M%_YU$EZ:B9=$F_89-TP07HPGYF9'T@L
MF>WW^GO^5DBBBK63Y**_:+N_:Y?]!;^#]6M_P78GR=5'HZSAO/[()FKX;GKP
MV>Z.CQJ6V[<.2=)2NLMBR9I5%BY4%BZ4T3I=!]CSY(PA2Q/QP8,2".Y)G";>
M6LX*'/QY)>'@0I"0_V58S"D7<[+%1AV+W:3A(TD 6P$5(PYB>9'MJKKEL3"4
M@PY7E50]":E03LE;<<)BQG$@#60 2*1N"Y8CBYH+]A3C/O@G8]95B]RS<>:9
M&O8V"SBW-O5,,R%VY(Y*N2.CW"7=4)]$/I>#EA=(F7ZF>"LT$[Y'(^"S0#ZM
M;8?28<RXHWSA:<U7>SB:[@HZUH+0+NBT#]-%'Z:K-@@.G<DNZ%H'0F/]/H_+
M?1X;]SG+6RZG[&WB^KH$R#DFM96GR+6SOX;:-A(Y4(>\TB!M6TMZW8:.;;N!
MW%$_*=5/C.H/4[%F"?U;9E>U P"'+(T$V$MC>51TY>9FTG)H9)L]FI8>3?MZ
M5+B!-W+BP8\! ?*7&%BE(I6I7WFK;>_3UG$<N2W_\C#T@NY(<4LIKE'*K5C+
M0XD]+TFEFH#B1QI00?4>N^T==1RD]=AM>]P!O6VS.C-W:A(W*\7-S'$RU'Y#
MM8=V-13;/[^YP-H,#C]>!TX*DOJ&PC<2'U;=%**W7:AG=E;@\SJNJKIA1$:M
ME!@CDT]5TX7FKGNXD2%X(K)Y4B_KM+RU3YF7*???T8).BE5W2OG,&2+4X6_5
M-:&Y;1[7!X&FDSVV<EGPU[=RICE9)QK<R-$ OVJ 75&I>A8T-ZW;F$1 #G7/
M1+3.!O@MP1''V9L?;CH:58^ D__A)%8- +[1 7Y*RIT6J]93#B%GZ,YVXW6F
MP]DR-1M]7@.#8SB$#=QE!PXY'3E0-1=H[BX?S?13V.XCCBZ#SS1 .-( SS7
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M"9E9?7RCI,WB>I,%L61!T<<B%\L*1?F<SX'M9^[MIX[M1[*BV[*2E[)>$V?
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M:!9VI5G&E]5\F;4",/8NSDZ+0JS>"CZ3.7/)/SK@:$ ;OV"N-+^WT:!5IM;
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( ".-0E12)>!+R00  &XI   /
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M[EB3<DMN&\T%TWY#Q^ L!=DI8" 3!-<QY)08V2E!*$.NUDZ".FA@2"4QLDK
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M#7\RFKT!4$L! A0#%     @ (XU"5 =!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  CC4)4<Y8A'.X
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ (XU"5/&G'TX;!
M-PX  !@              ("!JQ4  'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;%!+ 0(4 Q0    ( ".-0E1LGGN6] 8   $=   8              " @?P9
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    "  CC4)43&"0
MW.@"  #%"0  &               @($F(0  >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&UL4$L! A0#%     @ (XU"5)38H&8="P  (T,  !@
M ("!1"0  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( ".-
M0E1S' I$EP(  !<'   8              " @9<O  !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6Q02P$"% ,4    "  CC4)4PX'R'W0(  #H(P  &
M        @(%D,@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%
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M+GAM;%!+ 0(4 Q0    ( ".-0E1"FQ3$O@D   @A   9              "
M@3=D  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ (XU"
M5+PG*%0I!0  6@X  !D              ("!+&X  'AL+W=O<FMS:&5E=',O
M<VAE970Q-"YX;6Q02P$"% ,4    "  CC4)4/,Y.*"8'   -$0  &0
M        @(&,<P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0
M   ( ".-0E1'V]FD%0T  "PC   9              " @>EZ  !X;"]W;W)K
M<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ (XU"5#:B?$KZ P  W D
M !D              ("!-8@  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"% ,4    "  CC4)4&(1;?MH,  #!,P  &0              @(%FC
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( ".-0E0P:_5E
MBPP  'HI   9              " @7>9  !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&UL4$L! A0#%     @ (XU"5(COH(E^&P  >E@  !D
M ("!.:8  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  C
MC4)4MZ6D]F(*  #8*   &0              @('NP0  >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( ".-0E0;H/H!&PX  /DK   9
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M970R-BYX;6Q02P$"% ,4    "  CC4)4E0UPBQ8$   D"@  &0
M    @($%^   >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (
M ".-0E1U/KPI% 4  #\+   9              " @5+\  !X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L! A0#%     @ (XU"5*P +LZ9!   'PH  !D
M             ("!G0$! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"
M% ,4    "  CC4)4@DY)AGD#  #H"   &0              @(%M!@$ >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( ".-0E09#6XSG@(
M +@%   9              " @1T* 0!X;"]W;W)K<VAE971S+W-H965T,S$N
M>&UL4$L! A0#%     @ (XU"5&Z  33L @  6P8  !D              ("!
M\@P! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  CC4)4
ML([-.B\&  ";&P  &0              @($5$ $ >&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+ 0(4 Q0    ( ".-0E105SQAM@D  )P?   9
M      " @7L6 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%
M  @ (XU"5*57^E(/ @  : 0  !D              ("!:" ! 'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    "  CC4)4AA^]QNL%   )(0
M&0              @(&N(@$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+
M 0(4 Q0    ( ".-0E3,0SB/O04  *4:   9              " @= H 0!X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ (XU"5.-V:F @
M!   7Q$  !D              ("!Q"X! 'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6Q02P$"% ,4    "  CC4)4KOVECP,&    (@  &0
M@($;,P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( ".-
M0E2HUVJ.DP8  $\E   9              " @54Y 0!X;"]W;W)K<VAE971S
M+W-H965T-# N>&UL4$L! A0#%     @ (XU"5&OQRI<Z!0  1Q8  !D
M         ("!'T ! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
M    "  CC4)4D>YJL, &   J(P  &0              @(&010$ >&PO=V]R
M:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( ".-0E0/_[-S0P8  #@D
M   9              " @8=, 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL
M4$L! A0#%     @ (XU"5 ZCKRR*!0  AA@  !D              ("! 5,!
M 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    "  CC4)4; :S
MB\,#  #T#0  &0              @('"6 $ >&PO=V]R:W-H965T<R]S:&5E
M=#0U+GAM;%!+ 0(4 Q0    ( ".-0E0&O 9X_ ,   <1   9
M  " @;Q< 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @
M(XU"5&^RI;2)!0  KAL  !D              ("![V ! 'AL+W=O<FMS:&5E
M=',O<VAE970T-RYX;6Q02P$"% ,4    "  CC4)4QUR686T&   [)P  &0
M            @(&O9@$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4
M Q0    ( ".-0E03P,F)T 8  )8E   9              " @5-M 0!X;"]W
M;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ (XU"5!P1'Y1K P
M 0T  !D              ("!6G0! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX
M;6Q02P$"% ,4    "  CC4)4A:$V,>$"   Y"   &0              @('\
M=P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( ".-0E0X
M&C3KJ@,  %8,   9              " @11[ 0!X;"]W;W)K<VAE971S+W-H
M965T-3(N>&UL4$L! A0#%     @ (XU"5&M_[! &!@  51T  !D
M     ("!]7X! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ".-0E3:!?W330(  #X%   9              "
M@82; 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ (XU"
M5-H*M>M+!0  YQ<  !D              ("!")X! 'AL+W=O<FMS:&5E=',O
M<VAE970U.2YX;6Q02P$"% ,4    "  CC4)4W[\N#S,)  !,/0  &0
M        @(&*HP$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0
M   ( ".-0E1F;?.&K0,  &H+   9              " @?2L 0!X;"]W;W)K
M<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ (XU"5*9]=P6A#   L$@
M !D              ("!V+ ! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q0
M2P$"% ,4    "  CC4)41'.N!TL#   *%   #0              @ &PO0$
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ".-0E27BKL<P    !,"   +
M          "  2;! 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ".-0E12)>!+
MR00  &XI   /              "  0_" 0!X;"]W;W)K8F]O:RYX;6Q02P$"
M% ,4    "  CC4)4=TMQA08"  #Q)   &@              @ $%QP$ >&PO
M7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  CC4)4_R>G=>,!
M  !L)   $P              @ %#R0$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+
4!08     1@!& "$3  !7RP$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>454</ContextCount>
  <ElementCount>434</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>126</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>21</UnitCount>
  <MyReports>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSale</Role>
      <ShortName>Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Restructuring, Impairment, and Related Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</Role>
      <ShortName>Restructuring, Impairment, and Related Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113104 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119106 - Disclosure - Earnings (Loss) Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShare</Role>
      <ShortName>Earnings (Loss) Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2122107 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2127108 - Disclosure - Debt and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivities</Role>
      <ShortName>Debt and Financing Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2133109 - Disclosure - Pension Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefits</Role>
      <ShortName>Pension Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2135110 - Disclosure - Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivities</Role>
      <ShortName>Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2139111 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2143112 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2147113 - Disclosure - Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficit</Role>
      <ShortName>Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2151114 - Disclosure - Segments of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusiness</Role>
      <ShortName>Segments of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleTables</Role>
      <ShortName>Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HeldforSale</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables</Role>
      <ShortName>Restructuring, Impairment, and Related Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - Earnings (Loss) Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareTables</Role>
      <ShortName>Earnings (Loss) Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShare</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2323305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2328306 - Disclosure - Debt and Financing Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesTables</Role>
      <ShortName>Debt and Financing Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/DebtandFinancingActivities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesTables</Role>
      <ShortName>Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HedgingActivities</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2340308 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FairValueMeasurements</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2344309 - Disclosure - Commitments and Contingent Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables</Role>
      <ShortName>Commitments and Contingent Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/CommitmentsandContingentLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2348310 - Disclosure - Stockholders' Equity (Deficit) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitTables</Role>
      <ShortName>Stockholders' Equity (Deficit) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficit</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2352311 - Disclosure - Segments of Business (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessTables</Role>
      <ShortName>Segments of Business (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusiness</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Held for Sale - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleNarrativeDetails</Role>
      <ShortName>Held for Sale - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails</Role>
      <ShortName>Held for Sale - Assets and Liabilities Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/IncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2421410 - Disclosure - Earnings (Loss) Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareDetails</Role>
      <ShortName>Earnings (Loss) Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShareTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2424411 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails</Role>
      <ShortName>Debt and Financing Activities - Long-Term Debt Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2431416 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails</Role>
      <ShortName>Debt and Financing Activities - Revolving Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails</Role>
      <ShortName>Debt and Financing Activities - Commercial Paper (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Pension Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsNarrativeDetails</Role>
      <ShortName>Pension Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesNarrativeDetails</Role>
      <ShortName>Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails</Role>
      <ShortName>Hedging Activities - Derivative Instruments Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2441421 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2442422 - Disclosure - Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2445423 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2446424 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2449425 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2450426 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2453427 - Disclosure - Segments of Business - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails</Role>
      <ShortName>Segments of Business - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mck-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2454428 - Disclosure - Segments of Business - Reportable operating segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails</Role>
      <ShortName>Segments of Business - Reportable operating segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mck-20211231.htm">mck-20211231.htm</File>
    <File>mck-20211231.xsd</File>
    <File>mck-20211231_cal.xml</File>
    <File>mck-20211231_def.xml</File>
    <File>mck-20211231_lab.xml</File>
    <File>mck-20211231_pre.xml</File>
    <File>mck_exhibit311x12312021.htm</File>
    <File>mck_exhibit312x12312021.htm</File>
    <File>mck_exhibit32x12312021.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mck-20211231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1356">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mck-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 33,
   "contextCount": 454,
   "dts": {
    "calculationLink": {
     "local": [
      "mck-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mck-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mck-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mck-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mck-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mck-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 619,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 55,
   "keyStandard": 379,
   "memberCustom": 71,
   "memberStandard": 52,
   "nsprefix": "mck",
   "nsuri": "http://mckesson123.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://mckesson123.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Held for Sale",
     "role": "http://mckesson123.com/role/HeldforSale",
     "shortName": "Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Restructuring, Impairment, and Related Charges",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges",
     "shortName": "Restructuring, Impairment, and Related Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113104 - Disclosure - Income Taxes",
     "role": "http://mckesson123.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119106 - Disclosure - Earnings (Loss) Per Common Share",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShare",
     "shortName": "Earnings (Loss) Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122107 - Disclosure - Goodwill and Intangible Assets, Net",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127108 - Disclosure - Debt and Financing Activities",
     "role": "http://mckesson123.com/role/DebtandFinancingActivities",
     "shortName": "Debt and Financing Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133109 - Disclosure - Pension Benefits",
     "role": "http://mckesson123.com/role/PensionBenefits",
     "shortName": "Pension Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135110 - Disclosure - Hedging Activities",
     "role": "http://mckesson123.com/role/HedgingActivities",
     "shortName": "Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139111 - Disclosure - Fair Value Measurements",
     "role": "http://mckesson123.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143112 - Disclosure - Commitments and Contingent Liabilities",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147113 - Disclosure - Stockholders' Equity (Deficit)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficit",
     "shortName": "Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151114 - Disclosure - Segments of Business",
     "role": "http://mckesson123.com/role/SegmentsofBusiness",
     "shortName": "Segments of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Held for Sale (Tables)",
     "role": "http://mckesson123.com/role/HeldforSaleTables",
     "shortName": "Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables",
     "shortName": "Restructuring, Impairment, and Related Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - Earnings (Loss) Per Common Share (Tables)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareTables",
     "shortName": "Earnings (Loss) Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328306 - Disclosure - Debt and Financing Activities (Tables)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesTables",
     "shortName": "Debt and Financing Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - Hedging Activities (Tables)",
     "role": "http://mckesson123.com/role/HedgingActivitiesTables",
     "shortName": "Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340308 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344309 - Disclosure - Commitments and Contingent Liabilities (Tables)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables",
     "shortName": "Commitments and Contingent Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348310 - Disclosure - Stockholders' Equity (Deficit) (Tables)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitTables",
     "shortName": "Stockholders' Equity (Deficit) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352311 - Disclosure - Segments of Business (Tables)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessTables",
     "shortName": "Segments of Business (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Held for Sale - Narrative (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
     "shortName": "Held for Sale - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "if55a1f085e0849c78909dea0bbe21536_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i792e3f3cd2194564994f887fa0311091_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
     "shortName": "Held for Sale - Assets and Liabilities Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i792e3f3cd2194564994f887fa0311091_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "iafc802238be540dba818f29ae266827f_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "iafc802238be540dba818f29ae266827f_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "iafc802238be540dba818f29ae266827f_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Income Taxes (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i92bc310247354b8c924fe8c7f5b5b506_I20210412",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i92bc310247354b8c924fe8c7f5b5b506_I20210412",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "iafc802238be540dba818f29ae266827f_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i68c571fe607348cdab2a44a5f011467b_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421410 - Disclosure - Earnings (Loss) Per Common Share (Details)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareDetails",
     "shortName": "Earnings (Loss) Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424411 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "iafc802238be540dba818f29ae266827f_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
     "shortName": "Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i069e5020023e41c2aedab80fbb7726b6_I20210812",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i89b9210a5ce84d4c8f57ef708a9e06d0_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431416 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
     "shortName": "Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i41cdbb2354254500bac2539b51ef63ea_I20190925",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibb82d8e0e0254d2e8fef071a792829d2_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
     "shortName": "Debt and Financing Activities - Commercial Paper (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibb82d8e0e0254d2e8fef071a792829d2_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i3f3051bdb38143259288f549f974a0e9_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Pension Benefits - Narrative (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
     "shortName": "Pension Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i3f3051bdb38143259288f549f974a0e9_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - Hedging Activities - Narrative (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
     "shortName": "Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ic3f95e7d8ccb40f9b9eb2820e1c96850_D20211001-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i44441409ce5e4ca6988aff06c61dae4f_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
     "shortName": "Hedging Activities - Derivative Instruments Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i44441409ce5e4ca6988aff06c61dae4f_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441421 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ia57f313fd26c4d74b79a639aec5953e7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442422 - Disclosure - Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails",
     "shortName": "Fair Value Measurements - Schedule of Long-Term Debt is Recorded at Amortized Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ia57f313fd26c4d74b79a639aec5953e7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i6b6bcdc79602464fb68d237e91f2c420_D20210401-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445423 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
     "shortName": "Commitments and Contingent Liabilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i3b6ebdeadc4946d3be80756e21be72d2_I20211231",
      "decimals": "-2",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i85eff5aee4c3446698c4907a3978d21b_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446424 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
     "shortName": "Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i85eff5aee4c3446698c4907a3978d21b_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i489f4fe3b29441a9ac0c65293e1fd406_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449425 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails",
     "shortName": "Stockholders' Equity (Deficit) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i1f96be18861e4831bbe49116594b08c3_I20211208",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i178f7de2928e404a940f4fec020ed2b2_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i178f7de2928e404a940f4fec020ed2b2_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ib1ad330dab834c37a1beaf31343ccddc_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450426 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
     "shortName": "Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ifaba465936154095b5d4ba8b30a84938_D20201001-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453427 - Disclosure - Segments of Business - Narrative (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
     "shortName": "Segments of Business - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i10248887c7a5482389fdac7a1610cf69_D20210401-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454428 - Disclosure - Segments of Business - Reportable operating segment (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails",
     "shortName": "Segments of Business - Reportable operating segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "icea0af673fff48e587087205a66d4ec0_D20211001-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:CorporateOperatingExpenseandOtherIncomeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "i5dfc838eb1ac450fa9327128ad95b9f4_D20210723-20210723",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://mckesson123.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20211231.htm",
      "contextRef": "ibcf4e6dae78e4d2682b958d29b9de4c2_D20210401-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 126,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mck_A063EuroNotesDueAugust172021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.63% Euro Notes Due August 17, 2021",
        "label": "0.63% Euro Notes Due August 17, 2021 [Member]",
        "terseLabel": "0.63% Euro Notes due August 17, 2021"
       }
      }
     },
     "localname": "A063EuroNotesDueAugust172021Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A090NotesDueDecember32025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.90% Notes Due December 3, 2025",
        "label": "0.90% Notes Due December 3, 2025 [Member]",
        "terseLabel": "0.90% Notes due December 3, 2025"
       }
      }
     },
     "localname": "A090NotesDueDecember32025Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A130NotesDueAugust152026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.30% Notes Due August 15, 2026",
        "label": "1.30% Notes Due August 15, 2026 [Member]",
        "terseLabel": "1.30% Notes due August 15, 2026"
       }
      }
     },
     "localname": "A130NotesDueAugust152026Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1500NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.500% Notes Due 2025",
        "label": "1.500% Notes Due 2025 [Member]",
        "terseLabel": "1.500% Notes Due 2025"
       }
      }
     },
     "localname": "A1500NotesDue2025Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A150EuroNotesDueNovember172025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.50% Euro Notes Due November 17, 2025",
        "label": "1.50% Euro Notes Due November 17, 2025 [Member]",
        "terseLabel": "1.50% Euro Notes due November 17, 2025"
       }
      }
     },
     "localname": "A150EuroNotesDueNovember172025Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1625NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.625% Notes Due 2026",
        "label": "1.625% Notes Due 2026 [Member]",
        "terseLabel": "1.625% Notes Due 2026"
       }
      }
     },
     "localname": "A1625NotesDue2026Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A163EuroNotesDueOctober302026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.63% Euro Notes Due October 30, 2026",
        "label": "1.63% Euro Notes Due October 30, 2026 [Member]",
        "terseLabel": "1.63% Euro Notes due October 30, 2026"
       }
      }
     },
     "localname": "A163EuroNotesDueOctober302026Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Notes",
        "label": "2025 Notes [Member]",
        "terseLabel": "2025 Notes"
       }
      }
     },
     "localname": "A2025NotesMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A270NotesDueDecember152022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.70% Notes Due December 15, 2022",
        "label": "2.70% Notes Due December 15, 2022 [Member]",
        "terseLabel": "2.70% Notes due December 15, 2022"
       }
      }
     },
     "localname": "A270NotesDueDecember152022Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A285NotesDueMarch152023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.85% Notes Due March 15, 2023",
        "label": "2.85% Notes Due March 15, 2023 [Member]",
        "terseLabel": "2.85% Notes due March 15, 2023"
       }
      }
     },
     "localname": "A285NotesDueMarch152023Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A3125NotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125% Notes Due 2029",
        "label": "3.125% Notes Due 2029 [Member]",
        "terseLabel": "3.125% Notes Due 2029"
       }
      }
     },
     "localname": "A3125NotesDue2029Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A313SterlingNotesDueFebruary172029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.13% Sterling Notes Due February 17, 2029",
        "label": "3.13% Sterling Notes Due February 17, 2029 [Member]",
        "terseLabel": "3.13% Sterling Notes due February 17, 2029"
       }
      }
     },
     "localname": "A313SterlingNotesDueFebruary172029Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A380NotesDueMarch152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.80% Notes Due March 15, 2024",
        "label": "3.80% Notes Due March 15, 2024 [Member]",
        "terseLabel": "3.80% Notes due March 15, 2024"
       }
      }
     },
     "localname": "A380NotesDueMarch152024Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A395NotesDueFebruary162028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.95% Notes Due February 16, 2028",
        "label": "3.95% Notes Due February 16, 2028 [Member]",
        "terseLabel": "3.95% Notes due February 16, 2028"
       }
      }
     },
     "localname": "A395NotesDueFebruary162028Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMay302029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.75% Notes Due May 30, 2029",
        "label": "4.75% Notes Due May 30, 2029 [Member]",
        "terseLabel": "4.75% Notes due May 30, 2029"
       }
      }
     },
     "localname": "A475NotesDueMay302029Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A488NotesDueMarch152044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.88% Notes Due March 15, 2044",
        "label": "4.88% Notes Due March 15, 2044 [Member]",
        "terseLabel": "4.88% Notes due March 15, 2044"
       }
      }
     },
     "localname": "A488NotesDueMarch152044Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A600NotesDueMarch12041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.00% Notes Due March 1, 2041",
        "label": "6.00% Notes Due March 1, 2041 [Member]",
        "terseLabel": "6.00% Notes due March 1, 2041"
       }
      }
     },
     "localname": "A600NotesDueMarch12041Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A765DebenturesDueMarch12027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "7.65% Debentures Due March 1, 2027",
        "label": "7.65% Debentures Due March 1, 2027 [Member]",
        "terseLabel": "7.65% Debentures due March 1, 2027"
       }
      }
     },
     "localname": "A765DebenturesDueMarch12027Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase [Member]",
        "label": "Accelerated Share Repurchase [Member]",
        "terseLabel": "Accelerated Share Repurchase"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "label": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "terseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG",
        "verboseLabel": "Associated increase in Company's ownership interest on its equity"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "label": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "terseLabel": "Annual recurring dividend (in euro per share)"
       }
      }
     },
     "localname": "AnnualRecurringCompensationPerSharetoNoncontrollingInterests",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_AntitrustLegalSettlementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Antitrust Legal Settlements",
        "label": "Antitrust Legal Settlements [Member]",
        "terseLabel": "Antitrust Legal Settlements"
       }
      }
     },
     "localname": "AntitrustLegalSettlementsMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AssetImpairmentChargesIncludingAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment Charges, Including Accelerated Depreciation",
        "label": "Asset Impairment Charges, Including Accelerated Depreciation",
        "terseLabel": "Asset impairments and accelerated depreciation"
       }
      }
     },
     "localname": "AssetImpairmentChargesIncludingAcceleratedDepreciation",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AustrianBusinessOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Austrian Business Operations",
        "label": "Austrian Business Operations [Member]",
        "terseLabel": "Austrian Business Operations"
       }
      }
     },
     "localname": "AustrianBusinessOperationsMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_BritishPoundSterlingDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "British Pound Sterling Denominated Notes [Member]",
        "label": "British Pound Sterling Denominated Notes [Member]",
        "terseLabel": "British Pound Sterling Denominated Notes"
       }
      }
     },
     "localname": "BritishPoundSterlingDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canadian Health Benefit Claims Management and Plan Administrative Services Business",
        "label": "Canadian Health Benefit Claims Management and Plan Administrative Services Business [Member]",
        "terseLabel": "Canadian Health Benefit Claims Management and Plan Administrative Services Business"
       }
      }
     },
     "localname": "CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)",
        "label": "Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)",
        "terseLabel": "Cash, cash equivalents, and restricted cash classified within Assets held for sale"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cherokee Nation",
        "label": "Cherokee Nation [Member]",
        "terseLabel": "Cherokee Nation"
       }
      }
     },
     "localname": "CherokeeNationMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CommonStockVotingRightsNumberofVotesPerCommonShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "label": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "terseLabel": "Number of votes per share of common stock permitted on proposals presented to stockholders (vote)"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberofVotesPerCommonShare",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_CorporateOperatingExpenseandOtherIncomeNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Operating Expense and Other Income, Net",
        "label": "Corporate Operating Expense and Other Income, Net",
        "negatedTerseLabel": "Corporate income (expenses), net"
       }
      }
     },
     "localname": "CorporateOperatingExpenseandOtherIncomeNet",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CurrentAssetLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Asset / Liability [Member]",
        "label": "Current Asset / Liability [Member]",
        "terseLabel": "Prepaid expenses and other/Other accrued liabilities"
       }
      }
     },
     "localname": "CurrentAssetLiabilityMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value",
        "label": "Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Loss in Charge for Remeasurement to Fair Value",
        "terseLabel": "Accumulated other comprehensive loss in charge for remeasurement to fair value"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "terseLabel": "Gross purchase price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationExpected",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "label": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software",
        "label": "Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software",
        "terseLabel": "Impairment charge"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Member]",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities",
        "label": "Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities",
        "label": "Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current",
        "label": "Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current",
        "label": "Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "negatedTerseLabel": "Remeasurement of assets of business held for sale to fair value less costs to sell"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainonWritedown1",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EUBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E.U. Businesses (Disposal Group)",
        "label": "E.U. Businesses (Disposal Group) [Member]",
        "terseLabel": "E.U. Businesses (Disposal Group)"
       }
      }
     },
     "localname": "EUBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Global Low-Tax Income, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Global Low-Tax Income, Amount",
        "negatedTerseLabel": "Discrete tax benefit recognized due to GILTI"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGlobalLowTaxIncomeAmount",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EuroDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Notes [Member]",
        "label": "Euro Denominated Notes [Member]",
        "terseLabel": "Euro Denominated Notes"
       }
      }
     },
     "localname": "EuroDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EuropeanAssetsHeldForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Assets Held for Sale",
        "label": "European Assets Held for Sale [Member]",
        "terseLabel": "European Assets Held for Sale"
       }
      }
     },
     "localname": "EuropeanAssetsHeldForSaleMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EuropeanBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Businesses (Disposal Group)",
        "label": "European Businesses (Disposal Group) [Member]",
        "terseLabel": "European Businesses (Disposal Group)"
       }
      }
     },
     "localname": "EuropeanBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "terseLabel": "Estimated annual amortization expense, thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]",
        "label": "Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]",
        "terseLabel": "Forward contracts to hedge Euro against British Pound cash flows"
       }
      }
     },
     "localname": "ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GermanPharmaceuticalWholesaleBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "German Pharmaceutical Wholesale Business",
        "label": "German Pharmaceutical Wholesale Business [Member]",
        "terseLabel": "German Pharmaceutical Wholesale Business"
       }
      }
     },
     "localname": "GermanPharmaceuticalWholesaleBusinessMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GermanPharmaceuticalWholesaleJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "German Wholesale Joint Venture [Member]",
        "label": "German Pharmaceutical Wholesale Joint Venture [Member]",
        "terseLabel": "German Pharmaceutical Wholesale Business"
       }
      }
     },
     "localname": "GermanPharmaceuticalWholesaleJointVentureMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GovernmentalEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Governmental Entities",
        "label": "Governmental Entities [Member]",
        "terseLabel": "Governmental entities"
       }
      }
     },
     "localname": "GovernmentalEntitiesMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_HeldForSalePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Held for Sale",
        "label": "Held for Sale [Policy Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "HeldForSalePolicyTextBlock",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_IncomeTaxExpenseBenefitDiscreteItems": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit) Discrete Items",
        "label": "Income Tax Expense (Benefit) Discrete Items",
        "negatedTerseLabel": "Discrete tax benefit recognized due to temporary difference arising from buyer's excess tax basis"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitDiscreteItems",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncreaseDecreaseInLitigationReserve": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Litigation Reserve",
        "label": "Increase (Decrease) in Litigation Reserve",
        "terseLabel": "Litigation liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLitigationReserve",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IndividualClaimantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Claimant",
        "label": "Individual Claimant [Member]",
        "terseLabel": "An individual"
       }
      }
     },
     "localname": "IndividualClaimantMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternallyDevelopedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software",
        "label": "Internally developed software [Member]",
        "terseLabel": "Internally developed software"
       }
      }
     },
     "localname": "InternallyDevelopedSoftwareMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternationalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment",
        "label": "International Segment [Member]",
        "terseLabel": "International (1)"
       }
      }
     },
     "localname": "InternationalSegmentMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award",
        "terseLabel": "Portion of settlement to be paid by the Company (percent)"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "label": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "terseLabel": "Portion of settlement award to be used by state and local government for remediation (percent)"
       }
      }
     },
     "localname": "LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Accrual, Period Increase (Decrease), Net of Tax",
        "label": "Loss Contingency Accrual, Period Increase (Decrease), Net of Tax",
        "terseLabel": "After-tax expenses related to estimated litigation liability"
       }
      }
     },
     "localname": "LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyNumberOfAdditionalDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Additional Defendants",
        "label": "Loss Contingency, Number of Additional Defendants",
        "terseLabel": "Loss Contingency, Number of Additional Defendants"
       }
      }
     },
     "localname": "LossContingencyNumberOfAdditionalDefendants",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfEligibleStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Eligible States",
        "label": "Loss Contingency, Number of Eligible States",
        "terseLabel": "Number of eligible states"
       }
      }
     },
     "localname": "LossContingencyNumberOfEligibleStates",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfOtherDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Other Defendants",
        "label": "Loss Contingency, Number of Other Defendants",
        "terseLabel": "Number of other national distributors named in suit"
       }
      }
     },
     "localname": "LossContingencyNumberOfOtherDefendants",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfRelators": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Relators",
        "label": "Loss Contingency, Number of Relators",
        "terseLabel": "Loss Contingency Number of Relators"
       }
      }
     },
     "localname": "LossContingencyNumberOfRelators",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfStatesFiledOnBehalfOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States Filed on Behalf Of",
        "label": "Loss Contingency, Number of States Filed on Behalf Of",
        "terseLabel": "Loss Contingency, Number of States Filed on Behalf Of"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesFiledOnBehalfOf",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfTerritories": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Territories",
        "label": "Loss Contingency, Number of Territories",
        "terseLabel": "Number of territories that have joined the proposed settlement agreement"
       }
      }
     },
     "localname": "LossContingencyNumberOfTerritories",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStateAttorneyGenerals": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of State Attorney Generals",
        "label": "Loss Contingency, Number of State Attorney Generals",
        "terseLabel": "Number of attorney generals that have filed claims"
       }
      }
     },
     "localname": "LossContingencyNumberofStateAttorneyGenerals",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States",
        "label": "Loss Contingency, Number of States",
        "terseLabel": "Number of states in which court cases are pending"
       }
      }
     },
     "localname": "LossContingencyNumberofStates",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencySettlementAgreementAwardPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "label": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "terseLabel": "Period over which award would be payable under proposed framework"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementAwardPaymentPeriod",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementPaymentTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement, Payment Terms",
        "label": "Loss Contingency, Settlement, Payment Terms",
        "terseLabel": "Payment term"
       }
      }
     },
     "localname": "LossContingencySettlementPaymentTerms",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_MckessonEuropeSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mckesson Europe Subsidiary [Member]",
        "label": "Mckesson Europe Subsidiary [Member]",
        "terseLabel": "McKesson Europe Subsidiary"
       }
      }
     },
     "localname": "MckessonEuropeSubsidiaryMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MedicalSurgicalSolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical-Surgical Solutions Segment [Member]",
        "label": "Medical-Surgical Solutions Segment [Member]",
        "terseLabel": "Medical-Surgical Solutions"
       }
      }
     },
     "localname": "MedicalSurgicalSolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In re: National Prescription Opiate Litigation [Member]",
        "label": "National Prescription Opiate Litigation [Member]",
        "terseLabel": "National Prescription Opioid Litigation"
       }
      }
     },
     "localname": "NationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NativeAmericanTribesOtherThanCherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Native American Tribes Other Than Cherokee Nation",
        "label": "Native American Tribes Other Than Cherokee Nation [Member]",
        "terseLabel": "Native American Tribes Other Than Cherokee Nation"
       }
      }
     },
     "localname": "NativeAmericanTribesOtherThanCherokeeNationMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NewYorkOpioidTaxSurchargeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New York Opioid Tax Surcharge",
        "label": "New York Opioid Tax Surcharge [Member]",
        "terseLabel": "New York Opioid Tax Surcharge"
       }
      }
     },
     "localname": "NewYorkOpioidTaxSurchargeMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NoncontrollingInterestDecreaseForExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "label": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "negatedTerseLabel": "Exercises of Put Right",
        "terseLabel": "Decrease in noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseForExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestDecreaseFromReclassificationToLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease from Reclassification to Liability",
        "label": "Noncontrolling Interest, Decrease from Reclassification to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromReclassificationToLiability",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestIncreaseDecreaseDuetoOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "label": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "terseLabel": "Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDecreaseDuetoOther",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price",
        "label": "Noncontrolling Interests, Put Right, Exercise Price",
        "terseLabel": "Put right redemption price per share (in euros per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePrice",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePriceIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price Increase",
        "label": "Noncontrolling Interests, Put Right, Exercise Price Increase",
        "terseLabel": "Increase in put amount (in Euros per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePriceIncrease",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NoncurrentAssetLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-current Asset / Liability [Member]",
        "label": "Non-current Asset / Liability [Member]",
        "terseLabel": "Other non-current assets/liabilities"
       }
      }
     },
     "localname": "NoncurrentAssetLiabilityMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NotesAndDebenturesExtinguishedFebruary72018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes and Debentures Extinguished February72018",
        "label": "Notes and Debentures Extinguished February 7 2018 [Member]",
        "terseLabel": "Notes and Debentures Extinguished February 7 2018"
       }
      }
     },
     "localname": "NotesAndDebenturesExtinguishedFebruary72018Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_November2018CrossCurrencySwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2018 Cross Currency Swaps [Member]",
        "label": "November 2018 Cross Currency Swaps [Member]",
        "terseLabel": "November 2018 Cross Currency Swaps"
       }
      }
     },
     "localname": "November2018CrossCurrencySwapsMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NumberOfBusinessOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Business Operations",
        "label": "Number of Business Operations",
        "terseLabel": "Number of business operations"
       }
      }
     },
     "localname": "NumberOfBusinessOperations",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberOfInvestmentFundsThatFiledClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Investment Funds That Filed Claims",
        "label": "Number of Investment Funds That Filed Claims",
        "terseLabel": "Number of investment funds that filed claims"
       }
      }
     },
     "localname": "NumberOfInvestmentFundsThatFiledClaims",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberOfNationalBrandMedicalSurgicalProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of National Brand Medical-Surgical Products",
        "label": "Number of National Brand Medical-Surgical Products",
        "terseLabel": "Number of national brand medical-surgical products offered (more than)"
       }
      }
     },
     "localname": "NumberOfNationalBrandMedicalSurgicalProducts",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_OpenMarketShareRepurchaseTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Share Repurchase Transactions [Member]",
        "label": "Open Market Share Repurchase Transactions [Member]",
        "terseLabel": "Open Market Share Repurchase Transactions"
       }
      }
     },
     "localname": "OpenMarketShareRepurchaseTransactionsMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OperatingModelAndCostOptimizationProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Model and Cost Optimization Programs",
        "label": "Operating Model and Cost Optimization Programs [Member]",
        "terseLabel": "Operating Model and Cost Optimization Programs"
       }
      }
     },
     "localname": "OperatingModelAndCostOptimizationProgramsMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OtherAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Accrued Liabilities",
        "label": "Other Accrued Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PharmacyLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy licenses [Member]",
        "label": "Pharmacy Licenses [Member]",
        "terseLabel": "Pharmacy licenses"
       }
      }
     },
     "localname": "PharmacyLicensesMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, No. 18 O 455/17",
        "label": "Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, No. 18 O 455/17 [Member]",
        "terseLabel": "Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA"
       }
      }
     },
     "localname": "PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrescriptionTechnologySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment [Member]",
        "label": "Prescription Technology Solutions [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "PrescriptionTechnologySolutionsMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PutRightValueInterestRateSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Put Right Value, Interest Rate Spread",
        "label": "Put Right Value, Interest Rate Spread",
        "terseLabel": "Put right value, interest rate spread (as a percent)"
       }
      }
     },
     "localname": "PutRightValueInterestRateSpread",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "label": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "negatedLabel": "Reclassification of McKesson Europe redeemable noncontrolling interests",
        "negatedTerseLabel": "Reclassification of McKesson Europe AG redeemable noncontrolling interests",
        "terseLabel": "Reclassification of McKesson Europe redeemable noncontrolling interests"
       }
      }
     },
     "localname": "ReclassificationOfTemporaryEquityToNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ReclassificationofTemporaryEquitytoLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Liability",
        "label": "Reclassification of Temporary Equity to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "ReclassificationofTemporaryEquitytoLiability",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RedeemableNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Member]",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "terseLabel": "Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "label": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "terseLabel": "Maximum redemption value of redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestsMaximumRedemptionValue",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "label": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "terseLabel": "Shares purchased (in shares)"
       }
      }
     },
     "localname": "RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_RestructuringImpairmentandOtherRelatedCharges": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, Impairment and Other Related Charges",
        "label": "Restructuring, Impairment and Other Related Charges",
        "negatedTerseLabel": "Restructuring, impairment, and related charges"
       }
      }
     },
     "localname": "RestructuringImpairmentandOtherRelatedCharges",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RestructuringPlanRemoteWorkTransitioningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Plan, Remote Work Transitioning",
        "label": "Restructuring Plan, Remote Work Transitioning [Member]",
        "terseLabel": "Restructuring Plan - Remote Work Transitioning"
       }
      }
     },
     "localname": "RestructuringPlanRemoteWorkTransitioningMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments",
        "label": "Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments [Member]",
        "terseLabel": "Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments"
       }
      }
     },
     "localname": "RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RetailPharmacyReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail Pharmacy Reporting Unit [Member]",
        "label": "Retail Pharmacy Reporting Unit [Member]",
        "terseLabel": "Retail Pharmacy Reporting Unit"
       }
      }
     },
     "localname": "RetailPharmacyReportingUnitMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RevenueDerivedFromServicesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Derived From Services, Percentage",
        "label": "Revenue Derived From Services, Percentage",
        "terseLabel": "Revenue derived from services, percentage (less than)"
       }
      }
     },
     "localname": "RevenueDerivedFromServicesPercentage",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "terseLabel": "Canadian Dollar, British Pound Sterling, and Euros Sublimit"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "terseLabel": "The 2020 Credit Facility"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ShareholderDerivativeActionInsuranceProceedsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder Derivative Action, Insurance Proceeds",
        "label": "Shareholder Derivative Action, Insurance Proceeds [Member]",
        "terseLabel": "Shareholder Derivative Action, Insurance Proceeds"
       }
      }
     },
     "localname": "ShareholderDerivativeActionInsuranceProceedsMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfFloridaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Florida",
        "label": "State of Florida [Member]",
        "terseLabel": "State of Florida"
       }
      }
     },
     "localname": "StateOfFloridaMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of New York",
        "label": "State of New York [Member]",
        "terseLabel": "State of New York"
       }
      }
     },
     "localname": "StateOfNewYorkMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfOhioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Ohio",
        "label": "State of Ohio [Member]",
        "terseLabel": "State of Ohio"
       }
      }
     },
     "localname": "StateOfOhioMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfRhodeIslandMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Rhode Island",
        "label": "State of Rhode Island [Member]",
        "terseLabel": "State of Rhode Island"
       }
      }
     },
     "localname": "StateOfRhodeIslandMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TenderOfferNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tender Offer Notes",
        "label": "Tender Offer Notes [Member]",
        "terseLabel": "Tender Offer Notes"
       }
      }
     },
     "localname": "TenderOfferNotesMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeLargestU.S.PharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "label": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "terseLabel": "Three Largest U.S. Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeLargestU.S.PharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeNationalPharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three National Pharmaceutical Distributors",
        "label": "Three National Pharmaceutical Distributors [Member]",
        "terseLabel": "Three National Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeNationalPharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UKBusinessesDisposalGroupAndAustrianBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. and Austrian Businesses (Disposal Group)",
        "label": "U.K. Businesses (Disposal Group) and Austrian Business [Member]",
        "terseLabel": "U.K. and Austrian Businesses (Disposal Group)"
       }
      }
     },
     "localname": "UKBusinessesDisposalGroupAndAustrianBusinessMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UKBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. Businesses (Disposal Group)",
        "label": "U.K. Businesses (Disposal Group) [Member]",
        "terseLabel": "U.K. Disposal Group (Disposal Group)"
       }
      }
     },
     "localname": "UKBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UKPensionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. Pension Plan",
        "label": "U.K. Pension Plan [Member]",
        "terseLabel": "U.K. Pension Plan"
       }
      }
     },
     "localname": "UKPensionPlanMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_USPharmaceuticalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Pharmaceutical Segment [Member]",
        "label": "U.S. Pharmaceutical Segment [Member]",
        "terseLabel": "U.S. Pharmaceutical"
       }
      }
     },
     "localname": "USPharmaceuticalSegmentMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Piacentile v. Amgen Inc., et al.",
        "label": "United States ex rel. Piacentile v. Amgen Inc., et al. [Member]",
        "terseLabel": "United States ex rel. Piacentile v. Amgen Inc., et al."
       }
      }
     },
     "localname": "UnitedStatesExRelPiacentileVAmgenIncEtAlMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_VantageandClarusOneSourcingServicesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "label": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "terseLabel": "Vantage and ClarusOne Sourcing Services LLC"
       }
      }
     },
     "localname": "VantageandClarusOneSourcingServicesLLCMember",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of Deferred Debt Issuance Cost and Transaction Costs",
        "label": "Write-off of Deferred Debt Issuance Cost and Transaction Costs",
        "terseLabel": "Write-off of unamortized debt issuance costs and transaction fees"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts",
     "nsuri": "http://mckesson123.com/20211231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r149",
      "r200",
      "r213",
      "r214",
      "r215",
      "r216",
      "r218",
      "r220",
      "r224",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r316",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r149",
      "r200",
      "r213",
      "r214",
      "r215",
      "r216",
      "r218",
      "r220",
      "r224",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r316",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r71",
      "r73",
      "r147",
      "r148",
      "r325",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r0",
      "r154",
      "r159",
      "r236",
      "r495",
      "r496",
      "r497",
      "r512",
      "r513",
      "r579",
      "r581",
      "r582",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Adjusted balance, April 1"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r0",
      "r154",
      "r159",
      "r165",
      "r236",
      "r495",
      "r496",
      "r497",
      "r512",
      "r513",
      "r579",
      "r580",
      "r581",
      "r582",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Opening retained earnings adjustments: adoption of new accounting standard"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r0",
      "r154",
      "r159",
      "r165",
      "r236",
      "r495",
      "r496",
      "r497",
      "r512",
      "r513",
      "r579",
      "r580",
      "r581",
      "r582",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r0",
      "r154",
      "r159",
      "r165",
      "r236",
      "r495",
      "r496",
      "r497",
      "r512",
      "r513",
      "r579",
      "r580",
      "r581",
      "r582",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r324",
      "r363",
      "r475",
      "r485",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r684",
      "r686",
      "r710",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r324",
      "r363",
      "r475",
      "r485",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r684",
      "r686",
      "r710",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r324",
      "r363",
      "r413",
      "r475",
      "r485",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r684",
      "r686",
      "r710",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r324",
      "r363",
      "r413",
      "r475",
      "r485",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r684",
      "r686",
      "r710",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r72",
      "r73",
      "r147",
      "r148",
      "r325",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r228",
      "r229",
      "r387",
      "r388",
      "r685",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r228",
      "r229",
      "r387",
      "r388",
      "r685",
      "r698",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r53",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities",
        "verboseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r81",
      "r87",
      "r94",
      "r95",
      "r96",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r76",
      "r87",
      "r94",
      "r95",
      "r96",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r87",
      "r94",
      "r95",
      "r96",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r87",
      "r94",
      "r95",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]",
        "verboseLabel": "Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r44",
      "r84",
      "r86",
      "r87",
      "r665",
      "r691",
      "r692"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r94",
      "r95",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r83",
      "r87",
      "r94",
      "r95",
      "r96",
      "r151",
      "r152",
      "r153",
      "r540",
      "r687",
      "r688",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total Accumulated Other Comprehensive Loss",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r42",
      "r498",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r495",
      "r496",
      "r497",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r134",
      "r254"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r487",
      "r489",
      "r499",
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r134",
      "r249",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive securities (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r144",
      "r208",
      "r215",
      "r222",
      "r235",
      "r306",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r317",
      "r319",
      "r320",
      "r533",
      "r544",
      "r597",
      "r619",
      "r621",
      "r640",
      "r661"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r29",
      "r30",
      "r69",
      "r144",
      "r235",
      "r306",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r317",
      "r319",
      "r320",
      "r533",
      "r544",
      "r597",
      "r619",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNet": {
     "auth_ref": [
      "r26",
      "r693",
      "r694",
      "r696",
      "r697"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Net Assets",
        "terseLabel": "Net assets held for sale"
       }
      }
     },
     "localname": "AssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Assets held for sale",
        "totalLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r262",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r490",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r561",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Exit and other-related costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r27",
      "r51",
      "r136"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents at end of period"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Investments in money market funds"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r129",
      "r136",
      "r138"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r129",
      "r599"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r141",
      "r144",
      "r168",
      "r172",
      "r173",
      "r175",
      "r177",
      "r185",
      "r186",
      "r187",
      "r235",
      "r306",
      "r311",
      "r312",
      "r313",
      "r319",
      "r320",
      "r361",
      "r362",
      "r366",
      "r370",
      "r597",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r300",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingent Liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r303",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r151",
      "r152",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r40",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value, 800 shares authorized and 275 and 273 shares issued at December 31, 2021 and March 31, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComparabilityOfPriorYearFinancialData": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting any exceptions to the  comparability of prior year financial data with data shown for the most recent accounting period.",
        "label": "Comparability of Prior Year Financial Data, Policy [Policy Text Block]",
        "terseLabel": "Results of Operations"
       }
      }
     },
     "localname": "ComparabilityOfPriorYearFinancialData",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r90",
      "r92",
      "r93",
      "r106",
      "r653",
      "r678"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r90",
      "r92",
      "r105",
      "r531",
      "r532",
      "r548",
      "r652",
      "r677"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r90",
      "r92",
      "r104",
      "r530",
      "r548",
      "r651",
      "r676"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "auth_ref": [
      "r541",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]",
        "terseLabel": "Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r139",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r218",
      "r224",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r111",
      "r634"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r414",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross Currency Contract"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Cross currency swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r645",
      "r671"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r140",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r338",
      "r345",
      "r346",
      "r348",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt and Financing Activities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r143",
      "r149",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r350",
      "r351",
      "r352",
      "r353",
      "r612",
      "r641",
      "r642",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r321",
      "r350",
      "r351",
      "r610",
      "r612",
      "r613"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r336",
      "r350",
      "r351",
      "r595"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair values of liabilities"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r58",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on debt instrument (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r59",
      "r143",
      "r149",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r350",
      "r351",
      "r352",
      "r353",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price percentage of principal (percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Aggregate consideration of debt redeemed"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt principal redeemed"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r59",
      "r143",
      "r149",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r347",
      "r350",
      "r351",
      "r352",
      "r353",
      "r377",
      "r378",
      "r379",
      "r380",
      "r609",
      "r610",
      "r612",
      "r613",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Syndicated senior unsecured revolving credit facility term",
        "verboseLabel": "Debt instrument term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r334",
      "r609",
      "r613"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premiums"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate (percent)"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r502",
      "r503"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r406",
      "r414",
      "r416",
      "r460",
      "r462",
      "r463"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Cash contributions to the plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of plan assets to benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Funded Percentage",
        "terseLabel": "Percentage threshold of greater of projected benefit obligation or market value of assets (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r425",
      "r452",
      "r462",
      "r463"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Net periodic pension expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r134",
      "r263"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r553",
      "r554",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "U.S. Dollar notional amount, asset"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r70",
      "r73",
      "r74",
      "r563",
      "r632"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Fair value of derivative, asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r70",
      "r73",
      "r74",
      "r563",
      "r632"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Fair value of derivative, liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r73",
      "r562",
      "r564",
      "r567",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative, by Nature [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r578",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r559",
      "r562",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r553",
      "r554",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "U.S. Dollar, notional amount, liability"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r554",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional values of financial instruments"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r552",
      "r555",
      "r556",
      "r559",
      "r560",
      "r566",
      "r567",
      "r574",
      "r575",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated for hedge accounting"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r259",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is disposed of other than by sale. For example, but not limited to, abandonment, in an exchange measured based on the recorded amount of the nonmonetary asset relinquished, or in a distribution to owners in a spinoff. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Contributed to Joint Venture"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r261",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r20",
      "r258",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r262",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation": {
     "auth_ref": [
      "r5",
      "r18",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as defined benefit plan benefit obligations attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation",
        "terseLabel": "Reclassified pension liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r262",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r262",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": {
     "auth_ref": [
      "r134",
      "r261",
      "r266"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down",
        "terseLabel": "Charge for remeasurement to fair value",
        "verboseLabel": "European businesses held for sale"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r25",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r468",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson Corporation"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r107",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r166",
      "r168",
      "r175",
      "r176",
      "r177",
      "r181",
      "r182",
      "r582",
      "r583",
      "r654",
      "r679"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r107",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r168",
      "r175",
      "r176",
      "r177",
      "r181",
      "r182",
      "r582",
      "r583",
      "r654",
      "r679"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Loss) Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Reported income tax expense (benefit) rates (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r94",
      "r95",
      "r96",
      "r151",
      "r152",
      "r153",
      "r156",
      "r162",
      "r164",
      "r184",
      "r236",
      "r376",
      "r381",
      "r495",
      "r496",
      "r497",
      "r512",
      "r513",
      "r581",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r606",
      "r687",
      "r688",
      "r689",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r594"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Gains associated with equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r234",
      "r680"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gain (loss) on equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r585",
      "r586",
      "r587",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r585",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of information regarding the fair value of derivatives on a gross basis"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r336",
      "r350",
      "r351",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r462",
      "r586",
      "r623",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r585",
      "r586",
      "r588",
      "r589",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r336",
      "r414",
      "r416",
      "r421",
      "r462",
      "r586",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair value, inputs, level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r336",
      "r350",
      "r351",
      "r414",
      "r416",
      "r421",
      "r462",
      "r586",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair value, inputs, level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r336",
      "r350",
      "r351",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r462",
      "r623",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r585",
      "r586",
      "r588",
      "r589",
      "r590",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r591",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r561",
      "r566",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r615",
      "r618"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Lease and other obligation"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r253"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Estimated annual amortization expense, remainder of 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r250",
      "r251",
      "r253",
      "r256",
      "r635",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r253",
      "r636"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r250",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r253",
      "r635"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Period"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r73",
      "r414",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "verboseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r134",
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Pre-tax gain on sale of business",
        "terseLabel": "Pre-tax gain on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedTerseLabel": "Loss (gain) from sales of businesses and investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "terseLabel": "Net gain on settlement proceeds",
        "verboseLabel": "Claims and litigation charges, net"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r134",
      "r354",
      "r355"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on debt extinguishment",
        "terseLabel": "Loss on debt extinguishment",
        "verboseLabel": "Loss on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r239",
      "r241",
      "r621",
      "r639"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation adjustments, net"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r134",
      "r240",
      "r243",
      "r247"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill impairment charges",
        "terseLabel": "Goodwill impairment charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r108",
      "r144",
      "r208",
      "r214",
      "r218",
      "r221",
      "r224",
      "r235",
      "r306",
      "r307",
      "r308",
      "r311",
      "r312",
      "r313",
      "r315",
      "r317",
      "r319",
      "r320",
      "r597"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r559",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r134",
      "r260",
      "r265"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment, Long-Lived Asset, Held-for-Use"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r109",
      "r135",
      "r157",
      "r158",
      "r159",
      "r160",
      "r174",
      "r177",
      "r529"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income (loss) from continuing operations attributable to McKesson Corporation"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r100",
      "r208",
      "r214",
      "r218",
      "r221",
      "r224",
      "r637",
      "r647",
      "r656",
      "r681"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income (loss) from continuing operations before income taxes",
        "totalLabel": "Income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r144",
      "r155",
      "r208",
      "r214",
      "r218",
      "r221",
      "r224",
      "r235",
      "r306",
      "r307",
      "r308",
      "r311",
      "r312",
      "r313",
      "r315",
      "r317",
      "r319",
      "r320",
      "r530",
      "r583",
      "r597"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income (loss) from continuing operations",
        "totalLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r98",
      "r107",
      "r155",
      "r157",
      "r158",
      "r159",
      "r160",
      "r168",
      "r175",
      "r176",
      "r583",
      "r646",
      "r648",
      "r654",
      "r672"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in usd per share)",
        "verboseLabel": "Continuing operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r98",
      "r107",
      "r155",
      "r157",
      "r158",
      "r159",
      "r160",
      "r168",
      "r175",
      "r176",
      "r177",
      "r583",
      "r654",
      "r672",
      "r675",
      "r679"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in usd per share)",
        "verboseLabel": "Continuing operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r21",
      "r24",
      "r518",
      "r673"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Loss from discontinued operations, net of tax",
        "verboseLabel": "Loss from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r101",
      "r107",
      "r172",
      "r175",
      "r176",
      "r654",
      "r673",
      "r675",
      "r679"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in usd per share)",
        "verboseLabel": "Discontinued operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r172",
      "r175",
      "r176",
      "r550"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in usd per share)",
        "verboseLabel": "Discontinued operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r468",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r5",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r19",
      "r22",
      "r23",
      "r24",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r145",
      "r506",
      "r510",
      "r511",
      "r514",
      "r516",
      "r519",
      "r520",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r146",
      "r163",
      "r164",
      "r206",
      "r504",
      "r515",
      "r517",
      "r682"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)",
        "terseLabel": "Income tax expense (benefit) related to continuing operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "terseLabel": "Taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Assets [Abstract]",
        "terseLabel": "Changes in assets and liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r133",
      "r617"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r177"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Restricted stock units (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r99",
      "r202",
      "r608",
      "r611",
      "r655"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r137"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Accrued unpaid interest"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Forward starting interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r238"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory, LIFO Reserve, Period Charge",
        "terseLabel": "Credits associated with last-in, first-out inventory method",
        "verboseLabel": "Pre-tax credits related to LIFO accounting"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r28",
      "r65",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory impairments and excess inventory"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r47",
      "r144",
      "r235",
      "r597",
      "r621",
      "r644",
      "r668"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable noncontrolling interests, and equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r57",
      "r144",
      "r235",
      "r306",
      "r307",
      "r308",
      "r311",
      "r312",
      "r313",
      "r315",
      "r317",
      "r319",
      "r320",
      "r534",
      "r544",
      "r545",
      "r597",
      "r619",
      "r620",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities measured at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r262",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r37",
      "r642",
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Amounts outstanding under facility"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.",
        "label": "Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases",
        "terseLabel": "Committed balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Uncommitted balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "netLabel": "Outstanding notes (up to)",
        "terseLabel": "Syndicated senior unsecured revolving credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r54",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r61",
      "r292"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Award payable under proposed framework"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loan",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermCommercialPaperCurrent": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Long-term Commercial Paper, Current",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "LongTermCommercialPaperCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r37",
      "r335",
      "r349",
      "r350",
      "r351",
      "r642",
      "r663"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Debt outstanding",
        "verboseLabel": "Carrying amount of liabilities"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofLongTermDebtisRecordedatAmortizedCostDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Less: Current portion",
        "verboseLabel": "Long-term Debt and Lease Obligation, Current"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r59",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Total litigation liabilities",
        "totalLabel": "Total litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueCurrent": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Current",
        "verboseLabel": "Current litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Noncurrent",
        "verboseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in loss contingency liability.",
        "label": "Loss Contingency Accrual, Period Increase (Decrease)",
        "terseLabel": "Pre-tax expenses related to estimated litigation liability"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Charge recorded related to Company's share of the litigation settlement"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of defendants named in a legal action.",
        "label": "Loss Contingency, Number of Defendants",
        "terseLabel": "Number of distributors"
       }
      }
     },
     "localname": "LossContingencyNumberOfDefendants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Complaints filed against the entity"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r64",
      "r144",
      "r235",
      "r306",
      "r311",
      "r312",
      "r313",
      "r319",
      "r320",
      "r597",
      "r643",
      "r667"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Payments to noncontrolling interests",
        "negatedTerseLabel": "Payments to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Ownership percentage (as a percent)"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r64",
      "r110",
      "r528",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r129",
      "r132",
      "r135"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r24",
      "r88",
      "r91",
      "r96",
      "r102",
      "r135",
      "r144",
      "r155",
      "r157",
      "r158",
      "r159",
      "r160",
      "r163",
      "r164",
      "r174",
      "r208",
      "r214",
      "r218",
      "r221",
      "r224",
      "r235",
      "r306",
      "r307",
      "r308",
      "r311",
      "r312",
      "r313",
      "r315",
      "r317",
      "r319",
      "r320",
      "r583",
      "r597",
      "r649",
      "r674"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r88",
      "r91",
      "r96",
      "r163",
      "r164",
      "r537",
      "r547"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests",
        "terseLabel": "Net income attributable to noncontrolling interests",
        "verboseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "verboseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r381",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated for hedge accounting"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which entity segment operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r208",
      "r214",
      "r218",
      "r221",
      "r224"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating profit (loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment operating profit (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r218",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r134",
      "r265"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Goodwill and long-lived asset impairment charges"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r87",
      "r94",
      "r95",
      "r97",
      "r600",
      "r602",
      "r606"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r85",
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r77",
      "r84"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Unrealized gains (losses) on cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "verboseLabel": "Gain (loss) from net investment hedges recorded within other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r89",
      "r92",
      "r94",
      "r95",
      "r97",
      "r103",
      "r376",
      "r600",
      "r605",
      "r606",
      "r650",
      "r675"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r89",
      "r92",
      "r530",
      "r531",
      "r539"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Less: amounts attributable to noncontrolling and redeemable noncontrolling interests",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r89",
      "r92",
      "r530",
      "r531",
      "r539"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss) attributable to McKesson"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r82",
      "r84"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "verboseLabel": "Other accrued liabilities, noncurrent"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Settlement payment"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r116",
      "r119"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Share repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "negatedTerseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG",
        "terseLabel": "Payments for purchase shares of McKesson Europe"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r127",
      "r275"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Payments for debt extinguishments",
        "terseLabel": "Payments for debt extinguishments"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash, cash equivalents, and restricted cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Payments for property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireSoftware": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Acquire Software",
        "negatedLabel": "Capitalized software expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireSoftware",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r413",
      "r415",
      "r421",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r462",
      "r464",
      "r465",
      "r466",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r440",
      "r443",
      "r447",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r466",
      "r467",
      "r481",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r39",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r39",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r39",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r29",
      "r49",
      "r50"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt issuance"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Proceeds from Divestiture of Businesses and Interests in Affiliates",
        "terseLabel": "Proceeds from sales of businesses and investments, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from borrowing by issuing commercial paper.",
        "label": "Proceeds from Issuance of Commercial Paper",
        "terseLabel": "Proceeds from issuance of commercial paper"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuances of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r120",
      "r494"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised [Abstract]",
        "terseLabel": "Common stock transactions:"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for the settlement of litigation during the current period.",
        "label": "Proceeds from Legal Settlements",
        "terseLabel": "Company's shares of legal settlements"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r121",
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings under facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r122",
      "r126"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r24",
      "r88",
      "r91",
      "r96",
      "r128",
      "r144",
      "r155",
      "r163",
      "r164",
      "r208",
      "r214",
      "r218",
      "r221",
      "r224",
      "r235",
      "r306",
      "r307",
      "r308",
      "r311",
      "r312",
      "r313",
      "r315",
      "r317",
      "r319",
      "r320",
      "r530",
      "r536",
      "r538",
      "r547",
      "r548",
      "r583",
      "r597",
      "r656"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r32",
      "r33",
      "r264",
      "r621",
      "r657",
      "r670"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r41",
      "r48",
      "r621",
      "r669",
      "r695"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r87",
      "r94",
      "r95",
      "r97",
      "r600",
      "r604",
      "r606"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified to income statement"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Redeemable noncontrolling interests",
        "verboseLabel": "Carrying value of redeemable noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "terseLabel": "Repayments of commercial paper"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedLabel": "Repayments of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r246",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r138",
      "r638",
      "r664"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r27",
      "r31",
      "r138"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "negatedTerseLabel": "Less: Restricted cash at end of period included in Prepaid expenses and other"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r273",
      "r275",
      "r278",
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring, Impairment, and Related Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r274",
      "r277",
      "r284",
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected total pre-tax charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r134",
      "r272",
      "r281",
      "r284"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring, impairment, and related charges",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r274",
      "r275",
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r275",
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r275",
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r275",
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringSettlementAndImpairmentProvisions": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss.",
        "label": "Restructuring, Settlement and Impairment Provisions",
        "terseLabel": "Restructuring, impairment, and related charges recognized"
       }
      }
     },
     "localname": "RestructuringSettlementAndImpairmentProvisions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r43",
      "r381",
      "r498",
      "r621",
      "r666",
      "r690",
      "r692"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r151",
      "r152",
      "r153",
      "r156",
      "r162",
      "r164",
      "r236",
      "r495",
      "r496",
      "r497",
      "r512",
      "r513",
      "r581",
      "r687",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r440",
      "r443",
      "r447",
      "r448",
      "r449",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r440",
      "r443",
      "r447",
      "r448",
      "r449",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r440",
      "r443",
      "r447",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r481",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r440",
      "r443",
      "r447",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r481",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r199",
      "r200",
      "r213",
      "r219",
      "r220",
      "r227",
      "r228",
      "r231",
      "r386",
      "r387",
      "r634"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Segment revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r87",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r446",
      "r447",
      "r450",
      "r451",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r5",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r19",
      "r22",
      "r23",
      "r24",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Assets and Liabilities Held for Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of computations for basic and diluted earnings per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r168",
      "r172",
      "r175",
      "r177",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r250",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of information regarding intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r245",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r245",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of changes in the carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": {
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.",
        "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]",
        "terseLabel": "Schedule of Estimated Accrual Liability"
       }
      }
     },
     "localname": "ScheduleOfLossContingenciesByContingencyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r284",
      "r285",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r279",
      "r280",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring, Impairment, and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r275",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Asset Impairment Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r208",
      "r211",
      "r217",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r208",
      "r211",
      "r217",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r195",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r215",
      "r216",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r224",
      "r231",
      "r277",
      "r286",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r195",
      "r197",
      "r198",
      "r208",
      "r212",
      "r218",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r230",
      "r231",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segments of Business"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information, Profit (Loss) [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "negatedTerseLabel": "Selling, distribution, general, and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Service agreements"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance and employee-related costs, net"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r488",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r34",
      "r621",
      "r641",
      "r662"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r11",
      "r195",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r215",
      "r216",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r224",
      "r231",
      "r245",
      "r268",
      "r277",
      "r286",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessReportableoperatingsegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r141",
      "r144",
      "r168",
      "r172",
      "r173",
      "r175",
      "r177",
      "r185",
      "r186",
      "r187",
      "r235",
      "r306",
      "r311",
      "r312",
      "r313",
      "r319",
      "r320",
      "r361",
      "r362",
      "r366",
      "r370",
      "r376",
      "r597",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r63",
      "r94",
      "r95",
      "r96",
      "r151",
      "r152",
      "r153",
      "r156",
      "r162",
      "r164",
      "r184",
      "r236",
      "r376",
      "r381",
      "r495",
      "r496",
      "r497",
      "r512",
      "r513",
      "r581",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r606",
      "r687",
      "r688",
      "r689",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r184",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r39",
      "r40",
      "r376",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of shares under employee plans, net of forfeitures (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r39",
      "r40",
      "r376",
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of shares under employee plans, net of forfeitures"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized repurchase amount (up to)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Authorized amount available for future repurchases"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r39",
      "r40",
      "r376",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (in shares)",
        "terseLabel": "Share repurchases (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r39",
      "r40",
      "r376",
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock",
        "terseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r40",
      "r45",
      "r46",
      "r144",
      "r233",
      "r235",
      "r597",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r95",
      "r144",
      "r151",
      "r152",
      "r153",
      "r156",
      "r162",
      "r235",
      "r236",
      "r381",
      "r495",
      "r496",
      "r497",
      "r512",
      "r513",
      "r527",
      "r528",
      "r546",
      "r581",
      "r597",
      "r600",
      "r601",
      "r606",
      "r688",
      "r689",
      "r720"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r142",
      "r362",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r381",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r607",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r607",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r607",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and trade names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax": {
     "auth_ref": [
      "r598",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "verboseLabel": "Derivatives used in net investment hedge, gains (losses) gross"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price of shares repurchased (in usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r62",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r62",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Ending balance (shares)",
        "negatedPeriodStartLabel": "Beginning balance (shares)",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r40",
      "r376",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Common stock repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r62",
      "r383",
      "r384"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury shares, at cost, 125 and 115 shares at December 31, 2021 and March 31, 2021, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r376",
      "r381",
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "terseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r274",
      "r275",
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r501",
      "r507"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "verboseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "terseLabel": "Discrete tax benefit recognized due to statute of limitation expirations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "verboseLabel": "Unrecognized tax benefits that would reduce income tax expense and the effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r167",
      "r177"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in usd per share)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average common shares outstanding",
        "verboseLabel": "Weighted-average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r166",
      "r177"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 21
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429468&loc=d3e288-107754"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2599-110228"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=d3e5291-111683"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r712": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r713": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r714": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r715": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r716": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r717": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r718": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0000927653-22-000017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927653-22-000017-xbrl.zip
M4$L#!!0    ( ".-0E1=WT09]G,# &OZ*0 0    ;6-K+3(P,C$Q,C,Q+FAT
M;>R]6W<;1ZXV?+]_1;Y<OYK4 76 UTS>Y=A.)GM\VG:2>3,W>P%5*(N)1&I(
MRK'GUW\HZF#+=A(?*'4WS<DD$L5FL[N?IX 'J"K@K__WQ?'1%\]EN9HMYG_[
MTO[%?/G%__WZK__?P<'_^^;)_2_N+LKIL<S77]Q9"JVE?O';;'WXQ3^KK'[]
MHBT7QU_\<['\=?:<#@XVG[FS.'FYG#T[7'_AC'-OO+F\Q:: BZD<6)_M 31K
M#G+.[0 \5"R%0T'\/\]NQ1*RI<0'D9,>1CD?9 CQ@" [+SECJO!_ZBT@QQ!#
M<3GKYPOJ<1$DM]"0?,7-UQZN]>[T#N>K6[,7Z[]]>;A>G]SZZJO??OOM+R]X
M>?27Q?+95[/YT6PN_7:_6B]IOFJ+Y3&M]7%\I3=A#HP[L.[+\Y.<K@Z>$9U<
MGJC1BC<G.7^C?\0>&'O@[<5'7JQF5[[W-[_Y@#/&?O7_'MQ_6@[EF YF\]6:
MYD4N/Z57-WOW]>HG_5=O'G]<?KT\6G^7U6HQM\[_I2R.-]>DO]O7SUU?G?SU
M$\>OSM[\\O*A_=XU6/_:@WMU^/I@)>7*9_3U7YXMGO_A8[;AP.37GYD>^NN[
MGII%Q*\V[UX<6N6-.[GX/GUC<^<7!ZZ6Z[=ATS^^ [+9:@'.IC]Z_&='7'S@
MK<N]>G1_FVEU =;OWUBGZ\4YR^)TOEZ^?/?-G;_YZ@9O'='\V=^^E/G!CT^_
M5-X+U:__>BQK^J)__$#^?3I[_K<O[RSF:QW-!S^\/-&+*6>O_O;E6EZLO]I\
M]U=?_]=__==?U[/UD7RM-#JXH,Y?OSK[VU^_.CLS+^K+K_]:9\^_6*U?'LG?
MOJRSU<D1O;PU7\Q%OW_VXE8_4)9GO\YJE?GF5WW_H5J4Y:R<??V+]1-I?_MR
MQJ6!Q$J2LD!U,3O&D*M#QBI0W/_>[9=B0'%Z1><Y'?>OEMFM>W.]OI=W]&Z6
M=/3]O,J+?\C++[^853UU]3^]Y+N+Y_?=D^<_^P>G]9=[S__U'?[RZ)<GAP^.
MOS</?_GIEP>_/(,'_WGRZ\__.3I\=/>9>_C=C_"O7WXZ?O3/>__YU]VCP_O^
MX='/_UF8GW_X[]G#NS_;G__S/3RZ^\#\Z[L'X><?GL'#7YX</?KN9_NO7XX.
M'[C_"3__E,U]]Z^7/_^SQ(=WCWYY</PS//SNI]G#7[[7GS^:!^[;XW_]\NW1
MO_YY+SRZ^Z_C!\?WX,$_?WQ>O_MVQM_]&!^X'_WFNGYX]N+G'XZ.'MX]//SY
M/X>_//S/_[QX\-W#F7ZOUVMX\;.[=_Z9G_2[POQ?/RS^\Z\?BGOXSP<O'MW]
M]O#1/W\TC[[[]I='>OS#N_=^^]G]M]YCU?O]]A>]QO_<_^'[]8.GYL7]'_['
MZS,P_^N,#]P*'(AIX0"RFMV<?#UP/B= +"F$^N771O^'+L7@__K5%5"O$^,[
MI\NE OSM;%7HZ&>AY;UYO:M.Z<LOSDR)?L.+]:VJ?SDXUJ\]/*BTI\"?4L H
M]%<I@"':6M7S44(X  CV()N6#T(1MJ0< ,7E:S5KW2S<&/H72N05_-_J7U9[
M@/\,X!<*[LO[/]SK()N'>D\/;_]O04,E"!]8M IQS>D +8>#H*ZXE5BM->W+
MK[N&&PSAQWK^1=UC_)X8S][".*@Z+MG0@36FJMA.BG$4.,@M^=;U=$OYRZ__
MYR8M^&V%MVX@/J)G>U3_'-67;Z&:&R9$[PX4"G\ [-L!-G72,80@*)QK4/W5
MZ&@E;P'[U54IMI0FZE"+K-XA(+MDO;7:Q"8*_1<;R7UKK;+Q;U^N9L<G1UW+
M;OYVN.S,>%TK_N7%2B7"7[^Z>HJSKW_UG>>7L%J<+C>O-@'/K7.VG5'C8]AV
M<2+9",*+5[/:7[>9++_87)"\,T*Y\_T_KDJ;-S_\]<6?KI[]9&.J+EYI7+9<
M=UWR]5E@ 1I;7'SNU7N7EUE?'6K=@;>OON+LG8O7%U_RU94']<[G!JZD*(S(
MAB $I%#%4RTUQQ:EU@&>V_GMR[,^^L]>5OVR%R='LS);/Y!CUJ^H,WWW+ ]Q
M'D[?>KK69] _<^>(5JM'[>EZ47Z]_6*V^O+KBT/N+(Y5[FW>.#O/7[]ZY^DO
M']WE54P"S,C1BP>AT"J88M#:'"H:IW:\Z(C?#3#5?MRZ;8.:N<5:5G=/1>\E
M["*<.4MK6#P:%$!'.:-A4\462H04=PG.Z,)K<,9=A%,?:5/WRQB34X]$5$-U
M3:J.S):#SSL$I[=7X,1=A!,R-FCBV2& QKI43(G!H1?;K6_\W^]')#3.4L#K
M=SR!BW?>[PF<SF=GM[\Z)!5DEW=V++0Z7<K7YP!LWKPXQ<5[%Z_[.=[Y1(N0
MH18UY&@-LH2<3$[.!(JQ@A1S-D T1!FSAK/F)IAXB</I1C]??=#G">=;/SZ]
M^\$8-&*"&-!'&\!@X%"!*;,WE '/C92YP,",$0/S_AB8K5F#D(O$ A9RM* /
M#K-IT5,PD?6^3#M[;A?&?:3/[;VMZ"<]M]>Y^UB63[NQN'P6=?9<[^'U0S<A
M*:T7RX^D^5N?[W^\*_/%\6S^KM.^KPF[<HJOKE[]GXTR:B4;YWQFT5%6=8#9
MW!R2N*B1:VIGOL/X49#DBN\P_J-]QU7OZ1%CE&2KT_$B+8-K(8A/*;;F0SI_
M NC-Z#70O7^?]OFDQ?')8JXO5S<8<EZ%!@^\V0(T&7PD]I9L,^!2(H,IEQ),
M=I!3C3L#S>U:9WU2F8X>TZQ^/[]#)[,U'4T$IF1,,^JD(7@$#!I$M%+ MUB;
M"Q9I9V!Z(FN:S:7>H^5\-G^VF@@^ED6'2U"K9BJ$Z#3NJU'CA!2*6)]A9_"Y
M7<KI\>E17_+S:'THRW[<4@[[V9[+]_.R.):)0%9)G5+&D+ $B#:1BZX2&5&3
M:&2'+-\/RXV@>3DEMQ1S"<DVB29YR*42.P*@H$;00DR\,^ \7,S[C2\71T=J
M[K[71Z!*=#T1E-A2]=XH.ME#\8G4#%+SUH,OI=9R<R@-]00*I&"2R3&  T#*
M"3$0)([)6TXT0!9C5W34(*F6JZ*+]2%'M)FS 8WOD:.I,41C).F?</? O697
M,3RDQ;N$QI/X8J :)K549")41==S*;L'Z4TYF.&Q=9R=C=67X!!L##D$VV(T
M+;D:-9K=/6P'$>/# UUJDL 4$V0 2#'W"#@DXJBQ5Q"[>T!??U0\/*K!9C3"
MC4&B LLYB(AMI8J"FHV]N2FV:P;SYI*$GS#W=W7 %6I OIE4+9A&F7R"DFJV
MN;(KL#/0#),DW!9,KI9HQ#H72X56&DL%*CG9(. !S<[ =,-)PFWAPP8T)HR*
M"5? J!ZL5!<20"Y(^G)G\!D^2;@MR#! #55JRFKY;+%$C.R:$0=&'17N#&0W
MF23<FEO*SF! LHX82(,YT>@N6^,*BX]F=]S2($G";:%D;$[5$)OB&# Q62^<
M8S,HDMC6#4IF!U*Y-Z7KS/:RET)&,)8FO@(44L%0LL_-2;2^Y+8ST RAZ[8'
M$_E<HXGH<BO OG)LKKC,'#$%:65G8+I17;<]?)";5UBL16>AUH((K%$2. BJ
M'[+9&7R&UG7;@RPDD[/)U;>B.&72.%:'$GI7U%-9V1VG='.Z;GO@Q$H!;;*0
M00/8QA0:8/# +AF$$'<&G %TW?902JR!J[-47(G0:B)V'D,B:A%%(Z2;0VFH
M)^"P4@%C0K8%2#6NL:'9YARIG[98!U@^O2LZ:O@UWLIECKD:#Z6'+14%#7+U
MB9+SS'[WP+W)R=]!(,W&.'1!@T\#8&KFC&(B8PA9_?_YEI.=@G20R=]!L)7@
M Y.PJ=5#*A535@DA,7*#%NT.8CO\Y.\@0.NPK4)HG!."XCU&[Y-MM@(ZUUK:
M/:!O>/)W$%1M\4%J:8G4X9)&9KZ!K<VK@ RFU;-4[BZ >7-)PJUEV57"Z^ R
M''(WI95R2V*"35&U;N&P,] ,DR3<%DP H.%QB,'% J'G,U*LWA7%*]?H_,[
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ML:G.3@C,)W*R6/:=IAVOUQ, :YH=G==!?GGEH#\!]+V_>:SE>8;@$YK>Y[0
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M\[N+HR-:?K.<K6>KP\>+TWF]6)5%\]HGFE9/3_EH=CS;VO#8WH@<BZ4FTTS
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MJ\_'9Q_H;Z[N2E.=4;^1N?YR#3IC!.DC-"E *UFB!8G,5'N+IY90R,40)N0
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MRYB$!D-MJB%K=H18FRH&4\5CS&5">9KQ",G;^JC"#56TOOD42PJHA@V- &4
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M,=0@]/B. DEVA:=O3O9$'92HV[*H 1*SPPQ5/! "*HTB(^66&MLZ@0AOU$F
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MR?M.QW;;_E+J=4MWK-\_]GZPV7&;SC6'#I?TZJUN"I^*O'!MBBXC?&^>GBO
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MIKQ='K&EIPT?MI";WJ/<7!>?&0M$!"3C+L4HH Y%A5=$0Y9*:B!C!D*4W%P
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MGZXX[76_IOLLJ*-L[#3?C9\?L-KW+WBW<=BJ;>VB@T_;Y[M;QZW=QIOV;FE
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M^ST\9%512I^<W#:=Z_E^?_2?=W$ :"&)[5&&SO?/ BIIH'% 28(!5= "0Z0
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M#@I'[$<B^^WY_J!W9@=EO^758J=]JIN]Y*X?-K3?2Z7VDDO_.'5BR[KAT@@
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MSG1GT!S$NWP=-K.(?VB-?T_4VNJF(Z)^L6FZ9X-B5_>^^$&QU^Q_R7RY-$+
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M=;/SKMOO[Z4:]-XUNN]^+,Z^'PQ:96W>3%WWH:[I<BF<TJA0^@ 4) K0:%@
MY4( PBFLG><2N6AHB$?0UD]"IQ;@8&3)T3L#W\'CT)NUDIE!>]*'@*74&CD%
M(BDS0(-S42%!#@B"#1)2A&!T:6SP#.\EA?<,? AY<WX^!$^Z"SQV7ACN(X)U
M0C B0'L$ 6/>2.61%M:F^A4DXW<Y\3L#9T'>GBL"[NFJ#($@2!Q 7*<(!H:!
M=E( XWQ &$I,#8J:]VK4S:H,[Y<:HI 2DKXU6ZVBV3[5S5Z"R]AE\,)"$.::
M2C%:A9T?BY!([3IOA>:Y=^"[[W4S9=V'LJ8++W!*.(%> 2@H A0Z#HS6"@BN
M>!!,2^=QJHQ?]N%Z;-A5/L6H+HYGGQZ1<?R$.)[T#!!/13 1O9@D' M.@((V
M (\1L]!RYVS(.'X!.)Y]RD/&\1/B>-(_("D*&!$+H/,&4"H4D$8AX"24+,3]
MV028<;RH.)YK5,%M0,Z O0]@)VU^Q"2'F!" 2 KKHR*YY&$T_&WD7HV59:D@
M+9\NR9VC!*X-[[8.K$A.=F!-?YE;/YK^H'=F!V>],I7ATD\PS%_H#3UO4TZ#
MRT[OV1?Z)+Z#MOVR?FUM+CDNKDM]<.Q[(Z_HZ^'29-:[!^O5I^LP,&J0]E%-
MX4B)R'HFJBD.1G,#.J@)L9BY=(SQF/IN^12CPLB=F;<@(_>)D3OI*! ,Q?^3
M$A"6])6H00(I+ :"Z91Q'2U$JB)RV6/"&C-T*PS=F3D(,G2?&+J3O@&LI!*I
M]X74U@.*+ 1&AA233"&!6'IL0FHIF7?=)87NS%P"&;I/#-U)+X$3EBGG),!4
MP]2OP0"EJ0!QZ6!@R)C(OA&ZXC&I?XL<%[ 891<;W8%N%=U3G_)P.D<S*5"P
M5&5:YEJZH#Y>EU%^5#_'.LV,T::K%/!H*WA#HAU!RD9<"J8*39'@N(*4.B48
MI&65 @(?[_JL1G&F&9Y=O%C4SSS,(*/^*5$_W824<<MU "(@"6@T&B/J*0("
M884Q=RJD(@8(KC+TF CF#/LE@_W,HQ(R[)\2]I.>!\U$8-R[N-EC%C=[ZH%!
MS@&)";4>(6*(2'E'%#XF[RBC?LE0/_,0AHSZIT3]I-."4\FPD01XYBV@W H@
MH=5 .LX%-@P+F)J_T%4%9U"R:&&+,2YR(XD?@"J:'=MM^^*W5K??GUJ[^_A@
MEXKM*N'/V"F7)@=KW;<#3F,SL5GIN*AMV8OZUH?/4@;$<#1="#0*4)_ZYB(M
M@+<"(>ZQHQ*N;&"5NT>\!'17HZS"C3C/:LT,2>#B.@DX9RA35 /B%(YZ#0M
M6R6 B 1@0\ P4G9*TR3\,2WM,@,L  -4PH61<?\TN*]-;/[0Z^"\9,!P%'$?
M# 2*8P6,,%0&%74TE_K?K=(;"BOG[7_YP%^-L@V9!IZ:!B:V?V-"4)8I(!QD
M@!KBHPT@*/"1$!3%D<TY2Z4=(7O,R65N,?'\SHP4MS1R9#R\QN/B9I?-U5F1
MYK[6[72OL]F/4K69L^[!6=LW^"U(4CH)T%(90+7&P-AHMW!#*%+(1J/%IM#/
MG!&ZO)B=?>A$QNQ,,3NA9T FH4+< 1P)%%#J Y"<6."UL<H*+(B)F&4T8W9Y
M,3M[IT'&["PQ.^DBT)9XC50 AB !J/(&*"<X(-!:[+@P5KJTSSZZZV0&;75!
M._NPA0S:F8)V8J.E3@?IJ 7&\-0PC5D@)0U I(HIV"%%44I&9M4';14*,<P#
MG,GI5410.F\&11QG'/=9LW^<\I%>6)^&N59>U,U./RV%[]<[V]=6H1ZVXM+D
MHD\S8;"=*?.>* @%I HXG)I(<9:J,%("(JU9JQ%CUHN957W**9[5Q?3LJS!F
M3#\7IB>T$BZ\L,1@8+DG$=.> 16Q'+42Y!U%$>YP=A49,Z8K?';XM"T;?H'N
MC.)[H7@J9@!&78JP:$PPSB.*36KOR#6P"BID/;2*X-2OH=*)VQF\U?$%Y WY
MV: \L2$+XH,UT@).'8M0A@%( C%P*NK>F#C.4E_U1=F0'^ JN.DK^<K97OD2
MXBQV(C_V?'\PKG_QPL(LYEKD8CSWV7?\D$WAPY3GQ8M@1- <($,UH!)!H#&/
MZI[P1!E,L6)D98/.(+\M'_54$: S=[AD@#X2H!-:&[)<>0,5B$MC <4X%<2W
M"E@JO(TZ7-+I5C8>5:XR [3" )UY!$4&Z., .NDA"10+([4#04$)J+)Q!X6I
MH*PE"J& >5RJE0U$,D*7%*$S=Y%DA#X2H1-;*(,$R6 D<%A2$!<<1QTW815:
MP@3G1AH6$<HKC= 77ZIAYVJ!AB+TNNT2ALW.62K?, HMZG;ZA?&AV_/C@@X#
M??[  I7+F/(U7]-]G-_U)B[>ZQ]K5_^Q='^5*S>\KI'6;?M\T--Q_IL=W;O8
M&?AVO];MI%'VNJU6&4<V9,I,D?>BR(]3;@#A!!.*6*!<JL^+ @0*:@,@@91C
M$1??X52?=[J\54X,73Z6J$9=B"?EBYQ@.D,RF8S\\-CIJ  #AG D$Z<"D/$O
M@&KGN>=4$F6']24>4R,S,\D",,E\'1V9/Q:"/R8]*M0C$35,!(CP"E",%)#(
M!""LU5;1*!TAM>A9Q7+Z6"*K(\M'(M6H4Y'I9%'H9#(/55%8]NIS-*DC@CB@
MO$, QBV&&2^5Y[JL=[&HZLC+C<,8>W@*XSL^- ?%;Z.0C(=5\'P9_NHG<NQ$
MQALYK/\:+D8FKGL1U\%T5HSVBB,%@2,Z-1O ',1-S #H6=S/D'#,BI4-3![3
M[RR?+%77(GIJU\H-B,UZR SA/.D6(=YPB@RPF$<]A!@+C&8&L+B\+IJXRI.R
M_!Z2T\W2JY:HFU%=J8B.O/_. K"3?@A,G4!,<<"89( R98%2R +!* T<26)@
M!"Q1/.^_BX/4"OD2\O[[M'">V'^QUI JPU/)RZA.>^. )"2 N,9,:BF=9B[M
MOQ ]VJV8HT&J$@V2(S\6(O(C7M$Z2U/ZOMM+?]@<#'I-<S;0IN4;W1ST,0-"
MM--%-86%0B,*C%4*T* "4!YJ('V()@KCA@68])M\R/("^&%18CX>QA19KYHA
MC4SH59J%:,EZ#:B(*A4ET@,CF0;0"JDDB_]XE,Y7D)@N];D0YRN91)8CW",K
M&<_ #M/!'-8;Y +0BKJD9# @XZX!/-46ZVA:.QXM&"ESRY&70!"+$LJ1M8RY
M\\BD]P8B*V@J/X1#-%8@QT I3P"6EA-% R,I0IVMPAO*G"Z$EO%2HSC*VJ>E
M R?.P,B'X]T5%T[9RJ3HAA3H\<+".JKCM-FZLC:7-%GS@WIHZ/-<LVDFK'<T
MY:*QP1BG;4HN%JD\AZ! !@*!)4H$3J4BSLVL9E,^BZHNO)^@3D>&]_/#>T*I
MD21HY:4"VK/4CIE&]89Z"9CBE$DHC+,VPWM1X5V-&JGW WH&]+T /54N%3,G
M/4K5>@@'%&F?6C$P$%?6:*09(RI:*8^),\\HKC"*G\MED5$\6Q1/=DAE/!I2
MB($0$HHI%<!P*X /PF/EK, \18I4&<4O/D D@F%< F08))(C02K@5'C?ZX;F
M8-CC.9/4/4CJRY1K@&EEL(46:"L$H-90H"FR0$+BB1$$$F)S],8+P70UHC>N
MHCN?A<P0^I,%S93QWFD+&$,PZB>< ^-Q-#50M!>AA\BDDH,YXN(% '^>$1=Y
M,W\PHB?]!@A:&@+2 ,ITNDE3&6YFXXXN$(K(IE((EZ(D'MW",8-Z 4!=#9=#
MWLV?"/N3W@8N"5:8 *F%28W2,#"$<""$--8Q3"0AP\B&7)]BH2(;KK@@])7X
MH6+0+3K7(HCB5<,0HH>EJ[P,W^K,?1%Q>2Z]JCD6=-9,=[)Y0[,1AX3E!ACJ
M"*#$46 ,U@!+3Y!#&GN9FHWD?-HEA?#,@Q@RA)\<PI.]YIE(Q@@"S$6-A5J%
M@/2"Q9^L40B2J'&RJ*P\)@8S0[C"$)ZY$R%#^*DA/.EKB+I3X)Q9@"E+,0HB
ME>=E!%@BL$#>(NYI:EB2M^$EQ?#,&Y9D##\YAB>[@E$AB)<(")M.  (B0".O
M@1041Q-)DB&&J[T/YQB%R1B%*3_!KOV/[_<CG%]W>Z?=89S/T[A\;N2YRLW8
M?SW1RR\/N<_ 37*+/_@:RV<&OQ>#;T_Y0A!F<64"BUJ8=8!2PB-Y"P507$ 5
MK"(!IR8)B^GQO?=13^:PS&'/$:$RP6'Y6&N&!#=9=AT9KCFC )'4Q4$8"(S0
M*=7%.>LL)AS#%*2"\6,,S4QRF>2J\]:5<:1E]KHG>TTYR8+!))U-,4T#H,I+
M(!W"P'H%M4_[D\%1/;OAK&J) W(R@2T[@54C\BAK:4_'<Y,9R$*B0!0%6'$$
MJ'0<F'08( G%'EJID2R#CS!\3'?D:@8?C2\9(X"69#?K\X8[W./*O)#X\JY[
MEMQ_8[3/X@EYE$LZRKGXT,O?FQWG.X-U@.1IM?:P;=WKQ-?HCWWJI[X7IZ'=
MCKM9_UCWIH/Q[N)DGVD\<[Y'U>_QA"&KBW$TM=5LG0V\>Q ,9LB3^1YSO<<3
M[BYWEG[7_#J^]^@6(%V_7NX[5W<B1-98^4+SP,ME$<F;F@_$=[B[EOP";.5E
ML8C?^]Y^4BEF>P:+'U&X-(YH1-VC@8WL8YCMXSO8QQ^G0]8U0T9Q!:17 5 *
MHVG,96J9H$FTF*V#Z10#KL$99-HND*<O<U25WNTA'/7(,];,47/DJ,D$0H>I
M,E0!&]</4"-28ROF ,+2<V@A<]*E2B!K< 8)A)FD,DG-_&ST%HYZY!DISM3T
MW-0T>8RJTUFIT0I@#A6@EGF@7/Q5&:@A#3S^E:ULT#7YZ)9[F9XR/3VW#O7(
M$]"L0\V1J":;<UM,L.4($.93AU!!@%':IY+K!EEEN Y)A\)K6%99AZI"J87%
M<-AMW=QLXF:7W9(GC\W%Q?7P^K93W/>+ZO29$^_"B0=3OB_'16#8(\"@HH!B
MK8$B6$:[DGMC.8;>HER=_@6!_O$^HPSZRH%^4A%RP5EH!4 6"T Y84!!3 !T
M$&J!-;%$9M O*N@?8N4\W@LS@YKVV=YY',RG&E6PH()Q&&AL2=S;4_5HI!3@
M0HAHQAH,N2C/M2J=09[AO3!.C SO)X7WQ"ZNE%;>FU1I+:6O<"Z %LZ!( W%
M&'$5."OA_5*;6#S$FW'5=\'HW#P7C>Y MQX66I03=)8Z0>>YPY'&D=;CYXXH
M/+/WO=C;3CM>C":4<@A,P![0 "&0*/(XB_:W4R($"6<6=)03#S.O5>"M*Q7"
ME'EM1KPVZ5M200?$5&0SQ))#V0*#*00$\@ 99<2FI.H9!2IE8LO$5H&WKD#8
M4Z:SV=#9I ^-4 ^%)1"((*.17?9Q)IB X A16IM@*$_!3>)%]6#+E+;LE%8I
M+V,FMQF1VV2%6<V$QLP"9"*O42(P,)9PX(C&Q%EDE13#@*AI=EL(7>W%I_C^
MI?M-^Y@$WQ=6:B&/<B'*5CS6LT]03B->$&UJR76F^:81E]M#/HV]ORXUW:J;
M,XDMYQ)@PBB@&CH0C4,+J.!.>4VED28G$6>&6CB&FF\2<6:HAS/4A+4GO*$:
M!0:4TA)0@P+0CAL@D1-,AF @X3F%.%/4B_>E9V)Z6F*::HQNA4+$4,"C!@PH
M\Q88)"FPD,95=2)^CLH$XNE.&3F!.)-3Q?6G^2809YIZ.$U-M44E$@OJ@5<(
M ZJ$ %)(!D)D+RR,<W'+R>G#"^N6R\G"BYPL?)7G<M;@X_GO^W1G=ZE)\!!9
M0$GJ9J8"!II1";A3CFAD+0PA9PV^(,C/.54X0W[VD)]0>1QEB<(18);!B'OG
M@9%* *4M%L$R1IC*D%]4R"]RHG"V:QX,\BGW"XMJFT,2"*\9H%!S( ,+P%CD
M3=+8N+4Y3?@E@+LJ:<(9W \']\0.3C"+-IF50);@Y@9&<,O4A]A*Q8TD1)&<
M))R3A'. ]@L(T'ZV).&2P#-WWXN[I]O'\Q"7QZ@ HLGE  W! :D#!003(C6Q
M7F"74X0SJ[UP5GNV%.',:@]BM4F-5",<U4X*$ \RFIL4 \.A  II0Y"QT?00
M.4$XT]HRT5H%@IHRF<V"S"9]9Q;+5,9% L=DBJET$A@B+="2.V,%9D*J,G1I
MNK-R3@_.A+:PA%8I[V*FMIE0VZ2>)K"-JQ*YS&D:K<]T(A"X!B%X'A!6FGNT
MK,G!XTMRU_@\RD4=915\YO/8FCZ5OW@'=!R5/O+7^L+WB^[9H#_0G?0ZN?_[
MB[['BR\.\:O^[\MY,'ZKYCHDB-D>F0 VJ:R.Z6ESR$ZUL[;QO7JX6AF[7[_D
MJ!]J+,]J[!W4V ]3ARB,:RD%IP!ZY 'U&@--@P;:2X*5PCZ@:*$CAM9X#F!;
M:B@_\IP@0_G9H3QAD6JI);,\  =] -2IE(##/2#4>ZF\\$R[!&6U]FAO6X9R
MI:'\2.=XAO)S0WG2;\ZU0M))"QQ*K3@Q"2 RL0)(6L8\$0;"<E=F:].Y=!G*
MRP3E1WJ%,Y2?'<H3N[)G C&L& A6$4 1"T A$W^% FK,(SL'%*',T=IT_'C5
MH/R$/K/%< G\O%[DS_CJKO4*%IVOGLLA,$54UT^U,EO=A:T^3L=4&A\-/\F
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ME%(M*M.^B(H860K"*26%%>"$I:7UJKAYZ]5U L-;#+VI %L!5E.:*), 6<?
MRFA3\AY$4B%QR2Q6@%U;@)7S "MBU,X#44IK GDGS7:U9$3%O *4BWDEN-*[
MSK#*-BL8;@P8+E.SA[F8::7,YC0-(!5W5@7%T&KI(Q,&+D;#6Z[94V%Q=>[&
M^0SMC&P6. #A,3D"/"J"#"G);)1S"%8"-TUS/'63YGCK!(D/]0#A8J@X]P0A
MH+7*6*FMEZ"81JYX0*0Q6ZTT7MTX;7&_H?51ZKE$8643=X8K$H2$K-0^$'2)
M$TC6F92DIE&7QE.+5&<S5;JRG,IR;HY;E>6L#2#VYELM(*(4QA!6&BR BI2@
MB)S0;.Y;)HUVD)J.3U3<I"9[Q<2*B6UYZ24@41DO-4M142W ^(".(P#*1!D#
MI5T]4VTWV,VQOT@]=<XZXJ(M)IT,^:?BZE(N&>8U#:ZI K_85:8ZNBK<K2G<
M+4,!'<,@!,TX9P1XH9&YB$DP <+[$/R]4< *?$L!W\&\+RM"HMYIHKW,P*>T
M)PA6$BIUBOGO+O^[M7.CVM3W"'EWW,']DD+^34&2>0"<;\O>)G#8GTQ.2AAQ
MJ3MTVA&Y*5_4B4?'@]&G&#MYODKUEV&<EGNR*99B?WIR6:CZ%0I^KY\/L"GB
MPW^^7J'F-2W+7J54I73/!I@'+:FF1LER%&/1:&LE@G9*"^8T_KG;%#NFE)&K
M53UN"$E!O1AV3\:%AN17&(6F/_'>*>8U]SP_&?NW.(G/,_Y5_K$$_^@]78CA
MLL(:Y8PE#!D0"(P1*V,@R@C!)9,>?"K%CE=4%[^-BGP;908V$APJA%<I52E5
M*3T<*2WCH-&.:Z4L,\Y04 *M4S0HJ2B-.O_)7H$/7>:IJ<3H=HG1PO$;1(E"
M<4&HBY: II)8#X%H2Z5W:!$M;.VLH&=8U>:*N55*US)!(U),V=[,;PHF2I/-
M4<VI1*4"1$^K"=I*I)UW@5O&DF4!,]*6]/'$%3$L)>*U95&YP#4-6SORQBUF
M;UV3[]C;W::^]5?3[294DKBL..45CX[C<-(4YM^4MO6WN0_5]N552E5*;7)8
M/PGO3B;3H](0Y'#TM6!JJ9>Z/SRMEMH@7@-X3[_!NY>E,>6D/XVOXOA#IC$S
MFO$R^M%?P^8I#>.HQ&(98O%JP;>MA:4T022TR!2LU00!#+&1&AFD3-*;K1W1
MIM;U+4Y!WFP<J6A?I52E5*54I52E5*54I;0^/LMJA;3+"EEP;_(4017C0RD9
M"80(Q%EM"5H3':6H/-JU,$-:$<S;9O?F<_S4Z&%G.NH,OPN7[_1_6(%_(P]S
MZI%;E5*54I52*YQ35?)MD7R54I52E5*54I726DMIF?!8+[BV5& 4GD*@#D%X
MI J"0"N<]TO[/;K]X6C<9"W/+*O=Z$M5KOC+>'2TVY_,4I?SH"87I2[_>Y;[
M7/T;R_@W^HNE&SR/ H$)(@5+!!P$XI+GQ,@HDJ$2K2O^#5,C93=3L5?MT*R*
M?4^*/>^X#"(ZK[(F:UIR S5(@CQRXK-Z@[#)L!#:KM@U)/,'JC[K9^N_ZV?;
MSUIU%#L_#4:3R8(L-_LDIYZW52E5*54IM<)A627?%LEOI)26(/FE,C-307C)
M+3 EC90L*463YD%Q,$N3_(9V//V6=>PWI.-9IAR].#U(A_CQW#)DSW$<A[7L
MV%+<_IP2^BER+Y35Q"KA"2#-W%Y90[0,T0J7K EB:X?1U@<E5)VNR%NE5*5T
MWUZPF[NW+ZC^4'?*N]TIY]W;BM&HN:6$L?P/<&E*GYE(E$6D(2$V.^4*NE)4
MO6X?[UVY<[MJ\]UJ\[Q/.Z&7VH1 (*MNUF8E"'H5"0BFC$R)(82MG467=MNV
MZAJ+^P,ES\JT C_VVI[@U0"**J4JI2JE5OBQUU;R2UF 04?I4&DP * SFV 6
MI4:7F:*4D2UO 1[Y]X_S-O:5(%[6H&%Z03#$WL?3S[R,(<:C<FOMY'!C:GGP
M=*%9,\]VH ?%B4[49GJ)EIB4/-'H,5G@P:&L]0+72?LW#O>KE*J4JI2JE%;B
M&5M5/'=E.6UF.0ON<!#:.M! T&E.@$5)G(B!,&G !V>]47IK!]I?K+.J_KT[
MQ:OJMUKUYWWG0D1G$%56>$H)6,\(>BV),LDX+;D"S*HO;.M5OP:%_P ,7L;C
MTP+7I;-<ULZC41G"R+^OT> M./RIY[F;+:7V/:/&.S^L%5BE5*74NC.761?<
MU;==.J<'R%<"]%TCD%>G(ZB&Q-4-B6Q$=.=\"$RHP%.(),1R5())$Q<IDD!I
MB$Y:$*8DEM:0N@U0VEMIE'9UC:TE+*^CL/.]T)SGVLK(",2@"&B?B(W6DHB1
MAV30.8-;.YK?)!6\JFQE0U5*K:K$48%UU< Z[U)U2GNFF21@6 96R8&@*1!K
M/ U2&A><:SVPWJH[=76>AWIGO;/>696TWEGOW,@[5Y35,^/%])P3RN;W_C#$
MX?0QL<>M(LHOHQ_@9-)/>3P-41ZESCCZDW&AK)UOFXV6ZORCINH5>C\^B:$S
MZ*/K#_K3?JSE^=MP/E]#<ZJ4JI3N6THU2^BA2KY*J4JI2JE*J4IIK:5T+^7Y
MFYCN<^.OOZWC/6^M'8Z>G=I@G^J9PA)G"MW#_6GWT$]GY?U>B#P/]$^67/ (
M0!3UI2"_- 1%4@1\-!X-6)_,S<(KJB:W6)-7FIU1-?E.-?G]]YKLD@&!3!.6
M@LOZ:Y 89TH346F<%U111ENNR>N5:Q'Z'\Z>??H(4NY_;(\7O9_W P5/<?*V
MDX?9S^,(DZ*X QS'L-WYQV48\3R.F]C%U6+%?N^7^9"!ITVN2!,XL'LVR+,O
MWST=ZQ=<H!47KH +W6GWZ7=1 Q_"K[]#^/=_!F_XX(-[-Q*OW_F/!X=/>/?S
M"WIPN)_GX+>_7[_[?=#;_<_[[FZ9HU[^QCRF@?ET\.)/--1E21KB*1<$(,:2
MS*F(<)91:Z0+#+9VZ"-8+%;1.9XUBVCR@8I,OP!-7I(/)2:G1DY5*54I52FU
MPFN^MI*_X]I:W].4+]SD&[Y2F%4U69:D)O,!C51P%F6R)!B9N07U2)P0@3BF
MK<\VBY9-%:Q:+GE]%'7C(+I*J4JI2JE*J4IIK:5TKZDQE4"NRK<U[_-.*+A/
M1A'DNB0<1DN,,(D(ZF+4(#53JNT,LA5QO&TN,-2TP:BQMBTXGZDGK55*:R>E
M979^T)+FW5Y)X  6C;96(FB7R0!S&J_?F*O9\]_.>LWO_?>D/_W4H%IE $LQ
M@!?3^6(#,G,U%:PDPOE P'!)C&6:@$A>!AXX>MC:8:VO,E@CKUN% RMOSU!Q
M8+4X,.]*QD@55=P3H9(DH( 3QW@BFH8L0@F AFXV#FRDSE:&5:54I52E5*54
MI=0F*=VM-[ERR5OED@M>928X:)_)I!3&E/AI2M ))(@^TTLC):/QO"[.;5/:
MM0NGOF5=UN?J\K]P@$,?)]N=W>CCD8OCCF#;G:*,-P]8=:-Q5D\R>\G'(HLW
MC$[<(';.7NOTANGH^'$1_F0TZ(?FXB:AXKG%>"4SED:7'$25[6QG9(R1)1]B
MMK$-97_N7['P7//P@Y/I9(K#,F,5 )<"P-].P>^;DKN&(4:IB)4L$!#>$Y.B
M)Y", .M!0ZG@R;5<4>?K%2G)/1^@WR<4M.W([A_WM 26$'V;\'&1-:X,'!<X
MXF5MDPXO:)M4$7591)TK8AY1>\H5(SHTB(J66#1(&(#QP6NG?5@!HZQX6O&T
MXNFY5KC'!"@2S0H(-&7=$QJ\#H:9X+B'N\;3-!H?X30/[./T\?#DB(31E)Q^
M;P7;)<%V_DQ8!/1:!T\X6$?*@1VQD7FB><R[*<]"1KJUH[>!W?@\:*, ]S:.
ME"N(5Q!?&8CSX!6-C'/E R2?7 R WF@F(V3#E%807U\07RAVST%8%S41#CB!
MI('8O$\3GY2E1D<1M-O:,=M:0 7Q"K@5<&\E%<)18$ZKC+(N@%4.,_)RJ8O5
M:C'_>C'B7OG,JD+O?4-O-\/N=^=?7 ."YX:8$"P!+B6Q5F=E 1FL=&!$\?^R
M;247/<!+)U9L!NS6,Z'5=&BT$H(,,6B3[73F&:*SCB<:.5 'T5Z5XAV6FF,G
MXT\-WM1.C-?$A>[WN" M5]:+2'B&!P(>'+$RPP371E@=563&9%S@%14J&:MD
M;.5D[/K86,G8&H'N;]^#;K0@;?*<T) " :F16*<9<<@25T$F*7P&7;FME:JX
M6W&WXNZJCXX,IU9:9!P=('48128\C'+OHE#TSH^.*J N":AS%:\-H V(-".H
M* W%F2"&4B R)4Z-RL8MT*T=,(L%+:M?L4)JA=154%DP-D&*PG$+P-"BIUY)
M;D5D*0!5]T9E*[@N":YSH?-12L$< J$,D "SG!@G(?]#)43!DE%L:T>? ZZ;
M0557$'+_SV:)G@6=?U-D_)OQ^5A6[*F>[_RO&_]SY_M8]=OY6#.R+X*936]^
MM0$>3^+CLQ]^/GNS_K !B>9#/Q_A^*_^\$Q:<K$?9/-]L\L__]T/T[<%5A[1
M&5L[34,X_>;3RX^:2W/+979-J$<@X<++]!&[\-IECX5'2LAK/?7R:P*N]\E-
M&:M\Q,T]C_46@U\V2U;ZD91F3<:Z3O.Z3F-=LS4 _$I/_4'"VP^/_B1;N/<<
M8V:VF=X/<3\_ >[P[3C&3C??]W;2V1N&&!8RX>AWY.QTHLZ&>?8PV4S+-2?/
M?C5-KTK;VCVKLUJ/G<8PN;!XG5CBK2\+UQR/_EXX?MZ,:7R2QUKL QQTGF,_
MD/ZP\Q2/^U,<7#:IUYJ/.RVQM-%">QFGF/\8.GLX'N917]PI_39DM;GS^L3[
MDZ.3 4[SU#:Y_IV,,L?C^#8.)_T/L?-L-+G#J=XXR#X+&JFK=273^;V/K?$V
MG#G:*B"L:,6.RD989G;F].S\M!M3W_>G_W,5PF9N0MB6H2YK,9>S*+%;IVJ;
M-6E/CD8GP^D5)NWA3<V9 5"7U4J6U<,K1_,J'D]/K7 Z9X7?M![-1H06+Q=9
M3)G1@:*CGCNPVB$3T1F5J(U1.Q::(T=*K: /LMS,.Y_'L"]?__&?=Z_Y;^+-
MX0OVYO OV7OW7G9W]S^^YGNL]VMOD,?^=O[0L/?Y-7V=Q_&Z'!X>AD%O]_?!
MP>Y[?G#X_N_NNU_>O3[\C>9G\MX?OZ2SP@C=5Y3V\COUGOP) CF+S! *3A+P
M*A+D*9+@G3&")PF\U$;0BYV+;Q2/L1'A%@\YFF*M@R66B)58&7#5$(E[0+O/
M<VC'BC1M=(0K6@(D4!"+U) H&%H9.-<<5UX)IF)=2]2^8MV/BZ5&JWR*(@!X
M=#'XTM")1\6$-^FNL6[C,QON#@C9'! &KP4UU!$$PPE$RHDQ$0DK":8T1HK*
M;^VH;6WH0P+#>RS"4@%V\P$6A0F**LM-\N!$<"IQSXUSRFH9DZ\ N[8 *^<
MUD4N:19PMJMIMJLE!6($R&Q<"Y&15I@8U-8.$]O&/BB$K6BXV6BX5$JM2R*C
M(&.6,PC!6PN.)@0.TLI,0RZ&PYI2NRZX^'&^O#58DVA0IL!A-L&MY@2%I,1C
M=#P;XX)!R:C=EG9U60KMAL2'>H*P9'$2J:DQU 21?(8(@R:X3)JLX)ZB8_'*
MGKB-+4YRETH]5V%9<19=")P((7A)D_?$8! D:II<U#SCN\U*S5;0"GHM5+JR
MG,IR;HY;E>6L#2 N=,9E3#JK!%'6ER9&*A#'(R42K9'2),U":LP_9E97KZEB
M8DO@X4%BXA*0J )*RS0# P$P.90)K!3@N*86I*J'JNT&NSGVIZ6-D?I :-[C
M,MCY1%!FQ NH*$JO! UL:R<+M#JZ*MP]0+C3#L!PAIY[!2EH=%Q8J1&3LC'1
M6-W^ZXN%\Y73C;(J1)7MWR;")((F+GB>?XT:E:,:G"D'JW1-W/Y+!_Y>TE>3
MT7-PK/F]/PQQ.'U,[&)EBOO4\?W)Y*2$ W=&J3/S264USY/=B4?'@]&G&#O'
M@_ST[<XP3LL]6;%2[$]/+@LYW\B.O+5O<I52E=+=MV2Q 7U^BC3, P:*E,G$
M$N>8/# ;FN[6]*R[-;UBE<2">C'LGHP+K\BO, J_X^ D[IUB7G//\Y.Q?XN3
M^#SC7^4,2W"&WM.%6"S(=A)08$0RC 1X &*30J(L4BXH9SZ4$['%^K*;H\BW
MD>._D>!0(;Q*J4JI2NGA2&F9HS9AI5,F4 &^).L$&RVU+@B-F@OGQ!7XT&5G
M;I48W2XQ6CA%X\PDI#8O8D1+P'!%C,WT"#Q8R8&!1W]>NL[5#]"J-E?,K5*Z
M@0F:T"$H:85B$FC&7QG H7&"H@$K3#5!6XFT"V[K*$*(,1#*DB[Q"HX@4T"8
MU"*9H&,$R#;HC;M]KE"3[[HDQ3WH81.=2%Q>Y.45CX[C<()EUJ_E7#[G]=<#
MC:ZW9YPO[76)\ZU2JE+:-.?RD_#N9#(]BL/IY'#TM;)H*2RZ/SPM*]H@7@-X
M3[_!NY?QOR?]27\:7\7QA[Z/,TKP,OK17\/F*0T[J"1@&1+P:L$/G9CS07E)
MDLXF%\1L<EF0E!B%"22GR06WM2/9BLZMVZCS=^V'7EL<J6A?I52E5*54I52E
M5*54I;0^_L5JA;3+"EEP17K#J(E4$96T)T!C),Y31X3P)@3FO32B96;(BH)D
MV^R*?(Z?&IWI3$>=X7=QY9W^#\O*;^0A23W*JE*J4JI2:H4CJ4J^+9*O4JI2
MJE*J4JI26FLI+1-V:BCEEDMG% 6@P3ACL_WJK)3&A&R[+NVCZ/:'HW&3WCNS
MK':C+T6KXB_CT=%N?S++\<V#FER4X_OO69)P]44LXXOH+U8VL$%'I%(1:1(E
MH%DDQF/,*XXQ9U!BD&%K!Q9]$34"=1,4>^7.QZK8]Z38\TY&;3R#J!6Q3)22
M)=:2K.>:..:3#")22*8]BOT 0AUG#57]=PU5^UD#CF(-=JP'6%5*54I52C4\
M[<%*?B.EM 03CU)(A]'1$ 1H'ZPVENFHE$N0%%O>Q&[XQG?]V_<;ME&:N/?B
M]" =XL=SBVH]QW$<UIJ!2Q'P<\K H\TF-8A(T$5%P%%+7)8GH4QF60<AA/9;
M._;&"4=5IROR5BE5*54I52G=.XM9N3^QLIB[93'S;L0 (((22% H3O+Z, 0I
M5T1+[BR M%2DEK&8!Q"KF%?^J>^P\],@:\*"SW:S3SCJ 7.54I52E5(K7(AK
M*_EESHF#<2&BI9Q'!"^$54)HEE@ RWE*>OFZ8T?^_>.\C7UE<Y=5>I]><%B\
M]_'T,R]CB/&HW%I+PM\N23QXNM )ECGE--."4.D4 00@QOE$$GAJK"R\/Y2*
M\)PO5GBM821MA8>-VQBJE*J4JI2JE%;AYUI90.Q=TZ#*=)9A.@OALBPIK9GA
M1"9F"2@7"4(P)#F7.'612:W/C:JKJM]JU;_CF-EJ"VT,0LP[S)V(-GFO26 >
M"3CO"7JDA)LDA'(^ (W%&+I96]0:>KN,=K^,QZ>E=$L/JZQD1Z,RA)%_7T-O
MZW%KE5*54I52#;U]L)*O4JI2:IW=->M&NOKV-^?T8OA*#[]KR/#J= 35(+JZ
M092-H>Z<RX1:QD0PDCC*2M%EKXAA29+D@S4093:.^,U:W%2E;8O2WDK#JJMK
M;"U/>!V%G>])%8+64J(F#J(AX&567:48D5HISZB7GLJLL.(FJ<-592L;JE)J
M5>6&"JRK!M9YUW!2@B$SE+ ,JAE878985#;3(9ZD9,%2YEL$K#]P#*_.2U#O
MK'<^A#OO.C$A]#^</?OT$:3<_]B>/:,_#'$X?4QLL\?>PX;W%"=O.WF8_3R.
M,"G;TR#;W&&[\X_+=L*\)S6V^6IWQ/W>+_-;XM/FI*C9&'?/!GGVY;NG8_VR
M*]*Z*_YP5^R6P-&GW^V*'\*OOT/X]W\&;_C@@WLWXJ\_=]G!'_N?>T?=CP>[
M3V@>LWC]Q\OWO<]=WOOL9?>/U_F_77B3W_G@Q9_4N9"$%B3R$ B ]WE3]8Z@
MXIIRATBYV-JACV#1P] YGA7D:4X#BTR_[+)Y23Z4R(<:FE:E5*54I=2*,\&U
ME?P=Y])\3U.^<)-O^$IA5M5@7Y*:+!CL:)F6RI22J(: #9R8@(PXE<WU)#/M
M,'9K1^EV!')5B'Z($%VE5*54I52E5*6TUE*ZUZ.?2B!7Y=LZ?#^=U0%\(?(\
MT#]1L7*6KDB@/!$0FA/T7!/0WJ>0A'"!MH=!/H!4@*:>5(WZKV?_54I52E5*
M->I_+3Q\#2-[.^N,LO??D_[T4[./57ZV%#_;7W#P.0V6IH0DRXL2X,X1M,H0
MD$) EB)-8&ML\CJIZ<8!=)52E5*54I52E=):2^G^0[LK?;PQ?5QP[SD543EO
M29#&$T#!B8G2$R,IHM?!*$-;PQ]_X-V[093I+6N4/E>C_H4#'/HXV>[L1A^/
M7!QW!-ON%(VX>AS?:)QU@LS>Y;'($QM&)VX0.V7T/Y]>G8Z.'Y<YGXP&_3"[
MLG[XLUR>+?-"QN"31BH #34B 0M)<$HE30'^W+\B\#0//SB93J8X+#-6(6<I
MR.E.Y[L*983P0J @>2_(=JK*>X UV7;-2,2C TP*,"..%DM6(%N!(JR6/UQ$
M$VY;<]MV8/&/6Y38$I)J$V0M,J:5X=4"4;JL$MM%+8PKR"T+<G,E U ZZD$P
MPH)W!%SD!+4))%#)@PW&06+GT:H*<17B-A7B/+4B@*6N=!5,*J!).E+)M$HL
M>2?O&N)J#<G5X=]\!0;NHF+":&*IT@2XX<1)"AD)06#(EQ)WI8:D@<7 D0W!
MP-LXH*RX6G%U 5<!@&LJE>3*@S3!::V"X#X#K F*BXJKZXNK\\>]#!!IJ;T0
MLCP),.>)!>.),)QSXU,,3&[MZ&UI%VOS;@BN5@Q\*!BXS(D#L[XT,[ L<@"%
MRJ$#9V)4UG%#I;X8!.<JF5<T;"\:=F==F[Z>7D!PRC&9""3!"6CMB.&>$QI
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MI=$JH%$AL!"YUTHPL!C]O1&^BG=+XMW[>;R3P6L:2!21$4 CB6$8B',T!A6
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M,(]Z4A?]]1>]]R=')P/,UFBG*9W1R6AR/(YOXW#2_Q [ST:36Y[>C8/CLU#
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M_!=-=91A^8I?%>LJUFT"UK$ "%D%+)<,0F8%T@6.6JC$96(0[QKKUB&-<4V
MD,T!88B<6>,8\2'P3/L*XP.-1'&30.2?T*12^BLOA8<$AK=9#JP"; 58H-G
M8F $<D!)+6=2280D::+.JPJP:PNP<@Y@)=?)BE R**4E0'G)H(R!Y T6\Y[J
M#6K8VC';6> /"6 K&&XV&"Z33>D"2];P)!)0X-XZ#-XRS'0S)>H]NQ@-:_F,
M=8'%C_.-!91-CC$$XB-DXIFDRL0SV^(4;;8U&'5<I5(,#,QB;OG2[4S6 A(?
MZ@'"DK7! I?4*4\%E0#,6J<YIR$3*?1HO:=7Y4YMK@VV-DH]5T@?('$,41$'
M*1$PDA''="!)"^-01NZ]+J7!%FW)S53IRG(JR[DY;E66LS: .%]97X).*1A'
M*"WNM<QXB$DV$6:=B)ZAMUHT-<*4?B@TIV+B9F/B4CU& B@=A8R.@1?,>8?:
ML$S]K0+-ZIEJR\%NCOTY9P"5 >($0P)>1I))GR662YL"& :L@)U5U=%5X>X!
MPATF;RCGV12*$FAP:)A)W&+D2AFN4X6[5L/=?'</HR0$P$"T#)% 9(E8 9P(
M*VA :X#K4@=;K_/!Z1T'"J?F?^>^3U/&91[\FM_[PQ"'T\?$+I8^N4]@V)],
M3DKX<*G6-'-D=9JB3YUX=#P8?8JQD^>KU,P9QFFY)YMA*?:G)Y<%TU_F&3QG
M[M;#_[><^R])$,$K:PQX8$"1<4I%8 P,NF1<TZR<49@U*V=7+#5;A!7#[LFX
M8&A^BU&8>03W3F75W/3\9.S?XB0^+W*K\+D$?/:>+L0;F[P%I@B1!*9,)HLQ
MTT9N!6$RE<KI$)-1*XC NP11;HL0SGWEM=S\:ZO,31TS_G.54JNEM 1IC1%\
MZ8V+UCH0+IK\QH$SFRUUR#,B5H6WO^/@)%X(MQ5MET/;^3 _:W5D*#2A3@0"
MZ#0QC$I"(TTF:E,:$A:NNMBS97,T^38J>FPD.E0,KU*J4JI2>CA26N8<USCJ
M:29#S%,*J+S!;,D@!T$U9\Y=Q0"][$"W,J-;MD/GCVB-D"PYC"32TO)<24ZR
M%!-Q)CC/K(DJA*T=M43%_ZK.%72KE%9IA#J?(.LA9DLE0N#*<&>E"=PZ&[)]
MRJL1VDJHG3\Q <&$4B%;H1$- 9U!-YNCBG -*O&DA$PT6Z%T$6O;ILKK54#E
M'I2[<9\3ES6GO.+1<1Q.FL87USK:..?UUP/BKK<1G2_M=0E-KU*J4MHTG_63
M\.YD,CTJ#7<.1U\K$I>"Q/O#TW+$#>(U@/?T&[Q[&?][TI_TI_%5''_H^SCC
M&2^C'_TU;)[24([*+)9A%J\6W-O9%F>!QRS.I"PI-(,@&$]\H#';YI1[YDK>
MP:I2+-NH]'?MWEY;(*EP7Z54I52E5*54I52E5*6T/E[+:H:TRPQ9<' *QG4J
M10T<"XZ M))@$(I$D(P[E4U1SM?##FE%X'>;'9S/\5.CB)WIJ#/\+L&BT_]A
M4XR-/,^IIVY52E5*54JM\$Y5R;=%\E5*54I52E5*54IK+:5E0F0CBUP)+[42
M%*0&C,%+#AH#39')N+3CH]L?CL9-GOO,LMJ-OE1OB[^,1T>[_<DLV3T/:G)1
MLON_9]GRU<&QC(.COUCBPTB!CFM/I-26 #A!C$R.)+!62N,Y@"D.CAHMNYF:
MO7*79M7L>]+L>==ELCK80"E!QP*!I#EQ&"1QP)%)Q;1BO/6:7<,R?Z#KLV;2
M_KMFTH/+FDEOY!E./6FK4JI2JE)JA:>R2KXMDM](*2W#[C%E@TX[YB0 <*.=
M]$;&1$/D@EJIKY_:VO".I]_2COU,YH_BL\P]>G%ZD [QX[FUZY[C. YKK;JE
MV/UYW1:<E\B2)]0K18!+2] $(& \,*<"),^V=E90EKWJ=47?*J4JI;62TAW[
MMNL>V8H]<MZW325-3AI* L9$@&DD3B*0D""+V3OIM#NO(F'=(S=!KU?@V:YZ
MW0J]7J@ZP+-=HQ(2'80D8!,CUC$D/&'@*2M\EOC6SDW\VC4:][XU/>M1I]]H
M58VY;<$Y3#UAK5*J4KIO*=68VUMH6623%5K8R*P#Q$PAO+&!JLPMC&!273D
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M[$YGYP8O1!G3GZI4(LK+DP0E:=E;$W&9$1$>HX]*>N55*KWAVUQ^M*KMM0\
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M8>>/Z,S7<0I<I]]\>OE1<VF.=<VN"?4()%QXF3YB%UZ[[+'P2 EYK:=>?DW
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M+$WO*[[Q8IIN[%5LXW6WWV_&P4$ZM-\6%K1[8WNQ4^I8+L7J%Y2RMY(D''!
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M2REF6B-,A0;6+G/Q-ZJ1=(D2T&N/I=K8$IM<W/IT\O[\C:'5/VW;LSS8^&,
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MMKF?W6]?6V%P/%:7J2^.W@6??\4Z&/EP</E73FSOJ-6IWM-<A,K</"_V[JY
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M4N )O3O)&%-3W;J@;OYJNU7O"97Z3A0[*\[HY_XEX\U?'G/$SE3*3  P&.T
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MJG-!L<L*,U_"V\Z1$T!Q8NY.^Q86.)?F3=(+V'H%CLYBZ)Q=/>,TNIYU/7'
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MI)RU.'+F"9%+]85=V>Y>5LJ:K138[+W"#@GL(ZP4"R:#"A21X(.*DDA/&9
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M>?\.)[1@ZIQ@V@'\ WI3,8-C^R43ACHP8NSM]79<V.9B9?Y+_,?7\=A6,4%
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M$T6L=!%S+C%Q&J1U$9Q1GG-,Z,-\$"//5$6FBZT_[W+,;?!.*B(4DEYPE/U
M"'0D6&XN6  Q5%"LM[97: J4*HE@(\5)9H32C@$J.BDHI\Y&KQ_F:ZBV_.8M
M%_L[7XUWF"C )J94#K92 EE+(S)<19^HA5$E8!.Y?M-G?0.->\3\U<:.XRM
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MZ_'LV?5.&WG;.QE;K.]EL'ZZS5Y_V1B+]<C9=AC[_68,?S?Z)YU!_RWL#*V
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M/O_\]U_G,/;YY]8>@WE=[%\<BR^MSV?UB\]G7XZ^7^R_K\.\/R88D^1Z,X'
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M6M;2;CM,)"^&Y12.3H!$]]K_P.PZW?/+:ALK.3X>&K6]^/BX)F)[=S3AO1P
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M*B"HP<-<XN'2CUGV4@-<KKC32JABO/UE#MJ8*+(#_? 4YAZF#D#@2Y\/P3,
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M$!O 96:3X$ZM;=CQH]G_F72P-@693FQM>YUM-KX16]\[YZE0^R?Q(NGJK/?
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MP2FP-(ED8RDTJ"(P-8A-..L95^O0/#;9C=>AT0:,M=X0Z41I*1TB,5Y$PAP
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M=91;XD42A)H8C%?*!NK7-O2B.SL?H<;RRL+],4-SZN'''+E@U/>@K)0!5Y$
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M*P.HTMGQ&55W=B_-#T,/%$M5R;62ZZ.Y$!Z 7:?J!E7Y]DY\.WKBIKPUW,E
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M:WSW/?5Q\\-%A^_0SF$;UKW!V]M1?MS^H#["7FUM?]SO, ":#HZ3Q>1(R1J
M)O8("U0&DH+/@>%P0X6-5^[DZ]R*)_UJ^D%=9*=;C;?SEF*>>[%;H\Y6RTXS
M0#,QFR7@2^)"J!*V'+%4>R(9+T8[P;2C:\^5_NH.M8U'\_%R9DA, !E0%TR0
MQ;*0'5B"(181@ )2T\+ANW#F#-"4%&@.[#TBO0!^Y HG( 1-A%)H"HH<-4Y
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M*('5]RO!#ZV:G]UM[,R1G7]A__HF^5-W>?KT1IEUQ7$7MO?S,-=-/UM^D$'
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MMCI;VR_?MWYYL=79?M/Y\'+S7_>T>A[T=7[YT-GXL/EF>V[Y]=<9^5KK0UH
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M!Y?7O:N><7G5<.QV I5\#$B\=.%4CF&A_81$6YL:K4.T=$*&;4[5D0(PA&V
M(YFQH$:H,E^>.1Y6O<TUS^#%RWEH-..\!*>ES4D6=!IXJ8+(8+]HP1(?V2F2
M,G*OQM#O+LGA+UQFXZ=YA9G*:NOM+K=*4F<+<=CA2#*P2'S)GK@0N:8R\A#
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M^%QT!%COM(M!&&8-<X&Z8/6=T\N;TUS^-'7TO@3A28F2$MA^1GRBBM!@ *X
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M[\V!LT$AA:DL.D9"79&@-84F8)(F E9-H"))YP-?>\Z?<3K?3^YQ,&&C.%?
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M!3=\M@R?S44!/'>%Y6B)-]00600G7L1 "@ZO]"D78SPP&GU,98@/GLW_V&,
M36I_D]J_K,AFRNJ2.2]):ZD]]93:F$$\Z A86>LFM?^!I/;6BWG7OP*2I*$
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M..C<&8(H2KLXJMDU;.&DEVSD3K*!IWR^9?I&]U(::S5J^TJV.SO.=5,].=*
MN\EZW,8R^&188QY8,O2KSNA$#Y/0&4Q,+R:^G,$X0!)6]A0#O]7D^ 0NA2>
M_5I?4P6P;&'H->V@MPQ>EBRT;9#FX\XQC'.4?$[)3W:- :?\I:5A;[4(?FJX
MX[I-^E/+.[VNMH9;,T9GP&2$A*E-]=%OI26X"<O]HM2?F_+>M].9_ $3^1,L
M[0TW7LV-X?D[1TX5VNK<9\!Y1<:YR3.5$Y<57CFG)!QRC3F9A*^7O(V/\[I\
MZ$;Q"6TTF(R*%12DM!)&@**MI6%$2ZZ8C"1#P R/)$,V)'.G)//YF!P\WQ5[
MS^WY_N%;=O#JJ*#>E45P6<E4[._#,R6\S9A6-!2% I5*@S"_1;U-2.L+RRF7
M!>5 $DJ24# M2&'*0I"0**)A(AN*^)84@4WB26!,*4Z!EQ"9<:UI)IU2F3!$
M%V4AM1+TR5-97LU/4J84TL>U)'I;)VQ4O?Y4?$9A-43WU"JM#-2UZ@Q$&ER_
M=3U][,T8?B1Q"_+^ %2=Z$<8K0L\)6D/8A=4H<5 _NW&UZ8ZZ!7!M4W6R33K
M9+_J#Q]CXLEN'QTN495$$EB32SI-6#IK+5$[*(Q+-%L?@^NSM5()79>L"L\&
MY@L*\L1\@".*8^FWEWQ==GWG#]^'@Q45_.;9[6.\8IQSSXU#Q9Q)79L;,>$2
MQMP=X@O0[A@>7S]!\('O]LX*,SCMT[I]&8TJVXWL+.8,XZ6@Y0^J$? 8K%09
M1/;R8C*L!NA]Z\705@>^]8F?M@D&;^Y5YQBY#$O\;R[\UHO>O0HSZM!H\KT>
M[F[+OHB)32DHJ[O([1:C?GDKZ%</Z@T,:OM)9]4:M(S?>B$N(_05!#0UYGL5
MID "KW73)5VQA(NG N.$PXD=)PLUF7\IGGBS6;/IK%^WG[C5V9U2=(HOOJY-
MQ6<U>3<2;>>+9J^CA%L2N)>M2G=U*'47PP%]G8QVV/CCL\;[>UQ5+H: UYCC
M-0F^3DOS%\SK3-N+.JLEV:_=<=R!^M4K7[4^C%Q.E_:/9B0X+'B*[A]WT1&1
MUFX+#?*YL/)B\= VDN"\W^D.R&[-,MW[ C\.1HH:G,8@/LX))KB<=WGCX$>]
MEW'IEI7#.67PFOZU)HUJ=?J*;@M2$+[U9GWT4^VP+421&2>VW&VQDD%O$E/I
MX;D3%!X7;3_=DH\N9J?$0L:DY,[\?37)C<#JPL>-NK!E>M@LWL7<]]W1:.*'
M,T_M8\IA>32'8UB+_QM8[41((<#V*RTIN=!:.^.M)5()2<"<UZLC:[O[+Q>M
M]99*?V5VZ0H4#/*#&>C[AR_.#W:."N\]; '+J*0"W31EA@&WS+N<,A],@']N
M5'MO1'""D%+:W/"2&5T$G5-+'0N6:;D&)7:SG[>TGZ73FAE/,FTHR;@+(E,T
ME)D-0E'E#1=4/GG:KY:<+,M>EY0(US8+;JH?WFZ*ZO?F;D@.I)9'844YXO?-
M\=?:5(MJ[IQRHR/(\RA9@Z.36<1M,?%Z*QE(78LF2[IT978T7F=]-^H<\(<;
MZM XNU*MZZ@ST!?X[58[*]M40U#),,#6SJYM0K!SYO L =S5B=XPL/KO=F03
M1)>>C/Q4<<&78<IV6YV!K\/4QNCVT5ZK?1J/@RC:^4%3[7.TJ(WAYE=G9WX8
MEV&@![#TJ]R;5]5UMA9P3?G K14.+)6OWR&0P1M[XMVDYP_"L_K81!8RVNF[
M%PWE3:7B"$%IS'AWMA0Q5_*'!C[8.9):@M8A96:8X!DL=I%)4M L6!\D;)$6
M@2\"&7P?2"B'*\STZ F(;,T!*8"U-&?& <L%8QTM#S3H5D8BD.KGS^<J;\#"
M:S ^<?/"\T6LDB*N9,W5FY3T"'P#*]K3@Y'_M?GE-_1"]O3%K]U^7)=XTV_S
MCQ?+_5OCQJ6OZ_QLI;8Y%9BB76/.UR^NL[>W8_;V J!0^DZ([3QG:[\FVW3M
M=Y<]5FTSOO[.RYYZ^7? ?6Y]K'*[%%_VU,N_D[GZ;M;U+L8JMQ6Y-F6MP)%J
M#@<()G_S*Z_HP' EYJI:NO2A=11>R@>/11I+*NPU&B\\VL68U]ROL1+?A.8>
M"&3C]0W N)8_[?:;U(71M3IT7Q=Z[H'34*.R)K/W5B9^':#G1[)Z,X?!;?"A
MQ[<^&^KZ9M1UI[Q];3>IVX'GO&]9<:ED^'/.C&J7AS?NI]IIU&VY"J_9C&N#
MD7R7*_-H,)*U* .C++B\L-R5W)1*%TQI;X42S)?7K6A#4CX$2D8/U*-.A4T@
MR6<OV/L_7M!W'_[NO7^^=_[^\-4%_,W?/_\;GO,N/SA\>WYP^.)\[^S=IT60
M9'CVZ;O#O[O[__Q]NO?Y]][^\W_#WR>G^_^\^[S_X9W8/]P1>X<[%^\_O Q-
M.Z:]-X3LPYSV=XYH8))1FV><D2+C@2"0I[-946I2DF"\5?3)4[&EQ#(,S)>U
M]?L.<))O9Z37AJ'?L-@-B_WV+';>N3]U^V^X[2URV\\+W!9K?0EA-F.T+#.>
M&Y5I;RBB* =2!,D]*YX\+;98N>&V&VZ[X;;WSVUM*0DO9,@MU9RP7 E94%9H
MXX+/Z?7+]C<*[1VQ6+K 8KDJC1&!9$:KD''M62:),YDW97 %I]3EY9.GY1;E
MRT6"&Q:[8;$;%ON]LMB-0GOWW)8M<EMOG+'29L*5*N.2FDP*1%BA1>Z5$YYP
MB=RVE.*Q<MM;<&=_16>E#3;C-;$9RPTVXP,8RP:;<8/-^'U@,SYRK,55F>8W
M2,]<!Q]1@T2WTJQ3G=]<MO77H4Y? \\]KQ]V/X5WC[3PY/6L:@+;+CR.LH+7
MBZ4@TR+HNO:X+M/^"RA'@RZ)('/]40V\%TEX";YE_NQ<"UYO3<T[W5K&"[PQ
MQB@S!>CH7CO+%2\<,UZ24A1@61E?YBZ_;KA@ME*X^X_:J/KR:KD/>VSOU5%I
M@R@-<9DTQ&><R3PS)>593IE51):!^Q+119<QSI))U  3100,K/X>V6%UOHC(
M-\7UTQ>QZ'I6@C(85J#7PY4CCPVF4DGV\="GW[#2I1ITJZ[+FB?:GNZ>1<HZ
MKL "ZN-U\&2LADF54#<#CJ SO PX#F?=\:P"YEF4L\<XCE8EY@PQ8@YC<:%.
M:]TIN:2!T:CN*#+V9P-01N-!BJL*JVO\B>X%?.*DKT. H<2U./,NE@ -XI[
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MHW:)1<0X;^N(3^(80]>(Y"TX!LEIB]I*??G0'T]Z>AS5AUFJPKR7%ITV<:I
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M ,,8SL+U*A?NO<_/MPX5?[9D[_A(&TZ-,3X+09<9EWG(I,Q%%DC@11E<<"R
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M5#GF"WF;Z6!]1D#'DJ7B)%::T^UU^=[?)%_HR]C:QC"X PKZ< J?O>-[AWM
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M!B2NEPXX'P%IUBI#KAN#25?E"V9W$7%2UPHXM9QPW_SM\PM5;HL<5R$F7R>
ML:U9JLLLJ!PSXY="82!LKQ=+_EWW8L[IFQ/OX07=4;RX!C2;A=K&%28P#G07
M(=>ZF U<+47)%G-&%VI6OML<TMVP*ED45JI?C:>P4"OZL;=J3EOJ4,1B:RI_
MY[,_FT\C=,Q@Z >8A!53KUO9W:-9@G.=';55IS6WLUN[XUCA^E$CQW)8\3E*
MCQW/\JJ;QS19Q-WQ5@TFA^WHX<MXP\?N<06,<]2[2,]QT^MU#].1[4GSO&Y
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M%"I_!5T(JSD3.L _E <* I=:28,/QBJ@4+JAB[NG"QC[D2BU*ES.,U%@S_D
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MW/N\<W'$;.$LI1X$:LXSSI3(P,@@&6,@:JTPTEG^Y"G9YOGRL82C]27;+%P
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MS!6A++'5;CHWE,R%@S?GYE:CQJ=D__/Q^=Z'O8N#PW?B8.<HF,([4IJ,&*>
M-W.>J4!\5A22:9#.A:/FR5-V&6]>8R6TT$IN8DI^+94L-62>HY)H.S9$\I<>
MQK_WHG-G0S)7DXS]O+=S9(-5QI9 * 39KF$D,S;H3 I5&.4+[D5X\K3,Y7J2
M:9QUZSQ^=V,*?"5I;4R!KR,>^+ES!!Q&Z&!"%DI99!QLQ\SDTF56FQS^R)TP
MH OF.=N6RV)[:^9ZO0E+"3D1KO"AY,9SH%F-#0 9"[D7@GE>7K>U^T[JC_SG
MK#WR,\SEQV+.#>M8I:7MB(/#MY_ "OB\__S%!6AL)!0Z.)-G(;<RXZJDF2',
M920W1AAGN&,>I,VR7VK*.6(6>=VG&IC$DK+2Q*INW-AZ7GA=I]%U%&V+(08L
M=/-V,DY(!9@W/AMCJIH<CVL8 Q^A5_ZM^Q,]O-CNS*ISL0[/7:JC+=;-W9Z2
M!GISKEVAE58Y%\ LT8)QA):DM*$@TQAT8]RH>=S&C9)VJ\=F[_-;MG=\Q K#
M8EX0"BV0N(9DTCB;&<&IL*"_*6?0G\N_E9+VM52R4=+NDF0$D$PNA93*%)E@
MG&7<&@%REN>9!R8K@_:F=!+DK+R$U=Z/DO:5I+51TKZ.>-Z=[Y\?:=#NI9(R
MRSWH]5SS L0T#T \ 50HXR@3!(B'L.U\F7ZB[Q;V_QS_N9GP@<UD@6I/!5@1
M2E/# A-*:>^=0J_;0L(X*=:"!M]8^H3N)^^RSWY8_;B$T$*]V#^T!/X^,L K
ME- L\Y+1C'.I,U50D?'<:: +9:@#6Z^_ ENGS366E:3+U9M_3_I^JMD\HLS1
MJ28H5REMNM^OL/NIF^'9UKE5@\&PJKW6W;Y%DKZ:O2ZRU0#&N:=2%M1SV$L#
MII"BM!"*&R(M:VP@(J\X40O1TK^29[0NLOP,K#5FD]%-?/YJ7FLO0%!K5BBB
MA,ATB;I=4":3W&-%!V5,%-(IY3$X<E6LOC9D=+T1=6%]K+J?IG0 S33(LU<&
M\U/J7P1ZG'MDNQYA_O&CZ^0+K#':P*J[4;[)%Y4P7)EF4A/SZV;J,ZJ>7;.A
M[TM%R"YZ"*DR01?:(582R HF768HI9E0P18YM5)@10/?7N$AK,GYAXRTD-LR
MX@4G><FLSWD9N"]+8TTN"N.*$'+OO(YZ%&D<G603:;E+S^?GO>=[G_=WCK1A
M@A=@Q&OCP2+3 2PRS#GWA"C*/?&%MVC$BS6,_FXL^:\EE8TE?Y=T0\ 8*SFE
MQ'(%+%28# B%96 :YV#.ZY((G1.3 ]WD;!F\<)YN[L><_TKZVICS7TE!^=ZK
M(\)=4<(F9)(%#RJF)IGQBF3*@27O/772(N<1=)NN2L6Z7(@MN:)O38H1P0VC
M7#.?:VZ44\9*5E):"F%I88M$.HTGB&Q<T7>@SNV='^P<,5IJ6]@\8T:".B=S
M S*,NRR$@EHMI'>V1,FUK,[=I>3Z6O+82*[;II7/!Z^.%%>">!*RDA4AXZHH
M,U/*'%1_HFT(E!,+JG]>+ =W'X*T^DJ:VDBKFU/-J\AA."LU8T4F"PNZ,<]I
M)I7765$HELM"FT!9DE#Y<B+25SB<"U,(K(Q0I?'<>X5>;A.\L4P0K86M]YLW
M^[UQ.-_NYK_#I #KC W,RDQJIC)N!)!!,$5F<U^4NO2&4+O:Q_PU?F6R 56[
M U UMAY4;8./ML%'V^"C_;CX:*O[EU\%[;0(7N5 O=3&YH):;JA2- <CEF@O
MB3/>\:OZG;<H@=VWY_B&8 $[UD[.)@F)-*6UH2$U]">^/P(IA #S"#/Z$S9_
M^+FS!,-UER!M]L2[2<\?A-88XQ#G1I@&B,.++.<'AF[[C#6ZBDEL\)'EC!G0
M>I3-#&B@&2D584I*;P1?I'Y7"F_ ( 'CA')IX/^8%J47!DP3)4Q8A&Y;P[@?
M6)!DMX4$/FL,G' .1NL2--NG(0$ V+G3T*U/0P]/0QNR ,X!+NJPZO42'C<6
MSB/$= (H<-Z?18&X[KJM&B-B4/4C:L,,!1C537Q('V9X14E-O Z5T @-@8C#
M\)KJ?/3K#5!-6JRL6",%QG$F4VUT"/I!!KO:TX.1_[7YY3?7'0UZ^N+7;C_N
M3;SIM_GWH=2,[6O!4*E?$M^7OIZI9MLDJ6?C(?SGFC?77V_'KWX9N^7O&-UF
MHEC[-=FF:[^[[+&4;E.Y_NO+'GOY=S)GMS]86#WZI0-:_UV^+<KRU@>KMGG^
M9?MU#PL+7S+^O0R6;PM^O?WZ)9ZR=-+@,"/C^+]/0&.:6ED18?97TJ&1M3?/
MFUZJEB[-!Y_PXF5>LGCXT[G_]GIFY"XOJR'\V>^DX@M[T3E$OV#=]FC'H70[
M2W9,S4L7)WZ#-7I$EUZ37%;0 &(4?QL*4#?7C2-)_+3;;]*61S]?8]]K61C1
MF ?CV'K+=7#<OWWI,CPL$_E&YV0+7AC!I [UISMIKE-LBVL,>(5C#?<G8]LK
MM ^C1SZY73H_T45S\VOV_1JGZXN(YP'RT;?]H8=A? 8%]0_LS)),1P_&(] '
MDD1J7!1Q O_E7>SI%MV0R^1RNVSK$2S?,\1C? DJ_6;E+ETY7)"%U4/3:.;?
MJ*TL6+3??=^'[CAA)*[B63_B4A[&7-VK7$.XM'.K=(4N@+TBCX?5I.^R>B+6
M>A_";[<O-^]CT9HJ3CU>44BY2$VWLR2D\[ 69K4:]5]W-/GVI(?XO@<UZY]N
MD'3B-566\H('QSBCP017>,L4?.A+:NM2\E6Y)HC^";]=W>!BMW%5_57%'F\[
MX_&P:R;1+7-8[<^YI79KK]2C3DDY>7?VJ7?P88^__^?EZ=[SWT_A/K;W^16\
M\X78_^?]V=[S5Y_?_?."OG_^^@.,(V_N@7=-WN=OB[W/)[UW_[PZW_OC]>G[
M0_MY_SG,[_"4OC][=[[_?/_DW>'?I_M_[,.<WX>]+OGTY^&+\=X;0O9A3OL[
M1P6F/Y649#:4-.-.B4QI+C*I A.,*QXXIC]M";&,$;UDC-P:A^W<\&1=IM!^
M^6 6!>J&6VZX90LI+1!)%3-&$<MY*+17P"P+%PC3>2'TO7'+#4.\"4/\O,00
MC2N44YG*F<NXEBR3ILRSW$HFJ%96\/#D:;Y<R+#AAAMN^+BXX0V8H6;"T5 P
MRYC@Q'B=&ZH]4X4M/2@5;CTSW/# ^^>!=($'&DWR4+J0R8AD1 D%'AA(5O+<
ME,Q[1J@''KBN*&?#"#>,\%$QPINHA3D:T:7U3,J<E\XIRT,(4A3,<\0'VZB%
MWP5+9(LLT5EE#3.9\5*#G<P4]K$#+1&V.%!9!!7M9+*,4K71"S?L\,=EA]1X
M+DL1A"".BR(WJG %F%&EL)XRR3<^Q>^?5XI%7EEJ9[DPF2V( 1-:@PE=:))Y
MQQRA*MB2"_0I%L6#MZ)O'$L*\7\KWQU/UR(WF^N"K5;D MSG03^X*O>T8SR<
M(ZQ2LCT]&G4#C#Q6,*X-6^8W6[N58N#A<<2;6,K:$T8\,3FUG$JE=1"%MZ0,
MS(:\T#>& +\L%_WWN#VO%W=GWX\/PJ'^=&71WH8!7H,!7OP_]KZTJ:TD6?NO
M*)B)&]T1%%W[8M\@PNVEQ^\,LMO&X["_=&1M1C8(K@3MIG_]FW4DL1P!1D*
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MF2(G;NZ:O(%24\%^:V!ONS,U3=J;((CTLG@X+"->1DJX]-E)':0(<6US :G
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MCL )0"Y4&S*Q/%(2-(]:!L%X!E30I_<@5)ZM/%MY=N$.$.^UUADO@YR0<"F
MUMXDS6QBDFM].<U6=KU_=FVOA%".MHIQ'.FTU/2Q$(BW3)*R"I*I,Q+-&51D
M;QPH42FV4NSCIMA95%FP(='2+P )-1[N$)Q1 :JV^'W0JJJR*T&V[34G:ZUQ
MV@/1)B<B02D"C#N4-RFIHIY!232PP"+SE6<KSU:>O9QGF0M<>>M8XE)J0&AZ
MZ6U*VGENJ3+5=;OZ)#RUX,>U2M9P8E0L52Q#+(& B@BMF"W_>"H+_^OJ@G2M
MJ\3#S5K@+XV<36I.XX])B_=@\*77GS1,(++&WY36:/PX;@(IE/>$M?+ ?#T:
M'O;R\?DM%.6D16/>_0CRO($\.QF8.W_Z^8XR&XJ77G@[0*@.\%$=Q//1[F$G
M#_;W.H<[J? /#MNP$--^+BEGR(>-]QN=B P @T[N]:$?>K![6LUO6,XK5Y88
M >@?-QMNS5/\^B -1A4Q.[U^Y^71 +]H4MH\ASY$*/EK]B^\<) ."A?UOW1"
MDZX^'*]WSC1BN'&^4OFE4L/X>;$1JR8V?-G$YDR%Q\(-L0QL&<'#G4%*G3V\
MY\ZPD_KER-3R=MD>A#--ZI3M0:F1FG_.,A4FZ506AEFK)>JB'@0(%S2+QE$5
MXST57W_ $^%N^M>[X\\?XX'G4G=?_*ZVMN.WS]O?.)ZWB^U2GW][+3YO?Z*?
M/K[;^[37W</?O<\?7^7NBV=_%==- N]$EB18#6A-F$0 (B-@J#<Y&BD27]NT
MET6NH$3O%ID8I*:B19,>*QVB%/V)&D@AGLY.BE]0D!KJ*O2"'=_?WT.&*J?W
M]P_Q6*&;^>0-A(#,+0-KC)26>2HT"!O00#)4IU#E;9GD376__"&5U,8:3[22
MD4AN!7%!*A(=YS9'RP,7:YORLCVDL\E;&.!HD<G\U!E^AX/A1F=[)PW3:7:W
M06IN@9(WWAIY"']U?.JGW#N<51[O-,W1)6)8)?!2"7S]'24P4">L5X[X4G9>
MYF"(C5H0G9F7P>.\5?*MB\N<U6,)O*YZ,Z7.N#-?- IX\\T9_2:D8L!=J-Z,
MMNE.S(61XA^*NG4P3$\F?SR-O>'!+AP_Z?4;?:&YZ.GY5JGIC<K-\T:'GW[O
MQ<.=8@EOT-'"SC@:</SD\>&-YE#+B!D=$VQ#47[I8;K!+CUVU6T9VV#V\L-7
MW?;J8Y:+Q3<6>X_-VZ#+C_$-9<S"&^LV)->KTK%X4,A;:*R^A8YE<D/)Z]WV
M!W&W/XRW=U.G7N!\'+/+,H7;OL)9#!O1>3Z9I[<'>+?=9C;K/(O%WFM,V$MS
M$LS01P_HU&N*R[TZH$^,V.:&3WJ'^+!P'??KZWYG/-%>40'LS,+ =9U@U^Z&
M,Q/Z%'J6'"?K^,!&<T5-L',KO@F]H:[1XJ<'^\->:=R31EM'W?5I&2 B-BY0
M/SP,4[G!.3_<2+>ZT;A? UUS"<\2\NB'_B!A,_Y&L^@WZ/6'G9_^TQC5/W=0
M/HI(O#ZUDO[56$GKG?_U@U\V3\7E=BCV 73?<QCN=%[M[G^O/7=ESY4.:?5>
M\>Z,$A$5.W:_/_%&_SHVL=_NXJ//<M9C[LKM?9PB.V=JQ)[INM,<3J5KS_72
M#;=L+7#>O.?]6ELP"#LWW:SUJ!?U'\^ZO=$@)(.0HN'2AN@8%]XI8#)8<#R-
MUNVIJ.OV"U^W_YU]PN^Z>^_V/N_]=V_KQ>^L^^*E[/[6W=EZL?OMT]??C]_\
MMO7WFQ<[>U/K]B_^V_OT\7?^^;?/>Y\_?OK>??&!;FU_H9_XR^_-<U^\EI_^
MWI)O?ON<MZ9K$:BLLY!<DA!H(-)S1QPSG"03.21(@6M1UNV-7=Q6@*4*D9I!
M5:YL^=#9<@:RE(%SISCX[$J /G7!!NNTY3E1;7.^G"QK#.G]TV![.Q3E($2I
M3">M :1!Q@D.IB/>>$EU=N!R$[!O%QNQ7YFP,N'*,R%/I@1@YZ0R2&:I$T%&
M%1@'IG70KC+A,C-A>^M2M-KJ0",QB24BG?7$6VF)RCQJ[:G6/*UMRAMG<*I$
M6(EP%8AP%@,Z4V&9"%HHJZ4%X612UO#(%3AA++\W [I2XBR4V-Y@%&4$DZ,F
M4CC4$"DWQ 5G2/:Q%.P)QOMB([-J(5<ZK'1X)OC/A[+S(^7HI,PY^Q3!<2-E
MC)&YJ*H_<?6YLKT/B 4;57:"F,@$D<%J LD+HBQS+C*6$\3&G[C ?4#+DO;O
MD95*\4VX;=E5<3[>]B:E4AYVEE,6<HC&*4<]D_C?"1TYT\J5?$K<C0NB4'F;
MT= /K+S]'1'==#$4GI.Q2ANBN6&H&0(JA1D_LJR5#$$ _E[;%'I1Q5!6-*'Q
M"@)ZIEH&R=F 1@ :?D%Z;WT0@N(\QZE4*45V#43?QGZ;"NU9H-U>#&#>.6>]
M)(:7HB:)9^)\5 0D33K(Q"28M4U^HR24]X_J.0) [QZ/)5#\?_YA!3-/D3:-
M?=I\L$]_$!!9B2E*[9,S/N+,)%,0+FI*E97&A(0*2*K$M +$U/;-,VH3]=F0
MS#5'XRHC,2E."3?)>,JURIH7G6.E>:EJ&Y>#6JDD3.32X.QD@H$LO(Z14J^U
M@R@KJ%< U%,E4ZA*8%#;4"9I(K.EQ"O.2%$U5 C*9H"US>G @XKII<7T#)!6
M-I2!9M*6>N$4]4Z:M0!%M3=:T5Q= LN+Y+;O$PU R+(41 V)$@D\$1_ $,&"
M0<N!TVCDA3F5[\\C,&^<_$7/YG;5?)QG$L.,$3'*H##V<YXD"YK+H_DH*MPO
MP*-YB4;29JE7@_V],]M +J.YT5[ P[?XYONQ$ML<Q-:=KLM!E3&\K.?XH,H"
MN(@$T+@DUCKIE7<E_>;:IIS.L'E_=>[GY+.Y%)5'@?0%>#IO$^!GEW1S[Z\4
MR=]IL%^!/QOPVY[0E()S&I49(80EDG-'K$B6)*]+PGIG;%2-@XXS_K2B_^&B
M?P'NQ(K^94=_V]TH)5,<L#.SUXY(Y'KB<PY$BQA*,2YFE*GH?PSHOS6_8]7R
M[P_N;4>D8PGG=E!$6.Z)=$P3GW(BF3N05D;K2]$2?N.:K17IRXOT!;@C*]*7
M#NEM1Z6QW"2E)1%&,"*5M 08*O@B2K3DN-:*H5IOV!(A?4'!F$L=4?[#D,N;
M1%8^ULKR=QIS60EJ'H)Z/YV5@H:@E)%$YT)0(!7QGBH"97,I529D*)L0+]AQ
MLXSUX^]AT?1!H7WY S(K[N?#?=O?Z*Q0F;E(8E*)2&DY\3B,1$7(7-L80H %
M15Y6R#\4R-]/J&.%_'R0;SL9=5 .T$H@S'!>"E$'XIVQ! U/ZB%Z+:A?3$QC
M1?PR(_YNW9$5Y[>-\RGO8A+6)1!$*$.)]."(5\P0""YF9PVW0J]MLFF<5XW^
M48/]3@,D*]CG WO;P>A%!BHU$ $I$*E\(@ZU-)S4@:/]+CF#4,!^8P_CG:#]
M<0=)_B<-AT].JT.=2;#0%)LZEV*AR6T]2#&EO>:$UM'>. /#?%O$5W<!9J;B
MN;<647D=XJM9A6Z)(Z<S[S*C4C)9$1-B6831DC@:,Z'"*A^BTX:%XN.\>9J,
MNM*ZC$"_7T]E!?JM ;WMU+22H5D:#.%&>(*:+"<V@R(,;(XE>Y@K<145YRN$
M\_N,G%PXNFOPY")0/Y5'5=+ K'"$AYB(C-P2JW,BU FN ^-(\K0&3SX& K@/
M;V6=WF\-Z&W'9C:&"0B1**8UD29KXH70A(G I? NI[)_^\9IH"K$EUB7O[VP
MR0KV>P5[V[$I,D[K2MD2D2"(3&")YQ )8P:<=L)JT CVF\0G+%_0Y(/-8-EV
M9FZ%?Z?A<+]?XRQ7),[R0N9["R5BO#+=+$PWG=^2L5"J&FD"AC?)+#*Q@C'B
M1!224U1Q/%_;E&HUEG#J@NVC=FQ62IB'$MJ.S)P8*B>>D114(-(62P=-6R)=
MB-PFR-+3$IVY@%Q5E0T>"AO<;W1F98.%L<%4,DIM(3&12+0,%00N';$Z12(S
MM=1JB<2O:^#FPR>#E72%5@J8AP*F7)^90J(IC8'OG"(HOX%H%;+B.H-Q)<QK
M42GP*P\\$!ZXEYC.R@,+XX&V5]0);IGD@O 8 7E ,>(]TR1XM 4-]TCMQ3"@
MJ[%=<]YPSW&K1C?#%ES5L"79AVXN1/*OL O]D#IPV'F10MKS:= 1;+U3L#AG
MB::+.Z66@[MASRSWC#"+F6A$ "D=!>^<S [ "] Y<06<!>W"J%;<#-9AK16W
M7-/&F^FTHC+K!-I($G70:$'22)P,:%#BI)$I!6Z8*[7BQ(WV^RX.;G=;=O/J
M>63.RIN5ARL/7\G#-DOKHE=>)M2_G?!92UN6\+1@D5NX-QZN5#L+U;9=]R$H
MS[,M:WA:$:FS(2 "0]+-&< "3K;TPM3TE6<KSU:>7;@'I&1/UADO@YR0<"F
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MO]<YW$F%?W#8AH68]G/),D,^;+S?Z$1D !AT<J\/_="#W=,*?L-R7KFR! E
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M)BJ3RBN'?Q@7M- L*6E4]4VL% 6^GP[H 51>@V$D<D<)FJ.:^!R;I,76 XC
MDUG;%.O4+K^7=N;EI8KSDX5D9Q2WW 3@0;*4(0:6<18T-$F7LZ@!,"N&\[;C
M0@C.3+9 5-0.<<X2:CG!H>:#W"ZSIS2G!N?JQB9-Q?GRXCQ:95F0%+1S,B@-
MT6=@.J0L*,I#JJZ+%</Y5, (DK/6#(A)6A#I@B4N4T\TL"C+P/J4US;MNA$5
MYP\8Y]S@I!U*B<.09&3"9F&5,I);5.<CU=5UL6(X;[LN<@"@7#(2HHY$YA2)
M8SB])V\LX!P?;,+YW*P+>UD!R^7!>8VN^!'RSV42KI$4E[$>OF+BT<1 G9>6
M1<C2@6(*;5C\R[#JK5@IUNM->2N,1&O40R1<ES!^(0(!!:CL2(>:+4W,*+NV
MZ=:EOJQHZO(X;.O"S-PXET$H%D*F1GAIP'D1& 6;J'&4.4FKMV+%<#Z]74=%
M)80@Q2=5O!6*.*<,"0R "\,U!U5PSHVH.'^X./<^<>-S=*EX):.R6E"K6>#<
M2\:MJ]Z*%<-YVULAN;<XM)EP:161OM1(C(H3D5T2'DV;$$2I8[)NV8VWY56@
M+R_0;9+*:Z88Y"!#9CY%AGHZSNI"9A6JNV+5@-YV5SAFHZ(EOL(CVJ6(BMC(
M!?ZP K2SX&1L@"[T\@/]5OT5-[MY/7,IXV(:X1-FR;U,V_NC(G.CU&*S^@>O
MEV7M@>[2O.;+/Y@).R2@D+41^/+2)F4-M893!5I'F0*MGK95FK#?3.]9TM1*
M[300*Z) S5Q*XC4/Q.3 2P L-XJM;6J[KMFB%A*OG:9QF7>D5Q9\1"R8P8/4
MR@DT721URJN(-JSU@H*53MCJAUPQ%FS[(1F:GX+:2+P)CD@N';%9:>*CY3C/
M,6^Y0Q;DZ\JYRH*5!1\E"\Y58ZFRX/*R8-M+&Z/'T62:<$B:2,<X<4D(PB)$
MG7P4U)3]Z\ZL6UV5P4J#CY,&E0U)!\FD19,(M<&21%(+4%27O>$T5Q_VBM%@
MVX?MJ6$A>=0# ^4$%4-#'!A*:/94*V-1)11(@\:M4ZM7F 87XC&=G#)!DVJ(
M<]$+9[-E?1?837'_J)2OFS#'(IY06_E 6[D42P<_4@KP-=>6H"#):;7*@\%^
M[AUV?MK='PY_7L7Z)/SG5H',6]FB4.^Q[/=8K;#T.V" :]?[N"O47]2@>5$O
M+D/]C2-S5MB4N^@5'XS!YF2.GF4>.#AI2CER&0U-/I447VJ<]'^6-<PWDSGP
M=3^@A?8?G "KS35+&MF1O=4L179?A.,W+W[_@PL7A81,>/1H=%$N" 0*)&M/
M*5I?7@>^MFD>8B*F2CP/E'BL38REC"SCG$PF^L ,4!4YLHX(;/9D"Y5X%D \
MQ^>))TD!(),BC@I#)"A*?.) HL_!A<1"M'EM4XOE#U>LQ%.)9ZSQ>"="%-P9
MGB35$21748-/7C@CO)AYI>Y"XJDNZ,6Q4K>E#@$(SU/VA$*.1#*3B><@B38X
ME& D4"F;C'4W]T!77JJ\=%?[MIUBE'M5TLI)P8275C$'#54)RMS,2V>5EVZ;
MEUK:$N7)>@F..+33D)=$)B"!$9\=59(::20M*>[MS:L4K?;VC@>12?-VBGT\
MBL0\26D)06=O>,DE+ZR5&IPKP:,0&?75Z73G;/9ZRNE$>1#6ATP"%8I(+I#7
MLDA$22B&'Z.6E:IK?%$QGTL4TE21>A+/XV,23@?4KZ,T* /*!(U]D9W(VKE0
MO33W@=26WA%-J81H+7'".2(UC\1JXTGR-"<=(S."(U(7MD>E(G4)D>I25!JX
M-IEZZ;, X(X&9UW.5-L8%N/6J$B=":EMSX74,C(00&3R:"&$S!"SFI*@;!29
MHV$0V=HF&H 5J0\7J0A.E008DZ64)AI'A<_!1A6SD";-GN>A(G4!2&W-J=Z*
M&#0 <5$;G%.C)-9%()P+[66P-$5:<C7<.,7:K2.U1O#<L##&*@;RR)]_$+U7
ML^W$'+-+E'OID(8E<&6DL!&HY,F:5'T0=\["6].!+YD)G5DF3%E))$1/@(E$
M@F66&F8HTX#Z$KUQ>M_E6^>I2#VQ;").NC*DQH5N97(E*596609&8^*J^B#N
M ZDM?:E@TUH;B3!6H[ZD*+&)2<(@:V;1TJ$*YR5>4](^9*1*ZJ2UK!ES"0R<
MIF"2I\$&EJ*GU0=Q#TAM^R XS1XM&42J*):-,HF SI9X;7"@3-G %]8VM;FQ
M7[\B=7F1&HR0Q6D,!BW;C%J4Y9E[EQ2 8CFJZH.X#Z2VYM0@6"YS)T&,0JF[
MFXCGB1((7$3K1 0GUS:56/XHI]6*)K@W'\2Y"A>KZ'90/]PU^#"]OS_-5$TT
MH$84M#' I#2T64P%17W6.:5XG:R!0WQA_*MR\*(Y^/<I#T0I@6Z5B21JCW8-
MIXJX9 12LO) &2JZC**VI*<]$#\OCPNX+M;,#U>IO;0QY)!CE H\6KG2),5+
M- 1PK:_A?:APO3VXMMT0-C+OP1$#.A")VA.Q(#4)F6K P=,!S-KF!?&7%:T/
M JW),1!9Z6B<ESP&&X1W3#5)>0,/URF64=%Z:VAMNR*<\RPD$PA7TA$I&1 ?
M'!!(.87HA%!,(5HO"(>H<'T0</74VIS0IC6"RN2<BY"4MY0:E0,P>@TW1(7K
M[<&U-;DR+4/2RI/ E"(XU2;BM.!$YQ <<]'&6"*"V70YJB6":ZU;\6C.7%#L
MRK7K5HRR4-T'Y[X_\H>E;L5-JJ+>($_G\DU",\Q!(+G+,2"3.2DE"/R0C5#1
M"%;<,;$&@MSYU/-IR@TC;&;@C">\%$Q"15$0D,J0Q*T$EK5.$F&O+IAZYG.%
M+T?FW04N9SU6=!L:?(Q2:!F-3,%[S8PT4><LG(=)0MH:/'*WZ&XIEM;)8)6-
M)'E4)R4K6\U\= 0-]Z@]$]*7X!$G%A7F5=']0-#MN-1"0N)H.$J<M9VSH*FG
MWH?,J*VY/)8.^FT7D$I!*)49B=8#D2XRXJD1^#'%[+5RR862RT,NK"1B!?\#
M 3\-0K-L4 -T().PT,#?>QE*?I_(:L*,I0-_:]Y'/2PXEC,Q+B6"UE<BJ EP
M0IT R%X*WFRR65<WKZAQC^!?B>"7.\N@?3'LG^\/#O81?*F3_CI(_6$:KG?Z
MZ7 58V!TC8&YN\J9>^';DQ/9.>'OER,9@GY\<[B3!B,Z[Z;#2M@S$7:8<L-
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MI=-2 Y.0G?/&N)YG\"2+I^DL+:N"&JRUV5"A/-RQ=GIW$Z[C&L2\S *,^+J
M$4>2?7%*PO&H%KNE@N)$MFM&46)XH)-X#&R[R#08W'->8)B!8VSL3/S8G:Z
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M)*;E!Q,[=H '-U8N!QIY0!JQ3D'_L!/?"CU?3Y((:"1QN<X2U]1=9KA6"/:
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M6SV(K!])@C<XHU2'-7BBK,.RPOF5R ,IEE@4%:?."S9=JVF--O*D;N<R,KS
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MFP\R[!A-YQE8Z!] PM;G:.;]Q+/SM)X*$7&6@;H^2QF:D#D(,HK>XIM^X1B
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MU4BU:20^U^[Y8G61DDW[I2MA17G<B3]7W?+GW<!*#RX=4ED)'9?*1&6GAN*
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M$EH795G8*]DN45I'F -Q35.%D">B-08]6+%O;?Y(&]Y;$7GLEMU9,>%N%H!
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M'?@Z\"DO2IFV0(7[#XB3S_B\$CX8YW;<?!W[.A82G!.T5$$\@7X:(!57(%Q
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MS?$GF.RJR_UF&^VQK)H-S;9?2)']4.1)6AV(Z2:6-!=+NJOYEL'*>6N4D6F
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MH6S*M7F1PDRO."MP@#2/R[&V#J*E77+L30JC4/_/\(J&2?(LRR_QN1+.(4U
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M()^+,O@!E%1A2_5E$/Y T@HX:PX6&##C5P[DA;)B@3'+@9YWDIYO(&.D$NQ
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M$=S1Y]'OS/<!42C7T<HL\&P5 VZ448T((T"06RB^F_L<JQZ0< IX3.HS8)T
M8GK?>M%,H8H3Z768S$J1B@&CI"GA:."EI.AAX ;'&A>#0 I &, L;G])S)N'
ML\!>S-@2 H@D&ESTG&L6.FC2&@+:A]\ _)CTC_PGM$5>CR!83)C- 2"2M10M
M?LX;R4(4SI;\%1*)%MOX=01B\@(#4'/05Z!]X;D\3YE]28JR_:4:&WQ=&KGY
M3WE 61J01RH?-S>_CH1$/\1%71/; \Q.$YU)%&(M@.BH/L9)^ 2H@DX("TGF
MA#]L,K%'-I*TN,?)# 2EX/U8Z(WI;B2"Z-686R:RVC"E$^V)1]?[#N@_9ERF
M2X>%3)[#LO(IH7*TEQPO"C%EL:=$N0_2C(L[!.P&E1)M #!BO&"JG<WA#D>6
MKGTCIOZ( A2N8HZT"+L<T4$Q)>X^M0!=$66_HUS[87,!1=3'W\CEU8B?WW&I
MX AN. 09"^]B/%=P;B'-TC$Y"UF$8*7Z+#H\EQ3BQ3-WQ)5<6@"%/\I%@D?H
M90KX4"8A '^0P(4;>FNTHZH]SG[@EV^-?ES*Q]E0ZH8;N YG(F\-(PY(P*?R
M16E',ZR)JI0N;;VE*A,J,LFIK7)DU6.V,"O!0T&0\Y_2?5/"I-#E1B,V0U3$
M@L5UE5_+*(3J(6AX(WLAO6%#)J,D(N42K=,9X 3B#%?A,)M'\M9Y4BGB-X*<
M'V,NML,S,8>,@X@DS=1SPWL>]^%HQG<Z%JGQ$O!T4+]4=X[:\AN#B DU CN0
MZ=0IGI,06E@IGR?7UBMLF"HNW>M8#IOB7 F5(F"CJ0.7<B^96)0,2Q%!GHR;
MY'0<_ZB@T;<>X) ^-PR2&"99$U4\RGMP0I+KU&>#9/A"RG ?=&]<&',?X$9\
M7[!,%Y/J$ V7-IG8F\=<[]YR[/_B+_C6I!>%O"L"NZ)C1??@I]W<4V:-,6R9
MJ-/,X;^HTJVF%>X>M[VL3F?*5\UA*]SG0UG[L;HF>)O/G=/(6B+G<WH#5L91
M?"PZ=.3"/@*7FR2\A-<-'T)J71-XP#2 -9)@-6-4.:P%<U@-E<.J<EA5#JO*
M854YK)5&*Y7#JG)87R"'M9H.O/QS7I-">4D=D2B*?QQ:_[70D_FQ,.$TLAUE
M#JNO33QWSFOI_A.B:\EVL,,,U\[+U !2,FRVT4BB1Q4O !QH62=UJ?J_=/UV
M(C4G8]<81F38?,08SQ\4X_D<=]6JF@5#R579*%,B/!4W >.]M.X=V3S,385'
M>$3"3X06@J<%=]\E 8M^PB%+!,62@7$1?7MPT<9!=V/]X]KY9/^)2J,=0+-A
MH%W\P L,;7]:(KY]\!.OI?\[ZFS)SSC&,[+4&6,O:VDZ'V22WB.^L@#RLL,Y
MSS<V,@VWDKD_^+I'SP[8J3N9X-.A(QRKY',=8HS3#REY7E2RRQ)WD9-.V?*1
M&Q1?-\AT0J+4/WA5W+ .:>5?(: [G21@Y ."]W,> NLPA@&[A->=&"/&YY&X
M<%NK>4X_8CF$3_AV\03\] Q9%K6*J%*VTK$2-GEM,<(J4O..0YQ'IQ)I&NC1
M%4D6FV4/%VU#$<=<$JT@/+:PGF1BR5M#;T:5_;(;'H8C!"FO=M[R'&8DLQ0Y
M6IQ>GM8&\TU=6[H3E&P4"I-)7-CB$J\(.P+;<W)N J,)'1GKL>4*&.XAOA7O
M&\]H\^X:#L P<2#@35C$DV!H8M&8)64;:DXB9C"AX./1TA[U%;VS?F@G@OS>
M:;_QIE_'08>)Z%.I%G\4E8JS.AS9@C6 JY+H2PUO6_V4UIQX3#9/XR1G2I++
MJL6)'9;KZ%=L@ZU!M]@&FZLV>!W*="66^CFG00H!]SOZX"=:WNCJQD^;=57,
M:X?8:B86[OVT@]Z'NO8QF3%JRV#$JO-AE&F)ISJN<TK):[D%%;Q'E01JE+*V
MJI,QM0O):7>^U.$XU?R\9./S1C+2B3N9VS]P&1 =&(;#A._@D8'F)1/KX 9P
M]3_A(/[8'B7"A-B+Q:,P'S;ISU@XN$?!^/W5ZE<[4K]B#E0Q;>M86?X5)C7Q
M2S\+>'\H<ES#G5^YCJP6Y;E17-@6G:A1<4EPQ5TJ>' K<W G?7"I9>RPT,O#
MQ!2?D/-\9GFA?WUUH=T"'9*.<2N;9G[Z]*6A_6'Q,1S7#E[-_9/V3W>&[GD@
MOT^?SCD-"O+P, %9Y!N)=&0@1U!I.,7,40R(9!C2>/!9(+)6M_V^J?=;J#3&
M";$BK9"JBWDE:/05D) [G&%=MLB7M)XDD6;N+E&;3/I9=O6XCNR#&^6_G-W#
M]?*LPZM5H""U#*T^GF0,>IF%#IA$EO,B#'A>$7Q&VY<) I@Z 3!(I/:*5] 3
MR$YLV!2E/Z-125BQ"B5T;K?>//^DD!P$=51IPP!?D[H3699$9=Z!._HN+DZT
MQ@3U%9-- BW>=1X+%%WAX>H9"_PZE,#=LAE/ !=./L*43_9_0GN,9@15;%D+
M7!4.XR.55*J'%J<X.UD3=<,>;'A)PH\@15TGD;41X<PJ3DL+K/JR2N)1X^T9
M'#[61:A0T?&(4:XB"R)-=R0,K_$SV:BO00Z?H&_SW9(XSF,31R>*3V9T]JQ$
MSF61Z!]\>])[EPY3G'1U\]V*3H5;6!YO>^W,+).33MZ+MK%$/M@S:B$;*>'B
M-A9\ ,@<Q0))XQ+7T]2;[7=BPZV!WFR]V^&=M/7>0*YMZN;@W2ZN065S;9O-
M9:IL+I7-I;*Y5#:7RN:J-%JI;"Z5S:6RN3)5_?@'&Y^> 5M"KY?4B<^Y_GN+
M^J^O78<!%IH@7SL.$ZBPZD_C)JS92$P'C.*CEO8HK\X25Q>7%?G\UMSXUN#3
M-=)K,MDS.A^TJ8W1,?2T+6=T!GIG17;;%O:1T>GHZ7"@T<7(W^XF=V'Q9P;J
M8X%).3#?S'V=R%3 =,/2R09BE"66:#'>OB'&2"IR'4U7E#?:X[^_>5Z,#GIO
MR@Y46<$,*L,%KQ\P @"KPTW)1E8W/#MP]1#L='N=?K5/&)^*#Q8O.MM[->1>
MUMH$)5!O<NNNK+G9:NMF?_?F9D_OF)V-5EWWG0E[W6S58]EK1Q\8O9VO:NB#
MGL*!NNQU?SC0/:1_:*>BH/^<[M7D$3\,ET;,/NNU&!0Y$S?$7N94!;TQ=Z11
M?>:*U,6R(K7RP,M ;.)QWQ1Z]*#P?E[9+@+P$N>O*VY<H8ZM4&/7J%$'GC@H
MGQ=!-W/R ?55CW<VX\:B_Z[ 10FUETR<!26ZV&,-]_^^7B2#=N=.CEN 8H[H
MSIJ[X"7=FK+9<TH_442BB$0121DB>4:.#JW1=\P_=\:G8I.C$6.3R?N-4.*
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M)[-=7T8,X10R&X3-$P@::P2;%/+(!7O0V\^ MZ[>*;#'G.'0"/33EIYC).(
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M%@0S[G;#$"A^ IC*INX,0U/P_^T'[GRS^,H9Y"&/ IA[\(D?#OT 7^?CINW
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M05-;09.O97^W ]HD4G!*N2:M=@1:H@7D[(>+Q0QS8'"G6:4\E="SK(H#>7O
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M=2E574I5EU+5I?3P,OUU3_Z,RTJ/S2+**YC-6$1MO;5WA_*EH_TK!(L_FDI
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MJ.#%>T0"Y8/%Z4MF86K@ORPGM+PEBWV\%K*W;!&D3)XUH#7T=AE@FHELCUT
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MO,<>YMC0,IVL+9N[T9W'WO3LTI3 &V<TI3*;!;[@!V#C8]^C45QV?2S$=.F
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M0(Z'2TTM[/@*]M;("GWJ+&[[8I8NOF;(-#%#!9N'!QA>GUJS"1_*Q/A("?Z
MF/$4XC0,6E V!F?C9V7T1K=?/$UL3X9PL>**3-/+]0D$N;+L95,*.D9+;S:Y
M#9:?4I"RO%)?FAT)H%6) QM^:39[4@W;\<I&<U];[AK%MYQO"1OM/9K"%>[:
MN9-NLCO))#F,)?QY+UEDQ6[U_&4RV/)?_OL!#TZJT2$/K^WGZHN=?N6(ZC7<
MJ7,P[K2E^V\3-EOY>O</5L!^V5> X1 '^LB&'@Y%TDSRZN\AA>$8I=?AX/6S
M_[.F_0:V1Z#]2]?^P%[;KL.67;!*S=D/HM2J3VU^HJS"GKJPF8-VFXAS&?_
MCOQ?/.93/0!%@U:D0I4(!>W=>[43QX'R%"A/@6*"U6""RE.@/ 7*4Z \!573
MLI6G0$FO"L*+/ 6_LP?;T;[IVL6<>7Y^@9W2<I2C(%_\*^2I!Y,YJ)] ]'O+
M<Q+ ;SVPAPOY!8XB<ZXR27+=C-J8_-^A.WZ"_TR#^>S7_P=02P,$%     @
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M.ITO2+BS_6_G,>Q>7<ISS#6XT,+&:#U"")DLAJ;9]\8YL*8D*8V)-O79MM@
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M5#&L/[:/N!3:WVE^9^&(/(F]?#R>C.>+^I@OE[DDES./E@E YRB\RXSFW>0
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M<!,ANQ1%4EJYW*? >TO@@]K*>@*&-A?N+ABYT;)B+$:O LU8XK2L1,T)ZL3
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M"%Z$!,:CB<GZ$K%/8'D'F"'%$8UIL.W4]\[/7Q;72)>R-PQ8O1Y.91?!.9M
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M^&Y0*U%G5WN?N\P)-Y!1IWJVBP2U$TP+[A)H;\C'-_74)F$!*PKS*40N6)]
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M6-^O7TLFS?A_'=>=6TIG%[A_"M]&F#DAP@S%EE(O;9$064[@G$F*]("61N^
M-0^C')*R[<6?AG+JF0K[^W2:OXZ/CL+RTO5KISL(Z\=TB/GT"*?E[:1,9\?G
M)?>?PRR?Q1+7_F#SY%D/% W2;=TGIU&"[LUX0B1_-_Z"=^$<B5(,,I$A!4O^
M08H4Y0GZCEGG*+1$]$)UT0D/X]I6+S[PZ7^?U<5L<Q!"DTL4G%0T;D_?%87@
MT1CNF4J!]W$5'D,V)/O9D#LW%6)3 34SIP^@VDOI]/ATN9._=UQ3=_]S7AB2
M%3FV$L':7-W>',XR,U)ZG5VV.:H^KMCZ6 >5]'H:;K608D^36P]$DT6YHXGI
M#XMR]?#TYF9UTR<U,)U-!MG(/-;/7]9-GXP7X6A9J7H0C\:?SYWZP$S*Q3H0
M,I,6(J^,W+UHP;C"%4?/F>_3DOQA7-OJN:NS^]#HE<F\2%Y;)&=:%9+1JN")
M7%)-"U+')%*GQJ4KX1N2J6S(HYOJK(.PFAG,U;!='I[)5B@;!90Z%2I* S$E
M!8R5(K-S"7.?_:&U8 XI GUR6FTBN@$:R!'?G8D<\2<TDC<'NALS:406*5D&
MGM7<K\$$01$[5#!%.R*BN=DGZEF8R;/)Q^L]YT:9619HM)!+[31G8NU>7$^V
MEAQL\CHZWRUTO WG&1G!=5ARAT^_I2BZV+R1S&1=N: Q945C\EI#D&1_10E,
MQY*D<WW.!J][+\- +-8V'-AXXGL:I+H[.UXL=UQ)79_M#'R^W@=P?[X8'R]#
MSMKMER;E@K^;1V\MGMK 2#4??*NK&J;S^26:]/W\T3>O%@](3,R%W!GG*@-U
M >]\@<RUYI@L5[I/8>)*\+974W<]Y-HCKK1/C<4QE#F"1Z%!26XA1!- >%X8
M3PZ#[V/!UX(Y)&/7GF.W]5TO"3:TA8]"O(@@A.':V=KVE-7."4[03)14.R>@
MBCFC$*;/);FK8QR2'1T$O3:174]CN[P'[G!Z1)*8US8'U8J4<1I?V6][=5@K
MH.;CR954[[)C4KU=;H:'.)F/O^"/_=CXO?YB.J%A;FZ.=X.K@<%^@@EL9-(?
M@G"Q<WYG2?7[L*2P1<L41P4L,0M*< ]!! <&N<Y!H4ZV3_'#EL"WU="K/'ZD
M,-BZBL&YD&H>R=1M-P2EBPAD3D0H?4+:5= -R>CODH4W]75S23;S C:>E?OJ
MSYUW1@4.'%FN%^K1<'R6@)IF3PJG,N^S[]!X((/:<!TZ=7L19*<L'SFT+EH"
M96VHIR9# 6=#@&0QB:*B=VDHFK3M#/R*93K#'RU7TXVB-J^P&*,$,%5JGY_D
M(!;.($:9O66DFV2?XQI;@'YNEF<M]JVS1EL*M]EZO FG5E:NX+.>QS3O<3:>
MYLL1Q&Q-UA37U(L)05GZXK3S(+06/#!2=+)/_J/E*)Z=O=F*L$\F_Q4CW//7
MZY<8YOBW/_TO4$L#!!0    ( ".-0E2@ .RU=9L  /C)!@ 4    ;6-K+3(P
M,C$Q,C,Q7V1E9BYX;6SLO5F74TF2+OK>OR)O]NOU2I^'6EU]%@ED%:=)X #5
M=?J^:)F[FX-.14BT!A+.K[_F&H((A4*A8;L4(:@!@B#0_MP^V^YFYC;\V__X
M<GGQTV<<C?O#P5]^%G_B/_^$@S3,_<&'O_S\]_>_,?_S__CW?_F7?_M_&/O?
MO[Y]^=.S89I>XF#RT],1P@3S3W_T)Q]_^D?&\3]_*J/AY4__&([^V?\,C/W[
M[!\]'7[Z.NI_^#CY27(I5_]V].?(DY;6)2:4%TP7P9GWOC"M= XI19-"^'\_
M_-DFXP6XR&QT]&/@/?/:6 ;:2X7>!Y?U[$,O^H-__KG^$F&,/]'B!N/9'__R
M\\?)Y-.??_GECS_^^-.7.+KXTW#TX1?)N?IE^=,_+W[\RZV?_T/-?EJ$$'Z9
M_>W5CX[[ZWZ0/E;\\K]_?_DN?<1+8/W!> *#].T!]/@\N?J'U]&87^9_23\Z
M[O]Y//OW+X<))C-Z[EW"3W?^1/T36_X8J]]B0C(E_O1EG'_^]W_YZ:>YY&"4
M1L,+?(OEI\67?W_[XC;2_F#R2^Y?_K+XF5_@XH(0SSYA\O43_N7G<?_RTP4N
MO_=QA.5.],LE5U"FPOG7^FF_'(SI(P$9I6E$1M_%057P#C&N^_3#,5]]%LM8
M8'HQZ1#Q[<_N%._P$OI="OC61W> =O9![!(O(XZZA'KC<Z_A7()<17B9_HGC
M\7 @I/I3&E[^,D/W=/AY&U3T;^G)4M"_G;V\_SK_=]>>2O3V!_VZ8[RD/R[^
M<7W$SL_'+Q,<9,P__]3/?_FY;P)WD +/==,6HGBII? 9/414,9G>_",JDB66
MBV&Z\8D7=2\;7CWF@O[EQ>R[O8S]WO/!I#_Y^F)0AJ-+6"P 7TSP<MR3JF .
M=$XX2_N6CAE9L.!9M)!CR )BXK?I&R_588SI3Q^&GW^AI_Q2I5>_F(EQ3N#&
M9\]EN]^*EL?E>_K9GG/:%F43XR%PIDUVS <L3"0=K'68>30'K>'ZTVZB_J83
M3T9+_(O78L_WIA[VG3,W&78@NCDO!/[GGX:CC*.__,R[H/!_36$TP='%U[?X
M:3B:]$S)B&@<L\K0NBP$%CTO+"H3LP%O<K:=L+GRX+,A]A"!WN98=,'Q&QSU
MA_GY(#\CV[8GK4E&HV41,Y!MFI  6<MT0A>L=Z6HT G#-QY[-OSN+\S;[,I.
M-N$1D$51%[G0..5CI'4$YCF0RV%\8KYHP12"(V=#2RYD-QORRI//AN.#1'J;
M9G4(S?-E_M:_P%?3*HP>MTJ1;DEF0!NF756Y&!0#DXN" %F;P\[;U2<^>EH/
M$N%M.O7A=+[%#_WQA+1L\@HNR0XHR2MTAJ$5FFEA%8NR%.:,X3PFR,6I#BB]
M^=0SH?4 4=ZFUAQ.[8M!&HYHTY@M\MV$#HFGP^E@,OKZ=)BQ9Z,-4%"PK 0R
MC9HVDB "DQI--BD996,G!O\&$&="?'>"OJT']G ]> ]?7F0Z2_JE/P]T+?8>
M#$5DL(*)J +3*FCF;;%,<9*&%2ER=!UHP!V//Q/NNQ#N;=;=X:P_R7F$X_'B
MM[I<T2--\\DI7U&0C:B58:!D8$8*4;(*7(<NG/PUCSX3M@\5ZFVF?6=,/Z4O
M7X_>#_\8]%"13\>+9AEBJ!Y 9AX<&8ED4L140A ^=\?SMP>?%\M["O0VQZ$S
MCF>'R^O1F]'P<W^0L%>2%KSXR H/F;P!)1E8L"Q%F1!0!*>A.Z)7GGY>;!\B
MVC71DH-"8C> O1F.)W#Q__4_S:T):VQ2JC#(@C,=HF!!&\&LQPK4H=6'Q4SN
M?O9Y\;V_6->P?5!PK.XS3T8(,R B:<^+XRPXJ#L-V0TQ)<M\!.YIEW$Z^X/X
MO?ZT1\_HWJ);P^%!(;!ZAWSQYN-PL'3L@^#9IA#)ZB,(VEIDD$ Q%8/522KM
M[6$\KC[QT7-YD C7\'E0K.L=INF(5BAD?-^?7)!R@9<E",62,8EIIVB#$-&0
M/Y>E!U(PG]=<;^[ Y^H3'SV?!XEP#9\'!;O>CZ"FW+S[>AF'%SVA10F%DS>6
M-)GLCM8%@DL6)"^J")&].LP/NO&X1\_D_L);0^-!@:VE3CW_DC["X /. FTZ
M6\)$7K8*I%(:)1GG$CGS.=%&(;F@XZ"35_/Z4Q\]J0>+<@VW'02KGDY'(QQ,
MYK<=5>G(+)^.>PFD\-Q*EE#2C@%2TJE !P*BCX7+XDT\[#C=]/1'SW5GHEW#
M>0>AJA>#"8X@3?J?\1E,8(&SQZWF,BC-1(R*:4_  IGCC$X*%84"I4WI)$*]
M[NEGPGD'HEW#>0=!JWH'-GI*+O>'X>AKCQOMC5&)&2/(U"NNGBF:,Y[09(_*
M.=N%5WOCH6?"\/Z"7$-L!Y&J=Y=P<?'K=$S+&X][.0IRRE*U^7(A8R$$YITW
M+%N-$+Q+D'4'Q-YXZ)D0N[\@UZ1W=!".>GZ)HP]T;/QU-/QC\O'I\/(3#+[V
M4 JMHJ2MHR1'N- S0E*8E8Z6R&-TJHMKQ+4//Q.B#Q?L&L(/BD@M%/ C7EQ<
MP8G%"G2<.4,+TYPGYF/4S-%Q400X4+R+*X7KSSP3>O<6XQI6#XI1+:S X>5E
MO:4>IG^^^P@C'+^>3FKY1/7P>J:0H@5M6(1 2J?0,J^<822 %.LM!\@NSN%-
M&,Z$]<[$O$8+.LCB>DI6X @N7@PR?OD/)+VDE0&WD7DHY 08*5C@,=.R)<_D
M_4E]8++MVL>>"]<'"',-O0<%NI:)@[_UQPDN_@MA]!M]9TPJ1^:"IT,$2R'#
MT%M/7I[)# U$#U$I(0Z+7][QX$=/<1<"74/R06&PFYCF><!S5"H:+B/GM, @
MZB^%Q33+)T3I0P[1N"YIOO;H,R-Z7Z&NH?J@J-@3@I1GL"[@0\\Y;J3-F9DH
MZY5(#K0V85@*/J(,!A /N^^_\;A'3^G^PEM#XT&!KD7@Y=LFLDS;M]K'),E-
M5[(6WF:GZL4S9Q9U*N@2]_8P1N]Z\J,GMQ.1KN'Y\.!6'\?O(5Y@SSLNI"$;
M("L$ID,2+)JL:W1=09$RE-R!<[Q\7(>,7JLW/HX-M9?(UA4I_30O'OUSNAB.
M,?_EY\EHBM^^.1Q,\,OD^0763>$O/X_QP^6M6._VA$_'[ / I]XL=:A^T-,+
M&(]?EYG5_^1+?]SCY*AK,A1($I%4D0-G49#W5W1$AZYPQ$W^5(%QG/&S>-)<
M"_!B,EY^9Z8.C(M%I?F_W@NI0R794 "^1FGV8WC80M(=%K<M@5W'\VRV'6Z%
MJ+=2AMZI#MS&U.6>?U<E_3?J.R9MV$3BQ]$%#"G$0-Z!XS(QK8UGP9G T(?D
M+#HI^:94^X>O S>Z$YQ0!781= OJOT5]?I]90SVMHRG*<T:.0KU1UYR%[ I3
M)@LC9,H%-\5-#V!^%<KQ#+ZN^%FE^R#A=EBU?IG^V7LB#.>OAA,</YLB46 6
MD)QP*JM2:I&U8UI:R8!K3> PIPP%4:_41-YJ.+'AXQ\MAUV)K,-W=@[)2G,-
MDEU"*IQ#UI'9K!3M2B'1$D5D0A3K$'FU<[=B<>W'/W(6#Q=9A_7G,TA*W( 4
M%I",0Z%J22T SHIK!?-&!R85X8G%<1/"-BRN__C'S6('(KNSO/S??ED1"3F)
M_]RW:\_K5\^>OWKW_!E]\>[URQ?/GKQ__NS=>_KU]^>OWK][_=N[]Z^?_L??
M7K]\]OSMN^?_Z^\OWO_7L^>_O7CZXOU-F-NU^MG_81WT!^IHI2M-A02$6DMN
M7/1>:S#@R2N/SDLO0?@4>P<\MR.W^5L,00,8Z5 SFS@R;3 R[PPP%Y/2 4H0
M8M,U5 ?^\A660TW!%X,T0ACC,YS__F)NN7P<7M"K,G[^W]-:,3Z\N/AM./H#
M1KFG8LA2<T_.L(MT"M*;[&L)0_" 62BOO=B4[;;_TG<$>OQM[T ]634C6Q+3
MH9%YM?I;M\=T *?B43%5:FEQ\I9%ESPKO,C@=<J6;^JJ<L!+<KJ[^J.0MQIL
M.DCR#;S+]W7)T]'7:UD%/824)=8DSA MTP2,A9I5PDM4*1LA4&Q*L-M?&=:
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MYZBXM.;4"KII 3^4M27CK;-6[EO&D+Z<?'U#7D3U'ZIY\ZGZ%5?O8(Y9<5H
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MK!?)<F]RT42M$W.9?IF-/P?Z#D.2@$J"=J:X%?MW/N$[(+X;Z7:<L+8AP+D
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M#4=_P"CW>$G::NE8UC8S';*CXSADEH*@+3I)J6R;B,8]P![H=?LNNK+QNOU
M*EJ7_RS@]5*D0SK57BXE$B;0@OG@. L"A##6BB2.T+ES@>;$.G$H95NHPT[R
M;MT+;9D1$K@71M+2A*J%!PZ @<9,'IHT$*+F0AVA]_C#2,-IJ0/[R+MU*M9B
MO?.^Y_D?_<G'X73R%,8?9<]8[[30BG$5:A,X6QA$&YDMCEO%M=*-\CJW!'C&
MFM(1*PW2M][ UUG(CY9\ W$/K0>C>;TB]HGI+&1=.S C,065DG>-BKSN0G1>
MZM&)W!L4AZY;\ZS;W\6R\.?UY"..GN3_,QU/Z@IZ&I6T)5LF(?OY19&W6&?0
M<)]R(O<C'<_BV CUO#2H+5.W5<LTL5<ECT44< S)%V5:U@Q'A7246AF2\Z9(
MOU6CH0;V:MM<6,V#J,-^6(FE=ANR=>Z(JL/(% ?IC76AS<(?:R[L(9Y<*V).
MG0M[551R;2;GR^&U07?)<(E&V%HD2J>)*YH%6ZT+(M,$3*;P-EW4[T+T&%(?
M=M* U?*>+IAHX"BNP[4,/V^!K&D*Q-W83I,/T0V'6RC& 00<5T6P%$'_!^9L
MO>[U3C ZG0FK #))4W".M['QCJT:]V1,'%LS=I%[BRS;:D ^G8Y&=$2][$/L
M7Y"(K^:YD\VJ>,R:R<#I0+:"C%>13<T#5$(C%AO:>(@;81W?R.^*O]6\V\Z$
MWW$"QHTYI9LG>U_#O5C) KZM0P<<6?R*\)+9CX&!TH*)@$X*=,'(E6EV:^]T
M.X#RZ/7E%)2TVFM>#0?I+HV':"7)H3 (9)KIVF+5RQ28M298D20 ;]/-[#YD
MCUZ#FE#0<;OWN^I:HHTR>LFDJN=NI+TP&EF(PI(5=]8JM-LHQ9E7_.WCT70D
M]>9ZL$PNW@+3=UCQMPM36U7\[2'F8U7\@0[11QU8XC80-E'J@!-!-KF)P247
MK=@J+^0!4K]'Q5_7S.\BW2-6_+EB:5G"L*PAUN2Y.KI9DR,&QDGK0=*YU,8L
M>- 5?SNQM67%WRZB/FK%7S(V\^1,[;Y+IFLNG 63)%.%+%<>.4=HD_#PT"O^
M#M&";L1]](H_'@RYQ;3OS?13)QF93TDQL#JHP(W0NHTN//J*OT/"WMUQTGS$
MP39@ON^*OYWHVECYM8^LFU?\"6.A<!E8$;5K.QE*+(H0ZI5S#@)HJUSM=/]X
MB#^HXJ\[WG<1\5$K_J2WQD,J+"AIF+;TBP^TT86<K.*9<(=MXHX/NN)O)^%O
M7?&WB^1.4O%GHH-4LP*,EL@T=YQ!3:W1WH*G[XN(VQ1S/HJ*OWTI[EZ2)ZGX
MXTIEU @L!4?VB4':J!Q9N5&KD-$)+O4V;_&CJ/C;E^KN)7F\BC^R1 ,'T$RY
M6GHNM6%1Q9D6^J0L*$S;O,H/M^)O7U([DME1*OY>#.A+? ]?#FF?ON9##J^]
MNP_9:BOSP(,+TGHEHA990RXBNIR<M]J)Z'MK/N\P>W7^@=^,M6O7/;7S?L[]
MN0;4"[Z+X7A*N_JO7V_< 8XW7P*.7UZEU:4"*60;&*]%_)HK.M=-S0PMH:1<
MBA2Q33'=$1=YJ/]PXZFOAI/U%ZO#\?BO]'*_'OQCU)_@L^$?Y/\8&TMMZ@ST
M5C*M:X>$["0++G'(+CN -DF>^R(^_L;X4'5]U<$YB@XTB)I62$]G0#_@('U]
MDM)H"A=/833Z2M_Z3[B8XAL<]8>9I#A"&.,SG/_>"UYQ#IHS#%C3Q;UBT87"
MR!$()7HA>:-(VMZ0?VCO7=I['"WHV!E8#WH]SE<X>5WH".[9"#I)+&31&G)>
M+-E!$(TF406?N> IE;"%[;C/LW^HWSJ;M3F+#4HJV\MU'G)7VJI<=*[W:)E>
MKE ;=JA";U@1A7NCE=PJ?>4!&E]'+2!YZ._!0]:KAU+#TEXVLR W"B^+"^08
MEU3OMNH<7W#(LK(^IBRM*VTJ8HZSOE-=-#Y(S3[ZV[>SAC6X[-H)\"NXQ&7F
MZ!:PF]Z+[@G\-#>H#U&7-GFLC17A >DQ(#JPP;,<S&QR<R)76Y'_8I4H,6DA
M4AN;ZD'I[ST7P6>LOKOPW['#^GPZ&GY"&"QOUW%\8Q'+.Q=!AB.9C,QI,6NL
MJUG E!GYTMD+P47*V_0SW.IAQW=)CT+;L*7,.[Z]_OM_W &MOFC3\634_P9^
M6=SEG3+D +-B:MJ>R,@ 96:I=A,2$!!6JQK69RGL_.3S5Y?&;+0^!Y]>P'C<
M+_UKI:=.VI240::\YDS+.D TJ?I+$,(9971H<X%S#[ ?GLC=GDB7G#8(?VV
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MQ:AXR)$E6A@9-!Z$:C/@MN.%G*-RGI+K!I'[53%=E;"2:)_UQ_,%S#K'WK&
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M_GEMM%:BJ3>:&*R/D8=].L5L>N89OHE-Q=Z@C6)GOJ@L+@9OR8,!K$,JI60
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MVAPH\ 1P!NIPWXWXD;1A%VEWG+3W1#K^:CC!\;,I/L,TL\&$(7+DXJ*T!!/
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M[[$^8%)9+)SKNFTI\F4UK9Y'R43("9*5](\[-7]X)LW4#E9Q;T+LN]W6HWW
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M%=MS2$392W/[):+L(?8&9L'] W!5+"5DL$E%%J0@1"%X1O@<*T$31!?0-YJ
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MBDW8.<SZSM]$>X(\:5&2L0_@>W7C76 /9_]U!WX:J_ I<NFQW;PQ$5H;$7O
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M:!!9O??:W!/#ZRG^]W7-\UZ\,VBX3%HXYA(@TTY9%HT&IF1V):.4*K8)XG<
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M+:-,"Q%B2AI<RCHF&T4-[G)9BO6@$;9GE/4*\6A/NLMS[WS&+'W0VM>#N4X
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MBV9"(2,+ HGE4KL<C$T0.N7=/T'5[S\4LG?-[R/= 8="8DH6:L1825X[4OG
MHG*!B20"G5'*2=.FV.)I#X7<2UL=AT+N(^H&C4)OFT>]K8EM]T.1,JF(DDRA
MA%FR6O5#QQM!!*^,@*P#5VW2Q[9".@,6]"/N8<?S+78^95$$,EE94K(ZL\61
MM1J )>F2"<YG;_\>#MHP-:=/_9QD.&@7@'\/!SU2L7N/>3Q$*R<9#IIDIFV0
M2X8YZ=I)(["02Z[SF!T/F=L";7)2G^=PT+:LV4<93VDXJ#,%C38L(%;8QC*0
M"IG!Y'U*W(;0IKGD&0T'W4OU?0T'W4-O3VTX:"'S+<54"\\,U"@?&8MH:P4U
M*L=]*LC_'@XZ*/%::K#U9G<?^S\1QK-%?]]/ES#NLA(HQDFPB86 BD28,@,-
MF9D UB=5%!FGPW)Q[S7\-,QLJ]T&S>A^+- =U4E[;V%^/24/Z7[=;C5.>/&R
ME" 82<TS35^2P$AJ1GCELY2>8QM?LCO&G\6M;*2U!NVIU@K ERAOWL NT)KZ
MEH^ .XU7V4JOCU?E'ZV4!N?G8Q A12&=]JP889GF2K,(H)FO5[,0=$;9IJIZ
M<+[L<">? %WVT47/>1)O\<__.YG^^]W7T614A^Q\O)ZF10.D5=&$DC((@<S7
M1FF:2T*5A&<^BIC1TMF*:X/3-V?'//Z8X4V;WM0Q:2/+T^5#F6"#5802P0JF
M?7(LVA29*Y@$UZ(H_ESSH9HJOXV$F_39'F1RM$F!9Q$"K<W39IE"9L$%S404
M*102(]A6/52'6-_/8B4_0;8TZ,5YZ&CB+K"'N]DY]<CZ79;Y4^123S/K#R%"
MZXC9'O!U4=FGX%G2G#.-@G8(")(EE"Y"%)Z+?/[\W>$IG#%]]]%_WV/S>I_2
MKBQD9RTS6I.9K4"Q2 X;@T!VMT'AD^Q26]LWKA.';UN18?)$--FSP_3'?ZZP
MX.P'.:Y2EIP7,7%DX*5B.AM'J%*M0@Y*) >*_NI LAV/.7_.]"GGGC>F7Z^G
MDZ\(X\<!UB'':.H$KR S+1P%"][73F<J<AVER^OSTS82H=/#SI\._<N\YYK_
MWY!<K/&/;4;^=4D2K9?Y:]M7]-D9;S7#8&K_._+X8XF.6&RM<29)P[NT:MGC
MD>=/D%;R[[&J9,'C/QYGL#?><ZLT4\19\LCKE#7+'=EX(4$";CR&+KO&XX\Y
M?SKT*><6J:$8Y[^/ZW"!A>E3K7M'[#.!UL<Y&38Z9CK:4 ,3"L''DFW0C3RM
M!UA^EA#6D5IH,.7C1T3WWH,NN-K&D[8@.U&"\)&:>Y0(1XJ]1?1F&SX-6;A8
M%ODMGARA0MN8-(9)Y;2%2.:.:7-9.RP==B7^#L2&?:3=]W7L9(XS<I$)&V&J
M$:2[D>287V.<7L/TNY-<^)L3+J0<-"C.,(,@"=C:/\EF!I(#!)&"7!]5M_FZ
M;M\'G\"VZ$5?DZ&$W2 ;MPZ<F9,!7"51"_<7KX"VWI3D)<N.#D6=1&0^>E]'
ME9=B==2V=*I</R"1XR&:G\6D.%H3#29&K6-:O1T=4#5.$-N$ZU2Y8<?J;0<1
MCA!ZDP2PC>@$RL15CDSAHM->4 R22*0XB=H[E0#:^"!#4F%GVM<P3-A'UDT8
M ./9>_A>=[Q55#U*- 4+@^QJ\Q5/B&CCJTV2G1.FUO.W2D%>QW**U)_CM?1
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MDY)R:#:*\4:1V;SWI$73Y@72-.WYFMW<+C%*1=LM=_V_X7C]_H3KW5W=&U3
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M/,Q-!DW&";G;MX))_75M!&X>OBU;E.IB^-RL!?W*#!=)W7N.3#^\X>#T)4!
M)]%GJ@.E\#L9 4>VF"G4^B5,2Z1<OE;G&=VQBCZW!>W&&C0(+_@(ST/BE/=_
MTU-4C&[4.1%Z^4@MDL^WN$*,-LN(6D[P1WBWJOQ<16Q\Q<U^1MF%S?-\F8EZ
M;YX98277$U5*2L$.[2Z$SY7Y1]Q: 3MODA:3<.N8C7I"XEQ_O+[HBC8L3H-#
M4GMM:$BK8&C1+<%CD9WA1,'V_<4MR0!86EUG,G*.;!C&9=[GHW_ /"G7V"H0
M>'+O9 *&<^A.][=_-B42'I=$1^JU8.JZ7/)>79%3NDU:/MNCD&GCT[J\?=WM
M(5^48U=*DT@(;-XV\T!*=E!Y_[:(C]03ESIB82 D!O%/B,)!%O@&?_ /I8N
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MIBWS\:W+:]T/CNC'[4-]A8H7[AIH.U%8BR*C,,Z!R\59\_V=IACP^ WY@/(
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M_^5___;I&WL0CP1FB[(B"Z8%E-E?R_K#3SDC58WY2;W T2OT;W!U&=0?03^
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M%JJ_1E;]+,WD3FVS8*,H>-*:@J>UJCJ&3GVV8-D3F8-W[1\LB_6:#H?9I#,
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M%?UID*H4!HBXK835(6_<>EBG#=^KBF5PBWW=UZ_BJ:T?_T7J-#7QJ)= AQ=
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M@*P^L.P];3,.9K[80.@.3,!'P]PVB&_TUXU,&@N&"V,S@&W02+4N^6\:C&8
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MRVT-S$T[,'44]050-NJ-)F7E]G[S:@MJV]*.##"GKM\0H^#:.72JX]CNXQ
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M &E-LTSJMQDS,\IS/@XC)?RW:NL:I*UZ8*/YNF9IW4;C\A36]B4 >H#FMB"
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M,"EV_+4( T5$FE'(,R$@8DI 2B("XU0@G&BW282!BZ\T5)&Y>5 '=H 'N11
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M_:D*K*1!B$,2:(KE"8<(*]X$\2:)2B-"A4B=T@!ZY,V-:H]S=,"QPL/*V?0
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M3--0! @2A01$8:C'@R(&DSB+92Q%)C/F6+]XK&&9OI!QJVA=R&NK&=8H.^Z
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MQA!U.)6U%CS3<]B]RG5?[,='/4E*8\R VN>=P,<881X@L^)G)FE&<D@BPF&
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M=?,.]=URKM(<-*K#5G?0*C\2P@YKYY&0GJKQIS_$W1;. V#K6CJ[/&ZZQ?,
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M8L[/UW/'F(N*'_>,N?R('XTLYLNFU\1O:O8P9\^/8\$F39<(3(3"3(!49AF
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MZG>?OM_ ?6]8CF+S_4?P]S ]$@"JL']#J^N8_R]CQL>3JA9'DY*C2<J48AC
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M%WG./:OJ.L_M\_WW4XAFMRW+MA//1OC$GA=U;KIS82$D9QF&A00I%CF C-I
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M3_976+M=]+W*V1=^VLTVNK<MOU?SU^I4KHJB7-P*XU_-E1R)PE";U@AHB2F
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M(,Y--#0+8I.H_,MDMEC\S5; 3,3Z),'*G;"#,*??Q7^JQ<+F+L_FS[.Y1^O
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M,XI$X7=6V5F6X9UC[@J?S#;25]V_5PM9-?:J.GIY-@'OOEQ"TU0S@8!QYA2
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M>\F$<D!0S@"%L%"8**QX[MFO?'^&H1'FQW5_[5K*I!(S,7)Z]R0_ +*=_X+
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M<M/S/G5/VY[W?GI@ZLFFT]M7_;!<V9$_+<KEZKZE&GO%^M3H^WIFKC0:2T(
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M.+B]N'T :#TD[S/::&P_0,5#VA_R^, XZ+6H];_6YKOVX='\IZO[DRO%L."
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M3W__2_=_S'^$.43^_I=_ U!+ P04    "  CC4)4[E3HUKG'  #3" D %
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M?PN3"R3_Q2IKM(22L-26H0YJ4CUD&UFD8]D7WD;/;D7>$!!U$ SN&D.=RV0
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MU&_ M)UOT($ !H"D!U:0>!&.&T8[P)*AZDL-(-+6*)9%XZ1 7YI'R7;!3K/
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M/@#<K-7J#?I=3B8SGD&$6$<7\0#D2%NP!D,4SA31J-SF+B5]IQPV0<Q![!X
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M_W;T]0VW;M"P\8:Q$]$,#G"K)2R>7"P_DBOUGYA'Q7$A')W]?M5/7&(!%TT
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MHC/\)7V[&*D0M+"HP*2Z'W0]M*T.8&.2RH?B.3=-,'2?EKYSTKL/$^W'Y@$
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MS9>KXRV$KC'\Q#1$I!4%EFJH4_-LV[B3WZ=M.RC^&-=UW0IJ.';NIH6M?=6
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M51;# QP><5^2**+FC.7:^3AK<,HIT,(8+NB88*Q-H>6.A/;;C:A'%[%K(0[
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MI#!9WXZ,,D-G:KBD3F$!E9T%9YV#(&1T/*)H-9#^)A4]S_AN@YV]V3P B*R
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M.V+@\W68UUD6G_$9+L-XTGD ]-[G-P^$;EY1^X HXTRYDC4DEBRHY"*9]JY
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MV^#EM/8<F<V_7M6W(MF>WGC:\5B7RB)9GYYDX-'IZO*EA$=(-=F-Z'[]@A.
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ML=;S8K:2^T9#L,[6K22B*HQ;A&PM1;<J,@@^2.*8\^(M=[Z<HXU O]U*#L'
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MK%F'OJ0HVMRYWJ:BJ]S>85!SM) [ ,CMZ*-*@Z"_>;J:(,=HZC.8%C5;@X<
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MS-^ON[K=9R4PY[THZ[0X6Z]F19U(9D"7S%G.7-E&O?6>(*K/?NRGP&HH#70
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M[33704QP([7*SG5/*)2,\^056%[KF#3)*Z@4H 3C([?&,-&F)\!N>L8%6D,
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MGL/M9+%KI^%5(9/[B,_@2_ ,LR%V'87NH7@(=?*+%E8FQ8)(O$WOY2&YZ"7
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M!"9T+!:]$:+-X+XGR>HE?65@0 VGBBX>=G>YG9M#7^=<'!;0C",9V1K3A%3
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M )(2[?LH$[CH*6ICC!<TL<C4J$_K_X!L[$.PURX;^Q 5=W#6[Y,CHA+3DHD
M,=7N[YI.*\_00C3.H$@<A6_3QF6HQ*^NKXJ.@,T1B5^'Z+ G6#[QFN^R)L%@
M!%$4"4J0#X19"9 D+V/0LY3:--_X2R1^'02((Q*_#M%.IX![D%BDK4U<201O
ME*83QM3N#]* L39$Q80KKO'Q_:(3OPZ"Q#&)7X?HIR?,/5T78;.U7#&$6"]:
M56&B)A,52(*<>9YD\;PQZDZOA.KZIGS0$W@H3?:$S[TJ*4(4=:9] LU-V# 7
MI*VMR-%D$;@RXGS'\<NNA#H()R=50AVBM)X0>:OB1FQG F7-A4T2LJFL**[
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M,4..(A*<O2;4@W-*&"]%)5K+$Z0>F3'N?*"M:<T&D+MYZ7!W<NQO_"S"^VN
MY8M9NGNI=E>9O/CI]AL%W5$@WZ^7#16ILUR4IT7"9MS8.!K&,5S>P;.@+890
M(.HT53K/_,9](G[N<+9!S#2PD@Z:X!O_<4=P*7@$[@4C3*GBJ= <+LA,J+$@
M-(]4IC.$*_T%'C=<:1%[CVT?E8 P\GW)[__<73'"XIOI;C=!:\ %QA6QH$IG
MRX"[K[6>^!ASTMF"#WL,-?=>FCPQ3$.!<RTS=W5T/C)\+OS,IZF?_0/\S?)Z
MVV,!P[CIQ\5O^*VK]=+&Y5S:+KQ('Z>S::G_+=7K[V'^>1IQ36]5L6M-%8+
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MUR"H2V>VO#UL%+:?'0HG&RE[^>+$][IGNL!9(3F03F04";BTR1P3JKB%#<!
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M#!)!Z64"6 T2:49D3F9C4"G1*5U'TH2),CGZ$<EJE7C\9%J%(L)MPW8 ET@
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M^WB7)WPTM?+K/V-T'U2>_!=02P,$%     @ (XU"5)@1%AY !@  /"4  !H
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MCN7>ZQX^('C->XW\JK$[&-[ZK=3:)A!%,##<$C'TJE*OK!6(MI=?@+N:5@V
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M>T7F#:?]OP%02P$"% ,4    "  CC4)47=]$&?9S P!K^BD $
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M,#(Q,3(S,5]G,2YJ<&=02P$"% ,4    "  CC4)4-W\AT54J 0# , P %
M            @ '2=P0 ;6-K+3(P,C$Q,C,Q7VQA8BYX;6Q02P$"% ,4
M"  CC4)4[E3HUKG'  #3" D %               @ %9H@4 ;6-K+3(P,C$Q
M,C,Q7W!R92YX;6Q02P$"% ,4    "  CC4)4+^,C5U,(  "7*0  &P
M        @ %$:@8 ;6-K7V5X:&EB:70S,3%X,3(S,3(P,C$N:'1M4$L! A0#
M%     @ (XU"5.1J2XYH"   JRD  !L              ( !T'(& &UC:U]E
M>&AI8FET,S$R>#$R,S$R,#(Q+FAT;5!+ 0(4 Q0    ( ".-0E28$18>0 8
M #PE   :              "  7%[!@!M8VM?97AH:6)I=#,R>#$R,S$R,#(Q
:+FAT;5!+!08     "@ * )\"  #I@08    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
